Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.9399756440990913,1.9604123062146372,0.0,0.46284579240527335,0.36,1/10,0.17%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.9399756440990913,1.9604123062146372,0.0,0.46284579240527335,0.36,1/10,0.17%,ACE2
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.9049279432464685,1.8992568857067291,0.0,0.7690360858426081,0.59,2/24,0.17%,CPA1;ACE2
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.8057170182200382,1.8929593713022324,0.0,0.608820234625398,0.62,2/35,0.56%,CPA1;CYP4Z1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.764372145205862,1.8865372208959104,0.0,0.5240838510927404,0.66,8/28,11.50%,NRG1;EGFR;BTC;NRG2;ERBB4;EREG;PTPN12;PIK3R1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.7010119425416015,1.86672613699612,0.0,0.5459206782216045,0.73,14/51,14.17%,NRK;KIT;PHACTR1;NRP1;EFS;THSD7A;MCU;AUTS2;CASS4;RALA;FGF10;SIPA1L1;CDC42BPB;FER
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.8624544428822248,1.8420516201788644,0.0,0.6490013528671745,0.84,3/14,2.42%,CDH13;F2RL1;KDR
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.7899970800110755,1.8347693982803905,0.0,0.6052598823761267,0.88,14/33,11.44%,UBASH3B;PTPRT;DUSP5;DUSP2;PTPRB;DUSP4;PTPN9;PTPRO;DUSP8;PTPN6;PTPN12;DUSP10;PTPN13;PTPRS
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.9461398667053031,1.833087461524221,0.030303030303030304,0.5490854357765124,0.88,1/12,0.00%,CPA1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.9104101760149558,1.8266343602519042,0.0,0.4777345381749534,0.89,4/15,2.53%,ITGB5;FHDC1;PHACTR1;PDLIM1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.9104101760149558,1.8266343602519042,0.0,0.4777345381749534,0.89,4/15,2.53%,ITGB5;FHDC1;PHACTR1;PDLIM1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.7517055702196568,1.8088326716242435,0.0,0.5198114283936147,0.91,7/39,10.56%,NRG1;EPHA3;MCTP1;RAB7A;PXK;PRKD1;FER1L5
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.8407537679983362,1.786784838744427,0.0,0.6025211498766873,0.92,1/14,0.66%,PID1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.7477964851886746,1.7843874575199967,0.0,0.5747425773823724,0.93,3/24,5.71%,PLEKHH2;FGF13;NAV3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.8173194803621785,1.7416242073577832,0.0,0.8316982854297835,0.98,3/12,6.59%,ZC3H12C;ZC3H12B;NYNRIN
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.7158066179808068,1.7347982247980438,0.03571428571428571,0.8438034830773061,0.98,9/38,6.43%,ACE2;STAC;KCNJ16;KCNJ6;AMIGO1;KCNJ3;KCNN3;KCNN2;KCNJ2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.6044461927732332,1.7333166931643345,0.0,0.8058962032468289,0.98,35/109,17.05%,EPHA3;ROR2;TOX;IL1RAPL1;FBXW8;AMIGO1;PLPPR5;MDK;LRRC7;GRIP1;FUT9;APOE;FZD1;LTK;STYXL1;PRKD1;ZNF804A;RETREG3;ARSB;TIAM2;ROBO2;DVL2;CHODL;NTRK3;EP300;NGF;TIAM1;MAGI2;PLXNA2;MAP3K13;MAP6;WNT5A;PROM2;RAP1A;RAPGEF1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.7423717881568374,1.728564465567909,0.0,0.7991012826142326,0.98,3/22,6.59%,ZC3H12C;ZC3H12B;NYNRIN
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.594251166960559,1.7198087288812771,0.0,0.8155080520436234,0.98,14/162,4.02%,CPA1;KIT;PID1;COL15A1;HS3ST3A1;SGCD;STK32B;KDR;COBL;EXT1;SPRED1;UNC13B;SLC6A4;LRRC66
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.8930207558181616,1.7191259749737697,0.0,0.7818533539399849,0.98,1/7,1.39%,PTPRT
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6391569529958321,1.7183236312622183,0.0,0.7520820275127444,0.99,27/165,8.33%,PLEKHH2;LRIG3;ITGB5;CDH13;LAMB2;PROS1;NFIB;SRGAP1;EGFR;WWTR1;GOLIM4;IQGAP2;KITLG;RASSF8;KANK1;UNC13B;THSD7A;TRIB2;ADGRL2;FAT4;DDAH1;PTPRO;MYO1D;MID1;HTRA1;CAP2;GNG12
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.6639085953335714,1.710849588041745,0.0,0.778098800658935,1.0,19/80,10.69%,EPHA3;ROR2;ALK;TOX;COBL;BMP7;VLDLR;PLPPR5;MDK;LRRC7;FUT9;APOE;FZD1;LTK;STYXL1;PRKD1;ZNF804A;RETREG3;ARSB
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.879962358940277,1.7101959164330314,0.0,0.7492219515857937,1.0,2/10,2.75%,DGKB;GAL3ST1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.9137036895973286,1.7093260998228437,0.0,0.7227515066020808,1.0,4/14,3.87%,LAMB2;FLRT2;NTNG1;LAMB3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.9380260666752379,1.704002115341562,0.0,0.7337173915298364,1.0,3/8,3.87%,LAMB2;NTNG1;LAMB3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.7291538255243111,1.6963222442854358,0.0,0.7487694653467558,1.0,8/40,6.71%,KIT;CCL28;LEF1;ACKR2;NRP1;SEMA5A;PDGFRA;PRKCD
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.7847733638055339,-1.6916185052291415,0.0,1.0,0.75,4/40,3.48%,SERF1A;CALB1;HSPG2;B2M
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.8521617378674958,1.684657832102316,0.0,0.7964639846518095,1.0,2/10,1.91%,SGK1;SGK2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7677196382787144,1.6839698505828022,0.0,0.7741223033415672,1.0,7/27,6.43%,ACE2;KCNJ16;BCL2;KCNJ6;KCNJ3;PRKCB;KCNJ2
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6408852038703328,1.681512820731339,0.0,0.7680539197048781,1.0,41/110,13.49%,ETV1;UNC5C;RIMBP2;PTPRT;NFIB;SEMA6D;FGF14;ADGRA1;MAPK4;PLCXD3;THSD7A;ESRRG;TOX3;RGS7BP;SERTM1;GRIA2;GUCY1A2;PDZRN4;CNTN4;PTGFR;MEIS1;ADGRL2;NRXN1;PCDH19;PXK;TMEM196;RCAN2;CNTN1;NOVA1;CSRNP3;PAK5;ERBB4;SLC6A1;NOL4;ST8SIA3;PPFIA2;KALRN;PCDH17;RNF180;FGF12;RAPGEF4
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6973176931368125,1.6803877380009484,0.03225806451612903,0.7495728268799248,1.0,14/48,13.13%,NRG1;EGFR;TGFBR1;ZSWIM5;BTC;NRG2;PKHD1;PDPN;ERBB4;EREG;IGBP1;PRAG1;ACTN4;ZSWIM6
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.9230549604112321,1.6787363330626557,0.0,0.736878065526609,1.0,2/8,2.98%,KIT;COBL
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.8701832932297494,1.677776880085674,0.0,0.721416374508604,1.0,1/15,0.11%,NRG1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.9571656907502342,1.6739965044101137,0.0,0.7289012059417312,1.0,2/7,0.87%,RUNX1;LEF1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.8466493599244739,1.6698531886232244,0.0,0.7409721328189398,1.0,2/9,4.18%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.629837399229863,1.6696364058120319,0.0,0.7210221926524346,1.0,33/128,11.44%,GPC4;CDH13;IGSF11;CDH6;PTPRT;CDH20;NTNG1;CDH26;IL1RAPL1;CNTN6;DSCAM;SDK1;NECTIN3;TGFB2;AMIGO1;FGFRL1;UNC5D;DSCAML1;CNTN4;CDHR3;ACVR1;FAT4;LRRC4C;NLGN1;BSG;GRID2;LRFN4;ROBO2;ADGRL1;CLDN12;DCHS1;TENM4;PTPRS
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.8719418860945254,1.6688363385282854,0.045454545454545456,0.7041585559669971,1.0,2/8,5.79%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.8958621807795759,1.6667897351591074,0.0,0.701678070315853,1.0,2/11,0.48%,ITGB5;KIT
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.6359211751221037,1.6642604573121358,0.0,0.6974542669362055,1.0,10/48,5.56%,CDH13;IGSF11;PTPRT;CNTN6;DSCAM;SDK1;NECTIN3;AMIGO1;DSCAML1;CNTN4
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.8013401968333564,-1.6642041228875069,0.0,1.0,0.9,2/18,2.68%,TERF2IP;SHCBP1L
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.873886687981979,1.6607556712289675,0.0,0.7011155198565088,1.0,2/9,3.94%,SLC22A2;SLC6A4
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.8987448934680804,1.6578510801951407,0.0,0.6877558491275356,1.0,1/7,1.23%,F2RL1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.8987448934680804,1.6578510801951407,0.0,0.6877558491275356,1.0,1/7,1.23%,F2RL1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.8390043680639196,1.6574799565876641,0.0,0.6734151968621779,1.0,3/17,3.77%,RUNX1;IFIH1;CBFB
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7701529968234145,-1.656136056895394,0.0,0.882419132744593,0.92,12/42,11.35%,CD44;HCK;TRIM22;TRIM5;B2M;STAT1;IRF1;CIITA;IFNGR2;TRIM25;HLA-DPB1;HLA-A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8924596355485703,1.653690600661476,0.027777777777777776,0.6855748052085266,1.0,2/9,1.80%,ACE2;OXTR
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.9264209552611843,1.6524765299960043,0.0,0.6761432589752558,1.0,2/9,4.90%,MYRFL;KLK6
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6805157636000141,1.6511289379588747,0.03333333333333333,0.6706121258849739,1.0,8/35,14.19%,EPHA3;CDK2AP2;TRIM36;EFNA5;IGBP1;BICD1;MAP10;KLHL42
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8311395052666259,-1.6451508067308327,0.0,0.8407350894100011,0.94,1/19,0.02%,CD44
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7179309307759497,-1.6389478382403742,0.0,0.7664733629769895,0.96,15/63,11.35%,CD44;HCK;TRIM22;TRIM5;B2M;STAT1;GBP6;IRF1;CIITA;IFNGR2;EPRS1;TRIM25;CCL5;HLA-DPB1;HLA-A
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.7884766570471335,1.6356758774943965,0.03333333333333333,0.7619153813440654,1.0,2/18,2.10%,TRIP6;PTPRK
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.8081702936953387,1.6340791717968548,0.030303030303030304,0.7572187464620479,1.0,6/15,13.66%,NEDD1;PCM1;CEP83;PIBF1;HOOK3;CCDC14
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6472653807398199,1.6334537515881362,0.038461538461538464,0.7444103161184814,1.0,18/93,7.11%,FBXL7;RNF150;FLRT2;SEMA6D;PDE10A;WWTR1;NTM;CACNA2D1;ZNF462;RASSF8;LAMA4;PCDH18;SLC16A2;FIGN;GUCY1A2;ADGRL2;PPFIBP1;RBMS3
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.7274834579568442,1.6321345912242096,0.0,0.7385187808488537,1.0,10/24,15.02%,NRP1;MIEN1;PLPPR5;TGFB3;NLGN1;RALA;PIK3R1;GPM6A;FNBP1L;RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7434028947283483,1.6244878085911327,0.03125,0.7696057422024914,1.0,4/19,7.88%,NRG1;GREM1;MAML1;IGF1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.7580333641998429,1.6231788504575533,0.03125,0.7634512195692413,1.0,8/22,10.78%,PID1;IRS1;KANK1;PRKCB;PRKCD;ENPP1;PTPRE;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.8389420480499271,1.6161840302987083,0.02564102564102564,0.7736040849548808,1.0,2/8,7.88%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.8389420480499271,1.6161840302987083,0.02564102564102564,0.7736040849548808,1.0,2/8,7.88%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.8291302094614664,1.6117882507705104,0.0,0.7943541462818708,1.0,4/14,7.78%,TRPC7;TRPC3;SLC30A10;TRPC5
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6117849059129092,1.6100218648882871,0.0,0.791045536110831,1.0,49/105,19.09%,LRRTM3;GRIA4;TNR;CTNNA2;CACNG3;ADGRA1;OLFM3;CNTNAP5;GRIA2;SPHKAP;GRM5;KCTD16;GRIN2A;UNC79;LSAMP;MMD2;NRXN1;GRIA1;FUT9;TMEM196;CSRNP3;RBFOX1;PAK5;SLC6A1;KCNC2;TMEM132B;NOL4;ST8SIA3;ELAVL3;PPFIA2;BRINP2;NXPH1;NTRK3;SLC1A2;MAGI2;DLG2;GRIN2B;MEIS2;FRRS1L;SNAP91;GRIN1;KCNC1;CELF4;SLC1A6;UNC13A;CACNA1B;PHYHIPL;BSN;CLVS2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.7579491201136493,1.60999310247601,0.03333333333333333,0.7774283447158905,1.0,8/23,10.78%,PID1;IRS1;KANK1;PRKCB;PRKCD;ENPP1;PTPRE;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.8158792540488564,1.6097905332746174,0.0,0.7642889495102463,1.0,2/13,1.08%,NRG1;SGK1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.9798672481211665,1.6084141352752575,0.0,0.7594599659997404,1.0,2/5,0.87%,RUNX1;LEF1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.7329004764159912,-1.606585241660379,0.015151515151515152,1.0,0.99,4/29,7.97%,ENPP2;RREB1;RAC1;BRK1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.888703714026688,-1.605932593872554,0.0,0.9872247274144242,0.99,3/10,2.87%,CD44;ENPP2;RREB1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.8898149133378891,1.605336808201284,0.027777777777777776,0.7716912637912172,1.0,3/11,2.50%,CYP4Z1;GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6871298516002466,1.6036702710811905,0.0,0.7692734426592261,1.0,15/33,18.62%,GRIK4;BTBD9;GRIK1;LRRC4C;CEL;NLGN1;NLGN4Y;PXK;GRID2;NRG3;NGF;GRIK2;CACNA1A;RELN;CACNA1B
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.8942374392837036,-1.6025666131036127,0.0,0.9263477014895092,1.0,1/13,0.14%,NPY
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.8997051978062758,1.6021096992958253,0.0,0.766934894351235,1.0,1/7,0.61%,UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.6704616235772068,1.600339334823673,0.02857142857142857,0.7637529825049797,1.0,3/35,2.19%,ALK;CIDEA;EGFR
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7557406434132962,1.599877833096435,0.0,0.7536644062901986,1.0,5/24,4.68%,LHFPL2;TACR1;PDE3A;PLCB1;ANKRD31
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.9568302383873826,1.5970545812162067,0.0,0.760802771266168,1.0,1/6,0.61%,UBASH3B
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8045139833728671,1.5957676893922421,0.02631578947368421,0.7618058320440878,1.0,2/14,1.52%,PID1;IRS1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.9142714804983458,1.5952680363381273,0.029411764705882353,0.7528526665277384,1.0,1/8,0.48%,KIT
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.7462095100511055,1.5902649497016408,0.03333333333333333,0.779664003004612,1.0,3/17,6.33%,NRG1;MYH11;ACVR1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.9605769341069776,1.5881818893443098,0.0,0.7851623872069547,1.0,1/5,0.61%,UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.9607611171669854,1.5858164425614611,0.0,0.7948357398228351,1.0,1/6,0.04%,PLEKHH2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.8665140748565237,1.5841593608572853,0.027777777777777776,0.762403100830267,1.0,1/6,0.62%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.8665140748565237,1.5841593608572853,0.027777777777777776,0.762403100830267,1.0,1/6,0.62%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.8665140748565237,1.5841593608572853,0.027777777777777776,0.762403100830267,1.0,1/6,0.62%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.8665140748565237,1.5841593608572853,0.027777777777777776,0.762403100830267,1.0,1/6,0.62%,ELOVL6
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6606980258063402,1.582823380774028,0.0,0.7642247990192684,1.0,9/30,11.25%,IL1RAPL1;NECTIN3;AMIGO1;FAT4;NLGN1;GRID2;ADGRL1;DCHS1;TENM4
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7797529792983411,1.5826981061171703,0.06060606060606061,0.7544149059389337,1.0,2/10,6.11%,PRKCB;NEK6
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5594754288813758,1.5825764304366696,0.0,0.7458001027421004,1.0,21/195,9.13%,CPA1;TYSND1;CAPN13;KLKB1;TMPRSS7;VASH2;ADAMTS3;VASH1;DESI2;DPP3;PRSS57;HGFAC;HTRA1;ADAM19;PTCH1;PLAT;PCSK2;SRGN;CELA2A;THOP1;TASP1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8486607593199922,1.5825542011433873,0.02631578947368421,0.7362993404856716,1.0,2/10,2.57%,IFI16;CSF1R
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.7138746093392243,1.581754631959776,0.02127659574468085,0.7327022346833775,1.0,3/25,4.00%,RUNX1;CBFB;LATS1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.693743230503678,1.579879681185869,0.029411764705882353,0.7362267638493228,1.0,5/29,7.70%,CDH13;CDH6;CDH20;CDHR3;NLGN1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6759908538339274,1.5776803987508525,0.06060606060606061,0.7398411973985831,1.0,6/22,10.30%,PDE3A;GLP1R;EPHA5;PDE4D;CAP2;ADCY2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8692701259431256,1.577170993946169,0.02631578947368421,0.7333446534178141,1.0,3/8,10.73%,NPNT;BMP7;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7851146430520716,-1.5761808508433466,0.0,1.0,1.0,3/26,4.21%,CD44;CDKN2D;CD74
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.8987557237150685,1.575704311713811,0.023809523809523808,0.734300941947278,1.0,2/6,3.43%,NRG1;HDAC9
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6383897824888513,1.5736076978331905,0.045454545454545456,0.7374647695117201,1.0,10/50,11.55%,NRG1;TGFBR1;TGFB2;CFLAR;PDGFRA;IGF1;EREG;FER1L5;SCARB1;FGF10
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.8165599755242356,1.5733242443323625,0.0,0.7295331299340261,1.0,2/11,2.42%,NRP1;KDR
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.8764758821539591,1.5731066008613175,0.022222222222222223,0.72262584711093,1.0,3/8,6.67%,SLC22A2;SLC6A4;SLC22A3
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.7046440793400996,1.5704592453498118,0.03571428571428571,0.7324389766756795,1.0,3/26,1.23%,ACE2;PER2;F2RL1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.8285287102548936,1.568263677611606,0.0,0.7382615468604008,1.0,5/12,5.56%,EPHA3;SEMA5A;AMIGO1;EPHB2;CNTN4
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7815910541819125,1.5665046364314092,0.029411764705882353,0.7421716097799244,1.0,2/10,2.08%,ALK;CIDEA
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.78480127200087,1.564940327111719,0.029411764705882353,0.7451937269598472,1.0,6/17,13.66%,NEDD1;PCM1;CEP83;PIBF1;HOOK3;CCDC14
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8736479701946196,-1.5648865566247947,0.015384615384615385,1.0,1.0,2/10,4.55%,TICRR;GMNN
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.7219785677351735,1.5648392144154575,0.024390243902439025,0.7381796996822565,1.0,2/21,7.21%,EPHA3;EFNA5
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.798142089362558,1.5641163832029255,0.05714285714285714,0.7338238108498146,1.0,3/11,7.36%,PID1;IRS1;AKR1C3
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5612604652360449,1.5621448932916338,0.041666666666666664,0.7371477135230474,1.0,43/133,14.40%,CDH20;NTNG1;GRIA4;RAB3C;TNR;VWC2L;ZNF536;CTNNA2;CACNG3;NRL;PCBP3;OLFM3;CNTNAP5;GRIA2;SPHKAP;GRM5;UNC79;CNTN4;LSAMP;HCN1;MMD2;NRXN1;LIN7A;GRIA1;CADM2;SVOP;TMEM196;SEZ6L;PCSK2;AP3B2;RBFOX1;PAK5;SAG;ADGRB3;SGIP1;ST8SIA3;ELAVL3;PPFIA2;NTRK3;SLC1A2;MAGI2;PAK3;CNTNAP2
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6664021337857656,1.5616894679534505,0.03225806451612903,0.7316715289040184,1.0,8/25,20.26%,CHSY3;VCAN;ARSB;CHST12;CHST11;CHSY1;CHST9;CHST7
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.9486099220632617,-1.560684418363599,0.0,1.0,1.0,3/8,3.21%,ENPP2;CYP1B1;PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9252157902235355,-1.5562024639807892,0.015384615384615385,1.0,1.0,2/7,2.87%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.8365917248697362,1.5558076097747928,0.0,0.7599458247806387,1.0,3/8,8.90%,HSPB1;KDR;PRKD1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8092168194676763,1.5531937325282668,0.06521739130434782,0.7620637293544517,1.0,3/17,2.91%,GPC4;MDGA1;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8092168194676763,1.5531937325282668,0.06521739130434782,0.7620637293544517,1.0,3/17,2.91%,GPC4;MDGA1;IL1RAPL1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5822928407511189,1.5529489854381864,0.04,0.7558224073917041,1.0,18/72,14.47%,MYRFL;TYSND1;RCE1;PRSS12;KLKB1;ADAMTS3;KLK6;HGFAC;ADAM19;PTCH1;PCSK2;SRGN;EEF1AKMT4-ECE2;CASP2;ECE1;KEL;CPD;ADAMTS13
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.8767724982597078,1.550566966660768,0.0,0.7633685863437679,1.0,1/6,0.48%,KIT
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.7225157351230322,1.5501440974575165,0.023255813953488372,0.7510919105062805,1.0,8/17,22.93%,TEX15;FOS;GATAD2A;DMAP1;DNMT1;DNMT3B;EHMT2;BEND3
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.7225157351230322,1.5501440974575165,0.023255813953488372,0.7510919105062805,1.0,8/17,22.93%,TEX15;FOS;GATAD2A;DMAP1;DNMT1;DNMT3B;EHMT2;BEND3
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.6826697007867395,1.550142935512481,0.05555555555555555,0.7436553569369115,1.0,7/27,13.75%,PID1;IRS1;ENPP1;IGF1;IRS2;PIK3R1;AKT2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5891133624678998,1.5495092387019624,0.038461538461538464,0.7411117544757742,1.0,17/62,16.62%,LRRTM3;FGF13;DSCAM;SDK1;NRXN1;SHANK2;NLGN1;NLGN4Y;FZD1;RYK;GRID2;GPM6A;GABRB3;NRCAM;DNER;CDH1;WNT5A
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.7033305719491811,1.5491418775578432,0.02857142857142857,0.7358522202183314,1.0,3/23,2.91%,MDGA1;CTNNA2;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8409537214974948,-1.548360517481305,0.0,1.0,1.0,2/16,4.21%,CD44;CD74
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.7046178393860373,1.5470231695270096,0.03125,0.7394577748486616,1.0,5/20,8.54%,SLC22A2;SLC16A2;SLC7A2;SLC6A13;SLC7A1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6788566464623869,1.5456563428447494,0.04,0.7404176353817984,1.0,11/36,12.07%,ALK;COBL;BMP7;VLDLR;CSMD3;KNDC1;ADGRB3;NSMF;NEDD4L;HECW2;MARK1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.8609429368926903,1.543066734935449,0.02631578947368421,0.7514358539688517,1.0,2/7,6.95%,PID1;ENPP1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.6773052061802265,1.542327073231386,0.0,0.7494707856316591,1.0,12/29,18.87%,HS3ST3B1;EXT1;B3GAT2;GAL3ST4;CHST8;IGF1;EXT2;CHST12;CHST11;B3GAT1;B3GAT3;CHST9
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.813386067009831,-1.5414683099475688,0.0,1.0,1.0,4/17,10.95%,NES;CYP1B1;LAMA1;EFEMP1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.8274910172274677,-1.5409304345254413,0.0,1.0,1.0,4/16,9.22%,MYLK;RCSD1;YBX3;LRRC8D
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.8204945254484503,1.5407632892635188,0.02857142857142857,0.7532122980680688,1.0,5/11,8.64%,LRRTM3;C5AR1;NLGN1;NLGN4Y;FZD1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.570361519404565,1.5398722217293672,0.038461538461538464,0.7534881255613864,1.0,40/127,14.61%,KCNIP1;LRRTM3;CDH20;GRIA4;EGFR;TNR;ZEB2;NTSR2;CTNNA2;GRIN3A;ADGRA1;RGS7BP;GRIA2;SPHKAP;GRM5;GRIN2A;LSAMP;MMD2;NRXN1;GRIA1;LRRC4C;CADM2;PTCH1;SLCO1C1;RBFOX1;SLC6A1;DPP6;ADCY2;ADGRB3;SLC4A4;ST8SIA3;ELAVL3;PPFIA2;FAM181B;RAPGEF4;NTRK3;SLC1A2;MAGI2;DLG2;GPM6B
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8543156292695049,1.539483707071013,0.047619047619047616,0.7488391785376507,1.0,2/7,7.36%,H6PD;AKR1C3
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.7059885791647447,1.536601522644021,0.047619047619047616,0.7612097259433089,1.0,8/19,22.93%,TEX15;FOS;GATAD2A;DMAP1;DNMT1;DNMT3B;EHMT2;BEND3
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.8715254987958855,1.5361856388221018,0.023255813953488372,0.7572106301575283,1.0,4/11,5.99%,RUNX1;GFI1B;CBFB;PRKCB
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.8652894867003572,1.5361066247666948,0.020833333333333332,0.7510137718020488,1.0,3/7,6.71%,CA2;SLC30A10;PRKCD
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.8522277396794713,1.5350415615720645,0.043478260869565216,0.749672766592185,1.0,2/7,12.24%,ARL13B;BBIP1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.7331078444575332,-1.5348160306265186,0.014492753623188406,1.0,1.0,1/30,0.03%,SERF1A
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.9069935816601934,1.5341427080192869,0.0,0.7492219515857936,1.0,1/8,0.60%,CCNH
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.8664112368329047,1.5314320358326767,0.029411764705882353,0.7622836936457142,1.0,4/10,10.45%,BRCA2;MACROH2A2;LRWD1;RUVBL2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.8096527436025502,1.5312098797380973,0.0625,0.7577159915115916,1.0,5/14,5.54%,NRG1;BMP7;TGFBR1;TGFB2;HEY1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6290661589748414,1.5312059040358388,0.08108108108108109,0.7512946695496289,1.0,15/57,14.09%,CDH13;ITGA4;NRP1;KDR;TGFBR1;SEMA5A;VASH2;MDK;APLN;HMGB1;PRKD1;FGFR1;SIRT1;ECM1;PDGFB
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.7077630761527309,1.5306659092062014,0.03125,0.7472551073764775,1.0,3/18,4.60%,NRP1;KDR;GREM1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8520469476213701,-1.5296012140220248,0.0,1.0,1.0,6/11,11.23%,MYLK;ACTC1;ZFPM1;NOTCH1;TBX1;TTN
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5592357520066007,1.5295587185865185,0.0,0.7485047212051433,1.0,28/61,15.55%,ALK;BMP7;KCTD11;VWC2;HEY1;CNTN4;MMD2;BRINP1;ZC4H2;NLGN1;ZEB1;LTK;BIN1;MOSMO;FGFR1;TCF4;DISP3;CDK5RAP2;BRINP2;ID2;NGF;TIAM1;DTX1;ZFHX3;NRCAM;BEND6;SIN3A;MEF2C
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6839617225331222,1.528926789576101,0.05,0.7469089379793681,1.0,2/23,4.78%,PRELID2;PITPNC1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.9583380378301096,1.528847217992784,0.022222222222222223,0.7413703978728603,1.0,1/5,0.86%,RAB7B
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.7572899678133518,1.528034025600735,0.058823529411764705,0.7415953221652972,1.0,1/10,1.87%,NTNG1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7678883791671508,1.5278534102439225,0.04878048780487805,0.7361889650912661,1.0,6/16,8.65%,RGS14;PDGFD;NRP1;PDGFC;PDGFRA;PLAT
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.5684147952146665,1.5273144142762223,0.0,0.732805941354023,1.0,31/106,12.81%,ETV1;UNC5B;RIMBP2;PTPRT;KCNIP1;SEMA6D;RAB3C;LCORL;ADGRA1;MAPK4;KCNB2;TOX3;LEPR;RGS7BP;UNC5D;GRIA2;CNTN4;NRXN1;TMEM196;PCSK2;POU3F1;RCAN2;CNTN1;CSRNP3;SLC6A1;NOL4;ST8SIA3;RBP4;GABRB3;KALRN;PCDH17
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5912798961667618,1.527107297287346,0.0,0.7277812105732735,1.0,10/58,11.50%,NRG1;EGFR;SLC30A10;BTC;NRG2;SHC3;ERBB4;EREG;PTPN12;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.8929966825693293,1.5266792570550811,0.0,0.7241812543557252,1.0,3/5,8.90%,HSPB1;KDR;PRKD1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6978520642651603,1.5263115590367888,0.05,0.7210825914852348,1.0,4/12,10.10%,ALG8;MPDU1;ALG12;ALG13
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.9788080057743085,-1.5259312941579097,0.0,1.0,1.0,1/5,0.55%,CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.9788080057743085,-1.5259312941579097,0.0,1.0,1.0,1/5,0.55%,CD4
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.8452152774350089,1.5225530970704166,0.0425531914893617,0.7405532678484374,1.0,1/8,0.70%,NPNT
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.7088283827496139,1.5217874523361228,0.09090909090909091,0.7415392115482355,1.0,5/20,10.31%,DUSP5;DUSP2;DUSP4;DUSP8;DUSP10
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.7513311285050788,1.5205448374412187,0.03225806451612903,0.7431623809471402,1.0,3/16,4.60%,NRP1;KDR;GREM1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.929696905278987,1.5202098040781002,0.0196078431372549,0.7392585943032479,1.0,2/6,4.60%,UBASH3B;GREM1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8591662768019669,-1.5199442718840959,0.0,1.0,1.0,2/12,4.21%,CD44;CD74
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.8034407598771657,1.5197684293563904,0.045454545454545456,0.7365913721124061,1.0,4/11,9.80%,C5AR1;ZBTB1;TFCP2;EREG
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.95193829424935,-1.519675319794998,0.015151515151515152,1.0,1.0,1/5,1.99%,PTPRC
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6958675196861865,1.518524506254689,0.058823529411764705,0.737046055184976,1.0,6/26,9.47%,RUNX1;NFIB;SULF2;FGFR3;SOX5;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6741546836665006,1.5179072717583595,0.07692307692307693,0.7362280991900633,1.0,4/34,7.21%,EPHA3;CDK2AP2;TRIM36;EFNA5
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.5991938040830511,1.5177462822489738,0.0,0.7315476709826334,1.0,8/42,11.58%,CDH13;NRP1;KDR;SEMA5A;GREM1;ANGPT1;NAXE;YJEFN3
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6852016554858956,-1.5168564293202993,0.014285714285714285,1.0,1.0,20/52,15.40%,MS4A6A;HCK;SIGLEC1;PTPRC;HLA-DMA;CD74;AHR;FGL2;CD300LF;NCKAP1L;CIITA;CLDN1;SPI1;HLA-DPB1;WDFY4;MYO1F;TAGAP;IGSF6;HLA-DMB;TLR2
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.8381696125245964,1.5167534828982596,0.02857142857142857,0.7326529241712222,1.0,3/9,6.95%,PID1;PRKCB;ENPP1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.8419816247447034,1.516128896209286,0.07894736842105263,0.7313685910314766,1.0,3/8,7.57%,GALNT3;GALNTL6;GALNT13
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8442134712114058,-1.5155600680348063,0.027777777777777776,1.0,1.0,1/14,0.02%,CD44
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.814901470528252,1.5144814268085054,0.0,0.7359427397558558,1.0,5/14,11.44%,GPC4;NTNG1;LRRC4C;LRFN4;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.7508379161688452,1.5135216565342484,0.06896551724137931,0.7358739477493951,1.0,2/9,1.05%,NRG1;SPX
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6765667715520067,1.512727449381246,0.0,0.7362101431188298,1.0,3/30,4.00%,RUNX1;CBFB;LATS1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.9287628400946267,1.5126046745103499,0.06060606060606061,0.7319281891600617,1.0,1/5,3.20%,DSCAM
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.7543738348135816,1.5122434509486038,0.0,0.7293991573052656,1.0,6/16,12.61%,PNP;POLD3;ADA;HPRT1;APRT;GMPR
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.9320123120884386,1.5118161703250315,0.0,0.7265096561985338,1.0,2/6,4.60%,PMEPA1;GREM1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.8716456571446387,1.5098922130857118,0.05128205128205128,0.7270922100292745,1.0,2/11,8.17%,PER2;PGM2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.8716456571446387,1.5098922130857118,0.05128205128205128,0.7270922100292745,1.0,2/11,8.17%,PER2;PGM2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8369104222912197,1.5083593893243354,0.05555555555555555,0.7325122001834165,1.0,3/7,4.18%,NRG1;TGFBR1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.7686169095104071,-1.5070805947757717,0.013888888888888888,1.0,1.0,4/21,4.67%,CD44;CDKN2D;CD74;ING2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.7596547356888128,1.506903738307738,0.07894736842105263,0.7362231097074317,1.0,4/16,10.69%,PNP;RRM2;HPRT1;NMNAT3
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.9669710699836989,1.506814002213754,0.0,0.7314731748637185,1.0,2/5,2.50%,GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.828364073121262,-1.5058290916829968,0.015151515151515152,1.0,1.0,1/12,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.8156199087260478,1.5057201995154865,0.02564102564102564,0.733147735169953,1.0,2/12,6.67%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7145207398662955,1.5051349381968862,0.09090909090909091,0.7313104990953622,1.0,5/14,10.45%,HSPB1;KDR;SEMA5A;PRKD1;FGFR1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.8735305461886478,1.5012719818718687,0.0,0.748329826708688,1.0,2/9,6.63%,SPX;DDAH1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5308766395599523,1.5008433693807013,0.0,0.7457658097035798,1.0,39/150,12.81%,FILIP1;RIMBP2;KCNIP1;TOX;CACNA2D1;ZNF536;FSTL5;ADGRA1;MAPK4;OLFM3;LIX1;RGS7BP;GRIA2;GUCY1A2;KCTD16;LSAMP;TSHZ1;BRINP1;NRXN1;EFNA5;LRRC4C;CADM2;SHC3;IGF2BP3;TAFA1;TMEM196;CNTN1;NOVA1;RGMB;CSRNP3;RBFOX1;PAK5;ADGRB3;ST8SIA3;HIVEP3;ELAVL3;PPFIA2;KALRN;PCDH17
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.6109048274636718,1.5002389660951052,0.0,0.7459169153927941,1.0,8/45,11.72%,EPHA3;STAC;EGFR;EPHB2;PTPN9;PIK3R1;PRKCE;ZDHHC5
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.9526574394084221,-1.4995555737676072,0.01639344262295082,1.0,1.0,1/5,0.35%,TICRR
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9877211540480132,-1.4993297782841264,0.0,1.0,1.0,1/5,0.06%,SLC28A2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9877211540480132,-1.4993297782841264,0.0,1.0,1.0,1/5,0.06%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9877211540480132,-1.4993297782841264,0.0,1.0,1.0,1/5,0.06%,SLC28A2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.6446130862754773,-1.4992683926899488,0.012987012987012988,1.0,1.0,6/70,2.24%,CD44;TRIM58;TUBB1;GYPB;RGS10;DOCK2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.780447390539988,-1.4974432341360182,0.034482758620689655,1.0,1.0,2/13,8.87%,WFS1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.7329816356295986,-1.4970360130866855,0.04918032786885246,1.0,1.0,4/23,7.34%,TERF2IP;H1-0;H1-2;SUB1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.5599168460714762,1.497024611752645,0.0,0.7615019210828597,1.0,34/127,15.53%,PTPN3;UBASH3B;PTPRT;EYA4;DUSP5;DUSP2;PTPRK;CDC14B;PTPRB;DUSP4;PTPN9;PTPRO;DUSP8;PTPN6;PTPRE;EYA2;SSH1;PTPN12;DUSP10;DUSP12;PPEF1;PTPN13;PTPRS;TAB1;CTDSP2;PPP2R5E;EYA3;PTPRM;BTRC;CTTNBP2NL;PPM1H;PPM1E;PPP2R1B;PTPRH
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.879971063215734,1.496971848754279,0.02631578947368421,0.756803080678445,1.0,2/8,1.97%,CYP1A2;ALLC
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.7626127982217975,-1.4963850706916615,0.057692307692307696,1.0,1.0,1/15,0.13%,C3AR1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.9639326372692729,1.4950772123661609,0.0,0.7653169917733055,1.0,1/5,0.89%,CA2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.849747192909164,-1.494337320025952,0.03571428571428571,1.0,1.0,2/9,4.21%,CD4;CD74
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.7809870441147546,-1.4939755999541415,0.0,1.0,1.0,2/13,1.66%,RDH10;CYP1B1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.7267176378160606,1.4928196015330835,0.08108108108108109,0.7747146223414458,1.0,6/15,16.62%,NTNG1;SPRY3;GRIP1;DVL2;MAP3K13;WNT5A
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.9550964904914478,1.4923659986683269,0.0,0.7724396930243015,1.0,3/6,4.44%,SPRED1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.8793101520082818,1.4921999564418285,0.045454545454545456,0.7686800506176809,1.0,4/7,7.20%,MDGA1;SOX13;MDGA2;ZC4H2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.7833200976137331,1.4918655614520206,0.08823529411764706,0.765409391625959,1.0,7/10,20.95%,KLF2;MEF2C;MAPK7;HDAC3;SREBF2;NFE2L2;MTSS1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.696694279802317,-1.4893269718134836,0.02666666666666667,1.0,1.0,7/41,6.25%,CD44;ADAMTS4;MMP15;ELANE;TIMP2;KIF9;CAPN1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.8181353631175825,1.4891406000361629,0.058823529411764705,0.7771237995940392,1.0,2/8,2.57%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.5893670768222372,1.4889096553383765,0.0,0.7741909516759088,1.0,24/92,16.89%,ITGB5;PDE3A;PTPRK;TGFBR1;PARD3;TGFB2;WWOX;FOS;ACVR1;TGFB3;SOX5;SMAD2;TWSG1;LIMS1;TGFBR3L;SIRT1;NR3C1;CILP;GCNT2;MEF2C;GDF10;WNT5A;PXN;MAPK7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.8560952584631771,1.4884458563869936,0.06060606060606061,0.7731174652503093,1.0,2/7,3.36%,KIT;NFATC1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.7771728841571207,-1.486795149258897,0.046153846153846156,1.0,1.0,1/16,0.12%,WEE2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.6887708388637189,1.4827262650289814,0.03125,0.8001082509271579,1.0,7/18,20.26%,CHSY3;VCAN;CHST12;CHST11;CHSY1;CHST9;CHST7
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6400476331216245,1.4825719831879318,0.08108108108108109,0.7963178211502775,1.0,3/21,3.89%,NRP1;DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8411279507424814,-1.4821840049719124,0.015625,1.0,1.0,2/13,4.68%,CD44;RAC1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.7022616167003622,1.4819276098303218,0.02702702702702703,0.7947900110948223,1.0,5/18,8.38%,RUNX1;CBFB;PRKCB;CD22;ELF2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.6532817993546799,1.4814495319798273,0.05128205128205128,0.7924326863378197,1.0,11/45,10.73%,GPC4;MDGA1;IL1RAPL1;CLSTN2;LHFPL4;EPHB2;NRXN1;NLGN1;GRID2;LRFN4;ROBO2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5449762144359028,1.4811313351300175,0.0,0.7897661841460577,1.0,40/100,20.62%,MCTP1;GRIK4;CLSTN2;BTBD9;GRM5;GRIK1;SNCAIP;LRRC4C;CEL;NLGN1;NLGN4Y;PXK;SYN3;SLC8A3;DLGAP1;GRID2;MCTP2;DLGAP4;SYT1;NRG3;GRM8;NGF;GRIK2;MEF2C;CACNA1A;KCTD13;HOMER1;TMEM108;HCRT;RELN;OPHN1;UNC13A;PTEN;CACNA1B;DLGAP3;DLGAP2;CLN3;ITGB1;AKAP9;GRM7
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.8909185274970502,1.4801500924119029,0.02564102564102564,0.7876082157043042,1.0,2/5,3.62%,KIT;S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.8909185274970502,1.4801500924119029,0.02564102564102564,0.7876082157043042,1.0,2/5,3.62%,KIT;S100A13
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.8560091933830037,-1.4796857907609189,0.015625,1.0,1.0,1/9,0.12%,WEE2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.7863840314852462,1.479575252305099,0.075,0.786589450420411,1.0,3/6,20.86%,PUSL1;PUS10;RPUSD4
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6577141670025313,1.4786677491131521,0.03333333333333333,0.7867349467349395,1.0,1/27,0.11%,NRG1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8286823060210933,-1.4782411480976936,0.05172413793103448,1.0,1.0,1/9,0.11%,EPN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.7895358830180383,-1.4774942024977356,0.06060606060606061,1.0,1.0,1/13,2.87%,YBX3
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6835973308166248,-1.4771533324847836,0.029411764705882353,1.0,1.0,13/39,14.05%,C3AR1;MS4A6A;HCK;SIGLEC1;CD14;SLC7A7;FGL2;CD300LF;SPI1;WDFY4;MYO1F;IGSF6;AQP9
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.8077967677600992,1.476644008134221,0.12244897959183673,0.796127501808328,1.0,1/7,1.05%,SPX
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6845678946243061,-1.4766042837238917,0.034482758620689655,1.0,1.0,8/33,15.26%,ARIH2;ATP5IF1;LMAN1;PINK1;UBL5;BAG4;TOMM7;HSPA1L
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8386848937964186,1.4758932649553536,0.03333333333333333,0.7952402783972451,1.0,4/9,4.33%,ALK;COBL;BMP7;VLDLR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.5824473365071293,1.474189382677628,0.02857142857142857,0.7995418312511374,1.0,9/45,11.72%,EPHA3;STAC;EGFR;EPHB2;PTPN9;PIK3R1;PRKCE;GNAI1;ZDHHC5
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6920607751067389,-1.47417619138258,0.02666666666666667,1.0,1.0,7/41,6.25%,CD44;ADAMTS4;MMP15;ELANE;TIMP2;KIF9;CAPN1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.5580447363961295,1.473552256426587,0.07692307692307693,0.797921203525962,1.0,33/105,17.24%,UNC13C;GRIA4;FGF13;TNR;CATSPER2;CTNNA2;CACNG3;KCNJ6;CNTNAP5;GRIA2;PRKCB;HCN1;NRXN1;SVOP;SEZ6L;PCSK2;AP3B2;DPP6;XKR4;KCNC2;ADCY2;CACNB2;C4ORF50;ST8SIA3;SLC1A2;NR3C1;CACNA1A;FRRS1L;OTUD7A;PMP2;GNG7;B3GAT1;CELF4
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.894170140034212,1.4734921253135003,0.07894736842105263,0.7936785238825086,1.0,2/6,5.68%,LEF1;PDE4D
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.9173373331629602,1.473364031519346,0.029411764705882353,0.7898014922573526,1.0,3/9,3.89%,PLEKHH2;F2RL1;SEMA5A
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.8666345060430056,-1.4731782793646213,0.04477611940298507,1.0,1.0,2/7,9.74%,GNPDA1;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.9472866750236575,-1.4729583427150776,0.01818181818181818,1.0,1.0,1/5,3.54%,SFRP4
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.8607160282491854,1.4724181672335106,0.045454545454545456,0.7869755402698757,1.0,1/5,2.85%,RAB32
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.8607160282491854,1.4724181672335106,0.045454545454545456,0.7869755402698757,1.0,1/5,2.85%,RAB32
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.9297909582762874,-1.4722865540637855,0.0,1.0,1.0,1/5,1.16%,MYLK
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.850804555615604,1.472261894784541,0.0975609756097561,0.7834339938396614,1.0,2/7,2.41%,STAC;CACNA2D1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.7836476582564648,1.4716346778911145,0.03225806451612903,0.7821879881404629,1.0,1/9,0.48%,KIT
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9286026767451405,1.4710087249821724,0.058823529411764705,0.7810329249434137,1.0,3/5,6.33%,TGFBR1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7130383851314321,1.4706266255423066,0.11764705882352941,0.7793514847918482,1.0,6/16,8.14%,CNTN4;NRXN1;CEL;NLGN1;NCAM2;NLGN4Y
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.827600530207321,-1.4705306877052087,0.0,1.0,1.0,3/14,4.67%,CD44;CD74;ING2
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.8166696394155688,1.4701530336849409,0.047619047619047616,0.7775349912118363,1.0,1/10,0.84%,IMMP2L
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.9259731285594589,1.4700419364709376,0.03125,0.7738339936865459,1.0,1/5,0.48%,KIT
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8924545875827024,1.4697212626433716,0.05,0.7720661728632644,1.0,2/7,2.53%,ACE2;BCL2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5668136487503327,1.4696609470492936,0.037037037037037035,0.7680565180279938,1.0,11/77,7.23%,TRPC7;GPC4;NPNT;GEM;KCNIP1;PDZRN3;SPRED2;FAM222A;EPHA8;WWC1;GALNT18
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.7028940757977052,-1.4670633857499054,0.0,1.0,1.0,6/26,14.55%,CENPK;CENPO;CENPU;ITGB3BP;CENPL;OIP5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.7028940757977052,-1.4670633857499054,0.0,1.0,1.0,6/26,14.55%,CENPK;CENPO;CENPU;ITGB3BP;CENPL;OIP5
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.8873123318758289,1.466489183039118,0.046511627906976744,0.7826029017819367,1.0,1/5,2.50%,ABHD1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.8838245081257282,1.4652090267887743,0.10526315789473684,0.7873784241320477,1.0,1/5,0.76%,HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5662469528540963,1.4650557538423465,0.027777777777777776,0.7843159309123976,1.0,13/56,11.49%,TPD52L1;KIT;PDGFD;EGFR;PIK3R6;PDGFC;TNFRSF11A;RASGRP1;FGFR1;IL34;DVL2;MAP3K5;MST1R
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7092248124411733,1.464743007258938,0.09090909090909091,0.7818017011612389,1.0,6/9,18.94%,TGFB2;MYH3;PTCH1;LRP6;FBXW4;MBNL1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7922149849248299,1.4646083758107167,0.05714285714285714,0.7785792980571499,1.0,2/10,8.80%,DGKB;DGKH
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.7918565952797433,1.4638965761252827,0.08823529411764706,0.7790415885738936,1.0,4/8,16.72%,SLC16A2;SLCO1C1;SLC22A9;SLC16A10
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.7144828829260245,1.4638952151486397,0.02857142857142857,0.7750668865913737,1.0,2/16,2.26%,SLC39A11;SLC30A10
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.7742428259040999,1.4638441764326713,0.13333333333333333,0.7712771197457028,1.0,6/8,20.53%,FZD1;RYK;NR4A2;LRP6;WNT5A;CTNNB1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7630907426227523,-1.463641157368777,0.0,1.0,1.0,2/23,1.66%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.8870949554546121,1.4625374423207516,0.0,0.7747182641798289,1.0,2/6,3.62%,KIT;S100A13
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.7572981075313878,1.4620842800587133,0.10810810810810811,0.7743318861731825,1.0,4/12,16.02%,PCM1;SAXO2;BICD1;DAG1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.767132909696979,-1.4614013504782655,0.0,1.0,1.0,4/15,9.15%,TRPA1;PTGES;ALOXE3;SCN9A
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5889245471937957,1.4599210042042414,0.043478260869565216,0.7837047371096059,1.0,5/35,3.02%,CDH13;KIT;ZEB2;NRP1;KANK1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.903819536154005,1.4591827273525033,0.027777777777777776,0.7846236976802139,1.0,1/6,1.20%,PKD1L1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.845456732106572,1.459172455644019,0.09523809523809523,0.7808099239738618,1.0,1/7,0.70%,NPNT
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.6486856139269884,-1.4586771449706506,0.0,1.0,1.0,12/58,11.15%,EPHA1;TNK1;SLC14A1;TMEM184A;DENND1C;SYNGR2;CAPN1;SYTL1;ZBTB7B;TMCO4;TRIM25;TMC4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.765839375698511,1.4574631598490568,0.045454545454545456,0.7838359814670302,1.0,4/11,11.91%,MELTF;KANK1;EFNA5;ACTN4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.765839375698511,1.4574631598490568,0.045454545454545456,0.7838359814670302,1.0,4/11,11.91%,MELTF;KANK1;EFNA5;ACTN4
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6172884237248835,-1.4571980818331762,0.05263157894736842,1.0,1.0,9/78,7.41%,CD44;C3AR1;MS4A6A;HCK;PTPRC;CD14;FGL2;IFIT1;CD300LF
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.835361404291913,1.4569740992826987,0.05128205128205128,0.7830690839763214,1.0,2/8,2.89%,F11;KLKB1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.8022561275032951,1.4560008208810653,0.08333333333333333,0.7852823533878267,1.0,2/6,5.56%,XRCC4;MGMT
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7361643046620038,1.455372507292158,0.047619047619047616,0.7862358551627595,1.0,5/16,10.45%,ITGA4;MDK;APLN;HMGB1;FGFR1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.7468928235645904,-1.4544508391274489,0.03278688524590164,1.0,1.0,6/23,14.57%,CSRP3;SCN4B;ATP1B1;KCNQ1;TTN;TPM1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7106490940588199,1.4541576393365474,0.044444444444444446,0.7889603647760304,1.0,6/21,5.05%,HS3ST5;HS3ST3B1;SULF2;EXT1;HS6ST3;HS3ST4
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.788456038730122,-1.4541104111868917,0.046875,1.0,1.0,2/15,5.45%,WEE2;NODAL
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.9319431481098823,-1.4533526547663886,0.017543859649122806,1.0,1.0,1/6,1.13%,SIGLEC1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.7083928794855108,1.453347602987806,0.07407407407407407,0.7885924704462612,1.0,4/22,4.18%,NRG1;PKP2;TGFBR1;TGFB2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.6569159841222577,1.4521461488807181,0.07407407407407407,0.7920936051712224,1.0,6/29,8.68%,TPD52L1;BCL2;TGFBR1;CRADD;SGMS1;STYXL1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6622564736808871,1.4517776002882452,0.05555555555555555,0.7905669364116612,1.0,17/35,16.51%,HOMER2;GRIA4;GRIK4;GRIN3A;PLCB1;GRIA2;GRM5;GRIN2A;GRIK1;GRIN2C;GRID2;GNAQ;GRM8;GRIK2;GRIN2B;HOMER1;GRIN1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.790685881034938,1.451625523197585,0.1111111111111111,0.7875096116642989,1.0,2/11,6.58%,XRCC4;HMGB1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8195022822951963,1.4514986842501771,0.125,0.7846815774168708,1.0,4/6,12.80%,LHFPL4;NLGN1;APOE;GPHN
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.7183167356069589,-1.4511956672722945,0.0,1.0,1.0,1/28,0.22%,RAB6C
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.5991972933103644,1.4508599133118498,0.027777777777777776,0.7851408567645458,1.0,3/40,0.69%,RUNX1;KIT;IFI16
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.8439867691327193,1.4503358899611745,0.05128205128205128,0.7837411686209939,1.0,2/7,8.56%,MELTF;PDPN
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6179142732717384,-1.4500352300424069,0.028169014084507043,1.0,1.0,59/88,33.47%,RPL36;RPL15;SRP68;RPL38;RPLP2;SEC62;SRP9;RPL28;RPS21;RPS7;SRP14;RPL9;RPL37A;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;RPS8;RPL4;RPL3;RPL34;RPL37;RPL24;RPS24;RPS15;RPL7A;RPL13A;RPL27A;RPS4X;RPL23;RPL35;RPS3;RPS27A;RPS29;RPL19;RPL18;RPS13;RPL32;RPL13;RPS5;RPL27;RPS2;RPS9;RPL29;SRP54;RPS25;RPL31;RPL21;RPSA;RPS19;RPS4Y1;RPL11;UBA52;RPS12;RPS18;RPS28;RPS16
prerank,PanglaoDB_Augmented_2021__Basophils,-0.6232691143546447,-1.450001267346961,0.013333333333333334,1.0,1.0,16/81,11.77%,CD44;C3AR1;MS4A6A;CD4;HCK;SIGLEC1;P2RY1;CD14;IL3RA;FGL2;CD300LF;RNF39;SPI1;TEC;STAB1;MYO1F
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.6244816200759448,1.4496332168869073,0.03225806451612903,0.7843983464737232,1.0,5/26,15.07%,SLC22A2;SLC7A2;SLC7A1;SLC1A2;SLC25A29
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8147238012560102,1.4496283514271933,0.02702702702702703,0.780849236162771,1.0,3/6,14.60%,IGF1;SIRT1;LRP6
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5238112755845545,1.4494620866997867,0.0,0.7780512897031483,1.0,37/151,14.28%,EPHA3;ROR2;MYLIP;TOX;NTNG1;CTNNA2;IL1RAPL1;KANK1;PLPPR5;MDK;LRRC7;CSMD3;MINAR1;PTPN9;LZTS3;PTPRO;LRRC4C;FUT9;APOE;FZD1;LTK;STYXL1;PRKD1;KNDC1;ZNF804A;RETREG3;ARSB;SPOCK1;PTPRS;PRAG1;MARK1;PPFIA2;SIPA1L1;NTRK3;EP300;MAGI2;PAK3
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5088839777568808,1.4484820678066062,0.0,0.7802211193928305,1.0,31/140,10.85%,LUZP2;KCNIP1;LRRTM3;CDH20;NTM;NTSR2;SLC16A2;ADGRA1;MAPK4;RGS7BP;FGFR3;GRIA2;SPHKAP;GRM5;GRIN2A;SLC6A11;MMD2;BRINP1;NRXN1;HTRA1;CADM2;LCAT;APOE;RCAN2;SLCO1C1;RBFOX1;SLC6A1;SRR;BYSL;ADGRB3;SLC4A4
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7658144741191354,-1.448433746918581,0.02857142857142857,1.0,1.0,2/20,4.87%,CD44;ITGA5
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6185912206719738,-1.4475605539538279,0.0273972602739726,1.0,1.0,59/85,33.47%,RPL36;RPL15;SRP68;RPL38;RPLP2;SRP9;RPL28;RPS21;RPS7;SRP14;RPL9;RPL37A;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;RPS8;RPL4;RPL3;RPL34;RPL37;RPL24;RPS24;RPS15;RPL7A;RPL13A;RPL27A;RPS4X;RPL23;RPL35;RPS3;RPS27A;RPS29;RPL19;RPL18;RPS13;RPL32;RPL13;RPS5;RPL27;RPS2;RPS9;RPL29;SRP54;RPS25;RPL31;RPL21;RPSA;RPS19;RPS4Y1;SEC61B;RPL11;UBA52;RPS12;RPS18;RPS28;RPS16
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6702325006324328,-1.4474018231242523,0.02702702702702703,1.0,1.0,9/37,9.34%,ALPL;CYP1B1;CYP19A1;CDKN2D;DRD3;ABCB4;TGFB1;CCL5;IGFBP5
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7574010253516189,1.4470322734692542,0.08695652173913043,0.7845074347076235,1.0,2/11,6.07%,KLRD1;JAG1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.9394534712721162,-1.4466183564766428,0.0,1.0,1.0,1/6,0.12%,WEE2
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7813993277926051,1.446419405594387,0.11764705882352941,0.7843085470747765,1.0,1/11,0.47%,PNP
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.8637067670784755,-1.4463734861018085,0.030303030303030304,1.0,1.0,2/8,8.64%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.7442974214122671,-1.4455101469918266,0.04477611940298507,1.0,1.0,4/22,6.25%,NES;ATP5IF1;NOTCH1;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.8281456261433795,1.4451590205993528,0.08823529411764706,0.7875114272442323,1.0,2/9,5.68%,PDE3A;PDE4D
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.8778558244758322,1.444177303094539,0.05128205128205128,0.7892167371568635,1.0,3/5,9.60%,SLC6A11;SLC6A13;SLC6A1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5215561702247038,1.443743096257516,0.04,0.7887451786510744,1.0,25/124,14.55%,RUNX1;EPHA3;ALK;TRPS1;TGFBR1;CBFB;GREM1;KLK6;MDK;HEY1;PRKCB;NLGN1;LTK;BIN1;ANP32B;MOSMO;FGFR1;CDK5RAP2;BCL6;SMOC1;ID2;NGF;TIAM1;ZFHX3;MEGF10
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.9114201879654147,1.4431129547723989,0.08888888888888889,0.7894804196473129,1.0,2/5,2.73%,FRMPD4;CTNNA2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5074263398806539,1.4427670545546254,0.09523809523809523,0.7877515658078041,1.0,27/118,13.47%,KCNIP1;LRRTM3;LHFPL3;TNR;VCAN;NTM;ZNF536;ADGRA1;MAPK4;SLC35F1;GRIA2;PDGFRA;MMD2;BRINP1;LRRC4C;SHC3;ETV5;SLCO1C1;SLC6A1;ADGRB3;FYN;NYAP1;ST8SIA3;ELAVL3;BRINP2;EPN2;NXPH1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.5446266661762844,1.4426886166121795,0.08695652173913043,0.7844695070464979,1.0,33/131,14.62%,RUNX1;KIT;IRS1;NFIB;BCKDHB;NRP1;LTBP1;GRK5;ATXN1;VLDLR;SYNJ2;MGMT;PTGFR;ADGRL2;DDAH1;SFMBT1;CAP2;RASA2;SLC7A1;MT1E;FHL2;TOGARAM1;TFPI;FYN;PRKCE;CELF2;PTPRM;KALRN;SIPA1L1;MAGI2;NR3C1;COL11A1;ABCC1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5690632875778513,1.4425906566475948,0.09523809523809523,0.7816534745154644,1.0,20/63,14.98%,ROR2;KIT;UNC5B;PDGFD;F2RL1;KDR;TGFB2;PDGFC;PDGFRA;IGF1;PTPN6;IRS2;FSHR;FGFR1;PIK3R1;SIRT1;NTRK3;PDGFB;PIK3AP1;NEDD4
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.7130100179605607,1.4425303765414987,0.14285714285714285,0.7785510883603115,1.0,3/11,10.56%,ELOVL6;HACD2;TECR
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6339914789864041,-1.4424395506490673,0.045454545454545456,1.0,1.0,16/51,16.61%,HCK;NR1I3;MYLK;DOCK8;ELANE;CD14;CD300LF;SPI1;MYO1F;ARG2;OAS3;TAGAP;IGSF6;AQP9;TLR2;SLC11A1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.681279203158928,1.442198043375323,0.03225806451612903,0.7777047695799644,1.0,6/17,21.11%,CYSLTR2;ADCY2;ADCY9;CREB1;ADCY8;PRKACB
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7878834980960493,1.441939090921178,0.15384615384615385,0.7756327558109548,1.0,1/8,2.42%,KDR
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.846325568614772,1.4413656961357455,0.075,0.7760954049575426,1.0,1/8,0.27%,TAS2R7
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.8684243030832763,1.4404860350706536,0.05714285714285714,0.7768596925019511,1.0,2/5,7.70%,NRXN1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.8563766353501279,-1.4401822859964457,0.057692307692307696,1.0,1.0,2/7,4.21%,CD4;CD74
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.7793867943698257,-1.4401443405075225,0.015625,1.0,1.0,3/13,11.23%,CSRP3;CAV3;TTN
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.8218653409945864,-1.439727433287133,0.03225806451612903,1.0,1.0,3/10,9.13%,ACOT4;IL4I1;GNPDA1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.7804898809011185,-1.4384876946086433,0.04477611940298507,1.0,1.0,3/15,8.64%,CD44;CEMIP;TGFB1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7081204521858986,1.4383223247248131,0.07692307692307693,0.7864422523946013,1.0,6/14,13.75%,TYSND1;IRS1;IRS2;ABCD2;PLIN5;AKT2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7641044247271742,1.4381277060488313,0.08108108108108109,0.7839441139842378,1.0,1/12,0.47%,CDH13
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.84191323370735,1.4379424165720516,0.07692307692307693,0.7815274911917464,1.0,1/6,3.57%,GMDS
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.8655752781288424,1.4364756160695928,0.07692307692307693,0.7864622825057083,1.0,3/7,6.23%,DUSP5;DUSP2;DUSP4
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7005533678046478,-1.4360977433610405,0.041666666666666664,1.0,1.0,1/30,0.02%,CD44
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.9193128336823573,1.4353216380704916,0.029411764705882353,0.7893211179855153,1.0,2/5,2.11%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8650697936900351,1.4345766134873117,0.06060606060606061,0.7893554183447257,1.0,2/6,2.11%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.7115836564406782,1.4344927312221165,0.16216216216216217,0.7864224726598831,1.0,3/20,8.12%,PNP;FHIT;HPRT1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7355464181988051,-1.434303262497358,0.04838709677419355,1.0,1.0,5/15,14.86%,IL15;NCKAP1L;ZBTB7B;TGFB1;IL18
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.9551227132452238,1.4340726218552942,0.044444444444444446,0.7849911913580149,1.0,3/5,4.44%,SPRED1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.6422637360915698,1.4340280065915165,0.03571428571428571,0.7821593676870298,1.0,5/19,9.60%,SLC22A2;SLC16A2;SLC6A13;SLC7A1;SLC6A1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.563761730119675,1.433459114924104,0.02702702702702703,0.7817537226836268,1.0,7/47,4.31%,RUNX1;KIT;IFI16;LEF1;F2RL1;CSF1R;BATF3
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9424109946155399,1.4333434037113804,0.020833333333333332,0.7791334782872629,1.0,2/5,3.61%,LHFPL2;PLCB1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.887460154584404,1.4332484205215283,0.0851063829787234,0.773320086923032,1.0,1/5,6.00%,GDE1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.887460154584404,1.4332484205215283,0.0851063829787234,0.773320086923032,1.0,1/5,6.00%,GDE1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6696500285389558,1.4331133392452247,0.07407407407407407,0.7709387842106397,1.0,5/22,11.40%,PNP;ENPP3;FHIT;NMNAT3;AK5
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.7507766094350984,-1.4321979939104512,0.08064516129032258,1.0,1.0,3/17,9.19%,PINK1;HSPA5;SKP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.7838290534158082,1.4321198140250242,0.046511627906976744,0.7737449388174507,1.0,5/12,10.45%,ITGA4;MDK;APLN;HMGB1;FGFR1
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.9044027915790679,-1.431650444794361,0.09090909090909091,1.0,1.0,1/7,4.40%,LGSN
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.9408708026575424,-1.4311321925896092,0.016129032258064516,1.0,1.0,1/6,0.55%,CD4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.9408708026575424,-1.4311321925896092,0.016129032258064516,1.0,1.0,1/6,0.55%,CD4
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6785272659995562,-1.4307295641490863,0.0,1.0,1.0,2/40,3.18%,CD44;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.5782347691895622,1.430569791453068,0.05714285714285714,0.7800174132620474,1.0,10/45,11.01%,ACE2;NRP1;KDR;IL1RAPL1;CLSTN2;EPHB2;NRXN1;NLGN1;GRID2;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.7005337346047146,1.4305670605045737,0.075,0.7768973436089992,1.0,4/23,5.54%,IFI16;PER2;LEF1;HEY1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7404760416548382,1.4304092026034734,0.11428571428571428,0.7745964766064102,1.0,3/8,14.16%,RNF2;PCGF1;PCGF6
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.7668163406064394,1.4296686543533217,0.08108108108108109,0.7760437632856183,1.0,1/7,1.23%,F2RL1
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8734608700802183,-1.4291364701438005,0.06153846153846154,1.0,1.0,1/6,0.71%,MCM2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8734608700802183,-1.4291364701438005,0.06153846153846154,1.0,1.0,1/6,0.71%,MCM2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.7568890302775543,1.4288999864417165,0.05405405405405406,0.7770855778844388,1.0,2/15,2.21%,RUNX1;MELTF
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5212784443373257,1.4282007036370794,0.047619047619047616,0.7778388465219089,1.0,32/126,12.43%,EPHA3;FEZF2;LRRTM3;GRIA4;RAB3C;BCL2;ZNF536;CTNNA2;ADGRA1;MAPK4;SLC35F1;OLFM3;GRIA2;UNC79;LSAMP;MMD2;NRXN1;LRRC4C;CADM2;SOX5;FUT9;EPHA7;NOVA1;CSRNP3;RBFOX1;PAK5;ROBO2;ADGRB3;NOL4;ST8SIA3;ELAVL3;PPFIA2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6781756816418101,1.4279789477258136,0.08571428571428572,0.7762405633352512,1.0,6/15,13.61%,KIT;PDGFRA;RASGRP1;FGFR1;BICD1;NTRK3
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5899515872798479,1.4275225782582877,0.03333333333333333,0.7753779632866226,1.0,9/46,6.16%,GPC4;HS3ST5;HS3ST3A1;HS3ST3B1;SDC4;EXT1;B3GAT2;HS3ST2;CLN6
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.8437218523659827,-1.424971028561819,0.0967741935483871,1.0,1.0,2/8,7.91%,BTN2A2;PDCD1LG2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.5955127337646847,-1.4247275608275016,0.02631578947368421,1.0,1.0,64/97,33.63%,CHMP4B;RPL36;RPL15;SRP68;RPL38;RPLP2;SEC62;SRP9;RPL28;RPS21;RPS7;SRP14;RPL9;RPL37A;MAN1A1;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;SGTB;RPS8;RPL4;RPL3;RPL34;RPL37;RPL24;RPS24;RPS15;RPL7A;RPL13A;RPL27A;RPS4X;RPL23;RPL35;RPS3;RPS27A;RPS29;RPL19;RPL18;RPS13;RPL32;RPL13;RPS5;RPL27;RPS2;SPCS1;RPS9;RPL29;SRP54;RPS25;RPL31;RPL21;RPSA;RPS19;RPS4Y1;RPL11;UBA52;RPS12;RPS18;RPS28;RPS16;SPCS3
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.7853324263161601,1.4244738413927325,0.11428571428571428,0.7905921484880019,1.0,4/6,20.63%,KLF2;MAPK7;SREBF2;NFE2L2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5231023211799222,1.4238922197756714,0.10526315789473684,0.7902326015592002,1.0,8/68,4.90%,FRMPD1;GNG4;RGS14;KCTD8;CAMKMT;PLCB1;GRK5;KLK6
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6294227750884398,1.4233713638032208,0.034482758620689655,0.7904806785409219,1.0,3/28,3.87%,TRIP6;PTPRK;LAMB3
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7063682562733442,-1.422897679823804,0.03389830508474576,1.0,1.0,7/18,20.29%,ENC1;PSMB6;PSMB8;PSMA3;PSMA5;PSMA7;PSMB2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.9428483118115139,-1.4228362991356651,0.0,1.0,1.0,1/5,1.16%,MYLK
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6028383108959993,1.4220046573191107,0.09090909090909091,0.7943967487874177,1.0,7/28,16.74%,CACNA2D1;MICU1;MCU;SLC35G1;SLC8A1;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.8287116655499076,1.422001218886933,0.09302325581395349,0.7914076478686807,1.0,2/8,6.16%,HTR1F;HTR1E
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5459013687957258,1.421942831464696,0.03225806451612903,0.7887131471286574,1.0,15/77,9.24%,TPD52L1;TNFRSF19;F2RL1;RASSF2;SH3RF1;TRAF3;PLCB1;TGFB2;SH3RF3;HMGB1;RASGRP1;SEMA4C;MID1;KLHDC10;ANKRD6
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.6187329395506462,1.421312968256776,0.08,0.7897754761311392,1.0,8/33,5.27%,CDH13;HSPB1;F2RL1;NRP1;KDR;DSCAM;SEMA5A;MDK
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.8750233295691454,1.4209472475425164,0.06521739130434782,0.7885101337515014,1.0,1/5,0.77%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.6100497548232171,-1.4208046241735601,0.028169014084507043,1.0,1.0,19/72,13.11%,CD4;HCK;PTPRC;DOCK8;CLEC4C;IL3RA;GMFG;CD37;CD300LF;NCKAP1L;SLA;CARD6;ARHGAP9;BLNK;SPI1;WDFY4;MYO1F;CD83;TAGAP
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.679132995265286,-1.420155871004514,0.06349206349206349,1.0,1.0,9/38,10.96%,MS4A6A;HCK;PTPRC;CD14;DRD3;FGL2;CD300LF;TUBB;SPI1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.8448605630751136,-1.419697020606095,0.047619047619047616,1.0,1.0,3/7,10.93%,ATP5IF1;PINK1;DNAJA1
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.8771153709538856,1.4195285221013039,0.06521739130434782,0.7932733517206665,1.0,1/6,0.50%,TACR1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.7524161470438224,-1.4194009362855882,0.0,1.0,1.0,5/20,8.55%,RAB6C;CHMP4B;ATF5;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9099159510422727,-1.4193720862542225,0.04918032786885246,1.0,1.0,1/6,0.06%,SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.7603432239309716,-1.4191478947801333,0.04411764705882353,1.0,1.0,4/12,15.57%,CHAC1;SERPINE1;CTSZ;GAS1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.561827319887293,1.4189809952420473,0.058823529411764705,0.7928609993903636,1.0,4/48,3.09%,NRK;NYAP2;SGK1;BMP7
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.8135962726489692,-1.4176293056002676,0.09615384615384616,1.0,1.0,2/8,8.18%,NCKAP1L;ZBTB7B
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.7793032318116511,-1.4164781343901023,0.08695652173913043,1.0,1.0,2/15,3.21%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.9025860684729603,-1.4164101250631813,0.03571428571428571,1.0,1.0,2/5,5.51%,ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5277332526681685,1.4157387710487048,0.0,0.8084533189843536,1.0,12/69,6.94%,RUNX1;KIT;IFI16;TOX;KDR;CSF1R;KITLG;TGFB2;SELPLG;MEIS1;JAG1;TET2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6483780641992901,-1.4156520861642368,0.06557377049180328,1.0,1.0,8/32,13.82%,TERF2IP;RAD51AP1;H1-0;H1-2;PPP4C;FIGNL1;MRE11;CHEK1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6951220328978134,1.4155691739343428,0.1388888888888889,0.806286935495432,1.0,3/13,4.61%,ITGA4;SELPLG;JAM2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.7382384920591626,1.415271243499792,0.08571428571428572,0.8051954997645757,1.0,5/13,19.32%,PLCB1;RANBP3L;RIPOR2;MEF2C;AKIRIN1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.7499956840524333,-1.4146861285126335,0.07692307692307693,1.0,1.0,4/18,10.78%,CD44;CEMIP;TGFB1;HAS3
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.8919564949845391,-1.4144402716005373,0.06666666666666667,1.0,1.0,1/5,7.61%,NCBP2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.8919564949845391,-1.4144402716005373,0.06666666666666667,1.0,1.0,1/5,7.61%,NCBP2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7313364027803873,1.4141562279064406,0.034482758620689655,0.8095449825454286,1.0,5/20,8.76%,PPP1R3B;IRS1;ENPP1;IGF1;IRS2
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8523889485343048,-1.4136362075204643,0.06153846153846154,1.0,1.0,3/6,8.42%,STAT1;IL21R;STAT4
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8523889485343048,-1.4136362075204643,0.06153846153846154,1.0,1.0,3/6,8.42%,STAT1;IL21R;STAT4
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5786475802506704,1.4131602486397412,0.030303030303030304,0.8118654154832889,1.0,9/37,9.55%,NPNT;WWTR1;BMP7;BMP6;ACVR1;ZHX3;IGF1;PRKD1;NELL1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6982111814162256,-1.4129664562429805,0.0,1.0,1.0,6/28,14.55%,CENPK;CENPO;CENPU;ITGB3BP;CENPL;OIP5
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.8859577873566473,1.412743996676191,0.10869565217391304,0.8043797286090973,1.0,1/5,0.50%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.8859577873566473,1.412743996676191,0.10869565217391304,0.8043797286090973,1.0,1/5,0.50%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.8859577873566473,1.412743996676191,0.10869565217391304,0.8043797286090973,1.0,1/5,0.50%,TACR1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5902524639018079,1.4124879235801413,0.045454545454545456,0.8032154674356129,1.0,38/114,11.84%,RNF150;RIMBP2;CNGA3;ZNF385D;SGCD;SEMA6D;FGF14;GRIA4;PENK;RAB3C;NTM;CACNA2D1;ZNF536;PCDH18;OLFM3;PDZRN3;UNC5D;GRIA2;PDZRN4;KCTD16;CNTN4;LSAMP;PDGFRA;RAB27A;NRXN1;GRIA1;CADM2;TMEM196;PCSK2;NOVA1;CSRNP3;RBFOX1;ANGPT1;ROBO2;ADGRB3;SGIP1;FGF10;ST8SIA3
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.8231038010800388,1.4123984167759258,0.11904761904761904,0.8009244581621687,1.0,1/6,14.03%,SRM
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.904039384653716,1.4123158340064474,0.058823529411764705,0.7953673240602407,1.0,3/5,6.67%,SLC22A2;SLC6A4;SLC22A3
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.904039384653716,1.4123158340064474,0.058823529411764705,0.7953673240602407,1.0,3/5,6.67%,SLC22A2;SLC6A4;SLC22A3
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.6811900180211061,1.4120561140340142,0.07142857142857142,0.7939968349450265,1.0,3/18,4.31%,IFI16;CSF1R;BATF3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.8590464678424915,1.4118550908714826,0.0,0.7921783754628717,1.0,4/7,10.31%,PTPRT;PTPRB;PTPRO;DUSP10
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.9128271651822472,1.4116795849980044,0.047619047619047616,0.7899674093863669,1.0,1/5,0.84%,IMMP2L
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.7743741693015741,1.4107784673374235,0.12195121951219512,0.7925697617030398,1.0,3/9,10.45%,ZNHIT6;NAF1;RUVBL2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6833041748713973,1.4107696096699278,0.1,0.7897691618383648,1.0,6/20,16.51%,CACNA2D1;GRIN2A;GRIN2C;SLC8A1;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.8647682885198152,1.4104296035165602,0.10810810810810811,0.7862756862075008,1.0,1/7,0.27%,TAS2R7
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),0.8647682885198152,1.4104296035165602,0.10810810810810811,0.7862756862075008,1.0,1/7,0.27%,TAS2R7
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7769613182297489,1.4101906020875152,0.12121212121212122,0.7849705294757106,1.0,4/9,14.42%,MTHFS;MTHFD2L;MTHFD1L;MTHFD2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7108727758923803,1.409848991786194,0.08823529411764706,0.7841210626200086,1.0,2/17,1.60%,EPHA3;MCTP1
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.8249042842121861,1.4098145618733928,0.14705882352941177,0.7787931757437254,1.0,1/5,1.32%,PDE3A
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.8249042842121861,1.4098145618733928,0.14705882352941177,0.7787931757437254,1.0,1/5,1.32%,PDE3A
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7213105469108018,-1.409557071509204,0.07142857142857142,1.0,1.0,4/23,4.21%,CD44;MSX1;HIC1;CD74
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6363401314342083,1.4082524116056645,0.06060606060606061,0.7826881951570553,1.0,7/17,14.42%,MTHFS;MTHFD2L;SLC19A1;PM20D2;DHFR;MTHFD1L;MTHFD2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7213268864253197,1.4076274363016035,0.047619047619047616,0.7829349179909663,1.0,4/21,4.51%,PID1;ACADVL;LEPR;COX10
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.7161508809479821,-1.4075477818378521,0.031746031746031744,1.0,1.0,1/31,0.02%,CD44
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.942025296681742,-1.4068245680462623,0.016129032258064516,1.0,1.0,1/5,0.19%,SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6489694543863014,1.4066497628356482,0.125,0.785959952013802,1.0,2/15,8.86%,LRRTM3;SLC2A13
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6498053024618072,-1.406499777757961,0.058823529411764705,1.0,1.0,14/48,14.05%,C3AR1;MS4A6A;HCK;SIGLEC1;KLHDC4;CD14;FGL2;CD300LF;TRIM25;SPI1;WDFY4;MYO1F;IGSF6;AQP9
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5334088082092404,1.406020748661844,0.0,0.7867770902246426,1.0,6/53,8.90%,EPHA3;CDH13;MCTP1;CD22;APOE;PRKD1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6816001932576496,1.40510954601549,0.058823529411764705,0.7888481140052199,1.0,5/15,21.11%,CYSLTR2;ADCY2;ADCY9;ADCY8;PRKACB
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5460180070536167,1.4044239767203008,0.10714285714285714,0.7898913017298653,1.0,8/62,6.31%,FRMPD1;EGFR;NECTIN3;PARD3;ZDHHC14;ZDHHC11B;RAB3IP;REEP1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.8580683207282251,-1.404231789059438,0.03278688524590164,1.0,1.0,3/11,4.60%,PTGIS;CD74;PTGES
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.8434621936601678,-1.4037725204337628,0.11666666666666667,1.0,1.0,3/6,13.04%,ALOXE3;ALOX12;GSTP1
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.8434621936601678,-1.4037725204337628,0.11666666666666667,1.0,1.0,3/6,13.04%,ALOXE3;ALOX12;GSTP1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6669733557398126,1.4028126833157344,0.046511627906976744,0.795738727712143,1.0,8/27,14.04%,MCTP1;EPHB2;APOE;NSMF;SHISA9;PPFIA3;ZDHHC2;GRIK2
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.7944187578198596,1.4028049734287806,0.07547169811320754,0.7930594727366813,1.0,1/8,0.65%,ADARB2
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.8442982790126524,-1.4020424963225424,0.07547169811320754,1.0,1.0,1/7,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.707418131633543,-1.4019176809013596,0.0136986301369863,1.0,1.0,3/24,4.48%,KCNE2;ATP1B1;CAV3
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.7834113662625528,1.4018112772059699,0.06666666666666667,0.794269186347511,1.0,1/9,2.59%,SLC25A37
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7029750967423946,1.401438252318463,0.04878048780487805,0.7931845619681006,1.0,4/15,10.02%,SMPD4;GDE1;PLA2G4C;LYPLA2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.865724873829575,1.4013864461173233,0.08695652173913043,0.7908729129714722,1.0,3/7,4.21%,PNP;SLC2A9;SLC16A9
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.8893689916584513,1.4008970113687131,0.1282051282051282,0.7907530517218844,1.0,2/5,1.39%,NPNT;ITGA4
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.5649477862631314,1.4007384977981987,0.06666666666666667,0.788747704918044,1.0,3/50,2.42%,EPHA3;NRP1;KDR
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.940543898142166,1.3999943487395035,0.0,0.7902806959636727,1.0,3/5,3.89%,NRP1;DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.725484614487171,-1.3999719296790265,0.10606060606060606,1.0,1.0,5/15,18.28%,SOX10;PLP1;EIF2B2;CNTNAP1;EIF2B5
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.6962141702805041,1.3995516340883694,0.10810810810810811,0.7900702721573821,1.0,3/12,10.56%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7236017986306426,1.397621319640637,0.0625,0.7968651998172404,1.0,2/7,4.19%,TGFB2;GCH1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.8107868610110891,-1.3975984217756123,0.14814814814814814,1.0,1.0,1/7,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8345249090322513,-1.3973267096366562,0.05555555555555555,1.0,1.0,3/10,4.67%,CD44;CD74;ING2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8345249090322513,-1.3973267096366562,0.05555555555555555,1.0,1.0,3/10,4.67%,CD44;CD74;ING2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.8672063171218592,1.3965034755593932,0.11363636363636363,0.8008232830485208,1.0,1/6,0.65%,ADARB2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.6784764497268736,1.3961609930525292,0.08333333333333333,0.7999775184193375,1.0,4/15,18.40%,KCNB2;CHRM3;MYOCD;CHRM2
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.8690767794759708,1.3960297590032578,0.125,0.7981662406093736,1.0,1/5,3.64%,BMP6
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7556499563487407,1.3949087490374177,0.06976744186046512,0.8018973305510931,1.0,1/12,0.11%,NRG1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.769898218718986,1.3946910048328223,0.15789473684210525,0.8002293655491273,1.0,3/11,2.08%,ALK;TYSND1;CIDEA
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.7069744849776365,1.394027641377587,0.07894736842105263,0.801090704164022,1.0,2/12,4.18%,LTBP1;TGFB2
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.7790564068198932,1.393524459784406,0.08333333333333333,0.8008510283777636,1.0,2/10,2.21%,RUNX1;MELTF
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.863036264222077,-1.3934270752204903,0.07936507936507936,1.0,1.0,2/7,6.23%,HCK;KIF9
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.8293318601233526,1.3930844404843805,0.07547169811320754,0.8000668875551071,1.0,2/9,6.67%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.8911341538047681,-1.3929322690053434,0.03636363636363636,1.0,1.0,1/6,0.60%,SLC12A7
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.7055576462551119,1.3917720911321179,0.02702702702702703,0.8044128343067054,1.0,2/17,6.16%,ATP6V0D2;CLN6
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.7837514857913853,-1.391233374338127,0.08955223880597014,1.0,1.0,1/9,0.71%,MCM2
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.8287042159969316,1.3909040347981927,0.07894736842105263,0.8071940197903541,1.0,3/7,2.42%,CDH13;F2RL1;KDR
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.7262735850990213,1.3906836112213694,0.1,0.8062169795849985,1.0,5/7,24.54%,REL;PTPRS;YY1;CACTIN;RELB
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8729576117165406,1.3903018823915088,0.09523809523809523,0.8058301362167812,1.0,5/6,12.16%,RUNX1;CBFB;HMGB1;TWSG1;TARM1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5070086758749467,1.3898187272805733,0.041666666666666664,0.806341411926168,1.0,13/67,8.51%,CDH13;CDH6;F2RL1;CDH20;PKP2;CSF1R;SDK1;NECTIN3;TGFB2;CDHR3;TGFB3;CADM2;PKHD1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.7618409699164814,-1.389771807713215,0.034482758620689655,1.0,1.0,4/14,8.25%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7510246349179298,1.38937341137002,0.08333333333333333,0.805867316007484,1.0,6/13,14.59%,FHDC1;VTI1A;PRMT5;TMED5;STX6;TRIP11
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8644309182658734,1.3890195894350026,0.125,0.8018223825679851,1.0,3/5,12.64%,KCNC2;MTR;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8644309182658734,1.3890195894350026,0.125,0.8018223825679851,1.0,3/5,12.64%,KCNC2;MTR;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.6703499035220581,1.3887679905741468,0.07407407407407407,0.8005706343361542,1.0,3/22,4.81%,NRG1;CTNNA2;OLFM2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.4761914506633149,1.3885587232213867,0.0,0.7994589100159483,1.0,10/116,6.10%,FBXL7;TPD52L1;CCNH;NEDD1;KDM8;PCM1;PLCB1;LATS1;CDK14;TAF2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.8413908442756749,1.3878050342405093,0.058823529411764705,0.8012111209841712,1.0,2/9,0.67%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.8180611320665186,1.3867022608274482,0.03125,0.8017126929892946,1.0,2/9,4.33%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.8180611320665186,1.3867022608274482,0.03125,0.8017126929892946,1.0,2/9,4.33%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.6979078232377693,1.3865666084803445,0.05128205128205128,0.8000449029861089,1.0,2/16,6.40%,UBASH3B;LRRC17
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6006287216367745,-1.3859254318146623,0.028985507246376812,1.0,1.0,58/87,33.47%,RPL36;RPL15;RPL38;RPL28;RPS21;RPS7;RPL9;RPL37A;RPL26L1;RPL22;RPL35A;RPL5;RPS20;RPL22L1;RPL8;RPLP1;EIF4A2;RPS8;RPL4;RPL3;RPL34;EIF3I;RPL37;RPL24;ZC3H15;RPS24;RPS15;RPL7A;RPL13A;RPL27A;RPS4X;RPL23;RPL35;RPS3;RPS27A;RPS29;RPL19;RPL18;RPS13;RPL32;RPL13;RPS5;RPL27;RPS2;RPS9;RPL29;RPS25;RPL31;RPL21;RPSA;RPS19;RPL11;UBA52;TMA7;RPS12;RPS18;RPS28;RPS16
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.5430270783401444,1.385561299167945,0.125,0.8023384050522558,1.0,21/85,17.55%,PER2;GLP1R;IRS1;ITPR2;EPHA5;MCU;EFNA5;IRS2;CELA2A;KCNC2;MYRIP;RBP4;KCNS3;RAPGEF4;EIPR1;KCNA5;CACNA1A;RFX3;RAP1A;ENSA;GCK
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.7695826827342497,1.385343358242722,0.05128205128205128,0.8011117213041286,1.0,5/11,12.61%,PNP;ADA;HPRT1;APRT;GMPR
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5713758907266423,1.38533857530903,0.12,0.7987704215971286,1.0,15/51,17.55%,PER2;GLP1R;ITPR2;CHD7;CELA2A;KCNC2;KCNS3;RAPGEF4;EIPR1;KCNA5;CACNA1A;RFX3;RAP1A;ENSA;GCK
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.7796044964561561,-1.3847881935383373,0.12121212121212122,1.0,1.0,1/11,0.19%,SLC19A3
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.83487951963733,-1.384649117109483,0.078125,1.0,1.0,1/7,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.859222149881678,-1.3844761729660062,0.03333333333333333,1.0,1.0,2/7,6.25%,STAT1;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.626530963496099,1.384366227696949,0.12121212121212122,0.8004446313648809,1.0,3/29,3.34%,PLEKHH2;KANK1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.8077891645006637,-1.3843444087536108,0.14035087719298245,1.0,1.0,1/8,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.8761098576577228,1.3843092813155973,0.08333333333333333,0.7981623409902616,1.0,1/5,2.66%,CROCC
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.7641896903356473,1.384037024884838,0.05263157894736842,0.796877398927,1.0,3/12,4.68%,SLC2A9;SLC2A14;SLC2A11
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7730064163566797,1.3836591853816176,0.08571428571428572,0.7963676522112659,1.0,6/8,20.53%,FZD1;RYK;LRP6;WNT5A;WNT3;CTNNB1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.8454926900854538,1.38357460279312,0.06,0.7942455053508815,1.0,3/7,5.27%,LEPR;GREM1;MDK
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7651961845226869,-1.3830970308358583,0.078125,1.0,1.0,2/12,7.05%,TICRR;CDC6
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.7976069452122028,1.3830801831956954,0.18421052631578946,0.7945943287748772,1.0,2/6,9.47%,SULF2;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.8496084874506694,1.382448671583294,0.175,0.7953636757689706,1.0,1/5,6.04%,MACROH2A2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6207202246558702,1.3824197375774787,0.125,0.7933897379145469,1.0,10/24,20.26%,CHSY3;VCAN;B3GAT2;CHST12;CHST11;CHSY1;B3GAT1;B3GAT3;CHST9;CHST7
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.9022575402737162,-1.3813943515408242,0.11320754716981132,1.0,1.0,2/5,3.18%,ALPL;CDKN2D
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.5928769006597592,-1.3813048482973083,0.0410958904109589,1.0,1.0,8/71,8.64%,CD44;ENPP2;PTPRC;AGT;CD74;ITGA5;IL15;TGFB1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.7553637841284696,-1.3801858445913158,0.0967741935483871,1.0,1.0,1/8,1.47%,WFS1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8035019887497306,1.3801693768327254,0.05,0.802308050225179,1.0,3/8,9.61%,EFS;MCU;CASS4
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6768972770616783,1.3801482541869912,0.08823529411764706,0.8001996396479948,1.0,7/15,21.07%,NFATC1;HRH1;NFAT5;PPP3CA;EDN1;NFATC2;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),0.7884845478930873,1.3797900551160442,0.13157894736842105,0.799523559648685,1.0,2/6,1.33%,SPX;GLP1R
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6268583103286749,1.3796503944338407,0.07142857142857142,0.7978520362109796,1.0,8/24,11.11%,TEAD2;WWTR1;LATS1;WWC1;FAT4;AMOTL2;DVL2;DCHS1
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.9125961499914781,1.379587287774395,0.05714285714285714,0.7957750578371356,1.0,2/5,6.58%,CDH26;HMGB1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.689592473171604,1.3793925074781321,0.1935483870967742,0.7943311465903382,1.0,5/18,12.77%,LMCD1;HOMER2;IGF1;FHL2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7905495065644477,1.379209174385926,0.125,0.7929781647362586,1.0,6/7,18.50%,GRIN3A;NLGN1;PTPRS;SRGAP2C;NGEF;PTEN
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.8002843351480542,-1.379111374266592,0.08333333333333333,1.0,1.0,2/9,7.05%,TICRR;CDC6
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.6434877966735759,1.3786956140335171,0.08333333333333333,0.7934028896757714,1.0,2/21,3.77%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.7558684491857277,1.3785118546532733,0.06451612903225806,0.7917320488840726,1.0,2/11,3.94%,CTNNA2;SLC6A4
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.8085640343158884,-1.378441771799106,0.045454545454545456,1.0,1.0,1/10,0.55%,CD4
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6094513748262935,1.3779058407233156,0.125,0.7929354618607054,1.0,6/23,14.30%,IRS1;IGF1;IRS2;PIK3R1;AKT2;BRAF
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5792241597265196,1.3778244702129872,0.12903225806451613,0.7909898911160519,1.0,6/33,7.36%,ACE2;PID1;F2RL1;RAB27A;PRKCD;AKR1C3
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.667507432098543,-1.377640126003608,0.016129032258064516,1.0,1.0,6/32,14.55%,CENPK;CENPO;CENPU;ITGB3BP;CENPL;OIP5
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.828019118984253,1.3774620749479802,0.11538461538461539,0.790154060898286,1.0,2/6,6.67%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7145306724810125,1.3768659082180468,0.16279069767441862,0.790945945838124,1.0,4/8,7.35%,TGFBR1;TGFB2;ACVR1;TGFB3
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5786916914376307,-1.3758087326030701,0.025974025974025976,1.0,1.0,20/79,14.05%,C3AR1;MS4A6A;CD4;HCK;SIGLEC1;PTPRC;CD14;SLCO2B1;P2RY12;FGL2;IL21R;CD300LF;SLA;SPI1;WDFY4;MYO1F;MAFB;TAGAP;IGSF6;AQP9
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7830144855287656,1.3757133469024578,0.13953488372093023,0.7937562588460714,1.0,3/7,11.60%,PNP;HPRT1;PRTFDC1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.823795511486767,-1.375684056913639,0.0847457627118644,1.0,1.0,2/8,5.24%,ARR3;DRD3
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.45477325591480344,1.3756264044591289,0.0,0.7917900650900758,1.0,51/257,14.30%,NRG1;NRK;PTPN3;KIT;IRS1;DUSP5;EGFR;RCE1;FGF13;KDR;FGFR4;KITLG;PDE6D;SPRED1;FGFR3;LRRC7;GFRA1;MAP3K20;PDGFRA;BTC;RASGRP1;NRG2;NRTN;IGF1;SHC3;RASA2;IRS2;PSPN;ERBB4;EREG;FGFR1;ANGPT1;RASGRF1;IL2RA;MAP3K5;FYN;MAPK8;PIK3R1;FGF10;RASAL2;ABHD17A;MAPK12;BTRC;SPTB;PRKG2;IL17RD;MBP;SPTBN4;PDGFB;DLG2;BRAF
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5833050741083571,1.3756124925093496,0.1111111111111111,0.7895533699909514,1.0,2/21,3.95%,UNC13B;ZBTB20
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.653492704343671,-1.3751891690848757,0.09333333333333334,1.0,1.0,8/32,16.53%,H1-0;H1-2;NCAPH2;NCAPG;SMC2;TTN;GPER1;SET
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8068020353780382,1.3750767272797675,0.16279069767441862,0.7902577910805182,1.0,1/6,0.96%,RFWD3
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5526220352367086,1.3748312217810905,0.04,0.7893981003918115,1.0,13/85,3.13%,ABI3BP;KIT;PRRX1;ADAMTS2;COL15A1;ITGA4;SVEP1;SGCD;TLR1;SSC5D;LAMA4;PCDH18;FNDC1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7618184339624609,1.3747446547554139,0.17647058823529413,0.7875459283486237,1.0,2/9,4.06%,PPP1R3B;RUBCNL
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5938831644291317,1.3745503149092955,0.10810810810810811,0.7866588349646998,1.0,8/30,18.37%,KIT;S100A13;BORCS6;PLEKHM1;PIP4P1;BORCS5;MAP6;NR4A3
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8113406033929431,1.374318757828506,0.11764705882352941,0.7853403173128087,1.0,3/6,12.66%,HRH1;GABRB1;GABRB3
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8865686528125383,1.3741058821681678,0.09090909090909091,0.7839895652895477,1.0,3/6,8.39%,C5AR1;ZBTB1;TFCP2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.7448394970119704,-1.373053939350094,0.09230769230769231,1.0,1.0,4/13,12.16%,CSRP3;ACTC1;TTN;PDGFRB
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.8158427606066387,1.3727192164574815,0.15555555555555556,0.788563779619775,1.0,2/5,11.55%,BMP7;FGF10
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.6976313499106075,1.372440162560722,0.175,0.7881951084436593,1.0,3/12,4.61%,ITGA4;SELPLG;JAM2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.8357441780626793,1.3723908568393124,0.0975609756097561,0.7861807021834518,1.0,1/6,6.54%,ZNHIT6
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.4749409458981688,1.371611770025293,0.0,0.7878550905887565,1.0,26/164,11.58%,RUNX1;FRMPD1;GNG4;UBASH3B;RGS14;DOK5;KCTD8;RORA;WWTR1;PLCB1;GRK5;CBFB;KIF26A;SEMA5A;ACVR1;AKR1C3;RFNG;PTCH1;PRKD1;SLC8A3;TSPAN12;RGS11;ZDHHC3;FYN;PRAG1;YJEFN3
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.6901305751801057,1.371526194189955,0.07317073170731707,0.786320864433591,1.0,1/16,0.11%,NRG1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7671202628903161,1.3713168860535991,0.14285714285714285,0.7849506658420832,1.0,2/9,7.57%,GALNT3;GALNT13
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.7578822279475921,-1.370905426712138,0.09836065573770492,1.0,1.0,2/13,4.94%,HSD17B10;RPP38
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5504692629280785,1.3703010294149773,0.19047619047619047,0.7872744025418726,1.0,33/109,13.83%,PTPRT;KCNIP1;LRRTM3;ZNF536;NTSR2;ADGRA1;MAPK4;OLFM3;RGS7BP;HS6ST3;GRIA2;SPHKAP;GRM5;KCTD16;UBE2QL1;MMD2;BRINP1;CADM2;TMEM196;RBFOX1;PAK5;SLC6A1;PARM1;KCNC2;SYN2;ADGRB3;ST8SIA3;ELAVL3;PPFIA2;SEMA3C;BRINP2;NXPH1;SPTBN4
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.830967241425565,-1.3695280387785014,0.08620689655172414,1.0,1.0,3/7,13.72%,NOTCH1;CAV3;MLIP
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.4932352525612837,1.3695110871038034,0.12,0.7894307123139777,1.0,33/123,12.13%,FEZF2;LRRTM3;CDH20;OXTR;GRIA4;RAB3C;CTNNA2;CACNG3;ADGRA1;KCNB2;OLFM3;KCND2;NGB;GRIA2;SPHKAP;GRM5;GRIN2A;MMD2;BRINP1;NRXN1;GRIA1;CADM2;TMEM196;SEZ6L;POU3F1;RBFOX1;PAK5;SLC6A1;KCNC2;ADGRB3;DAB1;ST8SIA3;ELAVL3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6894560711313843,-1.3681987729502139,0.06451612903225806,1.0,1.0,2/28,4.87%,EPN1;ITGA5
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.6865084441419904,1.368047351248801,0.11428571428571428,0.7935436595909798,1.0,2/11,2.42%,NRP1;KDR
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.546599184594737,1.3674599414779858,0.09090909090909091,0.7940932676185609,1.0,23/56,22.37%,GRIA4;CACNG3;GRIA2;GRIN2A;LRRC7;CACNG4;GRIA1;NLGN1;DLGAP1;SHISA9;DLGAP4;DLG2;GRIN2B;MEF2C;GRIN1;RELN;DLGAP3;DLGAP2;CNIH2;AKAP9;DLG3;CACNG2;CACNG5
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7808298359898448,1.3669673618042462,0.1590909090909091,0.7946399127996321,1.0,3/6,12.58%,NRP1;ROBO2;PTPRM
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.8570994296371905,1.366747498516263,0.08571428571428572,0.7938437015149502,1.0,3/6,10.45%,MACROH2A2;LRWD1;RUVBL2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.6887871950700506,1.365523383528709,0.1388888888888889,0.7977098074426378,1.0,3/16,6.67%,SLC22A2;SLC25A26;SLC22A3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.5797712495834011,1.3652745041389729,0.029411764705882353,0.7967573311631378,1.0,6/31,13.49%,LRRTM3;IGF1;APOE;SLC2A13;BIN1;SORL1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7056753824908817,1.3642375971134904,0.1111111111111111,0.7995316896417,1.0,4/8,20.63%,KLF2;MAPK7;SREBF2;NFE2L2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6869606610734614,1.363609513623632,0.10714285714285714,0.80107925608605,1.0,2/15,1.23%,RAB7B;F2RL1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.674924304505041,1.3636032854344748,0.037037037037037035,0.7990299286640558,1.0,5/18,9.65%,RGS14;GRIN2A;SHANK2;SLC8A3;GRIN2C
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.8434142390853419,1.3634503128876396,0.16666666666666666,0.7975942552071338,1.0,2/5,8.11%,CCL28;FUT9
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6155044114446537,-1.3634225427449784,0.056338028169014086,1.0,1.0,5/59,9.76%,CD44;TERF2IP;PINK1;TGFB1;CALCR
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.710554696622338,1.3634112493348376,0.21428571428571427,0.7956025137078833,1.0,3/13,3.78%,ALK;CIDEA;SLC22A13
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.46401962588539586,1.3629116765788916,0.0,0.7954951246635088,1.0,10/115,6.10%,FBXL7;TPD52L1;CCNH;NEDD1;KDM8;PCM1;PLCB1;LATS1;CDK14;TAF2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.48618673487668396,1.3626418287513171,0.05555555555555555,0.7942295495277407,1.0,16/90,9.95%,LRIG3;KIT;LAMB2;EGFR;WWTR1;CACNA2D1;KITLG;FIGN;ADGRL2;DDAH1;PKDCC;MID1;CAP2;GNG12;AMOTL2;TSPAN12
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.8478720213791417,-1.3626165643974868,0.09523809523809523,1.0,1.0,3/7,11.23%,CSRP3;CAV3;TTN
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.5892831621645328,-1.3622579718200578,0.041666666666666664,1.0,1.0,15/68,14.79%,CSRP3;TRPV6;WFS1;GCM2;CALCB;ELANE;ATP1B1;DRD3;FAM20A;CCL5;SLC24A1;SLC24A5;HTR2B;ATP2A3;TMEM203
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.8118714256147447,1.3620332607528496,0.11764705882352941,0.7946855345075156,1.0,3/7,16.62%,SLC16A2;SIRT2;WNT5A
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.8516730561134064,-1.3616406357531716,0.140625,1.0,1.0,3/5,7.25%,DRD3;SLC51A;ABCB4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.5584512683337144,1.3609875420896127,0.1875,0.797184249317265,1.0,8/37,8.73%,MDGA1;B4GALNT2;JAG1;EFNA5;ADA;FUT9;PKHD1;EPHA7
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.6217257749300918,-1.3609530373141177,0.05714285714285714,1.0,1.0,13/42,15.49%,CD4;GNLY;PTPRC;GMFG;CD37;NCKAP1L;SLA;CD6;ARHGAP9;MYO1F;TAGAP;GBP5;GPR183
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7045246046490024,1.360689521967007,0.15151515151515152,0.7964804677640747,1.0,2/16,2.26%,SLC39A11;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.8419139993784486,1.3605259867584567,0.06896551724137931,0.7952994634735966,1.0,2/5,4.81%,KIT;OLFM2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.5706703516723239,1.360233487090911,0.03333333333333333,0.7944935267959471,1.0,10/57,7.06%,TPD52L1;TNFRSF19;F2RL1;RASSF2;SH3RF1;TRAF3;PLCB1;SH3RF3;HMGB1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5791729111603179,-1.3586986627218418,0.025974025974025976,1.0,1.0,10/63,14.88%,CD44;CDKN2D;NODAL;CARD8;IFI6;BCAP31;REST;GPER1;BEX3;CYCS
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.7278308769453397,-1.358681857626612,0.05263157894736842,1.0,1.0,1/14,1.02%,TERF2IP
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5167556734690503,1.358453599517869,0.1,0.8003524658336149,1.0,19/97,7.41%,FBXL7;LAMB2;PRRX1;SVEP1;SEMA6D;CACNA2D1;EFS;LAMA4;BMP7;PCDH18;PDZRN3;ALDH1A2;GUCY1A2;ADGRL2;GFRA1;FAT4;PDGFRA;PKDCC;HTRA1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.7649972835183607,-1.3581499819065475,0.15384615384615385,1.0,1.0,1/11,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.4606699195247063,1.3579264475971535,0.0,0.8004552768258686,1.0,18/139,10.81%,RUNX1;ATOH8;MDGA1;PER2;FGF13;NRP1;SH3RF1;IL1RAPL1;TGFB2;HEY1;LRP12;FUT9;TAFA1;FZD1;RYK;AUTS2;FGFR1;SPOCK1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.6103008120694818,1.3576106717561556,0.125,0.8002280664737563,1.0,4/33,2.26%,TRPC7;TRPC3;MELTF;SLC30A10
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5395370777539163,1.3570135798632976,0.041666666666666664,0.800841899269432,1.0,17/72,14.46%,NTNG1;CTNNA2;PARD3;SEMA5A;VASH2;AMIGO1;EPHB2;DSCAML1;CNTN4;RYK;MTR;SLITRK5;SVBP;DHFR;SPTBN4;PAK3;NRCAM
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6888350254741235,1.3566630142860276,0.12121212121212122,0.8004327471098397,1.0,4/14,16.44%,TPR;ANP32B;BAG3;EMD
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.5509777838187636,1.3565435634859915,0.0625,0.7987904582115184,1.0,7/37,6.43%,KCNJ16;KCNJ6;AMIGO1;KCNJ3;KCNN3;KCNN2;KCNJ2
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.8326458580926932,-1.3564959835188892,0.07142857142857142,1.0,1.0,1/7,0.72%,C4BPB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.8326458580926932,-1.3564959835188892,0.07142857142857142,1.0,1.0,1/7,0.72%,C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.8326458580926932,-1.3564959835188892,0.07142857142857142,1.0,1.0,1/7,0.72%,C4BPB
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.7123933461410423,-1.3558247179758207,0.13043478260869565,1.0,1.0,7/19,20.52%,ELANE;RARRES2;SERPINE1;ADGRB1;SLC11A1;LBP;ROMO1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.8396871580776112,-1.3550344263118086,0.07272727272727272,1.0,1.0,3/6,11.72%,LMAN1;DNAJA1;BAG4
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.637101611722611,1.354764600288603,0.17142857142857143,0.8055274315425188,1.0,4/14,13.92%,RORA;SIRT1;MLYCD;FOXK1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.7721292363119294,-1.3546229107177017,0.12903225806451613,1.0,1.0,3/12,7.84%,TNFSF18;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6921055791841912,-1.3545841229612277,0.10714285714285714,1.0,1.0,3/18,7.74%,LRPAP1;RAC1;RIN3
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8449146185716074,1.354554155019452,0.08333333333333333,0.8043142969622915,1.0,2/5,10.41%,EGFR;NOS1AP
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.8771087331911711,-1.3544736299531697,0.034482758620689655,1.0,1.0,2/5,3.85%,RAD54L;FANCM
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.8063648121653539,1.3537896381727357,0.11904761904761904,0.8056310988351184,1.0,1/5,1.99%,HORMAD1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.6856970337841094,-1.353243990452742,0.0847457627118644,1.0,1.0,6/27,11.06%,CD4;TNFSF18;FGL1;IL4I1;CCL5;HLA-DPB1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.8302011358545922,-1.3526395981776855,0.03333333333333333,1.0,1.0,1/8,1.16%,HSD17B10
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5313273567667661,-1.352342127889388,0.0547945205479452,1.0,1.0,13/116,6.27%,CD44;OLFML1;CALB1;LAMA2;ALPL;LRP4;HSPG2;SFRP4;TIMP3;ITGA5;OSMR;ANGPTL2;COL6A1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.7617527081657907,1.3521891192970452,0.20588235294117646,0.8089981251946309,1.0,1/7,5.18%,EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.7617527081657907,1.3521891192970452,0.20588235294117646,0.8089981251946309,1.0,1/7,5.18%,EEFSEC
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.8229876647989216,1.3521877173104657,0.05,0.8069654665886143,1.0,4/7,8.76%,NFIB;NRP1;EPHB2;RYK
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6966224217112273,1.352000735187598,0.15625,0.8057996228526277,1.0,2/13,3.43%,KDR;HDAC9
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5670913965945001,1.3517446782894225,0.11428571428571428,0.8048532294702776,1.0,4/32,5.75%,LEF1;NFATC1;PLCB1;GNAO1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.714688812250945,1.3512232131373154,0.12121212121212122,0.8054031751518734,1.0,8/12,18.37%,IRS1;IRS2;ABCD2;PLIN5;AKT2;MLYCD;PPARA;NR4A3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6668090878047833,1.3509994769685212,0.08108108108108109,0.8046041819447813,1.0,8/21,15.55%,GRIN3A;FOXO6;NLGN1;APOE;PTPRS;PPFIA2;SRGAP2C;MEF2C
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.7515283126117209,-1.3509638537679034,0.08450704225352113,1.0,1.0,2/13,13.62%,DDX20;PRPF19
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.9069594078137637,-1.3506771077958457,0.05,1.0,1.0,1/5,1.65%,LOXL4
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.8266474561739353,-1.3505295848430574,0.08955223880597014,1.0,1.0,2/7,8.85%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.7864380167256421,1.350455662704038,0.13043478260869565,0.8051520163513455,1.0,2/7,8.12%,PNP;HPRT1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.6484067428833638,-1.3504173479610206,0.1,1.0,1.0,4/39,7.34%,TICRR;TERF2IP;TOM1L1;SUB1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.5637588083218306,1.350138746132863,0.09090909090909091,0.8044281022611073,1.0,3/46,3.77%,RUNX1;RAB7B;CBFB
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7043010756540309,1.3500407562069392,0.2,0.8030396475714512,1.0,2/11,3.66%,UNC13C;UNC13B
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8349616994312841,1.3500212060268801,0.07894736842105263,0.801096794767081,1.0,3/8,4.44%,SPRED1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.780416985139039,1.3494310599363315,0.14285714285714285,0.8023476862485669,1.0,4/6,17.98%,SLC30A10;PRKCD;RELA;NFKB1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.8248298751879901,1.3486172684844002,0.2,0.8034528242522311,1.0,1/5,3.64%,BMP6
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.8089609668360311,1.3485605160929777,0.17543859649122806,0.8016973123444809,1.0,2/5,6.67%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7710378902843731,-1.3485589241925928,0.15789473684210525,1.0,1.0,2/9,4.79%,H1-0;H1-2
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.7899523038749928,1.3483440686977075,0.05,0.8006103316434631,1.0,2/6,2.27%,PHACTR1;NRP1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.6644653045402362,1.3479098053824237,0.06060606060606061,0.7983830670040775,1.0,3/12,6.92%,OGDH;AASS;HYKK
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.6644653045402362,1.3479098053824237,0.06060606060606061,0.7983830670040775,1.0,3/12,6.92%,OGDH;AASS;HYKK
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.7231592759052299,1.3474823161141634,0.175,0.7981051119553028,1.0,3/11,9.89%,LTBP1;GREM1;CHRDL1
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7472833909345948,1.347001741619913,0.06060606060606061,0.7989292849210311,1.0,5/10,21.32%,MDK;FUT9;NFAT5;RELA;TRAF6
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.656434864997111,1.3464211075440042,0.10256410256410256,0.7996122193761093,1.0,5/22,12.61%,PNP;ADA;HPRT1;APRT;GMPR
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.6343045251210877,-1.3462197088460883,0.078125,1.0,1.0,12/34,25.72%,CENPK;CENPO;CENPU;ITGB3BP;CENPL;OIP5;ACTR6;KNL1;ANP32E;SPTY2D1;VPS72;CENPI
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7068977433585139,1.3455097680647545,0.13157894736842105,0.801524300117209,1.0,2/9,3.09%,NPNT;BMP7
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.8411172965164788,-1.3449134126532463,0.07692307692307693,1.0,1.0,1/6,9.13%,GNPDA1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6468646625528193,-1.3448387155582646,0.06944444444444445,1.0,1.0,4/32,9.16%,CD44;NODAL;AGER;CCL5
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),0.8588515034532861,1.344535758456226,0.0975609756097561,0.803973643166393,1.0,1/5,2.42%,KDR
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6043563144554809,1.3442710500792188,0.15384615384615385,0.8033449347901319,1.0,8/30,13.92%,IRS1;RORA;RUBCNL;IRS2;SIRT1;AKT2;MLYCD;FOXK1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.5971704146075503,-1.3441032006564688,0.0945945945945946,1.0,1.0,5/67,1.91%,CD44;TUBB1;GYPB;NR1I3;UROD
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.7411634409245959,1.343500953503773,0.15789473684210525,0.8044866576420353,1.0,3/10,10.68%,PDE3A;DDAH1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7041315286630304,1.3434253531829785,0.17142857142857143,0.8028424781523559,1.0,5/8,25.33%,DPH5;DPH2;DPH3;DPH1;CPEB2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.6498181123936807,1.3433691358395654,0.13333333333333333,0.8011722819167911,1.0,5/19,11.41%,EGFR;FOS;AKR1C3;MT1E;MAPK8
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.6007204421753509,-1.343346382207584,0.08450704225352113,1.0,1.0,15/45,20.01%,TIMP3;AGT;TIMP2;SERPINI2;SERPINE1;SERPINA10;PSMB8;APH1B;SERPING1;PSMA3;A2ML1;TIMP4;PSME1;SERPINF1;KNG1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6478084692578185,1.3432111942899259,0.13157894736842105,0.8001512021822115,1.0,1/15,0.92%,INTS11
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.6558896700673069,1.3429643243659768,0.20454545454545456,0.7995726294841126,1.0,3/20,9.84%,RAB32;BLOC1S4;KIF13A
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7209189537196206,1.342822118537316,0.17647058823529413,0.7982242566408797,1.0,5/11,17.55%,IRS1;IGF1;IRS2;AKT2;GCK
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6134616236469812,1.342653984299002,0.1282051282051282,0.7971838118603767,1.0,9/17,20.24%,MOB3B;IQCJ-SCHIP1;WWC1;SHANK2;VGLL4;MAP2K3;CIT;MARK3;DLG5
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.6862920538711315,1.3420688894175155,0.09090909090909091,0.797686056524538,1.0,6/8,26.43%,NRXN1;CLN3;TPP1;MYO7A;SHANK1;PCDH15
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.8196699479371563,1.341748503257414,0.1282051282051282,0.7973521426073047,1.0,5/6,17.98%,LIN28B;PNPT1;ZSWIM8;RELA;NFKB1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.7614487485705126,-1.3410961017469292,0.06666666666666667,1.0,1.0,5/12,18.66%,NOTCH1;LRRC19;OCIAD2;LPCAT3;UBAP2L
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.8119432635592385,1.3408384535412177,0.15789473684210525,0.7996151860022376,1.0,3/6,12.91%,FGFR3;FGFR1;PLIN5
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5777915921110877,1.3408006704980626,0.13513513513513514,0.7978176746548993,1.0,5/34,2.66%,MDGA1;HSPB1;NTNG1;SULF2;CROCC
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.8518830099345511,1.3405543121423806,0.07894736842105263,0.7974857842809715,1.0,2/6,3.72%,TACR1;GRK5
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.7087558267013307,1.340476435074119,0.08108108108108109,0.7960319817837188,1.0,2/18,3.77%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.7319638162691025,1.3401879069900886,0.23529411764705882,0.7955079641404309,1.0,1/8,2.97%,TSFM
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7579774392361041,1.3401459121530537,0.2571428571428571,0.7937694335696478,1.0,5/8,22.12%,LEPR;SIRT1;GCK;NR4A3;STAT3
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.7940379916734697,-1.3400599813177902,0.11290322580645161,1.0,1.0,2/8,5.07%,DUOX1;TPO
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.7367865880329328,-1.3399245253132936,0.10294117647058823,1.0,1.0,3/15,4.60%,PTGIS;CD74;PTGES
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6558876336459294,-1.339830349384959,0.07575757575757576,1.0,1.0,5/31,7.54%,MCM2;POLE3;GMNN;CDC6;RPA3
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.7254617115584625,1.3397941679367904,0.15384615384615385,0.793614001369836,1.0,3/9,10.45%,FGFR3;RASGRP1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6914209759916158,1.3394379886202346,0.13953488372093023,0.7933938060583127,1.0,7/15,13.75%,IRS1;PRKCD;IRS2;PNPLA2;ABCD2;PLIN5;AKT2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.773929130385184,-1.3392000365335899,0.08333333333333333,1.0,1.0,1/14,0.02%,CD44
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.6110005069956377,1.3391114463801184,0.09090909090909091,0.7932399483812324,1.0,5/19,16.74%,MICU1;MCU;SLC8A3;MAIP1;MCUR1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7511251370157539,1.3390212432312898,0.16666666666666666,0.7919461785770497,1.0,2/9,11.36%,VCAN;CHST12
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6909985822486577,-1.3389654732152982,0.07462686567164178,1.0,1.0,4/14,2.07%,HSD17B2;HSD17B10;CYP1B1;CYP19A1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.8276604234430389,-1.3389465489479204,0.09090909090909091,1.0,1.0,2/6,5.24%,NOTCH1;DRD3
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.868832768548244,-1.3389077364208808,0.06779661016949153,1.0,1.0,1/8,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.8200460430361285,1.3388825542941383,0.10810810810810811,0.7908859188244377,1.0,2/5,14.20%,SDC4;TSG101
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.8557853031635378,-1.3384001905258085,0.10344827586206896,1.0,1.0,2/6,12.10%,CD74;CD27
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6977998766621428,1.3380143446941906,0.09302325581395349,0.7930096649971548,1.0,5/13,19.20%,APBA1;BAG3;DYNC1I2;BORCS5;DYNC1I1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.7963381313585223,-1.3377023895324769,0.11666666666666667,1.0,1.0,3/8,14.19%,CSRP3;TTN;HTR2B
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7281043345547153,-1.3375697985742543,0.06666666666666667,1.0,1.0,4/13,10.62%,SFRP4;GPC3;RSPO3;RNF213
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6076277514698321,1.3374113233211586,0.13333333333333333,0.7937643505557289,1.0,7/23,14.05%,SULF2;GAL3ST4;HS3ST4;CHST8;IGF1;CHST12;CHST11
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7121062744679068,-1.336832121720001,0.1346153846153846,1.0,1.0,8/13,22.03%,HSD17B10;CYP19A1;HSD17B11;SHH;HSD17B6;SRD5A1;SPP1;UGT2B7
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.6863937889273126,1.3367061609592268,0.21052631578947367,0.7947739610595628,1.0,2/8,13.49%,C5AR1;SORL1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.5194132726919284,1.3364198394716669,0.0,0.7938457802492951,1.0,7/66,9.20%,PLEKHH2;FGF13;KANK1;NAV3;PRKCD;APOE;SSH1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7656908078482463,1.3363142378304715,0.12903225806451613,0.7923752798197727,1.0,2/6,13.34%,MALT1;RC3H1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5114984787839791,1.3360277335206336,0.06666666666666667,0.7920019616126825,1.0,18/79,11.95%,TPD52L1;KIT;RGS14;PDGFD;EGFR;BMP7;PIK3R6;SPRY3;PDGFC;TRIB2;PRKCD;RASGRP1;APOE;STK38;FGFR1;IL34;MST1R;SNF8
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.6685584988278681,1.3357100939399649,0.16216216216216217,0.7916623244065167,1.0,2/15,2.19%,CDH13;EGFR
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.6543940393756753,-1.3349801557154641,0.0821917808219178,1.0,1.0,5/27,10.97%,RAB6C;CHMP4B;CHMP2B;CHMP2A;C10ORF90
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.6845564903886974,1.3348664965896762,0.125,0.7932081634452843,1.0,5/11,14.42%,MTHFS;MTHFD2L;DHFR;MTHFD1L;MTHFD2
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.7545145076931448,-1.3348369501670474,0.18518518518518517,1.0,1.0,1/9,1.02%,TERF2IP
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.46571214370095954,1.3341906297715538,0.07142857142857142,0.7932496671351916,1.0,17/77,10.11%,SV2C;UNC13C;PDE10A;TNR;CATSPER2;PMEPA1;GABRG3;KCNJ6;MGAT4C;SLC2A11;RNFT2;SAMD7;HCN1;SVOP;AP3B2;XKR4;SAG
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7287349092210987,1.3332976134771386,0.1388888888888889,0.7954208391184582,1.0,2/7,6.07%,KDR;JAG1
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.5105067383254429,1.3331336625518295,0.04,0.7944739700645733,1.0,12/71,8.64%,ACE2;NPNT;PHACTR1;PELI2;CAPN13;TMEM229A;SLC2A9;COBL;NR3C2;BTC;SCNN1B;FZD1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6470985486146857,-1.3329975217707377,0.136986301369863,1.0,1.0,13/30,23.37%,NDUFB9;NDUFA2;NDUFB3;NDUFC1;NDUFB4;NDUFB11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;NDUFB10;NDUFS5;NDUFA3
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.6377356418269127,1.332519385875976,0.16666666666666666,0.7957149920304813,1.0,3/13,11.40%,PNP;NMNAT3;AK5
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6814391125172408,-1.3322210092318303,0.14705882352941177,1.0,1.0,3/19,12.41%,GNPDA1;NANS;GFPT2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7314926402164572,1.3321401846635668,0.14705882352941177,0.7954979500101415,1.0,6/14,14.11%,PER2;HDAC9;HDAC1;SIRT2;SIRT1;SMARCAD1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.8065760716339909,-1.3315713164272633,0.15254237288135594,1.0,1.0,1/6,1.16%,MYLK
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.8104596211665639,1.3315399181421153,0.10810810810810811,0.7967942303701129,1.0,1/5,1.23%,F2RL1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.767490823059395,-1.3313665964208146,0.10526315789473684,1.0,1.0,1/9,1.49%,STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.767490823059395,-1.3313665964208146,0.10526315789473684,1.0,1.0,1/9,1.49%,STEAP4
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.8925270072921659,-1.3311255178083496,0.058823529411764705,1.0,1.0,2/5,2.07%,HSD17B2;CYP19A1
prerank,GO_Biological_Process_2021__norepinephrine transport (GO:0015874),0.8469701505078753,1.3305868551210425,0.1,0.7972052164139354,1.0,2/5,6.67%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.8469701505078753,1.3305868551210425,0.1,0.7972052164139354,1.0,2/5,6.67%,SLC22A2;SLC22A3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.7493597867869424,-1.3304106106364701,0.14492753623188406,1.0,1.0,2/11,12.41%,GNPDA1;GFPT2
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.8364850966310444,1.3301851376875775,0.11627906976744186,0.7970807066368684,1.0,3/7,5.00%,HS3ST5;F2RL1;EPHB2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5929224270233332,-1.329717914064817,0.08823529411764706,1.0,1.0,14/51,20.00%,ENPP2;PDXDC1;IL4I1;ELANE;TST;GNPDA1;ERAP2;CLPX;SIAH1;LVRN;LIPC;PLA2G10;ERAP1;BCKDK
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.8189115085808598,1.329448565818313,0.10638297872340426,0.7983309139988932,1.0,1/5,13.49%,SORL1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.475207432684785,1.329323251814892,0.08333333333333333,0.7969891358872154,1.0,17/124,8.76%,ETV1;RUNX1;ALK;EPHA5;GPRIN2;TGFB2;BTG2;EPHA8;CNTN4;LRP12;FRY;HMGB1;BLOC1S4;NLGN1;NRTN;APOE;RYK
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8165865631721525,-1.3289460260581472,0.07017543859649122,1.0,1.0,4/5,17.89%,SLC25A5;SLC25A4;TSC2;VDAC1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.7842190796947297,1.328747668243532,0.13636363636363635,0.7980786098672319,1.0,2/5,11.41%,CAP2;MAPK8
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.711540709271721,1.3286889036648832,0.12195121951219512,0.7964329576169573,1.0,5/11,20.21%,PDE4D;ADCY2;ADCY9;PTHLH;ADCY8
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.7404249390987604,1.3283543757132166,0.20833333333333334,0.7961257225218464,1.0,1/8,1.05%,SPX
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.6491817740720968,1.328324348308053,0.14285714285714285,0.7945532308135245,1.0,3/20,1.80%,ACE2;PER2;OXTR
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7290784454537557,-1.3278984650760695,0.07142857142857142,1.0,1.0,2/11,7.05%,GMNN;CDC6
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7852862234930316,-1.3273887644395492,0.05970149253731343,1.0,1.0,1/9,0.67%,ACOT4
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.5137911258032541,1.327168457533124,0.11538461538461539,0.7977655083215767,1.0,12/69,13.00%,ITGB5;PTPRK;TGFBR1;PARD3;TGFB2;FOS;ACVR1;TGFB3;SMAD2;TWSG1;TGFBR3L;SIRT1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.843109738938864,1.326553390444954,0.13333333333333333,0.798656986197237,1.0,2/6,3.66%,UNC13C;UNC13B
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.7056345459464107,-1.3262580063284746,0.14754098360655737,1.0,1.0,5/15,18.45%,ALOXE3;ALOX12;GSTP1;FADS2;ELOVL2
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.7424780773258395,1.3256313102583108,0.15384615384615385,0.8010792560860501,1.0,2/10,14.03%,HDAC10;SRM
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.7455374283879447,-1.3255939531281695,0.10606060606060606,1.0,1.0,2/11,7.74%,LRPAP1;RIN3
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.7771356627932873,1.325509663934383,0.13953488372093023,0.7996933985438606,1.0,2/6,3.77%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6917926058945247,1.3253704879368504,0.10869565217391304,0.7985274156327097,1.0,3/15,12.09%,SHLD1;PNKP;KMT5B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5307528040151996,1.3249114408869958,0.10526315789473684,0.798708229213409,1.0,25/89,14.98%,ROR2;KIT;UNC5B;PDGFD;F2RL1;EGFR;KDR;TGFB2;PDGFC;PDGFRA;IGF1;PTPN6;IRS2;FSHR;FGFR1;PIP4K2A;PTPN13;PIK3R1;SIRT1;IER3;NTRK3;PDGFB;PIK3AP1;FBXL2;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.6977479923574669,-1.3247359024793515,0.1506849315068493,1.0,1.0,2/15,1.99%,CCNE1;PTPRC
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.8294334934392642,-1.3241851103850844,0.14035087719298245,1.0,1.0,2/5,16.59%,RARRES2;PLCG2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.701763139848536,1.3241787328727745,0.06451612903225806,0.8001967756140085,1.0,2/10,5.41%,CD247;TGM1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.8240362332960118,-1.3241520480277953,0.14285714285714285,1.0,1.0,1/5,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8554411610941942,-1.3227628976538994,0.10526315789473684,1.0,1.0,2/5,5.13%,TIMP3;TIMP2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6850134030126006,1.322749429950077,0.14705882352941177,0.8052013696710273,1.0,4/8,16.62%,GRIP1;DVL2;MAP3K13;WNT5A
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.6149281185390576,-1.3226447049389192,0.046875,1.0,1.0,8/33,18.46%,CENPK;CENPO;CENPU;HAT1;ITGB3BP;CENPL;OIP5;H3-3A
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.5747186023492417,1.3224755236593324,0.1388888888888889,0.8046396083353213,1.0,3/26,6.57%,UBASH3B;HSPB1;PDGFRA
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5959157163320473,1.3223471749906357,0.13333333333333333,0.8036569208779853,1.0,9/37,7.35%,PMEPA1;BMP7;TGFBR1;BMP6;TGFB2;GREM1;BMP3;ACVR1;TGFB3
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.5916729017019384,1.3222374479503602,0.13513513513513514,0.8024068450603546,1.0,5/27,11.89%,ARL13B;PCM1;RPGRIP1L;TOGARAM1;PIBF1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.9090696997134071,-1.3221854476149202,0.06557377049180328,1.0,1.0,1/5,0.14%,NPY
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6168946200572863,-1.3221656260514671,0.07936507936507936,1.0,1.0,4/38,5.24%,ARR3;LDLRAP1;CAV3;DRD3
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.6593537543109173,-1.3219822231960423,0.1864406779661017,1.0,1.0,6/19,15.09%,CSRP3;CASQ1;TTN;MYPN;TPM1;SIX4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6724735393497063,1.3219530957871017,0.075,0.801854554778809,1.0,3/22,6.04%,RUNX1;CBFB;MACROH2A2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.45554500492627426,1.3216378156071644,0.1111111111111111,0.8017552723359117,1.0,30/118,15.15%,GPC4;UNC13C;NTNG1;C5AR1;DSCAM;SDK1;UNC13B;PDZRN3;GRM5;PPFIBP1;NRXN1;ZC4H2;LRRC4C;SHANK2;NLGN1;RYK;SLC8A3;SLC6A1;LRFN4;PTPRS;CACNB2;ARHGAP39;GPM6A;PPFIA2;GPHN;PPFIA3;PAK3;NRCAM;NEDD4;DNER
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.6793130216688131,-1.3210725459361443,0.22727272727272727,1.0,1.0,1/18,0.08%,ENPP2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6618867281481818,-1.320980490801908,0.07936507936507936,1.0,1.0,4/22,8.25%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.8115141228270333,1.3208729484087014,0.19148936170212766,0.8024659195936609,1.0,1/6,0.23%,FBXL7
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6504217024185953,-1.320789175896249,0.12727272727272726,1.0,1.0,1/17,1.03%,HENMT1
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.8350638519044293,-1.320474584062074,0.13559322033898305,1.0,1.0,2/5,11.23%,ACTC1;TTN
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.5488134424367118,1.3201541534096493,0.07142857142857142,0.803771959467852,1.0,10/48,13.01%,MCTP1;RAB3C;DNAJC1;SNCAIP;VAMP8;RALA;ARFIP1;MCTP2;VAMP3;SYT1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6585579533729369,1.3200909056628143,0.13157894736842105,0.8022958963724887,1.0,5/18,13.75%,IRS1;IGF1;IRS2;PIK3R1;AKT2
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7028676256668,1.3198416171633285,0.1,0.8017198215534922,1.0,2/9,2.27%,UNC5C;NRP1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8080065115267491,1.3196165575167011,0.05263157894736842,0.8014137359424534,1.0,3/5,13.33%,MTHFS;GCH1;DHFR
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.8231793451915096,1.3187918351793129,0.175,0.8035418330584627,1.0,1/5,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5136287330631777,1.3184745955340471,0.08695652173913043,0.803381271781525,1.0,5/62,6.08%,IFI16;HSPB1;TYSND1;WDR24;OSBPL7
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7182077870823969,1.3181824082711455,0.22857142857142856,0.8028668188336094,1.0,2/10,11.36%,VCAN;CHST12
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6900324859631894,1.318009145699611,0.15151515151515152,0.8018237603866224,1.0,3/9,23.66%,PIK3R1;WDR81;RBL2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.7632815674645376,-1.3178439182073232,0.13114754098360656,1.0,1.0,7/10,23.67%,B3GNT9;B3GNT4;B3GALT1;B3GNT3;B3GALNT1;B4GAT1;B3GALT5
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8310231582178107,-1.3172641322948575,0.14285714285714285,1.0,1.0,2/6,7.52%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8310231582178107,-1.3172641322948575,0.14285714285714285,1.0,1.0,2/6,7.52%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7734641264314258,1.3169135288253448,0.15217391304347827,0.8044630619427956,1.0,3/10,5.57%,SLC6A4;LATS1;WWC1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5366754840459499,-1.316491000653489,0.0410958904109589,1.0,1.0,60/104,33.47%,RPL36;RPL15;NCBP2;RPL38;RPLP2;RPL28;RPS21;RPS7;RPL9;NCBP1;RPL37A;RNPS1;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;RPS8;RPL4;RPL3;RPL34;RPL37;RPL24;RPS24;RPS15;UPF3B;RPL7A;DHX34;RPL13A;RPL27A;RPS4X;RPL23;RPL35;RPS3;RPS27A;RPS29;RPL19;RPL18;RPS13;RPL32;RPL13;RPS5;RPL27;RPS2;RPS9;RPL29;RPS25;RPL31;RPL21;RPSA;RPS19;EIF4A3;RPS4Y1;RPL11;UBA52;RPS12;RPS18;RPS28;RPS16
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.512121664633689,1.3163347891000634,0.125,0.805476474637212,1.0,16/61,16.97%,FLRT2;GALNT3;FGFR4;SPRED1;SPRED2;FGFRL1;FGFR3;FGFR1;FIBP;FGF10;TRIM71;TIAL1;FRS2;FGF17;HNRNPH1;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.867661049553279,-1.3160997070100404,0.03636363636363636,1.0,1.0,1/5,2.87%,YBX3
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6409859771223103,1.3160196957794401,0.14285714285714285,0.8054601010347419,1.0,8/21,16.51%,INSYN2A;GRIN2A;GRIN2C;GRID2;DRD4;GRIN2B;MEF2C;GRIN1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.8682091846932433,-1.3155806031409243,0.09615384615384616,1.0,1.0,1/5,2.24%,DOCK2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.588762648303216,-1.3153795163926885,0.09859154929577464,1.0,1.0,7/32,13.70%,ZFPM1;STAT1;NCKAP1L;INHBA;SPI1;MAFB;ZNF16
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5059504925394716,1.3148614220132346,0.2,0.8090114577091699,1.0,25/109,9.60%,FBXL7;PDGFD;DOK5;KCNIP1;SEMA6D;NTM;CACNA2D1;ZNF536;EFS;ADGRA1;MAPK4;SLC35F1;PDZRN3;RGS7BP;GRIA2;GUCY1A2;BRINP1;LRRC4C;NLGN1;SHC3;PCDH19;RCAN2;NOVA1;CSRNP3;SLC6A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.8316097458740939,-1.3141474039063488,0.0847457627118644,1.0,1.0,1/5,7.84%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7976277701963864,1.3138394275800631,0.125,0.8119062289096539,1.0,1/8,0.63%,RGS14
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7669884023274232,-1.3132450413771952,0.16071428571428573,1.0,1.0,4/12,8.25%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.8140577670428198,1.3131022921632753,0.175,0.8137698368027779,1.0,1/7,1.49%,PPP1R3B
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.7693482265226576,-1.3128876718192066,0.10666666666666667,1.0,1.0,2/10,4.71%,CHAC1;CHAC2
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.618710239659983,1.312429292324823,0.11363636363636363,0.8154514535331087,1.0,6/18,11.55%,PTPRK;MDK;TGM1;CASK;PRKD1;FGF10
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7873818023212303,1.3124142843021105,0.20588235294117646,0.8138196611817115,1.0,3/6,16.72%,SLC16A2;SLCO1C1;SLC16A10
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7772264198090926,1.3123869918519204,0.1282051282051282,0.8122523940390479,1.0,6/7,21.45%,NLGN1;SGIP1;MEF2C;CFAP20;NR4A3;NPAS2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6233081488138545,1.3116443987292525,0.09375,0.8142157281781891,1.0,3/20,11.59%,DGKB;DGKH;PNPLA2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7586731234657348,1.3115333775202833,0.21428571428571427,0.8130864359388558,1.0,1/5,18.35%,B3GAT3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.7677130428101113,-1.311398807874138,0.15384615384615385,1.0,1.0,2/9,3.27%,EPAS1;COPS9
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7998602527764549,1.3110760570243203,0.18604651162790697,0.8130549863790536,1.0,3/6,13.00%,PER2;CTBP2;SIRT1
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5015479148769758,-1.3109753441326968,0.06666666666666667,1.0,1.0,29/131,13.64%,OLFML1;LAMA2;STEAP4;CYP1B1;EPAS1;FBLN5;PXMP2;TIMP3;AGT;AOX1;PTGES;RARRES2;ANGPTL2;ACOX2;COL6A1;ECM2;F10;ADGRF5;RSPO3;PLSCR4;TBX1;ACTA2;MEST;PDGFRB;SERPING1;ADRB1;NQO1;BCAT2;EPSTI1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.8095911443328019,-1.3109727146536507,0.04225352112676056,1.0,1.0,3/7,11.98%,ALDH2;ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.7634709364797054,-1.310822146930574,0.08333333333333333,1.0,1.0,7/9,23.67%,B3GNT9;B3GNT4;B3GALT1;B3GNT3;B3GALNT1;B4GAT1;B3GALT5
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6753493869545263,1.3103662326362013,0.1282051282051282,0.8136840515491962,1.0,1/14,0.11%,NRG1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7580657494643179,-1.3100560090245381,0.1076923076923077,1.0,1.0,2/8,11.51%,MSX1;RPS7
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.6474427261773907,1.3098777168772433,0.19230769230769232,0.814425204255854,1.0,3/10,2.82%,KIT;KDR;KITLG
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6536462110199677,1.309725138551636,0.24324324324324326,0.813190173174937,1.0,1/15,0.92%,INTS11
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7218120165216242,1.3096873184720326,0.17647058823529413,0.8100798265722079,1.0,4/6,24.38%,DPH5;DPH2;DPH3;DPH1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7218120165216242,1.3096873184720326,0.17647058823529413,0.8100798265722079,1.0,4/6,24.38%,DPH5;DPH2;DPH3;DPH1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.7709733127316107,-1.3095611207478426,0.140625,1.0,1.0,2/8,14.03%,HENMT1;MRPL44
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.7234648352136798,1.309298211799923,0.2903225806451613,0.8100547548701412,1.0,1/8,1.05%,SPX
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.843569928565374,-1.3081970394481677,0.11290322580645161,1.0,1.0,2/6,8.85%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6656066508387918,1.3078933135875075,0.13043478260869565,0.8144837695345019,1.0,3/13,6.36%,SULF2;SPRY3;APLN
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.7160087245879232,-1.3076242363759425,0.12121212121212122,1.0,1.0,3/19,7.80%,WFS1;MYO5B;RAB11A
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.7045426864692623,-1.3072129389667666,0.203125,1.0,1.0,8/14,24.59%,DUOX1;PRDX4;NOX1;PRDX1;PRDX3;GPX1;MAOB;ACOX1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.765974912732847,1.3058867491512445,0.16216216216216217,0.8218397195991968,1.0,2/7,8.43%,NRP1;APOE
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6649352187918409,1.3057716138116757,0.16129032258064516,0.8207459637486917,1.0,8/17,23.03%,PARD3;LRRC7;PARD3B;DLG2;MTCL1;DLG3;CLIC4;MARK2
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.8056561582902404,1.3056292656950004,0.11363636363636363,0.8200231501331631,1.0,3/5,17.98%,RC3H1;RELA;NFKB1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6870499524335979,-1.3047614304678434,0.14285714285714285,1.0,1.0,4/15,7.35%,KCNE2;SCN4B;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5963974945891184,1.3047141697187465,0.11764705882352941,0.8224554421202126,1.0,6/21,8.08%,TRPS1;TGFBR1;GREM1;MDK;PKDCC;SOX5
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8371774919614356,-1.304504588069047,0.09230769230769231,1.0,1.0,3/6,12.51%,ATP5IF1;PINK1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.6898320590003418,-1.3039433572160235,0.16923076923076924,1.0,1.0,3/18,9.05%,CGAS;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6855512865493829,1.3038964244750455,0.1951219512195122,0.8247938705747864,1.0,1/14,0.47%,PNP
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.8342601812747428,-1.3035006256855681,0.109375,1.0,1.0,1/6,10.62%,RNF213
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.7209959042008934,1.3033607782572012,0.15789473684210525,0.8250765909315325,1.0,6/10,22.79%,MICU1;MCU;MAIP1;MCUR1;MCUB;SLC25A23
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.7061651997896975,-1.3032734427881236,0.109375,1.0,1.0,4/18,12.06%,GADD45B;AGER;SPI1;GADD45A
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.783914485597137,1.3025367027335395,0.13333333333333333,0.8265333264889939,1.0,1/5,1.61%,TOX
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.611629865847966,1.3022231478890578,0.15151515151515152,0.8261692678191505,1.0,11/30,16.51%,INSYN2A;GABRG3;GRIN2A;GABRA3;GRIN2C;GRID2;GABRA5;DRD4;GRIN2B;MEF2C;GRIN1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.58683153456323,1.3017539917124026,0.18181818181818182,0.8264197671048364,1.0,2/19,5.89%,RNF126;DNAJB12
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5384239436441552,-1.3016695764001402,0.05555555555555555,1.0,1.0,64/142,30.27%,RPL36;RPL15;RPL38;RPLP2;RPL28;RPS21;RPS7;MRPS18C;EEF1A1;RPL9;RSL24D1;GGTA1;RPL37A;MRPS14;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;RHD;PCSK5;RPS8;RPL4;ASMT;RPL3;RPL34;MRPL51;RPL37;RPL24;RPS24;COPS5;RPS15;WARS1;RPL7A;RPL13A;RPL27A;RPS4X;RPL23;FURIN;RPL35;MRPL43;RPS3;RPS27A;RPS6KB2;RPS29;RPL19;ABCF1;RPL18;RPS13;MRPL27;RPL32;RPL13;RPS5;RPL27;MRPL42;RPS2;RPS9;RPL29;MRPL34;RPS25;RPL31;RPL21;RPSA
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6979855823158805,1.3015795684215472,0.2571428571428571,0.8253063405322635,1.0,4/8,18.50%,NRXN1;NLGN1;TMEM108;PTEN
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.7901463946725038,1.3014684262540632,0.15625,0.8243638209911287,1.0,2/6,16.06%,PDCD2;THPO
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6905918775469533,1.3014002491268626,0.125,0.823037070541673,1.0,2/12,11.36%,VCAN;CHST12
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.629171652522696,-1.3008906343397377,0.125,1.0,1.0,3/26,11.63%,TERF2IP;GAR1;MRE11
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6719165893780341,1.30056529296824,0.1794871794871795,0.8243978349924426,1.0,5/14,13.55%,TIMELESS;KCNC2;MTR;FOXO1;SPIDR
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6249771518270388,-1.300191286155098,0.1,1.0,1.0,6/26,17.34%,ARIH2;PINK1;UBL5;TOMM7;HSPA1L;PDCD5
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.8794231948271848,1.2996922773437494,0.125,0.8264157162785392,1.0,3/5,8.54%,SLC22A2;SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.7215234379217572,1.299658542407963,0.18421052631578946,0.8249274182508985,1.0,1/9,0.96%,RFWD3
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.8614403144690401,1.299469731498126,0.07317073170731707,0.82265403031333,1.0,2/5,10.74%,CSF1R;IL34
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.8614403144690401,1.299469731498126,0.07317073170731707,0.82265403031333,1.0,2/5,10.74%,CSF1R;IL34
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.8510190173064522,-1.29894892908032,0.08620689655172414,1.0,1.0,3/5,14.19%,CSRP3;TTN;HTR2B
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6591924927145628,1.2986471710607344,0.1935483870967742,0.8244954189562577,1.0,6/17,10.15%,UNC13C;GRIK4;UNC13B;GRIA2;GRIK1;GRID2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6591678815862021,1.298643164336274,0.14285714285714285,0.8229128941597965,1.0,4/18,4.78%,HS3ST5;HS3ST3B1;EXT1;HS6ST3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.8352889874853469,1.2981862549920877,0.14285714285714285,0.8215359645163758,1.0,3/8,12.77%,HOMER2;FHL2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.8352889874853469,1.2981862549920877,0.14285714285714285,0.8215359645163758,1.0,3/8,12.77%,HOMER2;FHL2;CHP1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.8570422801348719,1.298026723790861,0.1111111111111111,0.8205388912805407,1.0,3/6,12.84%,RORA;NLGN1;BTRC
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5990025750018493,1.2964349787210507,0.14705882352941177,0.8264086192308661,1.0,11/23,20.59%,MICU1;MCU;CACNA1I;CACNB2;SLC8A1;MAIP1;CACNA1A;MCUR1;CACNA1B;MCUB;CACNA1D
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.6296932497199064,-1.296110476221071,0.13333333333333333,1.0,1.0,4/30,13.87%,ROPN1B;ODAD4;ATP6V1D;FSIP2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6776708125650033,1.295891988977587,0.15789473684210525,0.8273013180892385,1.0,5/10,24.40%,DSCAM;STAT3;MYO7A;CEP290;VEGFA
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.6592137948187153,1.2953059558950908,0.3157894736842105,0.8284608645609963,1.0,3/8,8.80%,RORA;TGFBR1;SMAD2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.46848191002482964,1.2952570310431892,0.058823529411764705,0.8271885059140399,1.0,23/115,16.62%,RUNX1;ATOH8;ALK;EPHA5;IL1RAPL1;TGFBR1;TGFB2;FUT9;FZD1;RYK;ERCC2;SPOCK1;TENM4;ATP8A2;NRBP2;ID2;NR4A2;PBX1;LRP6;MEF2C;PBX4;ADNP2;WNT5A
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.5409070207216008,1.2948318254315658,0.11428571428571428,0.8273747121123319,1.0,4/47,1.23%,IFI16;HSPB1;CARD18;F2RL1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.7420208415232867,-1.2946450334840651,0.1323529411764706,1.0,1.0,5/11,23.87%,TCP1;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.7420208415232867,-1.2946450334840651,0.1323529411764706,1.0,1.0,5/11,23.87%,TCP1;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7236536521153625,1.2943763428672235,0.20512820512820512,0.8275870862287381,1.0,2/9,10.69%,VCAN;ARSB
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.7009316905407698,-1.2942079278429235,0.171875,1.0,1.0,2/16,7.23%,MCM2;RECQL
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.7019961703206119,-1.294141454747181,0.09433962264150944,1.0,1.0,8/18,23.86%,HSD17B2;CYP19A1;DHCR7;HSD17B11;HSD17B6;SRD5A1;AKR1B1;TSPOAP1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.556747449872296,-1.2938401002565842,0.057971014492753624,1.0,1.0,12/53,13.11%,C3AR1;HCK;PTPRC;GMFG;CD300LF;NCKAP1L;SLA;CCL5;ARHGAP9;SPI1;MYO1F;TAGAP
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.7710410277956617,-1.2932121491008424,0.15384615384615385,1.0,1.0,4/10,21.39%,RIPPLY2;WNT8A;SHH;MESP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.7282138465820488,-1.292970508619087,0.1864406779661017,1.0,1.0,4/10,14.86%,IL15;ZBTB7B;TGFB1;IL18
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6895538901922547,1.292900149013234,0.1111111111111111,0.831902117272303,1.0,8/12,22.82%,WWC1;SHANK2;VGLL4;MAP2K3;CIT;MARK3;DLG5;WWC3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7001948515936508,1.2927178129152455,0.15555555555555556,0.8311414784614765,1.0,6/8,29.78%,NR1H3;PPARA;NR1H2;PPARG;TTC39B;ABCA1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5806080461367303,-1.2924036569860118,0.18333333333333332,1.0,1.0,5/30,10.74%,RAC1;PEX11B;RIN3;VAV3;MSN
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7729378687179784,1.292279856111497,0.1276595744680851,0.8312921514396228,1.0,2/6,9.69%,FHIT;MACROD2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5778944377169069,-1.2920190553765174,0.10294117647058823,1.0,1.0,13/47,15.49%,CD4;GNLY;ITK;PTPRC;SP140;SLA;CD6;CCL5;HLA-DPB1;TAGAP;CNGB1;GBP5;GPR183
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6906304700256143,-1.2911593236373244,0.09375,1.0,1.0,1/20,0.08%,ENPP2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5038246925803367,1.2897431615792732,0.09375,0.8408298555432705,1.0,7/41,5.49%,GPC4;HS3ST5;HS3ST3A1;HS3ST3B1;SDC4;EXT1;HS3ST2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.626905489091948,-1.2897261716628767,0.19642857142857142,1.0,1.0,3/23,14.46%,TERF2IP;MRE11;GNL3
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7177961989053857,1.289682904075226,0.17647058823529413,0.8394179276898858,1.0,5/12,17.55%,IRS1;IGF1;IRS2;AKT2;GCK
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6497007074556935,1.289505671382828,0.10714285714285714,0.8388349318040692,1.0,3/14,7.88%,NRG1;JAG1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.7150127734819629,1.2890353000440493,0.24324324324324326,0.8380460361314584,1.0,1/13,0.17%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.7150127734819629,1.2890353000440493,0.24324324324324326,0.8380460361314584,1.0,1/13,0.17%,RUNX1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.4788713824189529,1.2887391199635696,0.17391304347826086,0.8378387371012541,1.0,18/81,9.49%,EPHA3;ROR2;KIT;ALK;EPHA5;EGFR;KDR;CSF1R;FGFR4;FGFR3;EPHB2;EPHA8;PDGFRA;LTK;EPHA7;IRS2;RYK;ERBB4
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.45003469163315685,1.2885193806935837,0.0625,0.8370520002935026,1.0,12/102,7.41%,FBXL7;LAMB2;PRRX1;ADAMTS2;SVEP1;LAMA4;PCDH18;FNDC1;PDZRN3;COLEC11;PDGFRA;HTRA1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5230686929190891,1.2884925081189822,0.14634146341463414,0.8355574177014522,1.0,5/32,6.36%,ATOH8;NFIB;TGFB2;FOS;APLN
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.6881881808004104,-1.2883370817040776,0.14705882352941177,1.0,1.0,4/19,13.31%,PPP1R1B;FKBP1B;NCKAP1L;CRY2
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.7151384635015676,1.2883295603206772,0.3023255813953488,0.834725241733223,1.0,2/5,6.25%,ALKBH3;ALKBH2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5612603052528468,1.2881101305192812,0.20833333333333334,0.8342370854130576,1.0,9/47,9.25%,HIVEP1;BMP7;BMP6;TGFB2;ACVR1;TGFB3;SMAD2;RGMA;RGMB
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.6703428633843844,-1.2875127945567457,0.11428571428571428,1.0,1.0,6/19,18.43%,FKBP1B;FKBP4;PPID;PPWD1;PPIC;FKBP5
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5861125114291363,1.2873518750754986,0.1,0.8355832580311943,1.0,10/23,24.04%,CACNG3;CACNG4;NLGN1;SHISA9;MEF2C;RELN;CNIH2;CACNG2;CACNG5;SHANK1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.7296347445545239,1.2869212488190527,0.22857142857142856,0.8340092539959773,1.0,3/10,6.25%,ALKBH3;MGMT;ALKBH2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.7296347445545239,1.2869212488190527,0.22857142857142856,0.8340092539959773,1.0,3/10,6.25%,ALKBH3;MGMT;ALKBH2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.5615619376147808,1.2868574237477908,0.125,0.832692840866143,1.0,13/57,8.80%,EPHA3;LEF1;WWTR1;SPRED1;TGFBR1;SPRED2;TGFB2;SPRED3;GREM1;MDK;TGFB3;PDPN;SMAD2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.8982114652967168,1.2861169244138466,0.16216216216216217,0.8338760775355423,1.0,2/5,6.16%,HTR1F;HTR1E
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.7602248891971196,1.2858681448999272,0.21212121212121213,0.8330575747402521,1.0,2/5,14.42%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.8089163719457597,-1.2857964307317014,0.13114754098360656,1.0,1.0,1/5,1.07%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6941345687126168,1.2853716740663341,0.1388888888888889,0.8335626153348565,1.0,5/11,21.55%,MDK;NFAT5;RELA;TRAF6;ST3GAL4
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7979651546554621,-1.2852654764463074,0.16071428571428573,1.0,1.0,2/7,5.09%,ODAD4;CCDC39
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.6042419676649542,-1.2851562251861712,0.08823529411764706,1.0,1.0,17/41,19.26%,TXNRD2;MGST1;CDKN2D;PRDX4;SOD2;GLRX2;JUNB;GLRX;PRDX1;NQO1;TXN;IPCEF1;G6PD;NDUFB4;ATOX1;NDUFS2;LAMTOR5
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.6713409059648952,1.2850982804694255,0.19230769230769232,0.8331353495681465,1.0,2/9,6.95%,KIT;ENPP1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.7961584405951915,1.2844718009167513,0.15,0.8344898079904441,1.0,2/5,10.68%,SLC10A7;ANGPT1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7668860299985424,1.284213401763275,0.1836734693877551,0.8340881638292944,1.0,4/8,6.58%,RUNX1;SH3RF1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7363199961399277,1.2839519109214907,0.19047619047619047,0.8335337305604549,1.0,4/6,24.40%,SPHK2;WNT5A;ADRA1A;VEGFA
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.6965833157428549,-1.2839400018159444,0.09859154929577464,1.0,1.0,5/15,16.65%,LIPH;LIPI;PNPLA1;FABP3;LIPC
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7681396489638275,1.2836036370528328,0.2619047619047619,0.8334175185879902,1.0,1/5,1.26%,DOCK10
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8230166833915435,-1.28330834905512,0.10294117647058823,1.0,1.0,1/7,0.02%,CD44
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.729309624841922,-1.2829629248291965,0.18518518518518517,1.0,1.0,3/9,18.46%,TERF2IP;DAXX;H3-3A
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.729309624841922,-1.2829629248291965,0.18518518518518517,1.0,1.0,3/9,18.46%,TERF2IP;DAXX;H3-3A
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.7055720098160129,-1.2822342690845887,0.14285714285714285,1.0,1.0,1/14,0.13%,C3AR1
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6994142702275137,1.2819641977071663,0.1891891891891892,0.8384501476809196,1.0,2/10,5.79%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.6500236881835076,1.2815614115419995,0.18181818181818182,0.8385812069773874,1.0,5/18,11.41%,EGFR;FOS;AKR1C3;MT1E;MAPK8
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.6578726765728903,1.281490413413255,0.14285714285714285,0.8373591178949332,1.0,6/16,17.38%,LEF1;TFAP4;EP300;RRP1B;SMARCA4;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7159596614054267,1.2813095357963074,0.21052631578947367,0.836905698665927,1.0,5/9,13.75%,IRS1;IRS2;ABCD2;PLIN5;AKT2
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.5142914393137143,1.2812234090222743,0.16,0.8359198459539195,1.0,8/57,8.51%,EPHA3;CDH13;CCL28;UTRN;JAG1;EFNA5;CASK;PKHD1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.7550493639307185,1.2810515534309392,0.17073170731707318,0.8352421369377927,1.0,3/7,9.55%,GREM1;MN1;NELL1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7047189945440038,1.281004955049384,0.1282051282051282,0.8340093468186343,1.0,4/15,7.70%,CACNG3;NRXN1;CACNG4;NLGN1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5843858578922548,-1.2809436466705086,0.14864864864864866,1.0,1.0,5/46,4.21%,CD44;CD4;ITK;PTPRC;CD74
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.5631042005004508,1.2809173685782214,0.12121212121212122,0.8330591873907839,1.0,7/28,13.22%,SPX;CPT1A;APOE;SLC25A20;SLC27A2;ABCD2;SLC27A6
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8272517435128193,1.2807202171149217,0.21052631578947367,0.8320871465974345,1.0,2/5,6.07%,TGFB2;JAG1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7084095656867334,1.2802937635895295,0.08108108108108109,0.8323032302367394,1.0,2/14,3.77%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.7249564215622678,1.280208063299137,0.19444444444444445,0.8295181191141804,1.0,1/8,0.17%,ACE2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.7249564215622678,1.280208063299137,0.19444444444444445,0.8295181191141804,1.0,1/8,0.17%,ACE2
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.849154775063575,-1.2802035841444672,0.1206896551724138,1.0,1.0,2/5,12.10%,CD74;CD27
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.7806280098099012,1.2800827705710194,0.16279069767441862,0.8284839392441739,1.0,3/5,21.73%,ENPP3;PRPS1;CTPS2
prerank,PanglaoDB_Augmented_2021__Platelets,-0.513353992643066,-1.2794122786599194,0.06944444444444445,1.0,1.0,24/110,14.62%,TUBB1;C3AR1;HCK;CDKN2D;GMFG;P2RY12;FGL2;SERPINE1;CD300LF;ALDH2;SLC26A4;CCL5;ALOX12;SPI1;LTBR;HLA-A;NOX5;MYO1F;F11R;CXCL14;THEMIS2;AQP9;PREX1;ATP2A3
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.8300834825000399,-1.2793852537612251,0.1509433962264151,1.0,1.0,1/6,1.16%,HSD17B10
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.7521656319439917,1.2793458640118334,0.2,0.8298311340920285,1.0,1/8,2.33%,SULF2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.789284091578417,1.2792885175041415,0.16666666666666666,0.8285002146374556,1.0,4/8,7.80%,SPRED1;SPRED2;SPRED3;ZEB1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.6343131032043069,1.2790457421516184,0.19444444444444445,0.8278473685310971,1.0,5/13,13.34%,COL15A1;COL22A1;PKHD1;SIPA1L3;POF1B
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7057729568541649,1.2790394052890774,0.125,0.8264498780581304,1.0,4/10,5.56%,SEMA5A;AMIGO1;EPHB2;CNTN4
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.8339880560734766,-1.278801850828851,0.14545454545454545,1.0,1.0,2/6,5.24%,ARR3;DRD3
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.7450246750073276,1.278047436687166,0.23255813953488372,0.8283380088217451,1.0,2/6,2.67%,PNP;SH3RF1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4435759086312366,1.277571046504266,0.03571428571428571,0.828557235988963,1.0,10/77,7.21%,EPHA3;EPHA5;CSF1R;IQGAP2;PEAK3;ESAM;MDK;PDGFRA;PRKCD;EFNA5
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.47525839498944616,1.277322814038229,0.14285714285714285,0.8279583675888097,1.0,17/88,15.95%,CDH6;CDH20;PKP2;DSCAM;SDK1;CDHR3;NRXN1;SHANK2;NLGN1;RYK;LIMS1;DCHS1;GPM6A;PKP4;NRCAM;DNER;CDH1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.7260662384159746,-1.2766721553614202,0.08771929824561403,1.0,1.0,4/13,12.10%,IL4I1;NCKAP1L;INHBA;CD27
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.6710904979249677,1.2764150681181732,0.12121212121212122,0.8303038141321523,1.0,5/11,8.80%,LEF1;TGFB2;CHD7;TGFB3;SMAD2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.8269581750798736,-1.2757913110771106,0.125,1.0,1.0,4/5,16.50%,AGT;NOTCH1;TGFB1;RGCC
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.7888755676611962,-1.2755927119457644,0.208955223880597,1.0,1.0,1/7,3.52%,GOT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.8630051982173438,-1.2755811647104622,0.10909090909090909,1.0,1.0,2/5,11.56%,PINK1;REST
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.6883639118551357,1.2754348771606028,0.1724137931034483,0.8329126308763288,1.0,5/14,12.45%,GREM1;DSCAML1;ACVR1;PTCH1;FBXL15
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.7120273010551545,1.2753694154030213,0.24390243902439024,0.8303799097436976,1.0,2/7,12.03%,NRP1;SIRT2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.7120273010551545,1.2753694154030213,0.24390243902439024,0.8303799097436976,1.0,2/7,12.03%,NRP1;SIRT2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7031747753541466,-1.2751485301385257,0.2413793103448276,1.0,1.0,4/15,11.28%,H1-0;H1-2;CHAF1A;HAT1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.6807965141884593,1.27439266617403,0.23684210526315788,0.8327541140278433,1.0,4/9,17.89%,SMPD4;SGMS1;SGMS2;SMPD3
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.8382902777875996,-1.2739566927426635,0.0625,1.0,1.0,3/6,11.98%,ALDH2;ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.6675643858974586,-1.2738538909109682,0.17391304347826086,1.0,1.0,3/18,11.56%,KCNE2;KCNQ1;REST
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5564321810552817,-1.27370857223049,0.11666666666666667,1.0,1.0,5/47,4.79%,TERF2IP;POLQ;CGAS;H1-0;H1-2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.7972148405427377,1.2735808962038322,0.1891891891891892,0.8344093006364576,1.0,2/6,14.03%,HDAC10;SRM
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.8318527563942986,-1.2735155368610296,0.12698412698412698,1.0,1.0,2/5,5.24%,NOTCH1;DRD3
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.8069607116695976,-1.2734633075211614,0.15492957746478872,1.0,1.0,1/5,6.15%,SERPINE1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.6554449828458314,1.2732515272079303,0.1388888888888889,0.8344927337244006,1.0,3/15,4.68%,SLC2A9;SLC2A14;SLC2A11
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.44559648406274904,1.273175131578536,0.041666666666666664,0.8333056348500378,1.0,22/127,14.46%,NRK;NYAP2;SGK1;DOCK10;NTNG1;CTNNA2;BMP7;PARD3;EPHB2;DSCAML1;CNTN4;NLGN1;MYO16;RYK;SLITRK5;NYAP1;GPM6A;SPTBN4;NGF;PAK3;CNTNAP2;NRCAM
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.7857372246910663,-1.2731490049254652,0.1694915254237288,1.0,1.0,3/6,15.40%,PRDX4;DAB2IP;TLR2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.6457321715698032,-1.273114278737447,0.13846153846153847,1.0,1.0,9/19,21.87%,DNAH8;TEKT3;CCDC39;DNAH3;DRC1;DNAH7;RSPH9;CFAP54;EFHC2
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.7328388457043975,1.2729247676097029,0.2702702702702703,0.8325615489203603,1.0,2/5,23.23%,FERMT2;PLEKHA7
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.8650808027236038,-1.27287674767465,0.10526315789473684,1.0,1.0,2/5,13.01%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7336980774059332,1.2727086123407592,0.2222222222222222,0.8322582040741133,1.0,6/11,11.55%,IRS1;PLCB1;IGF1;EIF2AK3;PIK3R1;GIGYF1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.47166888208562735,1.2722157915079346,0.06451612903225806,0.8325148576862716,1.0,16/72,15.02%,F2RL1;NRP1;CROCC;MIEN1;PLPPR5;TGFB3;NLGN1;WASF2;AUTS2;RALA;CEP120;PIK3R1;GPM6A;FNBP1L;PLEKHM1;RIPOR2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.6159667167378999,-1.2720063217113748,0.13846153846153847,1.0,1.0,11/34,25.14%,BNIP3;PINK1;WIPI1;MAP1LC3B;MAP1LC3B2;GABARAPL2;FUNDC1;ULK1;ATG3;CTSK;GABARAPL1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.8186992551897232,-1.2711360505234233,0.13043478260869565,1.0,1.0,1/6,5.24%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.6816045145631182,-1.270038529415988,0.1875,1.0,1.0,4/11,14.96%,SERPINE1;IGFBP5;TPM1;NDRG4
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4945402513280311,1.2700094272100109,0.18181818181818182,0.8393939837839155,1.0,14/101,9.25%,ITGB5;PTPRK;HIVEP1;BMP7;TGFBR1;BMP6;PARD3;TGFB2;FOS;ACVR1;TGFB3;SMAD2;RGMA;RGMB
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.434539623424004,1.2699642247351999,0.0,0.8381117634951376,1.0,73/331,14.72%,NRG1;ATP6V0D2;EPHA3;ROR2;KIT;ALK;UBASH3B;RGS14;FLRT2;PDGFD;GALNT3;PTPRT;IRS1;EPHA5;EGFR;NRP1;SULF2;KDR;CSF1R;FGFR4;EFS;SPRED1;PLCB1;SPRED2;FGFRL1;FGFR3;MPZL1;EPHB2;EPHA8;PDGFC;PDGFRA;CNKSR1;EFNA5;IGF1;SHC3;WASF2;PLAT;LTK;EPHA7;IRS2;RYK;PRKD1;EIF2AK3;ERBB4;CASS4;ARPC3;SHC4;FGFR1;ANGPT1;FIBP;FYN;MST1R;PIK3R1;FGF10;GIGYF1;FRK;SIRT2;FOXO1;ELMO1;TRIM71;KALRN;SIPA1L1;NTRK3;AKT2;NGF;TIAM1;SOCS2;PDGFB;FER;PAK3;ANKS1B;CLNK;CRK
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.564801145767475,1.2696868853124341,0.18181818181818182,0.8378735924889611,1.0,6/23,8.90%,KIT;IRS1;FGFR3;EPHA8;PDGFRA;PRKD1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.7483993057153382,-1.2695279125284011,0.22950819672131148,1.0,1.0,2/7,22.63%,PDZD7;LRTOMT
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.6612423715336309,1.2690363182051139,0.13333333333333333,0.8394224394621009,1.0,2/13,5.27%,F2RL1;MDK
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.7574233016378447,-1.2690315926886293,0.21311475409836064,1.0,1.0,1/7,5.83%,SOD2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7385734666714951,-1.268826100564478,0.23636363636363636,1.0,1.0,1/7,9.82%,DAB2IP
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.7661294767508806,1.2684805897958784,0.21052631578947367,0.8400262565793482,1.0,3/5,22.39%,SIRT1;FITM2;NR1H4
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6152210272143653,-1.2682718368619679,0.1527777777777778,1.0,1.0,12/38,15.20%,STAT1;IFIT1;IRF1;IFI27;PSMB8;IFI6;IFIT3;XAF1;HLA-A;OAS3;IFIT5;ISG20
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6152210272143653,-1.2682718368619679,0.1527777777777778,1.0,1.0,12/38,15.20%,STAT1;IFIT1;IRF1;IFI27;PSMB8;IFI6;IFIT3;XAF1;HLA-A;OAS3;IFIT5;ISG20
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5667265336386343,1.2678980423420372,0.13953488372093023,0.8407242595103687,1.0,3/27,5.54%,PER2;HDAC9;HEY1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.5945547664753138,-1.2677832308225985,0.14084507042253522,1.0,1.0,5/28,10.07%,MYLK;DUOX1;RREB1;SERPINE1;CLDN1
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.8278343819558581,1.2673153785133493,0.16216216216216217,0.8412277813657758,1.0,2/5,10.94%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.5469004090976831,1.266991811627093,0.23076923076923078,0.8412500991409599,1.0,3/27,2.42%,NPNT;NRP1;KDR
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.5827524787365289,-1.2668880951984656,0.18571428571428572,1.0,1.0,9/45,16.61%,FRRS1;B2M;CP;ATP6AP1;NUBP1;SKP1;HEPH;ISCU;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.8141869816202925,-1.2668482009259894,0.1206896551724138,1.0,1.0,1/6,4.32%,ATP1B1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.7443008707567416,-1.266506083336987,0.18032786885245902,1.0,1.0,2/10,7.35%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5295350504522511,-1.2663095373102136,0.11842105263157894,1.0,1.0,14/90,9.16%,CD44;ENPP2;PTPRC;TNFSF18;AGT;CD74;ITGA5;DOK7;CTF1;IL15;FLT3;TGFB1;CRLF1;CCL5
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.479222013855603,1.2661322915385949,0.0967741935483871,0.843354699180339,1.0,10/42,14.52%,HSPB1;KDR;HDAC9;HMGB1;PRKD1;FGFR1;ANGPT1;SIRT1;PDGFB;MAP2K3
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6237254851799021,-1.266097888378276,0.16666666666666666,1.0,1.0,3/27,11.63%,TERF2IP;GAR1;MRE11
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.7654363507914064,1.2658996792614565,0.34146341463414637,0.842823788834218,1.0,2/6,17.55%,EP300;GCK
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.6505879901023439,1.2656495137701766,0.20689655172413793,0.8425093516902176,1.0,1/14,2.55%,ARID5A
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.5125358650652013,1.2655640757937834,0.10714285714285714,0.8413386238278106,1.0,12/67,11.72%,EPHA3;PID1;STAC;EGFR;EPHB2;PTPN9;NUMB;STX8;VAMP8;PIK3R1;PRKCE;ZDHHC5
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5641909156223806,-1.2655459263044808,0.19402985074626866,1.0,1.0,3/39,1.81%,MYLK;WFS1;SCN4B
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5462676880338087,1.265363550488739,0.1,0.8406710863571625,1.0,3/15,11.50%,BCL2L11;RNFT1;PIK3R1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7483150718497653,-1.2652855757715238,0.14035087719298245,1.0,1.0,4/11,16.37%,CHMP4B;HSPA5;SEC62;SGTB
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.7693553080303722,-1.2652524543900634,0.09722222222222222,1.0,1.0,2/9,4.71%,CHAC1;CHAC2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6452242349955177,1.2641336799886487,0.34285714285714286,0.8443494037555277,1.0,2/8,5.79%,IL1RAPL1;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7513012188836202,-1.264034434440319,0.14285714285714285,1.0,1.0,3/10,13.72%,NOTCH1;CAV3;MLIP
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5067795327338789,-1.2639768690899946,0.07317073170731707,1.0,1.0,17/94,19.46%,TICRR;MCM2;POLE3;RFC5;CDC6;RPA3;MRE11;CHEK1;POLE2;BRCA1;RAD9B;SET;DONSON;GRWD1;RMI1;CDK2AP1;RAD1
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.8390984937269862,1.2638077608359968,0.15384615384615385,0.8425851565601135,1.0,1/5,1.61%,TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.8390984937269862,1.2638077608359968,0.15384615384615385,0.8425851565601135,1.0,1/5,1.61%,TOX
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.651714020080971,-1.2637789847909786,0.16129032258064516,1.0,1.0,2/16,11.63%,TERF2IP;MRE11
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.8333235490103912,-1.263509769749996,0.14754098360655737,1.0,1.0,2/6,13.18%,CASP8;FADD
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.452309807188997,1.2633844442792903,0.08,0.8427938309469156,1.0,11/79,9.49%,ATP6V0D2;CYP4Z1;PTPRT;KCNJ16;PDZD2;ESRRG;JAG1;SCNN1B;CCDC30;SLC22A6;ERBB4
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8396574664575029,1.2633560305601195,0.21951219512195122,0.8415163693807542,1.0,3/6,8.54%,SLC22A2;SLC7A2;SLC7A1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.8397210100742334,-1.2632211111607192,0.11764705882352941,1.0,1.0,1/7,1.16%,HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.7492430850614028,1.262904159584028,0.13636363636363635,0.8420085947532933,1.0,3/10,8.05%,F2RL1;SEMA5A;CRACD
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4666051366937131,1.2627120985699667,0.19230769230769232,0.8412301591743674,1.0,31/158,16.56%,SGK1;GALNT3;STK32B;SGK2;TGFBR1;LATS1;PRKCB;NEK6;PRKCD;CLSPN;GALNT13;STK38;SBK1;PRKD1;EIF2AK3;MAST4;MAPK8;PRKCE;MARK1;SGK3;MAPK12;MAP3K10;AKT2;PDGFB;RPS6KA6;GALNT16;MAP3K13;DMPK;MAST2;ATM;DYRK3
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.7584854458332386,1.2625563869611809,0.2647058823529412,0.8405715982513612,1.0,4/6,22.87%,CFLAR;AKIRIN1;PPP3CA;LARGE1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.6145077545781604,1.2624396510857157,0.10526315789473684,0.8396106998363878,1.0,5/14,17.99%,MCTP1;SNCAIP;MCTP2;MEF2C;HCRT
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6635770653922338,-1.2623642797547678,0.13636363636363635,1.0,1.0,4/18,7.35%,KCNE2;SCN4B;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.7600233717613514,1.262233335607652,0.15151515151515152,0.8390037307018515,1.0,1/8,2.10%,TMOD4
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7419454434719811,-1.261979744007596,0.15517241379310345,1.0,1.0,3/10,12.59%,C4BPB;SERPING1;A2M
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.6121491105263493,-1.2618606075425671,0.18181818181818182,1.0,1.0,4/24,10.48%,LIPH;LIPI;PNPLA1;FABP3
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.8101045896709372,1.2617223254828427,0.15217391304347827,0.8393559610872328,1.0,3/6,4.78%,HS3ST5;HS3ST3B1;HS6ST3
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7404903668044915,1.2614906614285668,0.1794871794871795,0.8391010211048642,1.0,5/8,22.12%,LEPR;SGIP1;CFAP20;NR4A3;STAT3
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5161225644439821,1.261351416687875,0.1724137931034483,0.8382418870800783,1.0,17/64,15.63%,RGS14;CACNG3;CLSTN2;EPHB2;GRIN2A;NRXN1;CACNG4;SHANK2;NLGN1;SLC8A3;GRIN2C;ZDHHC3;SYT1;ZDHHC2;GRIK2;GRIN2B;KCTD13
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5213306074504452,1.2613223640350018,0.16666666666666666,0.8369673744355567,1.0,14/36,15.55%,KCTD11;VWC2;MMD2;BRINP1;ZC4H2;ZEB1;FGFR1;TCF4;BRINP2;NGF;NRCAM;BEND6;SIN3A;MEF2C
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.65915802596655,-1.2613066524457226,0.23728813559322035,1.0,1.0,7/14,24.16%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5PB;ATP5ME
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.6038557555154715,1.261125548566558,0.2571428571428571,0.836392847613839,1.0,7/27,11.44%,FGF13;SLC6A4;FGFR3;WWC1;PTCH1;DUSP10;PTPRS
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.7632875536321657,1.26101874824163,0.21428571428571427,0.8354496809704791,1.0,3/6,14.09%,F2RL1;PTPRO;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4819375007545638,1.260818304117705,0.125,0.8347638874314288,1.0,23/119,11.55%,NRG1;KIT;IRS1;EGFR;FGFR4;KITLG;TGFBR1;SEMA5A;FGFR3;PDGFRA;BTC;AKR1C3;NRG2;IRS2;ERBB4;CASS4;EREG;FGFR1;ANGPT1;FYN;MST1R;PIK3R1;FGF10
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.7446787411889334,-1.2607891624309158,0.11940298507462686,1.0,1.0,3/10,16.97%,HLA-A;SFTPD;WFDC2
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.7583495582717372,1.2606574980734928,0.16666666666666666,0.8340572351858648,1.0,1/7,2.33%,SULF2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.6253087617444226,1.2606218178812416,0.2222222222222222,0.8327998054137006,1.0,5/23,10.85%,RUNX1;CBFB;MDK;ZBTB1;IL2RA
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5865346006083884,1.2603017313286173,0.16666666666666666,0.8328808515403654,1.0,3/16,11.72%,CDH13;CD22;RGN
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7009985432513679,-1.2600991718858912,0.2830188679245283,1.0,1.0,3/12,15.08%,PINK1;CHMP4B;PHF23
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8164778463519173,-1.2598729731317868,0.22033898305084745,1.0,1.0,1/5,4.87%,ITGA5
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4574567335931756,1.2598478610024808,0.038461538461538464,0.8332372764020491,1.0,34/135,15.53%,PTPN3;PTPRT;DUSP5;DUSP2;PTPRK;CDC14B;PLPPR5;PTPRB;DUSP4;PTPN9;PTPRO;DUSP8;PTPN6;SGPP2;PTPRE;SSH1;PTPN12;DUSP10;DUSP12;PPEF1;PNKP;PTPN13;PTPRS;TAB1;CTDSP2;PPP2R5E;PSPH;PTPRM;BTRC;CTTNBP2NL;PPM1H;PPM1E;PPP2R1B;PTPRH
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6276094588819515,-1.259827648797845,0.2318840579710145,1.0,1.0,5/24,13.66%,ENO4;ALDOB;HKDC1;PGAM1;ENO2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5537013106319649,1.2593145883908157,0.1724137931034483,0.8342576111046222,1.0,9/19,24.40%,TGFBR1;CHD7;TGFB3;MBNL1;PTPRR;BMP2;HINFP;ADAM10;VEGFA
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5983708196579525,-1.2592114216914374,0.09230769230769231,1.0,1.0,12/38,25.86%,BNIP3;PINK1;WIPI1;MAP1LC3B;MAP1LC3B2;GABARAPL2;FUNDC1;ULK1;ATG3;CTSK;GABARAPL1;ATG14
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.7284008557418793,-1.2591601399681553,0.20634920634920634,1.0,1.0,1/8,3.43%,IL4I1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.7494395329044247,1.2591548740903453,0.1956521739130435,0.8335345571364817,1.0,1/7,2.08%,CIDEA
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.582560556080614,-1.2590982819737064,0.13846153846153847,1.0,1.0,2/36,7.84%,HCK;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.66904053875254,1.2589080482685786,0.11764705882352941,0.8333395906721442,1.0,3/14,8.56%,MELTF;FGFR4;PDPN
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.49884097691930424,1.2583682687523192,0.1111111111111111,0.8339896916209812,1.0,14/47,15.55%,MDGA1;FGF13;NRP1;SH3RF1;LRP12;AUTS2;FGFR1;SPOCK1;MARK1;GPM6A;NR4A2;NRCAM;DNER;MEF2C
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5729141753441251,1.2582858713839038,0.14285714285714285,0.8330654606935037,1.0,7/27,17.82%,LEF1;HDAC1;TLE2;EP300;SMARCA4;BCL9;CREBBP
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6256350791009841,-1.2578152543286971,0.22058823529411764,1.0,1.0,7/22,9.10%,CD4;TRIM22;TRIM5;CD74;TRIML2;CIITA;TRIM25
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7886283854021808,-1.2573286107184232,0.2807017543859649,1.0,1.0,3/6,16.84%,SOX10;PLP1;CNTNAP1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.681179127963568,-1.256776723524456,0.16666666666666666,1.0,1.0,3/12,18.46%,TERF2IP;DAXX;H3-3A
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.7411557489699142,1.256691529446142,0.275,0.8376723972550785,1.0,2/5,12.75%,BMP6;PTPN23
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.4836929928048971,1.256578249698377,0.0967741935483871,0.836836095182799,1.0,9/34,12.05%,MELTF;KANK1;JAG1;PTPRO;EFNA5;CASK;SPOCK1;ACTN4;NEXMIF
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5426643714219137,-1.2564849779941003,0.15789473684210525,1.0,1.0,22/67,22.39%,GNLY;ELANE;RARRES2;GBP6;SERPINE1;LYG1;HLA-A;STAB1;ADGRB1;OAS3;CXCL13;TLR2;SFTPD;ADAM17;SLC11A1;WFDC2;LBP;SHC1;ISG15;ROMO1;PGLYRP1;RAB1A
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.717881675801237,-1.2562239355813882,0.16666666666666666,1.0,1.0,7/16,20.15%,ALOXE3;ALOX12;CLDN1;STMN1;TMEM79;HRNR;MET
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.717881675801237,-1.2562239355813882,0.16666666666666666,1.0,1.0,7/16,20.15%,ALOXE3;ALOX12;CLDN1;STMN1;TMEM79;HRNR;MET
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.5382463322737815,1.2561791074282547,0.20588235294117646,0.836705455981625,1.0,2/32,0.80%,UBASH3B;HSPB1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5144424146439336,1.2560062082400818,0.13157894736842105,0.8357601435761699,1.0,5/35,8.07%,ACE2;SLC26A3;TOX3;MDK;FLI1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.8237814716565655,-1.255560863679769,0.09433962264150944,1.0,1.0,1/7,0.85%,KCNE2
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.8237814716565655,-1.255560863679769,0.09433962264150944,1.0,1.0,1/7,0.85%,KCNE2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4860834655102771,-1.2553846676348699,0.03529411764705882,1.0,1.0,66/186,29.02%,MCM2;POLE3;TCP1;PRDX4;EIF1AX;SLC25A3;NCBP2;EPRS1;SNRPD2;PCBP1;NCBP1;GNL3;VBP1;PCNA;RNPS1;XPOT;RPL22;DEK;H2AZ1;PSMA7;PSMC6;SET;RPL34;VDAC3;VDAC1;NDUFAB1;NOP56;EIF2S2;C1QBP;CDK4;CCT7;CBX3;COPS5;PSMB2;PRDX3;SRPK1;USP1;ERH;RRM1;APEX1;HSPD1;LDHA;RPS3;CCT2;RAN;SSB;HDDC2;RPL18;CANX;EIF3J;PA2G4;EIF4H;KPNA2;RPS5;HSP90AB1;PGK1;MCM4;RPS2;PWP1;SNRPB2;IFRD1;ACP1;PSMA1;PSMD8;PSMC4;IMPDH2
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.6679056437692374,-1.2551673140705484,0.11267605633802817,1.0,1.0,4/17,8.55%,CD4;CD74;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.6242040571469203,1.2550457319323154,0.175,0.8376209031396825,1.0,7/25,8.65%,F11;IFI16;PRSS12;KLKB1;GRIN2A;HGFAC;PLAT
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.7889662177133716,-1.2547970090443812,0.12698412698412698,1.0,1.0,2/5,4.21%,CD4;CD74
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.7889662177133716,-1.2547970090443812,0.12698412698412698,1.0,1.0,2/5,4.21%,CD4;CD74
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7170438655486329,-1.25477866883042,0.16666666666666666,1.0,1.0,2/10,7.52%,PRLR;STAT5A
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.7710340610200036,-1.2541633586200518,0.14754098360655737,1.0,1.0,1/7,4.32%,ATP1B1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.7854035458643351,-1.2540432976895783,0.23529411764705882,1.0,1.0,1/5,1.16%,HSD17B10
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6516599352971801,1.253996898066218,0.1891891891891892,0.8403108395871335,1.0,2/11,4.31%,F2RL1;BATF3
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5168556842353372,-1.253962940479655,0.056338028169014086,1.0,1.0,29/97,17.04%,C3AR1;MS4A6A;HCK;SIGLEC1;PTPRC;CD74;CD14;SLCO2B1;SLC7A7;AHR;FGL2;CD300LF;SLA;CCL5;SCIMP;FMNL1;SPI1;WDFY4;STAB1;MYO1F;CD83;TAGAP;IGSF6;AQP9;TLR2;NCEH1;SLC11A1;GPR132;CPM
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.692723279293917,1.2538395543643577,0.21875,0.8395445807031776,1.0,1/13,0.48%,KIT
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.7428238899807422,1.2536222220526063,0.2564102564102564,0.8390507221758301,1.0,3/10,3.77%,RUNX1;PNP;CBFB
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.8314331772438934,-1.2533825271524148,0.140625,1.0,1.0,1/6,1.99%,PTPRC
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.5407862924711055,1.2526585157725163,0.12121212121212122,0.8412314935975486,1.0,9/35,13.85%,IFI16;LEF1;HMGB1;IGF1;TFAP4;MAPK8;SIRT2;HMGA2;NGF
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6222234378252061,-1.252321697981314,0.1875,1.0,1.0,3/26,8.90%,CALB1;SCGN;AGER
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.7974796301092323,-1.252150794132181,0.18333333333333332,1.0,1.0,2/5,3.80%,LDLRAP1;AGT
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7863210018110568,1.25148826203767,0.25,0.8443473479090844,1.0,1/7,5.03%,XRCC4
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.6689983625940865,1.2512339081455572,0.15384615384615385,0.8442961104325512,1.0,1/9,1.61%,TOX
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8122170453801223,-1.2511065760954017,0.1509433962264151,1.0,1.0,2/7,12.51%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.552376927770102,1.2502988713714436,0.17391304347826086,0.846525447826749,1.0,9/50,9.25%,HIVEP1;BMP7;BMP6;TGFB2;ACVR1;TGFB3;SMAD2;RGMA;RGMB
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.578176855709745,1.25028809398859,0.1794871794871795,0.8452209273897119,1.0,9/25,16.51%,ITGA4;CACNA2D1;GRM5;GRIN2A;IGF1;FYN;ABCC1;CACNA1A;GRIN1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7762789029624207,1.2501606663272504,0.1794871794871795,0.8442547953342558,1.0,4/8,13.00%,HDAC9;HDAC10;SIRT2;SIRT1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6306558605638725,-1.2499574588665248,0.2028985507246377,1.0,1.0,7/29,12.01%,LDLRAP1;B2M;LRPAP1;RAC1;SERPINE1;PIK3CB;HIP1R
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.538801441880244,1.249836226874292,0.16666666666666666,0.8442040227053491,1.0,11/27,18.94%,AFF3;TGFB2;MAP3K20;MYH3;HDAC1;PTCH1;ECE1;LRP6;CREBBP;FBXW4;MBNL1
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),0.7927305901501946,1.249491232558361,0.20833333333333334,0.8443533658739955,1.0,3/5,15.07%,SLC7A2;SLC7A1;SLC25A29
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.8037483395264844,1.2494763172077812,0.15789473684210525,0.8430825394754287,1.0,2/5,6.95%,ENPP3;ENPP1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7627226113479695,1.2494313348451611,0.2564102564102564,0.842059298071831,1.0,1/6,5.87%,NBDY
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5710271707953981,1.2492115881154677,0.2222222222222222,0.8417247680994707,1.0,4/26,6.83%,CDH13;KIT;PTPRO;ARFIP2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6860202185667807,1.2491925737452143,0.23076923076923078,0.8404860075706206,1.0,5/9,22.66%,KNDC1;GRID2;OPHN1;PROX1;CBLN1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.5520755612707833,1.2491330579138302,0.2,0.8394494919365563,1.0,5/37,5.37%,CD38;BCL2;SHLD1;EPHB2;IGLL1
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.8313467857029122,-1.2489491878787653,0.16666666666666666,1.0,1.0,1/6,5.24%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.7541022963246652,-1.2485459463291297,0.20967741935483872,1.0,1.0,2/8,15.57%,CHAC1;GAS1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.6361868101893239,-1.2482899877238245,0.1694915254237288,1.0,1.0,9/23,27.43%,HSD17B10;IL4I1;ACMSD;ALDH4A1;DAO;FAH;GSTZ1;SARDH;TDO2
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.7475533937510027,-1.2481470900470364,0.2923076923076923,1.0,1.0,5/7,24.81%,ALDOB;ALDH1A1;GLYCTK;KHK;TKT
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.8511297296395814,1.248037046789894,0.2564102564102564,0.8427524362772894,1.0,2/5,5.27%,SIGLEC10;MDK
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.6986847559926577,-1.2478452186583875,0.125,1.0,1.0,5/14,9.16%,HCK;CD14;CD6;TGFB1;CCL5
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7365418058986146,1.24650282578942,0.24390243902439024,0.845531543105843,1.0,2/6,9.20%,IWS1;TPR
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7365418058986146,1.24650282578942,0.24390243902439024,0.845531543105843,1.0,2/6,9.20%,IWS1;TPR
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7490334619496806,1.2464928367687693,0.3125,0.8442307253472187,1.0,3/5,22.35%,ASH1L;SETMAR;SETD2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.5372569562227817,1.2463703768193237,0.18181818181818182,0.8433933042467449,1.0,9/33,19.99%,SRPK3;KHDRBS3;IWS1;KHDRBS2;PAPOLA;QKI;SLTM;SON;PTCD2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6424314911791384,1.2462632980414634,0.23809523809523808,0.8424492386634728,1.0,7/15,20.37%,GRIN2A;GRIN2C;GRID2;GRIN2B;MEF2C;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.7312711935456684,1.2453659410702587,0.23684210526315788,0.8442124056174214,1.0,2/6,14.92%,TGFB2;CR1L
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6686287844894772,1.2452586610754175,0.2,0.8434006297646973,1.0,3/14,5.27%,RUNX1;LEPR;MDK
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.841104569432319,-1.2451212730875933,0.15254237288135594,1.0,1.0,2/5,15.49%,P2RY12;GPR183
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.4691192775356364,1.2445984167597093,0.08333333333333333,0.844395969176803,1.0,9/75,3.13%,LRIG3;LAMB2;PRRX1;TEAD2;SVEP1;EGFR;WWTR1;PCDH18;FNDC1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5403181147310188,1.2441185710287215,0.18421052631578946,0.8449540847188389,1.0,3/28,2.42%,HSPB1;NRP1;KDR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6794081986501095,1.2440038120110315,0.1590909090909091,0.844188239560865,1.0,5/15,13.24%,RUNX1;TGFBR1;ERBB4;RBP4;VGLL4
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5512075083286323,-1.2437927851764834,0.16666666666666666,1.0,1.0,6/42,8.26%,TERF2IP;POLQ;CGAS;RAD51AP1;PPP4C;FIGNL1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.521029184367762,-1.243574549677484,0.08860759493670886,1.0,1.0,22/106,12.40%,CD44;C3AR1;MS4A6A;HCK;SIGLEC1;PTPRC;MGST1;NOTCH1;CD14;IL3RA;ABCB1;FGL2;FCGRT;CD300LF;FLT3;TAF7;ALDH1A1;PROCR;SPI1;WDFY4;STAB1;SERPING1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.8042569071734138,-1.2434827604987544,0.1935483870967742,1.0,1.0,4/5,19.56%,ALDOB;ALDH1A1;GLYCTK;KHK
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.8042569071734138,-1.2434827604987544,0.1935483870967742,1.0,1.0,4/5,19.56%,ALDOB;ALDH1A1;GLYCTK;KHK
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.6734583579952411,1.243195844212281,0.125,0.8456540005077785,1.0,2/10,4.60%,PLCB1;GREM1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.5516158197453473,-1.2430704917757944,0.12903225806451613,1.0,1.0,12/39,20.49%,TERF2IP;RAD51AP1;PPP4C;FOXM1;FIGNL1;OTUB1;CHEK1;SLF1;DEK;WAS;KDM1A;TWIST1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.7736212350433229,1.2430704680383056,0.18421052631578946,0.8448029749833988,1.0,5/5,22.66%,KNDC1;GRID2;OPHN1;PROX1;CBLN1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.4713500742460103,-1.2428592204978957,0.06493506493506493,1.0,1.0,56/180,25.15%,HSD17B10;ATP1B1;COX4I1;ATP6AP1;SLC25A3;ATP6V1D;ETFB;ATP6V1E1;NDUFA2;ATP5F1E;NDUFB3;UQCRB;MDH1;SLC25A5;SLC25A4;CYB5R3;RETSAT;ATP5F1C;COX6B1;CYCS;TOMM22;ISCU;NDUFC1;NDUFB4;COX7A2L;ATP6V1C1;VDAC3;COX6C;VDAC1;SLC25A11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;SUPV3L1;ATP5MC3;ATP5PD;ATP6V0B;PDHX;LDHB;PRDX3;HSPA9;ATP6V1G1;IDH3A;COX7A2;ATP5F1A;MAOB;COX7C;LDHA;NDUFA3;ATP5PB;COX7B;DECR1;ATP5ME;BAX;UQCRH
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.6398815495989054,-1.2425586600029717,0.20588235294117646,1.0,1.0,6/17,14.57%,ACTC1;ZFPM1;NOTCH1;TGFB1;TTN;TPM1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.657695452726285,-1.2425538928112405,0.22033898305084745,1.0,1.0,3/13,14.46%,SHCBP1L;MRE11;GNL3
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.57350960288384,1.2423351775490572,0.2222222222222222,0.8462633628131662,1.0,9/26,15.48%,PHACTR1;NTNG1;CTNNA2;MDK;NSMF;ZNF609;NEXMIF;SRGAP2C;SEMA6A
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.7956429097680758,1.2421515521038269,0.23255813953488372,0.8458664405833136,1.0,2/5,9.27%,CPT1A;CROT
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5736886852409717,1.2420243142840321,0.1951219512195122,0.844889874549138,1.0,13/30,22.83%,CLSTN2;ECE1;VAMP3;PTPN23;SYT1;NMB;GRIK2;KCTD13;HOMER1;HCRT;EDN1;RIMS2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.8152447307495945,-1.2419271110746846,0.14754098360655737,1.0,1.0,2/5,12.10%,NCKAP1L;CD27
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.8099603829266888,-1.2416295092944534,0.22388059701492538,1.0,1.0,1/5,5.89%,TST
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5500345923525796,-1.2415503311576306,0.14084507042253522,1.0,1.0,11/51,13.11%,CD44;GNLY;ITK;PTPRC;GMFG;SLA;CD6;ARHGAP9;MYO1F;THEMIS;TAGAP
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.8076572592289069,1.2414606439418294,0.16666666666666666,0.8457850365916063,1.0,4/8,12.86%,RAB7B;HMGB1;PTPRS;GRAMD4
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6787791796940189,1.241345433543854,0.2727272727272727,0.8448973262382268,1.0,3/16,7.06%,KLRD1;PIK3R6;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.6207156220461645,-1.2412030281979818,0.23214285714285715,1.0,1.0,5/21,14.69%,LMAN1;BAG4;UFM1;RAB23;APOD
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),0.7668167701105714,1.2410121312212878,0.17073170731707318,0.8447618335323731,1.0,3/5,15.07%,SLC7A2;SLC7A1;SLC25A29
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.612814291183781,1.2408606539995395,0.2571428571428571,0.8441990777716696,1.0,1/15,1.35%,GDAP1
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.7503750007731277,-1.2405977375880268,0.22058823529411764,1.0,1.0,2/6,23.17%,CELSR1;FUZ
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.488757664425937,1.2404734961217965,0.1111111111111111,0.8441077410656247,1.0,15/45,13.93%,EYA4;EGFR;TIMELESS;MGMT;HMGB1;ERCC8;HDAC10;EYA2;BABAM2;FAM168A;FGF10;EYA3;SIRT1;SPIDR;BRCC3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6392617834489782,1.2398594084600698,0.25,0.8451252904991913,1.0,5/11,22.60%,NLGN1;SYN3;ZDHHC3;CLN3;ADRA1A
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5892343849645715,1.2396532552554294,0.25,0.8446283778435797,1.0,12/29,18.00%,GRIA4;GRIA2;EPHB2;GRIN2A;LRRC7;GRIA1;NLGN1;DLG2;GRIN2B;MEF2C;GRIN1;RELN
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.7767004902650456,1.2394945943196813,0.23684210526315788,0.8439629018347361,1.0,2/7,12.26%,CDK2AP2;PRDM15
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5857983089292915,-1.2393488914548043,0.12698412698412698,1.0,1.0,10/36,20.01%,TIMP3;AGT;TIMP2;SERPINI2;SERPINE1;SERPINA10;SERPING1;TIMP4;SERPINF1;KNG1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5450586676111764,-1.23933773565778,0.16216216216216217,1.0,1.0,13/57,20.29%,MCM2;GMNN;PSMB6;CDC6;PSMB8;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4627702154721056,1.2386787590979726,0.1111111111111111,0.845909980607799,1.0,22/113,9.26%,FBXL7;DOK5;SEMA6D;PENK;VCAN;NTM;CACNA2D1;EFS;PCDH18;VAT1L;SLC16A2;MAPK4;PDZRN3;TGFB2;RGS7BP;GUCY1A2;ADGRL2;GFRA1;BRINP1;PCDH19;RCAN2;CSRNP3
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6896211442129966,-1.2381343598563175,0.18333333333333332,1.0,1.0,4/14,11.12%,ELANE;CD6;SIGIRR;ITIH4
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.7653248394039398,-1.2380544584512743,0.22413793103448276,1.0,1.0,1/7,0.13%,C3AR1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4178224033330936,1.237593878071513,0.08333333333333333,0.8478724570764733,1.0,23/124,11.49%,EPHA3;ROR2;KIT;ALK;EPHA5;EGFR;KDR;CSF1R;FGFR4;GREM1;FGFR3;EPHB2;EPHA8;PDGFRA;NAF1;LTK;EPHA7;RYK;ERBB4;PARM1;FGFR1;PNKP;MST1R
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.7459292292158969,1.2374447448874764,0.29411764705882354,0.8472474493689489,1.0,1/6,4.18%,TGFB2
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6712428716952055,-1.2367034446893164,0.21052631578947367,1.0,1.0,1/15,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5316564152864725,1.2365656700275423,0.1590909090909091,0.8492021180902961,1.0,8/40,10.15%,RGS14;IL1RAPL1;CLSTN2;EPHB2;NRXN1;NUMB;NLGN1;GRID2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.6163208512517588,1.2364354995303821,0.20833333333333334,0.8485136972381939,1.0,3/14,13.34%,KHSRP;TRIM71;RC3H1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5496919130094624,1.2356772726438732,0.17142857142857143,0.8497654930568551,1.0,4/16,10.10%,ALG8;MPDU1;ALG12;ALG13
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5981934516456486,-1.2355452069681996,0.21212121212121213,1.0,1.0,5/21,18.23%,ACTC1;MYBPC2;TTN;TPM1;MYL6B
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5981934516456486,-1.2355452069681996,0.21212121212121213,1.0,1.0,5/21,18.23%,ACTC1;MYBPC2;TTN;TPM1;MYL6B
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.7686571393918623,-1.2352994542750213,0.22950819672131148,1.0,1.0,1/7,6.61%,CHMP2B
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.7070245924170525,1.2351931163637964,0.25,0.8491492627082179,1.0,5/8,21.07%,NFATC1;NFAT5;PPP3CA;NFATC2;NFATC3
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.7070245924170525,1.2351931163637964,0.25,0.8491492627082179,1.0,5/8,21.07%,NFATC1;NFAT5;PPP3CA;NFATC2;NFATC3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.7551747831062354,-1.2351187891436854,0.234375,1.0,1.0,3/8,11.97%,CYP1B1;SERPINE1;SNAI2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.5516000964602689,1.2350941787527896,0.22857142857142856,0.8482762083624731,1.0,10/22,27.21%,EIF4EBP1;MEIS2;TTL;PKN2;SMOC2;PPP1R10;HSF1;CUL3;PRKCA;SPHK1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.6700303714386081,1.2350697759074765,0.23529411764705882,0.847133459592801,1.0,3/13,9.55%,GREM1;MN1;NELL1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7898342148237811,-1.2350219566728922,0.16393442622950818,1.0,1.0,2/9,8.69%,PTPRC;SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7780583390027338,1.234472907322102,0.2631578947368421,0.8487336037396598,1.0,2/7,10.41%,LRRC55;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.7363589059701062,-1.2344166598231037,0.2153846153846154,1.0,1.0,5/10,23.87%,TCP1;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),-0.7380523841707074,-1.233876841661618,0.25,1.0,1.0,1/7,1.01%,PTGIS
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4759281407471729,-1.2337301373433733,0.11688311688311688,1.0,1.0,32/147,19.12%,TRIM58;HCK;TRIM22;TNK1;TRIM5;B2M;CD74;RARRES2;TRIML2;IFIT1;IFI27;CIITA;SLA;IFI6;CORO1A;AGER;TRIM25;RNF39;IFNLR1;TRIM32;SERINC3;SIGLEC15;TLR2;SFTPD;MASP2;PLCG2;SLC11A1;WFDC2;LBP;STYK1;NLRC5;ISG15
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.6007705751211329,1.233626345164095,0.1891891891891892,0.8499949460797046,1.0,3/14,6.33%,UBASH3B;KIF26A;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.7543456981722614,1.2332018698445728,0.1891891891891892,0.8502100320002263,1.0,5/7,21.07%,NFATC1;PDGFB;DNMT1;NFATC2;NFATC3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5911083222214839,-1.2329384516758806,0.18309859154929578,1.0,1.0,16/33,30.87%,ENO4;ALDOB;MANBA;HKDC1;PGAM1;ENO2;NEU1;MAN2B2;LDHA;PKLR;PGK1;DERA;GAPDH;PKM;ENOSF1;HK3
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.4525255731519674,1.2327977278387368,0.06451612903225806,0.8504453097879351,1.0,23/64,23.86%,RGS14;IL1RAPL1;FBXW8;AMIGO1;NUMB;TIAM2;ROBO2;CHODL;NGF;TIAM1;PLXNA2;MAP6;ROBO1;PTPRD;NUMBL;CTNNB1;PLXNC1;MME;PLXNA1;CUX1;NEURL1;CAPRIN1;DISC1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7331084104212291,-1.2324593580837648,0.24615384615384617,1.0,1.0,4/8,18.11%,BCAP31;HERPUD1;SVIP;USP14
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.5416177943302156,-1.2323858360760136,0.14285714285714285,1.0,1.0,20/51,29.92%,RSL24D1;RRP15;RPL26L1;RPL35A;RPL5;EIF6;RPL3;RPL24;WDR12;RPL7A;SURF6;RPF2;NSA2;TRAF7;LAS1L;NIP7;MRTO4;MAK16;ZNF622;MRPL20
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6643982551677363,-1.2321756017704821,0.2463768115942029,1.0,1.0,3/9,17.89%,SLC25A5;SLC25A4;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.4726602036717321,1.2321574609355033,0.20833333333333334,0.8511996600856463,1.0,21/93,10.45%,EPHA3;ROR2;KIT;ALK;RASSF2;EPHA5;EGFR;KDR;CSF1R;FGFR4;FGFR3;EPHB2;EPHA8;PDGFRA;MMD2;LTK;EPHA7;RYK;ERBB4;EREG;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7022482909149724,1.2320493969227997,0.2857142857142857,0.8503532856116799,1.0,4/9,13.75%,IRS1;IRS2;PRKCE;AKT2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.6825342797526901,1.230663304764865,0.20512820512820512,0.8543808905602213,1.0,2/6,7.31%,KIT;TICAM1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7714066141961368,1.2305134619057887,0.30612244897959184,0.8536979503746998,1.0,2/5,13.45%,MAML1;ATP11A
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5740315424293267,-1.2302620169318141,0.1891891891891892,1.0,1.0,12/43,20.29%,PSMB6;PSMB8;PSMA3;NQO1;PSMA5;PSMC3;PSMA7;PSMC6;AZIN1;PSME1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5212845598283694,-1.2301750466693941,0.11842105263157894,1.0,1.0,2/78,1.02%,CD44;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),0.8055265720803668,1.2295273709651149,0.17777777777777778,0.8561587838436454,1.0,2/5,5.57%,SLC6A4;WWC1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5608166613784022,-1.2293795260684797,0.11764705882352941,1.0,1.0,22/53,25.15%,NDUFB9;COX4I1;NDUFA2;NDUFB3;UQCRB;COX6B1;CYCS;NDUFC1;NDUFB4;COX7A2L;COX6C;NDUFB11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;NDUFB10;NDUFS5;COX7C;NDUFA3;COX7B;UQCRH
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7681749099922568,-1.2289255247493143,0.21818181818181817,1.0,1.0,1/9,4.40%,LGSN
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.7948711611548834,1.228882366479553,0.2765957446808511,0.8571883435622477,1.0,3/5,10.92%,BMP7;MDK;BAG3
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5737109229732417,-1.228084282279505,0.1917808219178082,1.0,1.0,19/45,29.97%,PSMB6;PSMB8;PSMA3;NQO1;PSMA5;PSMC3;PSMA7;PSMC6;AZIN1;PSME1;BCKDK;PSMD12;PSMB2;PSMD2;PSMA1;PPM1K;PSMD8;PSMC4;PSMC1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.6507322846978515,-1.2280576556901432,0.23728813559322035,1.0,1.0,4/18,9.57%,TRPV6;WFS1;FAM20A;TMC8
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5591625708578296,1.22768545866842,0.1875,0.8605232269975455,1.0,1/15,2.14%,FARS2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.7904608297868294,-1.2276185915594073,0.29508196721311475,1.0,1.0,1/6,2.48%,NDP
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.5015940396838346,-1.2275225967571226,0.125,1.0,1.0,31/124,20.68%,BTN2A2;CD4;ITK;PTPRC;PSMB6;HHLA2;FYB1;TXK;PSMB8;SKP1;PIK3CB;HLA-DPB1;HLA-A;TEC;THEMIS;PSMA3;THEMIS2;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;EIF2B2;BTNL2;EIF2B5;PSME1;WAS;PSMD12;PSMB2;MOG;SKAP1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.42641252922197326,1.2267867376267774,0.11538461538461539,0.8622432265186188,1.0,14/88,13.00%,TPD52L1;KIT;PDGFD;EGFR;CSF1R;PIK3R6;PDGFC;RASGRP1;FGFR1;IL34;MST1R;TELO2;HMGA2;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6196646952562991,-1.2257983834921626,0.24242424242424243,1.0,1.0,3/20,7.91%,BTN2A2;IL4I1;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.7714086028307796,-1.224872886704332,0.2,1.0,1.0,3/5,20.26%,ATP6AP1;SIGLEC15;NOTCH2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.6283208106810899,1.2244680657793978,0.16216216216216217,0.8684587939636742,1.0,4/15,14.46%,METTL8;TRMT61A;ZC3H13;TRMT61B
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.6017375135679722,-1.2244251680696205,0.18181818181818182,1.0,1.0,8/30,20.58%,PPP1R1B;FKBP1B;CALM3;PDGFRB;CRY2;PPP4R4;CALM1;BOD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.631779411524556,-1.2243269013638491,0.296875,1.0,1.0,3/17,10.25%,ATP1B1;FKBP1B;CALM3
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.5674517423993715,1.2239957170636657,0.2,0.8687054280599619,1.0,2/25,0.77%,ELOVL6;CYP1A2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5676959632511752,-1.223809020960628,0.11940298507462686,1.0,1.0,22/52,25.15%,NDUFB9;COX4I1;NDUFA2;NDUFB3;UQCRB;COX6B1;CYCS;NDUFC1;NDUFB4;COX7A2L;COX6C;NDUFB11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;NDUFB10;NDUFS5;COX7C;NDUFA3;COX7B;UQCRH
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7819799140309781,-1.2237832872680214,0.18518518518518517,1.0,1.0,2/7,7.84%,RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6189792745031394,-1.223718224153023,0.2,1.0,1.0,4/21,20.41%,TERF2IP;TDG;EXOSC6;MPG
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.5218848345419957,1.2236871927287034,0.21212121212121213,0.8683366153388319,1.0,10/32,18.73%,EPHA3;BRINP1;LTK;BRINP2;CREB1;ADNP2;ATM;WNT5A;ABL2;WNT3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.6863301451851898,1.22332353698137,0.3076923076923077,0.8682144039588044,1.0,2/9,10.74%,CSF1R;IL34
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5546961833400729,1.2230722640019627,0.12121212121212122,0.8678269215684439,1.0,12/31,16.62%,BMP7;BMP6;TGFB2;ACVR1;PKDCC;TGFB3;NELL1;SLC8A1;ANO6;GPM6B;MEF2C;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.5709772129033341,1.222419650599524,0.23684210526315788,0.8688483678107191,1.0,6/25,9.80%,NRP1;GREM1;EPHB2;BTC;HDAC1;EREG
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7911583499461541,-1.2215852537100997,0.21818181818181817,1.0,1.0,4/5,19.62%,CIITA;TAF7;NLRC5;HSPH1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.7271211490726139,-1.2215223978188872,0.18181818181818182,1.0,1.0,2/10,10.43%,STAT1;TBX1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4570128243567913,1.2215145943597803,0.14814814814814814,0.8707225984383918,1.0,12/86,5.00%,GPC4;FREM1;NPNT;RIMBP2;TNFRSF19;PTPRT;CAPN13;COBL;BMP7;PDZRN3;TOX3;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.8176613846058687,-1.2215145546486015,0.20689655172413793,1.0,1.0,1/5,6.56%,BEX4
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6692882016910262,-1.2214089132139176,0.171875,1.0,1.0,4/13,15.92%,DOCK8;CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.6631539066184516,1.2212574261527473,0.24324324324324326,0.870394228161864,1.0,3/7,15.47%,OLFM2;EREG;MYOCD
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.65395089858287,-1.2211033637405588,0.2608695652173913,1.0,1.0,2/11,9.32%,MCM2;GINS2
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.49425778710077606,1.2209403078911527,0.17647058823529413,0.870168373984535,1.0,10/42,16.51%,ITGA4;CACNA2D1;GRM5;TIMELESS;GRIN2A;IGF1;FYN;ABCC1;CACNA1A;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.45129854431498156,1.2209402184833957,0.10256410256410256,0.868928817896238,1.0,13/86,13.75%,EPHA3;STAC;EGFR;BCL2;EPHB2;PTPN9;FYN;MAPK8;PIK3R1;PRKCE;ZDHHC5;CHP1;AKT2
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.64276521418626,-1.2206284696523833,0.18840579710144928,1.0,1.0,9/22,29.08%,NCAPH2;NCAPG;SMC2;TTN;SET;NCAPG2;NCAPD3;CHMP1A;PHF13
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.477241791898896,-1.2203931824119985,0.11538461538461539,1.0,1.0,37/151,17.55%,F8;ELK3;MYLK;SEMA3D;CYP1B1;EPAS1;HSPG2;CD82;NOSTRIN;RASIP1;TIMP3;RND1;APOLD1;ANGPTL2;IFI27;CHST1;USHBP1;CASZ1;ADGRF5;SRPX;PRKCH;PLSCR4;PROCR;TBX1;MEOX1;RGS5;STAB1;PDGFRB;A2M;SPARCL1;NOTCH4;PLAC8;PCDH12;RGCC;TMEM100;EMCN;PODXL
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.6284911939402174,-1.220266384409231,0.2786885245901639,1.0,1.0,7/15,24.16%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5PB;ATP5ME
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.744679351712809,-1.2201070929839006,0.22807017543859648,1.0,1.0,2/9,14.86%,CD74;IL18
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.5259139322744362,-1.2199650311777503,0.14864864864864866,1.0,1.0,14/63,18.53%,HCK;CD14;SERPINE1;PDCD1LG2;CD6;TGFB1;CCL5;DAB2IP;GSTP1;CXCL13;IL18;STAP1;ADAM9;LBP
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.7591679668778117,1.2199018649623887,0.27586206896551724,0.8714000113934932,1.0,4/8,20.83%,APOE;NRCAM;SIN3A;ABL1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.5763572005042215,-1.2197927040082222,0.19402985074626866,1.0,1.0,8/46,16.95%,ENPP2;RREB1;RAB11A;DAB2IP;DOCK1;CTSH;PLCG2;VIL1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4636932751870376,1.2197716859833136,0.25,0.8707084176882768,1.0,32/135,12.43%,GDAP1;LRRTM3;PPP1R1C;GRIA4;RAB3C;FGF13;ZNF536;ADGRA1;MAPK4;OLFM3;RGS7BP;GRIA2;SPHKAP;GRM5;KCTD16;LSAMP;MMD2;BRINP1;NRXN1;CADM2;TMEM196;DGKH;NOVA1;CSRNP3;RBFOX1;PAK5;SLC6A1;PARM1;ADGRB3;ST8SIA3;ELAVL3;PPFIA2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5946334835611339,-1.219562723449354,0.16129032258064516,1.0,1.0,2/28,0.72%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.8534757588858342,1.2192712053788008,0.20930232558139536,0.8711096172784552,1.0,1/5,6.63%,DDAH1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7089192256802546,1.2190457556725092,0.2558139534883721,0.8706624576943303,1.0,4/8,20.01%,RUBCNL;PIP4K2A;PLEKHM1;CLN3
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7467307975692771,1.2189508039273265,0.24324324324324326,0.8696726902972591,1.0,2/5,18.47%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5164239766056836,1.2188909881495307,0.125,0.868665603868828,1.0,8/36,16.34%,TNFRSF19;TAB3;MAP3K5;MAPK8;TAB1;MAP3K10;MAP3K13;IRAK2
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.7852051079473916,-1.2188406900912947,0.24561403508771928,1.0,1.0,3/5,20.15%,PBXIP1;STMN1;MET
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6707540578925978,1.2186742901948622,0.2894736842105263,0.8680430039619785,1.0,4/12,13.75%,IRS1;IRS2;SIRT1;AKT2
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.7067998439322156,1.2185895121869605,0.2857142857142857,0.8672215746323724,1.0,1/8,0.87%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.6062735577255949,-1.217723730822711,0.2033898305084746,1.0,1.0,4/29,4.40%,LRP4;OMG;B2M;NOTCH1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.40482949297274734,1.2176084086782124,0.08695652173913043,0.8697875447108769,1.0,41/182,12.93%,EPHA3;UNC5B;UNC5C;DOK5;NFIB;SEMA6D;EPHA5;TNR;NRP1;CNTN6;DSCAM;SEMA5A;VLDLR;UNC5D;EPHB2;DSCAML1;EPHA8;CNTN4;GFRA1;DOK6;PTPRO;NRXN1;SEMA4C;EFNA5;NRTN;SHC3;DOK1;EPHA7;IRS2;RYK;BSG;PSPN;LYPLA2;ROBO2;FYN;PIK3R1;DAB1;LAMA3;PTPRM;SEMA3C;SPTB
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.7667661075388206,-1.2174853450085783,0.27419354838709675,1.0,1.0,2/6,14.63%,TCP1;VBP1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5214975933319906,1.2172419591273638,0.23333333333333334,0.8700460794314858,1.0,4/32,4.57%,ACE2;SLC26A3;CAPN13;GALNT12
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5339719571023983,-1.2171888673527944,0.1774193548387097,1.0,1.0,11/59,21.28%,PRLR;CYP19A1;LIPH;LIPI;ACSL5;ACSM4;LIPC;ACSM6;NDUFAB1;ACSM3;SRD5A1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.719020449343995,1.2170838505698285,0.23529411764705882,0.8691653751867718,1.0,3/6,17.48%,ERCC8;UVRAG;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.7721579889836416,-1.2169972717212039,0.24561403508771928,1.0,1.0,3/5,16.78%,NOTCH1;NOTCH4;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.8188472685130825,-1.21676967833717,0.16129032258064516,1.0,1.0,2/5,6.95%,PINK1;NONO
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.6168513928002192,1.2164517135641089,0.2727272727272727,0.8698229761259024,1.0,3/18,6.58%,F2RL1;TLR1;HMGB1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.5468629900260831,1.2163697480286761,0.23529411764705882,0.8687259488222054,1.0,5/18,11.34%,UBASH3B;CACNA2D1;CBARP;NOS1AP;FYN
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6879668846996475,1.2161846263864466,0.25,0.8680894612692631,1.0,4/6,29.78%,APOE;APOA1;ABCA12;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.40115857909347324,1.2156074614162664,0.05263157894736842,0.8689642987635792,1.0,43/190,15.55%,NPNT;LEF1;WWTR1;KDR;CTNNA2;KITLG;BMP7;TGFBR1;PLCB1;BMP6;KCTD11;TGFB2;VWC2;MDK;ACVR1;ZHX3;MMD2;BRINP1;PKDCC;ZC4H2;TGFB3;ZEB1;IGF1;SOX5;PDPN;SMAD2;PRKD1;NELL1;FGFR1;RIN2;TCF4;MAPK12;BRINP2;ID2;NGF;TIAM1;NRCAM;RANBP3L;RIPOR2;GCNT2;BEND6;SIN3A;MEF2C
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5509776551462082,1.2155958870504113,0.1891891891891892,0.8678333814059536,1.0,8/30,12.03%,NYAP2;IRS1;MYO16;IGF1;LTK;NYAP1;PIK3R1;SIRT2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.8145235021435437,-1.2154270072560924,0.2033898305084746,1.0,1.0,1/5,7.80%,RAB11A
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.6662064281467802,-1.2153441355660017,0.15873015873015872,1.0,1.0,3/12,9.08%,ACOT4;GOT1;GAD1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6979494331068236,-1.215020739236205,0.29508196721311475,1.0,1.0,2/8,17.91%,CCDC39;DNAH7
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.5941856285044943,1.215018314153041,0.28,0.8686863343326446,1.0,4/19,4.30%,LAMB2;NTNG1;LAMB3;MYH11
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.6885330624844165,1.214990106819396,0.2926829268292683,0.8663556727061856,1.0,3/8,12.80%,CACNG3;CACNG4;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.6885330624844165,1.214990106819396,0.2926829268292683,0.8663556727061856,1.0,3/8,12.80%,CACNG3;CACNG4;GPHN
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.46275797670731295,1.2148494513195007,0.125,0.8657672073408165,1.0,12/70,9.55%,NPNT;WWTR1;BMP7;BMP6;GREM1;CRIM1;ACVR1;ZHX3;IGF1;PTCH1;PRKD1;NELL1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.6797852155089417,-1.2147506479348071,0.23943661971830985,1.0,1.0,4/12,28.69%,GNPDA1;GFPT2;NANP;PGM3
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.7092645479268638,1.2146857691867738,0.30434782608695654,0.8652591604633023,1.0,4/7,22.39%,FGFR4;SIRT1;PROX1;NR1H4
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6818345539736455,1.2145237649674474,0.22857142857142856,0.864732846575785,1.0,1/8,2.71%,FGGY
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7341932677885069,-1.2143544402886621,0.25757575757575757,1.0,1.0,1/8,0.71%,MCM2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5658450653656364,1.21432479439093,0.2413793103448276,0.8642865578796657,1.0,6/21,8.90%,KIT;IRS1;FGFR3;EPHA8;PDGFRA;PRKD1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.7065817865434889,1.2142877208354195,0.25,0.863253010653904,1.0,2/5,21.46%,MTMR9;MTMR3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.782394452883761,-1.2141764639258346,0.2459016393442623,1.0,1.0,1/5,5.83%,SOD2
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.7234085500722931,-1.2140451549457614,0.19696969696969696,1.0,1.0,4/12,13.19%,PDE6B;RP1;CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.7385421403958958,1.213935049069018,0.3076923076923077,0.8633780744670413,1.0,2/7,10.45%,ZNHIT6;RUVBL2
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.8263944183988835,-1.2138637383594058,0.18181818181818182,1.0,1.0,1/5,1.01%,PTGIS
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.7644543836980399,-1.2138010827117598,0.23076923076923078,1.0,1.0,1/7,2.24%,DOCK2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.8139351349562456,1.2135279366018537,0.20930232558139536,0.8634636699482824,1.0,1/5,5.99%,PRKCB
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.6621833340356928,-1.2134004283065762,0.25806451612903225,1.0,1.0,1/13,0.85%,KCNE2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7098555183745506,-1.2129696773158571,0.22033898305084745,1.0,1.0,3/8,13.91%,YBX3;CASP8;SLC25A4
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.7517751452927982,-1.212953667458876,0.1746031746031746,1.0,1.0,2/9,4.60%,PTGIS;PTGES
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.5028597150881028,1.212901718157806,0.21875,0.8644672010014036,1.0,12/55,11.85%,MCTP1;ACKR2;HRH1;MCU;DDAH1;LAT2;APOE;RCAN2;EIF2AK3;CHRM3;MCTP2;GUCY1A1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.787941215925967,1.2128476004531574,0.2972972972972973,0.8634390695917805,1.0,1/5,0.17%,ACE2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.7778550018539078,-1.2128269699047929,0.16923076923076924,1.0,1.0,1/7,10.62%,RNF213
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4984279387537456,1.2126445549569087,0.2647058823529412,0.8626865004103087,1.0,14/39,16.70%,NRP1;MIEN1;PLPPR5;PRKCD;TGFB3;NLGN1;RALA;PIK3R1;GPM6A;SRGAP2C;FNBP1L;RIPOR2;MYO10;ARHGAP44
prerank,PanglaoDB_Augmented_2021__Interneurons,0.417136081678327,1.2117964197819693,0.05555555555555555,0.864348466548511,1.0,59/274,13.71%,ETV1;TMEM132D;PTPN3;GNG4;TACR1;LRRTM3;SRGAP1;NTNG1;GRIA4;RAB3C;RORA;CALN1;CTNNA2;PCBP3;ADGRA1;MAPK4;SLC35F1;OLFM3;VLDLR;RGS7BP;GRIA2;GRM5;PLPPR5;TIMELESS;ADGRL2;PRKCB;PRKCD;MMD2;BRINP1;PTPRO;NRXN1;KCNQ5;CADM2;CACNA1I;CASK;TMEM196;PCSK2;RGMA;CSRNP3;RBFOX1;PAK5;DLGAP1;PARM1;KCNC2;ADGRB3;NOL4;ST8SIA3;POU2F2;ELAVL3;SHISA9;PPFIA2;NAT14;ELMO1;BRINP2;SYT1;FGF12;NXPH1;NMB;NRIP3
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.4387997145243432,1.2117872408302948,0.09090909090909091,0.8631692735518556,1.0,21/135,6.95%,UBASH3B;PID1;HSPB1;SAMSN1;RASSF2;WWTR1;PMEPA1;SPRED1;PARD3;ZBED3;SPRED2;CEP85;DNAJC3;SPRED3;GREM1;PRR5L;EPHB2;PDE4D;TRIB2;PRKCD;ENPP1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5983524268904794,1.2116368249737233,0.2647058823529412,0.8625365626231997,1.0,4/23,6.83%,CDH13;KIT;PTPRO;ARFIP2
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.591194176572755,1.211522561874817,0.18421052631578946,0.8619830776235855,1.0,1/14,0.87%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5982581244793619,-1.2114542359240492,0.16071428571428573,1.0,1.0,3/19,9.23%,C3AR1;DRD3;LPAR6
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5928354834065671,1.2111409166674425,0.2222222222222222,0.8620309386143366,1.0,1/12,0.47%,PNP
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.40019854145386946,1.210884720015527,0.0625,0.8620593462387665,1.0,61/367,14.26%,CD38;NRG1;ATOH8;IFI16;PER2;SOX13;LEF1;PHC2;PTPRK;ARID5A;KDM8;BMP7;HDAC9;PLCB1;KCTD1;ATXN1;SAMD13;TIMELESS;SAMD7;HEY1;HIC2;PRICKLE1;FOXN3;ZHX3;ID3;SFMBT1;ZEB1;ARID5B;PRDM5;HDAC1;NACC2;DAP;SMAD2;HDAC10;TFAP4;FOXP2;GATAD2A;EREG;MYB;SUV39H2;SCMH1;CTBP2;LIMS1;TLE2;ZMYND11;DACH1;SIRT2;BCL6;FOXO1;BTRC;HMGA2;POU2F1;SIRT1;MAP3K10;WWP1;VGLL4;ID2;FOXK1;PDGFB;PCGF6;NR3C1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6651705632960939,1.2107541307793095,0.2558139534883721,0.8613736766976938,1.0,1/10,1.05%,SPX
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5902461483402425,-1.210688200685979,0.1746031746031746,1.0,1.0,1/24,0.90%,FIP1L1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5902461483402425,-1.210688200685979,0.1746031746031746,1.0,1.0,1/24,0.90%,FIP1L1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.6230612434559983,1.2106201463310715,0.25,0.8607669475829682,1.0,3/14,11.25%,UNC13B;PARD3;TENM4
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.7847155366066108,1.2101098520318827,0.2926829268292683,0.8615475088817827,1.0,5/5,21.55%,ST3GAL1;ST8SIA3;ST3GAL2;ST6GALNAC2;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5140394423397976,1.209423312453164,0.2222222222222222,0.8624989359813746,1.0,5/34,4.25%,CDH13;CCL28;NRP1;KDR;UTRN
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.7587604903511789,-1.2093406316778579,0.21153846153846154,1.0,1.0,2/7,10.61%,HSPA5;SEC62
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.6871417563664806,-1.2093238706874494,0.15789473684210525,1.0,1.0,1/12,5.37%,LMAN1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.5193400658779468,-1.2093180523839362,0.2236842105263158,1.0,1.0,13/75,14.79%,CSRP3;GCM2;CALCB;ELANE;ATP1B1;DRD3;ATP1A1;CCL5;SLC24A1;SLC24A5;HTR2B;ATP2A3;TMEM203
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.8037940938268356,-1.2092913281089022,0.19117647058823528,1.0,1.0,2/6,9.40%,CAPN1;CASP8
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.7614951139127961,-1.209069022217053,0.19230769230769232,1.0,1.0,1/5,3.01%,LDLRAP1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.5103707519339681,-1.2089942474606774,0.175,1.0,1.0,8/65,15.18%,FANCI;WFS1;PINK1;UBE3A;TSPYL5;GNL3;PHF23;BRCA1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.6649925157135239,-1.2087459844181945,0.25,1.0,1.0,6/12,28.61%,SLC13A4;SLC26A4;SLC25A11;RACGAP1;SLC26A8;SLC26A11
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.6978544557507645,-1.2083689496688665,0.2753623188405797,1.0,1.0,1/10,1.65%,LOXL4
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.6486644688714455,1.208295624387835,0.2894736842105263,0.8654247057662773,1.0,1/14,0.17%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.681477940617846,-1.2082463181895473,0.20634920634920634,1.0,1.0,3/9,13.91%,YBX3;CASP8;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.7942933391600763,-1.2080939740830867,0.2222222222222222,1.0,1.0,1/5,3.01%,LDLRAP1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.544214342680312,-1.2080413989394612,0.18571428571428572,1.0,1.0,10/41,11.15%,FUT2;TMEM184A;SMIM22;LIPH;GGH;KLF5;GPX2;CBLC;B3GNT3;TMC4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.6408103774238845,1.207605162711457,0.17142857142857143,0.8665025256140467,1.0,3/12,23.56%,DESI2;ATG10;ATG7
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.5958330905031383,-1.2074806140163796,0.18333333333333332,1.0,1.0,2/27,0.72%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7361942325865329,-1.2071426392320843,0.21428571428571427,1.0,1.0,1/9,2.11%,ZNF703
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.6921401242159246,1.2070369242941703,0.2222222222222222,0.8673286062727602,1.0,3/8,13.85%,FGF13;PTPRS;NGF
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6511854221480025,1.2068295266302547,0.20930232558139536,0.8670055101514166,1.0,5/8,14.98%,COMMD1;NEDD4L;PRKCE;HECW2;NEDD4
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.6661922734459631,-1.2063164508187554,0.25,1.0,1.0,5/10,26.04%,B2M;TLR2;RPS27A;UBC;PGK1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6526330313929579,1.205948052584848,0.3333333333333333,0.867906162226657,1.0,2/13,7.06%,KLRD1;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6526330313929579,1.205948052584848,0.3333333333333333,0.867906162226657,1.0,2/13,7.06%,KLRD1;RASGRP1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.6059255649082802,-1.205283151419725,0.2878787878787879,1.0,1.0,5/26,16.61%,B2M;CP;TMC8;HEPH;SLC11A1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.755392287833542,-1.2051908139323342,0.23728813559322035,1.0,1.0,4/8,22.29%,PRDX4;PRDX1;PRDX3;GPX1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.7806554901879462,1.2050571369859973,0.30434782608695654,0.8698873471495079,1.0,1/5,0.87%,LEF1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.7381408806280159,-1.205044590328887,0.21212121212121213,1.0,1.0,3/6,13.20%,GAD1;ALDH1A1;BCAT2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.67426554225875,-1.2048206890350637,0.2786885245901639,1.0,1.0,2/11,8.95%,STAT1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.7044252596332158,1.204709749827789,0.23684210526315788,0.8697717131677859,1.0,2/5,16.09%,ACTN4;RALY
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5123086929991616,-1.204424167810269,0.20253164556962025,1.0,1.0,15/66,20.29%,EPAS1;NOTCH1;PSMB6;BACH1;PSMB8;PSMA3;PSMA5;PSMC3;HIF3A;PSMA7;PSMC6;PSME1;RBX1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4075606101801285,1.2044127137288576,0.0,0.8694854906353833,1.0,41/218,11.61%,EPHA3;UNC5B;UNC5C;DOK5;SEMA6D;NTNG1;EPHA5;TNR;NRP1;CTNNA2;CNTN6;DSCAM;PARD3;SEMA5A;VLDLR;UNC5D;EPHB2;DSCAML1;EPHA8;CNTN4;GFRA1;DOK6;PTPRO;NRXN1;SEMA4C;EFNA5;NRTN;SHC3;DOK1;EPHA7;IRS2;RYK;BSG;PSPN;AUTS2;LYPLA2;SLITRK5;ROBO2;FYN;PIK3R1;DAB1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6253357214083728,-1.2040780865635816,0.16666666666666666,1.0,1.0,6/20,23.30%,TERF2IP;POLR2J;POLR2K;DAXX;POLR2I;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6253357214083728,-1.2040780865635816,0.16666666666666666,1.0,1.0,6/20,23.30%,TERF2IP;POLR2J;POLR2K;DAXX;POLR2I;POLR2B
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5684460954760048,1.2040600225957703,0.21428571428571427,0.8695603323053901,1.0,7/27,10.15%,IL1RAPL1;CLSTN2;EPHB2;NRXN1;NLGN1;VSTM5;GRID2
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7734920173147034,-1.203923371518391,0.2608695652173913,1.0,1.0,3/5,15.18%,HLA-DMA;TAPBPL;HLA-DMB
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.694162284028089,-1.203643987914536,0.24242424242424243,1.0,1.0,3/10,12.46%,CGAS;B2M;ARG2
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.7526507755862231,1.2031366519084654,0.2894736842105263,0.8715098412724336,1.0,2/5,8.20%,COL15A1;COL22A1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.7934372141012975,-1.2029917873807183,0.22388059701492538,1.0,1.0,1/6,2.96%,CGAS
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5528787181842038,1.202592622003322,0.2571428571428571,0.8721491825917571,1.0,11/29,16.91%,BMP7;BMP6;ACVR1;PKDCC;TGFB3;NELL1;SLC8A1;ANO6;GPM6B;MEF2C;ODAPH
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.6614189564200154,1.202510982581163,0.30952380952380953,0.8712758032182353,1.0,2/8,7.36%,PTGFR;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.40166330464622946,1.2025023050758006,0.07692307692307693,0.8701595211186008,1.0,40/394,9.86%,CD38;MYRFL;RUNX1;CREB5;ATOH8;LEF1;TEAD2;NFIB;EGFR;ZNF496;RORA;KDM8;FANK1;BMP7;NFATC1;BRCA2;TGFBR1;PLCB1;ESRRG;FOS;HEY1;ARID1B;ACVR1;TGFB3;ARID1A;IGF1;FLI1;HDAC1;ELF2;APOE;MED30;FZD1;SMAD2;POU3F1;TASP1;RGMB;ERBB4;TFAP4;WBP2NL;MYB
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4417849907193635,-1.2022634041451903,0.06172839506172839,1.0,1.0,77/394,16.38%,CD44;CD4;HCK;PRLR;TRIM22;TNFSF18;DUOX1;TRIM5;B2M;STAT1;TCP1;IL3RA;OSMR;IL7;PSMB6;CTF1;SOD2;PLP2;NDN;IL18R1;JUNB;IFIT1;IRF1;IL21R;CD300LF;IFI27;STAT5A;PSMB8;IL15;FLT3;TOLLIP;CIITA;SLA;IFI6;STAT4;IL20RA;TGFB1;CRLF1;IFNGR2;TRAF3IP2;TRIM25;CCL5;SKP1;IL18BP;IFIT3;XAF1;MSN;PIK3CB;TXNDC17;SPI1;HLA-DPB1;TXLNA;LTBR;HLA-A;TMSB4X;CA1;TEC;BAG4;CD27;PELI3;IFNLR1;PSMA3;OAS3;IFIT5;CXCL13;PSMA5;PSMC3;IL18;ISG20;IL13RA1;PTPRZ1;CDKN1B;NFKBIA;ADAM17;PSMA7;INPPL1;PSMC6
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.6429894027350471,1.202227382097671,0.30434782608695654,0.8697997058497635,1.0,2/19,5.00%,ACE2;EPHB2
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.6082179954704452,1.202187387872805,0.1935483870967742,0.8688012006531014,1.0,3/10,16.62%,FGF13;GABRB3;WNT5A
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.6543619736962452,-1.2019940454565996,0.21875,1.0,1.0,2/14,7.05%,TICRR;CDC6
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6695926703688111,1.2019151956287297,0.39473684210526316,0.8687447369607239,1.0,3/7,23.51%,VCL;ROCK2;IKBKB
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5607626213125292,1.2016542403422912,0.2903225806451613,0.8687071854374925,1.0,3/22,5.68%,PDE3A;PEX5L;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.7009317308186318,1.2013294477850303,0.23333333333333334,0.8685010844696199,1.0,1/8,0.67%,KLRD1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6470621890827173,1.201126663629736,0.29545454545454547,0.8680709562927731,1.0,4/14,20.60%,NXF5;IWS1;NXF1;PCID2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.4584835821657798,1.2008287553108494,0.1794871794871795,0.8680531263499022,1.0,15/68,14.09%,ATOH8;CDH13;NRP1;KDR;TGFBR1;SEMA5A;VASH2;VASH1;APOE;PRKD1;ANGPT1;PTPRM;SIRT1;ECM1;PDGFB
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.5509094210070498,-1.2003223009600859,0.18571428571428572,1.0,1.0,8/35,14.05%,HCK;PTPRC;CD300LF;SPI1;MYO1F;TAGAP;IGSF6;AQP9
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5699428831937146,1.2003021235711266,0.26666666666666666,0.8691925742808255,1.0,1/21,1.20%,GFI1B
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.5834732133970921,-1.1996324249396402,0.2,1.0,1.0,10/26,24.39%,RARRES2;GBP6;LYG1;HLA-A;TLR2;ADAM17;LBP;ROMO1;PGLYRP1;PPP1R11
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.6121119761894219,1.199622180161855,0.2,0.8704222423022248,1.0,3/11,3.63%,NOX4;SGCD;SGCZ
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7729479212956474,1.1990073607436416,0.3181818181818182,0.8712949873079541,1.0,1/6,0.47%,PNP
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.7725385240332909,-1.1989005989668648,0.2153846153846154,1.0,1.0,2/6,9.77%,BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.6946179230402175,-1.1987545213444022,0.24193548387096775,1.0,1.0,3/9,12.46%,CGAS;B2M;ARG2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.5800460177571629,-1.1987496263879138,0.19047619047619047,1.0,1.0,2/29,0.72%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.7226810540914455,-1.1986658616415045,0.24615384615384617,1.0,1.0,3/8,15.95%,CHAC1;CHAC2;ALDH4A1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.44507385251085796,1.1986137464588316,0.1935483870967742,0.8716634718268261,1.0,19/66,17.82%,MAML3;EGFR;TGFB2;MAML1;RITA1;HEY1;JAG1;RFNG;PRAG1;YJEFN3;EPN2;EP300;TSPEAR;DTX1;BEND6;JAG2;BMP2K;ZBTB7A;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.679258582477684,1.1985596845422957,0.2978723404255319,0.8684481580095185,1.0,3/5,16.79%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.679258582477684,1.1985596845422957,0.2978723404255319,0.8684481580095185,1.0,3/5,16.79%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.679258582477684,1.1985596845422957,0.2978723404255319,0.8684481580095185,1.0,3/5,16.79%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.6534577142436988,1.1983876183132676,0.225,0.8678566680132923,1.0,3/7,14.17%,ENPP3;SPHK2;FER
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.5497009241721448,-1.1980962580461585,0.24242424242424243,1.0,1.0,16/41,19.94%,STEAP4;DUOX1;SMIM22;VWA2;AHR;FOXM1;ALDH1A1;B3GNT3;TMC4;DUOXA1;SYT2;CYP2B7P;SFTPD;WFDC2;ITGB4;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.7109191100801472,-1.1978746030724543,0.25806451612903225,1.0,1.0,3/9,20.22%,FKBP1B;CALM3;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.7109191100801472,-1.1978746030724543,0.25806451612903225,1.0,1.0,3/9,20.22%,FKBP1B;CALM3;CALM1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-0.7740175490876073,-1.1978060659036178,0.2542372881355932,1.0,1.0,1/6,5.24%,DRD3
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.6848190199203388,1.1975070915295938,0.3157894736842105,0.8697788156352194,1.0,2/9,13.00%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.728292659211121,1.1970903260128396,0.26666666666666666,0.8697774518181042,1.0,1/5,6.33%,ACVR1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6530348654423831,1.1970552821743825,0.23809523809523808,0.8687627959347464,1.0,3/12,13.00%,SLC30A10;HMGA2;SIRT1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.7856857665743949,-1.19701572539256,0.23076923076923078,1.0,1.0,3/6,14.75%,SERINC1;PEX16;TLCD2
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.46852720765475603,1.1969131642787911,0.13333333333333333,0.8680083584463832,1.0,15/90,7.05%,ACE2;PTPN3;SLC22A2;SLC12A3;KCNJ16;COBL;PDZD2;ESRRG;ABO;GSTO2;ABCA13;JAG1;BAZ2B;SLC16A7;COBLL1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7149304063588141,1.196845083873693,0.24390243902439024,0.8670537317657735,1.0,4/9,19.10%,PEX7;PLA2G4C;CHPT1;DHRS7B
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7580948024639366,-1.1966917075399794,0.2830188679245283,1.0,1.0,2/8,4.82%,AMBP;SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7580948024639366,-1.1966917075399794,0.2830188679245283,1.0,1.0,2/8,4.82%,AMBP;SLCO2B1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.6638594195453115,1.1966894876291307,0.21428571428571427,0.8664135550932973,1.0,1/11,0.48%,KIT
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6703439779458005,1.196121761897998,0.2558139534883721,0.8669480637865331,1.0,4/6,30.20%,ELAVL4;METTL16;TENT4B;LARP4B
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.7051239450110682,-1.1960885265969374,0.23809523809523808,1.0,1.0,2/11,8.18%,ING2;ZBTB7B
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6232081312334479,-1.1954484834275014,0.23333333333333334,1.0,1.0,7/17,26.19%,EIF4A2;EIF3I;MCTS1;EIF2S2;RBM4;EIF4H;EIF5
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5235194775725219,1.195172922297519,0.2,0.8692934085637345,1.0,14/42,24.77%,PRR5L;BTG2;MEX3D;KHSRP;CELF1;RC3H1;PNPT1;FTO;NANOS3;TNRC6B;ROCK2;AGO2;METTL16;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.744319608824962,1.195161064478917,0.3170731707317073,0.8682323441457981,1.0,2/6,12.91%,HDAC9;PLIN5
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.7293757301010477,1.1950688272759782,0.275,0.8674113572224745,1.0,1/7,5.89%,DNAJB12
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.7685029381462666,-1.195064780795398,0.25862068965517243,1.0,1.0,3/5,20.46%,FLT3;SPI1;SHH
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.7695971873464504,-1.1950512460033287,0.22727272727272727,1.0,1.0,1/5,12.34%,SLBP
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.6921183040816536,-1.1950221583609817,0.1791044776119403,1.0,1.0,5/12,22.26%,GNLY;CXCL14;CXCL13;ROMO1;PGLYRP1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5084044770361666,-1.194864333321632,0.2835820895522388,1.0,1.0,14/64,14.05%,HCK;GNLY;PDE6B;GMFG;SPON2;IL21R;CD300LF;TGFB1;ALOX12;ARHGAP9;SPI1;MYO1F;TAGAP;AQP9
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5913964835524625,-1.1947570146924245,0.19444444444444445,1.0,1.0,7/22,24.28%,RFC5;RPA3;PCNA;UFD1;RPS27A;RCHY1;UBC
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6374540153538792,1.1945740939644705,0.21212121212121213,0.8678506765663027,1.0,2/14,5.00%,DOCK10;EPHB2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.7534925787169116,-1.1945610829087265,0.23728813559322035,1.0,1.0,2/7,7.35%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.6780225878753802,1.1943289680529097,0.2972972972972973,0.867560411512981,1.0,3/7,25.52%,IGF1;FKTN;ABCA2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6322677003438038,-1.1942457408487899,0.20833333333333334,1.0,1.0,4/21,5.62%,PTGIS;CD74;PTGES;PTGR1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.7889188283891855,1.194033385797539,0.25,0.866073849697748,1.0,2/5,19.06%,DAG1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.7889188283891855,1.194033385797539,0.25,0.866073849697748,1.0,2/5,19.06%,DAG1;PHLDB2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.6208240122435212,-1.193929729902716,0.2909090909090909,1.0,1.0,1/15,1.03%,HENMT1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.7954340272322751,1.1928349354487853,0.2,0.8689980776565446,1.0,1/5,1.93%,ALKBH3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6913836915015528,-1.1927409373637554,0.3,1.0,1.0,4/12,13.68%,FIP1L1;CSTF2T;NCBP2;NCBP1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.6045208144451266,-1.1925267636496857,0.27419354838709675,1.0,1.0,4/23,12.35%,CGAS;STAT1;TRAF3IP2;IFNLR1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.4975840411888953,-1.19177324604165,0.18571428571428572,1.0,1.0,26/77,20.95%,TRIM5;B2M;IFI44;CD74;IL7;IRF1;IFI27;PSMB8;IL15;TRIM25;LPAR6;CASP8;IFIT3;PROCR;CNP;PSMA3;CMPK2;EPSTI1;ISG20;TMEM140;CMTR1;PSME1;ISG15;TXNIP;STAT2;WARS1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5457693413376689,1.1910102870242578,0.18604651162790697,0.874306551838875,1.0,4/21,5.60%,PDGFD;RASSF2;GREM1;PDGFC
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7382117984514647,-1.1904513310901783,0.30158730158730157,1.0,1.0,4/10,18.41%,AMBP;FADD;GPER1;FCRLB
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.7781087290786244,1.1904456021720586,0.23809523809523808,0.8752766350444987,1.0,3/6,11.65%,PARD3;PKHD1;PARD3B
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.5062975334201008,-1.1904077887316349,0.15789473684210525,1.0,1.0,19/83,19.22%,PTER;SOX10;STAT1;TST;TOLLIP;PPP2R3A;TGFB1;TBX1;MEOX1;RCN3;SNAI2;PCNA;NDRG4;WNT7B;VIL1;AKR1C2;VDAC1;KANK2;UPK1A
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.47184258885197705,1.1903242854417206,0.1875,0.8745454078286286,1.0,6/43,5.59%,HSPB1;SPRED1;SPRED2;SPRED3;GRM5;RABL3
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.6327309444759479,-1.1899632703550589,0.26666666666666666,1.0,1.0,7/15,27.79%,PTPRC;KDM1A;YAP1;FBLN1;NANOG;SOX11;GJA1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.6820830595289336,-1.189392937567607,0.2542372881355932,1.0,1.0,3/7,16.37%,CCDC39;DNAH11;DRC1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5430004402106806,-1.1891312477909566,0.25,1.0,1.0,9/43,16.72%,UPB1;HSD17B10;TRPA1;B2M;SOD2;ACOT13;MCOLN1;GBP5;THG1L
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.7585218818612467,-1.1888957429303748,0.26666666666666666,1.0,1.0,1/8,4.55%,GMNN
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.7140619620680404,1.1887852086416941,0.2702702702702703,0.8788158697719783,1.0,4/7,21.47%,GREM1;CHRDL1;GREM2;BMP2
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),-0.787275107963374,-1.188368682088729,0.296875,1.0,1.0,2/5,9.85%,PCARE;RP1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.6036395474056478,1.188234842776239,0.1875,0.8797585340199473,1.0,2/11,2.57%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.7190350502419349,-1.1879075710770246,0.27419354838709675,1.0,1.0,3/8,16.54%,C17ORF99;GPR183;EXOSC6
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.7205888000551451,1.187146660870653,0.3235294117647059,0.8823912199079041,1.0,1/5,3.02%,KANK1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5220795055242817,-1.186943332494856,0.21212121212121213,1.0,1.0,7/54,12.27%,HCK;CAV3;RAC1;PINK1;NCKAP1L;DCTN1;CDK5R1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.7404467105615755,-1.1868370689930006,0.3103448275862069,1.0,1.0,4/6,20.49%,OAS3;GSTP1;APOD;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7336097174917482,-1.1867565423150803,0.21212121212121213,1.0,1.0,3/9,20.46%,STAT1;TBX1;SHH
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5854779595007712,-1.1866258286139146,0.2,1.0,1.0,6/29,11.23%,CSRP3;ACTC1;SCN4B;ATP1B1;KCNQ1;TTN
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.5201238945158141,1.186406462614922,0.23333333333333334,0.8837945103620507,1.0,4/23,11.28%,CCDC63;JAM2;PLD6;RFX2
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.7642610448833083,-1.1861265159907854,0.328125,1.0,1.0,1/5,6.15%,SERPINE1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.7862702048626735,-1.1860032778679284,0.2857142857142857,1.0,1.0,3/7,14.89%,CCL5;MSN;MSMP
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.7327447150897791,-1.185388587849776,0.26785714285714285,1.0,1.0,3/7,19.22%,OSMR;PTGER3;IL6ST
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.8189872205572627,1.1853563897090658,0.2571428571428571,0.8842946427887923,1.0,1/5,3.97%,PEX7
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.8189872205572627,1.1853563897090658,0.2571428571428571,0.8842946427887923,1.0,1/5,3.97%,PEX7
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.6856218908431242,-1.1853012311284383,0.2857142857142857,1.0,1.0,3/11,25.00%,GMNN;ZNF304;DDX11
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.6398994021527663,1.1852689246599262,0.37777777777777777,0.8834152008695136,1.0,1/9,0.86%,RAB7B
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.4742010946631355,-1.1843201655711546,0.21621621621621623,1.0,1.0,22/117,20.29%,MCM2;POLE3;GMNN;PSMB6;RFC5;CDC6;RECQL;RPA3;PSMB8;MGME1;GINS2;PSMA3;POLE2;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;CDK2AP1;GINS1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.4713069816709209,1.1842694252240682,0.13333333333333333,0.8856331492019112,1.0,13/64,12.03%,NYAP2;IRS1;CSF1R;PLCB1;PDGFRA;MYO16;IGF1;LTK;IRS2;FGFR1;NYAP1;PIK3R1;SIRT2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.4378381100279436,1.1839177475715952,0.15789473684210525,0.8857370170345331,1.0,9/94,7.21%,EPHA3;CDK2AP2;EPHA5;IQGAP2;IQCJ-SCHIP1;TRIM36;PEAK3;PRKCD;EFNA5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.5891658396900218,-1.1838836795739098,0.19672131147540983,1.0,1.0,8/31,12.29%,TPX2;CHMP4B;CHMP2B;CHMP2A;GPSM2;BORA;DCTN1;EML3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6023455996124099,1.1838179316883806,0.2222222222222222,0.884983998441685,1.0,11/23,21.25%,CLSTN2;PTPN23;SYT1;NMB;GRIK2;KCTD13;HOMER1;HCRT;ANK3;EDN1;RIMS2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.5658231217670365,1.183599525985459,0.30303030303030304,0.8846962898251947,1.0,5/30,9.42%,TENT5A;ELAVL1;NAF1;TENT5C;TRDMT1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.42974808363544525,1.1834248399918503,0.16666666666666666,0.8841956793452893,1.0,25/135,13.68%,LRIG3;KIT;LEF1;TEAD2;ITGA4;ADGRA3;KITLG;FRAS1;PARD3;ADGRL2;MID1;PRDM5;GNG12;FZD1;SMAD2;AMOTL2;CDK8;LYPD6;PRTG;GULP1;ANO6;HMGA2;TSPAN6;IL17RD;FNBP1L
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6325912514406912,-1.1833014733725717,0.3114754098360656,1.0,1.0,3/11,14.69%,DOCK8;CCL5;APOD
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.7346883023120393,1.1832796850772211,0.375,0.883536302997701,1.0,1/5,2.22%,FGF13
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.8055477243295702,-1.1831168168515895,0.22727272727272727,1.0,1.0,1/5,4.68%,RAC1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6977060914672522,1.1830280233884953,0.30952380952380953,0.8834645641184409,1.0,2/5,23.37%,PXN;NCK1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6798062764893289,-1.1829517479529343,0.25757575757575757,1.0,1.0,1/10,0.71%,MCM2
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6619748262801346,-1.182798390776374,0.265625,1.0,1.0,4/11,16.61%,TNFSF18;DOCK8;MSN;SLC11A1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5921261253953656,1.1826573557017017,0.2571428571428571,0.8837477089972133,1.0,5/17,9.49%,NRG1;OXTR;APLN;TGFB3;ERBB4
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6089384819332501,-1.1820139977751856,0.29508196721311475,1.0,1.0,4/17,11.08%,TPX2;GPSM2;BORA;DCTN1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.46721959781962974,1.18148501691473,0.25,0.8865454232638319,1.0,12/54,20.68%,LEF1;CSF1R;CBFB;MED30;CDK8;MED15;MED27;RELA;NFKB1;PTEN;CTNNB1;SETX
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5993165625866036,1.1811780024174876,0.2702702702702703,0.8864348313142332,1.0,8/15,30.69%,BTG2;TNRC6B;AGO2;POLR2G;TOB1;TNRC6A;TENT4B;TNRC6C
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),0.7453245317106968,1.181098422113313,0.3142857142857143,0.8844497349639687,1.0,2/5,15.80%,MAPRE1;GAS2L1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),0.7453245317106968,1.181098422113313,0.3142857142857143,0.8844497349639687,1.0,2/5,15.80%,MAPRE1;GAS2L1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.7205512285727923,1.1809597331053585,0.30952380952380953,0.8839543861656234,1.0,2/6,2.53%,SLC26A3;BCL2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5050116235096714,-1.1806927960526232,0.15584415584415584,1.0,1.0,24/95,15.18%,MS4A6A;HCK;PTPRC;HLA-DMA;GPR68;CD74;CD14;FGL2;CD300LF;PDCD1LG2;FLT3;SLA;SCIMP;SPI1;HLA-DPB1;WDFY4;HLA-A;MYO1F;CD83;TAGAP;IGSF6;AQP9;PLAC8;HLA-DMB
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.47147567687604913,-1.1806667089260818,0.1724137931034483,1.0,1.0,21/125,15.35%,NPY;PPP1R1B;LRP4;SCN4B;SOX10;CD82;AGT;TST;SCN7A;CHST1;IGFBP5;DAB2IP;CTHRC1;MPZ;STMN1;CNP;SPARCL1;PLP1;APOD;NDRG4;CNTN2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7146700538016177,-1.180142579828138,0.25806451612903225,1.0,1.0,3/10,11.56%,PINK1;NONO;REST
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.44237199649627634,-1.1799240563833697,0.12790697674418605,1.0,1.0,55/363,16.61%,CD44;C3AR1;PTPRC;DOCK2;OSCAR;MGST1;B2M;ELANE;CD14;CLEC4C;RAC1;GGH;PRDX4;GMFG;TIMP2;HEBP2;FGL2;GM2A;CAPN1;ATP6AP2;MANBA;NCKAP1L;TOLLIP;ATP6V1D;PGAM1;TUBB;CCT8;ARHGAP9;CYSTM1;SRP14;EEF1A1;RNASET2;PDAP1;CTSZ;BRI3;SVIP;TMEM30A;GSTP1;PKP1;PSMA5;PSMC3;LAMTOR2;SLCO4C1;CYB5R3;AGL;PLAC8;PSAP;EEF2;TLR2;CTSH;RAB31;ADAM17;C6ORF120;LAMP1;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.6547580804709966,-1.179892263783529,0.2647058823529412,1.0,1.0,3/11,18.26%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.6547580804709966,-1.179892263783529,0.2647058823529412,1.0,1.0,3/11,18.26%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7179624935355089,1.1797622971265698,0.2653061224489796,0.8866817426133391,1.0,1/5,8.05%,CRACD
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6755688848925785,-1.17975425659112,0.26865671641791045,1.0,1.0,3/12,12.16%,PTPRC;CALM3;PDGFRB
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.7311703321540088,-1.1794209133031208,0.21428571428571427,1.0,1.0,1/7,12.31%,TRUB1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.4387930304797536,1.179366743259938,0.22727272727272727,0.8868002308580124,1.0,23/96,17.55%,PER2;GLP1R;ITPR2;BMP6;UNC13B;DNAJC1;TGFB2;TGFB3;IGF1;APOE;CELA2A;KCNC2;ARFIP1;KCNS3;RAPGEF4;EIPR1;DRD4;KCNA5;CACNA1A;RFX3;RAP1A;ENSA;GCK
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),-0.6981340546787778,-1.1793075649468996,0.23529411764705882,1.0,1.0,2/10,0.61%,SLC12A7;CA12
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),-0.6981340546787778,-1.1793075649468996,0.23529411764705882,1.0,1.0,2/10,0.61%,SLC12A7;CA12
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.716549181439786,-1.1791399553076403,0.22033898305084745,1.0,1.0,2/8,10.43%,GLI3;TBX1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6592778127871399,1.178918736697834,0.29411764705882354,0.887146710891185,1.0,3/10,6.33%,TGFBR1;TGFB2;ACVR1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.656330001368067,1.1788571254315754,0.2903225806451613,0.8862470911720678,1.0,1/9,2.25%,ZEB2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.6075571420611363,1.1788145101730791,0.25,0.8852971332148779,1.0,2/15,2.43%,C5AR1;OR3A2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.7708254865052881,-1.178752466300632,0.3387096774193548,1.0,1.0,1/5,4.22%,LRPAP1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.746707147281286,-1.1787147767786714,0.26666666666666666,1.0,1.0,1/6,7.84%,NCKAP1L
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.7963487372922408,-1.1786010567036667,0.26666666666666666,1.0,1.0,2/5,10.03%,NOTCH1;PRKCH
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.4599383455371339,1.1785446516828217,0.20689655172413793,0.8849618549024206,1.0,10/50,7.48%,KIT;ITGA4;BCL2;HDAC9;EPHB2;RABL3;PRKCB;LAT2;RASGRP1;CD22
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5556196899548286,-1.178418357039359,0.22388059701492538,1.0,1.0,10/42,21.74%,FRRS1;CP;ATP6AP1;NUBP1;SKP1;HEPH;ISCU;SLC11A1;FTH1;ATP6V1G1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.7415459084934422,-1.1784025796240656,0.3181818181818182,1.0,1.0,1/6,1.89%,POLE3
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.6538077683866227,-1.1782915223130672,0.2698412698412698,1.0,1.0,2/18,3.48%,SLC28A2;B2M
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.7201894982686778,-1.1781559850986079,0.2878787878787879,1.0,1.0,1/10,1.99%,PTPRC
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.7216939193121605,-1.1779672685258062,0.22807017543859648,1.0,1.0,1/7,8.18%,ZBTB7B
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5551388577625908,1.1779265582877847,0.20833333333333334,0.8858156396187078,1.0,10/33,13.49%,PID1;IRS1;KANK1;PRKCB;PRKCD;ENPP1;PTPRE;PIP4K2A;SIRT1;SORL1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.45683230227914173,1.1778614226195445,0.21428571428571427,0.8849220610149692,1.0,14/49,11.34%,EPHA3;KIT;EGFR;KDR;CSF1R;FGFR4;FGFR3;EPHB2;PDGFRA;PKDCC;PTPN6;ERBB4;FGFR1;FYN
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.752132512286574,-1.1777411023769266,0.36065573770491804,1.0,1.0,2/6,16.50%,NOTCH1;RGCC
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.5877754791478125,1.1777044697574817,0.29545454545454547,0.8844141594677093,1.0,1/11,0.66%,PID1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.43610876006649824,1.1776263647548304,0.21212121212121213,0.883594119095446,1.0,12/67,9.71%,LRIG3;LAMB2;CA3;EGFR;WWTR1;SDC4;LAMB3;MYH11;FERMT1;GNG12;FHL2;AMOTL2
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.6453070469263714,-1.1774413360503375,0.2857142857142857,1.0,1.0,5/15,15.26%,HSF2BP;ING2;TDRD9;BTBD18;SLC25A31
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.7591776023623904,1.1773868976823778,0.3409090909090909,0.8836629089302594,1.0,2/6,12.56%,IRS2;BCL6
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.7500324546603178,1.1772880807027002,0.27906976744186046,0.8828978875315,1.0,2/5,11.34%,NLGN1;ZDHHC3
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.6915268130514984,-1.177068673049672,0.2711864406779661,1.0,1.0,4/11,13.68%,FIP1L1;CSTF2T;NCBP2;NCBP1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6183156772492233,1.1769080586438827,0.275,0.8821877186406182,1.0,2/11,9.18%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6183156772492233,1.1769080586438827,0.275,0.8821877186406182,1.0,2/11,9.18%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.5728336403560774,1.1767353694383536,0.2222222222222222,0.8817041465716757,1.0,10/19,22.78%,SLC8A3;DLGAP1;DLGAP4;TYMP;TMEM108;DLGAP3;DLGAP2;AKAP9;CACNG5;ROCK2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.7713307111620091,1.17623509206254,0.3181818181818182,0.8823970101288734,1.0,2/5,18.35%,AK5;AK3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.591660813305778,-1.1761139160094638,0.22857142857142856,1.0,1.0,8/26,18.84%,CD74;IL7;CD300LF;TXK;FADD;ADAM17;C1QTNF4;NLRC5
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4408856394587959,-1.1759322801547603,0.14285714285714285,1.0,1.0,54/360,16.61%,CD44;C3AR1;PTPRC;DOCK2;OSCAR;MGST1;B2M;ELANE;CD14;CLEC4C;RAC1;GGH;PRDX4;GMFG;TIMP2;HEBP2;FGL2;GM2A;CAPN1;ATP6AP2;MANBA;NCKAP1L;TOLLIP;ATP6V1D;PGAM1;TUBB;CCT8;ARHGAP9;CYSTM1;SRP14;EEF1A1;RNASET2;PDAP1;CTSZ;BRI3;SVIP;TMEM30A;GSTP1;PKP1;PSMA5;PSMC3;LAMTOR2;SLCO4C1;CYB5R3;AGL;PLAC8;PSAP;EEF2;TLR2;CTSH;RAB31;C6ORF120;LAMP1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5371380260877233,1.1756522303827668,0.17647058823529413,0.8831745055865211,1.0,7/29,7.35%,BMP7;TGFBR1;BMP6;TGFB2;BMP3;ACVR1;TGFB3
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6495353234801576,1.1755442545768682,0.28125,0.88246735677702,1.0,3/8,23.01%,PRMT5;NR1H4;PRMT6
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.7217706761364673,-1.1755335014237065,0.26785714285714285,1.0,1.0,1/6,11.40%,SLC36A1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5878331670473835,1.1753903803420842,0.2702702702702703,0.8819685649271131,1.0,2/13,5.62%,ATF3;GSTO2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5529793289433956,1.1751464833035004,0.23076923076923078,0.8817633739668801,1.0,4/15,8.72%,TGFB2;SEMA4C;MID1;KLHDC10
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6224619755849583,1.174893905393057,0.2926829268292683,0.8814384248871551,1.0,1/9,0.55%,NOX4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5873229456317343,1.17487001954026,0.3142857142857143,0.8805137174740097,1.0,4/14,18.12%,CEPT1;CHKA;PCYT2;PHOSPHO1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.44125743867791056,-1.1748146225029918,0.15476190476190477,1.0,1.0,54/358,16.61%,CD44;C3AR1;PTPRC;DOCK2;OSCAR;MGST1;B2M;ELANE;CD14;CLEC4C;RAC1;GGH;PRDX4;GMFG;TIMP2;HEBP2;FGL2;GM2A;CAPN1;ATP6AP2;MANBA;NCKAP1L;TOLLIP;ATP6V1D;PGAM1;TUBB;CCT8;ARHGAP9;CYSTM1;SRP14;EEF1A1;RNASET2;PDAP1;CTSZ;BRI3;SVIP;TMEM30A;GSTP1;PKP1;PSMA5;PSMC3;LAMTOR2;SLCO4C1;CYB5R3;AGL;PLAC8;PSAP;EEF2;TLR2;CTSH;RAB31;C6ORF120;LAMP1;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.4732703412927911,1.1747480717407248,0.08695652173913043,0.8797797500293294,1.0,9/64,13.63%,EPHA3;MCTP1;BMP6;HSPA1A;CRACD;PRKD1;TMEFF2;SORL1;EP300
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.42047993449365806,1.1746521753897887,0.14285714285714285,0.8790646640075893,1.0,24/120,11.53%,KLHL17;MDGA1;NFIB;CTNNA2;PCDH18;SLC6A4;ATXN1;AMIGO1;AFF2;SYNJ2;DSCAML1;GRIN2A;CNTN4;MEIS1;ADGRL2;MACROH2A2;SMG9;JHY;PTCH1;EPHA7;GRIN2C;ROBO2;EEF1AKMT4-ECE2;CDK5RAP2
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7414722295769911,-1.1744793330570384,0.3275862068965517,1.0,1.0,1/6,3.43%,IL4I1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.6608744302907632,1.17433350926218,0.34285714285714286,0.8789496734083482,1.0,3/8,15.07%,SLC22A3;SLC25A48;SLC25A29
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7689399558499825,-1.1739241984142774,0.2727272727272727,1.0,1.0,2/7,11.35%,B2M;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7565247615977782,-1.1734145609813291,0.208955223880597,1.0,1.0,2/6,14.62%,B2M;ATP2A3
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.6842491617338186,-1.1732552850878692,0.26666666666666666,1.0,1.0,1/7,6.41%,ATP6AP2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6408574984732107,1.1731587704923283,0.22857142857142856,0.8818403398411041,1.0,2/16,4.47%,PID1;LEPR
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.7328388429247567,-1.17308012677813,0.3,1.0,1.0,1/5,4.68%,RAC1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.6634073960053604,1.1729682969903474,0.25806451612903225,0.8815176335501264,1.0,4/9,8.37%,BMP7;TGFBR1;TGFB2;PTCH1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4459477254848068,1.1729014246233562,0.28,0.8807187142934353,1.0,28/148,16.56%,SGK1;STK32B;SGK2;TGFBR1;LATS1;PRKCB;NEK6;PRKCD;CLSPN;STK38;SBK1;PRKD1;EIF2AK3;MAST4;MAPK8;PRKCE;MARK1;SGK3;MAPK12;MAP3K10;AKT2;PDGFB;RPS6KA6;MAP3K13;DMPK;MAST2;ATM;DYRK3
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.5232355531717036,1.1726792939611808,0.1935483870967742,0.8804831932869437,1.0,6/44,4.40%,TPD52L1;BCL2L11;BCL2;TGFBR1;CRADD;WWOX
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.417211574537457,1.1725394347351263,0.17647058823529413,0.879959327517997,1.0,31/155,14.31%,NRG1;KIT;IRS1;EGFR;FGFR4;KITLG;TGFBR1;SEMA5A;FGFR3;PDGFRA;BTC;AKR1C3;NRG2;PKHD1;IRS2;ERBB4;CASS4;EREG;FGFR1;ANGPT1;FYN;MST1R;PIK3R1;FGF10;SIRT1;OTUD3;NTRK3;AKT2;PDGFB;MAGI2;PIK3AP1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.64539249108052,-1.171472285195273,0.26666666666666666,1.0,1.0,1/14,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.643150114125632,-1.1712554831946265,0.2857142857142857,1.0,1.0,3/11,9.56%,ZNF703;ADAMTS18;ALOX12
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.6612559050522995,-1.1710263386916013,0.2459016393442623,1.0,1.0,4/10,22.40%,F11R;TJP3;RAB1A;RAB1B
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5582094675523396,1.1705114001758612,0.28205128205128205,0.8857171888771307,1.0,3/18,11.02%,CROCC;CEP135;CEP120
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.642601003940322,1.1704491888068822,0.23255813953488372,0.8849001204688952,1.0,7/15,12.56%,RUNX1;CBFB;MDK;SOX12;DUSP10;IL2RA;BCL6
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.6413792707176027,1.1704236985617382,0.24324324324324326,0.8838987222602416,1.0,2/10,8.12%,ADA;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5583631310789208,1.1703755282676003,0.2222222222222222,0.8830011853941057,1.0,3/31,1.23%,IFI16;HSPB1;F2RL1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.6321526300846767,1.1703192818980177,0.2926829268292683,0.882021309297539,1.0,2/10,10.52%,PRMT5;PRMT8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.49520754277993895,1.1702818845869518,0.25,0.8810775025969286,1.0,9/28,14.37%,KIT;IRS1;FGFR3;EPHA8;PDGFRA;PRKD1;PIK3R1;PDGFB;WDR81
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6289360803227797,-1.170279848138688,0.2,1.0,1.0,1/11,2.45%,DOCK8
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.6636571806069643,1.1702072163255508,0.2972972972972973,0.8803213208813706,1.0,3/6,25.99%,MTR;CTH;MTHFR
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.5663274728360865,1.1701498417926064,0.35294117647058826,0.8795332591958801,1.0,8/17,18.88%,NRP1;TGFB2;ACVR1;ROBO2;SEMA3C;PARVA;ZFPM2;ROBO1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.43442480739696343,1.1699550538754788,0.25,0.8791001511258674,1.0,27/117,11.49%,EPHA3;ROR2;KIT;ALK;PTPRT;EPHA5;EGFR;KDR;CSF1R;FGFR4;EFS;FGFR3;MPZL1;EPHB2;EPHA8;PDGFRA;CNKSR1;SHC3;LTK;EPHA7;RYK;ERBB4;CASS4;SHC4;FGFR1;FYN;MST1R
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.646027989227455,-1.1698709840335657,0.22727272727272727,1.0,1.0,4/17,12.16%,CSRP3;ACTC1;TTN;PDGFRB
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.4826301289573204,1.169842247221195,0.2857142857142857,0.8784665351645515,1.0,15/79,7.11%,ABI3BP;PRRX1;ADAMTS2;COL15A1;SVEP1;SGCD;SSC5D;CACNA2D1;LAMA4;PCDH18;FNDC1;MYH11;FAT4;PDGFRA;RBMS3
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3731195640454804,1.1692766235590328,0.0,0.8796460398199706,1.0,82/559,12.03%,NRG1;ACE2;RUNX1;ROR2;CDH13;KIT;ALK;TBX6;NOX4;LEF1;PDGFD;SGK1;CHRNA10;IRS1;SGK2;PTPRK;EGFR;MELTF;WWTR1;KDR;BCL2;CSF1R;FGFR4;RNF126;KITLG;TGFBR1;S100A13;BMP6;GRK5;SMYD2;TGFB2;ALDH1A2;GREM1;FGFR3;DBF4B;TIMELESS;BTG2;PDGFC;PTGFR;MEIS1;MINAR1;JAG1;PDGFRA;DDAH1;TNFRSF11A;BTC;TGFB3;AKR1C3;CDCA7;ADAMTS8;SHANK2;P3H3;MYO16;HSPA1A;IGF1;ZBTB17;PTPN6;HDAC1;NACC2;PKHD1;PDPN;LTK;IRS2;P3H2;ERBB4;TFAP4;TET1;EREG;SLC25A33;FGFR1;IL34;EGLN3;CTBP2;LIMS1;ZNF609;BRICD5;MST1R;FGF10;RERG;FRK;ATP8A2;SIRT2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6178118478998784,1.1690774721577961,0.3333333333333333,0.8794153828694294,1.0,6/17,16.51%,IFI16;EPHA7;FYN;NGF;GRIN2B;GRIN1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.43360625601502084,1.1689658341328204,0.17857142857142858,0.878566076307853,1.0,17/124,9.44%,PLEKHH2;KCNIP1;ZNF536;ADGRA1;MAPK4;SLC35F1;TOX3;GRIA2;PLPPR5;POU3F4;CACNG4;PCDH19;APOE;RHBDL3;CSRNP3;PHF21B;PAK5
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6701447951371092,-1.1688885828317035,0.2698412698412698,1.0,1.0,6/10,30.47%,COPS2;COPS5;COPS8;COPS7B;GPS1;COPS7A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.632611059397667,1.168773276854968,0.22857142857142856,0.8782703672932568,1.0,4/16,4.44%,SPRED1;PARD3;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.7520020069450926,-1.1686808164614741,0.3384615384615385,1.0,1.0,2/6,8.64%,EID2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.752631035865837,1.1686697846160081,0.3055555555555556,0.8775412641216909,1.0,2/8,11.76%,BMP6;SCAP
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6803227829164291,1.1686675704812444,0.35,0.8765303743615916,1.0,3/7,25.99%,MTR;MSRA;MTHFR
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.6753352531946807,-1.1683977897848192,0.2459016393442623,1.0,1.0,4/9,21.40%,ATP6AP1;SLC26A4;CLCN3;LACC1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.5097527455501067,-1.1683594501746766,0.1917808219178082,1.0,1.0,8/68,15.18%,FANCI;WFS1;FANCM;PINK1;UBE3A;TSPYL5;PHF23;BRCA1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.7784876981021654,-1.1683503038943004,0.36065573770491804,1.0,1.0,1/5,16.61%,SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.7784876981021654,-1.1683503038943004,0.36065573770491804,1.0,1.0,1/5,16.61%,SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.46617041738640447,1.168067124374524,0.14285714285714285,0.8774540170262671,1.0,7/41,6.43%,KCNJ16;KCNJ6;AMIGO1;KCNJ3;KCNN3;KCNN2;KCNJ2
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.7199249933383057,-1.1680383227733566,0.3582089552238806,1.0,1.0,2/9,12.07%,KCNQ1;F11R
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.4297774622840745,1.1676518379904501,0.09090909090909091,0.8778763868460336,1.0,11/88,7.06%,TPD52L1;TNFRSF19;F2RL1;RASSF2;EGFR;SH3RF1;TRAF3;PLCB1;SH3RF3;HMGB1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5147354121931397,1.1675811147596569,0.21621621621621623,0.877200999683948,1.0,6/31,12.77%,CA2;SLC26A3;GPR89B;SLC4A4;GPR89A;CHP1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.6331188805329088,1.1665967108187105,0.3488372093023256,0.8791995258352133,1.0,2/11,13.00%,POLD3;SIRT1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.4968403310669821,1.1660168105586355,0.2857142857142857,0.8802152345439517,1.0,6/42,7.57%,CDH13;CDH6;CDH20;NECTIN3;CDHR3;CADM2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.5378949009910032,-1.1658202858657063,0.31343283582089554,1.0,1.0,2/28,5.37%,SHCBP1L;LMAN1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5102592084748788,-1.165457435828702,0.25757575757575757,1.0,1.0,9/56,7.41%,C3AR1;MS4A6A;CD4;HCK;SIGLEC1;CD14;STARD5;FGL2;CD300LF
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.7259792813266178,-1.165310729904205,0.2898550724637681,1.0,1.0,1/7,5.14%,BNIP3
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.4878233477764046,1.1641935340974165,0.24390243902439024,0.8853519658374074,1.0,16/37,21.74%,CFAP46;RSPH6A;JHY;TOGARAM1;CDK5RAP2;CHP1;NUMA1;SPAST;GAS2L1;ZNF207;AAAS;SPAG16;MTCL1;RSPH1;TPPP3;NAV1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.5660876713038925,-1.1636677271831375,0.2465753424657534,1.0,1.0,5/35,10.48%,LIPH;LIPI;CAV3;PNPLA1;FABP3
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6147157639497286,-1.1634610437653166,0.36507936507936506,1.0,1.0,2/13,7.84%,IL4I1;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.5668257489958115,-1.1628091751399163,0.32857142857142857,1.0,1.0,4/27,8.64%,ZNF703;EID2;SFRP4;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5574092964431373,1.1627618737375396,0.2702702702702703,0.888872332281497,1.0,5/16,20.21%,EPHA5;PRKD1;CRTC3;RELN;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5043968236766819,1.1612210831770866,0.14285714285714285,0.8929792996432279,1.0,2/27,1.36%,GFI1B;CDK2AP2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.4395376652846923,1.1612083304440026,0.22580645161290322,0.8919445611731894,1.0,7/76,3.09%,FBXL7;LAMB2;PRRX1;SVEP1;NTM;LAMA4;PCDH18
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5631863242054201,1.1604581846577469,0.24324324324324326,0.8933846847708623,1.0,3/20,5.00%,CD38;BCL2;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.7078093740253276,1.159842674645212,0.2571428571428571,0.8941135241672985,1.0,3/6,28.48%,BICD1;MARK4;PARD6A
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7644241549490096,-1.1597768207263937,0.3620689655172414,1.0,1.0,2/5,12.66%,SERPINE1;CTSZ
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6979243535127341,1.1595408884528544,0.34285714285714286,0.8940677632154023,1.0,6/7,27.28%,DISP3;NR1H3;PPARA;ITGAV;PRKN;NR1H2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6860364835895555,-1.1593868367848723,0.265625,1.0,1.0,2/9,15.50%,IL4I1;ACMSD
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6860364835895555,-1.1593868367848723,0.265625,1.0,1.0,2/9,15.50%,IL4I1;ACMSD
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.5114644558428783,-1.1592374936875895,0.24324324324324326,1.0,1.0,1/53,0.08%,ENPP2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5728694420965088,1.1590009006189124,0.3125,0.8938945218654415,1.0,2/11,6.31%,SLC37A4;SLC20A2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5728694420965088,1.1590009006189124,0.3125,0.8938945218654415,1.0,2/11,6.31%,SLC37A4;SLC20A2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6664186383539533,1.1588155942360578,0.34615384615384615,0.893423075817151,1.0,2/8,12.91%,ACADVL;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5452597674396753,1.1587714034204881,0.2571428571428571,0.8925271082265296,1.0,5/35,6.58%,IFI16;HSPB1;F2RL1;S100A13;HMGB1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7374310875381618,-1.1587320530689478,0.3728813559322034,1.0,1.0,3/7,18.53%,SIGIRR;ITIH4;LBP
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.7042068781054145,-1.1584331933512297,0.3157894736842105,1.0,1.0,1/8,5.51%,PINK1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.6815117308199589,-1.158428861794277,0.26865671641791045,1.0,1.0,3/11,9.72%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7592800429003557,-1.1581526289898822,0.2826086956521739,1.0,1.0,1/5,8.87%,HSPA5
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5046478507548697,-1.157947286699896,0.24285714285714285,1.0,1.0,15/61,13.49%,ARR3;CRYBG3;RDH10;WFS1;CRYBB1;RABGGTB;CABP4;GPR179;SLC24A1;CACNA2D4;EFEMP1;CRYBA1;CNGB1;DNAJC19;RDH12
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.6871278855986358,1.1579262260181529,0.3055555555555556,0.8941838980856519,1.0,2/6,11.41%,PRKD1;MAPK8
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.45420870924845935,1.1577447505744738,0.16,0.893909724823932,1.0,11/48,17.27%,HTR1F;HTR1E;CHRM3;ADCY2;GNAI1;GRM8;CHRM5;DRD4;GNAI3;ADCY9;GNAL
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.7588008572292535,-1.1577043616003853,0.3384615384615385,1.0,1.0,2/5,9.74%,GAD1;ALDH1A1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.727973937988855,-1.1575797736425777,0.29310344827586204,1.0,1.0,4/7,19.73%,B2M;ERAP2;HLA-A;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6824481571769706,-1.1569752067239583,0.3333333333333333,1.0,1.0,7/8,30.53%,BNIP3;HEBP2;RNF122;ARL6IP5;BAX;PIP5KL1;PRELID1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.7148510749392275,1.156973398452873,0.2564102564102564,0.8956263880389221,1.0,4/8,24.11%,LARP1;CARD11;RPTOR;SMG1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.725890875054198,-1.1565374965009272,0.25396825396825395,1.0,1.0,2/7,13.19%,CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.725890875054198,-1.1565374965009272,0.25396825396825395,1.0,1.0,2/7,13.19%,CACNA2D4;CNGB1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.7693368619392862,-1.1559630019605935,0.3114754098360656,1.0,1.0,4/5,20.68%,CCL5;CXCL13;PODXL;SKAP1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.7696628402214769,-1.155844816208359,0.29508196721311475,1.0,1.0,1/6,5.42%,IL7
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.4603383018588661,-1.1553453128848103,0.20270270270270271,1.0,1.0,52/150,29.47%,NOB1;RPL36;RPL15;RPL38;RPLP2;RPL28;RPS7;RPL9;RPL37A;RPL22;RPL35A;RPL5;RPL8;RPLP1;DIS3L;EXOSC6;RPL4;RPL3;RPL34;RPL37;DDX54;RPL24;NOP56;WDR12;UTP11;EMG1;RPS24;RPS15;KRR1;RPL7A;RPL13A;RPL27A;SBDS;RPL23;EXOSC8;RPL35;RPL19;RPL18;WDR55;RPL32;RPL13;RPL27;IMP4;LAS1L;PELP1;RPS2;RPS9;MRTO4;UTP15;RPL29;RPS25;RPL31
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.6592739528319503,-1.1551926180028058,0.3090909090909091,1.0,1.0,2/8,4.40%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.6988223071416295,-1.154645062215335,0.27586206896551724,1.0,1.0,2/6,26.15%,YAP1;SMO
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.4432530634975606,1.1545789855805222,0.16666666666666666,0.9025207797832523,1.0,14/89,8.90%,CDH13;C5AR1;EGFR;NRP1;KDR;TGFBR1;BMP6;SEMA5A;VASH2;MDK;TGM1;IGF1;PKHD1;PRKD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.6791181052443809,-1.1545316202967546,0.3103448275862069,1.0,1.0,3/6,14.86%,IL18R1;IL18BP;IL18
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.6791181052443809,-1.1545316202967546,0.3103448275862069,1.0,1.0,3/6,14.86%,IL18R1;IL18BP;IL18
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5943505832372151,1.1545089594429128,0.2972972972972973,0.9016195346314734,1.0,2/18,3.98%,IL1RAPL1;FBXW8
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.8053451120587255,-1.1541252397485084,0.20754716981132076,1.0,1.0,1/5,7.35%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.7313954378181654,-1.1541035446983339,0.34545454545454546,1.0,1.0,2/8,14.64%,DRD3;VPS35
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5010388333098946,1.1540363754912792,0.3170731707317073,0.9019396458325312,1.0,3/27,6.46%,IFI16;GREM1;FHIT
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.42935685492435083,1.1537836549925835,0.16129032258064516,0.901706908540655,1.0,9/65,11.41%,ATP6V0D2;WDR24;DAP;PRKD1;EIF2AK3;EIF2S1;MAP3K5;KPTN;MAPK8
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.6093001491851294,-1.153548750996517,0.265625,1.0,1.0,5/16,19.16%,ODAD4;CCDC39;ROPN1L;CABYR;SPAG17
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.604052651910492,1.1535319730287703,0.2631578947368421,0.901636904238021,1.0,3/12,6.33%,UBASH3B;KIF26A;ACVR1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5435638545606938,-1.1533918755449342,0.2638888888888889,1.0,1.0,3/31,11.63%,TERF2IP;GAR1;MRE11
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.5705753178390292,1.153147260342463,0.2857142857142857,0.9019883068097095,1.0,5/10,18.87%,B3GAT2;CLN6;B3GAT1;B3GAT3;CHST9
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.683398380220698,-1.1529984253273902,0.2807017543859649,1.0,1.0,4/7,24.28%,B2M;TLR2;RPS27A;UBC
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.683398380220698,-1.1529984253273902,0.2807017543859649,1.0,1.0,4/7,24.28%,B2M;TLR2;RPS27A;UBC
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6061539689848995,-1.1529236842747015,0.3188405797101449,1.0,1.0,10/27,25.87%,B2M;BCAP31;TAPBPL;ERAP2;HLA-A;ERAP1;SEC23A;CALR;CANX;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.51468621575283,1.1525746928818723,0.27586206896551724,0.9028082298993209,1.0,4/30,8.34%,GFI1B;CDK2AP2;MYO16;NACC2
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7030099364646255,1.1525413988902484,0.35714285714285715,0.9019127963488981,1.0,5/6,29.31%,MMP24;FER;PLEKHA7;CDH2;AFDN
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.7333756311777615,-1.1524743270134037,0.3050847457627119,1.0,1.0,3/5,20.92%,IL15;IL18;TMBIM1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.5982029201607714,1.1522337052112743,0.325,0.9017944359265486,1.0,6/12,33.69%,WDR35;TTC21A;DYNC2I2;IFT43;TTC21B;IFT122
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.4714275937257384,1.1518862340637666,0.16666666666666666,0.9017247288992571,1.0,15/60,17.87%,GALNT3;TGFBR1;GALNTL6;ACVR1;PRKCD;GALNT13;SBK1;PRKD1;MAPK8;MAP3K10;CDC42BPB;GALNT16;DYRK3;OXSR1;CIT
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.474456880265059,1.1514061684224641,0.275,0.9020579343595012,1.0,4/46,5.00%,CD38;PNP;BCL2;EPHB2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6898266405025406,1.150531994240305,0.30434782608695654,0.9026095720342323,1.0,2/6,18.95%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6898266405025406,1.150531994240305,0.30434782608695654,0.9026095720342323,1.0,2/6,18.95%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.44759384038624117,1.1503309306032072,0.26666666666666666,0.9022502577127514,1.0,9/70,9.52%,NRG1;BCL2L11;SDC4;BMP7;RAB7A;STX18;FAF1;TPR;GNL3L
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.5541609386086774,1.1503213531059866,0.32142857142857145,0.9012983606162147,1.0,2/23,0.83%,ACE2;PER2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.40537391673770323,1.1498580416784376,0.16666666666666666,0.9016461912170428,1.0,15/94,14.28%,NRG1;NRK;TGFB2;PRKCD;CLSPN;IGF1;PAK5;ADCY2;ANGPT1;MALT1;PIBF1;NTRK3;PAK4;PDGFB;PAK3
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7108047944775815,1.1497657380787745,0.35135135135135137,0.9009531372717895,1.0,2/5,11.44%,FGF13;PTPRS
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6351974594033503,1.1497051558785254,0.3,0.9001977045071223,1.0,2/10,3.77%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6816997900019564,1.1492193378836082,0.3142857142857143,0.8990725753763973,1.0,1/8,0.80%,HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6816997900019564,1.1492193378836082,0.3142857142857143,0.8990725753763973,1.0,1/8,0.80%,HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6816997900019564,1.1492193378836082,0.3142857142857143,0.8990725753763973,1.0,1/8,0.80%,HSPB1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.5715346179894543,-1.1487371163872053,0.3064516129032258,1.0,1.0,8/20,29.87%,IRF1;TLR2;FLOT1;GPS2;NFKBIL1;NLRP2B;CD36;LRRC14
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7584151203985585,1.1485294994895463,0.3333333333333333,0.9000411364269696,1.0,3/5,6.58%,RUNX1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5292843461480101,1.1483627227574913,0.2702702702702703,0.8996882978471187,1.0,5/26,7.36%,LHFPL2;KIT;KITLG;TGFB2;AKR1C3
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.7522940671938552,-1.1482818828598598,0.288135593220339,1.0,1.0,3/5,23.43%,ALDOB;KHK;AKR1B1
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.6969867332891305,-1.1480545922930303,0.3125,1.0,1.0,2/8,15.09%,AGT;SIX4
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.6969867332891305,-1.1480545922930303,0.3125,1.0,1.0,2/8,15.09%,AGT;SIX4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.5100985412538681,-1.148003399349079,0.1875,1.0,1.0,17/51,19.18%,SIGLEC1;STEAP4;CLIC6;CD14;SLCO2B1;IFI27;CRLF1;AGER;ALDH1A1;ADGRF5;DUOXA1;CTSH;SFTPD;WFDC2;NRN1;C1QA;TNFAIP2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.4461408663798571,-1.1479360460006665,0.2345679012345679,1.0,1.0,58/163,30.23%,NOB1;RPL36;RPL15;RPL38;RPLP2;RPL28;RPS7;RPL9;RRP15;RPL37A;RPL22;RPL35A;RPL5;RPL8;RPLP1;EIF6;EXOSC6;RPL4;RPL3;RPL34;RPL37;DDX54;RPL24;NOP56;WDR12;UTP11;EMG1;NAT10;RPS24;RPS15;KRR1;RPL7A;RPL13A;RPL27A;SBDS;RPL23;EXOSC8;NSA2;RPL35;RPL19;RPL18;WDR55;RPL32;RPL13;RPL27;IMP4;LAS1L;PELP1;RPS2;RPS9;MRTO4;MAK16;UTP15;RPL29;RPS25;RPL31;TSR3;RPL21
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.7775446889645857,-1.1470884610753125,0.3492063492063492,1.0,1.0,2/5,12.79%,SOD2;ADRB1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.6877185518468969,-1.147083129803978,0.35384615384615387,1.0,1.0,1/8,1.16%,MYLK
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.695998861277126,-1.147077885047228,0.29850746268656714,1.0,1.0,2/9,15.61%,PTPRC;STAP1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.7051377408803565,-1.1466746976851783,0.39344262295081966,1.0,1.0,2/7,22.06%,PEX16;PEX1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5199166882911577,1.146627799243404,0.3157894736842105,0.9036388344237557,1.0,2/24,4.28%,MSH4;POLD3
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.6203789648970933,1.146516552002984,0.3611111111111111,0.902918017639261,1.0,4/9,12.10%,PCM1;NUMB;CEP120;HOOK3
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.5976165514599037,-1.1462669596168518,0.25,1.0,1.0,6/21,14.86%,BTN2A2;HHLA2;PDCD1LG2;AGER;FADD;IL18
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.642262484348552,1.1461359085959029,0.325,0.9031017636427563,1.0,4/13,20.32%,SHLD1;KMT5B;TP53BP1;SLC15A4
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5421492618502651,-1.1459705427681302,0.26865671641791045,1.0,1.0,9/36,17.96%,SLC7A11;SLC7A7;ABCB1;SLC38A11;SLC36A1;SLC38A8;SLC38A4;SLC23A1;SLC25A11
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5224806103077865,-1.1458508169369266,0.3150684931506849,1.0,1.0,10/49,12.45%,CCNE1;CDKN2D;CCNG2;CDKN3;CDC6;CCND2;CAMK2N1;GADD45A;CDK5R1;CDC25A
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6734411713326267,-1.1458412372950741,0.3225806451612903,1.0,1.0,2/10,8.58%,ATP1B1;GLRX
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5063105180596292,1.1455827993724723,0.25806451612903225,0.903981347983879,1.0,4/24,14.28%,DOCK10;EPHB2;FYN;PAK3
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5610216328635236,1.1453127736717972,0.2647058823529412,0.9039422187950202,1.0,10/26,15.55%,BMP7;BMP6;ACVR1;PKDCC;TGFB3;NELL1;SLC8A1;ANO6;GPM6B;MEF2C
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.6802482699490193,1.1452772007641732,0.325,0.9030979525768117,1.0,3/6,19.32%,CFLAR;ANGPT1;AKIRIN1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6635626570146507,-1.144654451571429,0.2786885245901639,1.0,1.0,3/8,27.98%,TMSB4X;TMSB10;TWF2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.6487735836256868,-1.1444174051323746,0.26153846153846155,1.0,1.0,6/12,23.87%,TCP1;CCT6A;CCT8;GNL3;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6423171403643111,1.1443521914472814,0.32432432432432434,0.9049366631713837,1.0,3/8,12.77%,PLCB1;IGF1;CHP1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7359703152775194,-1.1442321093738903,0.30303030303030304,1.0,1.0,3/5,26.23%,FLOT1;EMP2;RFTN1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5881361871562748,1.1440484251282694,0.3157894736842105,0.9048650995294109,1.0,4/15,12.76%,ARL13B;ALDH1A2;PTCH1;TRIM71
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.6116681773549439,-1.1436894856698332,0.3055555555555556,1.0,1.0,4/13,21.96%,GPR68;MCOLN1;HVCN1;GPLD1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.7631786965805142,-1.1436508868171986,0.2807017543859649,1.0,1.0,1/5,4.65%,TCP1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.7631786965805142,-1.1436508868171986,0.2807017543859649,1.0,1.0,1/5,4.65%,TCP1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.7520680556192902,-1.1435769752319316,0.3389830508474576,1.0,1.0,1/5,4.38%,STAT1
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.7592563807980188,-1.1434158485219577,0.25806451612903225,1.0,1.0,1/5,5.91%,P2RY12
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.7599407611241444,-1.1432734543514174,0.32786885245901637,1.0,1.0,2/5,8.64%,STAT1;TGFB1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.7599407611241444,-1.1432734543514174,0.32786885245901637,1.0,1.0,2/5,8.64%,STAT1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.6646341884861335,-1.1431789743446608,0.36363636363636365,1.0,1.0,1/10,1.76%,TMEM35A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.6939615690798122,1.1428018478311741,0.3,0.9081927485621942,1.0,3/6,29.38%,MALT1;PRKCQ;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7182168350903326,-1.1417242179970013,0.3,1.0,1.0,1/6,4.41%,RAD51AP1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.7531328530675122,-1.141615850859673,0.30158730158730157,1.0,1.0,3/6,15.82%,RCN3;CTSH;SFTPD
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.7531328530675122,-1.141615850859673,0.30158730158730157,1.0,1.0,3/6,15.82%,RCN3;CTSH;SFTPD
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.5736934457937346,-1.1414403238193875,0.328125,1.0,1.0,4/29,7.74%,BTN2A2;LRPAP1;PINK1;RIN3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.45877553860043435,1.141351625263616,0.2647058823529412,0.9116388037471977,1.0,8/34,14.09%,PDGFD;RASSF2;PDGFC;ENPP1;EPHA7;PPP2R5E;CHP1;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.7620383465031457,-1.1413245685835238,0.2698412698412698,1.0,1.0,1/5,5.91%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5105450400048581,1.141072946957347,0.29545454545454547,0.9115443857958015,1.0,4/24,6.36%,ATOH8;TGFB2;FOS;APLN
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7277995970397856,-1.1405358515700985,0.3333333333333333,1.0,1.0,2/5,26.44%,VDAC1;PLN
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5050057648710267,1.139957545938746,0.25,0.9141165189076293,1.0,7/30,10.30%,PDE3A;GLP1R;EPHA5;PDE4D;CAP2;APOE;ADCY2
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.6653720011095456,-1.1396745050011765,0.31666666666666665,1.0,1.0,2/8,13.95%,HSPA5;BOK
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.42896078651653863,1.1395626719995628,0.24,0.9144895964355018,1.0,11/72,10.75%,ATOH8;HSPB1;NRP1;KDR;SEMA5A;HMGB1;PRKD1;FGFR1;SCARB1;ANGPT1;RIN2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.711797983504874,-1.1390550957525638,0.36507936507936506,1.0,1.0,1/6,4.68%,RAC1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.7146599715988435,-1.139037986474606,0.3559322033898305,1.0,1.0,1/7,1.25%,POLQ
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.6539563991296231,1.1389868485214651,0.425,0.915409600512651,1.0,4/6,26.18%,HPRT1;DRD4;PRKN;ITGAM
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.6545194904588907,-1.1389210711520026,0.3548387096774194,1.0,1.0,6/11,26.07%,B2M;ERAP2;HLA-A;ERAP1;HLA-F;AZGP1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5916475470763995,1.1386099943936423,0.23529411764705882,0.9154990505996798,1.0,3/19,8.43%,RORA;ACADVL;APOE
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5211476208597393,-1.1385967512155533,0.26865671641791045,1.0,1.0,10/44,20.25%,POLE3;H1-0;H1-2;CHAF1A;NAP1L2;DAXX;GRWD1;H2BC18;H3-3A;CHAF1B
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.631704291860917,-1.1383396211066528,0.39285714285714285,1.0,1.0,2/10,10.45%,PATL2;DCP2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.6175801229770008,-1.1382387274761991,0.3235294117647059,1.0,1.0,3/13,10.89%,MYLK;SMTN;ACTA2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.43820022551448684,1.1380181396631257,0.22580645161290322,0.9164627770065145,1.0,11/57,10.31%,ATOH8;NFIB;PTPRK;BRCA2;TGFB2;MCC;VASH1;CASK;APOE;EREG;DUSP10
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.6701853333838698,-1.137993207624638,0.30357142857142855,1.0,1.0,4/6,27.17%,TEKT3;RSPH9;CFAP54;DNAI3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6304610435203273,-1.1373172275353371,0.38333333333333336,1.0,1.0,5/9,23.59%,ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5PB
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7017059729390251,1.1372477208816,0.36363636363636365,0.9175335816282075,1.0,2/6,7.70%,PHACTR1;NLGN1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5741920563665646,1.1368419363910642,0.3125,0.9179008796699092,1.0,6/10,22.37%,DLGAP1;DLGAP4;DLGAP3;DLGAP2;AKAP9;CACNG5
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.42336737901448046,1.1367316906371634,0.21052631578947367,0.9174268982778121,1.0,9/62,10.22%,PTPN3;PTPRK;BMP7;LATS1;BTG2;BRINP1;ZBTB17;TFAP4;HECA
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7518477820649121,1.1365981884434286,0.3902439024390244,0.9167673831027662,1.0,1/5,9.54%,CHRM3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5517436944102517,1.1364794021690532,0.2894736842105263,0.9160627150415249,1.0,1/15,0.80%,HSPB1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.45406801321023194,-1.1360479535387142,0.22077922077922077,1.0,1.0,17/101,11.48%,SLC28A2;NR1I3;ANKS4B;CDHR5;SOX10;PLIN2;KLF5;SLC51A;DEGS2;SPON2;ALDOB;GBA3;NKD2;GPX2;RBP2;TMC4;CA1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.605068217026347,1.1358646243214578,0.275,0.9167402852557337,1.0,6/12,26.27%,TET2;WDR82;BEND3;SETD1A;TET3;PRDM7
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.6746149869631028,-1.1358609128168877,0.3559322033898305,1.0,1.0,2/6,4.40%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.7220022617812356,-1.1352539379361553,0.3333333333333333,1.0,1.0,1/7,2.06%,CDHR5
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.7182821824568506,1.135050825795974,0.39473684210526316,0.9185476353571667,1.0,2/5,25.13%,MME;HYAL2
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5134696367080522,1.1348372432817138,0.32432432432432434,0.9181374461251361,1.0,10/24,21.46%,SYNJ2;MTMR8;MTMR9;PIP4P1;INPP5J;PTEN;MTMR6;MTM1;MTMR11;MTMR3
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.7433190088643262,1.1345507134894735,0.35135135135135137,0.9180683333061352,1.0,2/5,11.93%,HEY1;RBP4
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.6401483941017051,1.1345005903364056,0.3170731707317073,0.9172116135096793,1.0,5/7,22.12%,PIK3R1;SOCS2;PXN;JAK2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5205271306844432,1.1343490899203397,0.29545454545454547,0.9167270575870293,1.0,2/13,7.31%,KIT;TICAM1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.4830515246612078,-1.1341083265577088,0.2597402597402597,1.0,1.0,5/65,7.94%,PTER;ZNF703;OVOL3;TST;TOLLIP
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.7460882517211477,-1.133924534960886,0.3125,1.0,1.0,2/5,9.56%,PTGR1;ALOX12
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.43606416800827563,1.1335134613921405,0.22580645161290322,0.9180160202212084,1.0,27/66,20.98%,LAMB2;ITGA4;NTNG1;NRP1;ARL13B;LAMB3;PKHD1;PIK3R1;MEGF9;TMEFF2;VAMP3;SIPA1L3;POF1B;ITGA8;FER;RADIL;MEF2C;PARVA;PXN;RILPL1;RELN;OPHN1;ANTXR1;ITGAV;PROX1;FERMT3;LAMB4
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.6785382385698572,-1.1334969397414232,0.3333333333333333,1.0,1.0,2/8,2.87%,ZNF703;RREB1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7232178136880565,1.1332239283066845,0.38235294117647056,0.917854960832691,1.0,2/5,18.20%,LYPLA2;ABHD12
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6051280954381877,-1.1330662998946632,0.3389830508474576,1.0,1.0,2/14,7.52%,PRLR;STAT5A
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.7380436070227625,1.133035597406126,0.3409090909090909,0.9175404543910486,1.0,2/5,7.72%,JAM2;BCL11B
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4650954080405868,1.1328521567410788,0.21212121212121213,0.917119086190942,1.0,11/44,15.68%,PER2;TBL1Y;HDAC9;PRDM5;HDAC1;HDAC10;SIRT2;SIRT1;SMARCAD1;SIN3A;HDAC5
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4330417171581324,1.1326784182472251,0.16,0.916591201690642,1.0,22/81,15.41%,GPC4;HS3ST5;HS3ST3A1;HS3ST3B1;CHSY3;VCAN;SDC4;EXT1;ST3GAL3;HS3ST2;SLC10A7;ST3GAL1;ANGPT1;EXT2;CHST12;HS3ST1;HS6ST2;ST3GAL2;CHST11;HS2ST1;GCNT2;CHSY1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6329497811442509,-1.1325780851997371,0.3559322033898305,1.0,1.0,3/15,17.74%,EMC1;CAMLG;EMC3
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.7277674025786911,-1.1325693739116773,0.31746031746031744,1.0,1.0,2/5,10.78%,CEMIP;HAS3
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5245753461908254,1.1320935014711375,0.2564102564102564,0.9174747977035095,1.0,4/17,25.52%,STX18;AKAP9;MYO5A;STX5
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6636739873903461,-1.1320077078912554,0.3684210526315789,1.0,1.0,2/11,10.05%,ABCB1;MLC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.6306015740922314,1.1320062476262698,0.3157894736842105,0.9166567124360516,1.0,2/10,11.15%,F2RL1;SPHK2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.6415362478133826,-1.1315122506508004,0.29310344827586204,1.0,1.0,4/14,8.25%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.5307727191563459,-1.1313107829930085,0.3235294117647059,1.0,1.0,16/34,25.45%,BIK;MOAP1;BNIP3;PINK1;GHITM;HRK;GPER1;CIDEB;PDCD5;PLAUR;GPX1;MLLT11;AKT1;BAX;HGF;DNM1L
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5485712170538977,-1.131305402102782,0.35384615384615387,1.0,1.0,8/21,15.56%,SOD2;IGFBP5;OGN;GPER1;TPM1;APOD;NDRG4;CDKN1B
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5878290486508003,1.1311785622121606,0.3076923076923077,0.9174554051437774,1.0,3/8,20.60%,SCAP;ERLIN2;SREBF2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.5878290486508003,1.1311785622121606,0.3076923076923077,0.9174554051437774,1.0,3/8,20.60%,SCAP;ERLIN2;SREBF2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6472231440328453,1.1310738114171228,0.28205128205128205,0.9168078763043263,1.0,1/11,2.98%,COBL
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.576953742132106,-1.1308216528906796,0.32786885245901637,1.0,1.0,6/20,19.73%,CHAC1;CHAC2;ERAP2;CTSH;LVRN;ERAP1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3615355698277496,1.130699523140525,0.1,0.9168173877695364,1.0,91/904,9.95%,CD38;MYRFL;ETV1;RUNX1;CREB5;ATOH8;CDH13;ZNF300;PID1;IFI16;MAML3;LEF1;TEAD2;E2F5;F2RL1;NFIB;SSBP3;EGFR;ZNF496;ZEB2;NFIA;RORA;WWTR1;HIVEP1;ZNF462;KDM8;FANK1;BMP7;NRL;GABPB2;NFATC1;SERTAD2;BRCA2;TGFBR1;ZNF827;ZGLP1;PLCB1;CREB3L4;BMP6;MRTFA;ZBED3;ESRRG;TOX3;WWOX;ATF3;GREM1;MAML1;FOS;TOX2;HEY1;ARID1B;MEIS1;JAG1;ZNF407;ACVR1;SOX12;HMGB1;NFIX;TET2;TGFB3;ARID1A;BCL11B;IGF1;FLI1;ZBTB17;ETV5;HDAC1;ZNF263;ELF2;TFCP2;APOE;MED30;ASF1A;FZD1;SMAD2;POU3F1;PRKD1;ATF6;TASP1;RGMA;RGMB;CSRNP3;AUTS2;EIF2AK3;ERBB4;TFAP4;TET1;REL;WBP2NL;MYB;CDK8
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.42109008928283437,1.1305683030739175,0.16666666666666666,0.9162023892969807,1.0,15/82,9.67%,GALNT3;GXYLT2;GALNT12;TMTC2;ST3GAL3;GALNTL6;GALNT7;GALNT10;C1GALT1C1;TET2;GALNT18;GALNT13;CRPPA;TET1;ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.7235414470913124,-1.1305384107083114,0.36666666666666664,1.0,1.0,1/6,1.01%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.7235414470913124,-1.1305384107083114,0.36666666666666664,1.0,1.0,1/6,1.01%,PTGIS
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.5384552324248576,1.130289269871447,0.2765957446808511,0.9160603755208512,1.0,3/18,8.25%,SLC22A2;SLC22A3;ABCC11
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.7587360173612986,-1.1301619210698415,0.39344262295081966,1.0,1.0,1/5,5.24%,DRD3
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.4478678603692376,-1.1301577738067445,0.22666666666666666,1.0,1.0,5/166,1.91%,TRIM58;GYPB;GYPE;SLC7A11;UROD
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.6888955905402864,-1.1298392889023396,0.375,1.0,1.0,4/8,26.93%,ATP6AP1;NDUFS2;ATP6V1G1;ATP6V1A
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.45457238141450146,-1.129559064958844,0.2375,1.0,1.0,17/131,10.12%,SLC28A2;C3AR1;NDP;CD82;KCNA3;CD14;ITGA5;OSMR;AHR;IL18R1;SERPINE1;IRF1;IL15;GPC3;IFNGR2;CCL5;INHBA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6808421213036354,1.1294595680968809,0.37142857142857144,0.9176665432412179,1.0,4/7,19.12%,COMMD1;NEDD4L;NEDD4;WNK2
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.5286193517744984,-1.1292278170295624,0.3333333333333333,1.0,1.0,9/35,16.61%,CD74;STAT1;GBP6;CIITA;EPRS1;CCL5;GBP5;TLR2;SLC11A1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.6302561909132816,1.128907818275812,0.32608695652173914,0.918464601140384,1.0,3/6,12.64%,DNAJC3;EIF2AK3;FOXO1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.5782588853686672,1.1286166957934032,0.22916666666666666,0.9183054653413448,1.0,7/13,27.31%,PRKCD;SPHK2;SMPD3;SIRT3;NSMAF;SPHK1;SAMD8
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5658173372714008,-1.1284312375759384,0.3387096774193548,1.0,1.0,5/21,13.42%,AGT;INHBA;LTBR;FADD;GPER1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5328133565584154,-1.128348605720549,0.28169014084507044,1.0,1.0,6/45,8.64%,CD44;PRELP;HSPG2;GPC3;CEMIP;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7284822333346013,-1.1282370224087186,0.3584905660377358,1.0,1.0,2/6,16.50%,ATF5;RGCC
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.5244422427795136,1.128131020898073,0.3125,0.9186011811822107,1.0,5/38,7.17%,C5AR1;PTCHD1;GRM5;SOBP;CHD7
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.727991923210114,1.1280331319862742,0.39473684210526316,0.918063880097974,1.0,2/5,14.33%,TPR;NUMA1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.5937710939595504,1.1280223146048904,0.3684210526315789,0.9171648813345848,1.0,5/15,16.06%,KIT;ALAS1;LYAR;ABCB10;THPO
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5390303348411885,1.1280124763788073,0.38461538461538464,0.916207380303474,1.0,5/18,16.31%,MEX3D;LIN28B;CELF1;ZC3H18;FTO
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6231865264753967,1.1279399089600475,0.36363636363636365,0.9153725977829975,1.0,4/10,11.60%,CACNA2D1;BIN1;NOS1AP;CACNB2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.707354213273128,1.1279305268059252,0.4,0.9134825121925381,1.0,1/5,4.29%,DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.707354213273128,1.1279305268059252,0.4,0.9134825121925381,1.0,1/5,4.29%,DPY19L1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.4164504733194197,1.127920867446034,0.16666666666666666,0.9125329439737467,1.0,15/120,7.88%,FBXL7;ABI3BP;PRRX1;LEF1;COL15A1;PDE3A;SVEP1;LAMA4;PCDH18;CRIM1;MAP3K20;FAT4;PDGFRA;HTRA1;ARID5B
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5754879244285311,1.1276498448246526,0.2727272727272727,0.9122313501466349,1.0,3/16,8.08%,TRPS1;MDK;SOX5
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.679616376307012,1.1274717118525128,0.38461538461538464,0.9118703649092658,1.0,3/5,21.53%,COX10;HCCS;COA6
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.42177238218000473,-1.1273242698533386,0.2235294117647059,1.0,1.0,27/286,11.63%,CD44;ENPP2;CD4;TERF2IP;PTPRC;AGT;CD74;P2RY1;RAC1;ITGA5;RARRES2;NODAL;PINK1;TOM1L1;SPDYA;CCND2;IL15;CEMIP;FAM20A;TGFB1;AGER;CALCR;INHBA;CALM3;TBX1;TEC;MRE11
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4097181495274169,-1.1271966136416658,0.2077922077922078,1.0,1.0,34/246,19.46%,TICRR;RAD54L;MCM2;TERF2IP;POLQ;POLE3;RAD51AP1;GMNN;GLRX2;RFC5;BACH1;CDC6;RECQL;RPA3;DNASE2;INIP;FANCC;XRCC1;MRE11;GADD45A;CHEK1;POLE2;PCNA;BRCA1;TDG;RAD9B;HMGB3;RAD51C;PARG;NUDT1;PDS5B;NABP1;SUPV3L1;RAD1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.6898037924949546,1.1270308855587539,0.4411764705882353,0.912154750784896,1.0,3/5,15.60%,PCSK2;CELA2A;IDE
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.5981786409143895,-1.1269697720038951,0.30158730158730157,1.0,1.0,3/18,8.95%,STAT1;TXK;IFNGR2
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.5122285244334477,1.126741070713515,0.2558139534883721,0.9121390347134254,1.0,5/24,6.84%,CD38;BCL2;IGLL1;PRKCB;LAT2
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5596379847645349,-1.1266822192791,0.2857142857142857,1.0,1.0,4/34,6.15%,LDLRAP1;B2M;SFRP4;SERPINE1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.5326440516180407,1.1263749822822813,0.3793103448275862,0.9123477436073953,1.0,6/27,6.23%,ITGB5;ITGA4;DUSP5;DUSP2;LAMB3;DUSP4
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.655102012829121,1.1263078152730963,0.34146341463414637,0.9115697259414538,1.0,3/10,13.00%,FGFR4;AKR1C3;SIRT1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5972657638252146,-1.1262641070587966,0.2903225806451613,1.0,1.0,3/21,8.55%,CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5203323647137901,1.1260828166430636,0.26666666666666666,0.9113008947967205,1.0,3/23,6.88%,RGS14;PDE3A;NUMB
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5014317951870836,-1.1258174076545056,0.2328767123287671,1.0,1.0,8/47,10.31%,AMBP;FGL1;MYO5B;TOM1L1;FOXM1;CBLC;CLDN1;HNF4G
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.42196344916156175,1.125744437436822,0.2,0.9113457885223832,1.0,26/107,16.70%,PID1;VASH2;MARCHF5;VASH1;LZTS3;EFNA5;LRRC4C;FMNL2;KNDC1;TSPAN12;ADGRB3;NSMF;NEDD4L;HECW2;PPFIA2;BCL6;INF2;SIPA1L1;RC3H1;PAK3;NEDD4;PDZD8;MEF2C;FITM2;DAG1;ARHGAP44
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7123133097039247,1.1253380311999213,0.32558139534883723,0.9116438351408277,1.0,3/6,25.65%,MEGF10;AKIRIN1;THBS4
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.47249526310655376,-1.1252706714642497,0.29850746268656714,1.0,1.0,17/61,24.84%,POLE3;H1-0;H1-2;CHAF1A;SMARCE1;NAP1L2;DAXX;SET;GRWD1;H2BC18;H3-3A;ACTR6;CHAF1B;ANP32E;SPTY2D1;PAF1;VPS72
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6139636358283597,1.1250671222162827,0.4,0.9114501758134612,1.0,4/9,17.09%,NRP1;ZSWIM5;ZSWIM6;ZSWIM8
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5478965993750385,1.1248707227445975,0.34285714285714286,0.9110785315285687,1.0,1/16,1.52%,IRS1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.7769762200768713,-1.124726076935294,0.3230769230769231,1.0,1.0,2/5,21.66%,KHK;GCKR
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.41875501461601594,-1.124646191450826,0.26506024096385544,1.0,1.0,39/178,19.57%,MCM2;CCNE1;CDKN3;RAD51AP1;CDCA3;PRDX4;SUV39H1;SPC24;DDX39A;RPA3;TUBB;ATAD2;PSMC3IP;STMN1;MRE11;CBX5;SLBP;CDC25A;CHEK1;ILF3;PAICS;PCNA;BRCA1;DEK;PLK4;CDKN1B;H2AZ1;NAA38;DONSON;HMGB3;RAD51C;PDS5B;PMS2;DIAPH3;NOP56;DEPDC1;GINS1;RAD1;CDK4
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.3604931075310852,1.1245076917730574,0.18181818181818182,0.9112274217624121,1.0,17/181,11.27%,FBXL7;RNF150;MYLIP;RNF126;RNF217;FEM1A;CDC26;RNF130;PTTG1;RBBP6;RNF128;ANAPC16;KLHL25;CDC23;KCTD21;UBE2D4;NEDD4L
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5794895604752004,-1.1244568276647324,0.39655172413793105,1.0,1.0,2/22,2.07%,PRLR;CYP19A1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5355080420140886,-1.1242634583051956,0.2727272727272727,1.0,1.0,2/25,3.12%,LRP4;OMG
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.5451729212672951,-1.1242479083358707,0.2727272727272727,1.0,1.0,4/23,13.70%,STAT1;NCKAP1L;INHBA;ZNF16
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.42200153631423865,1.1241524509621628,0.22857142857142856,0.911227653797882,1.0,12/45,15.55%,HSPB1;KDR;VASH1;HMGB1;APOE;PRKD1;FGFR1;ANGPT1;SIRT1;PDGFB;MAP2K3;MEF2C
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.6426197282071713,1.1240082508790037,0.25806451612903225,0.9107240269676163,1.0,2/7,11.15%,PRKD1;SPHK2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.6377306677358056,1.1239763667270861,0.325,0.9088917503134658,1.0,1/8,10.00%,SLC25A33
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.6377306677358056,1.1239763667270861,0.325,0.9088917503134658,1.0,1/8,10.00%,SLC25A33
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4849142325663772,1.1232832214385777,0.28125,0.9100614907037871,1.0,9/43,10.11%,F2RL1;EGFR;TGFB2;GREM1;RASGRP1;SEMA4C;MID1;KLHDC10;IGBP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.48391461538616765,1.123277801295385,0.2857142857142857,0.909133179738288,1.0,4/20,10.45%,KIT;FGFR3;PDGFRA;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.6097656799369507,-1.123140645274655,0.34375,1.0,1.0,1/11,3.42%,TCHP
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.7594647559903944,-1.1224846110265931,0.3220338983050847,1.0,1.0,1/5,4.48%,CAV3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7000441896033229,-1.1224717481982893,0.375,1.0,1.0,2/7,9.13%,CTBS;GNPDA1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5488653713502049,-1.12236741966757,0.26865671641791045,1.0,1.0,4/37,8.36%,CD44;CDKN2D;CARD8;IFI6
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.6185745790577128,1.1222280768211443,0.34285714285714286,0.9114944037917132,1.0,1/11,0.96%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.5998346952094105,1.1220592884694565,0.3333333333333333,0.91111144529957,1.0,8/14,27.28%,MLYCD;NR1H3;PPARA;NR4A3;APOA1;ELOVL5;NR1H2;PPARG
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.7666332703443083,-1.1219452064338373,0.3333333333333333,1.0,1.0,1/5,0.67%,ACOT4
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.5978622199876812,1.1216922569306647,0.358974358974359,0.911317766019067,1.0,3/13,11.25%,PLCB1;ZBED3;TENM4
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.6229179579724106,-1.1216093916349361,0.3582089552238806,1.0,1.0,2/10,12.87%,AGT;RFK
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.5160239621339544,1.1215710763860314,0.26666666666666666,0.9107594160375451,1.0,10/39,12.88%,LEF1;BMP7;TGFBR1;TGFB2;HEY1;FGFR1;LIMS1;FAM83D;TGFBR3L;HMGA2
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.7428545721378955,-1.1214428239514818,0.3584905660377358,1.0,1.0,2/5,14.93%,NOTCH1;CCBE1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.4661504742257406,1.1214303678833646,0.2857142857142857,0.910231581022989,1.0,22/80,15.66%,STAC;FGF14;GRIA4;FGF13;CACNG3;GRIA2;JSRP1;GRIN2A;LRRC7;PDE4D;CACNG4;GRIA1;NLGN1;CACNB2;SHISA9;FGF12;SELENON;DLG2;GRIN2B;KCNS2;MEF2C;HOMER1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.5880746604906765,1.120966482897985,0.358974358974359,0.9109661732419847,1.0,8/14,21.51%,COQ6;PDSS2;COQ9;COQ2;UBIAD1;COQ7;PDSS1;COQ10A
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5152931705011127,1.1207166136315434,0.29411764705882354,0.9107175930461217,1.0,11/44,11.46%,MYLIP;KANK1;SPRY3;MINAR1;PTPN9;PTPRO;APOE;SPOCK1;FYN;PTPRS;PRAG1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.38960348662365796,1.1206839029090634,0.19047619047619047,0.9098694233245762,1.0,36/220,11.53%,KLHL17;POU6F2;MDGA1;TBX6;NFIB;VCAN;CNTN6;PCDH18;ATXN1;AMIGO1;AFF2;SYNJ2;KLK6;DSCAML1;GRIN2A;CNTN4;PDGFC;MEIS1;ADGRL2;GRIK1;MACROH2A2;SOX12;SMG9;JHY;CHD7;CHST8;PTCH1;EPHA7;SLC8A3;PSPN;GRIN2C;THOC6;ROBO2;SPOCK1;EEF1AKMT4-ECE2;CDK5RAP2
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.6770155742094544,1.1206642224585228,0.3902439024390244,0.9090229952246358,1.0,3/7,11.33%,FGGY;DCXR;RPEL1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.7586552010069542,-1.1206259651729953,0.4716981132075472,1.0,1.0,3/5,12.16%,NOTCH1;SNAI2;PDGFRB
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.6890863099524799,-1.120612872682877,0.32786885245901637,1.0,1.0,2/8,8.25%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6660298495988521,1.1205206753638968,0.3333333333333333,0.9086603203073657,1.0,3/5,26.70%,ROBO1;MYO9B;SLIT2
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.6247872238315705,1.120519377995691,0.3333333333333333,0.9077293158808213,1.0,3/9,20.21%,ADCY2;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.6848483879472046,-1.1205185206040236,0.34375,1.0,1.0,2/6,25.06%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.6848483879472046,-1.1205185206040236,0.34375,1.0,1.0,2/6,25.06%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.715960681067056,-1.120348003099497,0.3888888888888889,1.0,1.0,1/6,5.13%,TIMP2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5044454181737442,1.1203445177093476,0.2894736842105263,0.9074998975757846,1.0,9/32,8.80%,LEF1;WWTR1;TGFBR1;TGFB2;MDK;JAG1;TGFB3;PDPN;SMAD2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.48881061523144276,-1.120088529551919,0.3108108108108108,1.0,1.0,16/46,26.87%,ENO4;ALDOB;HKDC1;PGAM1;SLC16A8;SDS;ENO2;VDAC1;PDHX;LDHB;SLC16A1;LDHA;SLC16A3;PKLR;PGK1;PCK2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.4551088900423342,-1.1198791531690944,0.2564102564102564,1.0,1.0,28/125,15.40%,CD4;ITK;PTPRC;HLA-DMA;B2M;ELANE;CD74;STAT1;IL7;FYB1;CCND2;GCNT1;IL15;STAT4;TGFB1;IFNGR2;CCL5;INHBA;SPI1;HLA-A;STAB1;RPL9;IGSF6;CXCL13;IL18;HLA-DMB;BRCA1;TLR2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.6114146351916101,1.119697422645557,0.42424242424242425,0.9083922045564184,1.0,1/7,0.48%,KIT
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.6707746468355031,1.1196259306309073,0.4358974358974359,0.9076243427529573,1.0,2/7,13.47%,IGF1;SELENON
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6527281451101066,-1.119327220608678,0.38095238095238093,1.0,1.0,2/10,15.50%,IL4I1;ACMSD
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.6122571570846648,1.1192466517455628,0.325,0.9077445030642197,1.0,4/8,22.63%,CHRM3;CHRM5;CHRM2;HRH4
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.5467466929787332,1.1192389319037157,0.3235294117647059,0.9068772463189845,1.0,1/15,0.43%,PTPN3
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.6596433926577905,1.1190783466860805,0.425,0.9064468294753816,1.0,4/8,26.70%,ROBO1;EDN1;HIF1A;SLIT2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5148082175441612,-1.1190559063893888,0.27941176470588236,1.0,1.0,5/31,13.68%,FIP1L1;CSTF2T;NCBP2;SLBP;NCBP1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.521238489987067,1.1184685314785876,0.2972972972972973,0.9069879642457074,1.0,5/27,12.03%,PER2;HEY1;TENM4;ELAPOR2;SIRT2
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.743684746093269,-1.1182998590237054,0.42105263157894735,1.0,1.0,1/5,6.77%,ALDOB
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.5526893094439549,-1.11822705783879,0.2835820895522388,1.0,1.0,4/34,7.74%,HCK;PTPRC;DOCK2;IL15
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.42430966087633915,1.1182161911213768,0.16129032258064516,0.9068188232940839,1.0,9/66,11.41%,ATP6V0D2;WDR24;DAP;PRKD1;EIF2AK3;EIF2S1;MAP3K5;KPTN;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.694066546513905,1.1180310748027262,0.4090909090909091,0.9055282917477362,1.0,2/5,15.02%,MDK;RIPOR2
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.694066546513905,1.1180310748027262,0.4090909090909091,0.9055282917477362,1.0,2/5,15.02%,MDK;RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.38437003500315253,1.1170086612216663,0.2777777777777778,0.9077707844312357,1.0,34/206,11.55%,EPHA3;ROR2;KIT;ALK;PELI2;EPHA5;EGFR;NRP1;KDR;CSF1R;FGFR4;DSCAM;ZBTB20;LEPR;FGFR3;EPHB2;EPHA8;PDGFRA;RASGRP1;EFNA5;IGF1;LTK;EPHA7;RYK;KNDC1;ERBB4;EREG;FGFR1;ANGPT1;IL34;SLC4A4;DVL2;MST1R;FGF10
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.5913393247254259,-1.1170054098207984,0.35384615384615387,1.0,1.0,1/14,1.16%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.6752830351682058,-1.1169806827948792,0.3225806451612903,1.0,1.0,6/7,30.53%,HEBP2;RNF122;ARL6IP5;BAX;PIP5KL1;PRELID1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.49504449935485784,-1.1167125949465528,0.2857142857142857,1.0,1.0,14/60,13.49%,ARR3;CRYBG3;RDH10;WFS1;CRYBB1;RABGGTB;CABP4;GPR179;SLC24A1;EFEMP1;CRYBA1;CNGB1;DNAJC19;RDH12
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.7112738126657924,1.1163893789040054,0.45,0.9079222231296536,1.0,1/6,2.25%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.7112738126657924,1.1163893789040054,0.45,0.9079222231296536,1.0,1/6,2.25%,ZEB2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.5122844509428776,-1.11608003908967,0.3333333333333333,1.0,1.0,5/29,14.59%,TRPV6;REST;CACNA1G;SYT2;SYT4
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.5286648015345866,-1.1160065947102926,0.328125,1.0,1.0,8/34,13.82%,BNIP3;IRF1;CASP8;LTBR;GADD45A;F11R;FADD;CHEK1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),-0.6957961413624115,-1.1156697676796057,0.39655172413793105,1.0,1.0,1/6,5.24%,DRD3
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.48955553451263367,1.1156565507163285,0.2727272727272727,0.9091053781705069,1.0,5/35,4.44%,BMP7;SPRED1;PARD3;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.5669523775121258,1.115366530244495,0.36363636363636365,0.9091939687372328,1.0,1/13,0.89%,CA2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.6193664390017557,1.115258393642303,0.3611111111111111,0.9086363490358115,1.0,2/9,2.53%,KDR;BCL2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.42886119734297884,1.1152053027830857,0.2413793103448276,0.9077786746017253,1.0,10/59,13.53%,GFI1B;CDK2AP2;EGFR;PLCB1;MYO16;PTPN6;UBE2E2;FGF10;LSM10;ID2
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.730791206613774,-1.1150813091941654,0.4107142857142857,1.0,1.0,4/6,23.43%,AGT;LIPC;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5737069722861624,-1.114841078192595,0.36764705882352944,1.0,1.0,7/18,23.88%,TCP1;CCT6A;CCT8;DCP2;CCT7;CCT2;NOP10
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.62409405283879,-1.114824146038737,0.3484848484848485,1.0,1.0,1/13,1.89%,POLE3
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6689924211263019,1.11481918661728,0.4318181818181818,0.9082121894620114,1.0,1/6,6.63%,DDAH1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6137619238908233,-1.1147269310977284,0.40625,1.0,1.0,3/10,16.84%,SOX10;PLP1;CNTNAP1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.5645815777861865,1.1145974031566959,0.36585365853658536,0.9079148712684563,1.0,1/13,0.66%,PID1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.5876123839235637,1.1145902986609968,0.3076923076923077,0.9070319073595464,1.0,3/8,17.40%,PDE4D;PDPN;PDE4B
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7712076179864593,-1.1143736870010046,0.3194444444444444,1.0,1.0,1/5,8.00%,SLU7
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.6293828789131588,-1.11402536526566,0.3424657534246575,1.0,1.0,5/12,20.46%,PTPRC;GLI3;FADD;ADAM17;SHH
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.6746358808635112,-1.1139057624202913,0.4098360655737705,1.0,1.0,1/9,1.59%,ACTC1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6564161935699374,1.1138462811289216,0.3333333333333333,0.9083933437920209,1.0,2/11,5.54%,PER2;HEY1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.37745489798605764,1.1138096361096135,0.16,0.9075830196629502,1.0,23/144,16.00%,RUNX1;ATOH8;KDR;TGFB2;APLN;RBMS3;IGF1;HDAC1;APOE;SLC24A3;TET1;REL;PC;PARP10;CELF1;ANKRD13D;SIRT1;ID2;PDGFB;CCDC3;CILP;MEF2C;DNMT1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.5535067344619283,-1.113187274470747,0.2916666666666667,1.0,1.0,3/17,13.94%,DOCK8;CCL5;CXCL13
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5091814050785267,-1.1129651170056025,0.3,1.0,1.0,8/37,9.78%,CD4;GNLY;PTPRC;GMFG;CD37;SLA;CD6;ARHGAP9
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.622723920745173,1.1126949514836229,0.3225806451612903,0.9091003433289423,1.0,5/14,9.02%,UNC5B;EYA4;BCL2;HSPA1A;EYA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.622723920745173,1.1126949514836229,0.3225806451612903,0.9091003433289423,1.0,5/14,9.02%,UNC5B;EYA4;BCL2;HSPA1A;EYA2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.6612621323166321,-1.1125231142573317,0.43636363636363634,1.0,1.0,3/8,9.50%,H1-0;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.6612621323166321,-1.1125231142573317,0.43636363636363634,1.0,1.0,3/8,9.50%,H1-0;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.6612621323166321,-1.1125231142573317,0.43636363636363634,1.0,1.0,3/8,9.50%,H1-0;H1-2;ATAD2
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.600047565120208,1.112496406984294,0.35135135135135137,0.9087470112685602,1.0,9/13,29.78%,SCARB1;NR1H3;PPARA;SREBF2;NR1H2;PPARG;LPL;TTC39B;ABCA1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.6128612878306301,1.1120225623314997,0.35,0.9091476725624357,1.0,2/11,9.27%,CPT1A;CROT
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4351652496457673,1.1119116686688846,0.37037037037037035,0.9086246121141395,1.0,3/61,3.77%,RUNX1;KITLG;CBFB
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5311215211507294,1.1116553454220626,0.3548387096774194,0.9085990570799811,1.0,5/30,5.71%,RUNX1;PNP;HOMER2;PDE4D;NAV3
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5190578828861807,-1.1113102030062665,0.29411764705882354,1.0,1.0,8/41,13.47%,CD4;MYLK;WFS1;CAV3;CCL5;CASQ1;EFHB;SARAF
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.4384654870609072,-1.111261772062046,0.23076923076923078,1.0,1.0,19/151,10.03%,CD44;CCNE1;GPR83;GADD45B;PLIN2;COCH;IL3RA;ETV4;ABCB1;AHR;FGL2;IL18R1;SYNGR2;COL6A1;CDC6;CCND2;AGER;SCN9A;PRKCH
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.7337921536070995,-1.111128976440569,0.36507936507936506,1.0,1.0,2/6,14.19%,PTGER3;HTR2B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5197509590555685,-1.111093030796875,0.3333333333333333,1.0,1.0,5/45,6.02%,PRLR;HSD17B10;CYP19A1;BAAT;ACOX2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.6237327573822503,1.1108240154453004,0.42857142857142855,0.9100756318605089,1.0,2/8,11.25%,PARD3;TENM4
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5316515063446523,1.110686148158673,0.3333333333333333,0.9096381476309296,1.0,8/30,14.98%,IL1RAPL1;FBXW8;KNDC1;ADGRB3;NSMF;NEDD4L;HECW2;NEDD4
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.6693520623098131,1.110625703214612,0.3488372093023256,0.9088621143969107,1.0,2/6,14.63%,INSYN2A;DRD4
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.422545070443608,-1.1104195835823043,0.2328767123287671,1.0,1.0,25/174,17.05%,RAD54L;MCM2;POLQ;CDKN3;TPX2;SUV39H1;ATF5;DDX39A;CDC6;CHAF1A;TGFB1;GINS2;FANCC;SMC2;STMN1;CDC25A;KIF20B;CHEK1;ILF3;H2AZ2;PLK4;CDKN1B;H2AZ1;HMGB3;KIF11
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.6632306963952088,-1.110282336532353,0.36666666666666664,1.0,1.0,3/9,13.55%,CD4;CCL5;THEMIS2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6742371587304662,-1.110262943258617,0.34375,1.0,1.0,5/10,24.92%,CD74;GPER1;PLA2G10;LYN;PJA2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.4141878514050591,1.1097680303445905,0.2,0.9104611890775528,1.0,21/105,9.26%,RIMBP2;CNGA3;GLP1R;PTPRT;KCNIP1;SEMA6D;FGF14;RAB3C;CACNA2D1;KCNB2;PDZRN3;TOX3;RGS7BP;CNTN4;POU3F4;DDAH1;PKDCC;TMEM196;PCSK2;RCAN2;CSRNP3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.5899953226595089,-1.1096890597086941,0.3968253968253968,1.0,1.0,9/21,29.81%,SOX10;ARTN;ADGRB1;GPC1;GFRA3;SERPINI1;ADGRB2;ADGRG6;UGT8
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.37228924165882654,1.1096579746239155,0.3333333333333333,0.9098834796799862,1.0,68/436,14.26%,CD38;NRG1;ATOH8;IFI16;PER2;SOX13;LEF1;PHC2;PTPRK;ARID5A;KDM8;BMP7;HDAC9;PLCB1;KCTD1;ATXN1;SAMD13;SAMD4A;TIMELESS;BTG2;SAMD7;HEY1;HIC2;PRICKLE1;FOXN3;ZHX3;ENPP1;ID3;SFMBT1;ZEB1;ARID5B;PRDM5;IGF2BP3;HDAC1;NACC2;DAP;SMAD2;HDAC10;EIF2AK3;TFAP4;FOXP2;GATAD2A;EREG;MYB;SUV39H2;SCMH1;CTBP2;LIMS1;TLE2;ZMYND11;DACH1;SIRT2;BCL6;FOXO1;TRIM71;BTRC;HMGA2;POU2F1;SIRT1;MAP3K10;WWP1;VGLL4;DHFR;ID2;FOXK1;PDGFB;PCGF6;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5991744781424798,1.109575005210081,0.4,0.9092646130465819,1.0,3/11,14.17%,ENPP3;RC3H1;FER
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.6646950013983995,-1.1095538628789459,0.4067796610169492,1.0,1.0,4/7,32.65%,ARG2;CPS1;SLC25A15;ARG1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.6478505013524236,-1.1095244716642187,0.36666666666666664,1.0,1.0,3/10,9.40%,CD4;IL15;CASP8
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6500618416781769,1.1095197011282296,0.3181818181818182,0.9084779331840004,1.0,1/9,2.84%,KDM8
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.46476419270844543,1.1093479504405344,0.22580645161290322,0.9080305489495368,1.0,10/59,9.02%,UNC5B;EYA4;BCL2;SH3RF1;TGFBR1;CFLAR;ACVR1;HSPA1A;IGF1;EYA2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5761218984027855,1.1092450657957755,0.4444444444444444,0.9074856374746874,1.0,4/9,14.11%,HDAC9;HDAC1;SIRT2;SMARCAD1
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),0.7348887765233667,1.1090964755270822,0.3488372093023256,0.9069418007759226,1.0,2/5,13.15%,ABCC4;SLCO3A1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.5860388634394343,-1.1089724983297105,0.40625,1.0,1.0,5/21,12.29%,CHMP4B;CHMP2B;CHMP2A;GPSM2;EML3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5511024497884494,1.1087613375151848,0.3,0.9070584900833257,1.0,3/22,3.20%,EGFR;NRP1;DSCAM
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.473524889424901,1.1086765339337705,0.25,0.9064180244060267,1.0,5/53,8.28%,RUNX1;CBFB;MEIS1;PRKCB;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.417905006903677,1.1086247865188013,0.16666666666666666,0.905722804840199,1.0,12/90,9.52%,NRG1;RUNX1;FRMPD4;BCL2L11;BMP7;TGFBR1;TGFB2;NRXN1;TGFB3;APOE;FAF1;GNL3L
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.41257577159896325,-1.1086124546170706,0.23529411764705882,1.0,1.0,84/276,26.38%,TICRR;MCM2;POLE3;RPL36;RFC5;CDC6;RPL15;RPA3;GCNT1;RPL38;INHBA;RPLP2;RPL28;RPS21;RPS7;MRE11;MRPS18C;EEF1A1;RPL9;RSL24D1;POLR2J;POLR2K;GTPBP2;RPL37A;CHEK1;POLE2;RNPS1;MRPS14;RPL22;RPL35A;RPL5;BRCA1;RPS20;EEF2;RPL8;RPLP1;RAD9B;SET;RPS8;RPL4;ASMT;DONSON;RPL3;RPL34;MRPL51;RPL37;GRWD1;RMI1;RPL24;RAD1;RPS24;COPS5;RPS15;CREBL2;GTPBP1;EEF2K;WARS1;RPL7A;RPL13A;RPL27A;RPS4X;RPL23;POLR2I;RPL35;POLR2B;MRPL43;RPS3;RPS27A;RPS6KB2;RPS29;RPL19;ABCF1;RPL18;KAT5;RPS13;RBBP8;MRPL27;RPL32;RPL13;RPS5;RPL27;CDC7;HELB;BLM
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.7102019466786162,-1.1085468208439637,0.3492063492063492,1.0,1.0,3/6,20.97%,AMN;TCN2;CBLIF
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.4005812227455927,1.1084077368827068,0.16,0.9054906078048579,1.0,14/79,9.71%,FBXL7;WWTR1;ZNF462;PCDH18;SLC16A2;MDK;ADGRL2;EFNA5;MID1;GNG12;PDPN;PLAT;P3H2;AMOTL2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.6135293905998506,-1.108355981613494,0.328125,1.0,1.0,5/13,35.78%,PAICS;AMPD2;IMPDH2;AMPD3;ADSS2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.6166098042077954,1.1083328701913424,0.29411764705882354,0.9047976628766482,1.0,1/10,0.57%,CLEC2A
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4133863691713399,1.1082723635495746,0.23333333333333334,0.9041200388296675,1.0,13/107,9.71%,FBXL7;SEMA6D;NTM;CACNA2D1;EFS;PCDH18;FIGN;PDZRN3;ADGRL2;GFRA1;CAP2;CSRNP3;AMOTL2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.42689367599662437,1.1082562598698162,0.22857142857142856,0.9032763602676318,1.0,5/36,16.71%,PCM1;DYNLRB2;WDR35;TRIP11;IFT74
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6312686019368121,1.107614480526313,0.3,0.9042597971026043,1.0,2/12,7.49%,SRPK3;IWS1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.7663442561458035,-1.1076105114867967,0.3584905660377358,1.0,1.0,1/5,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.5608236356708793,-1.107274502896266,0.39344262295081966,1.0,1.0,3/14,16.29%,HSPA5;BCAP31;GABARAPL2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5220164972084277,-1.1072061387903867,0.2903225806451613,1.0,1.0,15/47,27.51%,MCM2;RECQL;MRE11;DDX1;SUPV3L1;RBX1;PURA;RPS27A;MCMDC2;UBC;DDX11;CETN2;BLM;TWNK;MCM4
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.5091191201040942,-1.1071937026693703,0.29577464788732394,1.0,1.0,15/30,38.39%,NSDHL;DHCR7;G6PD;SQLE;FAXDC2;ACAA2;PRKAG2;HMGCR;PMVK;DHCR24;INSIG2;ARV1;ACAT2;IDI1;ACLY
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7166801158081675,-1.107099644809496,0.4032258064516129,1.0,1.0,3/5,26.93%,ATP6AP1;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.654327402599211,1.1069513232735724,0.3870967741935484,0.9053526810522461,1.0,1/9,0.48%,KIT
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6238895033208544,1.1069209465297374,0.36585365853658536,0.9045380857045243,1.0,2/7,21.95%,BYSL;NVL
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.6115321939482943,1.1067446361927356,0.3684210526315789,0.9042113718256746,1.0,1/5,4.73%,IDH2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.5598716152726803,1.1066382936079393,0.43902439024390244,0.9037881312068423,1.0,1/11,0.47%,PNP
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.6381487689265329,-1.1066249379328417,0.328125,1.0,1.0,3/12,12.79%,DRD3;ADRA1D;ADRB1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.6963350513014593,-1.1065718475558968,0.3582089552238806,1.0,1.0,2/7,11.44%,ABT1;RPS21
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.44049547448761694,-1.106231012849888,0.29333333333333333,1.0,1.0,51/160,26.03%,PATL2;RPL36;RPL15;NCBP2;RPL38;RPLP2;DCP2;RPL28;RPS21;RPS7;RPL9;NCBP1;RPL37A;CNOT11;RNPS1;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;EXOSC6;RPS8;RPL4;RPL3;RPL34;RPL37;RPL24;CSDE1;RPS24;RPS15;UPF3B;RPL7A;DHX34;RPL13A;RPL27A;RPS4X;RPL23;EXOSC8;RPL35;RPS3;RPS27A;RPS29;RPL19;RPL18;AGO1;RPS13;RPL32;RPL13;RPS5;RPL27
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.4196471690760978,1.1060188635261763,0.20689655172413793,0.9045582768148719,1.0,14/87,8.42%,FBXL7;LMCD1;LAMB2;PRRX1;EGFR;WWTR1;CACNA2D1;FGFR4;PDZRN3;PKDCC;HTRA1;CAP2;GNG12;STK40
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6581922867879318,-1.1059461409588334,0.3793103448275862,1.0,1.0,7/9,30.53%,PINK1;IFNLR1;ISCU;IFNAR1;NUPR1;PARK7;PRELID1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.6461979937570073,-1.1057888141796326,0.25,1.0,1.0,3/8,29.86%,STRC;PDZD7;SOD1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.49657822642805705,1.105598903770104,0.39473684210526316,0.9048559047214257,1.0,9/28,16.51%,ITGA4;CACNA2D1;GRM5;GRIN2A;IGF1;FYN;ABCC1;CACNA1A;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.5861487291843496,-1.1055835258657218,0.35,1.0,1.0,12/21,25.45%,BIK;MOAP1;BNIP3;PINK1;HRK;GPER1;CIDEB;PDCD5;PLAUR;MLLT11;BAX;DNM1L
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6916961055155728,-1.105337564924823,0.32786885245901637,1.0,1.0,4/9,22.23%,P2RY12;CCL5;SFTPD;CXCL17
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.625014639576672,-1.105241929819183,0.3870967741935484,1.0,1.0,3/10,9.50%,H1-0;H1-2;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.5401711612836554,-1.1051834092753703,0.32727272727272727,1.0,1.0,4/25,15.16%,PINK1;CHMP4B;PHF23;TSC2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.4970271093502781,-1.105160623495337,0.29333333333333333,1.0,1.0,13/50,15.49%,C3AR1;MS4A6A;HCK;PTPRC;FGL2;IRF1;CIITA;CARD6;WDFY4;IGSF6;APOL6;TLR2;GPR183
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.7128546769382117,-1.1051276790153597,0.3888888888888889,1.0,1.0,2/5,25.86%,GPS2;ATG14
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.5361377806583585,1.1048689122432607,0.2564102564102564,0.9059279968145917,1.0,2/20,5.79%,ATP6V0D2;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.641680131842285,-1.104850365057431,0.3898305084745763,1.0,1.0,4/11,10.81%,TNFSF18;IL15;NCKAP1L;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5008007811078498,-1.1046823173636955,0.23880597014925373,1.0,1.0,9/60,12.71%,EPN1;HSPG2;STAT1;SERPINE1;DAB2IP;PIK3CB;STAB1;AMOT;ADGRB1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5928236369609257,-1.1045270422074018,0.3050847457627119,1.0,1.0,2/12,5.59%,TNFSF18;AHR
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.6050200683010365,1.104520597977637,0.25,0.9061407573135771,1.0,5/13,25.82%,ELP4;ADAT2;DPH3;ALKBH8;TRMT9B
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.5947983086019912,1.1041831950252532,0.30952380952380953,0.906311665486676,1.0,7/13,29.98%,ECE1;VAMP3;TBC1D16;SNCA;SCRIB;RAB29;AP1AR
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5242525245149207,1.1039291892571097,0.34375,0.9060406483649561,1.0,5/22,10.12%,HORMAD1;DIAPH2;MDK;DMC1;FSHR
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.6694460010632772,1.1037947154650514,0.4418604651162791,0.9055909320344088,1.0,2/5,18.14%,CHD7;ERBB3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.5658345705529702,-1.103624295376342,0.3142857142857143,1.0,1.0,3/25,15.60%,AMN;PREPL;RAB31
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5440016393863072,1.1035009514263234,0.3225806451612903,0.905679237351393,1.0,6/26,13.92%,RORA;ACADVL;APOE;SIRT1;MLYCD;FOXK1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.5777239453612425,1.1030368144236107,0.3225806451612903,0.9060012888928375,1.0,2/16,4.19%,TYSND1;ACADVL
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5218977807318109,1.1029047098113487,0.2647058823529412,0.9054979266863012,1.0,2/26,1.33%,RXFP2;GLP1R
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5486331397488563,-1.1027758446463491,0.3484848484848485,1.0,1.0,4/21,10.74%,CAV3;RAC1;VAV3;MSN
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5780838294748047,-1.10274163898379,0.3283582089552239,1.0,1.0,3/17,4.48%,CSRP3;PKD2L2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.714043548014759,1.1027068813696657,0.4166666666666667,0.905160334617063,1.0,1/5,0.86%,RAB7B
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.593595625047983,1.1019652889973048,0.3793103448275862,0.9062502779233887,1.0,3/9,10.75%,KDR;HEY1;RIN2
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.6911416453679237,-1.1018917069113945,0.43283582089552236,1.0,1.0,1/6,5.24%,DRD3
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.6911416453679237,-1.1018917069113945,0.43283582089552236,1.0,1.0,1/6,5.24%,DRD3
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.6897164109730172,1.1015123237121005,0.4358974358974359,0.9067898494814026,1.0,1/6,5.27%,MDK
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.6518943556582644,-1.1014998247790961,0.38333333333333336,1.0,1.0,2/11,10.43%,MSX1;TBX1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5978503149680603,-1.101413608022385,0.3181818181818182,1.0,1.0,2/12,12.02%,NOTCH1;TBXA2R
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.46539408302403146,1.1010818358635304,0.3,0.9072325277643246,1.0,12/40,15.48%,NRG1;SEMA6D;SEMA5A;SEMA4C;NRTN;ERBB4;PHACTR4;SEMA3C;SEMA5B;TCOF1;RADIL;SEMA6A
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.6643646727233623,-1.1009900523204235,0.34375,1.0,1.0,7/10,27.68%,FABP3;RCN3;TLCD2;ABCB11;HNF4A;LIPG;ANGPTL3
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6944764531188442,1.1009191615893807,0.43243243243243246,0.9068398445627239,1.0,2/6,21.82%,LIN28B;DIS3L2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.4945440973430472,1.1008756232124735,0.3333333333333333,0.9060788958366337,1.0,6/28,13.02%,ARL13B;PTCHD1;PTCH1;KIAA0586;DISP3;MAP3K10
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4300587315992917,1.1007532031732303,0.16,0.9055105661166906,1.0,33/100,14.61%,KCNIP1;GRIA4;RAB3C;NTM;CTNNA2;MAPK4;SLC35F1;UNC5D;GRIA2;GUCY1A2;LSAMP;BRINP1;NRXN1;GRIA1;CNTN1;NOVA1;RGMA;CSRNP3;RBFOX1;GRID2;ROBO2;ADGRB3;TMEM132B;ST8SIA3;ELAVL3;GABRB3;PCDH17;NTRK3;DENND2A;SEMA5B;MAGI2;PAK3;GPM6B
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.7101600691728509,-1.1003700722496714,0.46774193548387094,1.0,1.0,1/8,1.01%,PTGIS
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.5139323758933411,1.1002640719915815,0.21875,0.9059936972705168,1.0,2/12,6.11%,PRKCB;NEK6
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.5371899588811032,-1.1001407965239933,0.3380281690140845,1.0,1.0,13/34,20.03%,FUT2;DUOX1;VWA2;CP;CLCA4;IL20RA;CBLC;TMC4;DUOXA1;CYP2B7P;WFDC2;ZNF750;EXPH5
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.5571796125189128,1.0999373921804059,0.34210526315789475,0.9060125469236652,1.0,5/12,10.73%,NFATC1;TGFB2;HEY1;JAG1;ROBO2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.6888059685251335,-1.0992106055282769,0.40625,1.0,1.0,2/7,14.62%,B2M;ATP2A3
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.5634456173534657,-1.0990673473175434,0.3698630136986301,1.0,1.0,2/24,4.32%,PPP1R1B;FKBP1B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.46910970827858095,1.0989937062094406,0.34285714285714286,0.907420102139334,1.0,8/43,11.98%,RAB7B;F2RL1;IFIH1;TLR1;HMGB1;EREG;SPHK2;POU2F2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.48087755196007803,-1.0988321666864558,0.2676056338028169,1.0,1.0,14/77,16.68%,CSRP3;GCM2;CALCB;ELANE;ATP1B1;DRD3;CCL5;SLC24A1;SLC24A5;HTR2B;ATP2A3;TMEM203;SLC11A1;SLC24A4
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.6414382768361194,-1.0986687299684108,0.4107142857142857,1.0,1.0,6/9,30.06%,CHMP2B;CHMP2A;VPS4A;CHMP1A;CHMP5;VPS4B
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.6414382768361194,-1.0986687299684108,0.4107142857142857,1.0,1.0,6/9,30.06%,CHMP2B;CHMP2A;VPS4A;CHMP1A;CHMP5;VPS4B
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.5830181907230843,1.09863072614727,0.275,0.9075735745105299,1.0,2/11,4.68%,SLC2A9;SLC2A11
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.6260923035151358,-1.0984507587431835,0.40625,1.0,1.0,2/12,9.85%,PCARE;RP1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.508811962525164,-1.0983999806106346,0.3108108108108108,1.0,1.0,13/27,38.39%,NSDHL;DHCR7;G6PD;SQLE;ACAA2;HMGCR;PMVK;DHCR24;INSIG2;ARV1;ACAT2;IDI1;ACLY
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4390542375404666,1.0981797727655591,0.23076923076923078,0.9079985366099694,1.0,9/83,3.13%,FBXL7;PRRX1;ADAMTS2;COL15A1;GEM;SSC5D;LAMA4;PCDH18;FNDC1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.6160567049716154,1.0978760682029514,0.4318181818181818,0.9079203699609903,1.0,4/9,17.31%,ALDH1A2;CYP2C8;ALDH1A3;CYP3A4
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.6377756427407758,1.0978243442159912,0.35294117647058826,0.9072455693476552,1.0,1/6,0.45%,SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.6433363395168816,1.0977195584997792,0.3333333333333333,0.9067617576279319,1.0,2/7,8.07%,PTPRK;CASK
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.5280898801134868,-1.0976091546074072,0.3287671232876712,1.0,1.0,3/32,1.47%,SLC12A7;TRPV6;WFS1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5445216656782494,1.0973216595620503,0.28125,0.9070911133637831,1.0,2/21,4.33%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.6035154623539917,-1.0971930361235196,0.39705882352941174,1.0,1.0,2/11,5.91%,P2RY1;P2RY12
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.42184399306516823,1.0970701628631994,0.36363636363636365,0.9069600069748741,1.0,49/162,17.56%,NRG1;HOMER2;ZNF536;CLSTN2;INSYN2A;LINGO2;MAPK4;SLC35F1;OLFM3;GRIA2;PLPPR5;BRINP1;GALNT13;CADM2;NLGN1;FUT9;PCDH19;EPHA7;NOVA1;RGMB;CSRNP3;PHF21B;PAK5;GNL3L;SLITRK5;GRID2;ADGRB3;MAPK8;NOL4;ST8SIA3;DACH1;ELAVL3;TRIM44;PPFIA2;SYT1;CIB2;CNTNAP2;AATF;MEGF10;GPM6B;RIPOR2;KIF5C;DPYSL5;CDH4;SNAP91;MAP6;KCNC1;KCNH7;ABCC5
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4792036142097748,1.0970309114916668,0.2857142857142857,0.906221119568801,1.0,2/23,7.21%,EPHA5;EFNA5
prerank,GO_Biological_Process_2021__negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),0.6768298013132932,1.0967071098782646,0.30952380952380953,0.9064825563718241,1.0,1/5,9.86%,MYB
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6610968532478791,-1.0966828835518718,0.4098360655737705,1.0,1.0,2/9,14.86%,HLA-A;IL18
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5888885106614014,-1.096324977111589,0.3333333333333333,1.0,1.0,4/17,14.86%,B2M;IL18R1;HLA-A;IL18
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.4025920466144036,1.0962895156900379,0.2727272727272727,0.9070536802329218,1.0,4/77,4.06%,ELOVL6;RORA;FGFR4;RUBCNL
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.6065551552632854,1.0959491909930328,0.4166666666666667,0.9073273081189408,1.0,3/9,22.10%,APOE;SIRT1;ABCD1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.5731316541317644,1.0959343679517048,0.37209302325581395,0.9065370243163573,1.0,1/14,0.63%,RGS14
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.6482849249740877,-1.0958393287866453,0.31666666666666665,1.0,1.0,3/7,14.69%,UFM1;RAB23;APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.6482849249740877,-1.0958393287866453,0.31666666666666665,1.0,1.0,3/7,14.69%,UFM1;RAB23;APOD
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),-0.7352428018977417,-1.0957626847881523,0.4032258064516129,1.0,1.0,3/6,20.46%,STAT1;SIX4;SHH
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5297682723706197,-1.0954469593343896,0.3235294117647059,1.0,1.0,5/29,12.06%,GADD45B;AGER;DAB2IP;SPI1;GADD45A
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.6747479343457928,1.0947851176444972,0.38636363636363635,0.9088009240925682,1.0,3/5,19.30%,FBLL1;CREBBP;SIRT7
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.4921697291913675,-1.0946143608502568,0.3333333333333333,1.0,1.0,1/53,0.08%,ENPP2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.6242687497792099,-1.0945136334988141,0.3448275862068966,1.0,1.0,2/12,14.51%,RFK;PAICS
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4565918821630425,1.094261679522335,0.3103448275862069,0.9095020585449922,1.0,13/46,16.99%,IRS1;CSF1R;PLCB1;PDGFRA;IGF1;IRS2;FGFR1;PIK3R1;ADAP2;NGF;PLCB4;PIK3C2B;PLCL2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.6094069762557481,1.0939749069356317,0.30952380952380953,0.9093159778581961,1.0,2/8,7.52%,PRKCD;CCNA2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.5094054176633724,1.0935845500038257,0.3684210526315789,0.9096800571810554,1.0,2/18,0.77%,GLYATL2;CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.6438808897164914,1.093239465611368,0.40540540540540543,0.9096415302682062,1.0,1/6,9.33%,SLCO1C1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.6741265077216839,-1.092918535239464,0.3728813559322034,1.0,1.0,2/9,5.89%,NODAL;PLAC1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.340354414646029,1.0928055137443278,0.0,0.9099243105637737,1.0,229/1686,13.33%,CD38;MYRFL;NRG1;ETV1;RUNX1;POU6F2;CREB5;ATOH8;KIT;TBX6;ZNF300;CCNH;RGS14;IFI16;PER2;SOX13;PRRX1;LEF1;TEAD2;TRPS1;E2F5;GFI1B;NFIB;TOX;ZNF485;PHC2;DACH2;ZNF273;TBL1Y;PTPRK;ZNF18;EGFR;ZNF442;ZNF496;LCORL;ZEB2;NFIA;ZNF117;RORA;WWTR1;ZNF132;ZNF239;HIVEP1;ARID5A;ZNF707;ZNF536;KDM8;FANK1;BACH2;TSFM;ARID3B;BMP7;NRL;NFATC1;HDAC9;ZNF165;ZNF534;BRCA2;TGFBR1;ZGLP1;PLCB1;CREB3L4;ZNF354B;CBFB;OR7D2;ZBTB20;KCTD1;ATXN1;ESRRG;SAMD13;GTF2H2C;TOX3;BATF3;ZNF205;ATF3;ZNF347;CDK14;ZNF771;E2F6;FOS;ZNF628;ZNF264;TOX2;TIMELESS;HDX;SAMD7;HEY1;WWC1;ARID1B;NR3C2;MEIS1;HIC2;PRICKLE1;FOXO6;ZBTB39;PRKCB;POU3F4;TSHZ1;FOXN3;ZNF606;SPIN2B;ACVR1;ZBTB5;RRM2;SOX12;HMGB1;ZHX3;ZNF596;NFIX;BAZ2B;ZNF608;ZNF48;ELP4;ID3;MXI1;CHD7;TGFB3;ARID1A;SFMBT1;PRMT5;ZNF518A;BCL11B;ZEB1;IGF1;ARID5B;PRDM5;FLI1;SOX5;ZNF441;ZBTB1;ZBTB17;ETV5;HDAC1;ZNF263;NACC2;ZFHX4;ELF2;MED12L;TFCP2;APOE;ZNF782;MED30;FZD1;ZNF33B;DAP;SMAD2;POU3F1;ZNF780B;ZNF846;HDAC10;ZNF572;ATF6;TASP1;RGMB;CSRNP3;ERBB4;TFAP4;ZFP62;FOXP2;REL;ZNF589;GATAD2A;WBP2NL;ZNF276;EREG;MYB;ZNF678;SUV39H2;ZNF577;TCF24;MYPOP;ZNF586;ZNF778;ZNF429;RUVBL2;ZNF334;SMARCAL1;ZNF202;ZNF600;ZNF83;ARGFX;SCMH1;RYBP;DVL2;CTBP2;TCF4;LIMS1;MAP3K5;RFX7;ZNF609;RFX2;TLE2;ZMYND11;ATXN1L;ZNF444;CDK5RAP2;ZNF99;BRD3;ZNF155;HIVEP3;SNF8;PCGF1;POU2F2;DACH1;SIRT2;PRDM15;TRIM44;ZNF33A;ZSCAN20;BCL6;ZNF701;NAT14;FOXO1;ZNF292;BTRC;ZBTB10;HMGA2;SHOX;ZNF397;POU2F1;SIRT1;MAP3K10;BRDT;ZNF879;NFAT5;WWP1;VGLL4;ZNF646;DHFR
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.6865123231562302,1.0924672148545302,0.4166666666666667,0.9103670263967817,1.0,3/8,25.13%,RELA;MME;HYAL2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5570419468921689,1.092370353031018,0.3953488372093023,0.9097668573016109,1.0,6/16,25.45%,NAF1;TERF1;ATM;SMG6;TERF2;TNKS
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5993126838840969,1.0923621838185764,0.3939393939393939,0.9089275644728343,1.0,7/13,30.69%,BTG2;TNRC6B;AGO2;POLR2G;TOB1;TNRC6A;TNRC6C
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5154224661771575,-1.0921916756523582,0.3384615384615385,1.0,1.0,8/32,15.09%,CSRP3;ACTC1;CASQ1;TTN;MYPN;PDGFRB;TPM1;SIX4
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6588814039494425,-1.0920276845267205,0.4461538461538462,1.0,1.0,4/7,22.46%,MANBA;GBA3;NEU1;MAN2B2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.6663086752588273,-1.0919725001047342,0.4262295081967213,1.0,1.0,4/9,25.14%,MAP1LC3B;MAP1LC3B2;GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.6663086752588273,-1.0919725001047342,0.4262295081967213,1.0,1.0,4/9,25.14%,MAP1LC3B;MAP1LC3B2;GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.45758166222578617,1.0915680187701102,0.26666666666666666,0.9104634115196559,1.0,13/57,14.09%,EYA4;TOX;EGFR;FGFR4;HMGB1;ERCC8;EYA2;BABAM2;FGF10;EYA3;SIRT1;BRCC3;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.6780704776866593,-1.0911976902422145,0.39655172413793105,1.0,1.0,1/7,6.15%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.6780704776866593,-1.0911976902422145,0.39655172413793105,1.0,1.0,1/7,6.15%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5944626927431504,1.0910061256507513,0.40540540540540543,0.911170410061414,1.0,2/13,2.65%,RUNX1;FGFR4
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.4658003283289596,1.0909359952855426,0.3333333333333333,0.9106915213154858,1.0,6/33,15.77%,HSPB1;BLOC1S4;AP3B2;DLG2;SPAST;KIF5C
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.4441984222891301,1.0907539189860886,0.25,0.9102534187548829,1.0,8/51,14.62%,PRELID2;ATP11C;PITPNC1;APOE;SCARB1;ATP8A2;ATP11A;ABCC1
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.604842165570756,1.0906406655608758,0.4375,0.9096035752065632,1.0,4/6,39.28%,JADE3;KAT7;JADE1;JADE2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.6524406244075324,1.0904060388372183,0.42857142857142855,0.909260210776631,1.0,2/8,8.65%,MDK;LTK
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5083847959790835,1.0901423837838708,0.358974358974359,0.9090766076472805,1.0,3/28,5.00%,STAC;LRRC55;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5752601611760992,-1.0900955289440866,0.36363636363636365,1.0,1.0,2/14,3.43%,FGL1;IL4I1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.5648713775427509,1.090043867291187,0.35555555555555557,0.9085224070801071,1.0,1/12,0.42%,ATOH8
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6135674220665697,-1.090022191245477,0.36231884057971014,1.0,1.0,2/12,11.35%,B2M;HLA-A
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5958896496754307,1.0899430748060084,0.3902439024390244,0.9070468432266188,1.0,8/13,21.51%,COQ6;PDSS2;COQ9;COQ2;UBIAD1;COQ7;PDSS1;COQ10A
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5958896496754307,1.0899430748060084,0.3902439024390244,0.9070468432266188,1.0,8/13,21.51%,COQ6;PDSS2;COQ9;COQ2;UBIAD1;COQ7;PDSS1;COQ10A
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.5692836557273524,-1.0898999286440918,0.4,1.0,1.0,5/13,34.78%,ZWILCH;BOD1;KNL1;CHAMP1;SPDL1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.7920998802872414,-1.0897512024533262,0.41509433962264153,1.0,1.0,1/5,4.48%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.5790894591035933,1.089716135397583,0.35714285714285715,0.9068131307689559,1.0,4/11,14.86%,PDE3A;BMP6;ANGPT1;FGFBP3
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.6475007863432548,-1.0896919423981153,0.4126984126984127,1.0,1.0,2/7,16.59%,RARRES2;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6353989329403633,1.0895792511157698,0.40625,0.9064082682723246,1.0,2/10,8.08%,TGFB2;SOX5
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3743080082616188,1.0890631584100585,0.2,0.9071645666245236,1.0,50/243,16.86%,CDH13;KIT;FHDC1;NRP1;ARL13B;PCM1;PDE6D;CDC14B;DNAH5;CNGA4;CFAP70;TTC39C;RAB3IP;PTPRO;ARFIP2;UBXN10;PKHD1;KIAA0586;CEP83;VSTM5;CFAP43;ABCC4;RFX2;SCLT1;TTC36;PIBF1;BBIP1;PTPN23;ANO6;SNAP29;EXOC7;WDR35;FNBP1L;ABLIM1;EHD4;BBS9;MACIR;PARVA;KIF24;AIF1L;RAB11FIP3;B9D2;VCL;CFAP20;POC1B;RFX3;CFAP44;IFT74;RAP1A;B9D1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.6692624788569498,-1.088797206286087,0.4166666666666667,1.0,1.0,4/8,31.18%,NGLY1;AGA;PARK7;OGA
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5382193230846815,-1.0887853742088343,0.3333333333333333,1.0,1.0,4/25,17.38%,FKBP4;STMN1;SKA2;MAP1A
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.7264266859583348,-1.0887814464906378,0.36065573770491804,1.0,1.0,2/6,13.97%,SCN4B;CACNA1G
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6415953533340599,-1.0887489347810237,0.4067796610169492,1.0,1.0,2/7,10.45%,PATL2;DCP2
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5642726478079764,1.0885111926793754,0.36585365853658536,0.9079721628854036,1.0,5/16,25.06%,TPR;ATM;ZNF207;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.6516363422585961,-1.088466854311269,0.41935483870967744,1.0,1.0,2/6,16.28%,CCDC39;DNAH11
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.5316023911510364,1.08846174443811,0.35135135135135137,0.9073304336544156,1.0,1/15,1.52%,IRS1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.5750660278298334,1.088245556837373,0.3939393939393939,0.9071106883074244,1.0,1/10,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.32021334194201034,1.08824029636573,0.0,0.906287008160459,1.0,200/1645,12.04%,ETV1;RUNX1;POU6F2;CREB5;ATOH8;CDH13;KIT;TBX6;ZNF300;CCNH;PID1;IFI16;MAML3;PER2;SOX13;PRRX1;LEF1;TEAD2;TRPS1;E2F5;GFI1B;F2RL1;NFIB;TOX;ZNF485;SSBP3;DACH2;TBL1Y;ZNF18;EGFR;ZNF442;ZNF496;LCORL;ZEB2;NFIA;RORA;WWTR1;ZNF132;ZNF239;HIVEP1;ARID5A;ZNF707;ZNF462;CSF1R;ZNF536;BACH2;ARID3B;NRL;GABPB2;NFATC1;HDAC9;ZNF165;ZNF534;ZNF827;ZGLP1;CREB3L4;BMP6;ZNF354B;MRTFA;SMYD2;CBFB;ZBTB20;KCTD1;ATXN1;ZBED3;ESRRG;GTF2H2C;TOX3;BATF3;ZNF205;WWOX;ATF3;ZNF347;GREM1;ZNF771;MAML1;ZMYM5;E2F6;FOS;ZNF264;TOX2;HDX;RITA1;HEY1;WWC1;ARID1B;NR3C2;MEIS1;HIC2;FOXO6;ZBTB39;PRKCB;MACROH2A2;JAG1;POU3F4;ZNF407;TSHZ1;ZNF606;ACVR1;ZBTB5;SOX12;HMGB1;ZHX3;ZNF596;NFIX;AASS;BAZ2B;ZNF608;ZNF48;TET2;ELP4;ID3;MXI1;TGFB3;ARID1A;ZNF518A;BCL11B;ZEB1;IGF1;ARID5B;PRDM5;FLI1;SOX5;ZNF441;ZBTB1;ZBTB17;ETV5;HDAC1;ZNF263;NACC2;ZFHX4;PTCH1;ELF2;MED12L;TFCP2;APOE;ZNF782;MED30;RNF2;ZNF33B;SMAD2;POU3F1;ZNF780B;PRKD1;ZNF846;HDAC10;ZNF572;ATF6;TPR;FHL2;RGMA;CSRNP3;AUTS2;TFAP4;ZFP62;TET1;FOXP2;REL;ZNF589;GATAD2A;ZNF276;MYB;SUV39H2;CDK8;ZNF577;TCF24;IGBP1;MYPOP;ZNF586;ZNF778;ZNF429;RUVBL2;ZNF334;SMARCAL1;ZNF202;ZNF600;ZNF83;ARGFX;MRTFB;DVL2;CTBP2;TCF4;RFX7;ZNF609;NEDD4L;RFX2;PIK3R1;ZNF444;ZNF99;BRD3;ZNF155;HIVEP3;BCLAF3;SNF8;PCGF1;POU2F2;DACH1;FRK;SIRT2;ATAD2B
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4986281446878945,1.088076317325788,0.3076923076923077,0.9058454922726729,1.0,13/37,14.69%,ST6GAL2;ABO;ST3GAL3;GAL3ST4;B4GALNT2;GLA;MPDU1;FUT9;ST8SIA3;NEU3;ST3GAL2;ST6GALNAC4;ST8SIA4
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.683177799070597,-1.0880355102010864,0.3333333333333333,1.0,1.0,1/5,1.99%,PTPRC
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.6627669795832788,1.0876769935960868,0.4375,0.9060473576672375,1.0,2/6,6.09%,MYO3A;POU3F4
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.6074977675390056,-1.0871205412515044,0.31343283582089554,1.0,1.0,3/13,18.26%,DRD3;GRM3;AKAP5
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.6248689024439034,-1.0865644933812226,0.45454545454545453,1.0,1.0,3/9,27.29%,CHDH;LRTOMT;SARDH
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.554278362165032,-1.086405148240381,0.38235294117647056,1.0,1.0,7/24,22.29%,SERPINE1;CASP8;FADD;BRCA1;TMBIM1;RNF34;GPX1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5274695839328325,1.0862031862978774,0.3684210526315789,0.9093277211147237,1.0,4/17,13.49%,IGF1;APOE;BIN1;SORL1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.49233462432465275,1.0861921890569324,0.3125,0.9085312105502721,1.0,10/29,22.23%,CLN6;CLVS1;ARSB;HOOK3;CLVS2;CLN3;TPP1;VPS18;TFEB;MYO7A
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.4035740743967486,1.0861867945177683,0.2692307692307692,0.9077230853045823,1.0,20/85,18.37%,IRS1;SLC30A10;CYSLTR2;HDAC9;PRKCD;ENPP1;IRS2;SLC25A33;ADCY2;PIK3R1;FOXO1;AKT2;NR4A2;FER;HDAC5;ADCY9;GCK;RELA;NFKB1;NR4A3
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.6396618968578498,-1.0861148094442452,0.4857142857142857,1.0,1.0,1/7,3.80%,AGT
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5164290640651792,1.0858609006469655,0.35714285714285715,0.907765701192197,1.0,8/37,13.05%,RFWD3;SMYD2;CASP9;RADX;PRKCD;NSMCE1;HMGA2;IER3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.6388857841647895,1.0857682406516933,0.38461538461538464,0.9071816691754715,1.0,2/5,18.50%,NRXN1;PTEN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5684076259297669,-1.085528913084538,0.36363636363636365,1.0,1.0,14/23,33.99%,COPS2;RBX1;COPS5;COPS8;COPS7B;RPS27A;UBC;CETN2;GPS1;COPS7A;XPC;UBA52;RAD23B;UBB
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.5389043514665849,1.084793277183338,0.35135135135135137,0.9093113561472325,1.0,1/12,4.73%,IDH2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6706502945267965,1.0847739623607826,0.4,0.9085445635478163,1.0,4/7,13.84%,PRKCB;IRS2;AKT2;CTTNBP2NL
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6262325051158343,-1.0844773170646849,0.40298507462686567,1.0,1.0,2/9,11.56%,PINK1;REST
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.7103572294686843,-1.0841411351874375,0.38181818181818183,1.0,1.0,2/5,8.18%,NCKAP1L;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),-0.7224390768932064,-1.084043323698825,0.4032258064516129,1.0,1.0,3/5,26.81%,NOX5;SYTL4;RAB3A
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.41083778918435726,1.0840416910078392,0.3157894736842105,0.9096146742882429,1.0,38/127,17.43%,POU6F2;PROS1;NTNG1;EGFR;MAPK4;SLC35F1;IGDCC3;VLDLR;UNC5D;GRM5;PLPPR5;TSHZ1;RHBDL3;EPHA7;CSRNP3;PHF21B;PAK5;ERBB4;FBLL1;GRID2;NYAP1;DAB1;NOL4;ELAVL3;SIRT1;MSI1;SEMA5B;PHF1;PBX1;PPM1E;KIF5C;NCAM1;DPYSL5;SNAP91;PRR36;MAPK7;KCNC1;ST8SIA2
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.6450695780892717,1.083964542792748,0.43333333333333335,0.909070104720798,1.0,2/6,8.92%,SDF4;ERCC2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5456937864529586,-1.0836537334882577,0.35384615384615387,1.0,1.0,7/24,19.75%,FKBP1B;FKBP4;PPID;PPWD1;PPIC;FKBP5;FKBP10
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.44925405782303757,1.0831667530981817,0.30303030303030304,0.9106055667032329,1.0,16/48,13.93%,EYA4;EGFR;SPRED1;SPRED2;SPRED3;PRKCD;ERCC8;NSMCE1;NACC2;EYA2;BABAM2;FGF10;EYA3;HMGA2;SIRT1;BRCC3
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4450579336765689,-1.0831192291819471,0.34782608695652173,1.0,1.0,11/97,12.05%,UPB1;HSD17B10;POLQ;STEAP4;TRPA1;B2M;SOD2;CHMP2A;ACOT13;RNF213;MCOLN1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.6676524616810794,-1.0829351218671721,0.4067796610169492,1.0,1.0,2/9,6.39%,MC4R;ATP6AP1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.43801345185676793,-1.082518169267739,0.3670886075949367,1.0,1.0,19/108,14.79%,CALB1;CSRP3;WFS1;GCM2;CALCB;ELANE;ATP1B1;FKBP1B;CAV3;DRD3;SCGN;CCL5;SLC24A1;HERPUD1;SLC24A5;GPER1;HTR2B;ATP2A3;TMEM203
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.6927286260271459,-1.0822524079538347,0.3620689655172414,1.0,1.0,1/7,5.89%,TST
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.44675796286331837,-1.0820780254127442,0.35294117647058826,1.0,1.0,7/79,8.64%,ALPL;HSD17B2;CYP19A1;CDKN2D;WNT8A;CD6;TGFB1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.49768359722542577,-1.0818169229561072,0.33783783783783783,1.0,1.0,13/28,38.39%,NSDHL;DHCR7;G6PD;SQLE;ACAA2;HMGCR;PMVK;DHCR24;INSIG2;ARV1;ACAT2;IDI1;ACLY
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3768685882494263,1.0815493221418926,0.15789473684210525,0.9140725683544013,1.0,24/170,8.71%,ROR2;CDH13;KIT;LEF1;PDGFD;F2RL1;SEMA6D;TRIP6;EGFR;KDR;CSF1R;TGFBR1;SEMA5A;EPHB2;MIEN1;MDK;PDGFC;ACVR1;PDGFRA;NUMB;SEMA4C;IGF1;PDPN;FAM83H
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.5363083893188965,1.0814967872015822,0.4,0.9133697828549628,1.0,3/17,7.12%,PID1;NUMB;PKDCC
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.6840565202938602,-1.08137696681374,0.4461538461538462,1.0,1.0,2/7,13.18%,NCKAP1L;FADD
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),-0.6566689606463836,-1.0813337163702026,0.43333333333333335,1.0,1.0,3/6,20.41%,PPID;OPN1SW;OPN3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4678862452086816,1.0813022617574861,0.18181818181818182,0.9129404051443666,1.0,10/42,13.93%,EYA4;EGFR;RADX;ERCC8;EYA2;BABAM2;FGF10;EYA3;SIRT1;BRCC3
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3978080583896251,-1.0811612592185553,0.2891566265060241,1.0,1.0,33/282,16.42%,SERF1A;CALB1;ACTC1;LOXL4;CYP1B1;COL9A1;HSPG2;FBLN5;B2M;RND1;RAC1;MYO5B;COL6A1;P4HA3;FIGNL1;CORO1A;COL19A1;BMP1;DCTN1;STMN1;APH1B;MYO1F;HIP1R;MARCKSL1;SIAH1;KIF14;TPM1;MFGE8;TLL1;NEFL;ARHGAP12;INPPL1;COL10A1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.563798663005656,-1.0811224290709158,0.4067796610169492,1.0,1.0,2/12,9.16%,ZNF703;CCL5
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6130169361621356,1.0811041661077274,0.40625,0.9127577960941028,1.0,6/11,24.04%,NRXN1;NLGN1;BSN;PCLO;NPHS1;SHANK1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.4812961846985003,-1.0810878627061984,0.3230769230769231,1.0,1.0,8/55,10.63%,BTN2A2;PRLR;TMEM184A;KLF5;MYO5B;CBLC;CLDN1;B3GNT3
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.6699486198403531,1.080943108363015,0.45714285714285713,0.9122909492783211,1.0,1/5,2.12%,CDH26
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5633734394102091,1.0807892328692712,0.3333333333333333,0.91177325677982,1.0,7/19,12.52%,UNC5B;EYA4;BCL2;HSPA1A;EYA2;FGFR1;EYA3
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.430154193384769,1.0802493083937803,0.3333333333333333,0.9126122128123171,1.0,10/71,6.57%,PRRX1;ADAMTS2;COL15A1;SVEP1;SGCD;SSC5D;LAMA4;PCDH18;FAT4;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5722142499026397,1.0797216382505663,0.43902439024390244,0.9132174521111068,1.0,3/19,5.47%,TGFB2;EPHB2;SPRY3
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5480310070005165,1.0792745197732363,0.4,0.9137958196482755,1.0,4/19,10.13%,F2RL1;EPHB2;APOE;TFPI
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5237861203747043,-1.079224227628348,0.4057971014492754,1.0,1.0,6/24,15.72%,CYP19A1;ZNF703;SSTR1;TGFB1;GPER1;H2AZ1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.5976981736611725,-1.0792098425397862,0.3898305084745763,1.0,1.0,5/14,27.43%,IL4I1;ACMSD;FAH;GSTZ1;TDO2
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6455746500713052,-1.0790320461689968,0.46,1.0,1.0,2/10,7.25%,CYP19A1;ABCB4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6001165568606581,1.0789604103699404,0.36666666666666664,0.913806575312979,1.0,6/10,27.28%,ABCD2;NR1H3;APOA1;ABCD1;ELOVL5;NR1H2
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.39428067271678374,1.0789419335690964,0.27586206896551724,0.9130582843271341,1.0,11/109,3.90%,FBXL7;PRRX1;ADAMTS2;COL15A1;SGCD;EFS;LAMA4;PCDH18;FNDC1;SEMA5A;PDZRN3
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5694744546533236,-1.078640635315939,0.38095238095238093,1.0,1.0,5/16,18.75%,PINK1;RCN3;APH1B;CTSH;PSME1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.338202522248055,1.0784918319164924,0.23076923076923078,0.9136095230260158,1.0,67/684,9.95%,ETV1;RUNX1;ATOH8;CDH13;ZNF300;PID1;IFI16;MAML3;LEF1;E2F5;F2RL1;NFIB;SSBP3;EGFR;ZEB2;NFIA;RORA;WWTR1;HIVEP1;ZNF462;NRL;GABPB2;NFATC1;ZNF827;ZGLP1;CREB3L4;BMP6;MRTFA;ZBED3;TGFB2;TOX3;WWOX;ATF3;GREM1;MAML1;FOS;TOX2;HEY1;WWC1;MEIS1;JAG1;ZNF407;ACVR1;APLN;SOX12;HMGB1;NFIX;TET2;TGFB3;BCL11B;IGF1;ZBTB17;ETV5;HDAC1;ZNF263;TFCP2;MED30;SMAD2;PRKD1;ATF6;RGMA;CSRNP3;AUTS2;TET1;REL;MYB;CDK8
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.7105947201761907,1.0784226642317096,0.40540540540540543,0.9121301710178267,1.0,1/5,18.37%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.7105947201761907,1.0784226642317096,0.40540540540540543,0.9121301710178267,1.0,1/5,18.37%,NR4A3
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5643928419685557,1.078194138903854,0.3142857142857143,0.911988554911461,1.0,2/10,3.54%,BMP7;TGFBR1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5735036702100217,1.0781456842441088,0.43243243243243246,0.9113221055886676,1.0,3/12,8.80%,TGFBR1;ACVR1;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.5729550310742154,-1.0779563746023564,0.37681159420289856,1.0,1.0,2/20,4.32%,PPP1R1B;FKBP1B
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5255276090046135,1.0778607266432336,0.40625,0.9112198565304896,1.0,7/26,14.06%,ITGA4;KDR;SEMA5A;AKR1C3;ANGPT1;ANO6;PAK4
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.5973115726324058,1.0777595328857525,0.5,0.9090638465281076,1.0,2/8,8.43%,CEL;APOE
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.5973115726324058,1.0777595328857525,0.5,0.9090638465281076,1.0,2/8,8.43%,CEL;APOE
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.5973115726324058,1.0777595328857525,0.5,0.9090638465281076,1.0,2/8,8.43%,CEL;APOE
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.6584839817981349,1.0776862884530967,0.3953488372093023,0.9085177460289228,1.0,3/5,30.20%,ELAVL4;TENT4B;LARP4B
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.5942085700876671,1.077643803158566,0.3695652173913043,0.9078452395467572,1.0,1/7,8.11%,FUT9
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.6267014543003994,1.0775062458398075,0.358974358974359,0.9074921077186503,1.0,1/7,9.13%,SLC35G1
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),-0.7118044981178723,-1.0771887259802178,0.3870967741935484,1.0,1.0,2/5,15.09%,TBX1;SIX4
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.6639856162506272,-1.0771671799189444,0.4225352112676056,1.0,1.0,1/7,13.30%,IMPA2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.5240058292467656,-1.077097726121903,0.3472222222222222,1.0,1.0,4/34,4.38%,LRP4;WFS1;AGT;STAT1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.6666373856647354,-1.0770105987682443,0.4489795918367347,1.0,1.0,1/7,5.24%,DRD3
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.47579874068578387,-1.076935568821462,0.2876712328767123,1.0,1.0,21/94,24.07%,MEP1B;PEBP1;CDKN3;GAD1;RPL39L;ZC2HC1C;CCT6B;ZPBP;HSPA4L;HSPA1L;GSG1;VDAC3;NEFH;PCSK1N;CLGN;DDX4;NOS1;ACRV1;SCG5;TALDO1;SHE
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5150376901298425,1.076910380005738,0.3448275862068966,0.9082458587891172,1.0,6/19,16.74%,MICU1;MCU;SLC8A3;MAIP1;PDZD8;MCUR1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5717986565714441,-1.076641355713848,0.3787878787878788,1.0,1.0,1/16,0.56%,HCK
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.40291261824593194,1.0764094118499938,0.3076923076923077,0.9086552516570306,1.0,3/80,1.36%,FBXL7;GFI1B;CDK2AP2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.49141025520899706,-1.076367866777501,0.38095238095238093,1.0,1.0,7/44,13.04%,BTN2A2;NOTCH1;IL18R1;IL15;ALDH1A1;ACOT13;GSTP1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.7146266860572384,-1.0762895821617324,0.4166666666666667,1.0,1.0,1/6,6.02%,MPV17L2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5064927668264604,-1.0761735506704913,0.40625,1.0,1.0,14/50,18.11%,CD4;ERVFRD-1;TMEM184A;PTGES;KLF5;SERPINE1;TMEM40;INHBA;B3GNT3;LTBR;IL18;GPRC5A;TTPA;CDCP1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.35338581176503286,1.076044765443836,0.25,0.9088989073567643,1.0,50/202,15.66%,HTR1F;CHRNA10;HTR7;UNC13C;GRIA4;PENK;GRIK4;PTCHD1;HRH1;GABRG3;UNC13B;KCND2;NTSR1;APBA1;GRIA2;GRM5;GRIN2A;GRIK1;GABRB1;HTR1E;NRXN1;GRIA1;CEL;NLGN1;NLGN4Y;HCRTR2;NOVA1;GABRA3;CHRM3;SLC6A1;DLGAP1;SYN2;HRH2;CACNB2;CHRNA5;GABRB3;SYT1;MBP;GABRA5;GRIK2;SLC1A2;DLG2;CHRM5;LRP6;SLC6A2;DRD4;GABBR2;GRIN2B;CACNA1A;HOMER1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.5694076794062127,-1.0759185217537979,0.390625,1.0,1.0,4/12,13.45%,TBP;POLR1E;TAF7;TAF7L
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.36885373333594884,1.0751435968129102,0.2,0.9107526891751357,1.0,66/419,11.55%,NRG1;ROR2;CDH13;KIT;UNC5B;PDGFD;TNFRSF19;F2RL1;IRS1;TRIP6;PELI2;EGFR;BCL2L11;KDR;BCL2;FGFR4;KITLG;IQCJ-SCHIP1;TGFBR1;S100A13;SEMA5A;TGFB2;WDR24;FGFR3;EPHA8;WWC1;PDGFC;NR3C2;PRKCB;NEK6;CFLAR;CCDC22;PDGFRA;HMGB1;BTC;LGALS1;TICAM1;AKR1C3;NLGN1;NRG2;IGF1;PTPN6;PELI1;STYXL1;IRS2;RYK;PRKD1;EEF1D;ERBB4;CASS4;REL;EREG;MID2;FSHR;NOS1AP;FGFR1;ANGPT1;TAB3;LIMS1;SPHK2;GPR89A;FYN;MALT1;MST1R;PIK3R1;FGF10
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.45176984547616666,1.0748417235727623,0.2962962962962963,0.9108420017637638,1.0,12/56,17.98%,TNFRSF19;MAP3K20;TAB3;MAP3K5;MAPK8;TAB1;BTRC;MAP3K10;MAP2K3;MAP3K13;IRAK2;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.6354715839213987,1.0747470538274688,0.45454545454545453,0.9103361811541338,1.0,2/6,16.30%,DACH1;CREB1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6400243351686365,-1.07458462811274,0.42857142857142855,1.0,1.0,2/7,16.58%,MAP1LC3B;PEX5
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.5671891848220185,1.0744215271213715,0.45161290322580644,0.9107166041244463,1.0,1/11,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6355518939701751,-1.0743384999069552,0.4482758620689655,1.0,1.0,1/9,5.91%,P2RY12
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3371741171785963,1.0741297357796387,0.1111111111111111,0.9108688938135804,1.0,113/752,14.26%,CD38;NRG1;RUNX1;ATOH8;TBX6;IFI16;PER2;SOX13;LEF1;TRPS1;GFI1B;PHC2;PTPRK;ZEB2;ZNF239;HIVEP1;ARID5A;ZNF536;KDM8;BMP7;HDAC9;ZGLP1;PLCB1;BMP6;SMYD2;CBFB;KCTD1;ATXN1;SAMD13;BATF3;ZNF205;WWOX;ATF3;ZMYM5;E2F6;TIMELESS;SAMD7;RITA1;HEY1;WWC1;HIC2;PRICKLE1;MACROH2A2;FOXN3;ZBTB5;HMGB1;ZHX3;ZNF596;NFIX;AASS;ZNF608;ID3;MXI1;SFMBT1;ZEB1;ARID5B;PRDM5;ZBTB1;ETV5;HDAC1;ZNF263;NACC2;PTCH1;RNF2;DAP;SMAD2;ZNF846;HDAC10;TPR;FHL2;TFAP4;FOXP2;ZNF589;GATAD2A;EREG;MYB;SUV39H2;IGBP1;MYPOP;ZNF778;ZNF202;SCMH1;CTBP2;LIMS1;NEDD4L;TLE2;ZMYND11;PCGF1;DACH1;FRK;SIRT2;BCL6;FOXO1;LYAR;BTRC;HMGA2;POU2F1;SIRT1;MAP3K10;PER3;WWP1;VGLL4;THRB;ID2;EP300;FOXK1;ZNF875;PEX2;NR4A2;PDGFB;ZFHX3;PCGF6;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.6118131321859976,1.0736698684163588,0.4482758620689655,0.9115511787141499,1.0,2/13,4.19%,SLC22A13;ACADVL
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.7132885325008613,-1.0734916385877284,0.359375,1.0,1.0,3/6,18.53%,CD14;TLR2;LBP
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.7132885325008613,-1.0734916385877284,0.359375,1.0,1.0,3/6,18.53%,CD14;TLR2;LBP
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7097488690382943,1.0734426412740874,0.575,0.9105553616198392,1.0,2/5,14.40%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7097488690382943,1.0734426412740874,0.575,0.9105553616198392,1.0,2/5,14.40%,NRXN1;CNTNAP2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4475868259402865,-1.0733006977898125,0.38235294117647056,1.0,1.0,20/89,20.29%,TNFSF18;STAT1;PSMB6;PSMB8;TXNDC17;LTBR;TMSB4X;BAG4;CD27;PSMA3;PSMA5;PSMC3;NFKBIA;ADAM17;PSMA7;PSMC6;PSME1;TNFSF9;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.5687763074276256,1.0731722213667523,0.375,0.908873398369152,1.0,5/15,25.06%,TPR;ATM;ZNF207;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.5687763074276256,1.0731722213667523,0.375,0.908873398369152,1.0,5/15,25.06%,TPR;ATM;ZNF207;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.5687763074276256,1.0731722213667523,0.375,0.908873398369152,1.0,5/15,25.06%,TPR;ATM;ZNF207;KLHL22;KNTC1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.4152538299512989,1.0726835683504392,0.29411764705882354,0.909252427511442,1.0,9/62,11.98%,RAB7B;F2RL1;IFIH1;TLR1;HMGB1;PTPN6;EREG;SPHK2;POU2F2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6044384184165282,-1.0726726651459584,0.4,1.0,1.0,3/15,7.35%,KCNE2;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.5881158384595923,1.0725113979962908,0.358974358974359,0.9089532239276289,1.0,3/12,11.89%,F2RL1;HMGB1;PIBF1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5245261294938102,1.072469598495305,0.41025641025641024,0.9082533806600664,1.0,6/19,18.72%,NGF;MAGI2;FRS2;RAP1A;RAPGEF1;DDIT4
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.6440928906119148,-1.0722614508828865,0.47540983606557374,1.0,1.0,2/8,17.56%,AQP9;SLC23A1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.5031475183306283,1.0720551243681038,0.3333333333333333,0.9085693279072787,1.0,8/27,15.45%,PLCB1;LATS1;FGFR3;IGF1;APOE;MBD5;NRCAM;SIN3A
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.6427391471097685,1.0716505404717898,0.41025641025641024,0.9089723208209983,1.0,1/6,2.42%,KDR
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.5559010941023299,1.071582043345784,0.3235294117647059,0.9083993384163684,1.0,4/12,8.80%,TGFB2;HEY1;ACVR1;SMAD2
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.6614418593061466,-1.0715481479624107,0.4426229508196721,1.0,1.0,3/5,21.63%,HLA-A;CTSH;EMP2
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.5530434607953534,1.0712960188176974,0.40425531914893614,0.908476969373719,1.0,3/13,6.57%,TGFBR1;DSCAML1;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5211861676317322,1.0711195967363014,0.4,0.9081675372803909,1.0,4/19,13.49%,IGF1;APOE;BIN1;SORL1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.5794569972121004,-1.0709455745951302,0.38095238095238093,1.0,1.0,2/20,0.99%,GNLY;ITK
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.41967211721534753,1.0708919418199112,0.32,0.9079833529577788,1.0,5/65,2.53%,ITGB5;FHDC1;PHACTR1;TMOD4;PDLIM1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4108824416167528,1.0706113127248817,0.20689655172413793,0.90802376507488,1.0,11/62,10.10%,GAL3ST1;ALG8;MOGS;MGAT4C;B4GALNT2;OSTC;MPDU1;DERL3;ST3GAL1;ALG12;ALG13
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.638052996392894,1.0700804181859997,0.38235294117647056,0.908611853041315,1.0,3/9,25.44%,LRP6;VEGFA;SHROOM2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.42325278945061395,1.0700192948623004,0.25,0.9079924363364398,1.0,34/152,15.36%,POU6F2;NKAIN3;KCTD8;ADGRA1;MAPK4;SLC35F1;OLFM3;CDK14;GRIA2;PLPPR5;TOX2;GALNTL6;MMD2;BRINP1;GRIP1;TMEM196;MTUS2;RBFOX1;PAK5;NELL1;FBLL1;ADGRB3;NYAP1;ST8SIA3;ELAVL3;GALNT14;GPHN;FGF12;NXPH1;NGF;DTX1;CPNE4;DNER;YDJC
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6431191457028183,-1.0695003698316323,0.4727272727272727,1.0,1.0,3/11,10.03%,SFRP4;ETV4;PRKCH
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5881863933113557,1.0692865108205025,0.35135135135135137,0.9091511699980506,1.0,3/12,12.09%,PRKD1;LIMS1;PHACTR4
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6805222923997538,-1.068690872446736,0.43859649122807015,1.0,1.0,1/9,3.52%,GOT1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.4145845891690956,1.068266788768717,0.25,0.9113011811247386,1.0,14/67,11.89%,MCTP1;ACKR2;EGFR;KDR;MCU;GRM5;PTGFR;LAT2;RCAN2;EIF2AK3;CHRM3;ADGRL1;MCTP2;SLC8A1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5637983113192894,-1.0681036494219571,0.3684210526315789,1.0,1.0,4/16,26.55%,GOT1;ASPG;FOLH1;ASPA
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6387548530569767,1.0678601684918585,0.4,0.9107188937152648,1.0,5/8,23.41%,PRKCD;SPHK2;SMPD3;SIRT3;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.6387548530569767,1.0678601684918585,0.4,0.9107188937152648,1.0,5/8,23.41%,PRKCD;SPHK2;SMPD3;SIRT3;NSMAF
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.7219149784309115,-1.0678221926794866,0.46875,1.0,1.0,1/5,4.48%,CAV3
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.47351054937813397,1.0677330993863114,0.2916666666666667,0.910248943924142,1.0,7/42,8.22%,NRG1;COBL;TGFBR1;MDK;TGFB3;ARID5B;ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6072908164499651,1.067721604679446,0.4186046511627907,0.9094828569337597,1.0,4/9,12.85%,SLC30A10;FYN;ABCD2;TRAP1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.568531184970862,1.0670278425210222,0.3157894736842105,0.9104982760801493,1.0,1/18,0.17%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.4932082708189208,-1.06699290895055,0.4117647058823529,1.0,1.0,11/45,20.90%,ARIH2;PINK1;UBL5;CASP8;TOMM7;HSPA1L;NMT1;YWHAB;YWHAG;YWHAH;RHOU
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.5491079043424834,1.0668779046010284,0.32432432432432434,0.9101409049082654,1.0,3/16,10.73%,NRP1;TGFBR1;ROBO2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5231071094677248,-1.0668558033214137,0.40298507462686567,1.0,1.0,5/29,8.25%,KCNE2;SCN4B;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5045341875682839,-1.0667596531816599,0.4117647058823529,1.0,1.0,5/37,7.35%,CSRP3;SCN4B;RCSD1;ATP1B1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.6733385264554168,1.0666977812045746,0.4,0.909710107643107,1.0,2/5,13.00%,FGFR4;SIRT1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.3750472799256802,1.0666694662839329,0.2222222222222222,0.9089718007412414,1.0,25/138,13.26%,SLC22A2;SLC12A3;SGK1;CNGA3;KCNJ16;FGF13;KCNJ6;KCNB2;KCNJ3;KCNN2;KCNJ2;SLC22A3;KCNK7;SCNN1B;SLC7A1;SLC8A3;SCNN1D;SLC4A4;NEDD4L;SLC38A7;SLC8A1;KCNS3;CHP1;ANO6;KCNF1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5297343741536547,-1.0665510492620898,0.43548387096774194,1.0,1.0,6/31,15.18%,TCHP;CAV3;PINK1;CHMP4B;PHF23;BRCA1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.4648533721942793,-1.0664587432873796,0.43661971830985913,1.0,1.0,7/58,12.05%,UPB1;HSD17B10;TRPA1;B2M;SOD2;ACOT13;MCOLN1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5938328624369651,-1.0663548923048145,0.41935483870967744,1.0,1.0,1/10,1.66%,CYP1B1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.44548325089266055,1.066327901497804,0.30434782608695654,0.9092080162654774,1.0,39/119,13.49%,RIMBP2;PTPRT;KCNIP1;GRIA4;RAB3C;ADGRA1;MAPK4;KCNB2;SERTM1;UNC5D;GRIA2;UNC79;UBE2QL1;CNTN4;LSAMP;NRXN1;EFNA5;LRRC4C;CADM2;SVOP;TMEM196;SEZ6L;PCSK2;CNTN1;NOVA1;CSRNP3;EDARADD;RBFOX1;PAK5;DPP6;ROBO2;ADGRB3;NOL4;ST8SIA3;ELAVL3;GABRB3;PCDH17;FGF12;RAPGEF4
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.5172603440794721,-1.0658542647698255,0.4166666666666667,1.0,1.0,5/23,25.03%,DRD3;SYT2;SYT4;SYT13;SYT9
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.43732489762875987,1.0653927226021993,0.35714285714285715,0.9112409243415941,1.0,5/42,6.88%,RGS14;PER2;PCM1;HEY1;NUMB
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5151818410213814,1.065316784409915,0.4166666666666667,0.910663085851619,1.0,4/15,21.11%,ADCY2;ADCY9;ADCY8;PRKACB
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.5600915065561782,-1.0652457897454581,0.43548387096774194,1.0,1.0,5/18,11.56%,B2M;NOTCH1;CAV3;RFLNA;REST
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.7024737528400118,-1.064985307232008,0.5079365079365079,1.0,1.0,4/6,29.09%,COX7A2L;HIGD1C;COX7A2;RAB5IF
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.66459525943497,-1.0647667500712175,0.4603174603174603,1.0,1.0,4/10,17.85%,AGT;PRKCH;IL18;PLA2G10
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.704486200318728,-1.0647241299647339,0.41818181818181815,1.0,1.0,3/5,26.13%,MAOB;LRTOMT;MAOA
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.41036487832637,1.0642675131485524,0.32,0.9125069153939181,1.0,18/52,21.55%,ELOVL6;SGMS1;HACD2;SGPP2;SPTSSB;PRKD1;SPTLC1;SPHK2;CERS4;CERS3;ST3GAL2;VAPB;SGMS2;PLPP1;PPM1L;CSNK1G2;ACER1;ST3GAL4
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.6368681847743017,1.0639660139181715,0.45,0.9124446190279131,1.0,4/5,36.30%,SLC15A4;XIAP;BIRC3;SLC15A2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6212833125896517,-1.0636339538716661,0.453125,1.0,1.0,4/10,29.53%,ROMO1;TIMM8A;TIMM22;TIMM8B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.5140062121725822,1.0628160190363256,0.3333333333333333,0.914884796415687,1.0,4/21,11.50%,NRP1;KDR;LIMS1;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.646259086175119,1.0625882456458033,0.4666666666666667,0.91475928117423,1.0,1/5,4.60%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.6471193272399807,1.0625583341702443,0.4444444444444444,0.9140584476246215,1.0,4/7,6.33%,TGFBR1;TGFB2;JAG1;ACVR1
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5682409582055883,1.0624865429809467,0.46153846153846156,0.913456697356006,1.0,4/13,25.82%,ELP4;DPH3;ALKBH8;TRMT9B
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.47922845290230226,-1.0618818012470996,0.3787878787878788,1.0,1.0,4/46,5.66%,CYP1B1;CYP19A1;LDLRAP1;NSDHL
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.4989126173775705,-1.06186484061303,0.417910447761194,1.0,1.0,9/22,24.78%,SLCO2B1;STARD5;SLC51A;ABCC2;SLC10A5;SLC10A6;ABCB11;SLCO1A2;CEACAM1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.5437986904106447,1.0617802827630445,0.42857142857142855,0.9145307209355776,1.0,3/13,6.18%,STAC;JSRP1;MYH3
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.546826941372678,-1.061760642762229,0.45161290322580644,1.0,1.0,1/26,1.13%,SIGLEC1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.49095404337277293,-1.0617315315840523,0.4084507042253521,1.0,1.0,15/38,23.95%,HSPA5;ZNF430;CALM3;CNP;CKB;PLP1;COX6B1;SUDS3;G6PD;YWHAH;RAD1;CALM1;MAOB;ATP5PB;DYNLL1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.48659957730540626,1.0615568754508187,0.4074074074074074,0.9142349453257559,1.0,4/22,8.20%,COL15A1;F2RL1;PDE4D;COL22A1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.47385612935831556,1.061550994038275,0.34375,0.9134637426382421,1.0,14/38,21.46%,SYNJ2;PLPPR5;MTMR8;SGPP2;MTMR9;PIP4P1;PLPPR4;INPP5J;PLPP1;PTEN;MTMR6;MTM1;MTMR11;MTMR3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43791660621670153,1.0613945451704139,0.3333333333333333,0.9130718431050815,1.0,5/55,9.95%,LEF1;CSF1R;CBFB;MED30;CDK8
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6052896993969497,-1.0612033304275306,0.390625,1.0,1.0,2/11,8.18%,ING2;ZBTB7B
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.6292695872981265,-1.0611539403217918,0.39285714285714285,1.0,1.0,1/7,10.73%,MEOX1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.6354532006339368,-1.060974141724206,0.515625,1.0,1.0,3/9,24.59%,ALOX12;PLA2G7;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.5202169781993965,-1.0608063566618051,0.38596491228070173,1.0,1.0,7/25,26.70%,POLR2J;POLR2K;SUPT5H;POLR2I;POLR2B;CTDP1;POLR2D
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.46328603665072826,1.0607324350429406,0.3333333333333333,0.9143374417949065,1.0,8/35,11.34%,NOX4;CSF1R;GRM5;BTC;CASS4;EREG;IL34;FYN
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6359209413854527,1.0605709108042283,0.375,0.9124344370154783,1.0,4/11,18.95%,CDC23;ESPL1;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6359209413854527,1.0605709108042283,0.375,0.9124344370154783,1.0,4/11,18.95%,CDC23;ESPL1;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6359209413854527,1.0605709108042283,0.375,0.9124344370154783,1.0,4/11,18.95%,CDC23;ESPL1;NSMCE2;ANAPC7
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6137228433759226,-1.0602175535882539,0.45714285714285713,1.0,1.0,2/10,9.56%,ALOXE3;ALOX12
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.6084468016541088,-1.060024681238394,0.3548387096774194,1.0,1.0,3/10,35.78%,PAICS;IMPDH2;ADSS2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.48868063178885357,-1.0596468215915806,0.42028985507246375,1.0,1.0,14/32,24.78%,SLCO2B1;STARD5;SLC51A;SLC16A8;AQP9;ABCG5;ABCC2;SLC10A5;SLC16A1;GHRL;SLC10A6;ABCB11;SLCO1A2;CEACAM1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5349435429863582,1.0596138303940272,0.3611111111111111,0.9145946983456397,1.0,3/18,10.45%,MACROH2A2;LRWD1;RUVBL2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5433577954849295,-1.059518384542474,0.3972602739726027,1.0,1.0,2/19,3.81%,UROD;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5592893412270591,-1.059315838028634,0.41935483870967744,1.0,1.0,3/17,18.53%,PTPRC;HLA-DMB;LBP
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.49910095092559065,-1.0592646001597261,0.4084507042253521,1.0,1.0,9/34,26.81%,TRPV6;SYT2;SYT4;PREPL;DOC2A;SEPTIN5;SYT13;SYT9;RAB3A
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.4097324646771739,-1.0591393691056792,0.379746835443038,1.0,1.0,59/181,29.47%,NOB1;RPL36;RPL15;RPL38;RPLP2;RPL28;RPS7;RPL9;RPL37A;RPL26L1;RPL22;RPL35A;RPL5;RPL8;RPLP1;EIF6;EXOSC6;RPL4;RPL3;RPL34;RPL37;DDX54;RPL24;NOP56;WDR12;UTP11;EMG1;RPS24;RPS15;KRR1;RPL7A;SURF6;RPL13A;RPF2;RPL27A;SBDS;RPL23;EXOSC8;RPL35;RAN;RPL19;RBIS;RPL18;WDR55;RPL32;RPL13;RPL27;IMP4;LAS1L;PELP1;NIP7;RPS2;RPS9;MRTO4;ZNF622;UTP15;RPL29;RPS25;RPL31
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.7077192737031768,1.059054378303625,0.48936170212765956,0.9153319908722922,1.0,2/5,21.21%,EPHA4;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5852180139725466,-1.0590395755625583,0.4696969696969697,1.0,1.0,4/14,9.77%,TRIM5;CARD8;SIGIRR;SCIMP
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.5288538431285812,1.0589923391425158,0.37777777777777777,0.9147105494476878,1.0,4/14,13.00%,SLC30A10;MARCHF5;HMGA2;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.49022877735853665,1.058952046371223,0.4,0.9140296146879335,1.0,2/23,1.23%,KIT;F2RL1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.37968035018682994,1.058925952398108,0.25,0.9133256374910724,1.0,22/163,7.09%,CREB5;KIF6;PTPRT;LRRTM3;PEX5L;ITPR2;SGK2;TNR;NTSR2;ADGRA1;MAPK4;FAM163B;DPY19L1;VLDLR;RGS7BP;GRIA2;KLK6;DSCAML1;GRM5;MMD2;NRXN1;MYO1D
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6437107860611555,-1.0589254009231694,0.5,1.0,1.0,2/7,26.38%,DDX11;BLM
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6087000772342579,1.0589199008837502,0.425,0.9125744975763892,1.0,3/8,16.14%,OTUD3;OTUD7B;OTUD7A
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.47779775019174586,-1.058575685839419,0.4,1.0,1.0,9/44,22.31%,POLQ;RFC5;RPA3;XRCC1;PCNA;TDG;PARG;MPG;APEX1
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.7436311166745697,-1.0585166101932235,0.39622641509433965,1.0,1.0,1/5,7.74%,RIN3
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.6215775172366858,1.05795712613596,0.5,0.9145303787772076,1.0,2/9,6.07%,KDR;JAG1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.567127107512792,1.0575818068864062,0.35714285714285715,0.9146846653144944,1.0,5/10,10.73%,NFATC1;TGFB2;HEY1;JAG1;ROBO2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.4986868265635527,-1.0574138016753194,0.38235294117647056,1.0,1.0,5/28,25.03%,DRD3;SYT2;SYT4;SYT13;SYT9
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.6926143768813374,-1.0573030215316799,0.4117647058823529,1.0,1.0,3/5,27.82%,GBP5;TLR2;NLRP9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.7340849869155704,1.0573012205553305,0.4722222222222222,0.9147422203995785,1.0,1/5,1.06%,TRPC3
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6183763776318046,-1.0572112239789637,0.5,1.0,1.0,4/11,26.20%,HSPA5;KDELR3;KDELR1;GPAA1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.4295587444411894,1.0568663111316035,0.25806451612903225,0.91502860091679,1.0,10/43,12.76%,SULF2;BMP7;TGFBR1;ALDH1A2;CHD7;TGFB3;PTCH1;FGFR1;RBP4;TRIM71
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.6368919231014754,-1.056754539076223,0.4426229508196721,1.0,1.0,4/12,30.69%,BRCA1;METTL3;RLIM;YTHDC1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.4038177409167451,1.0566394493553681,0.2,0.9149051921973698,1.0,16/76,14.47%,TYSND1;ADAMTS3;ADAM19;PTCH1;PCSK2;SRGN;TASP1;TSPAN17;EEF1AKMT4-ECE2;TSPAN33;CASP2;ECE1;SORL1;KEL;CPD;ADAMTS13
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.552493725714675,1.0565681420443198,0.43333333333333335,0.914264778605115,1.0,2/18,8.90%,SLC30A10;MT1E
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.6321038966808005,-1.0565297692522637,0.4827586206896552,1.0,1.0,2/6,24.37%,RSPO3;PLEKHA4
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.5247434472418917,-1.056516748236043,0.38461538461538464,1.0,1.0,11/27,30.06%,CHMP4B;CHMP2B;RAB11A;CHMP2A;VPS37B;VPS4A;VPS28;VPS36;CHMP1A;CHMP5;VPS4B
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.5699579646677433,-1.0564731979652835,0.43283582089552236,1.0,1.0,4/21,8.26%,CYP1B1;FUT2;SERINC1;ALOXE3
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7148686527418302,-1.0561518413016167,0.45614035087719296,1.0,1.0,3/5,13.18%,CASP8;SPI1;FADD
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.4304632297338688,-1.055933424684517,0.38028169014084506,1.0,1.0,22/110,24.72%,CENPK;CENPO;SPC24;ERCC6L;WDR62;CENPU;GPSM2;ZWILCH;STMN1;NUP85;ITGB3BP;CENPL;SKA2;KIF11;EFHC2;SBDS;NDEL1;KNL1;DYNLL1;RAN;DSN1;SPC25
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6024509009638079,-1.0557331389397233,0.4788732394366197,1.0,1.0,2/12,11.44%,ABT1;RPS21
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.5572165841889406,-1.055610124294541,0.4166666666666667,1.0,1.0,5/19,17.85%,AGT;PRKCH;IL18;NFKBIA;PLA2G10
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.44864127847062535,1.0554452504018026,0.3548387096774194,0.9165578541457493,1.0,5/45,3.87%,LAMB2;ITGA4;NTNG1;NRP1;LAMB3
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.693521370276245,-1.0553004960116223,0.4117647058823529,1.0,1.0,3/5,29.57%,GLI3;AKT1;LMBR1L
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.6906090873336294,-1.0549089303144217,0.4393939393939394,1.0,1.0,2/5,15.18%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.6906090873336294,-1.0549089303144217,0.4393939393939394,1.0,1.0,2/5,15.18%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.6116471026630186,-1.0548063661268277,0.4057971014492754,1.0,1.0,4/11,27.99%,APOLD1;CEACAM1;CD24;PRKX
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6072771110685498,1.0547634491416784,0.4166666666666667,0.9178023725752305,1.0,3/6,26.42%,APOE;ABCA2;PTPN1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.5102415897982031,-1.054703275350115,0.3770491803278688,1.0,1.0,2/26,4.68%,PTGIS;RAC1
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),-0.7017585052814312,-1.0543375878720243,0.43283582089552236,1.0,1.0,3/6,21.25%,ARTN;SHH;RACGAP1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.6065513998402845,-1.0541246814881502,0.4090909090909091,1.0,1.0,1/9,3.12%,OMG
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6246114965729185,1.0538591120732688,0.4358974358974359,0.9195726980468454,1.0,1/6,2.22%,FGF13
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.4654996436798333,-1.0528868873334198,0.4444444444444444,1.0,1.0,5/57,5.73%,PRLR;HSD17B10;CYP1B1;CYP19A1;BAAT
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.6288437594787059,-1.0528405855339422,0.4153846153846154,1.0,1.0,5/8,32.65%,ARG2;AZIN1;HNF4A;AZIN2;ARG1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.34029979820358486,1.0527184047099314,0.3333333333333333,0.9218315396110001,1.0,53/255,14.63%,HTR1F;RIMBP2;CHRNA10;HTR7;UNC13C;GRIA4;PENK;GRIK4;PTCHD1;HRH1;GABRG3;UNC13B;KCND2;NTSR1;APBA1;GRIA2;GRM5;GRIN2A;GRIK1;GABRB1;HTR1E;NRXN1;LIN7A;GRIA1;CEL;NLGN1;NLGN4Y;APOE;SYN3;HCRTR2;NOVA1;GABRA3;CHRM3;SLC6A1;GRIN2C;DLGAP1;GRID2;SYN2;HRH2;CACNB2;CHRNA5;GABRB3;SYT1;PPFIA3;MBP;GABRA5;GRIK2;SLC1A2;DLG2;CHRM5;LRP6;SLC6A2;DRD4
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.6838501028052973,-1.0526693405836947,0.4444444444444444,1.0,1.0,1/5,4.22%,LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.43495515664397544,1.0525234422451757,0.2857142857142857,0.9214874346356292,1.0,11/55,12.75%,F2RL1;BMP6;UNC13B;TGFB2;MCU;TGFB3;IGF1;IRS2;MYRIP;RBP4;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.627795021202483,-1.052327533924345,0.4262295081967213,1.0,1.0,2/7,9.16%,DOCK8;CCL5
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.6951387291428437,-1.052236701364199,0.3620689655172414,1.0,1.0,2/5,18.98%,WNT7B;KANK2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5100677179449272,1.0520596071408073,0.3142857142857143,0.9218021243701662,1.0,1/19,0.55%,NOX4
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.3994648722117199,1.0519962771939935,0.32142857142857145,0.9211835989231402,1.0,2/49,1.35%,IMMP2L;GDAP1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6272548209784532,-1.0516236083373918,0.4067796610169492,1.0,1.0,2/7,20.45%,UBE3A;YAP1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),-0.6918243888577524,-1.0514166633558801,0.43103448275862066,1.0,1.0,1/5,3.43%,IL4I1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),-0.6918243888577524,-1.0514166633558801,0.43103448275862066,1.0,1.0,1/5,3.43%,IL4I1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3674196644762256,1.051249175416964,0.3,0.9224179723397401,1.0,27/171,14.60%,FRMPD1;ITGA4;RAB3C;FGF13;PKP2;RAB32;KCNB2;LRRC7;KCNIP4;NRXN1;LIN7A;NLGN1;PTCH1;BSG;DPP6;TSPAN17;ZDHHC3;TSPAN33;CACNB2;RAB40A;ABHD17A;ZDHHC2;SPTBN4;MAGI2;DLG2;BRAF;LRP6
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.5456950468099356,-1.0510672196195918,0.37333333333333335,1.0,1.0,2/17,3.81%,UROD;ATP5IF1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.45159005247698775,1.050895104913972,0.35135135135135137,0.9227430282118207,1.0,2/27,3.95%,UNC13B;ZBTB20
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.36649134360489855,1.050847581111075,0.3157894736842105,0.9220894863874983,1.0,20/136,9.44%,NRK;ROR2;KIT;PELI2;EGFR;KDR;SPRED1;GREM1;FGFR3;SPRY3;EPHA8;WWC1;HMGB1;RASGRP1;IGF1;PTPN6;PKHD1;EPHA7;RYK;PAK5
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3871684082681349,1.0507860407576544,0.3076923076923077,0.9215323783335737,1.0,4/71,6.57%,RUNX1;CBFB;JAG1;PDGFRA
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6065366390167966,-1.0506340708144206,0.4918032786885246,1.0,1.0,3/11,7.74%,CD4;STAT5A;IL15
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6065366390167966,-1.0506340708144206,0.4918032786885246,1.0,1.0,3/11,7.74%,CD4;STAT5A;IL15
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.5357481040649302,-1.0506048543127,0.45901639344262296,1.0,1.0,9/24,23.40%,SLC13A4;MGST1;SLC26A4;LRRC8D;SLC36A1;SLC25A11;RACGAP1;SLC25A19;SLC27A1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6328210106320004,-1.0505971074668536,0.44776119402985076,1.0,1.0,3/8,18.96%,PRELP;OGN;ACAN
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.4053358169330619,-1.0505375293626529,0.4,1.0,1.0,27/159,12.16%,CD44;LAMA2;MYLK;MSX1;GADD45B;FBLN2;FBLN5;SFRP4;TIMP3;ITGA5;RGS4;PDLIM4;SERPINE1;ECM2;IL15;LAMA1;TGFB1;CRLF1;BMP1;INHBA;CTHRC1;PCOLCE2;ACTA2;SNAI2;GADD45A;MEST;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.4478053146092161,1.0504827795998455,0.3488372093023256,0.9214525032027188,1.0,11/33,20.68%,PCM1;PRR5L;STX18;TPR;SORL1;EIPR1;NUMA1;NEDD4;B3GAT3;ICE1;PCNT
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.6654506895680282,1.0504659783009884,0.4418604651162791,0.9207421895367058,1.0,1/5,3.66%,UNC13B
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.4151308430532421,1.0501922190615043,0.3333333333333333,0.9207819838791642,1.0,13/61,19.67%,EPM2A;WDR24;MINAR1;PKHD1;TTI1;GNA12;FAM83D;TELO2;SIRT1;WDR59;DYRK3;DDIT4;HDAC3
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.5508365651237965,1.0493158658499377,0.45714285714285713,0.9222945514717924,1.0,3/10,13.99%,GABRG3;GABRA3;GABRA5
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.4169813508577408,1.0489995307404778,0.2857142857142857,0.9224991356270335,1.0,6/61,6.71%,PID1;NPNT;AFF3;GCH1;SMPD4;TNFRSF11A
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.41951385315658996,-1.0489179036400311,0.36585365853658536,1.0,1.0,13/110,9.16%,CD44;C3AR1;SIGLEC1;HSPG2;GPR68;CD14;RAC1;NOX1;PTGER3;CIITA;TGFB1;TRAF3IP2;CCL5
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.6399411307843133,-1.0487017482533172,0.45454545454545453,1.0,1.0,4/7,29.92%,TAS1R1;ASIC3;CD36;PKD1L3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6419344481283656,-1.0483633889252824,0.38571428571428573,1.0,1.0,2/8,25.86%,MAP1LC3B;ATG14
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.6831025182997612,-1.0480420847214105,0.48214285714285715,1.0,1.0,3/7,23.51%,OTUB1;TWIST1;RPS3
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5533349075746788,1.0478489409767295,0.35714285714285715,0.9246006525643087,1.0,5/11,21.07%,NFIB;PDGFB;RELA;PPARA;NFATC3
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.5629235509089954,-1.047805688937813,0.4126984126984127,1.0,1.0,6/15,15.58%,PINK1;PSMB8;RCN3;PSMA3;A2ML1;CTSH
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.533603199503275,-1.0477522179124599,0.38235294117647056,1.0,1.0,8/27,21.01%,KCNE2;ATP5IF1;CAV3;DAB2IP;PSMC3;PSMC6;MAGEF1;PYHIN1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.4868492310091357,-1.047346053083076,0.390625,1.0,1.0,4/35,10.65%,RND1;RAC1;NCKAP1L;FMNL1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5556630555616342,-1.0471127743640887,0.43636363636363634,1.0,1.0,2/17,2.96%,POLQ;CGAS
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),-0.6658007527354914,-1.0470810466195077,0.43859649122807015,1.0,1.0,2/5,24.42%,SLC36A1;SLC38A5
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.42215466619361597,1.0470253467454658,0.3684210526315789,0.9257982176566147,1.0,7/46,6.07%,MAML3;GMDS;MAML1;MDK;HEY1;WWC1;JAG1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5533708087157251,-1.0469249359083224,0.390625,1.0,1.0,1/14,3.01%,LDLRAP1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5305098060635277,-1.0469089284306028,0.42424242424242425,1.0,1.0,11/31,29.53%,SERPINE1;CASP8;TMC8;FADD;BRCA1;TMBIM1;RNF34;GPX1;MADD;SP100;FEM1B
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4473415353497473,-1.0468896966822279,0.39473684210526316,1.0,1.0,17/72,13.11%,PTPRC;DOCK8;RCSD1;STAG3;SP140;CD74;GMFG;CD37;ABCB4;ADAM28;NCKAP1L;P2RY14;TMC8;ARHGAP9;WDFY4;MYO1F;TAGAP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.3679719167725596,1.0466773749486455,0.37037037037037035,0.9260348939218648,1.0,20/131,9.76%,ITGB5;LMCD1;LAMB2;PDE3A;SVEP1;WWTR1;KDR;LAMA4;FNDC1;BMP6;GXYLT2;TMTC2;HTRA1;TAMALIN;P3H3;GNG12;PXDC1;TRIM47;AMOTL2;FKBP7
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.39403451273266615,1.0466513735578364,0.3,0.9253012471885336,1.0,24/146,15.11%,IRS1;EGFR;ZEB2;SLC25A37;FGFR4;SAMD4A;ZNF205;PRR16;ELAVL1;DDAH1;IGF1;IRS2;FAF1;EREG;NOS1AP;SCARB1;CHP1;PLIN5;SIRT1;EIF3E;AKT2;PDGFB;ABCB10;KLF2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.47421509276774343,1.0465787562584334,0.3333333333333333,0.9247224598829442,1.0,12/35,15.95%,LEF1;MAML1;HEY1;JAG1;NUMB;PTCH1;FZD1;DVL2;GNAI1;JAG2;HDAC5;FRAT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.5310397388866871,1.0463826782915007,0.35714285714285715,0.9244988963290329,1.0,2/10,7.19%,PID1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4888312724637378,-1.04606376920761,0.375,1.0,1.0,10/40,11.35%,PTPRC;DOCK8;IL7;IL15;NCKAP1L;PDCD1LG2;CD6;CCL5;HLA-DPB1;HLA-A
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5768093952664959,1.0460021560259232,0.43902439024390244,0.9246414726309771,1.0,3/10,7.42%,SERTAD2;ARID1B;ARID1A
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.5838214235420918,-1.045930671238197,0.41379310344827586,1.0,1.0,2/10,11.56%,NOTCH1;REST
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6318438654062477,-1.0458650075512095,0.45161290322580644,1.0,1.0,1/7,6.56%,BEX4
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.620140360058971,1.0458533502354146,0.43902439024390244,0.924324032290959,1.0,2/5,22.83%,AKT2;SNCA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6052765617933452,1.0458462150414642,0.5,0.9235712757787227,1.0,2/7,4.31%,MICU1;MCU
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.523957726297056,1.0457303937042808,0.34146341463414637,0.9231022377201675,1.0,3/19,6.36%,SULF2;SPRY3;APLN
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5830513383796098,1.0456368747111633,0.4222222222222222,0.9225751740886411,1.0,1/7,0.66%,PID1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.5375503553760643,1.045042089694352,0.45,0.9232827656319967,1.0,3/12,6.33%,TGFB2;HEY1;ACVR1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.5160811319059508,1.0444781004413775,0.42105263157894735,0.9241887815528164,1.0,3/12,12.80%,GCH1;NOXRED1;GPHN
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5532710509452834,-1.0444596753790478,0.46774193548387094,1.0,1.0,4/19,13.61%,H1-0;DNASE2;GPER1;BLCAP
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.6490195994644863,1.0442922356203599,0.45714285714285713,0.9240140547557005,1.0,3/7,19.40%,PGM2;GALE;GALT
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.6811047065882543,-1.0440835204894223,0.515625,1.0,1.0,3/5,27.79%,NODAL;CALR;GJA1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4023595519482668,1.043496864426161,0.42857142857142855,0.9257150274591016,1.0,2/61,1.52%,ATP6V0D2;IRS1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4114669829870843,-1.0434955314994931,0.40789473684210525,1.0,1.0,24/121,21.55%,CSRP3;ROPN1B;MSX1;ARL1;RAB11A;TOLLIP;ATP6V1D;DNAJA1;TMEM30A;OTOF;FSIP2;RIPOR1;VPS35;SIX4;GBP5;DDX1;GABARAPL2;LAMP1;TRAM2;CCDC47;ISG15;LAMP2;ARL6;OBSCN
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.6716250682187497,-1.0434558202935083,0.4426229508196721,1.0,1.0,2/7,20.22%,CALM3;CALM1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.573754354013976,1.0433598601036642,0.4358974358974359,0.925246540779388,1.0,5/13,8.97%,CNTN6;DSCAM;DSCAML1;CNTN4;BSG
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.46323235115232714,-1.043145633855715,0.4057971014492754,1.0,1.0,9/38,11.06%,PTPRC;TNFSF18;IL4I1;IL15;NCKAP1L;PDCD1LG2;CD6;CCL5;HLA-DPB1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.4448566016017747,-1.0431376459128316,0.38095238095238093,1.0,1.0,14/56,12.64%,C4BPB;UPB1;PRLR;HSD17B2;ANKS4B;TPO;LECT2;ALDOB;SERPINA10;SPTLC3;ABCC6;ITIH2;ASGR1;TSHR
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.6413910791828322,-1.042902059599424,0.43859649122807015,1.0,1.0,6/11,27.25%,RAC1;SEMA3A;NTN1;RHOH;CHN1;SLIT1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.5083424676262938,1.0428664587850216,0.40476190476190477,0.9256681806872976,1.0,1/14,3.02%,KANK1
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.7009893247419405,-1.0428180205284991,0.43661971830985913,1.0,1.0,1/6,11.75%,NOX5
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.5298261475103152,1.04266305498194,0.4166666666666667,0.925598045178382,1.0,3/12,6.33%,TGFB2;HEY1;ACVR1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.4249156760270493,1.0425183785959609,0.36363636363636365,0.9252359531855375,1.0,8/44,7.12%,KIT;TEAD2;KDR;KITLG;COBL;TGFB2;HEY1;PKDCC
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5806605501564714,-1.0425140783411875,0.4473684210526316,1.0,1.0,3/11,13.19%,PDE6B;RP1;CNGB1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.6730318793337243,-1.042343372198084,0.46551724137931033,1.0,1.0,2/5,23.51%,RNF34;RPS3
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5111423478769089,1.0422061508614693,0.3333333333333333,0.9250028609328189,1.0,3/27,5.80%,ATP6V0D2;RAB7A;GPR89B
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5367184825589748,-1.0421595982064744,0.38461538461538464,1.0,1.0,5/22,20.22%,CEMIP;CALM3;CASQ1;GPER1;CALM1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.42085367750534236,1.0420090847451413,0.375,0.9248168053881214,1.0,20/69,14.63%,SLC12A3;SGK1;FGF13;SLC6A4;SLC12A1;HCN1;SLC6A11;SCNN1B;SLC6A13;SLC8A3;SLC24A3;SLC6A1;SCNN1D;SLC4A4;NEDD4L;SLC38A7;SLC8A1;ANO6;SLC5A12;SLC6A2
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.610191972214486,1.0416626567999583,0.45161290322580644,0.9250389506830208,1.0,5/7,35.08%,MYOCD;SPHK1;F2R;NMU;CTTN
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5523199017853931,1.0414976752698455,0.42857142857142855,0.9247134340699457,1.0,4/10,19.69%,RGN;CYP2C8;PAH;SLC35D1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4120324917090478,1.0414423074068488,0.3888888888888889,0.9241092060330929,1.0,35/122,12.82%,KCNIP1;LRRTM3;PDE10A;GRIA4;PENK;RAB3C;PRSS12;ZNF536;ADGRA1;OLFM3;ATXN1;RGS7BP;GRIA2;SPHKAP;GRM5;LSAMP;GABRB1;MMD2;BRINP1;NRXN1;LRRC4C;CADM2;TMEM196;CSRNP3;RBFOX1;PAK5;SLC6A1;KCNC2;ADGRB3;SPOCK1;MRTFB;ST8SIA3;ELAVL3;PPFIA2;BRINP2
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.5024078802004626,1.0412558433859016,0.40540540540540543,0.9238082311309321,1.0,3/15,9.80%,EGFR;FAF1;EREG
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.43157055970856517,1.0409772375306539,0.25806451612903225,0.9238910804104258,1.0,13/52,11.27%,KCNIP1;KCNJ16;KCNJ6;AMIGO1;KCNJ3;KCNN3;KCNN2;KCNIP4;KCNJ2;BIN1;DPP6;NOS1AP;NEDD4L
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.6512346395529468,1.040966314371976,0.48717948717948717,0.9231497196350278,1.0,1/6,0.72%,GLYATL2
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.6450427955825353,1.0404815379572703,0.4,0.9237664432034489,1.0,4/6,32.88%,CRYZ;ACAA1;GSTO1;GSTM4
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.5204288958485921,-1.0404680379406113,0.45714285714285713,1.0,1.0,9/30,22.29%,CHAC1;CHAC2;GLRX2;GSTM5;GSTP1;G6PD;CNDP2;HPGDS;GPX1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.6364030347418352,-1.0401612223744123,0.46875,1.0,1.0,1/6,8.55%,CHMP2A
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5107475113649088,1.0399162212021698,0.40540540540540543,0.9246023313966119,1.0,4/22,14.46%,METTL8;TRMT61A;ZC3H13;TRMT61B
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.6004986042292579,-1.0397538891043745,0.39215686274509803,1.0,1.0,2/9,7.59%,RAC1;NOX1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.41830279433123707,-1.039597479205537,0.3924050632911392,1.0,1.0,64/193,26.03%,NARS1;PPA1;RPL36;RPL15;IARS2;EPRS1;RPL38;RPLP2;RPL28;RPS21;RPS7;MRPS18C;EEF1A1;RPL9;RSL24D1;GTPBP2;RPL37A;RPL26L1;MRPS14;RPL22;RPL35A;RPL5;RPS20;RPL22L1;EEF2;RPL8;RPLP1;RPS8;RPL4;ASMT;RPL3;RPL34;MRPL51;RPL37;RPL24;ZC3H15;RPS24;COPS5;RPS15;MRPS34;GTPBP1;EEF2K;WARS1;RPL7A;RPL13A;RPL27A;RPS4X;MRPL16;RPL23;RPL35;MRPL43;RPS3;RPS27A;RPS6KB2;RPS29;RPL19;ABCF1;RPL18;RPS13;MRPL27;RPL32;RPL13;RPS5;RPL27
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.54625716708835,-1.0394341623875867,0.40625,1.0,1.0,3/12,12.16%,MYLK;TBX1;PDGFRB
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7200662110147056,-1.039427694565358,0.5081967213114754,1.0,1.0,1/5,5.89%,TST
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.3720091310923638,1.0392589586197598,0.3225806451612903,0.9256684280479498,1.0,12/65,13.59%,ELOVL6;SMPD4;SGMS1;HACD2;SGPP2;SPTSSB;PRKD1;SPTLC1;SPHK2;ST8SIA3;CERS4;CERS3
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5693926234393908,1.0391053603702047,0.34375,0.9253676534929851,1.0,1/10,0.61%,UBASH3B
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.6922524824952243,-1.0386659035013872,0.515625,1.0,1.0,1/5,18.28%,EIF2B5
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.4320089300068513,1.03825741675344,0.38235294117647056,0.9266163516285393,1.0,4/35,2.70%,PENK;C5AR1;OR3A2;NTSR2
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.5483538280717415,-1.038249191965711,0.3939393939393939,1.0,1.0,4/18,13.97%,SCN7A;SCN9A;GPER1;CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5201190602404213,-1.0382313871036706,0.4576271186440678,1.0,1.0,4/16,14.69%,CTNNA1;UFM1;RAB23;APOD
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.3757184786185817,1.038127262116969,0.2962962962962963,0.9261882438428863,1.0,15/103,9.71%,LRIG3;LAMB2;SVEP1;DUSP5;EGFR;WWTR1;SDC4;FRAS1;COBLL1;HTRA1;GNG12;PXDC1;FZD1;ST3GAL1;AMOTL2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.5570818039876881,-1.0379501896039194,0.4426229508196721,1.0,1.0,4/19,13.42%,CHMP4B;CHMP2A;DCTN1;GPER1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.4886768580208354,1.0379219140436342,0.40625,0.9259916469125924,1.0,5/32,8.43%,RUNX1;ZBTB20;RAB27A;TGFB3;APOE
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.6441322213118119,-1.0378038974527293,0.43137254901960786,1.0,1.0,2/6,18.85%,LRRC8D;SLC25A18
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3914552527766706,1.0376672048597357,0.3181818181818182,0.9261413135157178,1.0,24/79,16.03%,LEF1;MYO3A;BMP7;FRAS1;VASH2;IGDCC3;TOX3;UNC5D;EPHA8;LIN28B;EPHA7;PHF21B;GRID2;GABRB3;TRIM71;ADAMTS20;MSI1;IL17RD;SEMA5B;CNTNAP2;CRABP1;SEMA6A;CDH1;DPYSL5
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6093357642507229,-1.0375266510513175,0.40350877192982454,1.0,1.0,3/8,20.49%,DAB2IP;TSC2;TWIST1
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),-0.6917089358794078,-1.037303576897239,0.43333333333333335,1.0,1.0,1/5,3.43%,IL4I1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.608369087125366,1.0367588895813618,0.46511627906976744,0.927857753816576,1.0,1/7,1.05%,SPX
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.5556595532732184,1.036648638074393,0.43243243243243246,0.9274645653970875,1.0,5/9,28.54%,AZU1;CXCL12;VEGFD;VEGFA;SCG2
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6446272467681768,1.0365281899346332,0.5111111111111111,0.9270490050542107,1.0,2/9,9.36%,NXF5;RBFOX1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.5478429806660635,1.0360052369817012,0.3888888888888889,0.9276226233186261,1.0,4/10,16.89%,UPP2;MACROD2;NT5C3A;TYMP
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6322540613332504,-1.0359583276414095,0.3968253968253968,1.0,1.0,2/8,8.64%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.538045182190319,1.0357953477573487,0.4186046511627907,0.9274143358989038,1.0,4/15,16.51%,CPSF7;KCNC2;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.6522552592946769,-1.0356910042866185,0.5333333333333333,1.0,1.0,2/6,29.54%,NAIF1;ACAA2
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6696550775287715,-1.0354843707812198,0.4153846153846154,1.0,1.0,3/6,25.13%,MSN;GPR183;PIK3CD
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5905523860905778,1.0354695407957228,0.46511627906976744,0.9274932779713383,1.0,2/6,7.21%,NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.4967066693030024,1.0352244186323192,0.40540540540540543,0.9274803608198424,1.0,5/13,17.89%,SDC4;RAB7A;SNF8;TSG101;SMPD3
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.43045175405333563,1.035099526608496,0.35135135135135137,0.9270779166598205,1.0,14/42,24.30%,GRM5;MEX3D;TRIM71;TDRD7;RC3H1;TCOF1;GCNT2;NANOS3;LARP1;FOXO3;GEMIN5;PUM3;METTL16;METTL18
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.5572805282795922,1.0349413285451126,0.46808510638297873,0.9267448079839645,1.0,3/9,8.53%,SPX;PDE4D;RNLS
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.6038565107599809,-1.0348981872616143,0.509090909090909,1.0,1.0,1/6,8.42%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.5920545057866471,1.034894058083278,0.3333333333333333,0.9261033845887756,1.0,3/7,16.72%,KDR;RIN2;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.508018675213458,1.0345513131390713,0.4117647058823529,0.9262402105182996,1.0,2/19,0.87%,RUNX1;LEF1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6089800074914498,-1.0345134029536687,0.5142857142857142,1.0,1.0,2/9,8.25%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.6989118201461134,-1.0343701401654726,0.5161290322580645,1.0,1.0,2/5,5.59%,IL4I1;AHR
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.6205389216002498,-1.0341868975719655,0.4666666666666667,1.0,1.0,4/9,26.19%,MCTS1;EIF2S2;EIF4H;EIF5
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5359872112663977,-1.0339412153950587,0.43478260869565216,1.0,1.0,7/19,30.30%,TPX2;TUBGCP4;NDEL1;TUBGCP2;GOLGA2;TUBGCP5;TUBG2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.5131221450685584,-1.0335569681092784,0.421875,1.0,1.0,4/26,13.68%,NCBP2;DCP2;SLBP;NCBP1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.5721569758145887,-1.0334266097590308,0.47761194029850745,1.0,1.0,2/14,9.13%,CHST1;GNPDA1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.5985663119267985,1.033351927329548,0.4634146341463415,0.9285695600048254,1.0,4/7,18.62%,EXT1;EXT2;HS2ST1;NDST1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.364299257189051,1.0333332877678574,0.4375,0.9279168049663414,1.0,21/103,14.17%,NOX4;PTPRK;EGFR;PRR5L;FOS;GPX7;PDGFRA;PRKCD;AKR1C3;HSPA1A;ETV5;AGAP3;PRKD1;ERCC6L2;VKORC1L1;EIF2S1;MAPK8;SIRT2;FOXO1;PNPT1;FER
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.594500585014603,1.033297631929601,0.4897959183673469,0.9272536929231174,1.0,3/9,21.51%,SLC22A3;SRM;SLC29A4
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.42007635503657736,1.0332459792354882,0.4090909090909091,0.9266144281135579,1.0,2/58,3.77%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.5754820026049596,-1.033141636966547,0.515625,1.0,1.0,1/10,12.96%,SESN3
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.46252787558112685,1.0331375765903168,0.4117647058823529,0.9261810976697591,1.0,5/17,17.89%,SDC4;RAB7A;SNF8;TSG101;SMPD3
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5506338757517164,-1.0331093939820515,0.4264705882352941,1.0,1.0,3/20,11.46%,POLE3;SUV39H1;ZNFX1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4763444266276273,1.0330869490823666,0.40425531914893614,0.925577835537407,1.0,7/28,21.57%,SHLD1;PNKP;KMT5B;HMGA2;SIRT7;HSF1;SETMAR
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.49717807724012725,1.0324425121635212,0.39285714285714285,0.9265440234975231,1.0,3/28,5.79%,ATP6V0D2;RAB32;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.5865015095375539,-1.0324399839470582,0.4626865671641791,1.0,1.0,3/9,15.92%,CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.42353985698142715,1.0318726422506124,0.4444444444444444,0.9270089719267045,1.0,14/65,15.53%,CA2;NKAIN3;KCNJ16;KCNJ6;KCNJ3;KCNJ2;PXK;NEDD4L;VAMP3;SYT1;KCNJ14;SPTBN4;NEDD4;KCNA5
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6573777458727115,-1.0314176482801796,0.4444444444444444,1.0,1.0,3/7,22.23%,CCL5;SFTPD;CXCL17
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.34601801756695644,1.0310418330660636,0.3333333333333333,0.9284831279287006,1.0,5/103,2.57%,NRG1;SGK1;DOCK10;EGFR;CSF1R
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5925352601143298,-1.0309986253756303,0.4074074074074074,1.0,1.0,2/12,16.58%,MAP1LC3B;PEX5
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),-0.6547735782680086,-1.0309608326701936,0.5384615384615384,1.0,1.0,3/5,29.86%,STRC;PDZD7;SOD1
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),-0.6547735782680086,-1.0309608326701936,0.5384615384615384,1.0,1.0,3/5,29.86%,STRC;PDZD7;SOD1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.33827451802105535,1.0308707288855001,0.29411764705882354,0.9281520830210305,1.0,69/424,14.30%,EPHA3;NRK;KIT;ALK;CCNH;SGK1;STK32B;MYO3A;SGK2;EGFR;KDR;CSF1R;FGFR4;TGFBR1;GRK5;LATS1;TGFB2;CDK14;PEAK3;FGFR3;MAML1;EPHB2;EPHA8;TRIB2;PRKCB;NEK6;MAP3K20;ACVR1;PDGFRA;PRKCD;PKDCC;CLSPN;CDKL1;CCNA2;PTPN6;PXK;LTK;RYK;SMAD2;STK38;SBK1;PRKD1;PAK5;EIF2AK3;ERBB4;CDK8;FGFR1;MAST4;MAP3K5;FYN;MAPK8;PRAG1;PRKCE;FASTK;FRK;MARK1;LMTK3;SGK3;MAPK12;NRBP2;MAP3K10;PRKG2;CDC42BPB;AKT2;PAK4;PDGFB;FER;PAK3;BRAF
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.6557633570941404,-1.0308207658036987,0.463768115942029,1.0,1.0,1/5,3.98%,AOX1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5937963243245903,1.0306806813951308,0.5454545454545454,0.928104806860172,1.0,2/8,19.78%,PDSS2;PDSS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.5382880645016677,-1.030048677947414,0.4838709677419355,1.0,1.0,2/22,1.99%,C17ORF99;PTPRC
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.411966303648102,-1.0299958925419772,0.359375,1.0,1.0,14/81,17.05%,TICRR;ALPL;FANCI;CDC6;DEPDC1B;ERCC6L;CHAF1A;ATAD5;TRIM32;CHEK1;PAICS;PLK4;SET;KIF11
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.35800862221312313,1.0299191992179726,0.45454545454545453,0.9297330657421521,1.0,34/321,7.10%,ROR2;CDH13;KIT;LEF1;PDGFD;SGK1;F2RL1;DOCK10;PTPRT;PHACTR1;MCTP1;SEMA6D;TRIP6;SRGAP1;NTNG1;PTPRK;EGFR;KDR;CSF1R;CTNNA2;KANK1;TGFBR1;SEMA5A;PRR5L;EPHB2;MIEN1;MDK;PDGFC;NAV3;JAG1;ACVR1;PDGFRA;NUMB;SEMA4C
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.4298564421158747,-1.0298422739837092,0.4520547945205479,1.0,1.0,12/59,13.75%,CCDC60;ANKUB1;TEX26;ECT2L;CCDC39;C11ORF16;DNAH3;TMEM212;ATP5MK;ARMC3;EFHB;CFAP126
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.5350831941254002,1.0297491044377998,0.42857142857142855,0.9293339467621443,1.0,1/9,6.63%,DDAH1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5388706557084714,-1.029700030628195,0.46875,1.0,1.0,4/16,13.42%,CEMIP;CALCR;CASQ1;GPER1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.5867778660784968,1.029661425155974,0.425,0.9288902504821143,1.0,1/10,0.17%,RUNX1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.639481725605044,-1.0295091109957142,0.45714285714285713,1.0,1.0,3/9,22.82%,RPS21;ERI2;EXOSC8
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.6199426698281775,-1.029250623975474,0.43283582089552236,1.0,1.0,3/7,21.31%,PDE6B;CNGB1;CNGA1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.5679007850895487,-1.0287652478769747,0.5079365079365079,1.0,1.0,2/9,24.74%,TSC2;AKT1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6349371542743669,1.0284691741198342,0.4666666666666667,0.9314626871083347,1.0,2/5,18.88%,ROBO2;ROBO1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.5159200007157634,1.0283989912251517,0.4411764705882353,0.93092772884751,1.0,2/21,7.19%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.591141810541969,-1.0283748900806846,0.4714285714285714,1.0,1.0,4/10,29.22%,NCBP2;NCBP1;PAF1;NUDT21
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5847551673082363,-1.0283405110384425,0.4857142857142857,1.0,1.0,1/10,1.62%,NOTUM
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.3972750426276256,1.0283050623830718,0.4074074074074074,0.9303372384184638,1.0,10/68,6.59%,LAMB2;ADAMTS2;COL15A1;SVEP1;EFS;FNDC1;SEMA5A;MYH11;PDGFRA;NYNRIN
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.6384825466387699,-1.027895281859285,0.4918032786885246,1.0,1.0,4/7,25.96%,TGFB1;ACMSD;CLTC;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5516388246161202,-1.0277316368202463,0.5079365079365079,1.0,1.0,2/14,10.25%,FKBP1B;CALM3
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.6311449795580946,-1.027705555469819,0.5,1.0,1.0,1/8,1.55%,CHRNB1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.6938960992199963,-1.0276083745314613,0.5344827586206896,1.0,1.0,1/5,7.06%,ORAI2
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.5963730676498227,1.02747927082856,0.48717948717948717,0.9316179939343338,1.0,4/12,13.81%,PRR5L;KHSRP;RC3H1;PNPT1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5309271977448676,-1.0273944713870036,0.38596491228070173,1.0,1.0,3/14,4.38%,DUOX1;P2RY1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.4165037542239985,1.0272792491041256,0.43243243243243246,0.9314219225018641,1.0,11/41,20.68%,EGFR;HSPA1A;LIN28B;PIK3R1;U2AF2;PNPT1;ZC3H18;RELA;NFKB1;SIRT7;SETX
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.45616131079032246,1.0265148957870414,0.37209302325581395,0.932767292756176,1.0,5/28,13.29%,PID1;ZBTB20;IGF1;SLC4A4;PFKFB3
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.4943509203768937,1.0264146183821061,0.4117647058823529,0.9322783769749445,1.0,5/28,8.76%,CD38;BCL2;EPHB2;CD22;IRS2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.6741963289189299,-1.0261425405165452,0.5087719298245614,1.0,1.0,2/6,7.52%,BAAT;STAT5A
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.4015370355296829,1.0261264083550008,0.4230769230769231,0.9322844137390082,1.0,12/56,13.99%,SLC37A4;SLC12A3;GABRG3;SLC12A1;GABRB1;SLC20A2;GABRA3;SLC6A1;ANO5;GABRB3;ANO6;GABRA5
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.5324500044801669,1.0255781041638563,0.2222222222222222,0.933031128927248,1.0,2/16,2.42%,NRP1;KDR
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.498228910702079,1.0255271141884512,0.38095238095238093,0.9324422369493225,1.0,2/11,7.36%,BCL2L11;AKR1C3
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6235958400716798,1.025338407819187,0.5,0.9323360816911694,1.0,2/8,4.89%,GRIN3A;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.6461952189417545,1.0252211219385436,0.45098039215686275,0.9319166032086438,1.0,3/5,11.25%,MDK;IL34;TENM4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5351880400543008,-1.0251529551289618,0.43548387096774194,1.0,1.0,3/21,8.64%,ZNF703;EID2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.5005099403175584,-1.025048519005467,0.4375,1.0,1.0,4/24,12.16%,MYLK;WFS1;CCL5;PDGFRB
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.49521757957972645,1.0249077296989049,0.3611111111111111,0.931922900451848,1.0,6/17,8.64%,LRRTM3;IL1RAPL1;CEL;NLGN1;NLGN4Y;FZD1
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.5925925958849559,-1.0247041152646554,0.4745762711864407,1.0,1.0,4/11,27.79%,NODAL;C1QBP;CALR;GJA1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.39450058327530907,-1.0244514412323298,0.4794520547945205,1.0,1.0,9/142,7.92%,STK16;EPHA1;HCK;ITK;TNK1;MAK;PINK1;TXK;FLT3
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5124594702312771,-1.0243605625333103,0.3870967741935484,1.0,1.0,8/19,28.63%,PTPRC;PRKCH;KCNN4;STAP1;TESPA1;RPS3;NFAM1;CD226
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.6095193076457595,-1.0243405052016141,0.49230769230769234,1.0,1.0,4/10,20.68%,RASIP1;P2RY12;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.5892673265953157,-1.0238857433307738,0.48148148148148145,1.0,1.0,5/9,25.45%,BNIP3;VPS35;ATG3;BAX;DNM1L
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5005159759902,-1.0238212593278662,0.4090909090909091,1.0,1.0,12/30,25.45%,BIK;BNIP3;SOD2;IFI6;BOK;VPS35;NAIF1;ATG3;HSPD1;BAX;BAK1;DNM1L
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.4306562415165075,-1.0238080642954066,0.4383561643835616,1.0,1.0,15/116,10.20%,CD44;ALPL;ADAMTS4;PRELP;NOTUM;HHIP;LECT2;ALX4;ETS2;RFLNA;PRDX1;COL19A1;TEAD4;BMP1;PHEX
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4843068737857979,-1.0234653804294642,0.3880597014925373,1.0,1.0,1/32,1.02%,TERF2IP
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.6264353624268871,-1.0231128065579926,0.5483870967741935,1.0,1.0,2/8,22.06%,PEX16;PEX1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.47550292164411945,-1.0223735287252993,0.4,1.0,1.0,15/50,23.37%,NDUFB9;NDUFA2;TMEM126B;NDUFB3;NDUFC1;NDUFB4;DMAC1;NDUFB11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;NDUFB10;NDUFS5;NDUFA3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.47550292164411945,-1.0223735287252993,0.4,1.0,1.0,15/50,23.37%,NDUFB9;NDUFA2;TMEM126B;NDUFB3;NDUFC1;NDUFB4;DMAC1;NDUFB11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;NDUFB10;NDUFS5;NDUFA3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6764197655137847,-1.021721068542634,0.5357142857142857,1.0,1.0,1/6,6.95%,NONO
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5920058221880953,1.021544609483619,0.42857142857142855,0.9400671358076046,1.0,3/7,20.01%,PKDCC;CSK;CLN3
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5472001947421634,-1.0214352604970043,0.38461538461538464,1.0,1.0,6/15,23.88%,TCP1;CCT6A;CCT8;CCT7;CCT2;NOP10
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.4568774994871864,1.0212905954006568,0.4411764705882353,0.9400446911330994,1.0,4/14,11.55%,BMP7;PTCH1;ROBO2;FGF10
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.598300712169553,-1.021222154255361,0.4576271186440678,1.0,1.0,6/11,35.03%,UQCRB;CYCS;UQCRH;UQCR10;CYC1;UQCRC1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4692292353063257,-1.0212000113078394,0.4461538461538462,1.0,1.0,11/42,18.69%,BTN2A2;CYP1B1;PINK1;FOXM1;STK17A;VPS35;EIF6;FASN;FLOT1;MBOAT7;ARF1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.41349085524307155,-1.021166773998066,0.45,1.0,1.0,22/108,20.49%,PTGIS;EPAS1;BNIP3;SUV39H1;PINK1;PSMB6;BACH1;PSMB8;PSMA3;PSMA5;PSMC3;HIF3A;PSMA7;PSMC6;RGCC;TBL2;OPRD1;PSME1;RBX1;PSMD12;PSMB2;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5551362851771783,-1.0211160300958182,0.4117647058823529,1.0,1.0,2/16,9.34%,LDLRAP1;IGFBP5
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.4750916405254959,1.0210971855887656,0.325,0.939799062061578,1.0,5/19,8.80%,GRIN3A;TGFBR1;GRIN2A;SDF4;SMAD2
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.45886836317546514,1.0209974826354582,0.4117647058823529,0.9392973161938232,1.0,1/30,0.16%,ATP6V0D2
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.4043589007739581,1.0207045414400158,0.38461538461538464,0.9393646746692507,1.0,12/65,15.58%,GLYATL2;ABHD1;ACADVL;EHHADH;CEL;CROT;AIG1;SLC27A2;ABCD2;PEX2;ACOT8;ECHDC1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.6464186500759623,-1.0206904713242089,0.5423728813559322,1.0,1.0,3/7,26.26%,LPCAT4;PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5593772243631412,1.0204588124662384,0.43243243243243246,0.939231501417627,1.0,3/11,12.82%,ITGA4;AKR1C3;ANO6
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.4583850148792644,1.0199260103211996,0.3548387096774194,0.9398884894045161,1.0,14/41,16.39%,GALNT3;GXYLT2;GALNT12;ST3GAL3;GALNT7;GALNT10;C1GALT1C1;GALNT13;ST3GAL1;GALNT14;ST3GAL2;ST6GALNAC4;ST6GALNAC2;GCNT4
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.4818305429777275,-1.0195984262256885,0.45161290322580644,1.0,1.0,6/23,26.73%,LMAN1;HERPUD1;SYVN1;UFD1;HSP90B1;SELENOS
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.5045216480867999,-1.0191504713140107,0.4714285714285714,1.0,1.0,6/26,12.78%,CYP1B1;PTPRC;NOTCH1;CRLF3;CCL5;OCIAD2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.49221381178217755,1.0191489560295326,0.4418604651162791,0.9411670269057403,1.0,1/16,3.02%,KANK1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.49921583460732316,1.0191367395374509,0.41304347826086957,0.940432887259168,1.0,6/17,23.46%,ZBED3;MARK1;MTM1;TRAK2;MARK2;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6005010650777342,-1.0189715806403057,0.5,1.0,1.0,4/8,36.47%,RSPO3;PLEKHA4;NKD1;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6051353325491733,-1.0185638735515103,0.5737704918032787,1.0,1.0,4/9,25.22%,DAB2IP;PIK3CB;DCN;ADAMTS12
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.5201633501602928,1.0185183206947424,0.4358974358974359,0.9411984034924862,1.0,6/13,13.33%,GCH1;S100A1;APOE;NOS1AP;SCARB1;DHFR
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.5733705902967146,1.0184518185036533,0.42105263157894735,0.9406539374095094,1.0,4/7,20.36%,PNPLA2;PLIN5;SORL1;APOA1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.4812541210274282,1.0181117807164877,0.5365853658536586,0.940697707598137,1.0,6/22,17.98%,ZBTB20;IGF1;SLC4A4;PFKFB3;PDGFB;NFKB1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.6732027846018191,-1.0180667919425515,0.48333333333333334,1.0,1.0,1/5,8.90%,BCAP31
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5615743399166843,-1.0178650688711575,0.484375,1.0,1.0,5/20,22.82%,ABT1;RPS21;ERI2;WDR12;EXOSC8
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.3322606910452467,1.0177424564356357,0.23529411764705882,0.9410514870492384,1.0,53/275,16.86%,FHDC1;NEDD1;ARL13B;PCM1;PDE6D;CDC14B;DNAH5;CNGA4;CFAP70;TTC39C;RAB3IP;CFAP46;RSPH6A;JHY;RPGRIP1L;UBXN10;PKHD1;KIAA0586;DYNLRB2;CEP135;CEP83;TOGARAM1;CFAP43;ABCC4;RFX2;SCLT1;CDK5RAP2;TTC36;PIBF1;BBIP1;PTPN23;SNAP29;EXOC7;WDR35;FNBP1L;ABLIM1;MAPRE1;TRIP11;DYNC1I2;ALMS1;EHD4;BBS9;MACIR;PARVA;KIF24;RAB11FIP3;B9D2;CFAP20;POC1B;RFX3;CFAP44;IFT74;B9D1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.6018417736194696,1.017712233410016,0.5294117647058824,0.940408813999454,1.0,3/8,24.50%,HMGB1;ERCC3;TOP3B
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.5788456382891275,-1.0176420707204885,0.49206349206349204,1.0,1.0,4/16,12.29%,CHMP4B;CHMP2B;CHMP2A;EML3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5239973509122475,1.017469311414815,0.41935483870967744,0.9403310456118984,1.0,6/18,18.72%,RASSF2;PDE4D;GPD1L;INPP5J;PTEN;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.7102220627589567,-1.0172406739205242,0.5344827586206896,1.0,1.0,3/5,28.00%,MAFB;HSPA9;LDB1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4440903426154231,1.017238294202907,0.3548387096774194,0.9402533978890251,1.0,11/36,18.88%,MAML3;TGFB2;MAML1;JAG1;ROBO2;EPN2;EP300;JAG2;BMP2K;CREBBP;ROBO1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5391430538197618,1.0172179056543804,0.46875,0.9395907583976245,1.0,3/16,10.56%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.6553476528383956,-1.0172117437333354,0.5079365079365079,1.0,1.0,5/6,32.04%,FURIN;FN1;CD24;HSP90AB1;CDH3
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.644680028685575,-1.0171901259628129,0.5490196078431373,1.0,1.0,2/8,19.68%,NOTCH1;CPE
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.6194067184407429,1.017169501409993,0.4782608695652174,0.9389512080595758,1.0,2/6,9.47%,JAM2;EIF2AK3
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.44083103404382323,-1.0170010576858155,0.410958904109589,1.0,1.0,21/70,29.22%,FIP1L1;CSTF2T;DDX39A;NCBP2;SLU7;SLBP;NCBP1;RNPS1;CDC40;ALYREF;UPF3B;DHX38;CLP1;THOC5;PAF1;CPSF4;CSTF1;POLR2D;SRSF5;SRSF9;NUDT21
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.4474793689951193,1.0169375367810383,0.4838709677419355,0.9388968541437575,1.0,5/33,12.03%,CDC14B;CDC26;ANAPC16;CDC23;SIRT2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.47223846720787016,1.0169293481002681,0.42857142857142855,0.9381817300562503,1.0,6/24,16.44%,EGFR;UBE2J2;REEP1;CYB5A;MAIP1;EMD
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4612866832994823,1.016839511163599,0.3888888888888889,0.9376658143227792,1.0,4/29,4.25%,PTPN3;FGF14;FGF13;UTRN
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.4922055709009363,-1.0166136624483115,0.47761194029850745,1.0,1.0,13/42,23.29%,MPV17L2;RPS27L;RSL24D1;RPL5;EIF6;RPL3;RPL24;C1QBP;RPS15;ERAL1;RPF2;SBDS;TRAF7
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.6047722413933783,1.016522272971362,0.4358974358974359,0.9377005567216026,1.0,1/6,3.02%,KANK1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.5534909063148995,-1.0163573665272152,0.484375,1.0,1.0,2/15,10.80%,UPB1;DPYS
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.6857881920640334,-1.0162671484848433,0.5245901639344263,1.0,1.0,2/7,24.42%,SLC36A1;SLC38A5
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.43172272828479463,1.0158579162129562,0.43902439024390244,0.9386473110509508,1.0,11/31,21.86%,SOCS6;PI4K2A;PIP4K2A;PIK3R1;SOCS2;IP6K1;PIK3C2B;EFR3B;IP6K2;PI4K2B;PI4KA
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.38347580904014306,1.0158237904134275,0.2962962962962963,0.9380773283330697,1.0,12/93,6.58%,TACR1;TRPC3;CHRNA10;F2RL1;GLP1R;ACKR2;C5AR1;CACNA2D1;GPR174;PTGFR;PDGFRA;HMGB1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.4764199162339007,-1.0155612251319237,0.463768115942029,1.0,1.0,8/33,20.25%,CHAF1A;HAT1;NAP1L2;DAXX;GRWD1;H2BC18;H3-3A;CHAF1B
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.47375985143664734,1.0155558913286975,0.42857142857142855,0.9379909834898477,1.0,14/42,16.62%,LEF1;BMP7;TGFBR1;TGFB2;FGFR1;LIMS1;FAM83D;TGFBR3L;HMGA2;FBXL17;LRP6;RANBP3L;MEF2C;WNT5A
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.5636228962308837,1.0154050268050006,0.5555555555555556,0.9376416508666076,1.0,5/13,22.90%,HDAC1;SIRT1;SIRT7;AURKC;CHD1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.5746783203161939,1.0152378448856807,0.4117647058823529,0.9374133599081478,1.0,2/8,8.08%,PKDCC;SOX5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.42069706820684427,1.014981295304556,0.3888888888888889,0.93736056405028,1.0,15/52,17.88%,PTPRK;EGFR;FOS;PDGFRA;PRKCD;AKR1C3;AGAP3;ERCC6L2;MAP3K5;MAPK8;SIRT1;FER;PXN;MAPK7;RELA
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.6144890689966616,-1.0148396973949423,0.484375,1.0,1.0,2/10,8.18%,ING2;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.6621175346460315,-1.014607564409036,0.4807692307692308,1.0,1.0,3/5,31.22%,CRY2;PER1;LMO3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5669236429314152,-1.014321925146389,0.421875,1.0,1.0,4/13,14.59%,CYP1B1;ARG2;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.6449041004322013,-1.0142929283094035,0.5217391304347826,1.0,1.0,2/5,10.96%,TAF7;SPI1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.48961160826725963,-1.0140515207039595,0.46774193548387094,1.0,1.0,3/34,8.83%,HENMT1;TDRD1;TDRD9
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7056468953439095,-1.0139578619133935,0.54,1.0,1.0,2/5,24.02%,RPF2;RAN
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.4525218672898764,1.0138667205160885,0.46153846153846156,0.9396814174582213,1.0,6/20,16.60%,RORA;APOE;SCARB1;SIRT1;FITM2;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.48773326745853235,1.0138296547739476,0.5,0.9390367577847918,1.0,6/14,21.82%,SCARB1;PNPLA2;PLIN5;NR1H3;APOA1;LDLR
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.6218789847053309,1.013800963534311,0.4772727272727273,0.9383930868531926,1.0,2/5,10.15%,RRM2;SAMHD1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5978693306088732,1.0134956485694342,0.5128205128205128,0.9385252223435523,1.0,3/7,26.11%,PDSS2;PDSS1;PHYH
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.6222611499079135,-1.0134828712824684,0.5666666666666667,1.0,1.0,1/6,3.52%,GOT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.6601228512026592,-1.0133954716587663,0.4838709677419355,1.0,1.0,2/5,31.22%,YAP1;LMO3
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.6793495466484165,-1.0132569333632708,0.5517241379310345,1.0,1.0,3/5,21.63%,CAV3;FLOT1;EMP2
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.6377888438972359,-1.0128924907203527,0.5,1.0,1.0,1/5,11.94%,UFM1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.6377888438972359,-1.0128924907203527,0.5,1.0,1.0,1/5,11.94%,UFM1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.6377888438972359,-1.0128924907203527,0.5,1.0,1.0,1/5,11.94%,UFM1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6664222091463409,1.0128632481301716,0.5106382978723404,0.9393114315466566,1.0,4/5,31.39%,PNPLA2;PPARA;PPARG;ABHD5
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.5591032188104345,1.0126077344297477,0.5111111111111111,0.9393228033685833,1.0,2/12,5.00%,NFIB;EPHB2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5022712627500215,-1.0125729369954808,0.5147058823529411,1.0,1.0,7/28,24.53%,POLR3K;TBP;POLR2K;GTF3C6;GTF3C4;POLR3G;GTF3C3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.560875043501354,-1.0124874329288245,0.47368421052631576,1.0,1.0,3/16,13.10%,ZFPM1;INHBA;MAFB
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.5477828223516371,1.0124648302645607,0.45714285714285713,0.9389639682718977,1.0,2/11,3.97%,PEX5L;PEX7
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.5702838986487136,1.0124134275563943,0.38235294117647056,0.9383228115833627,1.0,4/6,26.50%,ERCC2;ERCC3;CTNNB1;USH2A
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.46247397793335404,-1.0123505081717117,0.45161290322580644,1.0,1.0,6/53,10.67%,TRIM22;TRIM5;TRIML2;SLC26A4;TRIM25;BORA
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.3883955636393997,-1.012225069871185,0.4675324675324675,1.0,1.0,29/204,20.42%,EPN1;CD4;CHRNB1;LDLRAP1;SPAG4;CAV3;CHMP4B;SYNGR2;MTCH1;CHMP2B;CHMP2A;HIP1R;OTOF;LRP2;SYT2;TLCD2;MYADM;CNTN2;TGFA;LPCAT3;TTPA;ATP10B;MYOF;RABIF;CPTP;MITD1;NUP155;ACTG1;STEEP1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.5247013428466896,1.0119124402039443,0.38461538461538464,0.9389110911773069,1.0,3/17,11.55%,KDR;IGF1;FGF10
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4302172175595704,-1.011899917500645,0.4266666666666667,1.0,1.0,6/79,6.84%,CD44;SIGLEC1;FBLN5;VWA2;RAC1;ECM2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.689660017387553,-1.011772826515478,0.5087719298245614,1.0,1.0,1/5,14.01%,PSMC3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.47953370920014565,1.011604976046669,0.40540540540540543,0.9390313637948493,1.0,12/23,23.01%,SMYD2;PRMT5;FBLL1;SUV39H2;PRMT8;CREBBP;NSD1;SMYD3;SIRT7;SETD6;EHMT2;PRMT6
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5086087554044663,-1.0113835418819828,0.5344827586206896,1.0,1.0,6/21,24.28%,RFC5;RPA3;POLE2;PCNA;RPS27A;UBC
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6450921216025154,-1.011332799702425,0.509090909090909,1.0,1.0,1/7,5.41%,PEX11B
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5740729703989991,-1.011194300092212,0.43548387096774194,1.0,1.0,7/14,20.68%,P2RY12;NCKAP1L;CCL5;CXCL13;PODXL;ADAM9;SKAP1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5519613534699928,1.0108352877872657,0.43243243243243246,0.9403780378387909,1.0,1/10,0.66%,PID1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5075555046519271,1.0107970337981573,0.5172413793103449,0.9398028362235004,1.0,5/20,14.63%,STAC;CBARP;NOS1AP;CACNB2;DRD4
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.48287433153026804,1.0106915130781011,0.46153846153846156,0.9393043775809723,1.0,3/25,7.34%,TENT5A;ELAVL1;TENT5C
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.5111925323048154,-1.0105097005766284,0.4603174603174603,1.0,1.0,4/22,8.42%,STAT1;STAT5A;IL15;STAT4
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.3988685257371079,1.0101555822990977,0.42105263157894735,0.9398571840258986,1.0,6/107,2.82%,RUNX1;LRIG3;LAMB2;EGFR;WWTR1;KITLG
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.4138445142693339,-1.0101035566831509,0.4594594594594595,1.0,1.0,10/96,12.66%,NES;LDLRAP1;B2M;ZFPM1;LRPAP1;IFIT1;TMC8;HIP1R;EFHB;CTSZ
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.4670803657761322,1.0100401798653147,0.5128205128205128,0.9393919068396577,1.0,6/27,10.31%,PNP;LEF1;MDK;SOX12;ZBTB1;DUSP10
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.4558781909572056,-1.0099502467731156,0.4444444444444444,1.0,1.0,10/48,18.75%,KCNE2;PINK1;DAB2IP;UCHL5;TMF1;PSMC3;GABARAPL2;PSMC6;USP14;PSME1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6513494997246915,-1.0098962602675656,0.5081967213114754,1.0,1.0,4/7,28.99%,PSMC3;PSMC6;ESR1;PSMC4
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.5259483071909586,1.0098065123303335,0.45714285714285713,0.9391976742846239,1.0,2/11,18.28%,PARP10;PARP6
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5855475248739724,-1.0097087835901777,0.45,1.0,1.0,3/9,13.45%,TBP;TAF7;TAF7L
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3441273293927465,1.009539623184107,0.32142857142857145,0.9393495066408318,1.0,14/129,13.00%,ATP6V0D2;IFI16;WDR24;AKR1C3;DAP;PRKD1;EIF2AK3;EIF2S1;WDR45;MAP3K5;KPTN;MAPK8;FOXO1;SIRT1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.5104337717824738,-1.009191713502028,0.5394736842105263,1.0,1.0,4/25,9.19%,NPY;CCDC39;RARRES2;GLI3
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5906512231765283,-1.009000358707446,0.49206349206349204,1.0,1.0,1/9,6.25%,IFIT1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.4496431863968089,1.0087748863620025,0.2903225806451613,0.9402677047090041,1.0,17/41,16.95%,BMP7;BMP6;GREM1;ACVR1;ENPP1;PKDCC;TGFB3;SRGN;NELL1;ANKH;SLC8A1;ANO6;ECM1;GPM6B;MEF2C;BMP2K;SGMS2
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.6074324971651464,1.0086857910092861,0.4482758620689655,0.9398358932917429,1.0,4/6,14.60%,BMP7;IGF1;BAG3;LRP6
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.6466091301993793,-1.0084016787459416,0.5396825396825397,1.0,1.0,4/7,12.59%,F8;F10;SERPING1;A2M
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6143794039754287,-1.0082235259930303,0.48484848484848486,1.0,1.0,1/9,5.14%,BNIP3
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.6276973002380445,1.0079549244949713,0.5365853658536586,0.9409356062502733,1.0,1/6,5.00%,EPHB2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5462424696205646,1.0079209118552976,0.4375,0.9403208082735135,1.0,2/12,3.09%,SOX13;BMP7
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4419261452239522,1.0078402016666475,0.43478260869565216,0.9398468779557979,1.0,3/13,11.40%,ENPP3;ENPP1;AK5
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.5030781569126869,-1.0078131660028142,0.42028985507246375,1.0,1.0,2/19,1.55%,LRP4;CHRNB1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.3402463545376901,1.0069629736393078,0.32142857142857145,0.9414819083813332,1.0,25/163,8.37%,RUNX1;ABI3BP;NOX4;PRRX1;ADAMTS2;COL15A1;SVEP1;SGCD;PENK;ZEB2;SSC5D;LAMA4;PCDH18;FNDC1;NFATC1;GREM1;MDK;PDGFRA;PRKCD;IL1R1;HTRA1;IGF1;FLI1;SLC6A13;PTCH1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.519325489394641,1.0066601392437995,0.375,0.9416204664208716,1.0,3/10,10.59%,LCAT;APOE;SCARB1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.4119800923428565,-1.0060619411202572,0.39436619718309857,1.0,1.0,1/74,0.02%,CD44
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5221493664509981,-1.0058351968402932,0.46774193548387094,1.0,1.0,7/20,24.45%,RSL24D1;RPL5;RPL3;RPL24;RPF2;TRAF7;DDX28
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5928067657133063,-1.005550509661496,0.49122807017543857,1.0,1.0,2/11,8.55%,CHMP4B;CHMP2A
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.59590404412313,-1.005418107411168,0.5,1.0,1.0,3/12,10.43%,HESX1;GCM2;TBX1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.4837094530305252,1.0053880340071668,0.45454545454545453,0.9442075645322474,1.0,6/22,15.75%,PNP;PDE4D;HPRT1;PRTFDC1;MLYCD;FITM2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.38751168859429697,1.0050677059658915,0.4,0.9444297160154533,1.0,6/59,7.21%,EPHA3;EPHA5;IQGAP2;PEAK3;PRKCD;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.4613860839060373,1.0048807229397008,0.5142857142857142,0.9442225748308505,1.0,8/21,24.04%,FOXO6;NLGN1;APOE;RELN;DLG5;NEURL1;CAPRIN1;SHANK1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.48865112220774876,-1.0043966932535124,0.45454545454545453,1.0,1.0,9/26,21.11%,ACOT4;BAAT;ACOT12;ACOT13;ACOT2;ACSM4;ACSM6;ACOT1;ACSM3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.48865112220774876,-1.0043966932535124,0.45454545454545453,1.0,1.0,9/26,21.11%,ACOT4;BAAT;ACOT12;ACOT13;ACOT2;ACSM4;ACSM6;ACOT1;ACSM3
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6038052278523381,-1.0043505237780728,0.5555555555555556,1.0,1.0,2/7,15.92%,APH1B;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.5200940739375409,-1.0042294279308128,0.5333333333333333,1.0,1.0,4/22,18.69%,DRD3;SLC24A1;GRIK3;ARF1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.4042559153782448,1.0038745457723401,0.4230769230769231,0.9460517632111954,1.0,3/29,6.63%,MTHFS;DGLUCY;DDAH1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.4055763680565322,-1.0034703680901405,0.4567901234567901,1.0,1.0,17/119,10.31%,PRLR;VASN;EPAS1;HSPG2;TMEM184A;EPHX1;TIMP3;AGT;AARD;DOCK6;RARRES2;ACOX2;COL6A1;F10;IGFBP5;DAB2IP;PLSCR4
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.5120621550757191,1.003462126487664,0.4,0.946432644379986,1.0,1/11,2.26%,BCL2L11
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5880524488907577,-1.003379177155802,0.5161290322580645,1.0,1.0,4/10,15.49%,CCL5;CXCL13;MSMP;GPR183
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.5382117855143255,1.0031956539536353,0.43902439024390244,0.9464919597845015,1.0,5/9,21.07%,NFATC1;EREG;PDGFB;NFATC2;NFATC3
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.6322547368370048,1.0031883939229387,0.5121951219512195,0.9458348389775953,1.0,3/6,20.38%,PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.6109032209631337,-1.0031346055991952,0.47619047619047616,1.0,1.0,3/7,28.49%,MCTS1;MTIF2;GFM2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.6114505864615347,1.003078586508262,0.4594594594594595,0.9454457972903748,1.0,3/6,22.83%,CTTNBP2NL;WWP2;SNCA
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.6027772105024055,1.003065449049346,0.45454545454545453,0.9447477430262868,1.0,5/6,21.55%,ST3GAL1;ST8SIA3;ST3GAL2;ST6GALNAC2;ST3GAL4
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5238741594429522,-1.0029117461660535,0.47692307692307695,1.0,1.0,6/24,18.75%,SCN4B;SCN7A;SCN9A;CACNA1G;HCN4;YWHAH
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.536731268099549,1.0029008783112432,0.4318181818181818,0.9444987788643756,1.0,5/14,12.02%,NEK6;PTTG1;TPR;CDC23;HECW2
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.4966476541872815,-1.0028260412174093,0.5,1.0,1.0,4/23,18.28%,SOX10;TLR2;EIF2B2;EIF2B5
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6102503612189729,-1.0018772789791355,0.559322033898305,1.0,1.0,2/9,8.14%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.40988036300775565,1.0017734654214763,0.35,0.9467978646116164,1.0,21/70,22.31%,AFF2;PTBP3;PTBP2;KHDRBS3;HSPA1A;PIK3R1;U2AF2;FASTK;CELF1;KHDRBS2;BRDT;HNRNPL;RRP1B;HNRNPH1;QKI;MBNL1;SON;SRRM4;SETX;PTBP1;RBM39
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.43825511014618057,1.001606108022787,0.45714285714285713,0.9465051324397948,1.0,11/33,22.83%,SYNJ2;CEL;NLGN1;NLGN4Y;SYT1;SNAP91;MX1;OPHN1;PIP5K1C;ITSN2;SNCA
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5060992162946256,-1.001594793781263,0.45454545454545453,1.0,1.0,5/29,8.25%,KCNE2;SCN4B;CAV3;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5214883822139424,-1.0014844549213897,0.5,1.0,1.0,1/20,0.72%,CSRP3
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.40889488469395996,1.0012515906060608,0.3611111111111111,0.9467556718099727,1.0,5/29,11.59%,DGKB;APOE;DGKH;LYPLA2;PNPLA2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.5858309098275916,1.0011586520553997,0.5102040816326531,0.9462187837383844,1.0,2/5,5.77%,GREM1;ENPP3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.3858204191227253,1.0010798023720333,0.42424242424242425,0.9457145807437622,1.0,2/46,0.66%,ACE2;PID1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.44958527601611437,-1.000180473288631,0.45454545454545453,1.0,1.0,8/35,23.95%,ATP1B1;ALDOB;TPM1;GABARAPL2;DNAJB1;AHSA1;UHRF1;DYNLL1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5384240450697332,0.9994951246246679,0.425,0.9492148666364558,1.0,4/14,19.30%,MACROH2A2;SMARCA4;SMARCB1;SIRT7
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5295345794223111,0.9994050240384532,0.4,0.9487516308244561,1.0,3/13,8.90%,HSPB1;SEMA5A;PRKD1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.45862555406218575,0.9993304935690014,0.45714285714285713,0.9482784806882771,1.0,2/22,2.40%,ITGA4;PKP2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.5651755871040356,0.999203029351784,0.5476190476190477,0.9479331900820364,1.0,4/7,30.81%,FYN;INSR;MTMR2;IGF1R
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.511986338969693,0.9989114323327452,0.4,0.9481601869605951,1.0,5/14,11.89%,SLC12A3;SLC12A1;SCNN1B;NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.5954104907149154,0.9985553401727103,0.5,0.9482492995072673,1.0,6/9,24.14%,LAMB3;LAMA3;CD151;LAMC1;DST;ITGA6
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.5585911104554142,-0.9983415351953353,0.4745762711864407,1.0,1.0,2/10,4.40%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.35958062655178635,0.9983341065683499,0.3181818181818182,0.9481162533204339,1.0,24/103,19.34%,EYA4;TBL1Y;HDAC9;PRKCD;CCNA2;PRDM5;HDAC1;HDAC10;EYA2;RUVBL2;PRMT8;UBE2U;SIRT2;EYA3;SIRT1;EP300;SIN3A;HDAC5;TAF10;CREBBP;NSD1;BAZ1B;SIRT7;KAT6B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.520074591775064,0.9983099666582277,0.48484848484848486,0.9475079865753696,1.0,2/18,0.47%,RUNX1;PNP
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5435674039177976,-0.9981120146333351,0.4827586206896552,1.0,1.0,4/11,22.05%,CHMP2B;CHMP2A;VPS37B;VPS4A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5171578614597888,0.9981089050043681,0.4117647058823529,0.9474390292390092,1.0,1/19,0.69%,IFI16
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.6579748978181271,0.9976772263270792,0.5714285714285714,0.9479292812296992,1.0,2/5,6.58%,LEF1;HMGB1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.5550298605440707,0.9975794637533789,0.5789473684210527,0.9475017071014198,1.0,1/12,0.87%,LEF1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.5852506343360651,-0.9975641755309198,0.5263157894736842,1.0,1.0,1/11,6.16%,WIPI1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3556234259379408,0.9975265737282935,0.34615384615384615,0.9470010303734931,1.0,17/98,9.60%,FREM1;PTPRT;KCNIP1;NTM;KDR;ZNF536;EFS;SORCS1;MAPK4;RGS7BP;NRXN1;APOE;CRTAC1;RCAN2;CNTN1;SLCO1C1;SLC6A1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5665433388522311,-0.9972475036489978,0.45,1.0,1.0,2/10,7.75%,RPS27L;FOXM1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.5601226775663879,0.997175051448206,0.3870967741935484,0.9470905386103061,1.0,1/8,2.26%,SSC5D
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.4198110618986178,0.9971125592650587,0.4722222222222222,0.9465383149672847,1.0,6/33,11.93%,PER2;SLC37A4;G6PC3;SLC25A1;PC;RBP4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.5293620451666478,-0.9969674926044565,0.5079365079365079,1.0,1.0,6/17,12.78%,PRLR;CYP1B1;NOTCH1;CRLF3;CCL5;OCIAD2
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.6273520392664995,-0.996960345833223,0.5483870967741935,1.0,1.0,4/7,31.04%,MMUT;MMAA;PCK2;PCCB
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.5853597757988351,-0.9969436483688328,0.5076923076923077,1.0,1.0,3/11,8.25%,ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.5498842129874464,-0.9967654459259004,0.47619047619047616,1.0,1.0,3/11,11.67%,HSPA5;HERPUD1;EIF2AK1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.4304141060174568,0.9965372574818778,0.4411764705882353,0.9473006895323235,1.0,2/40,5.04%,PID1;MARCHF5
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.5881841184889371,0.9964648665805776,0.425531914893617,0.9467701304279142,1.0,3/7,11.55%,MDK;TGM1;FGF10
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5672204385068588,-0.9963853257305996,0.5079365079365079,1.0,1.0,3/11,20.52%,SERPINE1;CHEK1;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.5286826955448712,0.996252302582353,0.4827586206896552,0.9466811338114094,1.0,4/15,11.35%,MELTF;KLKB1;RHBDD1;BAG2
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5312019802067753,0.9957437730757797,0.47058823529411764,0.9472110040020187,1.0,2/18,7.19%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.6595871117322449,-0.9957151957636565,0.5625,1.0,1.0,1/6,15.92%,ADAM17
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.6285392250822216,0.9955232387092442,0.5434782608695652,0.9469227066855246,1.0,3/6,14.63%,SLC6A4;SLC22A3;SLC6A2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6166978644686778,-0.9954396209591059,0.5573770491803278,1.0,1.0,2/10,8.25%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.4732335590045938,-0.9952661476506025,0.48484848484848486,1.0,1.0,1/39,0.02%,CD44
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.5485211679432571,-0.9949017483166911,0.5396825396825397,1.0,1.0,5/19,13.30%,TRIM5;CHMP2B;CHMP2A;TRIM25;TRIM32
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5841628456212791,0.9948806137591091,0.5161290322580645,0.9480170877383305,1.0,2/8,7.21%,NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.37884652894883275,0.9948377586142753,0.4411764705882353,0.9474565596187301,1.0,15/62,13.46%,NFIB;KANK1;GRIN3A;GREM1;FGFR3;MARCHF5;SPRY3;HEY1;VASH1;SFMBT1;ANP32B;PTPRS;ELAPOR2;RC3H1;SRGAP2C
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.6134461425552108,-0.9947053091616896,0.5846153846153846,1.0,1.0,2/8,20.15%,CCDC39;MET
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5320555604376396,-0.994669977703587,0.5166666666666667,1.0,1.0,7/14,28.60%,CDKN2D;SNAI2;TRIM32;RPS3;ACKR3;SFRP2;TPT1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5439301116631572,0.9945425402866004,0.5294117647058824,0.9475242294404397,1.0,3/10,13.33%,GCH1;PRKG2;DHFR
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6105946695494769,-0.9943812017078112,0.48333333333333334,1.0,1.0,4/9,26.22%,IL4I1;PCBD1;FAH;GSTZ1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4680013725940849,-0.9941821260216374,0.42857142857142855,1.0,1.0,5/34,9.34%,DUOX1;STAT1;AHR;KCNQ1;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.635013538890374,-0.9941418553818904,0.5254237288135594,1.0,1.0,1/9,1.99%,PTPRC
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.47871387529492615,-0.9939056515242917,0.5285714285714286,1.0,1.0,8/39,18.75%,KCNE2;SCN7A;KCNQ1;SCN9A;GPER1;CACNA1G;KCNE3;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38734648729741156,0.9936221516428044,0.52,0.9493471607235338,1.0,10/51,14.18%,EGFR;RAD51B;PLCB1;DBF4B;CDC23;UBE2E2;FGF10;ESPL1;LSM10;NSMCE2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.4513823177968648,0.9935288330535722,0.3953488372093023,0.9488599767200279,1.0,8/19,23.38%,LIN28B;KHSRP;TRIM71;TARBP2;XPO5;DIS3L2;DGCR8;AGO2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.46726876705509435,-0.9933096841091774,0.4533333333333333,1.0,1.0,4/36,13.62%,DDX20;GEMIN4;SNRPD2;PRPF19
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5119923823878496,0.9932942956604528,0.5161290322580645,0.9487804039391546,1.0,3/21,10.56%,ELOVL6;HACD2;TECR
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.529439597951668,-0.9929667275309991,0.45588235294117646,1.0,1.0,5/19,22.34%,CAV3;CALM3;HCN4;CALM1;NOS1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.501359389376681,0.9928509776904806,0.45454545454545453,0.9493056341358749,1.0,3/11,10.59%,LCAT;APOE;SCARB1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.6599648951030448,-0.9928168892181521,0.5925925925925926,1.0,1.0,1/5,13.01%,OAS3
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.60142308403152,-0.9928042487557951,0.609375,1.0,1.0,2/10,8.14%,TRIM5;CIITA
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.366045173915314,0.992789770735015,0.5,0.9487882956712184,1.0,11/106,8.56%,LRIG3;LAMB2;NPNT;EGFR;WWTR1;SDC4;BTC;SCNN1B;GNG12;PXDC1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),0.5631991465196499,0.992648992348006,0.4888888888888889,0.9484695108965282,1.0,1/7,2.26%,BCL2L11
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.3589880035229744,0.9926181400083202,0.46153846153846156,0.947849511153711,1.0,12/129,4.30%,FBXL7;NOX4;LAMB2;PRRX1;PDGFD;COL15A1;SVEP1;SGCD;LAMA4;PCDH18;FNDC1;MYH11
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3973681950005478,0.992588035841906,0.34285714285714286,0.9472719972762029,1.0,5/55,4.18%,EGFR;BCL2;TGFBR1;PLCB1;TGFB2
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.581838692163045,0.9922881224751836,0.5,0.9473705203152273,1.0,1/6,7.31%,TICAM1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.5356116959783319,0.9920328760355611,0.4186046511627907,0.9473339592704031,1.0,1/7,17.10%,PHF14
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4385968300061329,-0.9920270841578527,0.4857142857142857,1.0,1.0,5/53,5.51%,PTGIS;EPAS1;BNIP3;SUV39H1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6303328454372935,-0.9915356232904808,0.5925925925925926,1.0,1.0,2/7,10.81%,DAB2IP;PIK3CB
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.40441993423464545,0.9914204835251662,0.5,0.9482309742866329,1.0,30/109,19.09%,RIMBP2;LHFPL4;ADGRA1;MAPK4;KCNJ6;KCNB2;OLFM3;HS6ST3;GRIA2;NRXN1;TMEM196;CSRNP3;PHF21B;PAK5;NOL4;ST8SIA3;ELAVL3;MSI1;NXPH1;NR4A2;DPYSL5;SNAP91;PRR36;KCNC1;CELF4;UNC13A;CACNA1B;PHYHIPL;BSN;CLVS2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.5518268681287363,0.9912408307189409,0.5,0.9480694611021823,1.0,2/8,7.80%,ATOH8;ZEB1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.6292900112982969,-0.990862052115219,0.5333333333333333,1.0,1.0,2/6,24.74%,PLCG2;AKT1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.41474957416852537,-0.990751398092516,0.5142857142857142,1.0,1.0,15/99,14.57%,CSRP3;LAMA2;ACTC1;NOTCH1;CAV3;TRIM54;PDE1A;CTNNA3;MYOM1;CASQ1;FABP3;TTN;CKB;SLC25A4;TPM1
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.5949902458308209,-0.990422772452879,0.5396825396825397,1.0,1.0,3/8,15.92%,CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.5949902458308209,-0.990422772452879,0.5396825396825397,1.0,1.0,3/8,15.92%,CCL5;CXCL13;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5362249861956672,-0.990301304193635,0.453125,1.0,1.0,1/15,1.47%,WFS1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.566922988665568,-0.990282221913078,0.4918032786885246,1.0,1.0,2/9,7.75%,RPS27L;FOXM1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4757748433198153,0.9900186203303497,0.5,0.9504561003829329,1.0,1/26,0.60%,CCNH
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.4047937698834244,0.9899605937754823,0.41379310344827586,0.9499723591616821,1.0,7/56,5.27%,CDH13;NPNT;CCL28;NRP1;UTRN;RSU1;MDK
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.5663179251610869,0.9894203246885123,0.5813953488372093,0.9508338253856481,1.0,1/8,2.27%,NRP1
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.6534160423284429,-0.9894173254886436,0.5806451612903226,1.0,1.0,1/5,6.77%,ALDOB
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.5589500251313639,0.9893872350393973,0.56,0.9502058243904353,1.0,1/8,2.26%,BCL2L11
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.5863942153045938,-0.9890414062997944,0.5087719298245614,1.0,1.0,3/9,13.91%,ABCC6;SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.6202928271809229,0.988996917733917,0.5405405405405406,0.9505081952673968,1.0,2/5,6.13%,GAL3ST1;GLA
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.5145935515918938,-0.9888942911255061,0.5094339622641509,1.0,1.0,4/18,30.28%,PINK1;VDAC1;DNM1L;PARK7
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.4633193454459815,0.9888431573184234,0.46875,0.9502218958149465,1.0,5/23,13.01%,SYNJ2;CEL;NLGN1;NLGN4Y;SYT1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.507890606154776,0.988463671048715,0.45454545454545453,0.9508125640407421,1.0,5/13,17.24%,TGFB2;FGFR1;CELF1;RAI2;CELF4
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3834839550779745,0.9884462290100936,0.52,0.9501348714538799,1.0,18/106,14.42%,IRS1;EGFR;KDR;SLC25A37;FGFR4;TGFB2;SAMD4A;PRR16;ELAVL1;IGF1;IRS2;FAF1;EREG;SIRT1;EIF3E;AKT2;PDGFB;ABCB10
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.335266601978812,0.988299839536121,0.43478260869565216,0.9496847033667353,1.0,27/198,10.78%,UBASH3B;RGS14;PID1;PTPRT;IRS1;EGFR;SULF2;BCL2;KANK1;NFATC1;KIF26A;WWOX;SPRY3;RITA1;HEY1;PRKCB;ACVR1;APLN;PRKCD;ENPP1;RPGRIP1L;PTCH1;PTPRE;PTPN12;KCTD21;MOSMO;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6378852961037511,0.988038321344555,0.5588235294117647,0.9497702676524395,1.0,2/5,20.32%,HMGB1;SLC15A4
prerank,GO_Biological_Process_2021__negative regulation of SMAD protein signal transduction (GO:0060392),-0.6917988973204349,-0.9877329966399033,0.6607142857142857,1.0,1.0,1/5,3.75%,PBLD
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.6807151501151918,-0.9876169154210364,0.5666666666666667,1.0,1.0,2/5,31.26%,KDM1A;CTR9
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.5634691888859791,-0.9875583274040098,0.515625,1.0,1.0,2/8,28.58%,KDM1A;RIOX1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.38798854310449404,-0.9873626488948141,0.4714285714285714,1.0,1.0,22/105,14.23%,LAMA2;PRLR;CYP19A1;EPAS1;TIMP3;RARRES2;ANGPTL2;ACSBG1;F10;IGFBP5;ALDH1A1;ADGRF5;INHBA;PLSCR4;EFEMP1;ADAM21;SERPING1;CXCL14;HSD11B2;MAFB;SPARCL1;DHCR7
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.5346447899730468,-0.9873397814450782,0.5142857142857142,1.0,1.0,4/18,22.82%,INTS5;EXOSC6;INTS14;EXOSC8
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5676738798409088,-0.9871280872349276,0.49206349206349204,1.0,1.0,2/10,12.93%,BCAP31;TMEM30A
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.6346552462100052,-0.9870168807863483,0.5254237288135594,1.0,1.0,3/6,24.41%,ITGA5;ADAM17;WNT7A
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.39940591388466856,-0.98678842312299,0.4411764705882353,1.0,1.0,11/89,11.63%,RAD54L;MCM2;POLQ;FANCM;RAD51AP1;MORF4L1;RECQL;RPA3;GINS2;XRCC1;MRE11
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.5724273319778419,0.986625254237378,0.5142857142857142,0.9527554032078959,1.0,5/7,33.38%,NMNAT3;NMNAT1;NMNAT2;KYNU;NADSYN1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6000818486839656,0.9866031303184957,0.5405405405405406,0.9520988150576674,1.0,2/9,7.31%,F2RL1;TICAM1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.5307780580300225,-0.9863558926962697,0.43333333333333335,1.0,1.0,2/10,7.35%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.33044994796634464,0.9860237850788897,0.4444444444444444,0.9529114660299217,1.0,7/134,5.12%,FBXL7;NEDD1;HMMR;KCNH5;RAD51B;PCM1;DBF4B
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.3869113496934127,0.985788673611367,0.41379310344827586,0.9529226363078555,1.0,4/60,4.36%,ELOVL6;CYP1A2;ABHD1;DECR2
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5195888413068852,0.9856207109322892,0.5263157894736842,0.9526569596574399,1.0,3/12,8.37%,RORA;OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.5611795732176952,0.9855021269370527,0.5789473684210527,0.9522277353878497,1.0,2/7,16.70%,SNAP91;MX1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.5770274835450384,0.9851329542698566,0.5116279069767442,0.952679617963902,1.0,2/6,16.70%,SNAP91;MX1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.47572626962775066,0.9851183957401988,0.38235294117647056,0.951342478689719,1.0,2/12,3.42%,HORMAD1;RAD21L1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.47572626962775066,0.9851183957401988,0.38235294117647056,0.951342478689719,1.0,2/12,3.42%,HORMAD1;RAD21L1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5011511625326621,0.9851131013309715,0.5333333333333333,0.9506600235400133,1.0,6/20,14.37%,RAB7A;STX8;SNF8;HOOK3;PTPN23;WDR81
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5402617199125266,0.9850893556668966,0.5121951219512195,0.9500398001926603,1.0,3/11,16.51%,CPSF7;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4825687855199929,-0.9849183198267342,0.5230769230769231,1.0,1.0,9/22,23.52%,ATP5IF1;PINK1;UBE3A;UCHL5;TMF1;USP14;PSME1;GPX1;NUDT15
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.5342114794995305,0.984829157338342,0.3548387096774194,0.9499815524481257,1.0,2/10,7.36%,SGK1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.6453774837280809,-0.9845860462160159,0.6140350877192983,1.0,1.0,1/5,7.25%,ABCB4
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.4754677121020141,-0.9845116799871284,0.46153846153846156,1.0,1.0,6/16,27.52%,TOMM20;DNAJC19;TIMM17B;ROMO1;TIMM17A;GRPEL2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5572883269072939,-0.9841670964028514,0.5303030303030303,1.0,1.0,10/14,40.08%,CD160;CEACAM1;PHPT1;EZR;DUSP3;THY1;PTPN22;LAPTM5;PRNP;SLA2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.6148284881681971,-0.9840936404271936,0.509090909090909,1.0,1.0,2/7,18.04%,CASP8;PRR7
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.5342027114126651,0.9840255790764917,0.36585365853658536,0.951391364396554,1.0,2/6,16.01%,FYN;FRRS1L
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.5419362343001378,0.9840137449716638,0.4666666666666667,0.9507312009155794,1.0,5/13,21.14%,P3H3;P3H2;EGLN3;ASPH;P3H1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4734806033061086,0.9840114166574402,0.4642857142857143,0.9500618014931931,1.0,5/23,7.10%,SEMA6D;NRP1;DSCAM;SEMA5A;SEMA4C
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5692101381958649,-0.9837815313854906,0.5142857142857142,1.0,1.0,2/12,10.80%,UPB1;DPYS
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.6562832331751777,0.9837006763030086,0.6170212765957447,0.9501868082855336,1.0,1/5,12.88%,HMGA2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.48551549758325485,0.9833479478771857,0.5945945945945946,0.9504234535399605,1.0,6/17,13.33%,GCH1;S100A1;APOE;NOS1AP;SCARB1;DHFR
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.5457200213672596,0.9831696000669775,0.46875,0.9501721808754366,1.0,1/6,2.59%,SLC25A37
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.40639326157089023,0.983119279436131,0.4827586206896552,0.9496065952147756,1.0,2/43,2.21%,ATP6V0D2;MELTF
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.42643241799691406,0.9831065005161576,0.41935483870967744,0.9490215283242905,1.0,8/31,14.60%,COBL;TGFB2;PRICKLE1;SEMA4C;DVL2;PHACTR4;MTHFD1L;LRP6
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.46616991210652525,0.9830187379052078,0.53125,0.9486197464841462,1.0,5/21,17.38%,EIF2AK3;LYAR;SMARCA4;UBTF;SMARCB1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.38280018497735996,0.9826904795394878,0.45,0.9486642132638822,1.0,20/80,16.74%,TRPC7;TRPC3;CACNA2D1;MICU1;MCU;GRIN2A;TRPC5;SLC35G1;SLC8A3;SLC24A3;GRIN2C;SLC8A1;ANO6;TRPC1;MAIP1;GRIN2B;CACNA1A;TRPV2;GRIN1;MCUR1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.5728937810499045,0.9820588866555362,0.4444444444444444,0.9497005557708071,1.0,1/9,5.12%,DBF4B
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.409552699659423,0.982016760573616,0.4358974358974359,0.9491474281800358,1.0,9/43,11.91%,MELTF;NRP1;KANK1;MDK;EFNA5;PDPN;CASS4;LIMS1;ACTN4
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.39189229361707145,-0.981927984258444,0.4880952380952381,1.0,1.0,21/137,14.14%,C4BPB;MSX1;POLE3;UROD;CCNE1;EPHX1;GGH;ABCB1;SOD2;TST;FKBP4;JUNB;IRF1;GRINA;DNAJA1;PDAP1;CNP;ENO2;SLC25A4;PSMC3;SELENOW
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5733963298008362,-0.9817299114787764,0.49206349206349204,1.0,1.0,1/9,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.5704273380359555,-0.981690259277714,0.5483870967741935,1.0,1.0,3/11,23.82%,ELANE;WAS;FBLN1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.3693853792629466,0.9813856244264211,0.42857142857142855,0.9501010970376305,1.0,27/149,10.76%,GNG4;LRRTM3;GRIA4;PENK;RAB3C;CTNNA2;PCBP3;ADGRA1;OLFM3;GRIA2;GRM5;TSHZ1;HCN1;MMD2;BRINP1;NRXN1;SHANK2;CADM2;TMEM196;SEZ6L;RBFOX1;PAK5;SLC24A3;SLC6A1;DLGAP1;GRID2;ADGRB3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5854918053327318,-0.9813645955969903,0.5074626865671642,1.0,1.0,2/11,10.80%,UPB1;DPYS
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5061999576915425,0.9813380392118369,0.4897959183673469,0.9496292722737327,1.0,2/15,3.09%,SOX13;BMP7
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3758265707237785,0.9810548593637335,0.38095238095238093,0.9498141698587635,1.0,19/114,11.00%,LRIG3;ITGB5;LAMB2;EGFR;RORA;SLC16A2;UNC13B;SLC7A2;ADGRL2;DDAH1;PKDCC;CHKA;GALNT18;CAP2;GNG12;AMOTL2;TSPAN12;PC;CLDN12
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.544543700637772,-0.9809540145085077,0.5076923076923077,1.0,1.0,4/14,14.59%,CYP1B1;ARG2;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.3994658068759727,-0.980937383412437,0.5066666666666667,1.0,1.0,22/86,26.70%,YBX3;EIF5A2;MPV17L2;RPS27L;CCL5;RCC1L;RPL5;EEF2;EIF6;EIF2B5;C1QBP;NAT10;FASTKD3;NIBAN1;UPF3B;RPS4X;FXR1;YTHDF1;RPS6KB2;EIF5A;METTL3;POLR2D
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.5760659140264799,0.9808742220837126,0.5,0.9495953662008386,1.0,1/9,1.05%,SPX
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.5153307542389348,0.9807687783379008,0.5428571428571428,0.9491954530208815,1.0,2/16,6.88%,PID1;NUMB
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.4861525996735558,0.9806985440718667,0.425,0.9486953883107893,1.0,5/21,12.03%,PARD3;JAM2;EIF2AK3;TENM4;SIRT2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.5631978071178169,0.9804357411824438,0.4,0.9487395188058297,1.0,3/9,4.46%,PID1;PTPRT;SELPLG
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.618492541397357,-0.9804309504896442,0.5483870967741935,1.0,1.0,3/7,26.20%,KDELR3;KDELR1;GPAA1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.521638853918985,-0.9803830049802332,0.5,1.0,1.0,4/19,21.65%,PTPRC;CBLC;GPRC5A;MVP
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.4108156133213825,-0.9802052298617213,0.5063291139240507,1.0,1.0,16/76,20.29%,EPAS1;PSMB6;BACH1;PSMB8;PSMA3;CHEK1;PSMA5;PSMC3;HIF3A;PSMA7;PSMC6;DNAJB1;PSME1;RBX1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.5385216236032054,0.9801536616401236,0.45454545454545453,0.9486830120473667,1.0,3/10,19.06%,TENM4;DAG1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.637880019068453,-0.980071782160415,0.5932203389830508,1.0,1.0,3/6,28.63%,CD300LF;LYN;CD226
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.47420853001535884,0.9798855511581591,0.5142857142857142,0.9486165346498916,1.0,4/25,10.56%,ELOVL6;HACD2;SLC25A1;TECR
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.41940292524298917,-0.9797705262165386,0.4788732394366197,1.0,1.0,17/57,24.02%,ACOT4;HINT1;BAAT;ACOT12;ACOT13;RAB23;ACOT2;ACSM4;ACSM6;ACOT1;GTPBP1;ACSM3;TPST2;AK4;ACOT6;GMPR2;RAN
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.5309017359329256,0.9797440833786559,0.4722222222222222,0.9475705641013473,1.0,3/9,13.49%,IRS1;SIRT1;SORL1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.5309017359329256,0.9797440833786559,0.4722222222222222,0.9475705641013473,1.0,3/9,13.49%,IRS1;SIRT1;SORL1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.4233700698672192,-0.9793019060373295,0.43243243243243246,1.0,1.0,9/46,24.02%,CHMP4B;CHMP2B;CHMP2A;NUP85;ANKLE2;NUP155;VPS4A;NUP188;RAN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.4233700698672192,-0.9793019060373295,0.43243243243243246,1.0,1.0,9/46,24.02%,CHMP4B;CHMP2B;CHMP2A;NUP85;ANKLE2;NUP155;VPS4A;NUP188;RAN
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5272290424593487,-0.9792558433707569,0.5074626865671642,1.0,1.0,4/13,9.10%,TRIM22;TRIM5;TRIML2;TRIM25
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.4239186715141927,0.978730312892756,0.425,0.9491397638494097,1.0,3/34,11.24%,IFI16;EIF2AK3;KPTN
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.5118680045012121,0.978617239881848,0.43478260869565216,0.9487825111506484,1.0,5/13,18.83%,SLC25A33;PNPT1;EARS2;TFB2M;FOXO3
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.5612748158949118,-0.9783721097127555,0.48214285714285715,1.0,1.0,1/6,10.66%,PLAAT5
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.5871488230885218,-0.9783178358598777,0.53125,1.0,1.0,2/7,19.34%,BRK1;WAS
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3496171935177099,0.9782687691200511,0.5,0.9491167997501969,1.0,72/371,14.80%,NRG1;POU6F2;TBX6;MYLIP;FGF13;ZEB2;VCAN;WWTR1;CNTN6;DSCAM;SDK1;TGFBR1;SEMA5A;ATXN1;ALDH1A2;VLDLR;CRIM1;APBA1;KLK6;EPHB2;DSCAML1;MDK;RITA1;CNTN4;PDGFC;NAV3;LSAMP;GFRA1;GRIK1;JAG1;FAT4;NRXN1;CHD7;ZC4H2;EFNA5;CHST8;SHANK2;NLGN1;TRPC5;NRTN;C3ORF70;IGF2BP3;RYK;POU3F1;PSPN;RBFOX1;ERBB4;CHRM3;NELL1;MTR;THOC6;ROBO2;SPOCK1;DCHS1;MST1R;CDK5RAP2;GPM6A;TRIM71;KALRN;HAPLN1;WWP1;MBD5;MSI1;FGF12;EP300;MBP;NGF;FBXL17;NRCAM;GPM6B;ST8SIA4;RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5760429676006649,-0.9782327296446428,0.5666666666666667,1.0,1.0,6/10,27.36%,TGFB1;TAF7;GSTP1;CLTC;SELENOS;AR
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.5036304894899342,-0.977986819797823,0.6268656716417911,1.0,1.0,4/28,5.89%,PRELP;CHAC1;CHAC2;TST
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5695625523404757,0.9776215752067713,0.46511627906976744,0.9502312438835285,1.0,3/7,13.00%,HMGB1;PRKCD;SIRT1
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.5972076139496713,-0.9772843308497435,0.47368421052631576,1.0,1.0,3/10,18.67%,STEAP4;STEAP2;ATOX1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.48211381955096316,-0.9771326158824857,0.5538461538461539,1.0,1.0,5/26,11.97%,CYP1B1;P2RY12;SERPINE1;NCKAP1L;SNAI2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.4973870569661871,-0.9770931994129797,0.5882352941176471,1.0,1.0,3/25,3.54%,NOTUM;PTPRC;SFRP4
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.37862213417711604,0.9768275194115538,0.3333333333333333,0.9514041287231214,1.0,16/104,10.86%,RXFP2;HTR1F;GLP1R;GRK5;GNAO1;PTGFR;ADGRL2;HTR1E;WASF2;GNA12;FSHR;ADCY2;ADGRB3;GNAQ;ADGRL1;ADGRG5
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.3369003151725558,0.9767386109072131,0.45454545454545453,0.9509763320123894,1.0,43/332,10.00%,NRG1;CDH13;TBX6;PID1;LEF1;PDGFD;IRS1;TOX;C5AR1;EGFR;WWTR1;KDR;BCL2;CSF1R;FGFR4;KITLG;TGFBR1;S100A13;BMP6;GRK5;TGFB2;GREM1;FGFR3;DBF4B;MDK;PDGFC;PTGFR;MEIS1;PDGFRA;TNFRSF11A;BTC;TGFB3;AKR1C3;SHANK2;IGF1;PTPN6;HDAC1;PKHD1;IRS2;ERBB4;TET1;EREG;SLC25A33
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.6225144073187401,0.9766125847728481,0.5405405405405406,0.9506390179625237,1.0,1/5,0.89%,CA2
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.44713110133251016,0.9765077223235933,0.5833333333333334,0.9501923970655183,1.0,2/31,2.27%,CDH13;NRP1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.538106064153042,-0.976480621466612,0.4827586206896552,1.0,1.0,1/13,8.23%,ETFB
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.484331201147595,-0.9764802715209373,0.5070422535211268,1.0,1.0,4/24,17.41%,WFS1;HERPUD1;SYVN1;LPCAT3
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.6293876910778524,-0.9763392642085972,0.5517241379310345,1.0,1.0,1/7,9.85%,RP1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.548076589866626,-0.9762875988111143,0.5223880597014925,1.0,1.0,3/14,8.25%,ATP1B1;ATP6AP1;ATP1A1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.4183220059220747,0.9760636000260512,0.5161290322580645,0.9504943748495883,1.0,5/29,8.14%,SYNJ2;PLD2;CEL;NLGN1;NLGN4Y
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.5398764602383052,-0.9758981828018058,0.559322033898305,1.0,1.0,1/15,6.16%,WIPI1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3748429738205175,0.975788485386734,0.42105263157894735,0.9505368140825788,1.0,20/150,8.76%,NRK;NYAP2;SGK1;DOCK10;GPRIN2;BMP7;VASH2;EPHB2;BTG2;EPHA8;CNTN4;LRP12;FRY;HMGB1;BLOC1S4;NLGN1;MYO16;NRTN;APOE;RYK
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6131229304225958,0.9757293124410671,0.6,0.9500712835691936,1.0,2/7,24.48%,RAP1A;PRKN
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5277780675808978,0.975568993552656,0.41379310344827586,0.9498651574547958,1.0,2/9,3.64%,BCL2;BMP6
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.5222631989670905,-0.975262184745039,0.45454545454545453,1.0,1.0,7/15,32.17%,HERPUD1;SYVN1;UFD1;HSP90B1;SELENOS;DERL1;SEC61B
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.39069253117714164,0.9752524886781898,0.5625,0.9499576727664744,1.0,1/44,0.38%,GPC4
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.37859375037804943,0.9752185599133673,0.5,0.9493742628566417,1.0,11/66,13.20%,ATOH8;NRP1;KDR;VASH1;APOE;PRKD1;SCARB1;ANGPT1;RIN2;PTPRM;SVBP
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.3944893350766543,0.9750968050677726,0.41935483870967744,0.949079672807852,1.0,4/37,8.76%,UNC13B;ZBTB20;ZBED3;IRS2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.4926914701986163,0.9750357829723092,0.5,0.9478966786437459,1.0,4/19,13.29%,ZBTB20;IGF1;SLC4A4;PFKFB3
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.4926914701986163,0.9750357829723092,0.5,0.9478966786437459,1.0,4/19,13.29%,ZBTB20;IGF1;SLC4A4;PFKFB3
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.5093455862514302,0.9748422257775277,0.4838709677419355,0.947742479047509,1.0,2/10,6.88%,GCH1;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.6565143248196237,-0.9748337748753346,0.5692307692307692,1.0,1.0,1/6,14.59%,SYT4
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6160583915240749,0.9747600461313711,0.5333333333333333,0.94734090335549,1.0,3/5,22.71%,PRIMPOL;SIRT7;DDX21
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.355337569212169,0.9746671250739016,0.5,0.9469398857950793,1.0,13/116,8.31%,FBXL7;SEMA6D;NTM;CACNA2D1;FIGN;PDZRN3;GUCY1A2;ADGRL2;GFRA1;PKDCC;IL1R1;HTRA1;CAP2
prerank,GO_Biological_Process_2021__regulation of system process (GO:0044057),0.6023203997754256,0.9746654646950565,0.5609756097560976,0.946282288652166,1.0,2/5,22.78%,MTG2;ROCK2
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),0.6264272781543085,0.9746327664640226,0.675,0.9457244342464189,1.0,1/5,2.07%,TEX15
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6164506904390169,-0.974590885818338,0.5714285714285714,1.0,1.0,3/6,26.86%,BRK1;WAS;EPS8
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.5048129600924357,-0.9744107837430223,0.5652173913043478,1.0,1.0,9/23,24.59%,PRELP;CHST1;B3GNT4;B3GNT3;OGN;ACAN;B4GALT3;B4GAT1;CHST2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5422259081511832,0.9743939214221532,0.5294117647058824,0.9455920280346293,1.0,1/12,4.24%,AFF2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.6151193967109528,-0.9743554610234895,0.5614035087719298,1.0,1.0,1/7,4.30%,P2RY1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3159118513759635,0.9739696631774055,0.6,0.9459730092658554,1.0,13/187,7.52%,FBXL7;TPD52L1;CCNH;NEDD1;KDM8;PCM1;PLCB1;LATS1;CDK14;TAF2;ACVR1;EIF4EBP1;CCNA2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4670010105163139,-0.9739130067304814,0.5,1.0,1.0,6/39,15.70%,CTNNA1;MARVELD2;CLDN1;F11R;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.4604123392243351,-0.9738981712118954,0.4838709677419355,1.0,1.0,7/29,18.29%,TBP;TBPL2;TAF7;TBPL1;TAF6;TTF1;TCEA2
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.5982718250461097,-0.9734078105422462,0.5555555555555556,1.0,1.0,4/9,26.22%,IL4I1;FAH;TYR;GSTZ1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.42065092983461233,0.9730305696434178,0.34375,0.9476651715456619,1.0,6/18,14.42%,MTHFS;MTHFD2L;SLC19A1;DHFR;MTHFD1L;MTHFD2
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.36538460326140837,0.9730166750272765,0.47368421052631576,0.9470192035438981,1.0,12/95,7.03%,LRIG3;NPNT;COBL;BMP7;MAPK4;SLC7A2;TOX3;FAM222A;FGFR3;WWC1;DDAH1;CACNG4
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.4059607876537533,-0.9726705597934575,0.49295774647887325,1.0,1.0,23/98,24.59%,ACOT4;LIPH;LIPI;BAAT;ACOX2;ACSBG1;ALOXE3;ALOX12;ACOT12;ACSL5;ACOT2;ACSM4;FASN;LIPC;ACSM6;NDUFAB1;ACOT1;ACSM3;GPX1;ACOT6;ABCB11;GPAM;ACOX1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.5698881072273105,-0.9723278390535285,0.5806451612903226,1.0,1.0,2/10,8.42%,STAT1;STAT4
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.5837302052382314,0.9723057575597847,0.5151515151515151,0.9483241974490683,1.0,4/8,18.50%,NLGN1;GRID2;WNT5A;PTEN
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5453770594650436,-0.9721846071871681,0.5230769230769231,1.0,1.0,3/12,8.25%,ATP1B1;FKBP1B;ATP1A1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5782493036447451,-0.9721498070966754,0.5254237288135594,1.0,1.0,2/10,17.74%,EMC1;EMC3
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.543995161347169,-0.9721440197288683,0.5254237288135594,1.0,1.0,3/12,20.27%,RAC1;WAS;ACTG1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5552730347567367,-0.972140995355552,0.5238095238095238,1.0,1.0,2/10,4.40%,ZFPM1;NOTCH1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4069589518087085,-0.9721382392314121,0.5,1.0,1.0,26/78,33.45%,RAB6C;ARCN1;ARF3;KIF11;KIF3A;RACGAP1;RAB1A;RAB1B;ARF4;KDELR3;RAB6D;ARF5;KIF5A;KDELR1;TMED10;KIF22;KLC1;NAPA;KIF1C;RAB6B;COPB1;ERGIC3;KIF4A;RINT1;SCYL1;DNAJC28
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.5524478037841358,-0.9719274428376057,0.5428571428571428,1.0,1.0,3/10,20.22%,KCNMB1;CALM3;CALM1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.5489468158882195,-0.9718932808027145,0.5757575757575758,1.0,1.0,3/13,20.27%,F11R;TJP3;ACTG1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.49500994143156546,0.9718473163003192,0.5172413793103449,0.9489089198652282,1.0,2/21,6.88%,PID1;NUMB
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.5158658772065734,-0.9717449446069226,0.532258064516129,1.0,1.0,6/16,16.52%,BNIP3;HEBP2;SLC25A5;SLC25A4;SLC25A31;NAIF1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.43229194915378316,-0.9713704688296941,0.5454545454545454,1.0,1.0,10/57,8.95%,CD44;STAT1;CD14;IL3RA;OSMR;IL7;IL18R1;IRF1;TGFB1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.5128217719927761,-0.9713396178961674,0.5737704918032787,1.0,1.0,3/21,8.64%,NOTUM;NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.34803660638939315,0.9712713855409238,0.5294117647058824,0.9496600335162766,1.0,34/190,10.74%,TPD52L1;ROR2;KIT;NPNT;PDGFD;F2RL1;PELI2;C5AR1;EGFR;SLC30A10;NRP1;KDR;CSF1R;FGFR4;PIK3R6;TGFB2;FGFR3;EPHA8;WWC1;PDGFC;PDGFRA;HMGB1;RASGRP1;SEMA4C;MID1;IGF1;APOE;KLHDC10;RYK;ERBB4;FSHR;FGFR1;ANGPT1;IL34
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.5016774858687119,-0.971054100414858,0.515625,1.0,1.0,2/20,13.66%,ENO4;ENO2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.44309420800107635,-0.9709255515579142,0.5223880597014925,1.0,1.0,5/33,10.74%,AGT;NOTCH1;PINK1;DAB2IP;MSN
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.44839895772132854,-0.9704672147067573,0.5223880597014925,1.0,1.0,12/37,15.18%,PTPRC;HHLA2;IL15;NCKAP1L;PDCD1LG2;CD6;AGER;CCL5;HLA-DPB1;FADD;IL18;HLA-DMB
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6226368985293195,-0.9702541973663322,0.5873015873015873,1.0,1.0,3/6,34.65%,GPLD1;ABCB11;ACSL3
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5339559404083217,0.970158063525482,0.5,0.9516976360226156,1.0,6/9,31.10%,RAP1A;RAPGEF1;RAP2A;PLK2;RAP2B;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5512577746959564,0.970048279024121,0.5,0.9512966560211683,1.0,1/8,2.19%,EGFR
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.3873986775700288,-0.9697935253717491,0.525,1.0,1.0,22/110,20.29%,MCM2;GMNN;PSMB6;CDC6;RPA3;PSMB8;CHAF1A;PSMA3;PSMA5;PSMC3;NAP1L2;PSMA7;DAXX;PSMC6;GRWD1;H2BC18;H3-3A;PSME1;RBX1;PSMD12;CHAF1B;PSMB2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.4122443654865829,-0.969636582900799,0.5211267605633803,1.0,1.0,9/58,10.52%,C3AR1;AGT;P2RY1;DRD3;P2RY12;TRHR;PTGER3;LPAR6;ADRA1D
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.6068250704862718,-0.9696115516071245,0.5,1.0,1.0,1/7,9.16%,CCL5
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5798596795586658,-0.969241806028081,0.5352112676056338,1.0,1.0,3/12,17.41%,WFS1;MBTPS2;LPCAT3
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.37596568258279345,-0.9691855669810424,0.5365853658536586,1.0,1.0,41/153,21.75%,CD44;CA12;PRLR;WFS1;NXT1;PTGES;TST;PLAC1;ACOX2;FKBP4;CDC6;PTGER3;ETFB;GINS2;CALCR;MEST;CXCL14;HSPA4L;CKB;IMPA2;GPER1;DHCR7;PRSS23;ISG20;PLK4;RAB31;TJP3;BLVRB;COX6C;FKBP5;IL6ST;MYOF;SCUBE2;CPE;CD9;OPN3;MOCS2;SLC16A1;EMP2;PDZK1;TSPAN13
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3383754699266734,0.9690729974651131,0.5333333333333333,0.9531143944162369,1.0,13/92,11.89%,TRPC7;TRPC3;CACNA2D1;CACNG3;GRIN3A;MICU1;CACNA1I;TRPC5;SLC8A3;SLC24A3;FYN;CACNB2;SLC8A1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.5366345318845537,0.9687569984537968,0.6097560975609756,0.9533014789750063,1.0,4/9,17.05%,NGF;MAGI2;RAP1A;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.38693245668447485,0.9687283831492887,0.4722222222222222,0.9527335995544961,1.0,6/29,13.50%,EGFR;PLCB1;UBE2E2;FGF10;FAM83D;LSM10
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.475267534811051,0.9685029446252433,0.48717948717948717,0.952812947611736,1.0,4/15,11.55%,NRP1;SEMA5A;ANGPT1;FGF10
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.41032703492937833,-0.9683761208468546,0.4594594594594595,1.0,1.0,17/65,26.70%,NCBP2;DNASE2;PCBP1;POLR2J;POLR2K;NCBP1;DDX24;DDX1;HNRNPA0;DDX54;DNASE1L1;POLR2I;POLR2B;RAN;KPNA2;METTL3;POLR2D
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.36013181755908674,0.9683612683225867,0.5,0.9525300339308271,1.0,5/71,3.03%,RXFP2;HTR7;GLP1R;CD247;CYSLTR2
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.642082077569362,-0.9680342597805417,0.578125,1.0,1.0,1/5,7.35%,KCNQ1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.4096763237086448,0.9677849922946574,0.4358974358974359,0.9533919078048775,1.0,6/46,2.90%,CD38;KLRD1;CD96;CD247;RORA;GPR174
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.5160436344456331,0.9676005680178467,0.4838709677419355,0.9531383085331383,1.0,5/15,16.89%,KDR;SEMA5A;ANGPT1;PAK4;MAPK7
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.6444415453423074,-0.9674641210044295,0.5161290322580645,1.0,1.0,2/5,29.40%,SLC27A1;CD36
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4937702006151241,-0.9674498782161463,0.5166666666666667,1.0,1.0,9/24,30.33%,RECQL;MRE11;DDX1;HMGB3;SUPV3L1;DDX11;BLM;RECQL4;RAD50
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.6204189274279018,-0.9673977655780668,0.4727272727272727,1.0,1.0,3/5,37.34%,RAB3A;TRAPPC11;TMEM167B
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6064162441844844,0.9673763828713875,0.5581395348837209,0.9530901803090546,1.0,1/6,5.12%,DBF4B
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5080052523662142,-0.967336630677725,0.5862068965517241,1.0,1.0,3/19,10.07%,MYLK;DUOX1;CLDN1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.40763150358061245,0.9673115095587576,0.46875,0.9526419139681567,1.0,4/42,4.71%,VWC2L;VWC2;GREM1;CRIM1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3777014552190433,-0.9672793695503751,0.5189873417721519,1.0,1.0,30/184,17.94%,MCM2;BIK;CASP12;TCHP;CD14;BNIP3;AHR;GLRX2;BCL2L14;IRF1;IFI27;IFI6;CASP8;TBX1;KREMEN1;NOX5;GADD45A;RFK;FADD;SIAH1;CHEK1;BOK;PAK6;TSC2;CIDEB;TLR2;NFKBIA;RNF152;VDAC1;CDK5
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5840152035920609,-0.9672091942389448,0.59375,1.0,1.0,5/7,31.40%,RTF1;PAF1;NANOG;CTR9;POU5F1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.5353102228572173,-0.9670429902213956,0.5483870967741935,1.0,1.0,4/10,20.23%,CNTNAP1;GPC1;NCMAP;CD9
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.3875746758497462,0.9667426672554504,0.4838709677419355,0.9532574901706583,1.0,4/67,0.77%,CYP4Z1;ELOVL6;GLYATL2;CYP1A2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.5675460030026573,-0.9666739311849359,0.5882352941176471,1.0,1.0,7/11,25.37%,PTGES;PTGR1;GSTP1;AKR1C2;HPGDS;ACOX1;PLAA
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.49957688385254106,-0.9665135596811272,0.5492957746478874,1.0,1.0,9/22,30.87%,ALDOB;PGAM1;ENO2;ADPGK;PKLR;PGK1;GAPDH;PKM;HK3
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.542709232129667,0.9664296756214619,0.5,0.9533166040424015,1.0,2/8,15.12%,LTC4S;CYP2C8
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.5298068641092815,0.9663599423622276,0.5,0.9528301384807789,1.0,4/9,13.36%,GREM1;ENPP1;SRGN;ECM1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3683371658982277,0.9658411312031796,0.5,0.953561136388575,1.0,7/76,5.99%,RUNX1;HSPB1;KDR;SEMA5A;VASH2;PIK3R6;PRKCB
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4988651302599474,-0.9656911494452735,0.5,1.0,1.0,5/22,22.49%,ATP1A1;SLC36A1;NOX5;HVCN1;ATP12A
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.5519793210246358,0.9656779465030155,0.475,0.9532113567045047,1.0,2/9,13.55%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4025906684056975,0.9655155334827966,0.4838709677419355,0.952891217830236,1.0,18/40,27.30%,AMIGO1;TIAM2;ROBO2;CHODL;NGF;TIAM1;PLXNA2;MAP3K13;MAP6;ROBO1;PLXNC1;LIMK1;PLXNA1;GOLGA4;SLITRK1;PLXNB1;SLIT2;MACF1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5130706463352577,0.9654424947325251,0.5,0.9524257986986633,1.0,2/11,7.21%,NRL;RPGRIP1L
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4430907700762507,0.96539679638269,0.4523809523809524,0.9519415983948132,1.0,10/21,24.48%,DPY19L1;TMTC2;CRPPA;DPM3;TMTC1;FKTN;DPM2;LARGE1;DPM1;FKRP
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5269924576099072,0.9653002720609604,0.5277777777777778,0.9516035762487041,1.0,2/12,18.00%,SOX12;RELN
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.4750922003896899,-0.9649866510605956,0.5588235294117647,1.0,1.0,2/27,4.48%,TMEM35A;CAV3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.4165831185672477,0.9649025349032659,0.47058823529411764,0.9519252490352662,1.0,3/37,9.66%,NOX4;DDAH1;SRR
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.5406552203819976,-0.9649014437615304,0.5645161290322581,1.0,1.0,4/13,19.40%,ABCB1;ABCB4;PSAP;CPTP
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.42520466807187285,0.9647874405414075,0.5142857142857142,0.9514811295386021,1.0,9/46,13.20%,PER2;MINAR1;HSPA1A;GNL3L;IVNS1ABP;BAG2;U2AF2;CHP1;SVBP
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.5471258329437308,0.9642979522753364,0.5135135135135135,0.9513783653046105,1.0,2/5,8.43%,LCAT;APOE
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),0.5471258329437308,0.9642979522753364,0.5135135135135135,0.9513783653046105,1.0,2/5,8.43%,LCAT;APOE
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.5882004666400888,0.9642388365536587,0.6341463414634146,0.9508775117877409,1.0,2/7,11.89%,TICAM1;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.3769681149915203,0.9641689835750482,0.46875,0.9504546317980158,1.0,40/139,18.50%,EGFR;RORA;WWTR1;PKP2;BMP7;SPRED1;TGFBR1;SPRED2;SPRED3;GREM1;CRIM1;HEY1;CNTN4;TRIB2;MEIS1;JAG1;ENPP1;PTCH1;ANP32B;MYB;DISP3;SIRT2;FOXO1;SIRT1;IL17RD;ID2;ANKRD26;DTX1;RANBP3L;MYOCD;MEIS2;GDF10;NR1H3;WNT5A;LRP3;SINHCAF;BBS12;ZFPM2;PPARA;PTEN
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.5947602345238185,0.9640250352694494,0.5434782608695652,0.9501674979004526,1.0,1/5,10.96%,TWSG1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.6010002122557905,0.9639276578666436,0.5333333333333333,0.9497842665623909,1.0,2/5,20.71%,SFSWAP;PRPF39
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.5746159990197054,0.9638003495177527,0.5897435897435898,0.9494690489857751,1.0,1/5,2.40%,PKP2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.4532392116227878,0.9636404484022186,0.5,0.949212071523595,1.0,3/16,13.70%,APOE;SCARB1;ABCG8
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.31936317014721255,0.9633617885382727,0.2916666666666667,0.9493598629138839,1.0,37/218,13.73%,TRPC7;SLC12A3;TRPC3;KCNJ16;SLC39A11;SLC30A10;KCNH5;KCNB2;SLC6A4;SLC12A1;KCND2;LRRC55;KCNN3;KCNN2;KCNJ2;HCN1;SLC6A11;KCNK7;KCNQ5;SCNN1B;TRPC5;SLC6A13;SLC8A3;SLC24A3;SLC6A1;KCNC2;SCNN1D;SLC25A27;SLC4A4;SLC8A1;KCNS3;KCNK12;ANO6;KCNC3;KCNF1;TRPC1;KCNJ14
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5613411494726055,0.9631686029040164,0.5853658536585366,0.9491995322293842,1.0,4/8,14.98%,NEDD4L;PRKCE;HECW2;NEDD4
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.40204630297687094,0.9630047430629216,0.5454545454545454,0.9490009537564852,1.0,5/28,14.98%,RAB7A;RNF128;KPTN;SORL1;NEDD4
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.48585487899161883,0.9627729586202688,0.5483870967741935,0.948860300797033,1.0,2/14,5.21%,HOMER2;GRM5
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.42290610922369437,-0.9626266684182758,0.5324675324675324,1.0,1.0,25/89,19.81%,C3AR1;HCK;SIGLEC1;OSCAR;CD14;SLC7A7;FCGRT;AGER;STAB1;SERPING1;CTSZ;RASSF4;MAFB;MMP19;AQP9;PSAP;IL13RA1;TLR2;CMKLR1;C1QA;SERPINF1;TNFAIP2;TCN2;ESR1;SLC2A1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.5333760503139984,-0.962177664769724,0.5263157894736842,1.0,1.0,1/17,0.72%,CSRP3
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.32026333062378626,0.961901869738765,0.6,0.950563634239037,1.0,53/347,14.30%,NRK;ALK;SGK1;DGKB;SGK2;FGGY;TGFBR1;GRK5;LATS1;TGFB2;CDK14;PEAK3;MAML1;EPHB2;TRIB2;PRKCB;NEK6;MAP3K20;ACVR1;PRKCD;CDKL1;PXK;LTK;EPHA7;RYK;DGKH;STK38;PRKD1;PAK5;EIF2AK3;CDK8;FGFR1;MAP3K5;SPHK2;PNKP;FYN;MAPK8;PRAG1;PRKCE;FASTK;FRK;MARK1;LMTK3;SGK3;PANK3;NRBP2;PRKG2;CDC42BPB;PAK4;PDGFB;FER;PAK3;BRAF
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.34741691656687645,0.9618095927226766,0.52,0.9501917985366646,1.0,14/125,9.54%,CCNH;MAML3;TEAD2;RORA;WWTR1;HDAC9;ESRRG;MAML1;NR3C2;TAF2;HDAC1;ERCC2;HDAC10;TAF12
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5278511644848801,0.9614400951851756,0.46875,0.9505109561805515,1.0,2/11,4.90%,GMDS;B4GALNT2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.5929429601551918,0.9611814918877924,0.5777777777777777,0.9504463354427618,1.0,1/6,5.27%,MDK
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.5811265190106546,0.9610320931926435,0.5777777777777777,0.9501711015533512,1.0,3/5,28.17%,MTCL1;MAP2;CFAP100
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.30906210458266936,0.9610202042711569,0.5,0.9495708290630519,1.0,36/261,14.91%,RUNX1;ATOH8;CIDEA;KDR;HDAC9;TGFB2;SAMD4A;BTG2;MACROH2A2;APLN;PTBP3;RBMS3;PTBP2;HSPA1A;IGF1;IGF2BP3;HDAC1;APOE;SRGN;EIF2AK3;SLC24A3;REL;PC;TWSG1;PARP10;CELF1;TRIM71;SIRT1;DHFR;ID2;PNPT1;PHF1;PDGFB;CCDC3;LSM14A;CILP
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.48839484777730235,-0.9607736466641886,0.5,1.0,1.0,2/15,4.40%,LRP4;NOTCH1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.6299699681558872,-0.9605902610974232,0.5774647887323944,1.0,1.0,5/7,34.65%,LPCAT3;DGAT1;MTTP;SOAT1;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.5657007587102302,-0.9604259943600371,0.5964912280701754,1.0,1.0,4/11,16.53%,TAF7;SPI1;BRCA1;SET
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.3936269994528218,-0.9604203774080117,0.4666666666666667,1.0,1.0,4/77,4.68%,ENPP2;RREB1;AGT;RAC1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.5205208975378341,-0.960243394678765,0.532258064516129,1.0,1.0,2/13,13.44%,STMN1;KIF14
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.4998118144799375,0.9600893983335449,0.45,0.9510468401841352,1.0,1/13,0.66%,PID1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.6060677035981531,-0.960039155237265,0.5409836065573771,1.0,1.0,3/6,26.13%,ATPAF1;ATPAF2;OXA1L
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.44909074367308777,-0.9600342562658462,0.5094339622641509,1.0,1.0,2/31,2.96%,POLQ;CGAS
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.5754278922958929,-0.9599501572889683,0.5789473684210527,1.0,1.0,2/8,18.98%,BRCA1;KANK2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.34537630710404427,0.9599085547911217,0.44,0.9508195473966792,1.0,18/97,14.09%,PID1;LEF1;IL1RL2;CSF1R;IL1RAPL1;TGFBR1;ACVR1;PTPN9;PTPN6;PTPN12;ROBO2;PTPN13;MAPK8;KHSRP;PTPN23;NFAT5;SOCS2;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.38323562693235086,0.9599081866839514,0.6,0.9501818414628115,1.0,8/55,9.20%,PCM1;BMP6;UNC13B;TGFB2;PRR5L;TGFB3;IGF1;TPR
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5527068735111692,-0.9591927634300415,0.5230769230769231,1.0,1.0,3/10,13.18%,CASP8;SCIMP;FADD
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.5976939436986133,0.9590893673918128,0.5853658536585366,0.951425390880347,1.0,2/6,26.70%,ROBO1;SLIT2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.4121359198352716,0.9587507717201953,0.5172413793103449,0.9517133957576659,1.0,4/32,5.59%,KIT;ITGA4;HDAC9;RABL3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.46975157520517624,0.9587465132285554,0.5757575757575758,0.951085904468,1.0,3/22,2.57%,KIT;KDR;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.445470355135852,0.9587007218585024,0.5263157894736842,0.9505640389184998,1.0,6/18,20.36%,PTCH1;APOE;EEPD1;SIRT1;NR1H3;APOA1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.629432730766,-0.9584809190210388,0.6101694915254238,1.0,1.0,2/5,24.74%,PLCG2;AKT1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5132318355176537,0.958239394016856,0.5714285714285714,0.9511376317685742,1.0,2/10,9.09%,PKP2;BIN1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.4207250714294938,-0.9581197258304334,0.5277777777777778,1.0,1.0,6/65,15.02%,HCK;KIF9;MSN;C10ORF90;TBC1D13;ODAD3
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5609793890364333,-0.9580936650965001,0.6086956521739131,1.0,1.0,2/10,16.24%,DCTN1;CLMN
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5491607684755301,0.9578208132052177,0.5,0.9515962987043766,1.0,2/5,18.37%,SPHK2;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4635035274239673,0.957737518504581,0.5185185185185185,0.9511321792539381,1.0,2/19,8.86%,LRRTM3;SLC2A13
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.40969693675817553,0.9576802563521013,0.4666666666666667,0.950592674191041,1.0,6/33,6.57%,NRP1;CSF1R;IQGAP2;ESAM;MDK;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.46268137939759807,0.9573572620243502,0.53125,0.9508324188267346,1.0,3/16,7.71%,RAB27A;NLGN1;CACNA1I
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4337359057335692,0.9573359435827068,0.5172413793103449,0.9496327017996549,1.0,8/28,14.60%,COBL;TGFB2;PRICKLE1;SEMA4C;DVL2;PHACTR4;MTHFD1L;LRP6
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.4337359057335692,0.9573359435827068,0.5172413793103449,0.9496327017996549,1.0,8/28,14.60%,COBL;TGFB2;PRICKLE1;SEMA4C;DVL2;PHACTR4;MTHFD1L;LRP6
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4446007913194001,0.9573178410079639,0.5833333333333334,0.9490387782695077,1.0,2/23,1.23%,RAB7B;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.37118664406734386,0.9572037621697921,0.5384615384615384,0.9487675912772335,1.0,17/76,13.49%,UBASH3B;HSPB1;PTPRT;WWTR1;SPRED1;CEP85;PTPRB;TRIB2;PTPRO;SLC8A3;DUSP10;GNAQ;SLC8A1;TAB1;CHP1;PRKRIP1;SORL1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.6403183926590549,-0.9570030652835526,0.5538461538461539,1.0,1.0,3/6,26.07%,HLA-A;HLA-F;AZGP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.6403183926590549,-0.9570030652835526,0.5538461538461539,1.0,1.0,3/6,26.07%,HLA-A;HLA-F;AZGP1
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.5582771584406311,0.9567012700033032,0.5238095238095238,0.9494619631498679,1.0,1/6,1.08%,SGK1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.4664784978085866,-0.9566046405547624,0.5211267605633803,1.0,1.0,3/25,9.40%,TRIM5;IRF1;CASP8
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5966066053597504,-0.9565930439065988,0.5666666666666667,1.0,1.0,6/7,34.71%,MYOM1;TTN;LCP1;RDX;EZR;PRKACA
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.5533555373048213,-0.9565225883028338,0.5245901639344263,1.0,1.0,2/9,31.26%,SUPT5H;CTR9
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.34495624554938564,0.9564086401629385,0.6428571428571429,0.9495502002817594,1.0,7/99,3.03%,RXFP2;IFI16;HTR7;GLP1R;SAMSN1;CD247;CYSLTR2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3793632697860903,0.9562639246364533,0.5862068965517241,0.9492603134361147,1.0,8/64,8.07%,VWC2L;SULF2;VWC2;GREM1;CRIM1;SPRY3;APLN;CASK
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.5192973470460851,0.9561702357353177,0.48936170212765956,0.9488102646678842,1.0,4/8,13.75%,MID1;MID2;FAM83D;MAPRE1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3613473731625253,0.955979042245971,0.6,0.9486533794360662,1.0,5/72,3.03%,RXFP2;HTR7;GLP1R;CD247;CYSLTR2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3628369614934639,0.9558681922715534,0.45,0.9483457996522681,1.0,23/153,10.13%,ETV1;PRRX1;CA2;F2RL1;GALNT3;IL1RL2;ZNF277;CIDEA;NRP1;HDAC9;CAB39L;ALDH1A2;EPHB2;TRIB2;LAT2;BTC;PTBP2;ETV5;PLAT;CROT;GABRA3;EREG;TFPI
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.5569027361959387,-0.9555436739362868,0.5636363636363636,1.0,1.0,4/9,34.78%,ZWILCH;KNL1;CHAMP1;SPDL1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.6315113329926062,-0.9555396012076914,0.5964912280701754,1.0,1.0,2/5,27.29%,CHDH;SARDH
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.4276715541138186,-0.9554341271462994,0.5862068965517241,1.0,1.0,10/48,25.61%,CDKN2D;ELANE;SLC24A1;TRIM32;CRY2;OPN1SW;OPN3;USP1;UVSSA;TYR
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3773820475943933,-0.9553336886950115,0.6052631578947368,1.0,1.0,39/180,25.01%,ENPP2;MYLK;RREB1;CCNG2;PLIN2;NKIRAS1;TST;STAT5A;PTGER3;ETFB;CD302;ALDH2;MRAP;GADD45A;GHITM;SPARCL1;DHCR7;RETSAT;NMT1;YWHAG;LPCAT3;DHRS7;NDUFAB1;NABP1;PRDX3;IDH3A;FAH;REEP5;TALDO1;SLC27A1;COX7B;DECR1;GPAM;UBC;ACOX1;ITIH5;STOM;TKT;G3BP2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.43037511717438853,-0.9552238800895202,0.5362318840579711,1.0,1.0,10/51,20.21%,AGT;OSMR;SERPINE1;IL15;IL18;TLR2;NFKBIA;LBP;IL6ST;SNX4
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.41898313805056747,-0.9551204606659996,0.5,1.0,1.0,9/63,11.94%,SLC12A7;KCNE2;TRPV6;ATP1B1;ATP1A1;SLC24A1;SLC9A6;SLC5A2;TRPV3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.50988909101502,0.9549572472005744,0.5348837209302325,0.9499142328069129,1.0,4/11,16.64%,JAG1;PTPRO;MAGI2;MYO1E
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.4689975588400336,-0.9548348141903377,0.532258064516129,1.0,1.0,5/39,9.04%,TARS3;NARS1;PPA1;IARS2;EPRS1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3874388815939899,-0.9547903559495318,0.5180722891566265,1.0,1.0,16/140,12.14%,TRIM58;TRIM22;PTPRC;YBX3;TRIM5;ATP1B1;AHR;TRIML2;RASA1;TXK;PRDM6;PCBP1;RNF39;REST;ATXN7L3B;CGGBP1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.45421865318653654,0.9547605930902804,0.5294117647058824,0.9496439016621261,1.0,1/17,0.47%,CDH13
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4191177443729727,-0.9546558220203298,0.5,1.0,1.0,13/88,16.41%,CSRP3;LAMA2;ACTC1;CAV3;ANGPTL2;TRIM54;CASQ1;FABP3;TTN;DOCK1;TPM1;SIX4;CMKLR1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.4497183178158903,-0.954562498928685,0.5,1.0,1.0,9/31,21.11%,ACOT4;BAAT;ACOT12;ACOT13;ACOT2;ACSM4;ACSM6;ACOT1;ACSM3
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.33310994814188405,0.954483334805603,0.47368421052631576,0.949684546828769,1.0,46/199,18.06%,FHDC1;ARL13B;PCM1;PDE6D;CDC14B;DNAH5;CNGA4;CFAP70;TTC39C;RAB3IP;TTC17;UBXN10;PKHD1;KIAA0586;CEP83;CFAP43;ABCC4;RFX2;SCLT1;TTC36;PIBF1;BBIP1;PTPN23;FAM161B;SNAP29;EXOC7;WDR35;FNBP1L;ABLIM1;EHD4;BBS9;MACIR;PARVA;KIF24;RAB11FIP3;B9D2;CFAP20;POC1B;RFX3;CFAP44;IFT74;B9D1;EXOC2;RILPL1;TMEM250;SPAG16
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.5970775354872374,-0.9540208058557004,0.6037735849056604,1.0,1.0,1/7,9.16%,CCL5
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.29598476619309627,0.9539574851340261,0.625,0.9503083399924306,1.0,111/800,14.30%,ACE2;RUNX1;POU6F2;FEZF2;ATOH8;SLC22A2;PID1;IFI16;SOX13;LEF1;TEAD2;ZNF273;NFIA;ZNF117;RORA;WWTR1;KDR;AFF3;ZNF462;FGFR4;ZNF536;BMP7;TRAF3;PCBP3;BRCA2;TGFBR1;ZNF827;BMP6;OR7D2;ATXN1;ESRRG;TGFB2;AFF2;ZNF205;EPHB2;ZNF628;HEY1;WWC1;ZNF407;FOXN3;SPIN2B;APLN;SOX12;RAB27A;PTBP3;RBMS3;CHD7;PTBP2;TICAM1;PRMT5;ADAM19;HSPA1A;TRIM11;IGF1;PRDM5;IGF2BP3;HDAC1;ZNF263;APOE;ERMAP;POU3F1;HDAC10;TRIM4;NOVA1;EIF2AK3;CIAO3;NELL1;SLC24A3;ZNF804A;REL;MYB;ZNF678;NOS1AP;PC;ANGPT1;RYBP;DVL2;LIMS1;PARP10;MAPK8;KHSRP;ATXN1L;FGF10;FASTK;SLC8A1;SNF8;PCGF1;TRIM44;ZNF33A;BCL6;CELF1;TRIM71;HMGA2;SIRT1;BRDT;ZNF646;TDRD7;RC3H1;ID2;NTRK3;EP300;NGF;PHF1;ZNF875;SPIN1;COQ7;PDGFB;ZFHX3;CCDC3;NR3C1;BRAF
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5718093624283023,0.9538307102483916,0.5909090909090909,0.9500570845600155,1.0,3/6,12.16%,SH3RF1;TWSG1;TARM1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.5497501622572887,-0.953751586367459,0.6129032258064516,1.0,1.0,4/13,20.68%,RASIP1;KIF14;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.5603009095349817,0.9535934970054587,0.5714285714285714,0.949937677568777,1.0,2/8,13.55%,TIMELESS;SPIDR
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.43912147800858026,-0.953535545903239,0.6176470588235294,1.0,1.0,17/50,23.96%,PTGES;KLRG2;TOM1L1;CELSR1;ALOXE3;SEMA3F;SIX4;IGSF3;PPIC;WNT7B;SH2D4A;YAP1;EMP2;AP1M2;MAL2;SHROOM3;CRABP2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5648914668125844,-0.9530961912570997,0.5538461538461539,1.0,1.0,1/7,11.60%,APH1B
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.3750009634032791,0.9530346228859777,0.42857142857142855,0.9505600702642573,1.0,6/80,4.29%,F11;ITGA4;EYA4;SGK2;AFF3;C6
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.4741384025287353,0.9527468610517386,0.4857142857142857,0.9506281230939807,1.0,4/13,18.38%,RAB27A;NLGN1;KIF5C;SYNDIG1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.3879651558143035,-0.9526130515663941,0.5571428571428572,1.0,1.0,26/135,24.72%,CENPK;CENPO;TPX2;SPC24;ERCC6L;RAB11A;WDR62;CENPU;GPSM2;ZWILCH;STMN1;NUP85;ITGB3BP;CENPL;SKA2;KIF11;MZT1;EFHC2;SBDS;NDEL1;KNL1;ABRAXAS1;DYNLL1;RAN;DSN1;SPC25
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.6140559968280863,-0.9526037182859465,0.5846153846153846,1.0,1.0,1/5,7.29%,ABT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.6140559968280863,-0.9526037182859465,0.5846153846153846,1.0,1.0,1/5,7.29%,ABT1
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.6140559968280863,-0.9526037182859465,0.5846153846153846,1.0,1.0,1/5,7.29%,ABT1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.6205726858283666,0.9524763197487948,0.6097560975609756,0.9506867108054312,1.0,2/5,23.64%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.4231835244362123,-0.9519674527875637,0.56,1.0,1.0,14/61,22.57%,FIP1L1;CSTF2T;DDX39A;NCBP2;SLU7;NCBP1;RNPS1;CDC40;ALYREF;SUPV3L1;UPF3B;DHX38;CLP1;THOC5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.5952876747734406,-0.9515360692618199,0.5522388059701493,1.0,1.0,2/7,18.60%,CAV3;KCNE3
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4243038198848129,0.9515161807140972,0.6176470588235294,0.9523942266800818,1.0,4/29,11.93%,MCU;IRS2;MYRIP;RBP4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5360740079570283,-0.9510866905612644,0.5483870967741935,1.0,1.0,2/12,8.58%,ATP1B1;GLRX
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3636589898450749,0.9510479495581434,0.4166666666666667,0.952882282856264,1.0,13/89,8.80%,CIDEA;VWC2L;PMEPA1;SPRED1;TGFBR1;SPRED2;SPRED3;VWC2;GREM1;CRIM1;ACVR1;HSPA1A;SMAD2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4477083220167185,-0.9509972531034899,0.532258064516129,1.0,1.0,9/32,31.27%,KIF9;UFM1;ULK1;MCTS1;KLC1;MTIF2;GFM2;GOLGA2;UFC1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.4385131304866243,-0.950904032320498,0.5333333333333333,1.0,1.0,8/41,19.19%,SLC7A11;SLC7A7;SLC38A11;SLC36A1;SLC25A44;SLC38A8;SLC38A4;SLC3A1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.4348341736984194,0.9508136320262164,0.4827586206896552,0.9528082755290443,1.0,6/32,5.54%,NRG1;SGCD;BMP7;SGCZ;MAML1;HEY1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.6006897544832563,-0.9507784941119336,0.5806451612903226,1.0,1.0,1/8,2.87%,RREB1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5404922771473016,-0.950703342419568,0.5588235294117647,1.0,1.0,3/13,18.53%,CD14;SCIMP;LBP
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.6107688128868163,-0.9505091571388865,0.6307692307692307,1.0,1.0,2/5,17.70%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.5737285567208168,0.9499069562536406,0.6060606060606061,0.954529736712721,1.0,1/6,3.54%,TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5050270713062931,0.9497760758562924,0.45714285714285713,0.9543145741531139,1.0,3/11,10.13%,HS3ST5;APOE;TFPI
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.5168421153528517,-0.9495280845077229,0.6,1.0,1.0,6/17,28.66%,RRP15;EIF6;WDR12;NSA2;LAS1L;MAK16
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.29499579241521495,0.9490369284420019,0.7142857142857143,0.955257683751381,1.0,123/864,14.36%,FBXL7;NRK;PTPN3;LAMB2;B3GALT9;HS3ST5;SGK1;PTPRT;DUSP5;DUSP2;SGK2;PENK;PTPRK;RCE1;MELTF;VCAN;CD247;LTBP1;SENP8;CDC14B;TGFBR1;GRK5;FBXW8;LATS1;DNAJC3;TGFB2;SOCS6;CDK14;PEAK3;MAML1;ST3GAL3;TGM1;FEM1A;PTAR1;PTPRB;TRIB2;PRKCB;AFP;NEK6;MAP3K20;DUSP4;ACVR1;FBXO27;PTPN9;CCDC22;PRKCD;PTPRO;LGALS1;COMMD1;ERCC8;CDKL1;CEL;DUSP8;FUT9;PTPN6;PXK;APOE;PLAT;LTK;RYK;PTPRE;STK38;PRKD1;SSH1;PAK5;EIF2AK3;CHRM3;ST3GAL1;MACROD2;KLHL25;CHRDL1;CDK8;PTPN12;DUSP10;RHBDD1;FGFR1;UBE2E2;DUSP12;USP25;KTN1;EGLN3;WDR45;PPEF1;MAP3K5;PARP10;PTPN13;FYN;MAPK8;PTPRS;PRAG1;PRKCE;PNPLA2;FASTK;ST8SIA3;FRK;SIRT2;MARK1;LMTK3;PGGT1B;TAB1;CTDSP2;SGK3;FBXL15;PPP2R5E;PTPRM;BTRC;NRBP2;SIRT1;PRKG2;CDC42BPB;AKT2;RABGGTA;CTTNBP2NL;KLHL20;ST3GAL2;SOCS2;PAK4;PDGFB;FER;KLHL42;PAK3;BRAF;PPM1H
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.43138553558560394,0.9489275832858621,0.5277777777777778,0.9549583335751993,1.0,4/15,13.33%,GCH1;SPTLC1;SPHK2;DHFR
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.477942722649796,-0.9489213678023073,0.6111111111111112,1.0,1.0,3/28,4.40%,LRP4;NOTUM;NOTCH1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.48178160617667865,-0.9487801796056681,0.5217391304347826,1.0,1.0,4/18,19.33%,POLE3;GINS2;PCNA;GINS1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3970117196084605,0.9484477837335178,0.5555555555555556,0.9556013416236787,1.0,17/42,22.37%,CACNG3;GRM5;GRIK1;NRXN1;CACNG4;NLGN1;SYT1;GRM8;MEF2C;HOMER1;RELN;OPHN1;UNC13A;CLN3;GRM7;CACNG2;CACNG5
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.6240223692317208,-0.9484242217660047,0.5932203389830508,1.0,1.0,1/5,5.51%,HEBP2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.417721416469702,-0.9483958572173787,0.5161290322580645,1.0,1.0,5/33,22.40%,PINK1;CHMP4B;PHF23;PIP4K2C;RAB1B
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.5367651420075956,-0.9483386499249542,0.5645161290322581,1.0,1.0,1/9,5.24%,DRD3
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.558107310789203,0.9480246635182165,0.6,0.9560664224555081,1.0,2/9,6.71%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.504661405652699,-0.9479325063210702,0.6029411764705882,1.0,1.0,3/18,8.25%,SLC12A7;ATP1B1;ATP1A1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.34884177442217484,0.9474006408279303,0.5185185185185185,0.9570152332456009,1.0,7/74,4.29%,F11;NOX4;SGK2;GLYAT;SLC22A13;SLC16A9;C6
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.5708626745779157,-0.9473708091586005,0.559322033898305,1.0,1.0,1/7,5.61%,CHMP4B
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.5854822798718663,-0.9472348435188609,0.6166666666666667,1.0,1.0,2/7,21.91%,SDS;DAO
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4022521843383998,-0.9472074880560093,0.5522388059701493,1.0,1.0,14/40,27.52%,TOMM20;HSPA5;PEX16;SEC62;DNAJC19;PEX5;TIMM17B;ROMO1;RTN2;PEX1;HSPD1;PEX10;TIMM17A;GRPEL2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.4108710175819319,-0.9471807004048,0.5070422535211268,1.0,1.0,11/66,14.95%,FIP1L1;POLR3K;CSTF2T;TBP;NCBP2;POLR1E;SLBP;POLR2K;NCBP1;POLR1H;TTF1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.3641051516098235,-0.9470258092269822,0.6,1.0,1.0,25/232,10.09%,CD44;MMP26;LAMA2;ADAMTS4;LOXL4;CYP1B1;COL9A1;HSPG2;MMP15;FBLN5;ELANE;ITGA5;ADAMTS18;TIMP2;SERPINE1;KIF9;CAPN1;COL6A1;ECM2;P4HA3;LAMA1;TGFB1;COL19A1;BMP1;MMP21
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.598515889459593,-0.9470134709478216,0.6307692307692307,1.0,1.0,3/7,23.32%,EXOSC6;HSPD1;RNF168
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.6074502117799045,-0.9469739178989202,0.5862068965517241,1.0,1.0,3/5,16.61%,IL18R1;IL18;SLC11A1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.5910807807179833,0.9469283457663132,0.6060606060606061,0.9574787820164594,1.0,3/6,17.56%,ABCC11;SLC25A33;ABCC5
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.390888762817639,0.946879921263291,0.5333333333333333,0.9569650120138131,1.0,9/36,18.21%,DGKB;PLPPR5;SGPP2;DGKH;CYP2C8;CYP3A4;MBOAT2;PLPPR4;PLPP1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.6141147546817916,-0.9467033540269483,0.5555555555555556,1.0,1.0,1/6,5.14%,BNIP3
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.5400378231975796,0.9464497550509378,0.5111111111111111,0.956868472347545,1.0,3/6,16.64%,JAG1;MAGI2;MYO1E
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.5400378231975796,0.9464497550509378,0.5111111111111111,0.956868472347545,1.0,3/6,16.64%,JAG1;MAGI2;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.5298738524959794,-0.9463699086745803,0.5606060606060606,1.0,1.0,3/16,9.72%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5675613461803617,-0.9462908590368997,0.5384615384615384,1.0,1.0,3/9,30.28%,PRR7;PLAUR;PARK7
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.31220516115283353,0.9459158863307607,0.5555555555555556,0.9577951000073663,1.0,84/539,14.26%,RUNX1;TBX6;IFI16;PER2;SOX13;TRPS1;GFI1B;NFIB;ZEB2;ZNF239;HIVEP1;ARID5A;ZNF536;HDAC9;ZGLP1;BMP6;SMYD2;CBFB;KCTD1;ATXN1;BATF3;ZNF205;WWOX;ATF3;ZMYM5;E2F6;RITA1;HEY1;WWC1;MACROH2A2;ZBTB5;HMGB1;ZNF596;NFIX;AASS;ZNF608;ID3;MXI1;HSPA1A;ZEB1;ARID5B;PRDM5;ZBTB1;ETV5;HDAC1;ZNF263;NACC2;PTCH1;RNF2;SMAD2;ZNF846;HDAC10;TPR;FHL2;FOXP2;ZNF589;GATAD2A;MYB;SUV39H2;IGBP1;MYPOP;ZNF778;ZNF202;BAG3;CTBP2;NEDD4L;PCGF1;DACH1;FRK;SIRT2;BCL6;LYAR;HMGA2;SIRT1;PER3;THRB;ID2;EP300;ZNF875;PEX2;NR4A2;PDGFB;ZFHX3;NR3C1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.5475338259889214,0.945822092911604,0.5,0.9573937962392377,1.0,2/6,7.48%,GCH1;PNPO
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.5054462183576132,-0.9457515074861387,0.5625,1.0,1.0,3/21,6.02%,HSD17B10;BAAT;ACOX2
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.4096633422882903,0.9457393066939802,0.5882352941176471,0.956983743251408,1.0,6/36,11.93%,PER2;SLC37A4;G6PC3;SLC25A1;PC;RBP4
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.4940912120346906,0.9454685266660852,0.5405405405405406,0.9570467754716637,1.0,4/12,14.37%,PCM1;BICD1;HOOK3;CCDC120
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.4493390757292183,0.9454621395092249,0.5714285714285714,0.9564337680812381,1.0,4/13,11.27%,CBARP;COMMD1;BIN1;NEDD4L
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.44235036109698445,0.9452874720048997,0.5666666666666667,0.9563397632370229,1.0,3/18,6.55%,BCL2A1;BCL2;CASP9
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5372269957330141,-0.9449819522918248,0.5370370370370371,1.0,1.0,1/10,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.4127151825501234,-0.9448690029944757,0.6176470588235294,1.0,1.0,6/50,9.50%,FANCI;FANCM;RAD51AP1;FAAP24;RPA3;FANCC
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.536019431450683,-0.9443469252528222,0.578125,1.0,1.0,2/12,8.25%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4259636672936902,0.9443283679525358,0.45714285714285713,0.9583728441584035,1.0,10/36,24.18%,MEX3D;KHSRP;CELF1;TRIM71;RC3H1;FTO;DCPS;DIS3L2;ROCK2;METTL16
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.5160576919820143,-0.9440253549976827,0.5254237288135594,1.0,1.0,7/14,30.28%,LTBP4;GHRL;RAB1A;SLC30A8;CDK16;CAMK2G;PARK7
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.5819531338502049,-0.9439262338191153,0.5538461538461539,1.0,1.0,2/7,30.43%,RIPOR1;CDC42
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.37371489253542006,-0.9435559509003723,0.6538461538461539,1.0,1.0,28/174,17.36%,CD44;BIK;POLR3K;GOT1;SPAG4;NSDHL;FKBP4;ALDOB;ARTN;CHST1;GPC3;GLRX;PGAM1;HSPA5;GNPDA1;B3GNT3;STMN1;MDH1;ENO2;TXN;AGL;G6PD;ISG20;IL13RA1;ERO1A;ALG1;TGFA;GPC1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.35031604671709976,0.9434183513633541,0.5806451612903226,0.9603293530915822,1.0,8/55,12.74%,HSPB1;NRP1;KDR;WASF2;PRKD1;FYN;PIK3R1;ELMO1
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),-0.5909581582092096,-0.9433842362331973,0.5172413793103449,1.0,1.0,2/5,20.57%,OPRD1;OPRK1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.3638514870561258,0.9433370445610176,0.6363636363636364,0.9599928772976899,1.0,18/74,17.05%,KANK1;TGFB2;EPHB2;SPRY3;RABL3;MMD2;RASGRP1;IGF1;IRS2;RASGRF1;FGF10;STARD8;DENND1A;NGF;RALGPS1;ARHGAP44;JAK2;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.4321289297736593,-0.9432222838041886,0.5571428571428572,1.0,1.0,13/50,19.12%,ZFPM1;CD14;IL18R1;TXK;PDCD1LG2;INHBA;HLA-DPB1;HLA-A;FADD;IL18;SLC11A1;C1QBP;ISG15
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.33689804307551824,0.9430790821795232,0.5666666666666667,0.9598506610893625,1.0,21/155,9.16%,HS3ST5;SPX;NFIB;CIDEA;EGFR;LAMA4;SPRED1;HDAC9;BRCA2;SLC6A4;SPRED2;SPRED3;MCC;MDK;HEY1;WWC1;PTPRO;SFMBT1;PTCH1;SRGN;NOVA1
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.5864442658926615,-0.9429007915695009,0.6,1.0,1.0,1/6,8.26%,ALOXE3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.38426042872720634,-0.9428256232306694,0.527027027027027,1.0,1.0,17/89,22.57%,FIP1L1;NXT1;DDX39A;NCBP2;SLU7;FYTTD1;SLBP;NUP85;NCBP1;RNPS1;CDC40;ALYREF;NUP155;UPF3B;DHX38;NUP188;THOC5
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.6235244151626012,0.9426530987875095,0.6060606060606061,0.9602436043073612,1.0,1/5,7.88%,IGF1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.4968210355072269,-0.9424994404544812,0.5833333333333334,1.0,1.0,7/19,29.42%,SERINC1;LPCAT4;LPCAT3;PLA2G10;SLC27A1;PLA2G4A;OSBPL10
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.49206344060394835,0.9423595030932985,0.40476190476190477,0.9602673292429525,1.0,2/13,9.30%,UPP2;DUT
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.5426352738778901,0.9422354337911171,0.5714285714285714,0.9600238819205966,1.0,1/6,2.40%,PKP2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.5796429924042432,-0.9421152261755933,0.543859649122807,1.0,1.0,2/5,41.40%,SFRP1;TNFSF4
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.39285765475207957,-0.9419627739733447,0.5,1.0,1.0,21/81,28.11%,HLA-DMA;CD74;HLA-DPB1;DCTN1;HLA-A;HLA-DMB;KIF11;ARF1;KIF3A;RACGAP1;AP1M2;SEC23A;DYNLL1;KIF5A;CANX;CLTC;HLA-F;SPTBN2;CLTA;KIF22;KLC1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6048112524164625,-0.9419299078816076,0.5932203389830508,1.0,1.0,4/7,26.89%,AGBL5;AGBL3;FOLH1;AGBL2
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.38214866870583625,0.9419208715429385,0.4857142857142857,0.9601858055681929,1.0,6/74,5.60%,ELOVL6;PER2;OXTR;ESRRG;LEPR;PDGFC
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.40411290435431213,0.9419165956313084,0.5151515151515151,0.9595747303766097,1.0,2/47,3.46%,CD38;ZNF165
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.354024830130991,0.9416224323811467,0.44,0.9596999591683381,1.0,28/106,19.90%,LEF1;TNFRSF19;EGFR;FGFR3;DDAH1;SHC3;CAP2;SLC19A1;FMNL2;AMOTL2;NYAP1;ARHGAP39;KAZN;EPN2;TBC1D16;CDC42BPB;NGEF;RBFOX2;ARHGEF17;NAV2;MPDZ;MTCL1;NCS1;FNDC4;MEIS3;ANTXR1;FARP1;SH3PXD2B
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.535985980240011,-0.9415325332327392,0.5806451612903226,1.0,1.0,2/13,8.25%,ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3998949313554852,-0.9414969232526179,0.618421052631579,1.0,1.0,14/75,16.50%,CCNE1;CDKN2D;CCNG2;CDKN3;SPDYA;CDC6;CCND2;GADD45A;CDK5R1;CDC25A;CDKN1B;INCA1;ADAM17;RGCC
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.4749690471519829,-0.9414397322063742,0.5671641791044776,1.0,1.0,6/24,24.45%,MORF4L1;TAF6;MORF4L2;MSL3;BRD8;KAT5
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.5822864050414274,-0.9413538369212677,0.5178571428571429,1.0,1.0,3/7,24.41%,WNT7B;BFSP1;WNT7A
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.6301069315915189,-0.9412153118615737,0.578125,1.0,1.0,3/6,18.32%,GOT1;CALCR;ADAM9
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3796597552691753,-0.9408665718337611,0.589041095890411,1.0,1.0,11/126,9.16%,MMP26;HCK;PTGIS;CASP12;AGT;ELANE;LRRC19;PTGES;SERPINE1;IL15;CCL5
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),-0.5916995068542563,-0.9406830064158052,0.6290322580645161,1.0,1.0,2/5,38.35%,PMVK;IDI1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.48430759527326556,0.9401708192237951,0.5172413793103449,0.962691684185555,1.0,3/12,14.27%,GCH1;PRKG2;MTHFD1L
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.5610507194432564,-0.9399766000011719,0.59375,1.0,1.0,3/9,13.18%,TGFB1;CASP8;FADD
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.3771898125472329,-0.9399578234637858,0.56,1.0,1.0,23/107,13.19%,LAMA2;ALPL;STEAP4;MSX1;FBLN2;TIMP3;RARRES2;ANGPTL2;COL6A1;ECM2;SLC38A11;ANGPT2;P2RY14;IGFBP5;PDE5A;ADGRF5;PLSCR4;ACTA2;RGS5;ZIC1;PDGFRB;SERPING1;SPARCL1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.38838511366862494,-0.9394915794460634,0.5733333333333334,1.0,1.0,26/107,25.86%,LIX1L;PINK1;CHMP4B;WIPI1;CHMP2B;TOMM20;CHMP2A;MAP1LC3B;MAP1LC3B2;TOMM7;TOMM22;GABARAPL2;FUNDC1;VDAC1;ULK1;VPS37B;ATG3;LAMP2;PRKAB2;VPS4A;DYNLL1;VPS28;VPS36;GABARAPL1;PLAA;ATG14
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.5488180629686521,-0.9389104457459848,0.631578947368421,1.0,1.0,1/12,2.53%,PATL2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.38247836891183407,0.9387748378113744,0.4166666666666667,0.9656887334832119,1.0,6/49,8.28%,WWTR1;PMEPA1;TGFBR1;ACVR1;ID3;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.5606661214167703,-0.9387391580597982,0.5666666666666667,1.0,1.0,2/8,31.26%,SUPT5H;CTR9
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.4929476193642367,0.9385529255034348,0.4594594594594595,0.9656629621245311,1.0,2/11,15.80%,GAS2L3;GAS2L1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5206700250723113,-0.9383955810415862,0.5932203389830508,1.0,1.0,3/13,12.80%,BCAP31;ERLEC1;SVIP
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.6525087568934579,-0.9383613410903745,0.7166666666666667,1.0,1.0,1/5,3.91%,RABGGTB
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.42184890839409706,-0.9382735510285752,0.5555555555555556,1.0,1.0,3/44,9.82%,PTGIS;CCL5;DAB2IP
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.5230194314783256,0.9381333339827549,0.5641025641025641,0.9660957368009897,1.0,2/9,8.11%,MDK;FUT9
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.3930067871275732,0.938113430100339,0.48,0.9655290397077988,1.0,2/33,3.66%,UNC13C;UNC13B
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.4088500391157985,-0.938046937187322,0.5416666666666666,1.0,1.0,18/63,29.97%,PSMB6;PSMB8;SKP1;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2;COPS8;AKT1;PSMD2;PSMA1;PSMD8;PSMC4;PSMC1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.49165190307617224,-0.9379223815160874,0.559322033898305,1.0,1.0,3/25,6.02%,HSD17B10;BAAT;ACOX2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.42166865313303686,0.9375062527301332,0.4,0.9663459993044771,1.0,4/34,5.00%,DOCK10;PHACTR1;CTNNA2;EPHB2
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.6046313559873915,0.9374368549288461,0.574468085106383,0.9658897006943505,1.0,2/5,23.49%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4981104076688105,0.9373308536360236,0.5945945945945946,0.9655254551909621,1.0,4/12,13.55%,KIAA0586;CEP135;CEP120;SPIDR
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.5033764386420837,0.9371620090420058,0.4782608695652174,0.9653079305059047,1.0,4/11,9.49%,SLC22A2;OXTR;APLN;ERBB4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.3684114281631462,0.9369179279472779,0.53125,0.9651728995542305,1.0,18/82,20.54%,SORCS1;CCDC22;CLVS1;ACBD3;COMMD1;BLOC1S4;AP4E1;VAMP8;EXOC6B;SORL1;KLHL20;AP4B1;GOPC;AP1S3;EXOC2;CLVS2;AP1S2;EXOC5
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.4236682799046046,-0.9363681915257447,0.5833333333333334,1.0,1.0,6/39,13.62%,ARIH2;TRIM5;MAGEL2;TRAF3IP2;PELI3;PRPF19
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.3587945299229862,0.936321865820908,0.5862068965517241,0.9661335347189366,1.0,12/80,14.21%,ACE2;PID1;GREM1;AKR1C3;APOE;SLCO1C1;DCXR;ANGPT1;ECE1;VAMP3;PDGFB;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.3527835072144521,0.9362407605067127,0.5555555555555556,0.9657062035557205,1.0,8/87,5.99%,RUNX1;HSPB1;KDR;SEMA5A;VASH2;PIK3R6;MDK;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.5992982525636157,-0.9362242413303353,0.6181818181818182,1.0,1.0,2/8,16.50%,TGFB1;RGCC
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3743328141280498,-0.9361776452509967,0.5555555555555556,1.0,1.0,19/129,13.33%,RIBC2;KCNE2;ACTC1;SOX10;STAG3;CALCB;PDE6B;PLAG1;SLC29A3;PROP1;SERPINA10;CHRNG;KCNMB1;NRIP2;ZC2HC1C;EFHD1;MYOT;HSD11B2;PKP1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.3478341709841968,0.9361531155724884,0.48484848484848486,0.965325006648146,1.0,6/49,12.66%,IFI16;PTPN6;TRAFD1;EREG;SAMHD1;LYAR
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.490402086254747,0.9360748731647046,0.4838709677419355,0.9648987395862718,1.0,5/14,7.17%,MYO3A;EPHB2;TTC39C;POU3F4;CHD7
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.4537196038381892,0.9360412939305806,0.4594594594594595,0.9643364312195175,1.0,6/18,23.31%,PARD3;FERMT1;SIPA1L3;OPHN1;MYO9A;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.29885198028113846,0.936014731950114,0.5384615384615384,0.9637475416321512,1.0,55/441,11.55%,NRG1;TBX6;LEF1;PDGFD;TRPC3;IRS1;EGFR;WWTR1;KDR;BCL2;CSF1R;FGFR4;KITLG;IL15RA;TGFBR1;S100A13;BMP6;GRK5;PARD3;TGFB2;GREM1;FGFR3;DBF4B;MDK;TGM1;PDGFC;PTGFR;MEIS1;PDGFRA;RAB27A;PRKCD;TNFRSF11A;BTC;TGFB3;AKR1C3;SHANK2;IGF1;PTPN6;HDAC1;NSMCE1;PKHD1;PDPN;IRS2;FAF1;ERBB4;TET1;EREG;SLC25A33;FGFR1;IL34;DVL2;TENM4;MAPK8;MST1R;FGF10
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.39796386452440613,0.9357455775224339,0.5333333333333333,0.9638323698257293,1.0,6/40,11.50%,EGFR;SLC30A10;BTC;SHC3;EREG;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.5650679345997371,-0.9356545758166629,0.6612903225806451,1.0,1.0,2/10,8.64%,NOTCH1;TGFB1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.49008022054212363,0.9356096461389349,0.5135135135135135,0.9635444683286452,1.0,1/8,1.23%,F2RL1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.5263598779217512,-0.9354940880016211,0.6271186440677966,1.0,1.0,5/14,26.26%,LPCAT4;PLA2G10;SLC27A1;GPAM;PLA2G4A
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.4788796207748207,-0.9354658543477864,0.5671641791044776,1.0,1.0,3/25,15.22%,ARL1;RIPOR1;GBP5
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.388599274783779,-0.9353678150846486,0.5675675675675675,1.0,1.0,17/95,12.16%,LAMA2;MYLK;CYP1B1;HSPG2;FBLN2;EPHX1;TIMP3;RARRES2;ANGPTL2;COL6A1;KCNMB1;IGFBP5;ADGRF5;PLSCR4;ACTA2;EFEMP1;PDGFRB
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.42818423339024636,0.9353574678873617,0.6060606060606061,0.9635929877090398,1.0,3/33,2.09%,F11;RIMBP2;SLC39A11
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.49636161858283556,0.9353026053936144,0.6097560975609756,0.963151301146411,1.0,3/14,7.59%,CCDC22;COMMD1;COX19
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.4063651636170283,-0.9351246537633214,0.5970149253731343,1.0,1.0,27/82,30.30%,CENPK;CHMP4B;NCAPH2;CHMP2B;RAB11A;NCAPG;CHMP2A;SMC2;TTN;EML3;KIF14;SET;PDS5B;BOD1;VPS4A;PSRC1;NCAPG2;RAN;DSN1;NCAPD3;CHMP1A;WRAP73;KIF22;CHMP5;PHF13;VPS4B;TUBG2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.501188758934643,-0.9348882142285847,0.5901639344262295,1.0,1.0,3/18,9.82%,ITGA5;TMEM204;DAB2IP
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4256369208424686,0.9347317562038573,0.4482758620689655,0.9639891827632183,1.0,2/40,1.89%,ACE2;ITPR2
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3826023545098412,0.934685875286171,0.5416666666666666,0.9634571544361722,1.0,15/93,10.72%,CREB5;TEX15;EGFR;GCNA;CREB3L4;MYO1D;DNAH6;MOV10L1;SPAG6;CCDC30;OSBP2;UBE3D;DMC1;PRNT;FAM229A
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.42293099263816614,-0.9344248410834335,0.5714285714285714,1.0,1.0,10/39,18.99%,WEE2;TOM1L1;TGFB1;ZWILCH;CHEK1;CDKN1B;GAS1;RGCC;NABP1;NME6
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.553877188138323,0.9343114824428636,0.5238095238095238,0.9631465810094928,1.0,1/5,6.95%,ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.553877188138323,0.9343114824428636,0.5238095238095238,0.9631465810094928,1.0,1/5,6.95%,ENPP1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.38436847575929733,-0.9341661751235036,0.5466666666666666,1.0,1.0,8/98,9.79%,ENPP2;PDXDC1;SERINC1;GM2A;DEGS2;GBA3;ALOXE3;SPTLC3
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.4359946208544516,-0.9341637621142402,0.5915492957746479,1.0,1.0,6/27,10.79%,SLC13A4;SLC22A25;SLCO2B1;SLC26A4;LRRC8D;SLC17A8
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.42074175329331115,0.9336735707981823,0.5405405405405406,0.9642537735942682,1.0,2/29,4.04%,PLCB1;ZBED3
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.4945918154776896,-0.9335363945060013,0.5714285714285714,1.0,1.0,9/22,15.92%,ELANE;CD74;IL7;SIGIRR;AGER;SNAI2;IL18;TLR2;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5040800120619099,-0.9334527241503013,0.6060606060606061,1.0,1.0,7/17,31.78%,CCL5;EIF2B5;YTHDF1;RPS6KB2;POLR2D;UHMK1;BOLL
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.43799956182236494,-0.933320295756841,0.5384615384615384,1.0,1.0,7/37,18.89%,TICRR;CDC6;MRE11;CHEK1;BRCA1;DONSON;NABP1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5265622762618237,-0.9330257950250445,0.5970149253731343,1.0,1.0,5/14,20.22%,PHKG1;PHKA1;AGL;MGAM;CALM1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.5857413976944199,-0.9327866280619551,0.5918367346938775,1.0,1.0,3/6,32.33%,SFXN3;SLC38A5;SLC38A2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.5689890993281905,-0.9326794154390905,0.5862068965517241,1.0,1.0,1/8,5.14%,BNIP3
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.6046223343332465,-0.9325265674192533,0.6190476190476191,1.0,1.0,2/5,17.79%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.5390666551610525,-0.9322954234289283,0.5454545454545454,1.0,1.0,1/11,4.94%,RPP38
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.5775038132131972,0.9320985586904591,0.5,0.9673217099042488,1.0,2/7,23.49%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4835833897843821,-0.9320845106762863,0.5757575757575758,1.0,1.0,1/21,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.4895689496498586,-0.932018599935864,0.5692307692307692,1.0,1.0,3/17,14.59%,CPNE5;SYT2;SYT4
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3748167678890606,-0.9320113447218116,0.6142857142857143,1.0,1.0,19/98,20.29%,ITK;RAC1;PSMB6;PSMB8;SKP1;VAV3;PIK3CB;TEC;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;SHC1;PSME1;PSMD12;CALM1;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.4392212464222507,0.9318173310685282,0.6111111111111112,0.9674127684016274,1.0,3/22,5.54%,EGFR;RITA1;HEY1
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.6072580474801851,-0.9316933882230278,0.6666666666666666,1.0,1.0,3/5,29.04%,CACNA1G;HCN4;SCN3B
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5042366369168065,-0.9316549482659616,0.5921052631578947,1.0,1.0,5/17,18.32%,TGFB1;APH1B;MBTPS2;ADAM17;ADAM9
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.38326945133787604,0.9313719092972245,0.6190476190476191,0.9679462155634716,1.0,9/73,8.26%,HSPB1;IFIH1;CIDEA;TLR1;EPHB2;HMGB1;RASGRP1;IGF1;PTPN6
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.5229660554506387,0.9313502355180763,0.5428571428571428,0.9673508648679271,1.0,3/9,17.82%,SIRT1;EP300;CREBBP
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4925345979382295,0.931234808805965,0.475,0.9663697359522215,1.0,4/11,18.50%,SYNJ2;INPP1;INPP5J;PTEN
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.4925345979382295,0.931234808805965,0.475,0.9663697359522215,1.0,4/11,18.50%,SYNJ2;INPP1;INPP5J;PTEN
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.5693654561898247,-0.9312238371910843,0.5666666666666667,1.0,1.0,2/7,14.19%,FABP3;HTR2B
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.601081957331908,-0.9311668184314906,0.6721311475409836,1.0,1.0,2/5,26.31%,KDM6B;KDM7A
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.429469202948767,0.9310774611492397,0.6052631578947368,0.9661728574436279,1.0,10/30,20.83%,FGFR4;XRCC4;MAPK8;PHACTR4;NCSTN;CHTOP;ABL2;B3GAT3;APOA1;ABL1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4866772401854326,0.930927499415766,0.5384615384615384,0.9659132127492175,1.0,4/13,20.01%,SHISA9;PPFIA3;GRIK2;CLN3
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.41060032250291645,-0.9307320118559559,0.5555555555555556,1.0,1.0,10/51,15.23%,H1-0;H1-2;TBP;POLR1E;ATAD2;POLR2K;CHEK1;POLR1H;ELOF1;DEK
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.38250289544848876,0.9305914873526079,0.5454545454545454,0.9659777689475955,1.0,14/62,14.33%,ZEB2;BMP7;TGFBR1;BMP6;TGFB2;BMP3;ACVR1;TGFB3;SMAD2;TWSG1;ELAPOR2;FBXL15;EP300;NUMA1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.35927829819912677,0.9301425799244337,0.5263157894736842,0.9665547185805927,1.0,21/102,13.73%,KCNJ16;KCNH5;KCNJ6;KCNB2;KCND2;LRRC55;KCNJ3;KCNN3;KCNN2;KCNJ2;HCN1;KCNK7;KCNQ5;SLC24A3;KCNC2;KCNS3;KCNK12;CHP1;KCNC3;KCNF1;KCNJ14
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.5081804740552733,-0.930081441712943,0.55,1.0,1.0,1/11,1.01%,PTGIS
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.4813008361652374,-0.9299102092397742,0.5217391304347826,1.0,1.0,10/23,41.11%,SLC36A1;SLC6A7;SLC38A5;CTNS;SLC38A2;SLC7A5;SLC6A15;SLC38A3;SLC1A4;SLC6A20
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.5621810279151078,0.9298565235466216,0.5609756097560976,0.9665558927718995,1.0,1/8,5.12%,DBF4B
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.4814478195447268,0.9298149577577169,0.5581395348837209,0.9660811545891659,1.0,2/10,10.22%,CPT1A;SLC25A20
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.6420025336628783,-0.9295265828598435,0.6349206349206349,1.0,1.0,2/5,29.81%,SLC39A6;SLC39A12
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.4046424836086368,-0.9294702500793439,0.6,1.0,1.0,18/64,13.11%,GNLY;ITK;PTPRC;DOCK2;GMFG;AHR;IL18R1;SPON2;TXK;SLA;CD6;TGFB1;CCL5;ARHGAP9;MYO1F;THEMIS;CD27;TAGAP
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.40616359826361836,0.9291490339363053,0.53125,0.9671056380692418,1.0,2/35,2.19%,PTPN3;EGFR
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4069930906388314,-0.9290596741087548,0.6973684210526315,1.0,1.0,17/64,23.33%,SLC19A3;AMN;AOX1;SLC52A2;PDZD11;RFK;CYB5R3;MMUT;SLC23A1;DHFR2;TCN2;SLC2A1;BTD;CBLIF;SLC25A19;SLC52A1;ALDH1L1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.5792475458624339,0.929041727630243,0.6410256410256411,0.9669001958568989,1.0,2/5,17.40%,PDE4D;PDE4B
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.5658337721547193,0.9285696086394039,0.5526315789473685,0.9673940870531131,1.0,3/6,22.78%,APOE;LDLR;ROCK2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.5261580459399002,0.9285205957004498,0.5,0.9669289728750632,1.0,1/10,1.23%,F2RL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.43966885504238395,-0.9284214768558621,0.6056338028169014,1.0,1.0,10/39,25.12%,TCP1;SOD2;STAT4;MSN;CA1;ARF1;CFL1;HSPA9;TALDO1;LCP1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.46916022920845457,-0.9283113140979279,0.5396825396825397,1.0,1.0,4/28,8.55%,CHMP4B;CHMP2B;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.5242317644970063,-0.9283058043075556,0.5714285714285714,1.0,1.0,2/11,14.50%,ARCN1;RIPOR1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.48573493988504535,-0.9278852921335421,0.6,1.0,1.0,8/21,30.87%,ALDOB;PGAM1;ENO2;PKLR;PGK1;GAPDH;PKM;HK3
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.48573493988504535,-0.9278852921335421,0.6,1.0,1.0,8/21,30.87%,ALDOB;PGAM1;ENO2;PKLR;PGK1;GAPDH;PKM;HK3
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.5788283269048375,-0.9278670409568147,0.6142857142857143,1.0,1.0,2/5,20.22%,CALM3;CALM1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.34188107178025057,0.9278652073671134,0.375,0.9679951039307387,1.0,23/191,13.83%,NRG1;HOMER2;CLSTN2;FSTL5;PPP1R14C;KCTD1;CNGA4;MORN4;CNTN4;EFNA5;DUSP8;RNF128;CAP2;CFAP43;SPOCK1;LRRIQ1;NYAP1;ARHGAP39;MARK1;NAT14;EPN2;FGF12;SPTBN4
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5756282369032025,0.9277233030222151,0.6666666666666666,0.9677001631084818,1.0,5/8,29.47%,ECE1;VAMP3;SNCA;SCRIB;RAB29
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.4564783065583776,-0.9274794230807273,0.65625,1.0,1.0,4/30,13.04%,AMBP;PINK1;DNAJA1;GSTP1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.3318052176577222,0.9269169163201953,0.5384615384615384,0.9689879713597521,1.0,15/115,9.85%,B3GALT9;GAL3ST1;ALG8;MOGS;MGAT4C;ST3GAL3;GALNT7;GALNT10;C1GALT1C1;TET2;GALNT18;FUT9;TET1;ST3GAL1;ALG12
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.3772905384788526,-0.9268779408163753,0.5733333333333334,1.0,1.0,17/93,22.57%,FIP1L1;NXT1;DDX39A;NCBP2;SLU7;FYTTD1;SLBP;NUP85;NCBP1;RNPS1;CDC40;ALYREF;NUP155;UPF3B;DHX38;NUP188;THOC5
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.5502307271536284,0.9268126296679322,0.5853658536585366,0.9686391714159351,1.0,1/5,7.17%,CHD7
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5357743988620436,-0.9266943583244242,0.6,1.0,1.0,1/11,7.46%,IFI27
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.5345818479284936,-0.9266126373155023,0.6212121212121212,1.0,1.0,1/8,4.68%,RAC1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.4651226298759581,-0.926415745010107,0.5645161290322581,1.0,1.0,2/17,6.22%,RND1;MTCH1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5121885478590988,-0.9263171359511607,0.5079365079365079,1.0,1.0,2/12,13.91%,MGME1;SLC25A4
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.43731293761254936,0.9261547262490197,0.6052631578947368,0.9695854823840084,1.0,3/20,9.95%,VASH2;VASH1;TSPAN12
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.5291144567660313,0.9256030238369323,0.6585365853658537,0.9702004495207357,1.0,6/16,16.20%,SIGLEC10;MDK;CASK;PTPRS;CRK;RTN4R
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.4093753892604913,-0.9254219648836199,0.6,1.0,1.0,12/53,20.29%,PSMB6;PSMB8;PSMA3;NQO1;PSMA5;PSMC3;PSMA7;PSMC6;AZIN1;PSME1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.5007378721151847,0.9253632800835284,0.575,0.9701369088189833,1.0,7/12,28.31%,XRCC4;BRCC3;ATM;XRCC6;NIPBL;IKBIP;LIG4
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.4730754991763589,0.9251804597408217,0.625,0.969877383188237,1.0,4/13,15.58%,PCM1;CEP120;HOOK3;SUN2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.5270825079768251,-0.925180090803529,0.6231884057971014,1.0,1.0,1/8,9.34%,IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.4613429096477318,0.9250239666081593,0.5609756097560976,0.9696359950617156,1.0,4/8,15.55%,TGFB2;GREM1;MYOCD;MEF2C
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.5343388599209061,-0.9244167367433704,0.6226415094339622,1.0,1.0,2/14,7.87%,H1-0;DNASE2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.4134200749073628,-0.9242191281003994,0.5573770491803278,1.0,1.0,9/55,13.30%,YBX3;BCL2L2;CDKN2D;PINK1;SOD2;HERPUD1;DNAJA1;SNAI2;TRIM32
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.5207120014127852,-0.923981189720532,0.6229508196721312,1.0,1.0,3/11,11.54%,TMIE;TBX1;ZIC1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.4334535537943417,-0.9239761763456524,0.5846153846153846,1.0,1.0,6/34,6.96%,TIMP3;AGT;TIMP2;SERPINI2;SERPINE1;SERPINA10
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.4688077597532246,-0.9238338024842607,0.5909090909090909,1.0,1.0,6/23,26.07%,B2M;HLA-A;FADD;HSPD1;HLA-F;AZGP1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4741191687691599,-0.9237935813262539,0.5671641791044776,1.0,1.0,4/21,19.69%,SUB1;PSMC3;PSMC6;ESR1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.32442450689133734,0.9237678162648738,0.5625,0.9721185781410449,1.0,26/227,11.41%,EPHA3;PID1;PDE3A;IRS1;SLC26A3;PTPRK;EGFR;RORA;FOS;HCN1;PDGFRA;HMGB1;PRKCD;BRINP1;TICAM1;AKR1C3;LTK;AGAP3;PRKD1;SSH1;ERCC6L2;KCNC2;MTR;RUVBL2;NSMF;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.4955577262468642,-0.9235740978759718,0.6290322580645161,1.0,1.0,3/17,13.40%,DAB2IP;F11R;GMIP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.4961267607325459,-0.9235262585709884,0.6307692307692307,1.0,1.0,7/25,22.34%,ATP1B1;CAV3;KCNQ1;CALM3;HCN4;CALM1;NOS1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.4442981339399456,-0.9231556952634333,0.5714285714285714,1.0,1.0,6/29,12.50%,SEMA3D;ELANE;NOTCH1;ANGPT2;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4363774739405213,-0.9227310585816998,0.5571428571428572,1.0,1.0,1/36,0.11%,EPN1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5147776966927857,-0.9225870657982225,0.5737704918032787,1.0,1.0,3/9,28.91%,DGAT2L6;PLA2G4A;DGAT1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.5803257819161524,-0.9225345377514711,0.6785714285714286,1.0,1.0,2/6,25.80%,SPI1;METTL3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.41585598719495837,0.9220976718842495,0.5172413793103449,0.9759056721238176,1.0,3/23,2.91%,NTNG1;CTNNA2;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.47635591515288167,0.9216680627985193,0.5,0.9761143512471684,1.0,8/19,18.24%,SLC30A10;RAB27A;SLC25A33;SPHK2;ABCD2;TRAP1;GRIN1;PPARA
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.33485202347686704,0.9214888938233441,0.6363636363636364,0.9759496326561562,1.0,20/160,9.27%,F11;ATOH8;CYP1A2;CA2;PROS1;DHRS1;TGFB2;GCH1;PAPSS2;IL1R1;HGFAC;AKR1C3;CSAD;IGF1;LCAT;HPRT1;APOE;ALAS1;SLC35B1;CROT
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5125317182271649,-0.9214680410177936,0.55,1.0,1.0,3/10,18.32%,ADGRB1;FLOT1;ADAM9
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5813248990436937,-0.9214465030848119,0.7241379310344828,1.0,1.0,2/8,8.91%,CIITA;TAF7
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.585344011715588,-0.9212950992082177,0.6792452830188679,1.0,1.0,1/6,10.96%,SPI1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.4212509571096882,-0.9211679767524272,0.48484848484848486,1.0,1.0,8/33,22.31%,RFC5;RPA3;XRCC1;PCNA;TDG;PARG;MPG;APEX1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.4626038274143993,0.9211231590851917,0.6052631578947368,0.976291204432984,1.0,3/10,14.37%,PCM1;HOOK3;CCDC120
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4128040326435881,0.9209915854533717,0.6129032258064516,0.976037849389651,1.0,4/42,2.53%,BCL2A1;IFI16;BCL2L11;BCL2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6000387626519235,-0.9209171329525061,0.6119402985074627,1.0,1.0,1/5,25.08%,NUCKS1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.36170846491167336,-0.9208806164792128,0.6025641025641025,1.0,1.0,13/167,6.84%,CD44;MMP26;LAMA2;ADAMTS4;COL9A1;HSPG2;MMP15;FBLN5;ITGA5;ADAMTS18;SERPINE1;COL6A1;ECM2
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.5223692176312769,-0.9208201884547415,0.6307692307692307,1.0,1.0,2/11,4.82%,SLCO6A1;SLCO2B1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5295906617551787,-0.9207221614157791,0.5967741935483871,1.0,1.0,3/9,35.95%,TWIST1;AKAP8L;RPS6KA4
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.36164896877588115,-0.9205073646230773,0.6363636363636364,1.0,1.0,13/167,6.84%,CD44;MMP26;LAMA2;ADAMTS4;COL9A1;HSPG2;MMP15;FBLN5;ITGA5;ADAMTS18;SERPINE1;COL6A1;ECM2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.5529752665247136,0.9205048328251317,0.5641025641025641,0.97666270493212,1.0,2/7,21.73%,AK5;CTPS2
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.5513293673550026,-0.9204236489530772,0.6,1.0,1.0,2/6,20.44%,TRPV3;PER1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.49270957828167966,-0.9203770792086761,0.5972222222222222,1.0,1.0,5/18,24.92%,CD74;PLA2G10;LBP;HSPD1;PJA2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.5346817317575414,-0.9202087170766667,0.5967741935483871,1.0,1.0,7/11,23.66%,COX4I1;COX6B1;CYCS;COX7A2L;COX6C;COX7C;COX7B
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.511939656065227,0.9201750290098644,0.5945945945945946,0.976870263689307,1.0,2/8,10.67%,TIMELESS;SMARCAL1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.3803597596042639,0.9197592093173785,0.5555555555555556,0.9772369830462659,1.0,8/48,7.17%,KIT;ITGA4;TOX;HDAC9;LEPR;RABL3;GPR89B;CHD7
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.6000124010855573,-0.919756348425518,0.5576923076923077,1.0,1.0,4/6,39.88%,SLC38A5;SLC38A2;SLC38A3;SLC1A4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.37721335159400715,0.9197524634730828,0.5588235294117647,0.9766296263134839,1.0,11/26,19.56%,MMD2;RASGRP1;IGF1;IRS2;RASGRF1;FGF10;NGF;JAK2;RAPGEF1;RELN;ITGAV
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.41789890945088054,0.9196675743442204,0.5833333333333334,0.97637684788713,1.0,5/33,8.37%,UNC5C;NRP1;VLDLR;HEY1;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.46238745351072646,0.9194162129678912,0.5,0.9763630661086803,1.0,2/16,7.88%,TRPC3;IGF1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.5021202907486811,0.9192926997250545,0.5652173913043478,0.9760489243163695,1.0,3/12,5.54%,TGFBR1;TGFB2;HEY1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5185691655324737,0.9192796080106423,0.6046511627906976,0.9754791268654532,1.0,3/10,12.03%,HSPA1A;BAG3;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6138218298246776,-0.9192106914472301,0.6417910447761194,1.0,1.0,3/5,27.69%,GPER1;STX1B;BAIAP3
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.40070952557909706,-0.919103800984509,0.6714285714285714,1.0,1.0,11/88,9.40%,AMBP;C17ORF99;OSCAR;FGL1;IL4I1;B2M;AHR;IRF1;CD300LF;IL15;CASP8
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.5661084138083304,0.9190241974598184,0.5625,0.9755365163003453,1.0,2/6,6.58%,LEF1;HMGB1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.556550473207087,-0.9188524859450384,0.6166666666666667,1.0,1.0,1/8,7.80%,RAB11A
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4283201790707013,0.918675927408479,0.5277777777777778,0.9757613806529309,1.0,2/25,2.98%,GPC4;SDC4
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.5146679116172022,-0.9184480293550888,0.5714285714285714,1.0,1.0,4/16,12.65%,HENMT1;TDRD1;TDRD9;BTBD18
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.4466682426747874,0.9183370626200403,0.5294117647058824,0.9758537754116666,1.0,2/23,8.17%,PER2;PGM2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.4402722295485011,-0.9182817018488239,0.6142857142857143,1.0,1.0,10/37,25.12%,TCP1;SOD2;STAT4;MSN;CA1;ARF1;CFL1;HSPA9;TALDO1;LCP1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.493333177851929,-0.9181852212799771,0.609375,1.0,1.0,4/15,20.45%,STAT1;SPI1;IL6ST;YAP1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.5517923394343447,-0.918012216506267,0.5873015873015873,1.0,1.0,3/8,24.61%,AGER;LYN;GRN
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.48961830725264355,-0.9177328366395235,0.5571428571428572,1.0,1.0,3/19,8.25%,KCNE2;SCN4B;ATP1A1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.6021146579487868,-0.9176621788088103,0.6363636363636364,1.0,1.0,1/5,14.86%,IL18
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.6021146579487868,-0.9176621788088103,0.6363636363636364,1.0,1.0,1/5,14.86%,IL18
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6048675067517122,-0.9175254631254945,0.5789473684210527,1.0,1.0,3/5,37.50%,PDHX;PDHB;PDHA1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3953729183553973,0.9175157493744072,0.6785714285714286,0.9773640316787593,1.0,9/43,15.68%,TBL1Y;HDAC9;PRDM5;HDAC1;HDAC10;SIRT2;SIRT1;SIN3A;HDAC5
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.3841131035311138,-0.9174496064034676,0.5945945945945946,1.0,1.0,23/72,27.66%,HSD17B10;IL4I1;GOT1;GAD1;SDS;SLC25A44;BCAT2;ACMSD;ALDH4A1;BCKDK;PIPOX;DAO;FAH;ACAD8;NOS1;AMDHD1;ABAT;GSTZ1;ASPA;DBT;SARDH;TDO2;DLST
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.4582017420005179,0.9171975117691241,0.5625,0.9769659350539133,1.0,3/8,24.48%,GABPA;ABL1;PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.4582017420005179,0.9171975117691241,0.5625,0.9769659350539133,1.0,3/8,24.48%,GABPA;ABL1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.5584970176325073,-0.9169755063400983,0.6,1.0,1.0,3/8,24.13%,RFC5;PCNA;CHTF18
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.5584970176325073,-0.9169755063400983,0.6,1.0,1.0,3/8,24.13%,RFC5;PCNA;CHTF18
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.40298999852509615,0.9166981138399214,0.5172413793103449,0.9777254736091565,1.0,3/21,7.15%,PTPN3;UTRN;COMMD1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.5826794366519087,-0.9163466142253981,0.6833333333333333,1.0,1.0,4/6,41.11%,SLC6A7;SLC6A15;SLC1A4;SLC6A20
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.4566550572999368,-0.9163182013242948,0.6451612903225806,1.0,1.0,7/19,24.74%,AGT;HIP1R;GPER1;SHKBP1;PLAUR;BCAR3;AKT1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.5696968616380976,0.9161307039856672,0.6190476190476191,0.9777754554460031,1.0,2/6,19.42%,PIK3R1;MAP4K4
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.5696968616380976,0.9161307039856672,0.6190476190476191,0.9777754554460031,1.0,2/6,19.42%,PIK3R1;MAP4K4
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.49626717491198585,-0.9154756925815295,0.5964912280701754,1.0,1.0,5/15,24.76%,ABCB1;SLC23A1;ABCC2;GPLD1;BEST1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5327007551952998,-0.9153472177649834,0.59375,1.0,1.0,5/13,20.22%,PHKG1;PHKA1;AGL;MGAM;CALM1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3874788429474115,0.9152525232358272,0.6,0.9791648728131579,1.0,8/28,20.63%,CEPT1;CHKA;LCAT;CHPT1;PHOSPHO1;PCYT1B;APOA1;GPAT4
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.46322357384080076,-0.9152057245162556,0.647887323943662,1.0,1.0,5/27,12.35%,PRELP;CHST1;B3GNT4;B3GNT3;OGN
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.44902105620164745,-0.914920512091802,0.6086956521739131,1.0,1.0,8/36,15.04%,CYP1B1;RASIP1;RASA1;LAMA1;TGFB1;TBX1;CCBE1;AGGF1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.5006774714936122,-0.9149116360965958,0.6379310344827587,1.0,1.0,8/20,27.47%,ZACN;HVCN1;KHK;SLC30A8;SLC30A4;GLRA1;MT1G;SLC30A5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.47528069810623247,-0.9143010715881453,0.5588235294117647,1.0,1.0,3/19,10.28%,FKBP1B;CALM3;CASQ1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.40039272640922186,0.9141978184043936,0.625,0.9810699701655922,1.0,8/21,24.04%,HEG1;NLGN1;BSN;PCLO;DSP;FERMT2;NPHS1;SHANK1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.5410500588991829,-0.9139872324001781,0.625,1.0,1.0,3/11,13.18%,CASP8;INHBA;FADD
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.4761039225065372,-0.9135587771345074,0.6615384615384615,1.0,1.0,8/25,15.22%,GNLY;ITK;PTPRC;CD6;THEMIS;CD27;TAGAP;GBP5
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.5347835329112787,0.9131795357291924,0.5652173913043478,0.9827974439028594,1.0,1/6,5.37%,IGLL1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.35836113879068654,0.9131770593381346,0.5185185185185185,0.9822105345388319,1.0,18/59,20.83%,F2RL1;NRP1;GPR174;KANK1;HEG1;APOE;PRAG1;STARD8;RIPOR2;KCTD13;RTN4R;ABL2;OPHN1;ROBO1;MYO9B;APOA1;GPR35;ABL1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.4027310362852008,-0.9130243979032727,0.6056338028169014,1.0,1.0,12/64,22.05%,ROPN1B;CHMP4B;RASA1;STMN1;NOX5;SEPTIN14;SEPTIN1;MITD1;SEPTIN5;RACGAP1;EFHC2;VPS4A
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.6024014695925114,-0.912976105094121,0.6538461538461539,1.0,1.0,2/5,9.19%,IRF1;GLI3
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.4703193921332176,-0.9123774058916518,0.6153846153846154,1.0,1.0,6/25,18.84%,CCL5;SPI1;FADD;GBP5;LBP;NLRC5
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.3885357497031397,0.9122421654799581,0.43478260869565216,0.9838388988656407,1.0,4/36,3.63%,ACE2;HTR7;SGCD;SGCZ
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.49113526353298886,0.9121202084665673,0.5,0.982919493524433,1.0,1/7,1.23%,F2RL1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.49113526353298886,0.9121202084665673,0.5,0.982919493524433,1.0,1/7,1.23%,F2RL1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.35830955395080144,0.9117474851935988,0.4838709677419355,0.9831028108963429,1.0,8/61,8.80%,CSF1R;PLCB1;PIGQ;SMPD4;GDE1;PLA2G4C;LCAT;DGKH
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5504386188912949,-0.9115248162620901,0.647887323943662,1.0,1.0,3/15,22.33%,SYNGR2;STX19;STX1B
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.6232602748035356,-0.9115169555207369,0.6833333333333333,1.0,1.0,4/5,37.57%,HSP90AB1;HSP90AA1;CLU;NAB2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.37759586472687534,-0.9114286749844793,0.6103896103896104,1.0,1.0,20/89,24.86%,C4BPB;WFS1;AGT;GPC3;TGFB1;DAB2IP;INHBA;TRIM32;IL18;CDKN1B;NFKBIA;PLA2G10;HECW1;C4BPA;RAB1A;RAB1B;UHRF1;WNT7A;AKT1;VPS28
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.34682355390658925,0.9113189737737896,0.5517241379310345,0.983635171631306,1.0,14/111,12.98%,FHDC1;FBXW8;VTI1A;TMED3;GOLGA8M;GOLGA8H;PRMT5;BET1;PRKD1;PI4K2A;ATL2;TMED5;UBXN2A;STX6
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.591935701001345,0.911311800713374,0.6666666666666666,0.9830586330622864,1.0,1/6,9.06%,LETM2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5483050994557458,-0.91117878146579,0.6060606060606061,1.0,1.0,1/11,6.25%,IFIT1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.4633665073495531,0.9108519656962454,0.6111111111111112,0.9834159486511516,1.0,3/14,8.08%,MDK;PKDCC;SOX5
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.3780154612448911,-0.9105259061100792,0.52,1.0,1.0,15/65,21.84%,NSDHL;ATF5;TMEM97;ANXA5;DHCR7;FASN;PNRC1;FADS2;NIBAN1;CD9;ACTG1;SQLE;PLAUR;AVPR1A;MAL2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.5810089546184348,-0.9103535986509511,0.65,1.0,1.0,2/8,13.42%,CD300LF;GPER1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.46860063106997984,-0.9099160116014365,0.6190476190476191,1.0,1.0,9/17,24.41%,ACTA2;WNT7B;TMEM79;DACT2;BFSP1;PDZD7;EXPH5;LRTOMT;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.48099265206418834,0.9097634449054111,0.6285714285714286,0.9854636673699171,1.0,3/10,14.09%,PDGFRA;APOE;PDGFB
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.49857622140946856,0.9096005308665168,0.6,0.9853138750766318,1.0,2/14,3.49%,CCDC63;DNAH5
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.42224037366927475,0.9094457432656217,0.5454545454545454,0.9851207408148875,1.0,3/27,3.87%,ITGB5;ITGA4;LAMB3
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4480633119166507,0.9094233902903894,0.6222222222222222,0.9845798545119949,1.0,3/15,5.57%,MAML3;MAML1;WWC1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.5662531603579665,-0.9093829135804989,0.6779661016949152,1.0,1.0,2/5,21.90%,CCBE1;ACVR2B
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.46818226563255544,-0.9093656739507929,0.6896551724137931,1.0,1.0,2/15,4.40%,ZFPM1;NOTCH1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.43843924454473454,-0.9092609595594014,0.631578947368421,1.0,1.0,7/41,10.43%,LAMA2;CAV3;CTF1;SMTN;MKX;TEAD4;TBX1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.37139957707195764,-0.9092512744826177,0.676056338028169,1.0,1.0,11/110,16.17%,AMBP;HSPG2;AMN;LDLRAP1;STAB1;HIP1R;ASGR1;LRP2;RAB31;SFTPD;WASF1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.5096959334492907,-0.9089908618846608,0.5753424657534246,1.0,1.0,2/12,9.77%,BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.44003086900505906,-0.9087620373135554,0.6610169491525424,1.0,1.0,6/35,19.00%,RAD54L;RECQL;MRE11;HMGB3;RAD51C;SUPV3L1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4220431218822286,-0.9087261883619283,0.5671641791044776,1.0,1.0,6/32,19.09%,EMC1;CAMLG;OTOF;EMC3;TRAM2;CCDC47
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.41682774616209334,0.9087222279033486,0.5333333333333333,0.9855524522982955,1.0,6/15,18.94%,TGFB2;MYH3;PTCH1;LRP6;FBXW4;MBNL1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.5230502031579537,-0.9086316176881648,0.676923076923077,1.0,1.0,5/9,37.07%,BOD1;CHAMP1;SEH1L;NUF2;RMDN1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4794776072730131,-0.9084447196764649,0.5967741935483871,1.0,1.0,4/22,13.40%,ELANE;TGFB1;CLPX;SIAH1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.37406643853179494,0.9084351065546121,0.48148148148148145,0.9856028203412993,1.0,9/54,8.80%,CIDEA;LTBP1;PMEPA1;SPRED1;TGFBR1;SPRED2;SPRED3;HSPA1A;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5139983590113264,0.9081649326554734,0.5357142857142857,0.9856618107458343,1.0,1/7,0.67%,KLRD1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.355474673879966,-0.908123447263627,0.7272727272727273,1.0,1.0,50/181,23.50%,MCM2;SLC7A11;GOT1;PPA1;FGL2;TMEM97;DDX39A;CCT6A;ATP6V1D;SLA;GLRX;PRDX1;CORO1A;HSPA5;EPRS1;IGFBP5;UCHL5;UFM1;CDC25A;PDAP1;PSMA3;DHCR7;G6PD;NMT1;PSMC6;ERO1A;SDF2L1;FADS2;EIF2S2;TUBA4A;NAMPT;PLOD2;SLC2A1;COPS5;SYTL2;NIBAN1;PSMD12;CD9;SQLE;WARS1;CACYBP;HSPA9;SRD5A1;AK4;RAB1A;HSPD1;LDHA;CALR;MLLT11;HSPA4
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.34034385880347395,0.9080406804057256,0.6,0.9853475540037,1.0,27/97,22.03%,CSF1R;PLCB1;PIK3R6;SYNJ2;MTMR8;PLA2G4C;PI4K2A;PIP4K2A;PTPN13;PIK3R1;MTMR9;LCLAT1;PIP4P1;PIK3C2B;PITPNM1;INPP5J;PTEN;MTMR6;MTM1;PIP5K1C;PI4K2B;MTMR11;PLBD1;PLEKHA1;MTMR3;PI4KA;PIP5K1B
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.3639321165097716,-0.9075704191072704,0.7037037037037037,1.0,1.0,7/152,7.45%,CD44;CA12;WFS1;NXT1;PTGES;FKBP4;CELSR1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),0.5010498941410024,0.9072828698746396,0.5,0.9856649925103845,1.0,2/5,5.83%,KCNJ3;KCNN2
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),0.5010498941410024,0.9072828698746396,0.5,0.9856649925103845,1.0,2/5,5.83%,KCNJ3;KCNN2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5382739684058379,-0.9071383328122984,0.6212121212121212,1.0,1.0,3/7,5.59%,PTPRC;IL4I1;AHR
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3925435561887028,-0.9068874595068933,0.6527777777777778,1.0,1.0,23/77,20.57%,PTPRC;CGAS;TRIM5;STAT1;BNIP3;IFIT1;IRF1;IFI27;IFI6;AGBL5;IFIT3;IFNLR1;OAS3;FADD;IFIT5;SERINC3;ISG20;TLR2;PLA2G10;NLRC5;ISG15;STAT2;OPRK1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.5273627342284916,-0.9068265735913683,0.65,1.0,1.0,4/11,22.98%,BRK1;WASF1;CYFIP1;WHAMM
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.5108816975015467,-0.9067714507339741,0.5833333333333334,1.0,1.0,1/12,2.87%,YBX3
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3990062831136311,0.9067382897756177,0.5,0.9863475129112715,1.0,6/33,10.67%,RFWD3;BRCA2;PRIMPOL;EME2;SAMHD1;SMARCAL1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.401261022452859,0.9065973438099337,0.5142857142857142,0.9860942052194613,1.0,2/35,2.05%,IFI16;IFIH1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.4832054149550692,-0.9063766119328657,0.5616438356164384,1.0,1.0,2/17,10.80%,UPB1;DPYS
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.46886210633569353,-0.9061090355823798,0.6875,1.0,1.0,7/21,14.16%,DUOX1;SOD2;NOX1;PRDX1;ALOX12;NOX5;PREX1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5348459000745395,-0.9060841262319562,0.5873015873015873,1.0,1.0,1/9,2.07%,CYP19A1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.5840088060757938,-0.9060423055809327,0.6417910447761194,1.0,1.0,2/5,18.84%,FADD;NLRC5
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.4948931197470843,-0.9056195437467713,0.6153846153846154,1.0,1.0,2/13,17.97%,UFM1;ULK1
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.5481075711551552,0.9055933741382513,0.6,0.987960977612505,1.0,1/6,3.61%,PLCB1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.4172490182508356,-0.9055551262195566,0.559322033898305,1.0,1.0,11/44,20.52%,PTPRC;CARD8;SIGIRR;PELI3;OAS3;GSTP1;STAP1;GPS2;NLRC5;ISG15;STAT2
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.5813745640859782,-0.9054747252310831,0.6607142857142857,1.0,1.0,4/6,30.43%,NTN1;WAS;RHOU;CDC42
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.35914070485949595,-0.9051717328327561,0.6172839506172839,1.0,1.0,16/111,12.27%,CD44;CD4;PTPRC;CD74;P2RY1;NOTCH1;NODAL;ATP6AP1;TGFB1;AGER;CCL5;CALCR;SCIMP;ROR1;PDGFRB;PRXL2C
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.4929566884815214,-0.9051505391088485,0.65,1.0,1.0,3/16,20.33%,WIPI1;ULK1;ATG3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.5405829981044089,0.9051140773890033,0.5121951219512195,0.9878767663293732,1.0,1/5,2.19%,EGFR
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.5405829981044089,0.9051140773890033,0.5121951219512195,0.9878767663293732,1.0,1/5,2.19%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.43420363349138985,-0.9049747403873862,0.5967741935483871,1.0,1.0,3/34,7.75%,AMBP;PINK1;FOXM1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.3796502725415163,0.9049231990856038,0.5652173913043478,0.9877354187917845,1.0,7/47,8.54%,SLC16A2;SLC16A9;SLC6A11;SLC16A7;SLC16A12;SLC6A13;SLC7A1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.5927796881904219,0.9045540849156837,0.6486486486486487,0.9881121120026201,1.0,3/6,24.78%,SGPP2;NR4A3;NR4A1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.3953817667436749,-0.9045298991001066,0.726027397260274,1.0,1.0,18/80,11.06%,MS4A6A;CLIC6;ANKUB1;TEX26;OMG;CD74;CD14;CP;SLCO2B1;SOD2;FGL2;ADAM28;FAM20A;CD302;ALDH2;ALDH1A1;L3MBTL4;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.3328661464947099,0.9044516678310819,0.5,0.9877810227033512,1.0,27/163,8.73%,ROR2;RGS14;NPNT;PDGFD;F2RL1;C5AR1;EGFR;SLC30A10;NRP1;KDR;CSF1R;FGFR4;SPRED1;SPRED2;SPRED3;FGFR3;EPHB2;SPRY3;PDGFC;DUSP4;PDGFRA;HMGB1;RASGRP1;PTPN6;APOE;PKHD1;EPHA7
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.547551985233612,0.904443261863448,0.525,0.9872089544250751,1.0,5/7,15.55%,MRTFA;HEY1;MRTFB;MYOCD;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3836038044608478,0.9043105824896615,0.5333333333333333,0.9870080444791833,1.0,6/48,7.06%,HSPB1;IFIH1;TLR1;EPHB2;HMGB1;RASGRP1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3392155693467078,0.9040012872252353,0.6129032258064516,0.9871431785301344,1.0,19/114,11.44%,PID1;LEF1;IL1RL2;AFF3;BCL2;CSF1R;IL1RAPL1;GCH1;ALDH1A2;PTPN9;TNFRSF11A;IL1R1;PTPN6;REL;PTPN12;IGBP1;PTPN13;MAPK8;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.33753189808821116,0.9039268695178604,0.5357142857142857,0.986693003771476,1.0,1/57,0.23%,FBXL7
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.3253149583055798,0.9038258850554283,0.64,0.986406770510681,1.0,14/88,15.18%,ITPR2;EGFR;PLCB1;CAB39L;PRKCB;SMAD2;ARPC3;ADCY2;MAPK8;NGF;TIAM1;PAK4;MAP2K3;PPP2R1B
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.5286012536647665,-0.9037996180811896,0.6875,1.0,1.0,3/12,6.02%,PINK1;HEBP2;ACOX2
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.3809891293375675,0.9035531794336902,0.6222222222222222,0.9864216970455528,1.0,7/40,16.02%,CROCC;SDC4;STX18;PIP4K2A;CEP120;NUMA1;ELAPOR1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5287407845193501,0.90347814878952,0.6285714285714286,0.9848449071207295,1.0,1/9,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5287407845193501,0.90347814878952,0.6285714285714286,0.9848449071207295,1.0,1/9,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5287407845193501,0.90347814878952,0.6285714285714286,0.9848449071207295,1.0,1/9,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.42164607744091137,-0.9034417875045968,0.6029411764705882,1.0,1.0,5/40,18.46%,TERF2IP;RPA3;MRE11;PCNA;H3-3A
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.5513250118642821,0.9033662967859822,0.6176470588235294,0.9839339776825016,1.0,1/5,2.40%,PKP2
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.5513250118642821,0.9033662967859822,0.6176470588235294,0.9839339776825016,1.0,1/5,2.40%,PKP2
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3528140205790397,-0.9033306694900886,0.6712328767123288,1.0,1.0,22/80,25.57%,SLC7A11;SLCO2B1;SLC7A7;STARD5;SLC51A;LRRC8D;SLC16A8;SLC36A1;SLC38A4;SLC23A1;SLC25A11;ABCC2;SLC3A1;SLC10A5;SLC16A1;SLC10A6;SLC27A1;ABCB11;SLCO1A2;SLC38A5;CEACAM1;SLC26A8
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.46613129281434384,-0.903303783190798,0.6,1.0,1.0,4/24,7.91%,FGL1;IL4I1;NCKAP1L;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.44440989728087105,-0.9033030169543875,0.5735294117647058,1.0,1.0,6/29,15.56%,LDLRAP1;SOD2;IGFBP5;GPER1;TPM1;CDKN1B
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.39345975797041505,-0.9032064372173572,0.5616438356164384,1.0,1.0,9/49,24.02%,CHMP4B;CHMP2B;CHMP2A;NUP85;ANKLE2;NUP155;VPS4A;NUP188;RAN
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.551359784787568,-0.9030782767950855,0.5833333333333334,1.0,1.0,6/10,32.70%,LPCAT4;LPCAT3;PLA2G10;PLA2G4A;OSBPL10;PLAAT3
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.43713991111276806,-0.9029609666738102,0.6896551724137931,1.0,1.0,7/40,8.31%,SLC28A2;HSD17B2;ANKS4B;PBLD;ALDOB;GBA3;SCGN
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.3700674825365609,0.9028823959017338,0.6206896551724138,0.9845497952957948,1.0,8/49,11.93%,PER2;SLC37A4;IRS2;G6PC3;SLC25A1;DCXR;PC;RBP4
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.35891667759317525,0.9028367047200703,0.625,0.9840693797439115,1.0,6/40,4.61%,GPR149;PENK;SORCS1;CYSLTR2;NXPH2;NTSR1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.4239677774592154,-0.9028221082826672,0.6,1.0,1.0,4/34,8.25%,SLC12A7;KCNE2;ATP1B1;ATP1A1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.4003001533129483,0.9027769639332759,0.6071428571428571,0.9835809878689693,1.0,4/25,2.90%,KLRD1;CD96;CD247;GPR174
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.30852802812198,0.9027484775585303,0.6956521739130435,0.9830675375046865,1.0,44/206,17.38%,TPD52L1;MAML3;IRS1;NRP1;SULF2;KANK1;TGFBR1;CRADD;BMP6;TGFB2;MAML1;ADAMTS3;KLK6;MN1;PRKCB;JAG1;NRXN1;NLGN1;IGF1;TEDC2;CTBP2;LIMS1;PIK3R1;ZDHHC5;TRIM44;SIRT1;EPN2;MBD5;SORL1;NTRK3;EP300;SPIN1;FGFBP3;KLF2;JAG2;HOMER1;TEDC1;SMARCA4;GRIN1;BMP2K;KIF7;JAK2;TMEM108;SMARCB1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.37426489340246427,-0.9024090104289879,0.6375,1.0,1.0,20/99,21.10%,ANKS4B;WFS1;CHAC1;RASGRF2;HSPA5;BCAP31;HERPUD1;DAB2IP;ERLEC1;RCN3;UFM1;ATP2A3;MBTPS2;ERO1A;FLOT1;SYVN1;EIF2B5;CCDC47;NIBAN1;ITPR1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.5383470882535446,-0.9015650285674393,0.65,1.0,1.0,1/8,7.59%,NOX1
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.49846279369170937,-0.9014134876718968,0.6349206349206349,1.0,1.0,2/16,5.00%,IHO1;RNF212B
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.46962976108269794,0.9013156036607688,0.575,0.9857583794467237,1.0,2/12,10.60%,REEP1;ATL2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.493606458262612,-0.9011010534049327,0.6785714285714286,1.0,1.0,2/11,13.68%,NCBP2;NCBP1
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.5853763459762947,-0.9009903801413057,0.6037735849056604,1.0,1.0,2/6,19.40%,TTPA;CPTP
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.46857741417573046,-0.9009871081472631,0.6103896103896104,1.0,1.0,2/18,8.20%,DRD3;GRM3
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.5807763172523106,-0.9008471879323682,0.6440677966101694,1.0,1.0,1/6,16.54%,EXOSC6
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.4887629747992582,-0.9007656851291789,0.5588235294117647,1.0,1.0,4/18,9.10%,TRIM22;TRIM5;TRIML2;TRIM25
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.4753578716468616,-0.9007384870127857,0.6282051282051282,1.0,1.0,2/18,4.71%,CHAC1;CHAC2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.5266017656060202,0.900434543497948,0.6410256410256411,0.9872165208015522,1.0,2/10,6.71%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.4788723299208483,-0.9000048700535934,0.6527777777777778,1.0,1.0,7/19,25.96%,TMEM35A;HSPD1;HSPA4;CCT2;HOPX;PSMG1;HSP90AB1
prerank,PanglaoDB_Augmented_2021__B Cells,0.34410598190319236,0.8998572199685606,0.6666666666666666,0.9880926776779434,1.0,11/88,9.14%,CD38;SEMA6D;GPR174;BACH2;IGLL1;TENT5C;CD22;FLI1;PXK;ARHGAP30;DERL3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.5669769082156493,-0.8996114156685789,0.6610169491525424,1.0,1.0,1/6,13.81%,LRP2
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.6156369614916931,-0.8993053227259339,0.6507936507936508,1.0,1.0,3/5,22.10%,EIF6;C1QBP;SBDS
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.4047667097663048,-0.8990777389837028,0.6865671641791045,1.0,1.0,8/59,9.16%,TNFSF18;FBLN2;RAC1;NODAL;P2RY12;ECM2;NCKAP1L;CCL5
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.37386655514330164,-0.8989402233969273,0.6029411764705882,1.0,1.0,19/77,28.11%,HLA-DMA;CD74;HLA-DPB1;DCTN1;HLA-DMB;KIF11;ARF1;KIF3A;RACGAP1;AP1M2;SEC23A;DYNLL1;KIF5A;CANX;CLTC;SPTBN2;CLTA;KIF22;KLC1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2914555491281749,0.8988339826495088,1.0,0.9895988417112399,1.0,45/319,15.05%,FBXL7;RNF150;MYLIP;RNF126;RNF217;FEM1A;CDC26;RNF130;ERCC8;PTTG1;RBBP6;RNF128;ZNRF1;ANAPC16;PELI1;AGAP3;FAF1;UBE3D;KLHL25;CDC23;UBAP1L;KCTD21;UBE2D4;UBE2U;KCTD5;NEDD4L;HECW2;SIRT2;UBXN2A;PTPN23;TRIM71;BTRC;SIRT1;RNF216;WWP1;RC3H1;KLHL20;RNF19B;KLHL42;TSG101;WDR81;FBXL17;OTUD7B;NEDD4;UBE2R2
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.42330239322977414,0.8987322304988546,0.5675675675675675,0.9891941212781008,1.0,4/16,16.68%,FEM1A;SPTSSB;ATM;JMJD8
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5494617996166149,-0.8980617620047266,0.6206896551724138,1.0,1.0,2/9,10.03%,ETV4;PRKCH
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.5773865017144112,-0.8979802322517209,0.6440677966101694,1.0,1.0,1/5,13.01%,OAS3
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.5077766372812427,-0.8979631084443874,0.6379310344827587,1.0,1.0,1/11,0.72%,CSRP3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.5221425132811572,-0.8979302667994462,0.6567164179104478,1.0,1.0,4/9,25.44%,HSPA5;COPS5;BAX;BAK1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.5854030804674653,-0.8977585918833882,0.6333333333333333,1.0,1.0,4/5,38.82%,ATPAF1;OXA1L;TMEM70;ATP5F1D
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.48766652151981604,-0.8976469283594782,0.6229508196721312,1.0,1.0,5/11,28.89%,NOTCH4;EIF6;RBM4;AGO1;AGO4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.48766652151981604,-0.8976469283594782,0.6229508196721312,1.0,1.0,5/11,28.89%,NOTCH4;EIF6;RBM4;AGO1;AGO4
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.37418194891759365,0.897563090166128,0.5,0.9913707144615785,1.0,8/32,15.55%,KIT;TGFB2;EEF1AKMT4-ECE2;GPM6A;HMGA2;FBXL17;LRP6;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4145238808879285,-0.8971917060695794,0.6338028169014085,1.0,1.0,1/39,0.11%,EPN1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.33112569465214337,0.8971111112974557,0.5714285714285714,0.9918507185375921,1.0,2/82,0.87%,GPC4;LEF1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4393417853591576,-0.8969739716954744,0.640625,1.0,1.0,6/25,16.50%,NOTCH1;TGFB1;ANGPT2;TBXA2R;GADD45A;RGCC
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.37732663017156237,0.8967174054707691,0.6785714285714286,0.9922705972425596,1.0,7/56,7.75%,RUNX1;CAPN13;FGFR4;LAMB3;BTC;SCNN1B;ANKRD30A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.4309991061976458,-0.896453576319663,0.5882352941176471,1.0,1.0,8/26,25.34%,BNIP3;PINK1;GHITM;SLC25A5;TMEM14A;GPX1;AKT1;HGF
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.46998499813272676,-0.8964129295391162,0.5675675675675675,1.0,1.0,2/18,5.51%,EPAS1;PINK1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.5187397100643827,-0.896360428999309,0.6984126984126984,1.0,1.0,1/13,0.16%,CALB1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.550369875968225,-0.8961687468354785,0.6451612903225806,1.0,1.0,4/8,29.06%,SLC5A2;SLC2A1;SLC27A1;SLC2A3
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.35815062990678537,-0.8960592723416977,0.6625,1.0,1.0,19/133,15.93%,CD4;TERF2IP;TRIM22;TRIM5;CD74;PINK1;TRIML2;TRAF3IP2;TRIM25;CASP8;ROR1;LTBR;CXXC5;FADD;TRIM32;IFIT5;HTR2B;GOLT1B;DDX1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5041929289587378,-0.8959332647443866,0.65625,1.0,1.0,4/13,20.22%,PHKG1;PHKA1;AGL;CALM1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5019477464296453,0.8959085272557203,0.6,0.9935657149739688,1.0,3/9,25.09%,TPR;NUP107;NUP98
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.48696812001333106,-0.8958331045358161,0.6774193548387096,1.0,1.0,5/20,21.45%,YBX3;CASP8;SLC25A4;FLOT1;SPATA2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.4225151512712956,0.8957439202142269,0.5925925925925926,0.993414752893345,1.0,3/22,5.68%,FGF13;PKP2;PDE4D
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.44589422842713866,-0.8957432245458739,0.64,1.0,1.0,2/27,1.01%,ACOT4;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5437423698321954,-0.8955327460962207,0.640625,1.0,1.0,4/9,24.82%,TAF7;BRCA1;SET;CTBP1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.36052679732794857,-0.8955152630797624,0.7162162162162162,1.0,1.0,21/151,10.48%,CSRP3;LAMA2;PTGIS;MYLK;CHRNB1;ACTC1;GADD45B;FKBP1B;NOTCH1;CAV3;KLF5;CTF1;SYNGR2;ATP6AP1;SMTN;CHRNG;TGFB1;MYOM1;TEAD4;CASQ1;FABP3
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.47106392551201215,-0.8954573633635862,0.5846153846153846,1.0,1.0,3/18,14.59%,CPNE5;SYT2;SYT4
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.34031542898606243,-0.8953986777185591,0.7435897435897436,1.0,1.0,33/235,15.34%,PNMA5;CYP1B1;PNMA2;GADD45B;SFRP4;MOAP1;DDX20;BNIP3;MTCH1;PXT1;RASGRF2;CASP8;DAB2IP;VAV3;PPID;DNAJA1;TFPT;REST;APH1B;HIP1R;GADD45A;STK17A;HRK;FADD;ITGB3BP;SIAH1;GPER1;BOK;PREX1;RNPS1;KLF11;SUDS3;FGD3
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.4908461666303026,0.8953619879964696,0.6571428571428571,0.9937650102849869,1.0,3/8,19.55%,ENPP1;CHP1;ERRFI1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.386891047633503,-0.8949117425511709,0.6774193548387096,1.0,1.0,9/58,14.62%,NES;B2M;ZFPM1;LRPAP1;IFIT1;TMC8;EFHB;CTSZ;ATP2A3
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.49076689383945515,-0.8947925012870989,0.6071428571428571,1.0,1.0,1/14,1.78%,C17ORF99
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5624941908431774,-0.894511132459258,0.660377358490566,1.0,1.0,1/6,5.51%,HEBP2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.5433681338363835,0.8940756484333721,0.6170212765957447,0.9961687363670405,1.0,4/6,15.66%,APOE;FYN;GRIN2B;HOMER1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.4549853509638966,0.8940031517473269,0.6136363636363636,0.9957959596532567,1.0,5/12,16.51%,GRIN3A;GRIN2A;SDF4;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.38668607980158193,0.8939963337405294,0.6060606060606061,0.9952201780213169,1.0,1/31,0.60%,CCNH
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.399858751621679,0.8938404499678817,0.5,0.9949331289706767,1.0,4/20,16.49%,FGF13;MAP7D3;KIF24;ZNF207
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.38178346863114654,0.8936996901476997,0.6666666666666666,0.9946464212387649,1.0,7/32,20.01%,SGMS1;AGPAT5;SPHK2;FITM2;PCYT2;SGMS2;CLN3
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.38481206108552085,-0.8935774765269691,0.6619718309859155,1.0,1.0,10/59,18.53%,CD14;SERPINE1;PDCD1LG2;DAB2IP;GSTP1;CXCL13;TLR2;STAP1;ADAM9;LBP
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),0.5431155421256673,0.8933427822077566,0.6857142857142857,0.994960850437487,1.0,2/7,15.84%,WARS2;EARS2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.4941174022706222,0.8932702365993997,0.5945945945945946,0.9945476133463358,1.0,2/14,5.36%,IFI16;GRIN2A
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.36724792055628414,0.8931876962661368,0.6071428571428571,0.9941940298677436,1.0,4/35,13.20%,RAB3C;OLFM2;STEAP3;SVBP
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.46294594845003834,-0.892596942233812,0.6440677966101694,1.0,1.0,6/20,20.78%,NOTCH1;MMP21;TBX1;ODAD3;DNAH11;ARL6
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.4355682165602576,-0.8924929876500122,0.6285714285714286,1.0,1.0,3/24,7.97%,ABITRAM;RASA1;BRK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.46134645335513114,-0.892489156428475,0.6268656716417911,1.0,1.0,10/18,37.66%,SYVN1;RPS27A;MAN1B1;UBC;MARCHF6;RNF139;UBA52;UBB;RNF5;AMFR
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.5682767488114837,-0.8921609859045595,0.6551724137931034,1.0,1.0,1/6,5.12%,STARD5
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.5682767488114837,-0.8921609859045595,0.6551724137931034,1.0,1.0,1/6,5.12%,STARD5
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.5610189575209228,0.8920200291316449,0.6,0.9961046247866462,1.0,3/7,20.38%,PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.3120759400061143,0.8919556089590295,0.8571428571428571,0.9956745608543152,1.0,8/109,8.76%,ROR2;LEF1;NFATC1;PLCB1;GNAO1;PRICKLE1;FZD1;RYK
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.4688133638344391,0.8918456749348765,0.5238095238095238,0.9952871907447629,1.0,6/12,18.24%,CIDEA;PNPLA2;PLIN5;OSBPL11;FITM2;PPARA
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.48847721360603136,-0.8918360157121811,0.6029411764705882,1.0,1.0,3/13,11.94%,TRPV6;SLC24A1;TRPV3
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.48847721360603136,-0.8918360157121811,0.6029411764705882,1.0,1.0,3/13,11.94%,TRPV6;SLC24A1;TRPV3
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.4311771028817439,-0.891774363545642,0.6557377049180327,1.0,1.0,6/40,13.44%,CHMP4B;CHMP2B;RAB11A;CHMP2A;EML3;KIF14
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.2810444696163559,0.891383945814793,0.6842105263157895,0.9957603288992258,1.0,41/286,15.05%,FBXL7;MYLIP;PELI2;BCL2;RNF126;TRAF3;TRIM36;CBFB;MARCHF1;FBXW8;RNF217;MARCHF5;UBE2QL1;CDC26;UBE2J2;FBXO27;ERCC8;RBBP6;ZNRF1;PELI1;UBE3D;THOP1;CDC23;UBE2E2;MARCHF8;UBE2D4;UBE2U;NEDD4L;HECW2;FBXL15;TRIM71;BTRC;RNF216;WWP1;RC3H1;KLHL20;RNF19B;KLHL42;FBXL17;NEDD4;UBE2R2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.35701581124205617,0.8913145007510223,0.7096774193548387,0.9953902202039743,1.0,8/72,13.25%,LRRTM3;SAMD4A;PRR16;ELAVL1;PRKCD;SLC2A13;SPHK2;EIF3E
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6041412481624795,-0.8910799793891726,0.6612903225806451,1.0,1.0,3/5,27.36%,MSN;SPP1;AR
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6041412481624795,-0.8910799793891726,0.6612903225806451,1.0,1.0,3/5,27.36%,MSN;SPP1;AR
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.38620616231398625,-0.8910033170037785,0.6857142857142857,1.0,1.0,18/84,15.40%,PTPRC;CGAS;TRIM5;STAT1;BNIP3;IFIT1;IRF1;IFI27;IFI6;AGBL5;IFIT3;IFNLR1;OAS3;FADD;IFIT5;SERINC3;ISG20;TLR2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.47897016268308573,-0.8909462942954103,0.6271186440677966,1.0,1.0,7/20,16.71%,RASIP1;NOTCH1;RASA1;TGFB1;PDGFRB;AGGF1;WNT7B
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.3959327563423344,-0.8907954591176986,0.647887323943662,1.0,1.0,18/60,28.87%,CENPK;TPX2;CHMP4B;RAB11A;CHMP2A;KIF11;MZT1;NDEL1;NCAPG2;ABRAXAS1;RAN;DSN1;CTDP1;EPS8;WRAP73;UBE2S;KLHDC8B;GOLGA2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.44428955567165973,0.8907873071960931,0.5609756097560976,0.9961238162964275,1.0,4/13,18.60%,AASS;TET1;CHTOP;NSD1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.5768272716898295,-0.8904678401413768,0.6507936507936508,1.0,1.0,2/6,19.40%,PSAP;CPTP
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5686526716072186,-0.8903997290045034,0.6610169491525424,1.0,1.0,3/6,20.25%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5686526716072186,-0.8903997290045034,0.6610169491525424,1.0,1.0,3/6,20.25%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.3881222454888355,0.8900327087674468,0.6,0.9973278921238997,1.0,3/33,2.19%,KIT;C5AR1;EGFR
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.4169729984995151,0.8890873140588484,0.6153846153846154,0.9989511423744074,1.0,5/32,6.03%,KANK1;TGFB2;EPHB2;SPRY3;HEG1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3769721851668933,0.8887956978820551,0.7222222222222222,0.9991180701591554,1.0,2/25,3.43%,KDR;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.5556796424245549,0.8887079596367942,0.6382978723404256,0.9987386702504641,1.0,3/5,27.36%,NCK1;PTPN1;PPP1R15B
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.5077500352626914,-0.8884439256866905,0.65,1.0,1.0,4/9,19.22%,PTGES;OSMR;GSTP1;IL6ST
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.32339169038928695,0.8884298784014965,0.7096774193548387,0.9989307176363594,1.0,7/91,3.62%,ACE2;IFI16;IFIH1;CIDEA;TRAF3;HDAC9;S100A13
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5567751258051139,0.8883296897757814,0.6410256410256411,0.9985938358168404,1.0,2/6,13.53%,PDGFRA;ID2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.40927856605790325,0.8881540161392857,0.5833333333333334,0.9983747711290047,1.0,2/23,2.90%,F2RL1;GPR174
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4272331698904519,0.8878742958739083,0.6216216216216216,0.998382284529631,1.0,7/40,6.23%,RGS14;SPRED1;SPRED2;SPRED3;EPHB2;SPRY3;DUSP4
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4338373558170312,-0.8878560051406433,0.6451612903225806,1.0,1.0,5/27,16.67%,TICRR;MRE11;CHEK1;BRCA1;DONSON
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.35671547933320574,-0.8877096539667239,0.7037037037037037,1.0,1.0,18/108,20.29%,PTGIS;PSMB6;PSMB8;TOLLIP;CCL5;SKP1;DAB2IP;PELI3;PSMA3;PSMA5;PSMC3;NFKBIA;PSMA7;PSMC6;PSME1;RBX1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.4174521051764351,0.8877025901978083,0.6060606060606061,0.9982138658033513,1.0,12/26,18.12%,RORA;WWTR1;TRIB2;ENPP1;SIRT2;FOXO1;SIRT1;ANKRD26;WNT5A;LRP3;BBS12;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.35772026447828204,0.8875707834889308,0.696969696969697,0.9979033147340393,1.0,6/84,5.60%,ELOVL6;PER2;OXTR;ESRRG;LEPR;PDGFC
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4886520975917472,0.8875567165609187,0.6764705882352942,0.997358839839945,1.0,1/11,2.19%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.3854926865357626,0.8872490174686422,0.5714285714285714,0.9973920197729716,1.0,6/46,7.06%,HSPB1;IFIH1;TLR1;EPHB2;HMGB1;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.50584245602144,-0.8870795428367779,0.6774193548387096,1.0,1.0,2/9,9.56%,ADAMTS18;ALOX12
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.36678311342771713,-0.8869200250088634,0.6666666666666666,1.0,1.0,18/105,18.89%,WFS1;CHAC1;WIPI1;IFIT1;GEMIN4;HSPA5;HERPUD1;DCP2;NFYB;DCTN1;XPOT;EEF2;TUBB2A;EIF4A2;ERO1A;NOP56;SHC1;NABP1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.4498814829715481,0.8868851808979532,0.6153846153846154,0.9977594661379333,1.0,5/17,20.43%,DDAH1;NOS1AP;KLF2;TMEM106A;EDN1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5201928723588873,0.8867999407880787,0.6111111111111112,0.9973580300862019,1.0,5/9,22.12%,LEPR;SIRT1;GCK;NR4A3;STAT3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.4732249485764679,0.886755345595544,0.5,0.9969904559970098,1.0,4/12,18.50%,SYNJ2;INPP1;INPP5J;PTEN
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.289696105433803,0.8867383889035797,0.7058823529411765,0.996423081868127,1.0,37/284,12.03%,ROR2;CDH13;NOX4;PER2;PTPRK;SLC16A2;SMYD2;TGFB2;ALDH1A2;GREM1;MN1;MCC;BTG2;MINAR1;DDAH1;TGFB3;ADAMTS8;P3H3;MYO16;HSPA1A;ZBTB17;PTPN6;NACC2;PDPN;P3H2;ERBB4;TFAP4;NELL1;EREG;DUSP10;CTBP2;PARP10;RERG;RBP4;FRK;ATP8A2;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.5422297292452085,0.8867369769118955,0.7096774193548387,0.9958480340502868,1.0,2/9,14.21%,ACVR1;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.5262420744683033,0.8866203086137182,0.6,0.9954653223954476,1.0,1/8,0.83%,PER2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.43856577249004786,-0.8865688894583023,0.6896551724137931,1.0,1.0,5/31,14.25%,HSD17B10;DALRD3;WDR6;TRMO;BCDIN3D
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4678552534781374,0.8862812128109897,0.7142857142857143,0.9955910852272353,1.0,3/15,7.35%,CATSPER2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.38168193912885473,-0.886205845214939,0.6307692307692307,1.0,1.0,8/59,16.95%,HCK;ABITRAM;RASA1;NCKAP1L;HIP1R;KANK3;MYADM;VIL1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.47599465278565783,0.8861471456005844,0.6578947368421053,0.995400410263843,1.0,2/10,6.58%,F2RL1;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.46878570739037884,-0.8861158624923887,0.6065573770491803,1.0,1.0,5/14,25.03%,ATAD5;ZNF16;PLCG2;PAF1;STXBP4
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3365685044164055,0.8856871644627174,0.625,0.9958588072932657,1.0,13/112,8.65%,LAMB2;HSPB1;PRRX1;EGFR;WWTR1;RASSF8;LAMA4;PPFIBP1;ENPP1;HTRA1;GNG12;PXDC1;PLAT
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.5421822849715531,0.8856381154159975,0.5454545454545454,0.9953772183269327,1.0,3/5,27.55%,SCARB1;SREBF2;LPL
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4692576261079424,-0.885610354586004,0.5522388059701493,1.0,1.0,2/13,23.32%,SUPT5H;RNF168
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5194196852088333,-0.8855039927584177,0.6779661016949152,1.0,1.0,6/10,28.49%,PPP2R3A;MEOX1;SHH;SOX11;SMO;SFRP2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.3821720161148365,-0.88546703249685,0.6428571428571429,1.0,1.0,7/59,11.80%,HCK;RAC1;NCKAP1L;BRK1;VAV3;PIK3CB;DOCK1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.3821720161148365,-0.88546703249685,0.6428571428571429,1.0,1.0,7/59,11.80%,HCK;RAC1;NCKAP1L;BRK1;VAV3;PIK3CB;DOCK1
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.5395138179102612,0.8854369353387402,0.625,0.9952036196236247,1.0,1/5,6.46%,FHIT
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.48027632883317084,-0.8853861086583324,0.6307692307692307,1.0,1.0,5/13,20.79%,NOTCH1;ITGA5;SNAI2;ZNF304;PTRH2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.533907625040528,-0.8853744596712515,0.6557377049180327,1.0,1.0,1/8,4.87%,ITGA5
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.40106637664256395,0.8853090966651774,0.625,0.9949720951677962,1.0,12/29,23.29%,ALG8;B4GALNT2;OSTC;DERL3;MAGT1;UGGT2;DPM3;UBE2J1;RPN2;DPM2;STT3A;DPM1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.4138306033106932,-0.88514999120309,0.6521739130434783,1.0,1.0,2/36,4.68%,EPHA1;RAC1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.5229339871923202,0.8851067670784059,0.6122448979591837,0.9948653283948743,1.0,2/6,28.00%,PRUNE1;PRUNE2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.4758520868402384,-0.8847635398017855,0.6428571428571429,1.0,1.0,3/16,8.55%,CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.5335411164853624,0.8846690710221713,0.5945945945945946,0.9956130046389855,1.0,1/6,0.43%,PTPN3
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.44635897987739986,-0.884364733429185,0.6164383561643836,1.0,1.0,9/31,16.61%,PTPRC;DOCK2;CD300LF;IL15;NCKAP1L;RAB31;STAP1;SFTPD;SLC11A1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4620080091514463,-0.8838863316593635,0.6307692307692307,1.0,1.0,3/19,8.42%,STAT1;STAT5A;STAT4
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.5648587213624778,0.8838351870208724,0.7272727272727273,0.99702297271504,1.0,1/6,0.41%,LHFPL2
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.5200365954558233,-0.8837793275943472,0.6818181818181818,1.0,1.0,3/13,8.55%,CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.5037216253768313,-0.8837404923859765,0.6229508196721312,1.0,1.0,2/12,8.77%,STAT1;CRLF1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.48089607490659697,0.8835230503056763,0.5294117647058824,0.9971803097877714,1.0,4/9,14.63%,HRH1;GABRB1;GABRB3;DRD4
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.4392090083629419,-0.8833651964865062,0.5901639344262295,1.0,1.0,5/28,18.75%,ATP5IF1;SCN7A;SCN9A;CACNA1G;YWHAH
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4602670304075698,-0.8832971591385154,0.6612903225806451,1.0,1.0,4/22,22.57%,BTBD18;SUPT5H;ALYREF;THOC5
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.5651090755933348,-0.8831913215796671,0.6538461538461539,1.0,1.0,1/5,8.45%,MGME1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4621659598658211,0.8830302325956965,0.40540540540540543,0.9977597382469601,1.0,1/10,4.60%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.463704528545104,-0.8829513047485399,0.6056338028169014,1.0,1.0,5/15,12.78%,CYP1B1;NOTCH1;CRLF3;CCL5;OCIAD2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.5312269044000048,-0.8827549793319747,0.6935483870967742,1.0,1.0,1/9,1.32%,LRP4
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.5476052909437196,0.8827394329590627,0.6666666666666666,0.997784063126995,1.0,4/6,17.40%,ARL13B;ZDHHC3;BBIP1;SPATA7
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.4665728324308327,-0.882684692745121,0.6417910447761194,1.0,1.0,5/17,20.79%,NOTCH1;ITGA5;SNAI2;ZNF304;PTRH2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.5901820962373311,-0.8825703558456661,0.6923076923076923,1.0,1.0,2/5,25.37%,CDK5;PLAA
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.5741449845893203,-0.8825164485748935,0.6507936507936508,1.0,1.0,3/7,26.38%,TXNIP;VPS4A;BLM
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4516845476940629,0.8820630055136265,0.6,0.9987511708037243,1.0,4/19,11.10%,RGS14;RPGRIP1L;ADA;BICD1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.32202714093930546,0.8819629680293648,0.75,0.9984277421955444,1.0,8/92,7.23%,ACE2;F2RL1;IL1RL2;CAMKMT;TRAF3;EPHB2;PDGFRA;IL1R1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4609174278254937,-0.8819155292669271,0.6268656716417911,1.0,1.0,3/29,7.74%,SFRP4;LRPAP1;RIN3
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.5266943395928547,-0.8818509769028618,0.6491228070175439,1.0,1.0,3/9,11.35%,NHEJ1;XRCC1;TMSB4X
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.3852337214816533,-0.881625408568764,0.6790123456790124,1.0,1.0,13/87,13.04%,PRELP;MGST1;CHAC1;CHAC2;MAT2B;CHST1;GSTM5;B3GNT4;B3GNT3;SLC35B3;OGN;GGTA1;GSTP1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.34752423931812637,0.8813933988468462,0.6896551724137931,0.9991124915194183,1.0,2/38,3.50%,LEF1;BRCA2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.35806964557615695,-0.8812953575630414,0.6756756756756757,1.0,1.0,17/95,22.57%,FIP1L1;NXT1;DDX39A;NCBP2;SLU7;FYTTD1;SLBP;NUP85;NCBP1;RNPS1;CDC40;ALYREF;NUP155;UPF3B;DHX38;NUP188;THOC5
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.37484877898949615,-0.8812011947801721,0.6623376623376623,1.0,1.0,16/79,15.77%,CD14;KLF5;AHR;SYNGR2;JUNB;ZBTB7B;ANXA5;B3GNT3;LTBR;MARCKSL1;CTSZ;OAS3;MFGE8;IL13RA1;CTSH;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4209316927524139,-0.8811974091845978,0.6714285714285714,1.0,1.0,10/33,19.12%,ZFPM1;CD14;IL18R1;TXK;HLA-DPB1;HLA-A;FADD;IL18;SLC11A1;ISG15
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3815701287602601,0.8807684437094878,0.6875,0.9999945882736008,1.0,8/41,12.84%,FGFR4;TRAF3;DNAJC1;TM4SF20;CLN6;PLAT;PERP;BTRC
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.41398998267546083,-0.8807683177360935,0.5588235294117647,1.0,1.0,6/34,9.56%,PTGIS;CYP1B1;EPHX1;PTGES;ALOXE3;ALOX12
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.5377883869603436,-0.8807548725885939,0.6724137931034483,1.0,1.0,2/6,19.91%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.4774035827745584,0.880754708868163,0.6111111111111112,0.9994317193452813,1.0,2/13,6.95%,ENPP3;ENPP1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3135480127814289,-0.8804707466014909,0.7625,1.0,1.0,32/266,18.05%,TICRR;RAD54L;POLQ;FANCI;CDKN2D;FANCM;RAD51AP1;FAAP24;RFC5;BACH1;RECQL;RPA3;MGME1;INIP;FANCC;XRCC1;APLF;EYA1;MRE11;GADD45A;CHEK1;POLE2;PCNA;BRCA1;TDG;HPF1;DDX1;RAD9B;RAD51C;NUDT1;PDS5B;PMS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.3404663649900279,0.8801584166021358,0.6666666666666666,1.0,1.0,14/70,11.55%,C5AR1;EGFR;BMP6;TGFB2;MCC;IGF1;SGPP2;PKHD1;PRKD1;EREG;DUSP10;ANGPT1;LIMS1;FGF10
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5024384332268933,-0.8800873268872006,0.6666666666666666,1.0,1.0,1/8,3.75%,PBLD
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.46291658821523013,0.8795068334805384,0.6,1.0,1.0,4/13,18.76%,RAD21L1;SMC1A;POGZ;DSCC1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.5498716883413481,0.8793745642039944,0.6285714285714286,1.0,1.0,3/8,3.54%,NRP1;SPRED1;TGFBR1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5157055494528247,-0.8791497677507599,0.7230769230769231,1.0,1.0,2/11,2.35%,MSX1;HIC1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5308726920520912,0.8789197348429134,0.6923076923076923,1.0,1.0,2/6,25.05%,EIF3E;EIF4G1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.5766171644474962,0.8788721617404814,0.6666666666666666,1.0,1.0,2/6,19.50%,FRS2;PTPRD
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.39956954531906935,0.8787668393025287,0.6,1.0,1.0,2/26,6.33%,TBX6;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.5563145141683972,-0.8785714327767044,0.6545454545454545,1.0,1.0,1/6,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.5613371097301983,-0.8784160916869193,0.7058823529411765,1.0,1.0,2/5,38.45%,SLC27A1;APPL1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4033193511536623,-0.8779255088697792,0.696969696969697,1.0,1.0,16/50,29.52%,WIPI1;RAB19;MAP1LC3B;MAP1LC3B2;RAB23;GABARAPL2;ULK1;ATG3;RAB1A;RAB1B;GABARAPL1;ATG14;ATG16L2;ATP2A2;TMEM41B;ATG101
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3977374307728706,-0.8779233924326715,0.6923076923076923,1.0,1.0,8/56,15.77%,AGT;SERPINE1;IL15;CCL5;IL18;GBP5;TLR2;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.5593451368077588,0.8778195361741006,0.625,1.0,1.0,1/5,13.34%,RC3H1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.41045525916712255,-0.8777015112148702,0.7230769230769231,1.0,1.0,5/37,12.27%,CAV3;RAC1;DCTN1;STMN1;CDK5R1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.44093333771440846,-0.8776963409304763,0.6666666666666666,1.0,1.0,6/22,17.12%,HSF2BP;ING2;TDRD9;BTBD18;SLC25A31;MEIOB
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.394079673620143,-0.8776894067718501,0.6164383561643836,1.0,1.0,4/46,14.81%,TERF2IP;RPA3;MRE11;PCNA
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.42872184725407264,-0.8776545539434248,0.6707317073170732,1.0,1.0,6/28,17.94%,CCNE1;BACH1;CDC6;PCNA;KLF11;CDK5
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.5713338648954701,-0.877637609491619,0.6851851851851852,1.0,1.0,2/7,16.59%,CD74;PLCG2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.36589410020629587,-0.8775786797088524,0.6615384615384615,1.0,1.0,12/52,25.35%,CD14;PRDX4;NKIRAS1;DAB2IP;TLR2;NFKBIA;NFKBIL1;RPS27A;TIFA;UBC;AKT1;RIPK2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.44661017826621124,0.8775362641996987,0.5675675675675675,1.0,1.0,5/14,30.69%,NANOS3;TNRC6B;AGO2;TOB1;TNRC6C
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.44661017826621124,0.8775362641996987,0.5675675675675675,1.0,1.0,5/14,30.69%,NANOS3;TNRC6B;AGO2;TOB1;TNRC6C
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.49705261779932974,-0.8770295060269494,0.7017543859649122,1.0,1.0,2/12,9.79%,DEGS2;SPTLC3
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3422845363945439,0.8769147177933857,0.6666666666666666,1.0,1.0,3/56,5.43%,RFWD3;CRADD;BTG2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.4685446528007359,-0.8768986363432046,0.6388888888888888,1.0,1.0,3/15,17.70%,SLC9A6;SLC5A2;HCN4
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3475496671473314,-0.8765206197909734,0.7435897435897436,1.0,1.0,19/121,15.72%,CYP1B1;CTNNA1;ZNF703;P2RY1;AHR;P2RY12;SSTR1;ABCB4;KCNQ1;ATP1A1;TGFB1;CCL5;IGFBP5;MSN;GPER1;AQP9;IL18;BRCA1;H2AZ1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.49739545691015186,0.876465562884171,0.6470588235294118,1.0,1.0,1/7,2.75%,GAL3ST1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.5033563804778811,0.8763969329388691,0.625,1.0,1.0,2/7,24.56%,ANKRD2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.4856005465654746,-0.8762491896407294,0.6984126984126984,1.0,1.0,4/12,14.57%,KCNQ1;ADRA1D;ADRB1;TPM1
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.4697688919335624,-0.8758965726090474,0.6290322580645161,1.0,1.0,2/13,18.85%,ETFB;SLC25A18
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.5218640294578638,-0.8758036518698401,0.6461538461538462,1.0,1.0,2/7,14.74%,LRP2;CYP2R1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.545312598060203,-0.8757045728782602,0.7076923076923077,1.0,1.0,1/5,11.60%,APH1B
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.41066557492305716,0.8756726979199461,0.6451612903225806,1.0,1.0,9/24,21.52%,TGM1;JAG1;AKR1C3;EREG;CERS3;WNT5A;DSP;CLIC4;ACER1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.49420806476376056,0.8756681554770793,0.5862068965517241,1.0,1.0,2/6,16.62%,ROBO2;WNT5A
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.37926376939890005,-0.8756039864844412,0.696969696969697,1.0,1.0,12/69,13.81%,WFS1;MARVELD2;TMIE;NDUFB9;KCNQ1;CEMIP;SLC26A4;TBX1;ROR1;EYA1;SNAI2;LRP2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.41685574181261914,0.875589233103165,0.6046511627906976,1.0,1.0,4/17,20.21%,ADCY2;GUCY1A1;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.4775597319173239,-0.8755708294735417,0.639344262295082,1.0,1.0,3/16,18.99%,PDCD1LG2;INHBA;C1QBP
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.5099832726362509,-0.8755687550876339,0.64,1.0,1.0,4/9,25.53%,HSPA5;MBTPS2;CALR;HSP90B1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3280384429770864,0.8755592090280442,0.6896551724137931,1.0,1.0,14/94,13.70%,PRELID2;PITPNC1;ABCA13;CHKA;ABCC11;APOE;SLC27A3;SLCO1C1;SCARB1;ABCC4;ABCA6;ABCD2;SLCO3A1;ABCG8
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.519135560568393,-0.8755337487013893,0.7142857142857143,1.0,1.0,5/9,33.99%,ISG15;RPS27A;UBC;UBA52;UBB
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.40155426470575095,-0.8755080232152402,0.703125,1.0,1.0,16/52,29.52%,WIPI1;RAB19;MAP1LC3B;MAP1LC3B2;RAB23;GABARAPL2;ULK1;ATG3;RAB1A;RAB1B;GABARAPL1;ATG14;ATG16L2;ATP2A2;TMEM41B;ATG101
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.5594486284293085,0.8753824263058894,0.625,1.0,1.0,1/5,6.79%,PTPRO
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.5594486284293085,0.8753824263058894,0.625,1.0,1.0,1/5,6.79%,PTPRO
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.39161543657179204,-0.8753666886217016,0.6818181818181818,1.0,1.0,11/28,27.52%,TOMM20;PEX16;DNAJC19;PEX5;TIMM17B;ROMO1;PEX1;HSPD1;PEX10;TIMM17A;GRPEL2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.4708381104941928,-0.875239764331586,0.6461538461538462,1.0,1.0,3/14,10.74%,PTPRC;FLT3;MSN
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3759604037476612,-0.8749334201247773,0.7,1.0,1.0,7/61,11.80%,HCK;RAC1;NCKAP1L;BRK1;VAV3;PIK3CB;DOCK1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.459847528844314,-0.8748967936967049,0.6065573770491803,1.0,1.0,2/14,7.05%,IHO1;CDC6
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.5629603374789462,0.8748134787230519,0.575,1.0,1.0,2/5,12.53%,VAMP8;VAMP3
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.5565987152572095,-0.8747148582232379,0.6666666666666666,1.0,1.0,2/6,24.21%,DDX1;SSB
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.3614010581911373,0.8746660478869744,0.6956521739130435,1.0,1.0,5/25,15.26%,AK6;RRM2;DUT;AK5;AK9
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4450282304450196,-0.8746552651783733,0.6129032258064516,1.0,1.0,3/29,9.72%,TCP1;CCT6A;CCT8
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.345858214316239,0.8746343154208949,0.6923076923076923,1.0,1.0,14/66,12.93%,KBTBD12;FILIP1;FGF13;PTCHD1;SLC35F1;FAM110D;CADM2;RGMA;RBFOX1;ANO5;ADCY2;CACNB2;LRP1B;SPTB
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.546827925096753,0.8745401413677509,0.5897435897435898,1.0,1.0,2/7,12.03%,PARD3;SIRT2
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.546827925096753,0.8745401413677509,0.5897435897435898,1.0,1.0,2/7,12.03%,PARD3;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.47788647864233524,-0.8744280287141417,0.7058823529411765,1.0,1.0,4/23,9.22%,HHIP;GPC3;GLI3;RFX4
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.49126024894370207,0.8743834017475381,0.6428571428571429,1.0,1.0,1/8,6.58%,HMGB1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.48652457027981755,-0.8742732009439134,0.6176470588235294,1.0,1.0,1/14,1.99%,PTPRC
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4924880654254697,-0.8742396561418655,0.6461538461538462,1.0,1.0,4/14,22.13%,PINK1;COX7A2L;COX7A2;AK4
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.38547978214913603,-0.87420201925537,0.7419354838709677,1.0,1.0,12/46,30.60%,LDLRAP1;TGFB1;RAB31;NSG1;CD9;RAMP1;ARFGEF2;ACKR3;CLTC;CD36;AP2M1;LGMN
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.43527839720034833,-0.874142835493083,0.6666666666666666,1.0,1.0,7/29,24.82%,ING2;ZBTB7B;BRCA1;KDM1A;NOS1;PAF1;CTBP1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.3497547633006422,0.8737807958521321,0.6470588235294118,1.0,1.0,4/65,2.80%,ACE2;CAPN13;EGFR;GPRIN2
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.4012604506845522,0.873743106858839,0.6842105263157895,1.0,1.0,2/16,12.18%,KCNB2;TNNC2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.49002073215776143,-0.8735237059964344,0.6323529411764706,1.0,1.0,11/15,36.89%,ABT1;RPS27L;RPS15;ERAL1;RPS5;RPSA;RPS19;RPS28;RPS27;RPS14;MRPS11
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.48294026804214696,-0.8733092419557943,0.6129032258064516,1.0,1.0,1/15,5.14%,BNIP3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.5873364309264416,-0.8730901107838913,0.7407407407407407,1.0,1.0,3/5,37.70%,NLRP3;CD81;PRKCZ
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.5873364309264416,-0.8730901107838913,0.7407407407407407,1.0,1.0,3/5,37.70%,NLRP3;CD81;PRKCZ
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.4015132967868268,0.8730211060733409,0.696969696969697,1.0,1.0,12/28,23.29%,ALG8;B4GALNT2;OSTC;DERL3;MAGT1;UGGT2;DPM3;UBE2J1;RPN2;DPM2;STT3A;DPM1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5091235895507147,0.8729765836824582,0.717948717948718,1.0,1.0,4/8,22.90%,ST3GAL1;ST3GAL2;ST3GAL4;CHD1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.40932931208278567,-0.8725438918159178,0.6153846153846154,1.0,1.0,10/35,14.96%,ELANE;STAT1;NOX1;CCL5;IGFBP5;PDGFRB;OGN;APOD;IL18;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4534302850394557,0.8725345049443353,0.6578947368421053,1.0,1.0,3/14,18.24%,EP300;GCK;PPARA
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3427475621959981,0.8725039589489391,0.71875,1.0,1.0,10/51,11.55%,F2RL1;GPR174;MMD2;RASGRP1;IGF1;IRS2;AUTS2;RASGRF1;PRAG1;FGF10
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.3851650278951761,0.872438903860991,0.6666666666666666,1.0,1.0,9/27,20.60%,PTCH1;APOE;EEPD1;NAXE;YJEFN3;SIRT1;NR1H3;APOA1;SREBF2
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),-0.5587176562335894,-0.8724161214523792,0.7368421052631579,1.0,1.0,1/5,7.74%,IL15
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.46264228209516217,0.8723711814379348,0.6764705882352942,1.0,1.0,6/17,15.68%,HDAC9;MAML1;HDAC1;ATP11A;DMPK;HDAC5
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.36044563795623086,-0.8723492752637684,0.6911764705882353,1.0,1.0,8/125,3.85%,MMP26;HCK;RXFP1;PTGIS;MC4R;GPR83;CALCB;ELANE
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.4405528398036457,-0.8721002333050956,0.6515151515151515,1.0,1.0,7/23,30.06%,STMN1;KIF14;VIL1;CFL1;CFL2;TWF2;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.44425235342008107,-0.8720623912742642,0.7,1.0,1.0,3/31,9.72%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.47679567629510344,-0.871973679630213,0.6956521739130435,1.0,1.0,3/15,12.79%,DRD3;ADRA1D;ADRB1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.4923042181275346,-0.8719037926306539,0.6507936507936508,1.0,1.0,3/12,18.85%,LRRC8D;SLC25A11;SLC25A18
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.37151125495672516,0.8719018324382468,0.6785714285714286,1.0,1.0,13/32,21.52%,TGM1;JAG1;AKR1C3;HDAC1;ERCC2;EREG;CERS3;WNT5A;ERCC3;CTNNB1;DSP;CLIC4;ACER1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5178312812648547,-0.8717583374771489,0.6349206349206349,1.0,1.0,5/10,38.46%,RIPK2;CHMP5;NLRP1;PTPN22;ARHGEF2
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.42984543568116956,0.8717357919316411,0.6341463414634146,1.0,1.0,8/14,30.82%,DMC1;NSMCE2;TPRKB;SMC6;RAD51;MSH3;SMC5;XRCC3
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3383695594906586,0.8714739309336319,0.65625,1.0,1.0,12/74,11.03%,UNC5B;SLC30A10;BCL2;TGFB2;TOX3;MDK;TGFB3;APOE;EPHA7;GRID2;EGLN3;NSMF
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.3751736817835243,0.8710891670185354,0.6216216216216216,1.0,1.0,5/30,14.47%,IFI16;TRAFD1;SAMHD1;LYAR;FAM3A
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.415712174058184,0.8710246394012342,0.6363636363636364,1.0,1.0,1/23,0.51%,TBX6
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3044630833356343,0.8709852422389154,0.7857142857142857,1.0,1.0,3/108,3.43%,ATP6V0D2;IRS1;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4158592427457174,-0.8708309638986748,0.6060606060606061,1.0,1.0,4/31,11.34%,TPX2;TRIM54;FKBP4;STMN1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3943735142989444,0.8707824526192111,0.59375,1.0,1.0,9/22,18.23%,RNF126;UBAP1L;SNF8;PTPN23;TSG101;NEDD4;VPS25;UBAP1;MVB12B
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.4955256104416369,0.8706545637145048,0.6216216216216216,0.9997614271877998,1.0,2/7,20.32%,ZDHHC5;SLC15A4
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.5110052270476494,-0.8706328662532792,0.5737704918032787,1.0,1.0,2/7,7.86%,GM2A;GBA3
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.5275141924974818,0.8705055038700793,0.625,0.9994857787988394,1.0,2/6,20.86%,RPUSD1;RPUSD4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.38084601805740487,0.8704067742712305,0.6486486486486487,0.9991621116558042,1.0,4/25,12.46%,TXNL4A;SF3B4;KHSRP;SRRM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.3834489440642186,0.8703429485282792,0.6333333333333333,0.9987502544818578,1.0,5/35,6.73%,F2RL1;CSF1R;MDK;HMGB1;MOSPD2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.5415626369470692,-0.8702804614181856,0.6833333333333333,1.0,1.0,2/7,22.61%,AGER;LYN
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.3670161474278941,-0.8701376669690013,0.7083333333333334,1.0,1.0,6/69,8.55%,WFS1;LRPAP1;BNIP3;PINK1;CHMP4B;CHMP2A
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.3278458196059405,0.8699094652317261,0.7,0.999063002123779,1.0,12/72,14.17%,IRS1;HDAC9;ZBED3;ENPP1;IRS2;CELA2A;SLC25A33;PIK3R1;FOXO1;SIRT1;AKT2;FER
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.29661434100585754,0.8698497679039404,0.8076923076923077,0.9986516660248637,1.0,26/243,9.06%,ELOVL6;IFI16;PER2;LEF1;F2RL1;OXTR;WWTR1;SHLD1;TGFBR1;PLCB1;S100A13;ZBED3;ESRRG;TGFB2;LEPR;MDK;PDGFC;MACROH2A2;ACVR1;TGFB3;NLGN1;SOX5;APOE;PDPN;SMAD2;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4786561292760878,-0.8697884771534982,0.6129032258064516,1.0,1.0,3/14,12.10%,IL7;NCKAP1L;CD27
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.3925469388482189,-0.8697452456740041,0.6617647058823529,1.0,1.0,5/50,15.56%,C4BPB;GPC3;DAB2IP;TRIM32;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.36449854912607027,-0.869728457300392,0.703125,1.0,1.0,16/65,24.05%,POLR3K;CGAS;STAT1;CD14;IRF1;MRE11;POLR2K;OAS3;TLR2;FLOT1;ISG15;HSPD1;POLR1C;IRF3;STAT6;POLR3G
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.4129851108556606,0.8695015127932384,0.8529411764705882,0.99887571027751,1.0,3/25,4.58%,CCDC63;DNAH5;DNAI4
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4189517500207824,0.8693588032331078,0.6875,0.9986014942671422,1.0,4/16,14.26%,BMP7;AKR1C3;TFPI;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.3368359379478057,0.8693398671679309,0.5263157894736842,0.9980787240026091,1.0,6/75,5.00%,PID1;WWTR1;PPP1R8;ZBED3;PRR5L;EPHB2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.39983173918489007,0.8692423423801233,0.6111111111111112,0.99770898602623,1.0,5/26,10.73%,TGFBR1;TGFB2;HEY1;ACVR1;ROBO2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.44537598876226697,0.8691611569087202,0.6774193548387096,0.9973557020441907,1.0,8/24,18.95%,NEK6;CDC23;CDK5RAP2;HECW2;ESPL1;NSMCE2;LCMT1;ANAPC7
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.5457772863540103,0.869110676921283,0.675,0.9968986297959735,1.0,3/6,12.64%,KCNC2;MTR;FOXO1
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.5248083261272012,-0.8690067395920044,0.6875,1.0,1.0,2/7,11.23%,ACTC1;TTN
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.5477234276651223,-0.8687169503442832,0.6607142857142857,1.0,1.0,1/6,14.51%,PAICS
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.44653365162344744,0.8685555001035267,0.6153846153846154,0.9975954816422876,1.0,8/13,28.02%,SCARB1;PLIN5;FITM2;NR1H3;LDLR;C3;NR1H2;FBXW7
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3304978326356976,0.8683635482339015,0.6486486486486487,0.9974429894428547,1.0,7/87,4.51%,RUNX1;SULF2;KANK1;NFATC1;CBFB;WWOX;CDK14
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.456208501518685,0.8683559084516017,0.6285714285714286,0.996890629004402,1.0,2/9,15.47%,SIRT1;MYOCD
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.4223502635597629,-0.8680926753283308,0.6825396825396826,1.0,1.0,3/26,4.67%,CGAS;B2M;ING2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5097411103548588,0.8677473544416564,0.6571428571428571,0.9976023041315958,1.0,3/9,16.45%,SNCAIP;HSPA1A;DNAJB2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.3727066906399562,0.8676300045554971,0.7407407407407407,0.997290228584333,1.0,10/42,13.99%,SLC12A3;GABRG3;SLC12A1;GABRB1;GABRA3;SLC6A1;ANO5;GABRB3;ANO6;GABRA5
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.4875146232474398,-0.8669789177532717,0.671875,1.0,1.0,4/13,19.27%,MPV17L2;RCC1L;C1QBP;FASTKD3
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.44568607460355353,0.8667448433025008,0.5609756097560976,0.999167031453389,1.0,2/12,16.00%,TET1;DNMT1
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.5383687544574255,0.8666683705494318,0.574468085106383,0.9987746001515312,1.0,2/6,5.27%,F2RL1;MDK
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.3373339616753903,0.866507780390923,0.6333333333333333,0.9986778086230602,1.0,6/56,5.69%,UBASH3B;HSPB1;WWTR1;SPRED1;CEP85;TRIB2
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.4771638712068547,0.8664475901903154,0.575,0.9981824298231463,1.0,3/10,14.27%,TGFBR1;PDGFRA;MTHFD1L
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.4598177573599386,0.8663620477010403,0.5555555555555556,0.9978948111751763,1.0,4/20,6.07%,NRP1;TGFBR1;TGFB2;JAG1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.38307172526321875,0.866254992103996,0.6818181818181818,0.9976075142482892,1.0,8/27,23.38%,LIN28B;SMAD2;TRIM71;TARBP2;PUS10;SRRT;DGCR8;AGO2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.368181653283438,-0.8660753155077857,0.7538461538461538,1.0,1.0,11/64,18.40%,DENND1C;JUNB;SYTL1;IRF1;CTDSP1;ZBTB7B;SIGIRR;ISG20;B3GALT4;OSTF1;RPS6KA1
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.5769183157417932,-0.8654665193959443,0.7884615384615384,1.0,1.0,2/5,14.64%,DRD3;VPS35
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.5754780520260258,0.8652695724929101,0.5897435897435898,0.9993186344550645,1.0,1/5,8.12%,HPRT1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.385424244714001,0.8650979103168013,0.6470588235294118,0.9991820288921542,1.0,4/25,7.70%,ITGA4;LRRC7;NRXN1;NLGN1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.32595581796989953,-0.8650740857208427,0.7317073170731707,1.0,1.0,55/233,29.90%,FIP1L1;SYF2;CSTF2T;DDX39A;NONO;NCBP2;SLU7;UBL5;SNRPD2;PCBP1;ZMAT2;PPWD1;FRG1;POLR2J;POLR2K;PRPF19;BUD13;NCBP1;SNRNP48;RNPS1;CDC40;RBM4B;ALYREF;HNRNPA0;USP39;CWC25;RBM4;CRNKL1;MFAP1;UPF3B;SF3B2;DHX38;CLP1;DHX16;LSM4;POLR2I;POLR2B;BUD31;SMU1;METTL3;SNW1;CPSF4;CSTF1;POLR2D;SRSF5;SNRPB2;PRCC;SNRNP70;SRSF9;HSPA8;NUDT21;ZCCHC8;WBP11;ELAVL2;DHX15
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4778856023122148,-0.8650048791966763,0.6379310344827587,1.0,1.0,1/14,1.01%,PTGIS
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.5052525065937116,-0.8649512651648233,0.7246376811594203,1.0,1.0,5/12,31.18%,CHST1;CHST2;EXTL2;PGM3;OGA
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.45269445364356065,0.8647150385410504,0.7027027027027027,0.9994590617876327,1.0,3/17,7.88%,PER2;HEY1;IGF1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5342057632301921,-0.8644082225363321,0.7313432835820896,1.0,1.0,3/7,30.28%,PRDX3;NOS1;PARK7
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.4364978621370687,-0.8640177398830705,0.65,1.0,1.0,3/22,7.47%,ITK;P2RY12;TXK
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3640290789428269,-0.8636850093688491,0.6621621621621622,1.0,1.0,7/64,9.90%,EPHA1;ARHGAP15;RASIP1;ATP5IF1;ARHGAP9;DAB2IP;VAV3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.4424761466934591,-0.8632220764668397,0.7014925373134329,1.0,1.0,8/18,32.67%,MRE11;BRCA1;KAT5;RBBP8;RNF138;BLM;RAD50;SLX4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4114186402759732,0.8631756546625571,0.631578947368421,1.0,1.0,3/19,9.47%,BCL2L11;HSPA1A;EIF2AK3
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4976755796971765,-0.8631722843780862,0.6923076923076923,1.0,1.0,4/14,30.98%,INTS5;INTS14;SSB;PTCD1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.30711616583356904,0.8627793465520281,0.7894736842105263,1.0,1.0,10/105,8.09%,LAMB2;NPNT;UNC5B;SDC4;COBL;UNC13B;OGDH;MYO1D;TMEM117;RNF128
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.457978572682756,0.8626313921139687,0.625,1.0,1.0,2/10,15.04%,SMARCAL1;TERF1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.457978572682756,0.8626313921139687,0.625,1.0,1.0,2/10,15.04%,SMARCAL1;TERF1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.457978572682756,0.8626313921139687,0.625,1.0,1.0,2/10,15.04%,SMARCAL1;TERF1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5404395575599972,-0.8626258945567492,0.671875,1.0,1.0,3/7,20.95%,XRCC1;HPF1;WARS1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.5368170537894833,-0.8625132455431532,0.6724137931034483,1.0,1.0,3/8,19.32%,CCDC39;BBOF1;RSPH9
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.4789007397388982,0.8625054050421488,0.5714285714285714,1.0,1.0,1/11,0.69%,IFI16
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.4651577397928778,-0.8624072716939403,0.6417910447761194,1.0,1.0,4/11,22.34%,GAD1;ALDH4A1;DAO;NOS1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.5198982690345793,-0.8623847872418037,0.6617647058823529,1.0,1.0,2/8,9.77%,HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.5307917632261111,-0.8620718788365138,0.6774193548387096,1.0,1.0,1/7,10.80%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.4323357689585134,-0.8620325681509758,0.7272727272727273,1.0,1.0,4/28,10.96%,CTNNA1;CAV3;DNAJA1;SPI1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.56789650738018,-0.8617114229022099,0.7272727272727273,1.0,1.0,2/6,18.55%,RNF26;HOOK2
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.5247175274984758,0.8616820220428956,0.64,1.0,1.0,2/5,28.00%,PRUNE1;PRUNE2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.4349368930268528,-0.8616629699509124,0.640625,1.0,1.0,6/20,15.18%,CYP1B1;NODAL;NOX1;TGFB1;CCBE1;BRCA1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.3289106283521563,-0.8614841864869586,0.7875,1.0,1.0,59/189,29.48%,NOB1;RPL36;RPL15;RPL38;RPLP2;INTS5;RPL28;RPS7;RPL9;RPL37A;MRPL44;RPL22;RPL35A;RPL5;RPL8;RPLP1;EXOSC6;RPL4;THG1L;RPL3;RPL34;RPL37;DDX54;RPL24;NOP56;WDR12;UTP11;EMG1;RPS24;RPS15;KRR1;RPL7A;RPL13A;RPL27A;SBDS;RPL23;EXOSC8;RPL35;RPL19;SSB;RPL18;AGO1;WDR55;RPL32;RPL13;METTL3;RPL27;IMP4;LAS1L;PELP1;RPS2;RPS9;MRTO4;AGO4;UTP15;RPL29;RPS25;RPL31;ZCCHC8
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.3659402451942705,0.861467080098874,0.5897435897435898,1.0,1.0,7/39,10.31%,RGS14;BMP7;SPRY3;PRKCD;APOE;STK38;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.43281862975573276,0.8608937738283556,0.6666666666666666,1.0,1.0,1/19,0.85%,STAC
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3122429373060633,-0.86070921635923,0.8888888888888888,1.0,1.0,30/306,16.28%,TICRR;RAD54L;POLQ;POLE3;HIC1;CGAS;BCL2L2;MOAP1;RAD51AP1;SUV39H1;RFC5;BACH1;SPDYA;RECQL;INIP;FANCC;VAV3;OTUB1;APLF;MRE11;CBX5;GADD45A;CHEK1;POLE2;BOK;SLF1;BRCA1;CIDEB;HPF1;RAD9B
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.3883263231313842,0.8605110830191819,0.7428571428571429,1.0,1.0,4/40,3.87%,F2RL1;GALNT3;HRH1;LAMB3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.4258920385268986,-0.8604815468833465,0.7377049180327869,1.0,1.0,4/24,14.81%,RFC5;RPA3;XRCC1;PCNA
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.31804768606865197,-0.8603993886144944,0.8313253012048193,1.0,1.0,85/322,26.93%,FIP1L1;NXT1;DDX20;RPL36;DDX39A;RPL15;NCBP2;SLU7;ANGPT2;RPL38;FYTTD1;RPLP2;RPL28;RPS21;RPS7;MRPS18C;EEF1A1;SLBP;RPL9;RSL24D1;POLR2J;POLR2K;NUP85;NCBP1;RPL37A;MRPL44;RNPS1;MRPS14;RPL22;RPL35A;RPL5;RPS20;RPL8;RPLP1;CDC40;RPS8;RPL4;ASMT;RPL3;RPL34;ALYREF;MRPL51;RPL37;DDX54;RPL24;RBM4;RPS24;NUP155;COPS5;RPS15;CREBL2;UPF3B;WARS1;RPL7A;RPL13A;RPL27A;DHX38;RPS4X;CLP1;NUP188;THOC5;HSPD1;RPL23;POLR2I;RPL35;POLR2B;MRPL43;RPS3;RPS27A;RPS6KB2;RPS29;RPL19;ABCF1;RPL18;RPS13;MRPL27;RPL32;RPL13;RPS5;RPL27;NUP214;CPSF4;GLE1;POLR2D;NUFIP1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.4353781862949813,-0.8601629617680361,0.6349206349206349,1.0,1.0,6/19,22.45%,PTPRC;HTR2B;ERO1A;PLCG2;ITPR1;RYR3
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.4028914427367369,0.8600787579814121,0.7142857142857143,1.0,1.0,5/22,10.73%,TGFBR1;TGFB2;HEY1;ACVR1;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),-0.5545008488177148,-0.8599569527973044,0.6491228070175439,1.0,1.0,1/5,15.08%,PHF23
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.5015186472389679,-0.8593523152354557,0.7258064516129032,1.0,1.0,3/8,22.89%,BRK1;WASF1;CYFIP1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.4766573507094571,0.8593212539456193,0.6538461538461539,1.0,1.0,2/16,7.88%,COBL;ARID5B
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.4254794945924337,-0.8593144920070478,0.6896551724137931,1.0,1.0,12/25,27.66%,NOTCH1;TGFB1;ANGPT2;DAB2IP;GADD45A;ADGRB1;RGCC;ADAMTS9;NR2F2;DCN;JUP;SP100
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.5356119592564254,-0.8590496767935516,0.6935483870967742,1.0,1.0,3/7,19.75%,TTLL4;METAP1D;FKBP10
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.5735112089121166,-0.8589516372815081,0.7307692307692307,1.0,1.0,5/5,42.67%,RAB3GAP2;TMEM33;LNPK;ATL3;RAB3GAP1
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5362433445254675,-0.8589035840991697,0.7101449275362319,1.0,1.0,3/9,15.70%,CLDN1;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4974133841058782,-0.8588435928628965,0.7096774193548387,1.0,1.0,4/13,20.49%,H1-0;TGFB1;LAMTOR5;TWIST1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3516175179769624,0.8586182283483802,0.7428571428571429,1.0,1.0,5/37,10.67%,RFWD3;TIMELESS;PRIMPOL;EME2;SMARCAL1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.5606642803114119,-0.8585886176373655,0.7321428571428571,1.0,1.0,3/6,20.68%,FADD;IL6ST;SKAP1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.3490575042689129,-0.8584794201275892,0.7530864197530864,1.0,1.0,10/125,6.27%,CD44;NES;LRP4;RDH10;SCN4B;COL9A1;TIMP3;AGT;ANGPTL2;COL6A1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.3906034867353716,-0.858443189496336,0.6268656716417911,1.0,1.0,15/45,13.11%,CD4;GNLY;PTPRC;NOTCH1;GMFG;CD37;NCKAP1L;SLA;CORO1A;TMC8;ARHGAP9;MYO1F;CD27;TSHR;TAGAP
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.3610998196983881,0.8584111576432852,0.7142857142857143,1.0,1.0,5/43,5.94%,CCDC63;DNAH5;CFAP70;DNAI4;RSPH6A
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.41675212474751594,0.8580533551809698,0.6571428571428571,1.0,1.0,7/19,20.36%,ABCA13;OSBPL6;NAXE;YJEFN3;NR1H3;NFKB1;APOA1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.41115357278023784,0.8578688669810565,0.5945945945945946,1.0,1.0,5/26,20.68%,ARL13B;WDR81;DYNC1I2;DYNC1I1;PCNT
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.35057465248371644,0.8578105651581436,0.75,1.0,1.0,23/117,9.36%,RIMBP2;KCNIP1;SEMA6D;GRIA4;RAB3C;CACNA2D1;ADGRA1;MAPK4;RGS7BP;UNC5D;GRIA2;GUCY1A2;KCTD16;LSAMP;BRINP1;NRXN1;PLD2;SHC3;TMEM196;PLAT;CNTN1;CSRNP3;RBFOX1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.37658923420335877,-0.8576696503816771,0.6986301369863014,1.0,1.0,14/55,13.64%,CD4;GNLY;ITK;PTPRC;ARHGAP15;GMFG;SLA;CD6;TMC8;ARHGAP9;THEMIS;CD27;TAGAP;EPSTI1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.3668452797398485,-0.8575152266975673,0.676923076923077,1.0,1.0,8/62,17.94%,HCK;NES;NCKAP1L;GPSM2;PLK4;STAP1;VIL1;CDK5
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.30034480502493643,0.857235282800025,0.7894736842105263,1.0,1.0,48/379,14.72%,NRK;HSPB1;SGK1;F2RL1;MOB3B;ARHGAP31;PEX5L;RASSF2;SRGAP1;EGFR;TRAF3;SPRED1;SMYD2;WWC1;TAF2;PRMT5;NLGN1;SGMS1;HDAC1;PKHD1;STYXL1;ARHGAP30;SYDE2;PLEKHG2;PAK5;TAF12;TTI1;GNA12;FSHR;TIAM2;PIP4K2A;SPHK2;PTPN13;GNAI1;RGN;FAM83D;ARHGAP39;STARD8;KALRN;TELO2;IER3;NTRK3;EP300;TIAM1;PAK4;PAK3;FBXL2;CRK
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5021505163637372,-0.8572181710112753,0.640625,1.0,1.0,2/12,1.66%,RDH10;CYP1B1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.47890153492608256,0.8571571148716182,0.6388888888888888,1.0,1.0,6/14,17.43%,ST3GAL1;ST8SIA3;ST3GAL2;ST6GALNAC4;ST8SIA4;ST8SIA2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.43945150550978274,0.8570820488161294,0.575,1.0,1.0,2/13,16.00%,TPR;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.5710047314394195,-0.8569076146100657,0.7142857142857143,1.0,1.0,1/5,10.12%,INHBA
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.38716145289761006,0.8567594875323917,0.6666666666666666,1.0,1.0,10/27,24.04%,NRXN1;NLGN1;SLC8A3;GRIN1;TMEM108;RELN;PTEN;RIMS2;CBLN1;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.518694721858079,0.8566776732331947,0.6944444444444444,1.0,1.0,1/6,2.26%,BCL2L11
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.465304180302119,-0.8566506815330359,0.6984126984126984,1.0,1.0,6/16,25.29%,MORF4L1;MORF4L2;MSL3;ACTL6A;BRD8;NAA40
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.4548957429272554,-0.8565887159211386,0.582089552238806,1.0,1.0,5/15,26.81%,C2ORF49;DDX1;CLP1;CPSF4;FAM98B
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.3019048555174101,0.856578323889516,0.7272727272727273,1.0,1.0,24/215,7.10%,ROR2;CDH13;KIT;LEF1;PDGFD;F2RL1;SEMA6D;TRIP6;EGFR;NRP1;KDR;CSF1R;TGFBR1;SEMA5A;TGFB2;EPHB2;MIEN1;MDK;PDGFC;ACVR1;PDGFRA;FERMT1;NUMB;SEMA4C
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.5827065743953633,-0.8565603446717188,0.75,1.0,1.0,2/5,17.34%,SGTB;PDCD5
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.3910674502200433,-0.8562161427115696,0.726027397260274,1.0,1.0,3/43,3.80%,LRP4;WFS1;AGT
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.42098948972023054,0.8559701776122424,0.625,1.0,1.0,3/13,19.10%,PEX7;TMEM86B;DHRS7B
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.45582107464258603,-0.8558100267539286,0.6833333333333333,1.0,1.0,5/18,15.61%,CDKN2D;INHBA;ANKLE2;CDKN1B;STAP1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.4405528558469875,0.8556285379403454,0.6470588235294118,1.0,1.0,3/15,10.59%,RORA;APOE;SCARB1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.5182664121824458,0.8554173424162081,0.6666666666666666,1.0,1.0,2/7,12.56%,IRS2;BCL6
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3469927502043683,0.8553688925063151,0.6842105263157895,1.0,1.0,16/57,19.72%,PCBP3;AFF2;PTBP3;PTBP2;IGF2BP3;NOVA1;FASTK;CELF1;BRDT;RC3H1;HNRNPL;RRP1B;HNRNPH1;MBNL1;SON;SRRM4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.5009461314842022,0.855280490598888,0.6666666666666666,1.0,1.0,4/10,16.79%,ACADVL;PIBF1;SIRT1;ERLIN2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5404206927255265,-0.8549492563107719,0.6231884057971014,1.0,1.0,2/8,22.82%,ERI2;EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5404206927255265,-0.8549492563107719,0.6231884057971014,1.0,1.0,2/8,22.82%,ERI2;EXOSC8
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5537702966624621,-0.8547572437978577,0.7580645161290323,1.0,1.0,3/6,33.37%,EXOSC6;RNF168;RNF8
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.45456791955506437,-0.8547391959776425,0.6212121212121212,1.0,1.0,5/16,26.81%,C2ORF49;DDX1;CLP1;CPSF4;FAM98B
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.4709960102210575,-0.8546520599336334,0.7096774193548387,1.0,1.0,4/15,9.40%,PTPRC;IL21R;PRDX1;CASP8
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.4525143637040502,-0.8546016657421838,0.734375,1.0,1.0,2/19,7.57%,RGPD3;RGPD1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.5079163993737378,-0.854526232955255,0.6440677966101694,1.0,1.0,3/9,22.62%,RPS7;RPL5;RPL23
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.31720733411432706,-0.8542561789058598,0.8205128205128205,1.0,1.0,48/306,16.26%,CD4;HCK;PTGIS;PRLR;DOCK8;DUOX1;YBX3;LDLRAP1;STAT1;IL3RA;OSMR;IL7;CTF1;GBP6;PLP2;NDN;IL18R1;JUNB;IFIT1;IRF1;STAT5A;FLT3;SLA;STAT4;IL20RA;TGFB1;SIGIRR;CRLF1;IFNGR2;EPRS1;CCL5;IL18BP;DAB2IP;PIK3CB;TXLNA;TEC;BAG4;IFNLR1;GPER1;IL18;BRCA1;GBP5;IL13RA1;PTPRZ1;TLR2;CDKN1B;INPPL1;TCF7
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.4908155909450549,0.8541918580360799,0.6285714285714286,1.0,1.0,3/8,18.87%,SIRT1;PKIA;PKIG
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.36647329414932023,-0.8541903852811402,0.6764705882352942,1.0,1.0,13/82,15.77%,AGT;RARRES2;P2RY12;SERPINE1;IL15;TGFB1;CCL5;SCIMP;PDGFRB;IL18;GBP5;TLR2;NFKBIA
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4336833675382495,0.8539360970405461,0.5517241379310345,1.0,1.0,1/16,0.43%,PTPN3
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.46658534575912847,-0.8537521403794759,0.5689655172413793,1.0,1.0,4/13,13.91%,LRRC8D;ABCC6;SLC25A5;SLC25A4
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.3597858383234765,-0.8536664769059296,0.7397260273972602,1.0,1.0,22/126,15.56%,CD44;BIK;GADD45B;BCL2L2;TIMP3;CD14;H1-0;TIMP2;SOD2;IRF1;CCND2;BCAP31;CASP8;DNAJA1;GADD45A;PDGFRB;ENO2;RETSAT;IL18;BRCA1;ISG20;CDKN1B
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.35692970616631337,0.8532823515215825,0.6521739130434783,1.0,1.0,27/111,15.55%,FLRT2;SGCD;PKP2;PDLIM1;BMP7;HDAC9;TGFBR1;SGCZ;TGFB2;HEG1;ACVR1;APLN;SMG9;CHD7;ERBB4;DVL2;EEF1AKMT4-ECE2;ADAP2;RBP4;ECE1;FGF12;ID2;NTRK3;PDGFB;ALPK3;MYOCD;MEF2C
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.42343611003232495,-0.85317547943323,0.7183098591549296,1.0,1.0,1/28,0.14%,NPY
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.5069399765316865,-0.8531138535655216,0.6507936507936508,1.0,1.0,2/8,31.46%,GSTZ1;PDK4
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.5069399765316865,-0.8531138535655216,0.6507936507936508,1.0,1.0,2/8,31.46%,GSTZ1;PDK4
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.49500377045667426,0.853019823711481,0.6111111111111112,1.0,1.0,1/5,3.36%,MICU1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.32961607658030123,0.8528111237463744,0.6538461538461539,1.0,1.0,10/58,13.99%,SLC12A3;GABRG3;SLC12A1;GABRB1;GABRA3;SLC6A1;ANO5;GABRB3;ANO6;GABRA5
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.4564135170303578,-0.8522499064832266,0.6515151515151515,1.0,1.0,1/13,4.40%,CD14
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.534982745673238,0.85217877949856,0.7058823529411765,1.0,1.0,3/8,19.56%,LYPLA2;ABHD17A;ABHD17C
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.534982745673238,0.85217877949856,0.7058823529411765,1.0,1.0,3/8,19.56%,LYPLA2;ABHD17A;ABHD17C
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.4663978379521235,0.851983855684605,0.6129032258064516,1.0,1.0,4/8,21.82%,CEL;ABCG8;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.31375927076238186,-0.8519279489482341,0.84,1.0,1.0,29/242,15.56%,PTPRC;ZNF703;GADD45B;CDKN2D;SMIM22;CDKN3;NOTCH1;GMNN;JUNB;CRLF3;IRF1;FOXM1;FIGNL1;TGFB1;WDR6;DAB2IP;INHBA;CAMK2N1;LIN9;GADD45A;CDC25A;TAF6;TRIM32;KIF20B;GPER1;CHEK1;TSC2;BRCA1;CDKN1B
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.5200626081930406,-0.8517778354634452,0.6486486486486487,1.0,1.0,3/9,24.02%,MBTPS2;LPCAT3;RAN
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.45953853651290905,-0.8517394708614752,0.746031746031746,1.0,1.0,3/20,13.68%,CELF3;NCBP2;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.4860178681834113,0.8514999189913574,0.6521739130434783,1.0,1.0,4/13,16.40%,SAMSN1;RC3H1;ID2;ATM
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.3935465009251571,0.8514196595584621,0.6896551724137931,1.0,1.0,3/17,10.59%,VLDLR;SLC10A7;SCARB1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5046765191864642,-0.8512843814429079,0.7101449275362319,1.0,1.0,3/10,23.35%,GNPDA1;ST6GAL1;NANP
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4595978954452371,0.8510349587076061,0.6060606060606061,1.0,1.0,4/12,20.60%,TPR;CDK5RAP2;LCMT1;PCID2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.4239909096808379,-0.8507891491071282,0.6865671641791045,1.0,1.0,7/20,17.40%,B3GNT9;B3GNT4;B3GALT1;B3GNT3;HAS3;B3GALNT1;NDST4
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.5130929186900823,0.8505316974028702,0.6829268292682927,1.0,1.0,2/6,10.32%,VSTM5;LRFN4
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.4394809167178432,0.8504055250260033,0.59375,1.0,1.0,6/27,10.13%,F11;KLKB1;PDGFRA;APOE;PLAT;TFPI
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.4908826144587455,-0.8503004870711375,0.7076923076923077,1.0,1.0,1/11,1.32%,LRP4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4102462505573733,0.8502311218412791,0.7105263157894737,1.0,1.0,7/24,13.20%,MCC;VASH1;APOE;DUSP10;PTPRM;PTPN23;SVBP
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4160144300032053,-0.850056482811213,0.6805555555555556,1.0,1.0,8/33,14.86%,LDLRAP1;ELANE;STAT1;NOX1;CCL5;IGFBP5;PDGFRB;IL18
prerank,PanglaoDB_Augmented_2021__T Cells,0.33398657668453685,0.849962012370193,0.75,1.0,1.0,12/73,4.46%,LEF1;GEM;SEMA6D;DUSP2;CD96;CD247;RORA;BCL2;GRAP2;GPR174;BATF3;SELPLG
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.5438506680553961,-0.8499306543722707,0.75,1.0,1.0,2/6,28.63%,CEACAM1;CD226
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.31044376256499095,0.8493244362778521,0.9259259259259259,1.0,1.0,26/170,14.06%,GNG4;SGK1;SGK2;EGFR;MELTF;BCL2;SERTAD2;TGFBR1;KIF26A;TGFB2;MINAR1;ENPP1;HSPA1A;PAK5;SLC25A33;SPOCK1;SPHK2;RERG;SGK3;BCL6;SIRT1;VGLL4;NRG3;CHPT1;SOCS2;PAK4
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.31862230112024387,-0.8492767874273579,0.7926829268292683,1.0,1.0,93/338,26.23%,WFS1;PAPPA;NOTUM;MMP15;RABGGTB;CP;RPL36;SERPINA10;RPL15;MANBA;PCMT1;GPC3;PAPPA2;UBL5;IGFBP5;RPL38;DAB2IP;PHEX;RPLP2;ITIH2;RPL28;RPS21;RPS7;APH1B;MRPS18C;EEF1A1;RCN1;RPL9;RSL24D1;L2HGDH;SPARCL1;PIGH;RPL37A;PRSS23;MRPS14;TTF1;RPL22;RPL35A;RPL5;MFGE8;RPS20;RPL8;RPLP1;CTSH;SFTPD;ADAM17;PCSK5;ERO1A;RPS8;RPL4;MEPE;ASMT;RPL3;RPL34;MRPL51;RPL37;RPL24;PLOD2;RPS24;CPE;COPS5;RPS15;KNG1;RAB12;ATG3;WARS1;RPL7A;RPL13A;SPP1;RPL27A;RPS4X;RPL23;FURIN;RPL35;MRPL43;RPS3;RPS27A;RPS6KB2;FN1;RPS29;RPL19;ABCF1;RPL18;IGFBP4;RPS13;MRPL27;RPL32;HSP90B1;MGAT4A;RPL13;RPS5;RPL27;CSF2RA
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.45927695389446455,-0.8489826286570155,0.7424242424242424,1.0,1.0,4/15,18.46%,CGAS;IFIT1;FLOT1;ZCCHC3
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.4206885544617798,0.8489486485801294,0.65625,1.0,1.0,3/15,6.91%,TGFB2;GCH1;SNCAIP
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.4498581676685268,-0.8488920543657368,0.7049180327868853,1.0,1.0,7/15,25.16%,ZNF703;SSTR1;GPER1;H2AZ1;ESR1;KAT5;FAM210B
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.46548263232894,0.8486495095016473,0.6428571428571429,1.0,1.0,3/9,11.60%,CACNA2D1;NOS1AP;CACNB2
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.45623041947511805,0.8483815409857067,0.5957446808510638,1.0,1.0,1/7,1.26%,DOCK10
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.5280351390335266,0.8483321401503006,0.7297297297297297,1.0,1.0,2/6,17.06%,CDK5RAP2;LCMT1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.5280351390335266,0.8483321401503006,0.7297297297297297,1.0,1.0,2/6,17.06%,CDK5RAP2;LCMT1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.40080115695878266,0.8479292653391696,0.6052631578947368,1.0,1.0,1/21,1.35%,GDAP1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.38224847493681324,-0.8476220149365125,0.7,1.0,1.0,4/42,9.10%,CDKN2D;RFC5;RPA3;TRIM25
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.5180699447697124,-0.8474689060453868,0.6981132075471698,1.0,1.0,3/6,24.41%,WNT7B;BFSP1;WNT7A
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3153334593122478,0.8474150821740449,0.84,1.0,1.0,24/136,13.98%,ELOVL6;GCH1;GAL3ST4;GSTO2;CEPT1;CHKA;PLA2G4C;SGMS1;LCAT;HACD2;LCMT2;APOE;SGPP2;ALAS1;SPTSSB;GSTT2B;PRKD1;SPTLC1;SPHK2;GPHN;CERS4;CERS3;CHPT1;ST3GAL2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.39539218788156627,-0.8472946293739217,0.696969696969697,1.0,1.0,2/41,5.06%,GYPB;GMFG
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.3936146486242105,0.8472145726151739,0.6875,1.0,1.0,8/30,10.59%,EGFR;GCH1;GLA;DDAH1;S100A1;APOE;NOS1AP;SCARB1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.5184819072050896,-0.847196887547481,0.7076923076923077,1.0,1.0,3/8,26.93%,ATP6AP1;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.3853393811988327,-0.8471043788879267,0.6666666666666666,1.0,1.0,8/57,22.95%,F8;LMAN1;CTSZ;TRAPPC4;TGFA;RAB1A;RAB1B;SEC23A
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3853393811988327,-0.8471043788879267,0.6666666666666666,1.0,1.0,8/57,22.95%,F8;LMAN1;CTSZ;TRAPPC4;TGFA;RAB1A;RAB1B;SEC23A
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.3853393811988327,-0.8471043788879267,0.6666666666666666,1.0,1.0,8/57,22.95%,F8;LMAN1;CTSZ;TRAPPC4;TGFA;RAB1A;RAB1B;SEC23A
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.3409899684153256,-0.8469598904665601,0.7468354430379747,1.0,1.0,9/114,8.31%,ENPP2;NPY;MC4R;TRPA1;NKX2-2;RIPPLY2;CELF3;MAGEL2;SCGN
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.5062046928492369,-0.8467878529304239,0.6935483870967742,1.0,1.0,1/8,7.35%,KCNQ1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.5062046928492369,-0.8467878529304239,0.6935483870967742,1.0,1.0,1/8,7.35%,KCNQ1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.40074523364181885,-0.8467777330249338,0.7543859649122807,1.0,1.0,1/27,1.66%,CYP1B1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.38946804500603877,0.8467310774385856,0.6875,1.0,1.0,5/26,13.55%,GPC4;STX8;VAMP8;FYN;ZDHHC2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.3484280043096679,-0.8465532648095151,0.7428571428571429,1.0,1.0,30/146,20.65%,F8;TIMP3;RARRES2;SERPINE1;SYNGR2;TGFB1;ANXA5;CDC37L1;ITIH4;TTN;TMSB4X;FAM3C;SERPING1;MAGED2;A2M;OTOF;STEAP2;GTPBP2;SYT2;SYT4;PSAP;RAB31;SYTL4;TMEM79;CDK5;TUBA4A;KNG1;CALM1;CD9;LAMP2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.4827742175768003,-0.8464319026685876,0.6923076923076923,1.0,1.0,4/13,19.17%,NOTCH1;DRD3;PTPRZ1;DAAM2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4662813095395355,0.8463553789687004,0.6842105263157895,1.0,1.0,3/10,18.35%,B3GAT2;B3GAT1;B3GAT3
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.4884688332949726,-0.8462673614284134,0.7391304347826086,1.0,1.0,6/14,28.21%,CAV3;MYADM;FLOT1;EMP2;RFTN1;PPT1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.5147075899202938,-0.846119683016326,0.7,1.0,1.0,1/7,7.74%,RIN3
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.5133209480756091,0.8459905046150201,0.6046511627906976,1.0,1.0,1/6,8.94%,SRGN
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.5455380307837443,0.8457991228628234,0.6666666666666666,1.0,1.0,1/5,5.03%,XRCC4
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5370507501964616,0.8455115238464876,0.7,1.0,1.0,2/5,26.91%,ABHD12;ABHD12B
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.44846463312202206,0.8454710201468189,0.6842105263157895,1.0,1.0,2/13,5.27%,HORMAD1;MDK
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.32456948995758017,0.8453474625604296,0.6785714285714286,1.0,1.0,4/69,4.22%,CD38;GPR174;BACH2;SLC12A1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.45780898711141815,-0.8451870254420762,0.6440677966101694,1.0,1.0,2/15,3.57%,CHRNB1;CHRNE
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.46815037893993283,0.8450353852456282,0.7,1.0,1.0,3/12,18.87%,SIRT1;PKIA;PKIG
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.2835745450852915,0.8450133930102234,0.8235294117647058,1.0,1.0,41/158,22.03%,DGKB;PIK3R6;SYNJ2;CEPT1;PLD6;CHKA;MTMR8;PLD2;PLA2G4C;LCAT;DGKH;PI4K2A;AGPAT5;PIP4K2A;PTPN13;PIK3R1;MTMR9;ABHD8;CHPT1;LCLAT1;ABHD4;GPD1L;PIK3C2B;PCYT2;PITPNM1;PHOSPHO1;INPP5J;PTEN;PCYT1B;MTMR6;MTM1;CLN3;PIP5K1C;APOA1;GPAT4;PI4K2B;PLEKHA1;MTMR3;PGS1;PI4KA;PIP5K1B
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.4860470270688091,-0.844906657240874,0.6727272727272727,1.0,1.0,2/7,16.78%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.3409100334240087,-0.8449031066494112,0.7307692307692307,1.0,1.0,3/75,5.42%,SLC28A2;SLCO2B1;ABCB1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.5367166479131518,-0.8446891865832185,0.7761194029850746,1.0,1.0,2/6,13.04%,FOXM1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.4377203856052784,0.8446159748225801,0.6486486486486487,1.0,1.0,2/12,6.36%,TGFB2;APLN
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.4275096567321065,0.8443995552610292,0.6578947368421053,1.0,1.0,1/11,3.74%,SMYD2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.3935911300058438,0.8443396754102183,0.7317073170731707,1.0,1.0,3/25,8.43%,ATOH8;VASH1;APOE
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.31854574428662596,-0.8442615472265688,0.7972972972972973,1.0,1.0,42/227,16.78%,CD4;ITK;CYP1B1;PTPRC;POLR3K;CGAS;AGT;ELANE;ZFPM1;CD74;CD14;IL7;NODAL;IL18R1;SERPINE1;IRF1;HHLA2;TXK;NOX1;IL15;ZBTB7B;CD6;TGFB1;AGER;SCIMP;HLA-DPB1;HLA-A;MRE11;NOX5;POLR2K;FADD;HTR2B;IL18;CCBE1;BRCA1;GBP5;TLR2;ADAM17;RGCC;PLCG2;SLC11A1;FLOT1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.34560767621271354,-0.8438672327005531,0.7236842105263158,1.0,1.0,12/78,15.56%,LRPAP1;BNIP3;CHMP4B;ACOX2;CHMP2A;CCL5;CALCR;CTSZ;HTR2B;VPS35;CIDEB;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3558302095215997,0.8437740425001439,0.6129032258064516,1.0,1.0,5/24,13.50%,EGFR;PLCB1;UBE2E2;FGF10;LSM10
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3358113189978491,-0.8437333170679201,0.7027027027027027,1.0,1.0,9/82,17.49%,RAB6C;LMAN1;MAGEL2;ARL1;DCTN1;VPS35;PREPL;VPS52;STX16
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.5698380524820507,-0.8437225208722139,0.7674418604651163,1.0,1.0,3/5,34.51%,RPS6KA1;PLA2G4A;SOX15
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.545250331902571,-0.8436501706221824,0.7678571428571429,1.0,1.0,4/8,38.46%,RIPK2;CHMP5;PTPN22;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.5438189014486886,-0.8433877408197716,0.7183098591549296,1.0,1.0,1/6,4.48%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.3780224946055011,-0.8433084984859837,0.7285714285714285,1.0,1.0,3/48,2.77%,AMBP;WFS1;HHIP
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.5533812266428291,-0.8432950727030263,0.6379310344827587,1.0,1.0,1/5,5.45%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.49691111452969744,-0.8432184019276738,0.703125,1.0,1.0,1/9,4.32%,ATP1B1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5462531613976009,-0.8428577421983975,0.734375,1.0,1.0,1/6,9.95%,SDS
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.46946343231125215,0.8426344857200747,0.717948717948718,1.0,1.0,1/8,2.27%,NRP1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.3687793405823736,-0.8425610141887637,0.7301587301587301,1.0,1.0,10/53,22.28%,ARIH2;UBE3A;IFI27;KBTBD6;TRIM32;SYVN1;RNF152;RBX1;RNF187;RNF34
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.41512924955487623,-0.8425204325523421,0.7096774193548387,1.0,1.0,7/26,22.89%,RAC1;P2RY12;NCKAP1L;RHOU;RHOH;NEFH;CYFIP1
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.5351817544235633,-0.8421701654437587,0.7037037037037037,1.0,1.0,3/6,38.26%,NPPC;GUCY2F;NPR2
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5176260893619505,-0.8421379116149876,0.7014925373134329,1.0,1.0,1/7,11.28%,HAT1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.5182380729823485,0.8420719771527678,0.7209302325581395,1.0,1.0,3/5,17.99%,FGF12;TYMP;HCRT
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.43424478083799123,-0.8420595087320522,0.7230769230769231,1.0,1.0,1/21,1.01%,PTGIS
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.47822779582172426,-0.8418267165673304,0.7428571428571429,1.0,1.0,3/13,15.36%,C10ORF90;BRCA1;PLK4
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.3994290735626564,0.8413021399266034,0.6129032258064516,1.0,1.0,3/23,4.46%,PID1;PTPRT;SELPLG
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3536371277901442,-0.8412688434780894,0.8266666666666667,1.0,1.0,12/70,23.01%,C4BPB;GPC3;DAB2IP;MSN;TRIM32;VPS35;CDKN1B;ADAM9;HECW1;C4BPA;GPLD1;FURIN
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.40871939108231703,-0.8411395288353838,0.671875,1.0,1.0,2/29,5.24%,KCNE2;DRD3
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.354196061546628,-0.8409845825398765,0.7837837837837838,1.0,1.0,14/70,14.49%,CA12;SLCO6A1;SLC22A25;MGST1;SLCO2B1;LRRC8D;SLC52A2;ABCC6;CYB5R2;CA1;SLC25A4;AQP9;SLC4A9;SLCO4C1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4062631282532495,0.8407430096399018,0.7631578947368421,1.0,1.0,4/24,6.07%,PKP2;TGFB2;HEY1;JAG1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.3400635470861024,0.8403479552056169,0.84,1.0,1.0,2/46,3.50%,LEF1;BRCA2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.5459017860694939,0.840336465679348,0.5769230769230769,1.0,1.0,2/6,16.57%,DLG2;CARF
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.5459017860694939,0.840336465679348,0.5769230769230769,1.0,1.0,2/6,16.57%,DLG2;CARF
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.5501260643804005,-0.840335183002808,0.7413793103448276,1.0,1.0,2/7,8.90%,PDCD1LG2;AGER
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.4768276436095805,-0.8402164281869923,0.640625,1.0,1.0,6/11,45.71%,USP7;ATP9A;LRRK2;DENND10;CHMP3;MAPK3
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.5358023384281861,-0.8400154536862112,0.7246376811594203,1.0,1.0,1/6,2.24%,DOCK2
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.47758081590770607,-0.8395241749794247,0.7090909090909091,1.0,1.0,1/8,9.22%,LRRC8D
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.3770833225704664,0.8394665324804258,0.7352941176470589,1.0,1.0,7/30,21.84%,MCTP1;SNCAIP;MCTP2;MEF2C;HCRT;RIMS2;VPS18
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.5473726193106113,0.839434878663235,0.7027027027027027,1.0,1.0,2/5,20.03%,FGFBP3;SMOC2
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.47937023340456086,0.8391285742164665,0.6410256410256411,1.0,1.0,3/8,14.74%,VAMP8;VAMP3;UVRAG
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.3799119575240662,-0.8389948587985147,0.6857142857142857,1.0,1.0,2/31,6.10%,ABITRAM;RASA1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.5687421090731049,-0.8389051862880346,0.7192982456140351,1.0,1.0,2/5,27.79%,ADAMTS12;GJA1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3388363621052287,0.8385149452862652,0.6521739130434783,1.0,1.0,1/52,0.23%,FBXL7
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.28581398752374126,0.8379533891453678,0.9473684210526315,1.0,1.0,34/217,14.17%,PID1;HSPB1;PELI2;EGFR;WWTR1;KDR;CSF1R;BMP7;ZBED3;ATF3;LEPR;PRR5L;EPHB2;GRM5;RASGRP1;EFNA5;EPHA7;KNDC1;EIF2AK3;ERBB4;ANGPT1;IL34;DVL2;PTPN13;FYN;FGF10;PPP2R5E;CHP1;SIRT1;SLCO3A1;NTRK3;AKT2;SPTBN4;FER
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.48710717607348253,-0.8379411033308154,0.6666666666666666,1.0,1.0,1/9,10.18%,CEP72
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5037641815028082,-0.8379042863628141,0.7241379310344828,1.0,1.0,4/9,20.68%,CCL5;CXCL13;PODXL;SKAP1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.4286025375312277,-0.8377604090261975,0.6507936507936508,1.0,1.0,6/20,22.45%,PTPRC;HTR2B;ERO1A;PLCG2;ITPR1;RYR3
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.5733463587376211,-0.8375564530354974,0.6964285714285714,1.0,1.0,2/5,24.84%,PLK4;DEUP1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.5188772232448396,-0.8372996743169039,0.6911764705882353,1.0,1.0,1/7,7.35%,KCNQ1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.544533683543508,-0.8370303403050103,0.7333333333333333,1.0,1.0,3/5,31.26%,RTF1;PAF1;CTR9
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.3612879670166281,0.8369056857986478,0.5897435897435898,1.0,1.0,9/28,14.98%,KCNJ16;KCNJ6;KCNJ3;KCNJ2;CHRM3;NEDD4L;ANO6;KCNJ14;NEDD4
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.43994400938428047,-0.836853603596945,0.65625,1.0,1.0,2/17,12.16%,CAV3;PDGFRB
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.5307931484367013,0.8367805322952906,0.6578947368421053,1.0,1.0,1/6,1.07%,DOK5
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.3413915335491551,-0.8367241349251812,0.7901234567901234,1.0,1.0,14/105,12.34%,AMBP;NR1I3;EID2;FGL1;CP;BNIP3;AHR;TMEM97;ALDOB;GPC3;ITIH2;MRPS18C;ASGR1;SLBP
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5109633439088426,-0.8367190357897816,0.7142857142857143,1.0,1.0,5/8,40.01%,TDG;SMUG1;UNG;MBD4;OGG1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.3920291121736885,0.8365769046811905,0.6666666666666666,1.0,1.0,4/20,12.66%,IFI16;TRAFD1;SIRT2;LYAR
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.47834690336408636,0.8365484475881173,0.7105263157894737,1.0,1.0,1/8,2.27%,NRP1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.47834690336408636,0.8365484475881173,0.7105263157894737,1.0,1.0,1/8,2.27%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.34116924041324087,0.8363538351032814,0.6666666666666666,1.0,1.0,8/93,10.35%,NRG1;BCL2L11;UNC13B;FERMT1;FAF1;ERCC2;GNL3L;STMP1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.5171428137787506,0.836265127016349,0.625,1.0,1.0,3/7,22.10%,SLC27A2;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.5296356264418653,-0.8362215338463879,0.6949152542372882,1.0,1.0,1/5,16.54%,EXOSC6
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3816378723164285,0.836148649226082,0.7878787878787878,1.0,1.0,9/32,15.91%,PTPN3;UTRN;CHRM3;SPHK2;NEDD4L;FGF12;NEDD4;HOMER1;GPD1L
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.32687119620338023,0.8360840426632974,0.5555555555555556,1.0,1.0,18/72,16.51%,EPHA3;EPHA5;EPHB2;EPHA8;EFNA5;EPHA7;ARPC3;FYN;KALRN;SIPA1L1;TIAM1;PAK3;ANKS1B;CRK;GRIN2B;NGEF;ANKS1A;GRIN1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.434936810319133,-0.8359143128721994,0.7428571428571429,1.0,1.0,4/23,11.03%,LRP4;GLI3;RSPO2;KREMEN1
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.40496010232932333,0.8358835734937927,0.6388888888888888,1.0,1.0,5/20,8.24%,SGCD;BMP7;SGCZ;CFLAR;SVIL
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.486086092768148,-0.8356672210115593,0.7377049180327869,1.0,1.0,2/11,5.42%,CD74;IL7
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3370805968753525,-0.8356410570598757,0.7710843373493976,1.0,1.0,35/142,20.68%,BTN2A2;CD4;ITK;PTPRC;PSMB6;HHLA2;FYB1;TXK;PSMB8;NCKAP1L;SKP1;VAV3;BLNK;PIK3CB;HLA-DPB1;HLA-A;TEC;THEMIS;PSMA3;THEMIS2;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;SPG21;EIF2B2;BTNL2;EIF2B5;PSME1;WAS;PSMD12;PSMB2;MOG;SKAP1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.368028330075954,0.8355827855568548,0.7428571428571429,1.0,1.0,1/29,0.60%,CCNH
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.526528154513479,0.8355280850413904,0.6829268292682927,1.0,1.0,2/5,20.83%,BICD1;ABL1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.35528277927166824,0.835502164720265,0.6,1.0,1.0,3/36,5.68%,UBASH3B;JSRP1;PDE4D
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.5316041615437315,-0.8354366855625285,0.696969696969697,1.0,1.0,1/5,3.73%,TIMP3
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.33899031312537503,-0.8353780270335942,0.7692307692307693,1.0,1.0,3/77,5.42%,SLC28A2;SLCO2B1;ABCB1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4473706167895357,-0.8353120113565791,0.6363636363636364,1.0,1.0,3/17,8.90%,PTPRC;FKBP1B;BCAP31
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.5475616401258364,0.8351997131604646,0.6216216216216216,1.0,1.0,1/5,9.07%,CEP135
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5242154000979034,-0.8351987455852772,0.7246376811594203,1.0,1.0,3/7,19.69%,TGFB1;BCDIN3D;ESR1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.5156425182041748,0.8351711937192051,0.775,1.0,1.0,1/6,2.67%,SH3RF1
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),-0.5799852465375209,-0.8351241124653206,0.7666666666666667,1.0,1.0,2/5,3.54%,GCM2;SFRP4
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.5231958812424355,-0.8346203101596377,0.7407407407407407,1.0,1.0,1/6,9.21%,DGAT2L6
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.35686079352877487,-0.8345402754389462,0.7536231884057971,1.0,1.0,9/67,8.55%,CCDC60;FUT2;TEX26;ATP1B1;VWA2;MYO5B;DNAH3;MROH9;IL20RA
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.48460932391661427,0.8341829475856013,0.7142857142857143,1.0,1.0,2/8,6.71%,F2RL1;PRKCD
prerank,MSigDB_Hallmark_2020__Hypoxia,0.30644872259512684,0.8341272080347213,0.6923076923076923,1.0,1.0,25/165,13.29%,GPC4;SLC37A4;EGFR;RORA;BCL2;SDC4;EXT1;VLDLR;ATF3;B4GALNT2;FOS;MXI1;TGFB3;PGM2;IRS2;MT1E;BNIP3L;SLC25A1;TPD52;SCARB1;NEDD4L;HS3ST1;ZNF292;IER3;PFKFB3
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.5233822380014584,-0.8337297054176448,0.7,1.0,1.0,1/7,8.45%,MGME1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.39943516908660526,-0.8336392045426785,0.6615384615384615,1.0,1.0,9/31,20.78%,ODAD4;NOTCH1;CCDC39;MMP21;TBX1;ODAD3;DNAH11;SHH;ARL6
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.42266973788785506,-0.8335667678608374,0.7,1.0,1.0,3/27,10.34%,IFIT1;CCL5;PPID
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.42822498145358057,0.8334822743426351,0.696969696969697,1.0,1.0,3/10,9.16%,PCBP3;IGF2BP3;NOVA1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.5121064524704559,-0.8332712118521314,0.7301587301587301,1.0,1.0,2/7,12.16%,CALCR;PDGFRB
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.46055505498890853,-0.83309867110263,0.6896551724137931,1.0,1.0,4/11,34.78%,ZWILCH;KNL1;CHAMP1;SPDL1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.4618008690974037,0.8329746961185607,0.7111111111111111,1.0,1.0,2/8,14.55%,PLAT;MEGF10
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.4488868491756055,-0.8329164077761194,0.6619718309859155,1.0,1.0,4/12,26.88%,CELSR1;ACTG1;FUZ;AHI1
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.4821221493695955,0.8328589332075745,0.6333333333333333,1.0,1.0,1/6,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.2909065645062924,0.8328397872709142,0.8666666666666667,1.0,1.0,25/149,12.09%,ALK;KDR;COBL;SHLD1;BMP7;PLCB1;ZBED3;MCU;VLDLR;MARCHF5;MDK;FOXO6;ACVR1;NRXN1;PLD6;NLGN1;GRIP1;SOX5;APOE;RALA;FGFR1;ADGRL1;DVL2;ELAPOR2;KMT5B
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.43534256031608853,-0.8327932640792496,0.6515151515151515,1.0,1.0,3/13,14.69%,UFM1;RAB23;APOD
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.5598927788202114,-0.8324791451844583,0.7580645161290323,1.0,1.0,1/5,3.37%,FBLN5
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.4809958250582811,-0.8320423228903276,0.7258064516129032,1.0,1.0,1/9,3.75%,PBLD
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.41034650177116705,0.8319231498874176,0.6764705882352942,1.0,1.0,8/25,19.14%,TLR1;C5AR1;FER1L5;CRTC3;TMEM106A;JAK2;SBNO2;AZU1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.3541588656987013,-0.8318485523812911,0.8529411764705882,1.0,1.0,10/76,8.31%,ENPP2;MYLK;ANKS4B;TRPA1;AGT;ANGPTL2;SSTR1;ALDOB;SLC38A11;SCGN
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.49454558058066533,0.8318056836533269,0.75,1.0,1.0,4/8,13.78%,RCE1;PTAR1;PGGT1B;RABGGTA
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.32873414245403365,-0.8313257883045381,0.8108108108108109,1.0,1.0,46/144,20.95%,HLA-DMA;B2M;IFI44;CD74;STAT1;IL7;SOD2;GBP6;FGL2;IFIT1;IRF1;IFI27;PSMB8;IL15;CIITA;STAT4;P2RY14;TRIM25;CCL5;CASP8;IL18BP;IFIT3;RNF213;XAF1;HLA-A;ZNFX1;SERPING1;PSMA3;OAS3;CMPK2;EPSTI1;APOL6;ISG20;NFKBIA;CMKLR1;CMTR1;GPR18;PSME1;NLRC5;NAMPT;ISG15;TNFAIP2;PSMB2;TXNIP;STAT2;WARS1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.31233927067824396,0.8311644743267743,0.8055555555555556,1.0,1.0,27/118,19.67%,BAZ2B;LRWD1;ARID1A;ZBTB1;HDAC1;HDAC10;MYB;SUV39H2;RUVBL2;HMGN4;PBRM1;HMGA2;SIRT1;BRDT;PHF1;SMARCAD1;MECOM;HDAC5;SMARCA4;BPTF;SMARCB1;ZBTB7A;HP1BP3;BAZ1B;KDM4C;TADA2A;HDAC3
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3938619952551357,-0.8310634201556176,0.7681159420289855,1.0,1.0,4/40,8.55%,SPAG4;CHMP4B;CHMP2B;CHMP2A
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.5119246514229666,-0.8309408929339561,0.7068965517241379,1.0,1.0,1/8,12.09%,EEF1A1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4556052873080818,-0.8306301159154901,0.7049180327868853,1.0,1.0,3/14,11.53%,ITK;TXK;TEC
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.5202418600438596,-0.8306252010617602,0.7611940298507462,1.0,1.0,3/6,24.53%,GTF3C6;GTF3C4;GTF3C3
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.32536522195296497,0.8304459573649783,0.8928571428571429,1.0,1.0,3/58,3.23%,ACE2;IL1RL2;TRAF3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.4671268530621662,-0.8303496821713777,0.7272727272727273,1.0,1.0,5/17,22.51%,MGST1;GSTM5;GSTP1;HPGDS;AKR1A1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.4671268530621662,-0.8303496821713777,0.7272727272727273,1.0,1.0,5/17,22.51%,MGST1;GSTM5;GSTP1;HPGDS;AKR1A1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.2989181791024821,0.8301765690551036,0.8928571428571429,1.0,1.0,18/148,6.23%,BCL2A1;SGK1;F2RL1;GEM;DUSP5;DUSP2;IFIH1;SDC4;PMEPA1;IL15RA;LAMB3;GCH1;ATF3;FOS;BTG2;JAG1;CFLAR;DUSP4
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.522629672981826,-0.830016852582349,0.7903225806451613,1.0,1.0,3/7,20.81%,SERPINE1;CPB2;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.32395269378487224,-0.8299566870184627,0.8552631578947368,1.0,1.0,39/170,26.64%,CD4;TERF2IP;CD74;P2RY1;RAC1;RARRES2;PINK1;CCND2;FAM20A;TGFB1;AGER;CALM3;TBX1;SVIP;GPER1;ANKLE2;TXN;ADAM17;DAXX;FLOT1;CDK2AP1;NIBAN1;CALM1;MUSK;PLAUR;FAXDC2;FXR1;NTRK1;LYN;GPNMB;RAMP1;KAT5;AKT1;HGF;AXIN2;ATG14;ASPSCR1;CHRNA7;FGF7
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.4382856834553793,-0.8297110377375915,0.7464788732394366,1.0,1.0,3/16,11.56%,GOT1;CALCR;REST
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.3907317999866473,0.829569057338773,0.5769230769230769,1.0,1.0,5/20,12.53%,F2RL1;EPHB2;SPHK2;RBP4;VAMP3
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5183564774801868,-0.829519432346335,0.7846153846153846,1.0,1.0,1/8,3.30%,SMIM22
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.5379240193394014,-0.8292191689400096,0.7777777777777778,1.0,1.0,1/5,7.77%,PCMT1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.38772841710980677,-0.8290769850788602,0.7910447761194029,1.0,1.0,2/41,4.68%,EPHA1;RAC1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.40656897866114416,0.8287597471853367,0.7142857142857143,1.0,1.0,4/19,7.35%,WWTR1;TGFBR1;BMP6;TGFB3
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.5045095072040879,-0.8286420400965095,0.7037037037037037,1.0,1.0,2/5,16.84%,CNTN2;CNTNAP1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.49958337039699163,0.8285490425138086,0.6923076923076923,1.0,1.0,3/6,19.40%,PGM2;GALE;GALT
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.3661923945022153,0.8283276576700431,0.8387096774193549,1.0,1.0,1/26,0.89%,CA2
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.3592661720618846,0.8281947019977947,0.6578947368421053,1.0,1.0,5/33,10.74%,NOX4;CSF1R;GRM5;CASS4;IL34
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.3768800509091076,0.8281932105536081,0.7407407407407407,1.0,1.0,10/35,23.01%,CAMKMT;PRMT5;PRMT8;ETF1;LCMT1;NSD1;EHMT2;ICMT;SNRPB;PRMT6
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.4847589793669549,-0.8281780627592864,0.7413793103448276,1.0,1.0,6/12,20.68%,IL4I1;AHR;IRF1;FADD;IL6ST;SKAP1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.5266364572112778,-0.8280906656175597,0.7627118644067796,1.0,1.0,1/7,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.4801785762960767,-0.8277934067716043,0.6774193548387096,1.0,1.0,4/16,19.85%,DAB2IP;GSTP1;TRIM32;FTH1
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.5673962629573258,-0.8277741569735296,0.8333333333333334,1.0,1.0,1/5,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.4793016210836844,-0.8277192578090886,0.765625,1.0,1.0,3/8,30.11%,DPYS;ALDH6A1;CRMP1
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),0.4843549176133902,0.827645283758304,0.6808510638297872,1.0,1.0,3/5,22.26%,EREG;ID2;PTBP1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4160923201328071,-0.8276186188133221,0.6666666666666666,1.0,1.0,7/21,29.03%,H1-0;DNASE2;DNASE1L1;DNASE2B;REXO4;DFFA;DFFB
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4367070576399896,-0.8274950299210726,0.6885245901639344,1.0,1.0,6/19,15.18%,CYP1B1;NODAL;NOX1;TGFB1;CCBE1;BRCA1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.44780023596280305,-0.8274945996250682,0.7536231884057971,1.0,1.0,3/19,16.40%,TTLL4;AGBL5;TPGS1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.4620265164105996,0.8271844249431,0.625,1.0,1.0,3/11,10.30%,SLC22A2;SLC22A6;TPD52
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.5254362887493351,-0.8271069586021046,0.7796610169491526,1.0,1.0,1/9,11.50%,PHKA1
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.4859231965445895,-0.8269568659467472,0.7142857142857143,1.0,1.0,2/6,41.40%,SFRP1;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.42540709097498497,-0.8269316473261324,0.7333333333333333,1.0,1.0,6/23,23.47%,NODAL;CRY2;BRCA1;KANK2;PER1;CALR
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.4085570311306828,-0.8268832242961206,0.6875,1.0,1.0,3/19,13.20%,HSD17B10;SLC25A44;BCAT2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.4085570311306828,-0.8268832242961206,0.6875,1.0,1.0,3/19,13.20%,HSD17B10;SLC25A44;BCAT2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.3942673401907896,0.826750773140671,0.6363636363636364,1.0,1.0,3/24,8.26%,CIDEA;IGF1;PTPN6
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.4710261810528823,0.8265266581484891,0.717948717948718,1.0,1.0,6/10,30.82%,NSMCE2;TPRKB;SMC6;RAD51;SMC5;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.43847764446278337,-0.8262225038142212,0.7457627118644068,1.0,1.0,4/12,28.63%,KCNN4;TESPA1;RPS3;CD226
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.4420094343454406,0.8262012954190671,0.7560975609756098,1.0,1.0,2/11,7.59%,CCDC22;COX19
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.3646876124540803,-0.8261987013979738,0.7352941176470589,1.0,1.0,12/52,19.16%,BNIP3;TOMM20;BCAP31;TOMM7;SLC25A5;DNAJC19;SLC25A4;SLC25A31;TOMM22;TMEM14C;TIMM17B;TMEM14A
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.40294078439823444,0.8260837713169009,0.6764705882352942,1.0,1.0,2/12,10.03%,TRIM11;MID2
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),0.4667284329754643,0.8256383425506039,0.5714285714285714,1.0,1.0,1/5,2.33%,SULF2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),0.5194869038505843,0.8256047117689826,0.6976744186046512,1.0,1.0,2/5,25.44%,MRI1;BHMT2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.4652845092924508,-0.8255278571297457,0.7941176470588235,1.0,1.0,4/12,18.46%,CGAS;IFIT1;FLOT1;ZCCHC3
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4750959289186304,-0.8254386960407174,0.7058823529411765,1.0,1.0,2/8,14.96%,APOD;NDRG4
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.4753245315567699,-0.8253905969084512,0.7169811320754716,1.0,1.0,3/11,19.16%,ROPN1L;CABYR;SPAG17
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.39715529746766026,0.8253845491504415,0.6875,1.0,1.0,2/25,7.06%,KLRD1;RASGRP1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.46636230852553484,-0.825298073021753,0.6911764705882353,1.0,1.0,1/16,3.18%,CDKN2D
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.43772602891253287,0.8252160560339444,0.6571428571428571,1.0,1.0,2/8,5.59%,TOX;RABL3
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.4282554028429927,-0.8248113723232777,0.734375,1.0,1.0,4/14,15.40%,B2M;NOTCH1;REST;TLR2
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.4772641364943342,-0.8246796418705922,0.7846153846153846,1.0,1.0,1/12,6.15%,SERPINE1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.3485521622026982,-0.8245899076163344,0.8533333333333334,1.0,1.0,10/58,12.16%,EPHA1;HCK;ITK;PRLR;TXK;IL15;FLT3;EFEMP1;TEC;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3233659729890094,-0.8244275397587453,0.8333333333333334,1.0,1.0,16/116,16.78%,TERF2IP;TRIM22;TNFSF18;TRIM5;AGT;TRIML2;IL18R1;AGER;TRIM25;PRKCH;ROR1;TRIM32;IL18;TLR2;NFKBIA;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4177897838099861,0.8240341954354489,0.7435897435897436,1.0,1.0,4/16,20.43%,DDAH1;NOS1AP;KLF2;EDN1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.4693447706615146,-0.8238951887178168,0.7230769230769231,1.0,1.0,1/13,4.87%,ITGA5
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.42279501411937476,0.8236949486522286,0.7435897435897436,1.0,1.0,2/14,13.00%,ZBED3;ESPL1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.36365241457007663,0.8236928889147782,0.7916666666666666,1.0,1.0,5/49,6.86%,ACE2;CAPN13;KCNN2;JAG1;BTC
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.3738869957665266,-0.8236914201460516,0.7164179104477612,1.0,1.0,2/49,3.12%,LRP4;OMG
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.46772882747432054,-0.8236610654034315,0.7121212121212122,1.0,1.0,2/11,14.57%,IGFBP5;TPM1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.42370892591928433,0.8236454978837299,0.717948717948718,1.0,1.0,2/11,4.60%,TGFBR1;GREM1
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.49532158106769286,-0.8235811264580885,0.711864406779661,1.0,1.0,2/9,19.12%,IFIT1;ISG15
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.5085555416768088,-0.8235129015580207,0.8,1.0,1.0,2/8,18.63%,STAT5A;SHC1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.5085555416768088,-0.8235129015580207,0.8,1.0,1.0,2/8,18.63%,STAT5A;SHC1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.35799519224064463,-0.8233224591307119,0.7536231884057971,1.0,1.0,14/59,26.70%,IFIT1;CCL5;PPID;POLR2J;POLR2K;SUPT5H;SRPK1;VPS4A;POLR2I;POLR2B;CTDP1;KPNA2;NR5A2;POLR2D
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.4098806549038731,-0.8231674111894991,0.704225352112676,1.0,1.0,3/28,1.99%,GNLY;ITK;PTPRC
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.36159452261593666,-0.823130138606322,0.7857142857142857,1.0,1.0,1/65,0.06%,SLC28A2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.3266743119143035,-0.822610466037994,0.8441558441558441,1.0,1.0,14/107,18.24%,NPY;ROPN1B;RAC1;RAB11A;AGER;STMN1;CDK5R1;PLP1;CFAP126;TPM1;UNC5A;CDK5;ULK1;TBC1D24
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.36051068602896497,0.8224002015130929,0.6486486486486487,1.0,1.0,4/35,5.48%,RGS14;BACH2;ATXN1;RITA1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.42500536764667485,-0.8223194308115342,0.6610169491525424,1.0,1.0,5/17,28.12%,SPAG4;NUP155;VPS4A;SUN3;NEMP1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.4796237609712029,-0.8222805978210748,0.7241379310344828,1.0,1.0,1/10,1.81%,SCN4B
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.4795676494464253,0.8222330839187676,0.5833333333333334,1.0,1.0,1/7,2.05%,IFIH1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.3842062505388673,-0.8221926179776458,0.8260869565217391,1.0,1.0,17/37,34.09%,NOB1;RPS27L;RPS7;EMG1;RPS24;RPS15;ERAL1;SURF6;RPS5;RPS25;TSR3;RPSA;RPS19;SNU13;RPS28;RPS16;RPS27
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.3770016967238164,-0.8221282736459447,0.7605633802816901,1.0,1.0,9/40,18.45%,CYP1B1;EPHX1;PTGR1;ALOXE3;ALOX12;GSTP1;PLA2G10;FADS2;ELOVL2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.37092263749850835,0.8221251191084814,0.7096774193548387,1.0,1.0,7/27,15.55%,CTNNA2;HDAC9;MAPK12;ID2;MEGF10;MYOCD;MEF2C
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.4671695015854379,0.8220243620390375,0.6,1.0,1.0,4/7,21.82%,CEL;ABCG8;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.4494463431445352,0.821949775955594,0.6590909090909091,1.0,1.0,1/12,0.57%,MSH4
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.3324342945460103,0.8217749546616774,0.825,1.0,1.0,5/50,11.06%,IFIH1;NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3354755314483925,0.8217514946539324,0.7878787878787878,1.0,1.0,11/46,17.55%,RUBCNL;NUP210;NUP42;TPR;NUP37;EP300;PNPT1;JMJD8;AAAS;ZBTB7A;GCK
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5230916272569117,-0.8213167815735906,0.7868852459016393,1.0,1.0,1/8,3.54%,SFRP4
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.3384766459479681,0.8210914221507573,0.8285714285714286,1.0,1.0,4/52,4.47%,IRS1;FGFR4;MCU;LEPR
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.3386593771128626,-0.8210859144929634,0.8382352941176471,1.0,1.0,11/104,10.07%,PRLR;WFS1;SLC13A4;CLIC6;MMP15;AGT;ATP1B1;RARRES2;IGFBP5;DAB2IP;CLDN1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.5504291261623762,0.8210292363010245,0.7948717948717948,1.0,1.0,2/6,14.01%,ARFIP1;EIPR1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.3448939592309878,0.8208668659977405,0.7352941176470589,1.0,1.0,5/35,8.54%,SLC22A2;SLC16A2;SLC6A13;SLC19A1;SLC7A1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.385217448908602,0.8205446133262221,0.7567567567567568,1.0,1.0,3/20,12.41%,CAMKMT;PRMT8;ETF1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),-0.5521831684394122,-0.8204784464173971,0.8275862068965517,1.0,1.0,2/5,10.99%,XRCC1;APLF
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.4962442601765883,-0.8202222397342152,0.7205882352941176,1.0,1.0,3/7,20.81%,CCL5;F11R;PLAUR
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.49775012979812494,0.8200769279931245,0.6923076923076923,1.0,1.0,1/6,2.75%,GAL3ST1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.49775012979812494,0.8200769279931245,0.6923076923076923,1.0,1.0,1/6,2.75%,GAL3ST1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4379783534593687,-0.8200262645882177,0.6949152542372882,1.0,1.0,5/15,25.80%,OAS3;NLRC5;ISG15;STAT2;METTL3
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.4781825341984346,0.8198369651487072,0.7209302325581395,1.0,1.0,1/6,10.76%,UBE2D4
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.31186529917101913,0.8194263091213325,0.7666666666666667,1.0,1.0,13/62,18.39%,ARID5A;AKR1C3;TFPI;ROBO2;NSMF;THRB;SOCS2;NR3C1;MEF2C;GAS2L1;GCK;NR4A3;AKR1C1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.30848268247636473,0.8194012236904284,0.8666666666666667,1.0,1.0,11/71,13.62%,TRPC3;CACNA2D1;CACNG3;GRIN3A;TRPC5;SLC8A3;NIPAL2;FYN;SLC8A1;MAGT1;TRPC1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.3400911509263222,0.8191220014171141,0.6451612903225806,1.0,1.0,10/52,11.46%,MYLIP;KANK1;MINAR1;PTPN9;PTPRO;NLGN1;APOE;SPOCK1;PTPRS;PRAG1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.464994757883524,0.8189904761841839,0.6578947368421053,1.0,1.0,5/8,28.89%,SPHK2;FER;BLK;GAB2;SYK
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.49704218656260263,0.8189779950104239,0.6808510638297872,1.0,1.0,3/6,20.03%,ADAMTS3;ROBO1;SMOC2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.319153055520489,0.8189762602690803,0.7407407407407407,1.0,1.0,7/60,11.70%,FARS2;CDKAL1;LCMT2;TRDMT1;TRMT61A;WDR4;CPSF1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4702834538950231,-0.818963039032261,0.6833333333333333,1.0,1.0,3/10,19.16%,ROPN1L;CABYR;SPAG17
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.3585925696992585,-0.8188990700541054,0.8421052631578947,1.0,1.0,13/71,25.35%,B2M;GMNN;STMN1;HIP1R;NCBP1;TXN;FLOT1;MET;PLAUR;PYHIN1;RAN;DDX11;RIPK2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.3329279082794873,-0.8188654758514108,0.7922077922077922,1.0,1.0,4/98,4.68%,RAB6C;RREB1;RAPGEF5;RAC1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.4427623278479706,-0.8188263106696941,0.7333333333333333,1.0,1.0,2/14,9.19%,MSX1;GLI3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.4228849285020804,-0.818401400517928,0.7076923076923077,1.0,1.0,4/24,16.32%,LAMA2;CLDN1;F11R;TJP3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.45288189506664384,-0.8182519206547706,0.7714285714285715,1.0,1.0,2/12,12.41%,GNPDA1;GFPT2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.37474698990604266,0.8181371815371146,0.7575757575757576,1.0,1.0,5/24,19.03%,KDM8;HR;KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.4267015845801074,0.8177142986853536,0.75,1.0,1.0,2/12,12.09%,SHLD1;KMT5B
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4155682628620744,-0.8175543359553852,0.7352941176470589,1.0,1.0,5/28,13.10%,NKX2-2;SCGN;SRP9;SRP14;MAFB
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.5145081083607995,0.8175067396956228,0.7380952380952381,1.0,1.0,3/6,13.83%,SPX;RNLS;SPTBN4
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.4701562004143961,-0.8174381245144986,0.734375,1.0,1.0,1/11,4.40%,CD14
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.52776210089987,0.8173553743179142,0.6842105263157895,1.0,1.0,2/5,6.86%,HMGB1;LGALS1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.47791421359945574,-0.8170391075324858,0.7241379310344828,1.0,1.0,1/7,12.38%,MDH1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.28970481630844513,-0.8170278567179554,0.9895833333333334,1.0,1.0,72/572,15.77%,CD44;HCK;PRLR;PNMA5;WFS1;CYP1B1;PNMA2;TNFSF18;GADD45B;BCL2L2;SFRP4;AGT;MOAP1;RABGGTB;CD74;STAT1;DDX20;BNIP3;IL7;PINK1;ATF5;RASA1;MTCH1;BCL2L14;PXT1;CCND2;RASGRF2;NCKAP1L;FLT3;FIGNL1;IFI6;HSPA5;CASP8;TP53I3;DAB2IP;VAV3;IFIT3;ANXA5;PPID;DNAJA1;TFPT;REST;APH1B;MRE11;BAG4;UFM1;HIP1R;GADD45A;CD27;STK17A;HRK;GSTP1;FADD;ITGB3BP;SIAH1;GPER1;KIF14;ZNF16;ANKLE2;LRP2;BOK;PREX1;HTR2B;RNPS1;SIX4;KLF11;SUDS3;CIDEB;FGD3;GAS1;CTSH;NFKBIA
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.39399238939254905,-0.8168759659877476,0.7647058823529411,1.0,1.0,10/44,22.41%,FUT2;GM2A;B3GNT5;GBA3;B3GALNT1;PSAP;NEU1;CPTP;SUMF1;PGAP3
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4574265679437166,-0.8168295553688505,0.7313432835820896,1.0,1.0,7/12,35.39%,TXN;MET;HGF;PARK7;GPR37L1;RACK1;LRRK2
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.41152463515264914,-0.8166796445884772,0.796875,1.0,1.0,11/25,30.04%,RRP15;EIF6;WDR12;RPL7A;RPF2;NSA2;RPL35;RPL7L1;LAS1L;MAK16;DDX18
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.5047843257956732,-0.816606107672778,0.7777777777777778,1.0,1.0,4/8,35.83%,ENTPD2;ENTPD5;ENTPD7;ENTPD1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3489489161262806,-0.8165697342231512,0.7012987012987013,1.0,1.0,13/94,15.83%,CCNE1;CDKN2D;CCNG2;CDKN3;CDC6;CCND2;DAB2IP;CALM3;GADD45A;CDK5R1;CDC25A;CDKN1B;MTCP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.3983071578333985,-0.8164741586931669,0.6833333333333333,1.0,1.0,2/21,7.97%,RAC1;BRK1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.49367806086992305,-0.8163592570330653,0.78125,1.0,1.0,1/7,3.43%,IL4I1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.47667806279513036,-0.8163028997226462,0.7121212121212122,1.0,1.0,3/9,22.59%,STAP1;LBP;HSPD1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.3936555141211959,-0.8161953276285756,0.7142857142857143,1.0,1.0,4/35,9.04%,NARS1;PPA1;IARS2;EPRS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.334695674997566,0.8159108019929802,0.8125,1.0,1.0,2/36,2.53%,PID1;BCL2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.29078726673234917,0.8156160416228213,0.9615384615384616,1.0,1.0,11/146,5.99%,RUNX1;HSPB1;KDR;SPRED1;SEMA5A;VASH2;PIK3R6;TGFB2;VASH1;MINAR1;PRKCB
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4723220632722662,-0.8154498040598592,0.8059701492537313,1.0,1.0,4/11,27.98%,VIL1;CFL1;CFL2;TWF2
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.4571344869760159,-0.8154117096129201,0.7014925373134329,1.0,1.0,7/12,25.08%,HHLA2;AGER;FADD;IL18;TNFSF9;RPS3;CD24
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.43745735926851625,0.8153737598680142,0.8125,1.0,1.0,4/11,19.14%,PARD3;DGKH;PLPP1;AZU1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.48601500168240036,-0.8153645084899791,0.7931034482758621,1.0,1.0,3/9,34.55%,GNL3;MUL1;PIAS3
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.43390449267431397,0.815350605754954,0.71875,1.0,1.0,5/11,25.95%,MALT1;CHI3L1;CARD10;TRAF6;MAP3K7
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.45450174232087703,-0.815198264000795,0.6944444444444444,1.0,1.0,1/11,4.22%,LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.5523669658924454,-0.8149275371741794,0.7619047619047619,1.0,1.0,1/5,4.21%,CD74
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.47353891166335016,-0.8148572964569157,0.7222222222222222,1.0,1.0,1/11,4.62%,COASY
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.47353891166335016,-0.8148572964569157,0.7222222222222222,1.0,1.0,1/11,4.62%,COASY
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.47353891166335016,-0.8148572964569157,0.7222222222222222,1.0,1.0,1/11,4.62%,COASY
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.32439839963444345,0.814511863251958,0.8378378378378378,1.0,1.0,10/56,14.46%,METTL8;THADA;MTERF4;LCMT2;TRDMT1;FBLL1;TRMT61A;TYW3;ZC3H13;TRMT61B
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4133634993207934,0.8140677918811942,0.6956521739130435,1.0,1.0,2/14,6.07%,BACH2;JAG1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.30647149135441504,0.8139739579839074,0.7777777777777778,1.0,1.0,14/94,11.28%,FAM216B;PTPRT;CROCC;CFAP70;SAXO2;MYO16;DNAH6;SPAG6;DYNLRB2;TMEM232;MYB;CFAP43;LRRIQ1;RFX2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.32677072481750746,0.8139567642696626,0.76,1.0,1.0,8/77,5.28%,ADAMTS2;COL15A1;TGFBR1;LAMB3;TGFB2;GREM1;ADAMTS3;COL11A2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36611590085157336,0.8139209746015004,0.6538461538461539,1.0,1.0,4/24,11.89%,SAMSN1;PRKCD;PTPN6;PIBF1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.5352921628025952,-0.8136822126169136,0.7183098591549296,1.0,1.0,4/6,39.33%,PLN;ATP2A2;SLC8B1;TRDN
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3348843713994772,0.8134999755667454,0.6666666666666666,1.0,1.0,16/68,15.47%,RGS14;BMP7;LATS1;SPRY3;HEG1;PRKCD;APOE;STK38;SLC8A3;TFAP4;SLC8A1;SIRT1;SORL1;PKIA;LRP6;MYOCD
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.3587713447424674,0.8134741027720759,0.6578947368421053,1.0,1.0,7/35,13.63%,ZDHHC14;NAT9;ZDHHC3;ZDHHC5;FOXO1;ZDHHC2;EP300
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.3927503423845527,-0.8132647536524955,0.6901408450704225,1.0,1.0,2/18,11.56%,NODAL;REST
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.31819396318108706,-0.8131082998293183,0.9027777777777778,1.0,1.0,28/196,19.99%,HSF2BP;POLR3K;RREB1;GCM2;TBP;ABT1;NCBP2;ZBTB7B;TBPL2;NFE2L3;TAF7;COPS2;TBPL1;POLR2J;TAF6;POLR2K;NCBP1;RNPS1;TTF1;DEK;SUPT5H;TCEA2;GTF3C6;RTF1;BTF3;GTF3C4;RNMT;CREBL2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4456724447514941,0.8131081740654404,0.8518518518518519,1.0,1.0,3/11,11.50%,BCL2L11;ATF6;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4238369338936512,0.8130097259938478,0.6857142857142857,1.0,1.0,3/14,7.88%,NRP1;MDK;IGF1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.4824850532901361,0.8129604289841026,0.75,1.0,1.0,1/6,1.76%,PDE10A
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.5273758458191535,-0.8129152230402283,0.7575757575757576,1.0,1.0,1/5,18.28%,EIF2B5
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3898009522283465,-0.8126323159245498,0.6984126984126984,1.0,1.0,8/47,23.87%,TCP1;CCT6A;CCT8;DCP2;NAT10;CCT7;PKIB;CCT2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.49797858280452634,-0.8126152977767018,0.7413793103448276,1.0,1.0,2/8,10.96%,TAF7;SPI1
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.4700794766607217,0.812407413517102,0.7142857142857143,1.0,1.0,4/9,22.58%,TGFBR1;ID2;MYT1L;ASCL1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.3929623719051865,-0.8122755808698684,0.7727272727272727,1.0,1.0,4/34,9.45%,KCNE2;SCN4B;KCNQ1;CTNNA3
prerank,MSigDB_Hallmark_2020__Androgen Response,0.3077878781984846,0.8122102678630949,0.7692307692307693,1.0,1.0,16/95,16.47%,SGK1;HOMER2;IQGAP2;PMEPA1;CDC14B;ARID5B;TPD52;ABCC4;ANKH;GUCY1A1;ZBTB10;GNAI3;HERC3;NDRG1;GPD1L;ALDH1A3
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4329441601968564,-0.8121530131719733,0.7428571428571429,1.0,1.0,5/21,20.22%,FKBP1B;DRD3;CALM3;KCNE3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.35897493716037693,-0.8120753123512897,0.8051948051948052,1.0,1.0,5/74,11.01%,KCNE2;ARIH2;NKD2;DAB2IP;DDA1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.4362644920988087,0.8119567439327201,0.6666666666666666,1.0,1.0,2/12,5.73%,BMP7;NR3C2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.3488400054884929,-0.8118484714089674,0.8076923076923077,1.0,1.0,14/75,17.94%,CCNE1;CDKN2D;CDKN3;CRLF3;BACH1;SPDYA;CDC6;INHBA;CDC25A;PCNA;KLF11;CDKN1B;GPR132;CDK5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.29635858446689073,0.8115520554291079,0.9259259259259259,1.0,1.0,14/87,16.86%,NEDD1;PCM1;RAB3IP;RPGRIP1L;CEP135;CEP83;SCLT1;CDK5RAP2;MAPRE1;DYNC1I2;ALMS1;KIF24;B9D2;B9D1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.4333889162726017,0.8113527272969278,0.8285714285714286,1.0,1.0,4/16,11.93%,SULF2;DSCAML1;PDGFRA;RBP4
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.3653027420381695,0.8111647241088341,0.75,1.0,1.0,2/30,2.40%,NKAIN3;PKP2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.30568336392158796,0.8108090341057084,1.0,1.0,1.0,14/153,9.54%,CCNH;MAML3;TEAD2;RORA;WWTR1;HDAC9;ESRRG;MAML1;NR3C2;TAF2;HDAC1;ERCC2;HDAC10;TAF12
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.38734799740206716,0.8107757020527879,0.7096774193548387,1.0,1.0,5/17,16.38%,RNF2;RYBP;PCGF1;PCGF6;RING1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.3843462553697915,0.810733753273582,0.6428571428571429,1.0,1.0,9/17,24.48%,TMTC2;CRPPA;DPM3;TMTC1;FKTN;DPM2;LARGE1;DPM1;FKRP
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.44818215844962034,0.8103291282773306,0.6410256410256411,1.0,1.0,3/8,16.45%,HSPA1A;SORL1;DNAJB2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.44975084663419274,0.8102141933388723,0.7352941176470589,1.0,1.0,4/7,36.99%,CPEB2;CPEB4;UNK;CPEB3
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.40179763109490063,-0.8101643249330155,0.6964285714285714,1.0,1.0,7/24,22.41%,PIGC;MPPE1;PIGH;PIGO;PGAP4;GPLD1;PGAP3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.3837370212321309,-0.8101579284267734,0.7741935483870968,1.0,1.0,4/28,10.07%,MYLK;DUOX1;SERPINE1;CLDN1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.33060055553263523,-0.8100338824698127,0.8076923076923077,1.0,1.0,16/91,14.88%,CASP12;NODAL;MTCH1;CARD8;KHDC1;RPS27L;BCAP31;CASP8;REST;HIP1R;FADD;GPER1;BOK;ATP2A3;BEX3;CYCS
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.35494681641193465,0.8100057393596143,0.71875,1.0,1.0,1/33,0.60%,CCNH
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.34893077976407505,0.8096516565266353,0.8518518518518519,1.0,1.0,10/57,14.33%,VWC2L;VWC2;GREM1;CRIM1;SMAD2;TWSG1;ELAPOR2;FBXL15;SORL1;NUMA1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.4453699981577427,-0.8095482117643975,0.7142857142857143,1.0,1.0,3/18,16.06%,NCBP2;NCBP1;SUPT5H
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3697814625808845,0.8091471356966721,0.6923076923076923,1.0,1.0,11/29,23.31%,PARD3;LRRC7;LIN7A;PARD3B;DLG2;OPHN1;MTCL1;MYO9A;DLG3;MARK2;RAP2A
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.5077983096090426,-0.8091330062734049,0.7014925373134329,1.0,1.0,2/5,42.60%,CSNK1A1;AMER1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.30427952947180287,-0.8088983477732999,0.9047619047619048,1.0,1.0,35/253,15.34%,PTGIS;PNMA5;CYP1B1;PNMA2;GADD45B;SFRP4;MOAP1;DDX20;BNIP3;MTCH1;PXT1;RASGRF2;CASP8;DAB2IP;VAV3;PPID;DNAJA1;TFPT;REST;APH1B;HIP1R;GADD45A;CDK5R1;STK17A;HRK;FADD;ITGB3BP;SIAH1;GPER1;BOK;PREX1;RNPS1;KLF11;SUDS3;FGD3
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.476208758243365,0.8087075980750039,0.6818181818181818,1.0,1.0,2/8,8.51%,MDK;PKHD1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.3387320841781584,-0.8085203125246918,0.8157894736842105,1.0,1.0,16/102,13.94%,C3AR1;CALB1;CALCB;P2RY1;FKBP1B;CAV3;DRD3;PTGER3;SCGN;BCAP31;CALCR;ADRA1D;TBXA2R;GPER1;CHRNA9;CXCL13
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.4345306837886407,-0.8084219166473636,0.6666666666666666,1.0,1.0,2/13,7.86%,GM2A;GBA3
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.43218163615334965,0.8083525860768633,0.6363636363636364,1.0,1.0,3/19,6.58%,F2RL1;TRIB2;HMGB1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.35566794544713465,0.8082759878838839,0.7419354838709677,1.0,1.0,12/47,15.28%,PID1;PER2;SDF4;CTBP2;FOXO1;HMGA2;SIRT1;OSBPL11;EP300;AKT2;NR4A2;BBS9
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.3641454082549231,-0.8081962377799196,0.7571428571428571,1.0,1.0,7/35,16.59%,TRPV6;PTPRC;SLC24A1;TRPV3;HTR2B;ERO1A;PLCG2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.38726801409143685,0.8081794006143139,0.7142857142857143,1.0,1.0,4/25,10.76%,CDC26;CDC23;UBE2E2;UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.4124808911186922,0.8079307519965885,0.7,1.0,1.0,4/10,21.82%,SCARB1;PLIN5;NR1H3;LDLR
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.31090473194133483,0.807671426300862,0.8918918918918919,1.0,1.0,3/71,1.12%,IFI16;LEF1;CARD18
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3550323921341894,-0.8076609256976246,0.7536231884057971,1.0,1.0,9/59,22.07%,ABITRAM;RAC1;TBC1D13;ODAD3;PODXL;TBC1D24;WAS;ATG3;FXR1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4006310136460045,-0.8075713756996121,0.71875,1.0,1.0,4/23,20.27%,RAC1;VIL1;WAS;ACTG1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.41559292981385265,-0.8073287099760453,0.7323943661971831,1.0,1.0,3/23,5.00%,IHO1;STAG3;RNF212B
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.47339627991448685,0.8071386304488063,0.75,1.0,1.0,2/6,16.72%,SLC25A29;SLC16A10
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.35421613435722094,-0.8070109596911402,0.6962025316455697,1.0,1.0,2/64,5.37%,F8;LMAN1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.30221345269458705,-0.8067404008077508,0.8571428571428571,1.0,1.0,42/256,23.56%,FIP1L1;DDX20;SYF2;CSTF2T;GEMIN4;DDX39A;NONO;NCBP2;SLU7;UBL5;SNRPD2;PCBP1;ZMAT2;PPWD1;FRG1;POLR2J;POLR2K;PRPF19;BUD13;NCBP1;SNRNP48;RNPS1;CDC40;DDX1;RBM4B;ALYREF;HNRNPA0;USP39;CWC25;RBM4;CRNKL1;MFAP1;UPF3B;SRPK1;SF3B2;DHX38;CLP1;DHX16;LSM4;POLR2I;POLR2B;BUD31
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.46984864210921606,0.8067033738477322,0.7317073170731707,1.0,1.0,2/6,8.90%,PRKCD;PRKD1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3122979193832007,-0.8065989525919134,0.821917808219178,1.0,1.0,32/140,26.66%,ING2;TPX2;RFC5;TBP;RPA3;TAF7;MRE11;CDK5R1;TAF6;CHEK1;RPL5;BRCA1;RPS20;RAD9B;DAXX;RPL37;RMI1;CDK5;RAD1;RPS15;RPF2;PRKAB2;RNF34;RPL23;PRDM1;KAT5;AKT1;TAF5;RBBP8;SETD9;BLM;CHD4
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.4200564780031006,-0.806204940580869,0.7727272727272727,1.0,1.0,1/19,0.60%,SLC12A7
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.38875072412831146,-0.8051992475672696,0.7727272727272727,1.0,1.0,9/24,24.74%,AGT;HIP1R;GPER1;ADAM17;TGFA;SHKBP1;PLAUR;BCAR3;AKT1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.4773960285527444,0.805168064940399,0.6428571428571429,1.0,1.0,2/7,16.60%,FOXO1;RFX3
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.48921400176810237,0.8050991393270035,0.6756756756756757,1.0,1.0,2/6,4.19%,BMP7;GCH1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.386631798304,-0.805008678004362,0.7837837837837838,1.0,1.0,13/27,29.96%,HSPA5;HSPA1L;ERO1A;SDF2L1;DNAJB1;ST13;HSPA9;CCT2;ENTPD5;GAK;HSPA2;HSPA8;HSPA13
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4124499183603983,-0.8048412456888916,0.7580645161290323,1.0,1.0,4/24,12.27%,CAV3;RAC1;DCTN1;CDK5R1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.35011050942574745,-0.8048349485858382,0.8450704225352113,1.0,1.0,29/72,34.83%,PSMB6;PSMB8;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2;RPS27A;ANAPC2;UBC;PSMD2;UBE2S;PSMA1;PSMD8;PSMC4;PSMC1;BUB1B;ANAPC15;UBA52;PSMB4;PSMD3;ANAPC11;UBB;PSMD7;PSMD4;PSMA8
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.3293347009362924,-0.8047292155149719,0.8333333333333334,1.0,1.0,17/92,22.57%,FIP1L1;NXT1;DDX39A;NCBP2;SLU7;FYTTD1;SLBP;NUP85;NCBP1;RNPS1;CDC40;ALYREF;NUP155;UPF3B;DHX38;NUP188;THOC5
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5216119779340306,-0.8041813760185477,0.7936507936507936,1.0,1.0,3/7,25.37%,OTUB1;GPS2;PLAA
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.4663365282916659,0.804103655887398,0.6857142857142857,1.0,1.0,3/12,7.42%,SERTAD2;ARID1B;ARID1A
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.4793384878624637,-0.8040342819019872,0.703125,1.0,1.0,4/7,39.23%,KCNJ11;ABCC9;CACNA1H;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.5086429288667561,-0.8040085193487452,0.7413793103448276,1.0,1.0,3/5,45.71%,RPS6KA4;FMR1;MAPK3
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.49175228014557804,0.8037531381269413,0.7073170731707317,1.0,1.0,2/6,6.71%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.4241822242014123,0.8037038217114847,0.6744186046511628,1.0,1.0,2/11,10.46%,APOE;PC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.4864346793311632,-0.803584145824367,0.7121212121212122,1.0,1.0,1/8,8.64%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.5261594741768973,0.8031459815171369,0.8181818181818182,1.0,1.0,2/6,11.15%,VAMP8;SPHK2
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.5011014645759979,-0.8031379017740762,0.7540983606557377,1.0,1.0,3/7,24.53%,GTF3C6;GTF3C4;GTF3C3
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.3579254777074929,-0.8031318075767867,0.7878787878787878,1.0,1.0,2/37,6.06%,CYP1B1;GLRX2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.3465412416090714,0.8030194953835077,0.717948717948718,1.0,1.0,2/43,3.09%,SOX13;BMP7
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.4137697021782749,0.8028700693587548,0.7096774193548387,1.0,1.0,2/20,8.90%,SLC30A10;MT1E
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.45830236952411546,0.8025968353703488,0.6842105263157895,1.0,1.0,3/11,17.55%,SLC22A13;EP300;GCK
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.42490253921496784,-0.8024879895410084,0.8059701492537313,1.0,1.0,2/21,1.66%,RDH10;CYP1B1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.4753969233583841,-0.8023442275364273,0.6515151515151515,1.0,1.0,3/11,18.53%,DOCK2;PLCG2;LBP
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.45982194399024523,-0.8022337352580273,0.7241379310344828,1.0,1.0,1/11,12.65%,BTBD18
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.47029095079089617,0.8021190783905716,0.6923076923076923,1.0,1.0,2/5,19.16%,PTPN23;PTPRR
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3272183722649807,-0.8020483677036595,0.8831168831168831,1.0,1.0,17/105,13.19%,PPP1R1B;LAMA2;EPAS1;TIMP3;ARVCF;ENC1;ANGPTL2;ALDH2;IGFBP5;ADGRF5;PLSCR4;RGS5;DRAM1;DOCK1;SLC14A2;SERPING1;SPARCL1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.32638612380798443,0.8017777049753512,0.9032258064516129,1.0,1.0,14/65,18.24%,ZBTB20;NUP210;NUP42;IGF1;TPR;SLC4A4;NUP37;PFKFB3;EP300;JMJD8;AAAS;ZBTB7A;GCK;PPARA
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4609169292466798,-0.8012863688918379,0.7419354838709677,1.0,1.0,7/11,37.13%,LAMP1;AP4M1;GAK;RBSN;ANKFY1;AP1G1;LAPTM5
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.4401193126904393,0.8012560177181622,0.7142857142857143,1.0,1.0,4/9,27.35%,PIK3AP1;IRAK2;TRAF6;EPG5
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.29013913486928733,0.8009314247166152,0.9545454545454546,1.0,1.0,16/109,14.17%,HSPB1;EGFR;NRP1;BMP7;DSCAM;NUP210;GRM5;NUP42;TPR;EREG;NUP37;SIRT2;SIRT1;PRKRIP1;EP300;FER
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.4025262174466716,-0.8006349010850652,0.7794117647058824,1.0,1.0,6/19,22.89%,RAC1;NCKAP1L;RHOU;RHOH;NEFH;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.47239792695883925,-0.8005812033722727,0.8,1.0,1.0,1/14,3.80%,AGT
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3041675884660946,0.8005572978128387,0.8636363636363636,1.0,1.0,4/75,3.10%,NEDD1;HMMR;KCNH5;PCM1
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),-0.5492977383147815,-0.8005151757858598,0.7833333333333333,1.0,1.0,3/5,13.81%,NOTCH1;TBX1;LRP2
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.46465226606174925,0.7996699458517658,0.6666666666666666,1.0,1.0,4/7,15.75%,CIDEA;PLIN5;OSBPL11;FITM2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.4098993200941113,-0.7996688861927592,0.7230769230769231,1.0,1.0,6/22,21.01%,H1-0;TGFB1;TXN;TWIST1;PLAUR;PYHIN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.4420604918246448,0.7995559296242516,0.72,1.0,1.0,1/6,4.04%,ZBED3
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.2566378657515817,0.7994212064754618,1.0,1.0,1.0,20/206,12.03%,ATP6V0D2;IFI16;HSPB1;BCL2;LEPR;WDR24;OSBPL7;HMGB1;TICAM1;MTMR8;VPS26B;DAP;PRKD1;ATF6;MID2;PIP4K2A;TAB3;MAPK8;MTMR9;SIRT2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3308257231285199,0.7993672478551346,0.7096774193548387,1.0,1.0,6/35,13.92%,UNC13B;ZBTB20;PIK3R1;FOXO1;SIRT1;FOXK1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.30881953087230285,-0.7990767176615707,0.8767123287671232,1.0,1.0,21/127,21.68%,ARIH2;PINK1;CEMIP;TGFB1;UBL5;CASP8;ZIC1;TOMM7;TMEM30A;KIF20B;RIPOR1;HSPA1L;NMT1;YWHAB;TCAF2;YWHAG;AKAP5;YWHAH;RHOU;MIEF1;PDZK1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.4086277361123057,0.7990536772754832,0.7894736842105263,1.0,1.0,1/15,2.17%,C5AR1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.4761434234201072,-0.7989973529529143,0.7636363636363637,1.0,1.0,2/9,12.93%,ABCB4;TMEM30A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.3850690995555557,0.7988893251994674,0.725,1.0,1.0,2/13,5.71%,HOMER2;NAV3
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.4399535632260438,-0.79868647152062,0.75,1.0,1.0,1/11,6.16%,WIPI1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.4701391906037443,-0.7986629261036637,0.7428571428571429,1.0,1.0,1/9,12.41%,GFPT2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.43677986884832815,-0.7986320027818687,0.734375,1.0,1.0,3/12,12.08%,HCK;TBX1;MEST
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.3409684244856255,-0.7985461202398744,0.8309859154929577,1.0,1.0,22/96,20.65%,F8;TIMP3;RARRES2;SERPINE1;TGFB1;ANXA5;CDC37L1;ITIH4;TTN;TMSB4X;FAM3C;SERPING1;MAGED2;A2M;GTPBP2;PSAP;SYTL4;TUBA4A;KNG1;CALM1;CD9;LAMP2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.41326208939005,-0.7979674004395915,0.7058823529411765,1.0,1.0,3/18,9.77%,WFS1;BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.37288394514686807,0.797920967532307,0.7586206896551724,1.0,1.0,8/28,17.38%,LEF1;HDAC1;TFAP4;HMGA2;EP300;RRP1B;SMARCA4;SMARCB1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.3903568946326479,0.7977267354308755,0.6410256410256411,1.0,1.0,4/14,21.52%,IGBP1;MTMR9;MTMR3;SMG6
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.48184635319299646,-0.7974830051525004,0.7692307692307693,1.0,1.0,2/9,14.96%,APOD;NDRG4
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.4016362123741261,-0.7974419410622258,0.75,1.0,1.0,8/24,20.52%,STAT1;STAT5A;STAT4;AGER;CALCR;EIF2B2;EIF2B5;STAT2
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4244572114802026,-0.7973031160891242,0.7288135593220338,1.0,1.0,5/16,27.79%,AGT;SIX4;PIK3CD;SMO;GJA1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.3705200090378816,0.7971670665097569,0.7027027027027027,1.0,1.0,6/20,16.47%,DSCAML1;ACVR1;PDGFRA;RBP4;ID2;ALDH1A3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.43964558593468805,-0.7968728022066781,0.7586206896551724,1.0,1.0,5/11,34.52%,HPF1;PARG;PARK7;AKAP8L;NNMT
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.4502674644515326,0.79675891746156,0.7272727272727273,1.0,1.0,1/7,2.27%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.39007668949136615,0.7967276655848631,0.7575757575757576,1.0,1.0,3/25,8.26%,CIDEA;IGF1;PTPN6
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.4007933208868548,0.7967086380809147,0.7619047619047619,1.0,1.0,5/16,14.10%,BMP7;HEY1;CNTN4;DISP3;DTX1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.43794542417234467,-0.7966541855966359,0.7796610169491526,1.0,1.0,3/16,7.84%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.3203754727953308,0.7966154449757964,0.75,1.0,1.0,15/113,7.31%,SLC12A3;KCNJ16;KCNH5;KCNJ6;KCNB2;SLC12A1;KCND2;LRRC55;KCNJ3;KCNN3;KCNN2;KCNJ2;HCN1;KCNK7;KCNQ5
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.4204169126093839,0.7965230257356043,0.8285714285714286,1.0,1.0,1/16,0.48%,KIT
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.34030444270456883,0.7961259860649997,0.9259259259259259,1.0,1.0,5/39,13.59%,SVEP1;LAMB3;HDAC1;LAMA3;CERS3
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.49578153839236905,0.796068364911764,0.7428571428571429,1.0,1.0,4/6,23.08%,BSN;PCLO;ERC2;ERC1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.47040156919541914,-0.7958657781786599,0.6935483870967742,1.0,1.0,2/11,19.00%,CLDN1;SUPV3L1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.3623073090521691,0.7954486768586205,0.825,1.0,1.0,6/21,22.40%,PPP6R1;MTMR9;CHP1;PPP1R35;BMP2;URI1
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.5209641824000485,0.7951746197657252,0.825,1.0,1.0,1/5,9.95%,TSPAN12
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.37720073326393755,0.7949290301289769,0.6944444444444444,1.0,1.0,2/15,7.36%,ITGA4;AKR1C3
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.3657769573832228,0.7948636208674514,0.7777777777777778,1.0,1.0,5/22,6.57%,TGFBR1;WWOX;FGFR3;DSCAML1;PDGFRA
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.33714749575056135,-0.7947395465102624,0.875,1.0,1.0,14/95,13.19%,SLC12A7;CHRNB1;TRPA1;CNGB3;PLP2;SLC26A4;SLC24A1;SLC9A6;SLC17A8;SLC24A5;KCNN4;SLC36A1;MCOLN1;CNGB1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.41617572049562773,0.7946734536561285,0.7804878048780488,1.0,1.0,4/12,8.56%,SLC16A12;SLC6A13;SLC19A1;PDPN
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.40422386768434115,0.7945902292337299,0.5952380952380952,1.0,1.0,3/10,6.11%,MARCHF5;VASH1;NEK6
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.47933522993593813,0.7945633235251297,0.7647058823529411,1.0,1.0,2/8,13.53%,PDGFRA;ID2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.34859349102824155,-0.794502657612819,0.7733333333333333,1.0,1.0,21/68,29.86%,FRRS1;CP;ATP6AP1;NUBP1;SKP1;HEPH;ISCU;SLC11A1;ATOX1;ARF1;FTH1;ATP6V1G1;SLC30A8;MT1G;ATP6V1A;SLC30A5;SLC39A6;SLC31A1;ABCG2;SLC39A12;SOD1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.4318016753282117,-0.7944842303689161,0.7058823529411765,1.0,1.0,2/13,20.68%,ULK1;SCTR
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3582605594326515,-0.794299649930189,0.8732394366197183,1.0,1.0,9/44,15.58%,ATP5IF1;PINK1;NKD2;CASP8;RCN3;FADD;TRIM32;CCBE1;CTSH
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.4379139151586247,-0.7941030026074801,0.7884615384615384,1.0,1.0,3/18,7.84%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.48470045343581425,-0.7937796663575356,0.8125,1.0,1.0,2/7,16.71%,RCN3;WNT7B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.33039241879347103,-0.7935749078970213,0.8805970149253731,1.0,1.0,26/94,25.93%,AGT;RPS27L;TGFB1;CASP8;INHBA;MSN;FADD;TRIM32;VPS35;RPL5;EEF2;NFKBIA;EIF6;PLA2G10;NAT10;NIBAN1;UPF3B;RPS4X;FXR1;YTHDF1;UHRF1;WNT7A;AKT1;BAK1;METTL3;ASPSCR1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.45463504021582685,-0.7934784397960906,0.746268656716418,1.0,1.0,4/13,22.13%,PINK1;COX7A2L;COX7A2;AK4
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.48933530549181653,0.7934764591964574,0.7105263157894737,1.0,1.0,5/6,36.00%,ATP10A;SH3GLB1;PLEKHM2;DNM2;ASAP1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.4669119207913605,0.7934529855587639,0.7073170731707317,1.0,1.0,1/6,3.64%,BMP6
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.44598495473330113,0.7931891132438834,0.7567567567567568,1.0,1.0,1/8,4.12%,CEP85
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.37533458703568523,0.7930192320043562,0.7692307692307693,1.0,1.0,4/19,9.90%,KDR;MCU;MARCHF5;RALA
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.45482024308929303,0.7928770246213998,0.7027027027027027,1.0,1.0,3/7,14.01%,SORL1;ZDHHC2;EIPR1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.45811399264745234,-0.7926090359303419,0.7868852459016393,1.0,1.0,2/11,16.40%,TTLL4;TPGS1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.28716539661511076,0.7925646200293692,1.0,1.0,1.0,25/121,13.81%,IRS1;ZBTB20;PRR5L;HMGB1;PRKCD;TICAM1;LIN28B;IGF1;APOE;IRS2;PRKD1;FAF1;ATF6;MID2;SLC4A4;KHSRP;PNPLA2;ABCD2;FOXO1;PLIN5;VGLL4;PFKFB3;RC3H1;AKT2;PNPT1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.5046237626137036,-0.7925491609574864,0.765625,1.0,1.0,2/8,18.46%,SUV39H1;H3-3A
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4067862850424214,-0.7925403751838392,0.7777777777777778,1.0,1.0,3/19,18.64%,USP21;ATXN7L3;EPOP
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.39243994147688144,0.7925197397995509,0.8518518518518519,1.0,1.0,1/23,2.19%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.45181962513983864,-0.7924307326045352,0.7777777777777778,1.0,1.0,3/13,7.84%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.45181962513983864,-0.7924307326045352,0.7777777777777778,1.0,1.0,3/13,7.84%,CD74;RAC1;NCKAP1L
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.44338463210120943,-0.7915281765783995,0.7,1.0,1.0,1/10,1.32%,LRP4
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.32306251645196404,-0.7914920918948287,0.8108108108108109,1.0,1.0,22/95,24.90%,PEX11B;ABCB1;SOD2;ABCB4;PRDX1;ALDH1A1;ECI2;HSD11B2;SIAH1;SLC25A4;ACSL5;RETSAT;PEX5;ESR2;YWHAH;HSD17B11;SLC25A19;MVP;CRABP2;ACOX1;CTBP1;ISOC1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.502674420149139,-0.7914369689395913,0.7846153846153846,1.0,1.0,3/5,35.39%,DNM1L;ARMC1;LRRK2
prerank,MSigDB_Hallmark_2020__Complement,-0.30175958142099507,-0.7914017087774704,0.88,1.0,1.0,31/147,20.81%,F8;C4BPB;MMP15;CP;TIMP2;SERPINE1;IRF1;PPP4C;HSPA5;CCL5;F10;PHEX;ANXA5;CALM3;ERAP2;L3MBTL4;CDK5R1;SERPING1;NOTCH4;HPCAL4;CTSH;CPM;USP14;ADAM9;ATOX1;C1QA;RABIF;WAS;CALM1;LAMP2;PLAUR
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.4056491538182385,0.7912650895928575,0.7,1.0,1.0,1/12,2.27%,NRP1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.4681532748985904,-0.7912259056966731,0.6842105263157895,1.0,1.0,2/11,5.14%,MOAP1;BNIP3
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.4188278171121298,0.7911878646869298,0.7631578947368421,1.0,1.0,2/13,4.18%,NFIB;TGFB2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.445537310295381,0.7911719755465046,0.782608695652174,1.0,1.0,3/11,8.80%,COBL;PTCH1;SMAD2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.3352595937305007,-0.7910784756961317,0.8082191780821918,1.0,1.0,14/82,16.40%,CYP1B1;HIC1;HINT1;BCL2L2;CHAC1;MOAP1;BNIP3;IFI6;DAB2IP;BOK;ATP2A3;BRCA1;CIDEB;ERO1A
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.33212971260077406,-0.7909093316770441,0.8205128205128205,1.0,1.0,19/97,15.21%,MSX1;EMILIN2;TMEM184A;LIPH;ITGA5;KLF5;MYO5B;PRG4;GPX2;AGER;CBLC;CLDN1;B3GNT3;TMC4;CRYBA1;KIF20B;BOK;BRCA1;STAP2
prerank,PanglaoDB_Augmented_2021__Neurons,0.26195805327567157,0.7904371608453816,1.0,1.0,1.0,48/265,13.47%,LUZP2;DGKB;LRRTM3;GRIA4;RAB3C;RORA;CACNA2D1;CTNNA2;LHFPL4;ADGRA1;PPP1R14C;OLFM3;B3GAT2;RGS7BP;GRIA2;GRM5;UNC79;CBARP;MMD2;BRINP1;NRXN1;CADM2;IGF1;TMEM196;CTTNBP2;PCSK2;CSRNP3;RBFOX1;PAK5;GNL3L;DLGAP1;RHBDD2;SFSWAP;RASGRF1;ADGRB3;SGIP1;ZMYND11;GNAI1;NOL4;ST8SIA3;ELAVL3;GPATCH8;PPFIA2;ZCCHC7;PNISR;CHODL;FAM181B;NXPH1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.35319749909551545,0.7903986061853863,0.75,1.0,1.0,9/23,21.44%,AUTS2;TET1;MYB;SIRT1;PHF1;DNMT1;CHTOP;CTNNB1;DNMT3B
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.4604221235726263,-0.7903352179468682,0.746268656716418,1.0,1.0,3/13,22.82%,DIS3L;EXOSC6;EXOSC8
prerank,MSigDB_Hallmark_2020__Apical Junction,0.26868303731772547,0.7903335940370864,1.0,1.0,1.0,28/158,16.45%,CDH6;IRS1;EGFR;VCAN;NECTIN3;LAMB3;AMIGO1;RSU1;MPZL1;MDK;MAP3K20;CADM2;NRTN;CNTN1;CDK8;GNAI1;ACTN4;LAMA3;ADRA1B;ITGA10;AKT2;ICAM5;TRAF1;PARVA;CDH1;TIAL1;VCL;CDH4
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.4518958120607966,-0.7902705524302688,0.7534246575342466,1.0,1.0,2/9,5.51%,FBLN5;PINK1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.35361616673867596,-0.7901580696175283,0.8412698412698413,1.0,1.0,3/61,3.85%,MMP26;PTGIS;ELANE
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.3592097010059473,0.7899795989502378,0.7714285714285715,1.0,1.0,5/25,16.32%,GREM1;CRIM1;PTCH1;RANBP3L;GDF10
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3376362863591388,0.7897359571116602,0.7692307692307693,1.0,1.0,11/54,17.87%,TGFBR1;ACVR1;PRKCD;SBK1;PRKD1;MAPK8;MAP3K10;CDC42BPB;DYRK3;OXSR1;CIT
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.41949229341739286,0.7897286199385289,0.7391304347826086,1.0,1.0,3/13,18.72%,NGF;FRS2;DDIT4
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.48911934098974147,-0.7893645195158239,0.7741935483870968,1.0,1.0,1/6,19.20%,RBX1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.45712300223777574,0.7893490173716837,0.7222222222222222,1.0,1.0,3/11,7.35%,TGFBR1;BMP6;TGFB3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.38011894887845776,0.789285023360987,0.8125,1.0,1.0,1/25,0.51%,TBX6
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.4225338723807171,-0.7891122157381766,0.7704918032786885,1.0,1.0,5/16,14.96%,SERPINE1;CCL5;IGFBP5;PDGFRB;NDRG4
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.4804431524035443,-0.7883801963577717,0.7794117647058824,1.0,1.0,3/8,24.53%,GTF3C6;GTF3C4;GTF3C3
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3302089112451724,0.788207543275969,0.8108108108108109,1.0,1.0,6/43,11.01%,NRP1;IL1RAPL1;FBXW8;MDK;CASS4;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4005045208404541,-0.7881982584521672,0.8,1.0,1.0,3/22,10.25%,FKBP1B;DRD3;CALM3
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.4290860436140881,-0.7878930132850105,0.7285714285714285,1.0,1.0,3/17,10.34%,SMIM22;HSD17B13;PPID
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.43700554309215595,0.7876907597908946,0.7142857142857143,1.0,1.0,1/9,2.19%,EGFR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.4856146407221664,-0.7872763255583449,0.7962962962962963,1.0,1.0,1/9,5.59%,AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.4856146407221664,-0.7872763255583449,0.7962962962962963,1.0,1.0,1/9,5.59%,AHR
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.5032098104572627,0.7872733832794319,0.7435897435897436,1.0,1.0,1/6,13.90%,PHF1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.4562800373581647,-0.7871190253997197,0.7540983606557377,1.0,1.0,2/8,18.06%,DAB2IP;PIP4K2C
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3659440479417699,0.7867147120326188,0.7428571428571429,1.0,1.0,4/26,7.36%,KIT;KITLG;TGFB2;AKR1C3
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.349702765641645,0.7865673926655093,0.8333333333333334,1.0,1.0,4/31,8.73%,UNC5C;SEMA6D;SEMA4C;EPHA7
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.33101574717257226,0.7862386104636745,0.9285714285714286,1.0,1.0,12/58,13.92%,PTPN3;BCL2;LEPR;MTMR8;DAP;NELL1;TAB3;MTMR9;SIRT2;PLIN5;SORL1;FOXK1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.325771287881988,-0.78616479092667,0.8732394366197183,1.0,1.0,13/81,16.40%,TXNRD2;PINK1;SOD2;NOX1;PRDX1;GPX2;LRRC8D;FANCC;NOX5;GSTP1;CYCS;G6PD;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.38404112449463934,-0.7861202161775821,0.765625,1.0,1.0,9/31,22.08%,STAT1;CARD8;CASP8;DAB2IP;GSTP1;ESR1;PER1;RHOH;CARD19
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.36194065248338325,-0.785702594293443,0.7258064516129032,1.0,1.0,9/38,26.70%,POLR2J;POLR2K;TRIM32;SUPT5H;TRIM14;POLR2I;POLR2B;CTDP1;POLR2D
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.3441237873927761,0.7856754695158674,0.8,1.0,1.0,3/24,9.43%,NRP1;SEMA5A;AUTS2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.4510867279032055,0.7856502478224183,0.6904761904761905,1.0,1.0,2/6,10.15%,CTNNA2;GRID2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3453174847044079,-0.7856192421622498,0.8714285714285714,1.0,1.0,13/70,13.42%,RXFP1;MC4R;CALCB;GPR26;DRD3;PTGER3;CALCR;ADRA1D;TBXA2R;TSHR;ADGRB1;ADRB1;GPER1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.37963055824365716,-0.7855006481160961,0.7681159420289855,1.0,1.0,5/26,18.11%,CAMLG;UCHL5;SVIP;MAP1A;USP14
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.5089687788964442,-0.7854954033769717,0.8305084745762712,1.0,1.0,2/6,24.81%,G6PD;TKT
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.4717635532701617,-0.7853758544327212,0.8064516129032258,1.0,1.0,2/11,13.30%,TRIM5;TRIM32
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.40920851988756335,0.7853551914609832,0.7368421052631579,1.0,1.0,1/16,0.69%,IFI16
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.46738535943659654,0.7848599193679283,0.7105263157894737,1.0,1.0,3/7,28.43%,SETD1A;SETD4;KMT2C
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.3948625825297021,0.7847493686557641,0.6764705882352942,1.0,1.0,2/11,8.99%,ATF3;ATF6
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.43540142848570157,-0.7847148751459996,0.7818181818181819,1.0,1.0,2/17,10.65%,NCKAP1L;FMNL1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.31115931386895845,0.7846538041167502,0.8260869565217391,1.0,1.0,4/45,9.90%,RAB3C;IL1RAPL1;RAB27A;RALA
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.4811857167163986,-0.7845385448965028,0.796875,1.0,1.0,1/10,4.48%,CAV3
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3255358793560974,-0.7843171967429841,0.8589743589743589,1.0,1.0,15/88,22.45%,TRPV6;CPNE5;KCNMB1;CALM3;TTN;MCOLN1;SYT2;SYT4;NEUROD2;PLCG2;RASGRP2;ADAM9;CALM1;GPLD1;RYR3
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.4943031314468082,0.7843129354410272,0.7307692307692307,1.0,1.0,4/5,30.14%,KMT5B;BEND3;SETD4;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.4943031314468082,0.7843129354410272,0.7307692307692307,1.0,1.0,4/5,30.14%,KMT5B;BEND3;SETD4;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.3267842625908637,-0.7842810207960105,0.8208955223880597,1.0,1.0,12/74,13.42%,PEBP1;PTPRC;TIMP3;AGT;CAV3;FOXM1;CBLC;DAB2IP;CAMK2N1;PIK3CB;GSTP1;GPER1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.3658520720940786,-0.7836694568053815,0.8787878787878788,1.0,1.0,11/52,15.24%,BIK;MOAP1;BNIP3;PINK1;ZDHHC6;HIP1R;HRK;GPER1;BOK;VPS35;CIDEB
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.3176979358826257,-0.7836687804256491,0.8625,1.0,1.0,31/120,26.70%,DDX20;CELF3;GEMIN4;ABT1;RPS27L;RPL38;SNRPD2;RSL24D1;PRPF19;NCBP1;RPL5;DDX1;EIF6;RPL3;USP39;MCTS1;RPL24;EIF2S2;CRNKL1;RPS15;ERAL1;SRPK1;RPF2;CLP1;LSM4;TRAF7;EIF4H;RPS5;HSP90AB1;EIF5;POLR2D
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.37401625075788,0.7836610418449872,0.7631578947368421,1.0,1.0,5/18,21.59%,LATS1;TFAP4;MYOCD;PTEN;CDK5RAP1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.4313834267902875,-0.7836486986391443,0.8571428571428571,1.0,1.0,2/14,4.38%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.46063668970081373,-0.7832613100138965,0.6984126984126984,1.0,1.0,6/10,39.68%,TXN;PARK7;GPR37L1;LRRK2;STK26;PDE8A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3889603193492754,0.783195735248075,0.8108108108108109,1.0,1.0,1/21,4.20%,SAMD4A
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.3972632960930753,-0.7831759357315327,0.7746478873239436,1.0,1.0,6/21,27.19%,NUBP1;ISCU;HSPA9;NFS1;CIAO2A;ISCA2
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.49106086652907494,0.783154049543518,0.7575757575757576,1.0,1.0,3/6,30.70%,PTEN;CBLN1;MTMR2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.44260281063571544,0.7830856483443354,0.7931034482758621,1.0,1.0,5/11,24.40%,RYK;NR4A2;LRP6;CTNNB1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.4023887543693843,0.7829915977790138,0.7692307692307693,1.0,1.0,2/18,7.88%,CARD18;IGF1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.37012162339371213,-0.7826955498736482,0.8360655737704918,1.0,1.0,5/39,9.87%,NOTCH1;IL18R1;IL15;ALDH1A1;ACOT13
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.30963294705263744,0.7822518279006715,0.9375,1.0,1.0,13/83,11.41%,PTPRK;EGFR;CASP9;PRKCD;ERCC8;SDF4;ZBTB1;ERCC2;PRIMPOL;EIF2S1;RHBDD1;RUVBL2;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.530203997972268,-0.7820660860846836,0.8166666666666667,1.0,1.0,2/5,39.68%,INPP5K;DMTN
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.34472557954586414,-0.7820220219213837,0.8904109589041096,1.0,1.0,9/56,16.93%,CCNE1;CDKN2D;CDKN3;CRLF3;SPDYA;INHBA;CDC25A;CDKN1B;GPR132
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.4151888600130426,0.7819596880358473,0.8043478260869565,1.0,1.0,1/11,2.07%,TEX15
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.27246262719591224,0.7819136152593005,0.95,1.0,1.0,25/285,8.95%,CCNH;MAML3;PRRX1;TEAD2;INTS11;C5AR1;RORA;WWTR1;HDAC9;CBFB;ESRRG;MAML1;NR3C2;TAF2;NFIX;ELP4;IWS1;CPSF7;SOX5;ZBTB1;HDAC1;TFCP2;GTF2I;ERCC2;HDAC10
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.4072576088490382,-0.7816619901251999,0.7419354838709677,1.0,1.0,10/19,38.82%,UQCRB;UQCRH;OXA1L;UQCR10;MTFR1L;MTFR1;UQCRC1;SLC25A14;SDHC;ATP5F1D
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.3892884153014854,-0.7815421652150524,0.7714285714285715,1.0,1.0,5/33,15.70%,MARVELD2;CLDN1;F11R;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.4697604678275686,-0.781177199908298,0.75,1.0,1.0,4/8,35.39%,TXN;PARK7;GPR37L1;LRRK2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.33644294241481565,-0.7811103226250213,0.8767123287671232,1.0,1.0,12/62,14.88%,CASP12;MTCH1;CARD8;KHDC1;RPS27L;CASP8;HIP1R;FADD;BOK;ATP2A3;BEX3;CYCS
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.42917120108576584,0.7810199245048978,0.7857142857142857,1.0,1.0,5/13,23.68%,RNF128;KPTN;SH3GLB1;SH3BP4;LAMTOR4
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.4381345275627194,-0.7809421562203723,0.746031746031746,1.0,1.0,1/7,11.08%,DCTN1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.4526526773027446,-0.7808092950254781,0.8125,1.0,1.0,2/8,16.61%,GBP6;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.4238701635703392,0.7806601552337865,0.717948717948718,1.0,1.0,2/15,7.88%,CARD18;IGF1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.39610977671187153,0.780600110008143,0.8205128205128205,1.0,1.0,12/23,26.54%,PRKCD;HMGA2;SIRT1;ID2;NSMCE2;KAT6A;PML;TERF2;ECRG4;ULK3;MAPK14;SMC6
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.37895633091878445,-0.780503271468404,0.8,1.0,1.0,7/34,17.55%,ZNF703;NOTCH1;TGFB1;NOTCH4;MYADM;RGCC;PODXL
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.40456955775971937,-0.7804043420212983,0.7575757575757576,1.0,1.0,3/20,9.55%,PXMP2;PEX11B;PEX16
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.4320590208181739,-0.7800529874716392,0.7384615384615385,1.0,1.0,1/11,4.48%,CAV3
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.45260859286720273,0.7799724021015676,0.7428571428571429,1.0,1.0,1/7,7.58%,P3H3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.35775770043186406,0.7798691918842047,0.7575757575757576,1.0,1.0,2/22,6.08%,SLC26A3;TM4SF20
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.328882703711779,-0.7798650635032487,0.8695652173913043,1.0,1.0,6/75,13.99%,EPHA1;GRTP1;ARHGAP22;GMIP;CXCL13;TBC1D13
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.3570659085990516,0.7798157737352426,0.8157894736842105,1.0,1.0,1/18,1.06%,TRPC3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.37597239901653035,-0.7797821996842607,0.7384615384615385,1.0,1.0,3/23,15.18%,NOTCH1;HSPA5;MBTPS2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.33862576057878424,-0.7796127334783609,0.85,1.0,1.0,12/76,17.97%,TRIM22;TRIM5;BNIP3;PINK1;TRIML2;PIK3CB;SVIP;SESN3;TSC2;SUPT5H;RNF152;ULK1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.49860462521215865,-0.7791524147466081,0.8181818181818182,1.0,1.0,1/9,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.4989404596441384,-0.779062443437304,0.8148148148148148,1.0,1.0,1/6,17.97%,ULK1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.5286308369675141,-0.7789967715089996,0.7894736842105263,1.0,1.0,1/5,5.91%,P2RY12
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3048982592191695,0.778969040942222,0.8888888888888888,1.0,1.0,8/81,4.44%,CIDEA;ZEB2;PMEPA1;SPRED1;TGFBR1;LATS1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.381257271992931,0.7788103379598191,0.7105263157894737,1.0,1.0,3/19,10.41%,EGFR;DDAH1;NOS1AP
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2779839341002498,0.7787013057260137,1.0,1.0,1.0,9/111,8.62%,GDAP1;CACNG3;PARD3;ZDHHC14;ZDHHC11B;RAB3IP;AP4E1;NLGN1;SRPRB
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2639180174847581,0.7784416489115188,1.0,1.0,1.0,18/219,9.74%,TEAD2;LRRTM3;HORMAD1;CD247;PKP2;QRICH2;RAD21L1;PARD3;CFAP46;RSPH6A;LIN7A;WIPF1;JHY;NLGN1;NLGN4Y;FZD1;TFAP4;TOGARAM1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.41127862346986793,-0.7782921201174458,0.7666666666666667,1.0,1.0,3/22,10.43%,MSX1;INHBA;TBX1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.36075517973127236,-0.7780503571624754,0.8823529411764706,1.0,1.0,9/35,25.57%,SLC13A4;SLC26A4;SLC11A1;SLC25A11;TTYH1;RACGAP1;GLRA1;BEST1;SLC26A8
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.4710075203258296,-0.7780056163919219,0.7076923076923077,1.0,1.0,2/6,5.51%,FBLN5;HEBP2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.46174295521852626,0.7779387895868729,0.7368421052631579,1.0,1.0,3/8,13.75%,MID1;MID2;MAPRE1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.3440104836758354,0.7779155211927475,0.6756756756756757,1.0,1.0,11/30,15.79%,TGFB2;MEIS1;SMG9;ATF6;CHRDL1;RBP4;SMOC1;SIPA1L3;PBX1;MEIS2;PBX4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.34126120174370567,-0.777852911157828,0.868421052631579,1.0,1.0,5/66,11.01%,ARIH2;NKD2;BCAP31;HERPUD1;DDA1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.40638661713858565,0.7777933825097256,0.7619047619047619,1.0,1.0,2/11,7.42%,PMEPA1;ARID1A
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.4487340943418207,-0.7776933793403633,0.8095238095238095,1.0,1.0,4/12,20.26%,MSX1;CACNA1G;HCN4;NOTCH2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3201741713278049,-0.7774505717028448,0.8354430379746836,1.0,1.0,16/90,24.74%,MSX1;NXT1;RANBP6;SKP1;SPRN;NUP85;SIX4;TSC2;NUP155;RPF2;GCKR;NUP188;CALR;RAN;PAF1;AKT1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.42577198118222626,-0.7769519625333411,0.7627118644067796,1.0,1.0,5/14,30.60%,DCTN1;MAP1A;ARF1;CHRNA7;LGMN
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.4324631457892261,0.7768988437641755,0.7272727272727273,1.0,1.0,4/12,15.53%,KCNJ3;KCNN2;CACNB2;KCNA5
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.5095112166398753,0.7766883579001385,0.8,1.0,1.0,3/5,28.81%,BAG3;PRKN;MAPT
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.47134974087549897,0.7763867725216533,0.7857142857142857,1.0,1.0,2/6,21.61%,CEP135;MAP4
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.4196112386520895,0.7761914590745282,0.8928571428571429,1.0,1.0,4/15,8.80%,TGFBR1;OSBPL7;PTCH1;SMAD2
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.3476272569288036,0.7760147055288505,0.75,1.0,1.0,2/23,4.30%,IL1RL2;MYH11
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.4655991839829088,0.7759696430500341,0.7441860465116279,1.0,1.0,2/5,7.35%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.27504947647919403,0.775919562764084,0.9545454545454546,1.0,1.0,29/142,17.82%,ALK;SGK1;CIDEA;BCL2L11;FANK1;CRADD;TOX3;LGALS1;PTPN6;ANP32B;BNIP3L;PERP;STEAP3;MALT1;ACTN4;CASP2;BCL6;SIRT1;RABGGTA;IKZF3;MECOM;NDRG1;ATM;MAGED1;JAK2;LCMT1;ZBTB7A;TRIAP1;CREBBP
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.4900327769073479,-0.7758754366690676,0.7543859649122807,1.0,1.0,1/7,5.83%,SOD2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.2744664863456805,0.7758338435577706,0.96,1.0,1.0,3/103,3.93%,ATP6V0D2;KDR;EPM2A
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.3136245519366298,0.7756850979093397,0.8611111111111112,1.0,1.0,7/56,8.43%,UNC5B;SLC30A10;BCL2;TOX3;MDK;TGFB3;APOE
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.46815313089048893,-0.7755290792015711,0.7049180327868853,1.0,1.0,1/7,13.20%,BCAT2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.4381817861204969,0.7754927711430198,0.6470588235294118,1.0,1.0,1/11,3.89%,SEMA5A
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.38794698598452526,-0.7750699346330788,0.7702702702702703,1.0,1.0,6/22,27.19%,NUBP1;ISCU;HSPA9;NFS1;CIAO2A;ISCA2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.35316987590870585,0.7750067905722906,0.7297297297297297,1.0,1.0,2/21,2.40%,FGF13;PKP2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.376904242056759,-0.7749800843458763,0.8405797101449275,1.0,1.0,3/22,8.58%,ATP1B1;ABCB1;GLRX
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.428766915112735,-0.774235831269112,0.803030303030303,1.0,1.0,1/16,3.01%,LDLRAP1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.3775785706149931,-0.7737562369383119,0.7857142857142857,1.0,1.0,16/27,40.08%,KCNN4;TESPA1;CD160;RPS3;CEACAM1;PHPT1;CD226;EZR;DUSP3;THY1;CD81;PTPN22;LAPTM5;PRNP;IKBKG;SLA2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.39693768358324494,0.7733564379647261,0.8947368421052632,1.0,1.0,1/16,2.07%,TEX15
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.4824462546482904,-0.7732572262151254,0.8088235294117647,1.0,1.0,1/7,6.48%,TBX19
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.45925670149566533,-0.7731487530994237,0.7758620689655172,1.0,1.0,3/8,21.07%,DRC1;LAMP1;NEFH
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.5306157788589212,-0.7728315186587663,0.7936507936507936,1.0,1.0,2/5,16.78%,TGFB1;FLOT1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.2523890723494037,0.7728249814522541,1.0,1.0,1.0,17/286,7.25%,FBXL7;LAMB2;PENK;MELTF;VCAN;LTBP1;SENP8;FBXW8;DNAJC3;SOCS6;FEM1A;AFP;FBXO27;CCDC22;LGALS1;COMMD1;ERCC8
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.3674030979493499,-0.772715802596784,0.8571428571428571,1.0,1.0,7/36,14.19%,ACTC1;ZFPM1;NOTCH1;TBX19;TBX1;TTN;HTR2B
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.30429486105523607,-0.7726893703506266,0.8765432098765432,1.0,1.0,21/174,14.19%,CD4;TERF2IP;TRIM22;TRIM5;CD74;STAT1;PINK1;TRIML2;CARD8;TRAF3IP2;TRIM25;CASP8;DAB2IP;ROR1;LTBR;CXXC5;GSTP1;FADD;TRIM32;IFIT5;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.3359930925987099,-0.7726455839281304,0.8852459016393442,1.0,1.0,7/83,8.69%,MMP26;PTGIS;ELANE;DRD3;SERPINE1;CARD8;SIGIRR
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3149863982980646,-0.772620235929635,0.9130434782608695,1.0,1.0,21/126,16.38%,TNFSF18;YBX3;STAT1;PSMB6;PSMB8;CCL5;DAB2IP;TXNDC17;LTBR;TMSB4X;BAG4;CD27;PSMA3;GPER1;PSMA5;PSMC3;BRCA1;NFKBIA;ADAM17;PSMA7;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.402580199302111,-0.7725798488395214,0.7538461538461538,1.0,1.0,1/19,0.95%,NES
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.41712074378684016,-0.7725427422825937,0.7837837837837838,1.0,1.0,2/14,13.94%,CCL5;CXCL13
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.429259322323706,-0.772261772600694,0.8088235294117647,1.0,1.0,1/13,5.45%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.3263322737043214,0.7722164915534596,0.75,1.0,1.0,10/36,18.83%,TGFB2;FOS;EPHA7;EIF2S1;MAP3K5;FYN;GRIN2B;WNT5A;DDIT4;FOXO3
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.42408572801674926,-0.7720399768656566,0.7857142857142857,1.0,1.0,2/12,17.23%,HPF1;PARG
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.41247655153616497,0.7720326255207762,0.7222222222222222,1.0,1.0,1/19,1.39%,ITGA4
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.3309476846723573,0.7719999263895192,0.7878787878787878,1.0,1.0,13/39,15.79%,TGFB2;MEIS1;SMG9;CHD7;ATF6;CHRDL1;RBP4;ECE1;SMOC1;SIPA1L3;PBX1;MEIS2;PBX4
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.347241442468955,0.7719971871750364,0.8461538461538461,1.0,1.0,4/25,10.13%,CATSPER2;TGFB2;TGFB3;TFPI
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.3696419101218972,-0.771730063768896,0.8983050847457628,1.0,1.0,16/33,35.73%,MLC1;GAS1;LAMP1;RBM4;NEFH;REEP5;NDEL1;LCP1;NUP214;ANTKMT;RNF139;INPP5F;RINT1;ATP9A;LRRK2;CRYAB
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.4399082502907027,-0.7712754576732221,0.7592592592592593,1.0,1.0,1/14,0.55%,CD4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.37576062118340237,-0.7711088157374234,0.7936507936507936,1.0,1.0,5/31,12.46%,CGAS;B2M;ACOX2;IL15;ARG2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.4729797517296601,-0.7710241146093468,0.7936507936507936,1.0,1.0,4/6,40.32%,AXIN2;RMI2;TCF7L2;MSH6
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.4799111139098354,0.7706082491215946,0.7872340425531915,1.0,1.0,1/6,4.03%,PIK3R6
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3631638617761883,0.7705594981523102,0.7631578947368421,1.0,1.0,2/18,5.12%,RAD51B;DBF4B
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.46457001430602807,-0.7703710207161759,0.8,1.0,1.0,2/9,20.99%,CUX2;DBN1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2634567259555033,0.7701267977834134,1.0,1.0,1.0,27/381,8.29%,POU6F2;SOX13;TEAD2;ZNF273;NFIA;ZNF117;RORA;WWTR1;ZNF536;BRCA2;TGFBR1;OR7D2;ATXN1;ESRRG;ZNF205;GRM5;ZNF628;WWC1;RABL3;FOXN3;SPIN2B;SOX12;CHD7;CCNA2;PRMT5;RBBP6;ZNF263
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.35095699584723294,0.7697543224459558,0.8125,1.0,1.0,9/25,22.50%,NAT9;FOXO1;SIRT1;EP300;CREBBP;DSCC1;NAA15;KAT6A;GTF2B
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.5037043877660384,-0.769662729459016,0.7301587301587301,1.0,1.0,1/5,4.91%,EIF5A2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.28354587135199094,-0.7695672451379895,0.9775280898876404,1.0,1.0,45/358,15.77%,CD44;HCK;PRLR;WFS1;TNFSF18;BCL2L2;CDKN2D;CD74;NOTCH1;ITGA5;BNIP3;IL7;PINK1;SOD2;ATF5;RASA1;CCND2;NCKAP1L;FIGNL1;IFI6;CRLF1;HSPA5;ALOX12;PRKCH;IFIT3;ANXA5;TBX1;RNF213;DNAJA1;MRE11;BAG4;UFM1;SNAI2;CD27;GSTP1;KIF14;ZNF16;ANKLE2;LRP2;HTR2B;BEX3;SIX4;PTPRZ1;CTSH;NFKBIA
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.47123595196439166,-0.7695397793619845,0.7878787878787878,1.0,1.0,1/8,4.95%,SLC7A7
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.3285679151144465,0.7694783961531722,0.896551724137931,1.0,1.0,12/50,14.17%,PTPRK;EGFR;FOS;PDGFRA;AKR1C3;APOE;AGAP3;ERCC6L2;FYN;MAPK8;SIRT1;FER
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.3176149459839679,0.7693516489945904,0.8333333333333334,1.0,1.0,12/64,14.73%,SGK1;SGK2;IL15RA;ZNF205;RAB27A;APOE;NEDD4L;LYAR;CHP1;AKT2;NUMA1;CD151
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.306618987291691,0.7692861903486725,0.9166666666666666,1.0,1.0,9/91,6.72%,UBASH3B;HSPB1;RASSF2;C5AR1;WWTR1;SPRED1;CEP85;TRIB2;MMD2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3360004719185959,0.7692484256890315,0.8421052631578947,1.0,1.0,9/45,13.20%,PER2;MINAR1;HSPA1A;GNL3L;IVNS1ABP;BAG2;U2AF2;CHP1;SVBP
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.3418830891169635,0.7692310369772695,0.825,1.0,1.0,3/24,6.41%,ALG8;GAL3ST4;RRM2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.372498194040712,0.7692091203793029,0.75,1.0,1.0,3/18,6.58%,PLCB1;MDK;HMGB1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.2676973228288476,0.7690135688829609,1.0,1.0,1.0,26/212,12.27%,SOX13;EGFR;ZEB2;WWTR1;KANK1;SEMA5A;LATS1;ZBED3;CDK14;GREM1;MCC;MDK;PRICKLE1;PTPRO;RBMS3;HDAC1;APOE;ANKRD6;RUVBL2;GNAQ;DVL2;UBAC2;TLE2;FGF10;PRDM15;LYPD6
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.2949708670290077,0.7686016028957224,0.9142857142857143,1.0,1.0,7/88,6.07%,PTPRT;MCTP1;SRGAP1;PTPRK;KANK1;NAV3;JAG1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.3336861291454164,-0.7685285176097781,0.9,1.0,1.0,12/66,19.46%,TICRR;RAD51AP1;NHEJ1;FIGNL1;INIP;EYA1;GADD45A;BRCA1;RAD9B;AEN;NABP1;RAD1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2742233381876467,0.7682639247669821,1.0,1.0,1.0,46/268,17.00%,SLC22A2;PID1;LEF1;FGFR4;BMP7;TGFBR1;BMP6;GREM1;ANKRD31;EPHB2;HEY1;RAB27A;RBMS3;TICAM1;ADAM19;HSPA1A;IGF1;POU3F1;EIF2AK3;SLC24A3;ZNF804A;NOS1AP;ANGPT1;LIMS1;MAPK8;FGF10;SNF8;ECE1;VAMP3;CELF1;HMGA2;ID2;NTRK3;NGF;PDGFB;MAGI2;BRAF;KLF2;NWD1;MEF2C;DNMT1;ATM;WNT5A;FGF17;MAPK7;LRP3
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.412738569357017,-0.7681688564795331,0.8064516129032258,1.0,1.0,2/14,7.59%,RAC1;NOX1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.4774913249401669,-0.7680822652090099,0.8571428571428571,1.0,1.0,2/8,17.38%,DCTN1;MAP1A
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.3208235224211326,0.7672093581045807,0.88,1.0,1.0,21/87,15.55%,PKP2;PDLIM1;HDAC9;TGFBR1;TGFB2;HEY1;HEG1;ACVR1;SMG9;ERBB4;DVL2;EEF1AKMT4-ECE2;ADAP2;RBP4;ECE1;FGF12;ID2;NTRK3;PDGFB;ALPK3;MEF2C
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.39402607376306276,-0.7669458866451752,0.835820895522388,1.0,1.0,12/27,37.71%,ABT1;RPS21;RPS8;NGDN;HELB;TSR2;RPS19;RPS16;RPS14;HEATR1;MRPS11;UTP6
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.4761275792859916,-0.7668575927476535,0.7413793103448276,1.0,1.0,5/10,14.69%,ELANE;SIGIRR;OAS3;GSTP1;APOD
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.4043548730852672,-0.7668160885840507,0.8,1.0,1.0,2/21,4.21%,AGT;CD74
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.31589513847110723,-0.7667492759758333,0.8588235294117647,1.0,1.0,19/84,26.73%,WFS1;HSPA5;TRIM25;HERPUD1;ERLEC1;RCN3;MAN1A1;SGTB;PSMC6;SYVN1;CCDC47;UFD1;TMUB1;MAN1B1;SEL1L2;HSP90B1;ANKZF1;MARCHF6;SELENOS
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.34127756669104414,-0.7666579600154209,0.875,1.0,1.0,11/56,23.35%,PIGC;WIPI1;ZDHHC22;ZDHHC6;MPPE1;PIGH;PIGO;PGAP4;GPLD1;PGAP3;HHAT
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.37812034461339505,0.7665339118450294,0.8,1.0,1.0,5/16,13.36%,GREM1;HEY1;ENPP1;SRGN;ECM1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.32337893837644494,-0.7662297376649522,0.8769230769230769,1.0,1.0,9/74,13.30%,POLR3K;CGAS;CD14;IRF1;TRIM25;MRE11;RNF26;POLR2K;TRIM32
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.34041384830468707,0.7657937470879893,0.8,1.0,1.0,7/64,9.19%,ACE2;ITPR2;TGFB2;PDE4D;APLN;S100A1;SLC8A3
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.2953553756714878,0.7656810820552967,0.9166666666666666,1.0,1.0,11/65,13.92%,IRS1;FGFR4;MCU;LEPR;PIK3R1;BACE2;RBP4;FOXO1;SIRT1;MBD5;FOXK1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.37043203864132446,-0.7655868615187296,0.8507462686567164,1.0,1.0,14/40,24.74%,STAT1;STAT5A;ZBTB7B;STAT4;IGFBP5;GPER1;EIF6;EIF2B2;EIF2B5;KHK;STAT2;SLC27A1;STAT6;AKT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.31102100566905727,0.7651116797304726,0.9310344827586207,1.0,1.0,17/75,15.07%,CDC14B;ANKRD31;DBF4B;MAP3K20;BTC;IGF1;SVIL;TPR;EREG;CEP120;PRKCE;SIRT2;MAP10;PKP4;PDGFB;NUMA1;SPAST
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.3935057150969166,0.7649326359513486,0.7096774193548387,1.0,1.0,4/18,17.42%,PPP1R8;CHP1;PPP1R35;ENSA
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.36937495346339233,-0.7648353943950494,0.8059701492537313,1.0,1.0,7/29,24.82%,TAF7;SPI1;CHEK1;BRCA1;SET;NOS1;CTBP1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.3267348568033984,-0.7641178304179631,0.9210526315789473,1.0,1.0,15/76,20.78%,PXMP2;PEX11B;CHMP4B;ZDHHC22;PEX16;ZDHHC6;SEC62;SRP14;SGTB;PEX5;NACA;VPS37B;ATG3;ZDHHC24;ARL6
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.4025846716309951,0.7640994720863858,0.7105263157894737,1.0,1.0,4/12,13.75%,IRS1;IRS2;PRKCE;AKT2
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.4582129922523267,0.7639919769838245,0.8,1.0,1.0,5/5,54.19%,MPHOSPH8;MECP2;KMT2A;GRHL2;KDM1B
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.30433373504382666,0.7635438358971146,0.8421052631578947,1.0,1.0,6/78,5.00%,PID1;WWTR1;BMP7;ZBED3;PRR5L;EPHB2
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.3887632363972724,0.7634992667871523,0.8095238095238095,1.0,1.0,7/17,13.53%,TOX;SLC16A2;MDK;TAFA1;DISP3;TRIM71;ID2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.3702551957980196,-0.7631156887348707,0.7714285714285715,1.0,1.0,2/26,8.00%,CELF3;SLU7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.4830870285464476,-0.7630786700271515,0.7936507936507936,1.0,1.0,2/7,8.90%,NCKAP1L;AGER
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4640652266630634,-0.7630579748463449,0.8153846153846154,1.0,1.0,2/9,10.25%,DRD3;CALM3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.4515190236604746,0.7630456292532874,0.7,1.0,1.0,3/7,29.35%,CTNNB1;RBPJ;STARD13
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.48229190784005865,0.7630092005249071,0.825,1.0,1.0,3/5,17.38%,AUTS2;SIRT1;SMARCB1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.501249290254188,-0.7629443118936016,0.7543859649122807,1.0,1.0,1/5,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4018396308769552,-0.762758100828445,0.7903225806451613,1.0,1.0,1/13,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2596037069359756,0.7626109370339634,1.0,1.0,1.0,62/358,16.86%,FHDC1;TMOD4;ARL13B;RAB32;PCM1;PDE6D;CDC14B;DNAH5;CNGA4;CFAP70;TTC39C;RAB3IP;RAB7A;NEK6;GOLGA8M;GOLGA8H;PLA2G4C;UBXN10;PKHD1;KIAA0586;PATL1;CEP83;EIF2S1;CFAP43;ABCC4;WDR45;BICD1;RFX2;SCLT1;TTC36;PIBF1;SNF8;UBXN2A;BBIP1;PTPN23;SNAP29;EXOC7;WDR35;RC3H1;FNBP1L;ABLIM1;MAPRE1;TSG101;RCC1;LSM14A;EHD4;BBS9;EMC6;MACIR;FITM2;PARVA;KIF24;ELAPOR1;VPS25;RAB11FIP3;B9D2;CFAP20;POC1B;RFX3;CFAP44;IFT74;B9D1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.34870769620879943,-0.7625132970964065,0.8656716417910447,1.0,1.0,11/51,17.99%,HSD17B10;LIPH;LIPI;BAAT;ACOX2;SDS;ACMSD;ACSM4;LIPC;ACSM6;NDUFAB1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.32526301143845726,-0.7624403038151671,0.8615384615384616,1.0,1.0,6/73,12.27%,HCK;CAV3;RAC1;NCKAP1L;DCTN1;CDK5R1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.296989202339955,0.7623764317223146,0.9487179487179487,1.0,1.0,15/68,19.83%,EPHA8;CBARP;FOXO6;MID1;PHF21B;ARHGAP39;LYPD6;MSI1;TMEM198;KIF7;RBFOX2;VGF;MEIS3;DLX2;C2CD4C
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3052003142167596,0.7621969067916434,0.8823529411764706,1.0,1.0,9/61,14.16%,SH3RF1;MARCHF5;SH3RF3;ERCC8;RNFT1;UBE3D;TRIM71;RNF19B;RNF208
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.4265908014055009,-0.7621096345049979,0.7619047619047619,1.0,1.0,4/11,31.11%,DPYS;ALDH6A1;CRMP1;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),-0.5161295109727388,-0.7615044026772801,0.8983050847457628,1.0,1.0,2/5,24.55%,TCAF2;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.31821892234512483,0.7613885920150638,0.8461538461538461,1.0,1.0,4/62,8.26%,RUNX1;CBFB;CFLAR;PTPN6
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.28001152765053705,-0.761334766217651,0.967391304347826,1.0,1.0,29/286,14.19%,CD44;HCK;PRLR;WFS1;TNFSF18;BCL2L2;CD74;BNIP3;IL7;ATF5;RASA1;CCND2;NCKAP1L;FIGNL1;IFI6;HSPA5;IFIT3;ANXA5;DNAJA1;MRE11;BAG4;UFM1;CD27;GSTP1;KIF14;ZNF16;ANKLE2;LRP2;HTR2B
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.30523760430889996,-0.7608611726506003,0.9154929577464789,1.0,1.0,19/98,20.29%,ITK;RAC1;PSMB6;PSMB8;SKP1;VAV3;PIK3CB;TEC;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;SHC1;PSME1;PSMD12;CALM1;PSMB2
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.43299046038558553,0.7606921542373314,0.782608695652174,1.0,1.0,3/10,18.83%,SLC25A33;TFB2M;FOXO3
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.4912369748971564,-0.7606696873077748,0.8059701492537313,1.0,1.0,2/6,20.05%,C1QBP;UFD1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.29430359695980957,0.7602655373414402,0.9545454545454546,1.0,1.0,16/70,19.52%,NTNG1;CTNNA2;PARD3;DSCAML1;CNTN4;RYK;SLITRK5;SPTBN4;PAK3;NRCAM;MEF2C;MAP6;PLPPR4;OPHN1;ANK3;FARP1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.46829235242036965,-0.7602485940672242,0.8333333333333334,1.0,1.0,1/8,4.48%,CAV3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.4348192870103617,0.760166093103134,0.7714285714285715,1.0,1.0,2/9,9.67%,B4GALNT2;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.3478557729646643,-0.7601513331081401,0.7761194029850746,1.0,1.0,7/43,15.22%,PTPRC;CD74;IL15;CCL5;FADD;HLA-DMB;GBP5
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.4109797776672255,-0.7600874878390955,0.7166666666666667,1.0,1.0,1/11,1.32%,LRP4
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.31770953961119003,-0.7600681925592058,0.9342105263157895,1.0,1.0,13/92,14.23%,ENPP2;SCN4B;CD14;SLCO2B1;P2RY12;SSTR1;ALDH2;SERPING1;A2M;RASSF4;SPARCL1;PLP1;GALNT15
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.35304843880313336,0.7600135119120469,0.8125,1.0,1.0,4/18,14.21%,GREM1;APLN;ANGPT1;MAGI2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.36564238467583954,0.7591262370056693,0.7575757575757576,1.0,1.0,10/24,17.14%,RORA;SGCZ;MRTFA;SEMA4C;MRTFB;NEBL;MEGF10;MYOCD;MEF2C;SYNE1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.35256617412617786,0.75892025127601,0.9722222222222222,1.0,1.0,5/24,9.74%,DNAI4;CFAP46;RSPH6A;JHY;TOGARAM1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.4040120521779354,0.7588753520129623,0.7428571428571429,1.0,1.0,1/10,1.23%,F2RL1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.46610382651720605,-0.7588551293421453,0.8571428571428571,1.0,1.0,2/10,13.04%,DNAJA1;GSTP1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.4551171968198593,0.7586976548099815,0.7391304347826086,1.0,1.0,1/6,4.72%,APBA1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.38506625059647104,-0.7586026859803835,0.8064516129032258,1.0,1.0,4/25,13.18%,CD14;CD300LF;CASP8;FADD
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.38506625059647104,-0.7586026859803835,0.8064516129032258,1.0,1.0,4/25,13.18%,CD14;CD300LF;CASP8;FADD
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.34436219306314314,-0.7585071162411423,0.8088235294117647,1.0,1.0,5/46,6.15%,PTPRC;ELANE;CD74;CD14;SERPINE1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.49162427969843514,-0.758469788136533,0.8166666666666667,1.0,1.0,1/5,7.86%,GBA3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.47292027737527365,-0.7584167216736551,0.7884615384615384,1.0,1.0,2/7,14.64%,RAB11A;VPS35
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.35062816179226275,-0.7580156470385587,0.7792207792207793,1.0,1.0,3/28,14.69%,RASA1;SERPINE1;APOD
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.32615946042586147,0.7579403970394718,0.8717948717948718,1.0,1.0,4/31,7.36%,KIT;KITLG;TGFB2;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.34829255474310095,-0.7578218067798804,0.8026315789473685,1.0,1.0,4/39,13.40%,ATP5IF1;DAB2IP;F11R;GMIP
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.44435022219669756,-0.7576103774389327,0.8513513513513513,1.0,1.0,3/11,22.34%,ISCU;AKAP5;NOS1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.31385449324500203,0.7573964918073427,0.8888888888888888,1.0,1.0,4/62,8.92%,CCNH;ELP4;IWS1;ERCC2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.26356370413697927,0.7573940171081506,0.9583333333333334,1.0,1.0,26/143,17.05%,EPHA3;F2RL1;DOCK10;EPHA5;RGS7;RSU1;RASGRP1;EFNA5;TBC1D10B;TBC1D2;RASGRF1;LIMS1;DOCK9;SIPA1L1;PKP4;LRCH1;PLXNA2;CRK;SNX18;RRP1B;RTN4R;NGEF;PROM2;ARHGAP44;RAP1A;RAPGEF1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.47400752101915455,-0.7571813425291793,0.8656716417910447,1.0,1.0,3/9,27.11%,CELSR1;SHROOM3;MAL
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.2998196201143342,0.7566952899719379,0.9642857142857143,1.0,1.0,12/61,18.61%,THADA;CDKAL1;LCMT2;TRDMT1;TRMT61A;WDR4;TYW3;TRMT61B;PUSL1;ADAT2;TPRKB;PUS10
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.31034328713380804,0.7566410541209853,0.875,1.0,1.0,6/59,6.55%,BCL2A1;BCL2;CRADD;TGFB2;FGFR3;CASP9
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.33541582587167235,-0.7565515735086489,0.8732394366197183,1.0,1.0,12/51,20.51%,ALOXE3;ALOX12;CLDN1;STMN1;TMEM79;HRNR;ADAM9;ITGB4;DACT2;MET;OPN3;TXNIP
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.26009846006738524,0.7562245608727775,1.0,1.0,1.0,41/345,14.26%,POU6F2;SOX13;TEAD2;ZNF273;NFIA;ZNF117;RORA;WWTR1;ZNF536;BRCA2;TGFBR1;OR7D2;ATXN1;ESRRG;ZNF205;ZNF628;WWC1;FOXN3;SPIN2B;SOX12;CHD7;PRMT5;ZNF263;HDAC10;MYB;ZNF678;RYBP;DVL2;ATXN1L;ACTN4;PCGF1;ZNF33A;HMGA2;BRDT;ZNF646;EP300;PHF1;ZNF875;SPIN1;ZFHX3;NR3C1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.2615011076058939,0.7558787481175965,1.0,1.0,1.0,15/147,13.00%,PTPN3;BTG2;CDC26;NEK6;BRINP1;EIF4EBP1;PRMT5;ANAPC16;ERCC2;TFAP4;CDC23;HECA;BRINP2;BTRC;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.3745520550840484,0.7555769032336928,0.7837837837837838,1.0,1.0,4/17,13.02%,TNFRSF11A;DVL2;MAP3K5;MAP3K10
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3278135776839838,0.7554145470143545,0.8461538461538461,1.0,1.0,9/63,12.27%,ZBED3;SMPD4;UBE2J2;REEP1;STX18;SPTSSB;EIF2AK3;ATL2;CYB5A
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.4831666772341652,0.7553976598138622,0.7045454545454546,1.0,1.0,4/5,24.33%,RC3H1;ATM;TNFRSF21;BLK
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.31308186905385804,-0.7553309380645796,0.9047619047619048,1.0,1.0,6/77,10.62%,UPB1;POLQ;CHMP2A;LRRC8D;CLDN1;RNF213
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.40811482244340647,-0.7551980488349203,0.7666666666666667,1.0,1.0,3/12,13.91%,LRRC8D;ABCC6;SLC25A4
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.45350599885958365,-0.754880055827025,0.7966101694915254,1.0,1.0,1/10,12.96%,SESN3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.45350599885958365,-0.754880055827025,0.7966101694915254,1.0,1.0,1/10,12.96%,SESN3
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.3732475811678784,-0.7547550529680194,0.8333333333333334,1.0,1.0,8/28,10.63%,TMEM184A;SMIM22;LIPH;PTGR1;ANXA10;GPX2;CBLC;B3GNT3
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.296614763068293,0.7543393345907938,0.96875,1.0,1.0,10/86,13.90%,RFWD3;GEM;LATS1;LRWD1;HDAC1;HDAC10;HMGN4;HMGA2;SIRT1;PHF1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.3162796482511063,0.7541990268482803,0.9090909090909091,1.0,1.0,10/28,22.35%,MAP3K20;CLSPN;CDC5L;ATM;CHEK2;ATRIP;TP53BP1;HINFP;HUS1;RAD9A
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.33159761531757737,0.7540926403734652,0.8787878787878788,1.0,1.0,2/49,2.05%,IFI16;IFIH1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.37968171383476573,0.7538309089302134,0.8125,1.0,1.0,3/11,22.48%,ARID5B;SH3PXD2B;SPTLC2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2606284634774767,0.7538245787327479,1.0,1.0,1.0,16/231,9.85%,FBXL7;LEF1;TEAD2;CD247;PARD3;MCU;DNAJB12;ZNHIT6;LIN7A;GRIA1;WIPF1;PPP6R1;HDAC1;BET1;TFAP4;CTSC
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.44706327619082276,-0.7537567944948267,0.7741935483870968,1.0,1.0,1/9,1.99%,PTPRC
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.29867278794588126,-0.7536278107764716,0.9259259259259259,1.0,1.0,1/137,0.02%,CD44
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4355337369737472,0.7535925165896165,0.7142857142857143,1.0,1.0,2/12,9.64%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3165292984976029,-0.7535258472308801,0.8767123287671232,1.0,1.0,7/61,8.64%,CYP1B1;PTPRC;RND1;NOTCH1;RASA1;SERPINE1;TGFB1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.2808708090299445,0.7533217482846347,0.9629629629629629,1.0,1.0,7/98,8.92%,CCNH;BRCA2;GTF2H2C;POLD3;COMMD1;ERCC8;ERCC2
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.33254564455406277,-0.7532683792586838,0.8356164383561644,1.0,1.0,19/67,20.23%,MYLK;EPAS1;BNIP3;KLF5;HEBP2;PLP2;CAPN1;CBLC;CLDN1;B3GNT3;LTBR;PKP1;DUOXA1;SRPX2;CDCP1;ITGB4;TMEM14A;MYOF;CD9
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.4094573509275637,0.7530795782899116,0.8055555555555556,1.0,1.0,2/12,10.60%,PKP2;TCHH
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.3549700098798727,0.753040272100533,0.8529411764705882,1.0,1.0,6/31,7.17%,KIT;SOX13;LEPR;RABL3;GPR89B;CHD7
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.37663678464218897,0.7529963369542549,0.8,1.0,1.0,6/16,17.98%,CIDEA;SCARB1;PLIN5;OSBPL11;FITM2;NFKB1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.4716214506934472,0.7526866752690273,0.8461538461538461,1.0,1.0,1/5,10.76%,UBE2D4
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.4300323425180201,-0.7526629438804837,0.8103448275862069,1.0,1.0,2/13,12.01%,PIK3CB;HIP1R
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.3997202659237988,0.7525978186609019,0.7906976744186046,1.0,1.0,1/7,7.70%,ADAM19
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),0.45314749896993917,0.7524402948490511,0.7380952380952381,1.0,1.0,1/7,2.78%,PM20D1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.48888431135385246,-0.7523903177276265,0.7692307692307693,1.0,1.0,2/6,44.26%,RAB11FIP5;SELENOT
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.329066655488654,0.7522679887919347,0.90625,1.0,1.0,4/32,7.10%,SEMA6D;NRP1;SEMA5A;SEMA4C
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.37007641159827925,-0.7522528321541218,0.8181818181818182,1.0,1.0,4/18,20.46%,UCHL5;TXNDC15;PDCL;SHH
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.4206300312941663,-0.7520830888938269,0.7681159420289855,1.0,1.0,6/13,24.82%,TAF7;BRCA1;SET;TWIST1;JARID2;CTBP1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.30972605392330244,0.7520560300348316,0.8333333333333334,1.0,1.0,5/38,13.04%,IFIH1;TRAF3;REL;PTPRS;RNF216
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.4022266010798409,-0.7518184634063798,0.9016393442622951,1.0,1.0,7/17,32.17%,HERPUD1;SYVN1;UFD1;HSP90B1;SELENOS;DERL1;SEC61B
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.36759938392437963,0.7517087014197475,0.8936170212765957,1.0,1.0,3/21,4.44%,SPRED1;SPRED2;SPRED3
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.4563417375706984,0.7517012981418878,0.7708333333333334,1.0,1.0,1/6,12.03%,SIRT2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.3675246676511747,-0.7513789547818133,0.8307692307692308,1.0,1.0,3/33,6.27%,NPY;AGT;SSTR1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.41027748488485133,-0.7513356744867544,0.7692307692307693,1.0,1.0,6/18,19.90%,MSX1;HIC1;RPS7;RPS20;RPL37;RPS15
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.35833120540648317,-0.7513034886638095,0.7941176470588235,1.0,1.0,7/36,17.39%,TERF2IP;CD14;LRRC19;AGER;CD27;TLR2;C1QTNF4
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.325648889386742,-0.751270769264071,0.9014084507042254,1.0,1.0,7/57,13.42%,EPN1;AGT;IFI6;CBLC;DAB2IP;HIP1R;GPER1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3454879019873094,-0.7511717161937745,0.8333333333333334,1.0,1.0,8/39,16.44%,SLC7A11;SLC7A7;SLC38A11;LRRC8D;SFXN3;SLC36A1;SLC38A8;SLC38A4
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.31298851948634815,0.7510062623142031,0.7575757575757576,1.0,1.0,10/47,10.64%,SLC16A2;SLC22A13;SLC16A9;SLC6A11;SLC16A7;SLC16A12;SLC6A13;ABCC11;SLCO1C1;ABCC4
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.2698831345809143,0.7510007797158013,0.9565217391304348,1.0,1.0,3/84,2.27%,CDH13;RAB3C;NRP1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.3656328183678473,-0.7502527399101242,0.8493150684931506,1.0,1.0,7/34,22.94%,DRD3;ERLEC1;RCN3;SYVN1;CCDC47;GLRA3;GLRA1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4210979045457205,-0.7501770077111872,0.8166666666666667,1.0,1.0,3/10,16.50%,NOTCH1;NOTCH4;RGCC
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.3713775531823726,-0.7499638085957222,0.8333333333333334,1.0,1.0,4/27,13.77%,TGFB1;CALM3;PDGFRB;ANKLE2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.3555082691488479,-0.7498366433729788,0.8571428571428571,1.0,1.0,5/29,12.93%,ABCB1;ABCB4;PLSCR4;PLSCR5;TMEM30A
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.4170509059531488,0.7496608249901191,0.75,1.0,1.0,1/10,0.77%,CYP1A2
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.4025758857952404,0.7495676393438738,0.8157894736842105,1.0,1.0,1/10,6.04%,MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.41173560620145533,0.7495612479277085,0.7142857142857143,1.0,1.0,4/13,20.21%,EPHB2;ZDHHC2;RELN;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.4594500312323565,-0.7495483362863307,0.7910447761194029,1.0,1.0,1/8,8.58%,GLRX
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.41643179038301037,-0.7491939371198095,0.8,1.0,1.0,4/10,27.68%,PCSK5;LIPC;FURIN;ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3367468688556925,0.7491545897986176,0.8571428571428571,1.0,1.0,4/29,11.17%,GREM1;NAF1;PARM1;PNKP
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.34713554520725654,-0.7491139354120636,0.8589743589743589,1.0,1.0,3/44,7.45%,PLEKHG7;ROPN1B;CELSR1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.29530547017247427,0.7489380328077438,0.9130434782608695,1.0,1.0,6/50,11.39%,MYLIP;VLDLR;RAB7A;BNIP3L;CTSC;MALT1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.47875120341081023,0.7488670540689771,0.8214285714285714,1.0,1.0,5/5,52.14%,CTU1;CTU2;MOCS3;TRMU;URM1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.39913054892923044,-0.7488559675922825,0.8181818181818182,1.0,1.0,6/21,13.30%,DUOX1;RARRES2;P2RY12;TGFB1;PDGFRB;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.40702818772106897,-0.7487422326616819,0.7931034482758621,1.0,1.0,1/11,5.91%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.46777233576894395,-0.7487356101959833,0.7666666666666667,1.0,1.0,3/6,14.57%,ADRA1D;ADRB1;TPM1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.34929612939616345,-0.7485740069813495,0.8769230769230769,1.0,1.0,11/46,20.78%,RAC1;CHMP4B;CHMP2A;CASQ1;PREX1;WASF1;VIL1;DIAPH3;WAS;CATIP;ARL6
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.4281494664240443,-0.7484100770203417,0.7638888888888888,1.0,1.0,1/10,10.93%,DNAJA1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.48302554344404397,0.7484044872674617,0.7297297297297297,1.0,1.0,1/5,7.31%,TICAM1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.36398716951667104,-0.7483289826058587,0.8095238095238095,1.0,1.0,6/25,26.64%,CCDC39;RCN3;WNT7B;SHH;SOX11;FGF7
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.349517473762531,-0.7482778718110594,0.8769230769230769,1.0,1.0,13/43,27.52%,PINK1;TOMM20;BCAP31;TOMM7;DNAJC19;TOMM22;TIMM17B;ROMO1;HSPD1;AKT1;TIMM22;TIMM17A;GRPEL2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.33203799110779264,0.7474679861140576,0.9032258064516129,1.0,1.0,14/38,17.79%,TRAF3;APOE;FAF1;SSH1;PM20D2;NEDD4L;MAPK8;FAM83D;SNF8;ZDHHC2;KLF2;MAPK7;CHEK2;SPOP
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.35480185748804044,-0.7471297775794384,0.8260869565217391,1.0,1.0,5/43,15.60%,AMN;STEAP2;STXBP6;PREPL;RAB31
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.34694613779410133,-0.7470776047963326,0.8382352941176471,1.0,1.0,10/41,24.28%,RFC5;RPA3;TRIM25;POLE2;PCNA;ISG15;UFD1;RPS27A;RCHY1;UBC
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.490929977727198,-0.7467948770064035,0.7666666666666667,1.0,1.0,3/5,22.86%,SLC52A2;RFK;SLC52A1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.490929977727198,-0.7467948770064035,0.7666666666666667,1.0,1.0,3/5,22.86%,SLC52A2;RFK;SLC52A1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4039101464844578,-0.7464681547924569,0.8805970149253731,1.0,1.0,4/13,15.56%,SOD2;GPER1;TPM1;CDKN1B
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.3998781163935555,-0.7464219185144713,0.7586206896551724,1.0,1.0,8/14,35.83%,NUDT1;ENTPD2;NUDT15;ENTPD5;NUDT18;NUDT9;ENTPD7;ENTPD1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.4762389514570058,-0.7463874328693999,0.8524590163934426,1.0,1.0,3/5,20.46%,WNT7B;DACT2;SHH
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.25194385130388647,0.7460668844411935,1.0,1.0,1.0,45/352,14.30%,SLC22A2;PID1;IFI16;LEF1;EGFR;FGFR4;BMP7;TGFBR1;S100A13;BMP6;SAMD4A;PRR16;EPHB2;HEY1;ELAVL1;RAB27A;RBMS3;TICAM1;ADAM19;HSPA1A;IGF1;POU3F1;EIF2AK3;SLC24A3;ZNF804A;EREG;NOS1AP;ANGPT1;LIMS1;SPHK2;MAPK8;PIK3R1;FGF10;U2AF2;SNF8;TAF1B;CELF1;HMGA2;EIF3E;ID2;NTRK3;EP300;NGF;PDGFB;BRAF
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.32347232736038417,0.7460256195274285,0.8108108108108109,1.0,1.0,4/25,11.55%,CSF1R;ACVR1;PKHD1;FGF10
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.35686011351427693,0.7459827631416664,0.7894736842105263,1.0,1.0,1/30,0.60%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.35686011351427693,0.7459827631416664,0.7894736842105263,1.0,1.0,1/30,0.60%,CCNH
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.3691830854914881,-0.7459740264478486,0.8225806451612904,1.0,1.0,10/23,35.25%,MAN1A1;SYVN1;RPS27A;MAN1B1;UBC;MARCHF6;RNF139;UBA52;UBB;RNF5
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.31776224913883194,-0.7458132715035986,0.9545454545454546,1.0,1.0,13/91,22.91%,CELF3;NONO;NCBP2;SLU7;SNRPD2;NCBP1;SNRNP48;RNPS1;USP39;SRPK1;SF3B2;DHX16;LSM4
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3342726573866376,0.7456750142414419,0.775,1.0,1.0,3/34,7.34%,TENT5A;ELAVL1;TENT5C
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.3649684786977156,0.7455801258590176,0.775,1.0,1.0,5/15,25.69%,TAFA1;CTNNB1;DISC1;VEGFA;SMARCD3
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.38906880231341767,0.7455753850173279,0.8095238095238095,1.0,1.0,10/14,31.39%,PNPLA2;NR1H3;PPARA;ITGAV;NR1H2;PPARG;TTC39B;PTPN2;ABCA1;ABHD5
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.35843502018487544,-0.7454914023114502,0.8,1.0,1.0,8/34,23.63%,PIGC;B3GNT5;MPPE1;PIGH;PIGO;PGAP4;PGAP3;ST6GALNAC5
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.479311596367466,-0.7452874044172323,0.8461538461538461,1.0,1.0,2/7,8.18%,PRLR;ZBTB7B
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.27422297764691417,0.7447557882484429,0.9722222222222222,1.0,1.0,12/92,14.18%,IFIH1;HDAC9;NUP210;NUP42;P3H3;HDAC10;TPR;NUP37;SIRT2;SIRT1;EP300;NSMCE2
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.4543236669250677,0.744331369219766,0.7631578947368421,1.0,1.0,1/6,3.42%,RAD21L1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.3502018330905031,-0.7442802095144018,0.9117647058823529,1.0,1.0,10/47,14.19%,SEMA3D;SOX10;PDXDC1;FAT2;GPC3;TBX1;SEMA3F;AMOT;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.3600942492086757,0.7442686592461681,0.84375,1.0,1.0,2/15,3.84%,NRP1;KIF26A
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4047072981343492,-0.7441838789763329,0.7833333333333333,1.0,1.0,4/12,24.02%,RAB23;GTPBP1;AK4;RAN
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.37344147275186673,-0.7441603616791417,0.8611111111111112,1.0,1.0,11/22,29.96%,HSPA5;HSPA1L;ERO1A;SDF2L1;DNAJB1;ST13;HSPA9;GAK;HSPA2;HSPA8;HSPA13
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.30829154508890294,0.7441074196578522,0.896551724137931,1.0,1.0,14/46,22.35%,MAP3K20;CASP9;CLSPN;CDC5L;NDRG1;ATM;CHEK2;TRIAP1;ATRIP;TP53BP1;ABL1;HINFP;HUS1;RAD9A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.31991172750299857,-0.7440579610040406,0.9117647058823529,1.0,1.0,11/72,11.97%,WFS1;MARVELD2;TMIE;NDUFB9;KCNQ1;CEMIP;SLC26A4;TBX1;ROR1;EYA1;SNAI2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.3872487460834574,-0.7440141070161315,0.8524590163934426,1.0,1.0,4/25,12.27%,CAV3;RAC1;DCTN1;CDK5R1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.37403289572834536,-0.7437020147115565,0.8032786885245902,1.0,1.0,7/25,20.24%,RAC1;PREX1;WASF1;VIL1;DIAPH3;WAS;CATIP
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.4456161291580709,-0.7435591777164398,0.819672131147541,1.0,1.0,2/14,5.91%,PTPRC;P2RY12
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.33990189685961203,-0.7435510241375782,0.835820895522388,1.0,1.0,8/42,22.17%,PLCD3;PLCH1;IMPA2;INPPL1;PLCG2;CALM1;IPMK;PLCD1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.3760428702657736,0.7434068298359716,0.8461538461538461,1.0,1.0,4/18,11.62%,PTBP3;PTBP2;SFSWAP;U2AF2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.4101820387656283,0.7433558942777295,0.7948717948717948,1.0,1.0,3/10,9.97%,PDE3A;APOE;KCNC2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.38282346513468485,-0.7433002046439056,0.8360655737704918,1.0,1.0,2/21,5.96%,TPX2;TRIM54
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3301172073553801,-0.743296317266275,0.8904109589041096,1.0,1.0,15/66,24.74%,NXT1;PINK1;RANBP6;RAB11A;SPRN;NUP85;NEURL1B;TSC2;LAMP1;NUP155;LAMP2;GCKR;NUP188;RAN;AKT1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.46494421481666653,-0.74306837022746,0.796875,1.0,1.0,1/6,4.12%,ZFPM1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.40693147058554474,-0.7428658237434486,0.8125,1.0,1.0,2/14,24.21%,DCP2;SSB
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.4015205785974787,-0.7423382649735786,0.8387096774193549,1.0,1.0,3/15,20.05%,ZCCHC3;C1QBP;UFD1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.3260333812633234,-0.7423053196728422,0.9076923076923077,1.0,1.0,9/64,20.27%,EPHA1;RAC1;STMN1;F11R;TPM1;RGCC;WAS;MET;ACTG1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.4767090327710795,-0.7421786971463218,0.8571428571428571,1.0,1.0,1/6,2.11%,ZNF703
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4024194312537256,-0.7420325012360248,0.8245614035087719,1.0,1.0,3/12,11.97%,NOTCH1;TGFB1;SNAI2
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.448082463282385,-0.7416930662934957,0.8548387096774194,1.0,1.0,2/8,14.19%,ACTA2;HTR2B
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.35114623389660554,-0.7408316908802938,0.8823529411764706,1.0,1.0,3/23,5.25%,LRP4;PPFIBP2;DOK7
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.3280108715254617,0.7407589867724043,0.9393939393939394,1.0,1.0,5/30,13.55%,ZDHHC14;ZDHHC11B;ZDHHC3;ZDHHC5;ZDHHC2
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.40476863806266367,-0.74052450684645,0.8088235294117647,1.0,1.0,1/17,10.74%,MSN
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.36479225300752494,-0.7404001996474536,0.8333333333333334,1.0,1.0,7/26,18.11%,ELANE;RARRES2;P2RY12;TGFB1;PDGFRB;GPR183;USP14
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3165852910027913,-0.7403849406922416,0.8961038961038961,1.0,1.0,12/90,11.55%,MYLK;CHRNB1;ACTC1;CHRNE;CAV3;MYBPC2;SMTN;CHRNG;MYOM1;ACTA2;TTN;MYOT
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.44014210496045697,0.7403798435229542,0.7714285714285715,1.0,1.0,1/6,2.73%,CTNNA2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.4075689596658261,-0.7400277926962247,0.8103448275862069,1.0,1.0,5/15,26.68%,HIP1R;NSG1;CALY;CLTC;CLTA
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.311280821559405,-0.7400133258697219,0.9583333333333334,1.0,1.0,9/105,11.35%,PTGIS;WFS1;CYP1B1;SFRP4;CARD8;SIGIRR;DAB2IP;SPI1;TMSB4X
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3099071048140993,-0.7398677882598308,0.8636363636363636,1.0,1.0,19/79,28.11%,HLA-DMA;CD74;HLA-DPB1;DCTN1;HLA-DMB;KIF11;ARF1;KIF3A;RACGAP1;AP1M2;SEC23A;DYNLL1;KIF5A;CANX;CLTC;SPTBN2;CLTA;KIF22;KLC1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.3121868243957905,-0.7398238090491653,0.8831168831168831,1.0,1.0,17/68,26.99%,RGPD3;NXT1;RANBP6;RGPD1;SPRN;NUP85;TSC2;NUP155;RGPD4;GCKR;NUP188;RPL23;RAN;AKT1;KPNA2;NUP214;KPNA5
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.3633557972624671,-0.7397001490649056,0.782608695652174,1.0,1.0,4/20,16.27%,WNT8A;ATP6AP2;TBX1;PCSK5
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.3036083449940595,0.739438267981205,0.8695652173913043,1.0,1.0,34/101,19.73%,ZNF536;LHFPL4;MAPK4;SLC35F1;UNC5D;GRIA2;MMD2;LRRC4C;GALNT13;CADM2;PCDH19;RHBDL3;CSRNP3;PHF21B;PAK5;SAG;NOL4;ELAVL3;MSI1;SEMA5B;MEGF10;CRABP1;DPYSL5;SNAP91;MAP6;KCNC1;LGR5;UNC13A;CACNA1B;PHYHIPL;CLVS2;WNK2;PCLO;EFR3B
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4214042610263393,-0.7393810202372864,0.8032786885245902,1.0,1.0,2/11,8.64%,IFI27;TGFB1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.438155542492749,-0.7393564803671503,0.8412698412698413,1.0,1.0,1/8,1.99%,PTPRC
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.30302446589666,-0.7393020829191683,0.9714285714285714,1.0,1.0,7/98,7.86%,PPP1R1B;KCNE2;RAPGEF5;CP;MYO5B;KCNQ1;PAIP2B
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.3135521437889426,0.7390557068584869,0.9375,1.0,1.0,3/31,9.43%,NRP1;SEMA5A;AUTS2
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.46503219167895427,0.7390250931511873,0.775,1.0,1.0,1/5,11.33%,RPEL1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.29657750812106565,0.7383436669507901,0.9655172413793104,1.0,1.0,15/64,18.12%,RORA;WWTR1;TRIB2;ENPP1;SIRT2;FOXO1;SIRT1;ID2;ANKRD26;CREB1;FTO;WNT5A;LRP3;BBS12;ZFPM2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.29350156253712295,0.7381981757859928,0.9130434782608695,1.0,1.0,10/97,8.73%,CDH13;DSCAM;SEMA5A;RSU1;EPHB2;MDK;EPHA8;EFNA5;PKHD1;EPHA7
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.46440575040777776,-0.7380946863698437,0.8846153846153846,1.0,1.0,1/7,14.51%,PAICS
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.37507399612443515,0.7377871607416046,0.8095238095238095,1.0,1.0,2/14,7.09%,ENPP1;PAPSS2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.30033686486977057,-0.7374553450701917,0.9315068493150684,1.0,1.0,11/109,18.55%,RAB6C;MAGEL2;ARL1;DCTN1;VPS35;PREPL;LAMP1;VPS52;ANKRD27;STX16;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.3436817402845314,0.7373917647785512,0.875,1.0,1.0,1/24,0.80%,HSPB1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.29744110743187396,0.7370138280560073,1.0,1.0,1.0,4/71,3.50%,SEM1;RFWD3;RAD51B;BRCA2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3769147139442419,-0.7366160327880942,0.8260869565217391,1.0,1.0,2/24,4.48%,FKBP1B;CAV3
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.47964838804693744,-0.736541018492382,0.8125,1.0,1.0,1/6,8.64%,TGFB1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.3722151717880844,0.736500602801747,0.7948717948717948,1.0,1.0,2/9,11.15%,SLC25A33;SPHK2
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.40120495869031314,-0.7364755884965788,0.8,1.0,1.0,4/15,13.18%,PTPRC;AGER;HLA-A;FADD
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.30131486265820706,0.7361934093457793,0.9354838709677419,1.0,1.0,7/65,7.88%,BCL2;SH3RF1;TGFBR1;CFLAR;ACVR1;HSPA1A;IGF1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.29986389704644534,-0.7358950320158423,0.9090909090909091,1.0,1.0,28/134,23.73%,HSD17B10;UROD;EPHX1;IL4I1;SERINC1;NSDHL;NCAPH2;ALDH1A1;ECI2;MDH1;ENO2;ACSL5;RETSAT;ACOT2;H2AZ1;FASN;PSME1;YWHAH;HSD17B11;HSPH1;GPD1;ACSM3;PCBD1;CPOX;APEX1;XIST;LDHA;DECR1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.36137255774323923,0.7357690741091203,0.8378378378378378,1.0,1.0,1/25,0.83%,PER2
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.4530419871697556,0.735628786380425,0.7857142857142857,1.0,1.0,2/6,26.32%,SELENON;RYR1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.40391847056659846,-0.7355262175912065,0.8307692307692308,1.0,1.0,5/14,25.96%,CALM3;PDGFRB;CALM1;GPLD1;HSP90AB1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.3226064062821761,0.7355172794111354,0.7741935483870968,1.0,1.0,2/27,3.97%,GDAP1;PEX7
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.4550014517349856,0.7353021068506786,0.7954545454545454,1.0,1.0,3/7,12.02%,NEK6;CDC23;HECW2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.3306813186632197,-0.7352731158639252,0.9027777777777778,1.0,1.0,20/63,29.86%,GLRX2;GSTM5;ERAP2;GSTP1;G6PD;RHD;LVRN;PCSK5;CPM;CPE;ERAP1;HPGDS;GPX1;FURIN;GSTZ1;SPCS1;TRHDE;NAALADL1;CTNS;SOD1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.3656898516440166,0.7348552074646628,0.868421052631579,1.0,1.0,7/17,25.09%,TPR;TSPAN33;ANO6;NUP107;ADAM10;PLEKHA7;NUP98
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3570699735753123,-0.7348390130335075,0.8783783783783784,1.0,1.0,7/30,19.73%,TGFB1;APH1B;MBTPS2;CTSH;ADAM17;ADAM9;ERAP1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.34707618858688466,-0.7348172996764957,0.8648648648648649,1.0,1.0,2/46,3.52%,ACOT4;GOT1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.32882105168858144,-0.7347164302126344,0.9166666666666666,1.0,1.0,6/61,11.35%,PTGIS;CYP1B1;CARD8;DAB2IP;SPI1;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.42962589400330087,0.734660026806773,0.8095238095238095,1.0,1.0,6/6,57.05%,PPM1F;ADAR;CORO1C;DUSP26;ADARB1;NPM1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.46330155410273816,-0.7344771093668162,0.8153846153846154,1.0,1.0,1/6,7.86%,GBA3
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.46330155410273816,-0.7344771093668162,0.8153846153846154,1.0,1.0,1/6,7.86%,GBA3
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.49081708723511075,-0.7344259112408174,0.8275862068965517,1.0,1.0,2/6,15.09%,GLI3;SIX4
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.3779305434045952,-0.7341848788481894,0.7678571428571429,1.0,1.0,6/18,24.78%,ADAMTS18;ALOX12;F11R;CD9;LYN;CEACAM1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.5116074838707373,-0.7341567138137213,0.8983050847457628,1.0,1.0,3/5,35.39%,ADAM9;D2HGDH;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.44616941615107036,0.7341463889414241,0.7619047619047619,1.0,1.0,3/5,15.55%,GREM1;MYOCD;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.3975732073815895,0.7340036240628507,0.75,1.0,1.0,2/10,11.39%,MYB;MALT1
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.3717170543851115,-0.7338995963207646,0.8059701492537313,1.0,1.0,3/24,7.58%,MSX1;LRPAP1;CCND2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.4022031178202224,-0.7338806509011058,0.8181818181818182,1.0,1.0,8/14,37.44%,CMPK2;ENTPD2;AK4;ENTPD5;AK1;ENTPD7;ENTPD1;AK8
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.38199184268353986,0.7337617777688701,0.7368421052631579,1.0,1.0,6/17,14.48%,SLC30A10;SIRT2;ABCD2;TRAP1;PLIN5;AATF
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.34779755628768855,-0.7336856078598529,0.8095238095238095,1.0,1.0,5/28,20.44%,CD6;APOD;GBP5;CUEDC2;PER1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.2876108703254385,-0.7336703178120106,0.972972972972973,1.0,1.0,14/154,12.01%,WFS1;MSX1;ATP1B1;TCP1;PINK1;CCT6A;GBA3;CAMLG;CCT8;C10ORF90;CDC37L1;RPS7;BAG4;HIP1R
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.2967794650969139,0.7335432535114638,0.9642857142857143,1.0,1.0,7/62,9.69%,HSPB1;DNAJC3;ATF3;EIF4EBP1;TPR;EIF2AK3;KLHL25
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.3364617791789973,-0.733483850042013,0.8767123287671232,1.0,1.0,11/44,24.74%,AGT;TGFB1;INHBA;VPS35;NFKBIA;RBM4B;PLA2G10;CYFIP1;UHRF1;WNT7A;AKT1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.4192853913697969,0.7334325133352384,0.8125,1.0,1.0,1/9,15.04%,TERF1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.3669026379849371,-0.7331725621519702,0.9193548387096774,1.0,1.0,9/27,28.39%,PIGC;MPPE1;PIGH;PIGO;PGAP4;PGAP3;GPAA1;PIGX;PIGV
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4518445846290756,-0.7330239493558892,0.8088235294117647,1.0,1.0,4/8,24.18%,PKP1;SLIRP;PHAX;ZCCHC17
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.48581906450566215,-0.7325572771697924,0.8666666666666667,1.0,1.0,2/7,25.13%,PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.2881262210560054,0.7325147954699449,0.9615384615384616,1.0,1.0,23/120,18.40%,CDH13;SGK1;SGK2;MELTF;LATS1;SNCAIP;CD22;APOE;PAK5;SPOCK1;SGK3;NRG3;CHPT1;SOCS2;PAK4;NEDD4;PACSIN2;WNT5A;RAP1A;RAPGEF1;HIP1;ABL2;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.333865188060404,0.7323248626429787,0.8823529411764706,1.0,1.0,4/31,11.93%,MCU;IRS2;MYRIP;RBP4
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.2977510313186493,-0.7323035750092897,0.987012987012987,1.0,1.0,30/111,24.80%,SLC7A11;AMN;SLC7A7;CHMP2B;CHMP2A;SLC48A1;LRRC8D;SLC52A2;RCN3;SLC36A1;TMEM30A;LRP2;AQP9;SLC18A2;SLC38A4;SLC11A1;SLC23A1;ABCC2;SLC3A1;TCN2;SNX4;TXNIP;KIF3A;CBLIF;SLC52A1;RAMP1;SCAMP1;SLC38A5;ARL6IP5;SLC22A4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.33636304740246464,-0.7322630215795097,0.8805970149253731,1.0,1.0,4/49,11.52%,HSD17B10;ACOX2;ETFB;ECI2
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.47230402021576,-0.7321640162538946,0.8909090909090909,1.0,1.0,2/8,15.35%,MTCH1;CNTN2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.40813121023500765,0.732102546910851,0.8823529411764706,1.0,1.0,2/17,9.64%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3307797567224512,0.7320535233405419,0.8611111111111112,1.0,1.0,8/29,16.20%,SEMA6D;SEMA5A;SEMA4C;PTPRS;SEMA3C;SEMA5B;SEMA6A;RTN4R
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.36141784825758855,0.7317844057000504,0.8055555555555556,1.0,1.0,1/24,0.83%,PER2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.4166852186579068,-0.7316148746429448,0.8360655737704918,1.0,1.0,2/12,6.25%,ATP5IF1;IFIT1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.36721964296717513,-0.7311662606647782,0.828125,1.0,1.0,4/17,16.78%,NOTCH1;NOTCH4;RGCC;FLOT1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.4336126947330859,-0.7310683148268992,0.8524590163934426,1.0,1.0,5/11,39.03%,METAP1D;NAA40;NAA35;NAA16;METAP1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.42019772486790397,0.7309204986389509,0.7674418604651163,1.0,1.0,1/7,2.42%,KDR
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3336012019751482,-0.7306511955401359,0.9253731343283582,1.0,1.0,6/69,11.55%,LRP4;MARVELD2;PPFIBP2;TGFB1;CLDN1;MYOT
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.48014337587187966,-0.7305007219469924,0.8431372549019608,1.0,1.0,1/5,14.19%,HTR2B
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.3903336221340525,0.7304726386974391,0.7941176470588235,1.0,1.0,1/13,1.23%,F2RL1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.3498552169952818,0.7302702045088809,0.7575757575757576,1.0,1.0,4/18,13.06%,GCH1;SGPP2;SPHK2;PRKG2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.38975417259979217,-0.7302007964737922,0.8695652173913043,1.0,1.0,3/21,10.25%,CEMIP;TGFB1;CALM3
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.4882765931800409,-0.7300457837659426,0.85,1.0,1.0,1/6,5.31%,SUV39H1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.4174330529937085,-0.7300197635682087,0.8305084745762712,1.0,1.0,1/10,10.43%,TBX1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.3792475818868778,-0.7295169603587874,0.8153846153846154,1.0,1.0,1/23,1.62%,NOTUM
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.3024655128188115,-0.7294719702339209,0.8732394366197183,1.0,1.0,16/68,26.70%,TBP;NCBP2;INTS5;POLR2J;TAF6;POLR2K;NCBP1;PHAX;NABP1;INTS14;POLR2I;POLR2B;ELL2;TAF5;GTF2A2;POLR2D
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.2943527894330521,-0.7293667406732067,0.9324324324324325,1.0,1.0,14/118,15.96%,ARHGAP15;RAC1;DEPDC1B;FOXM1;RASGRF2;ARHGAP9;VAV3;A2M;ARHGAP22;TAGAP;GMIP;PREX1;FGD3;ARHGAP12
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.32506767430775635,-0.7292860766354687,0.9166666666666666,1.0,1.0,16/64,22.57%,TST;DDX39A;NCBP2;SLU7;SLBP;NCBP1;RNPS1;CDC40;FLOT1;ALYREF;SIDT1;NUP155;UPF3B;DHX38;NUP188;THOC5
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.3072353608694465,-0.7290958697815704,0.8780487804878049,1.0,1.0,16/71,26.73%,WFS1;HSPA5;TRIM25;HERPUD1;MAN1A1;SGTB;PSMC6;SYVN1;UFD1;TMUB1;MAN1B1;SEL1L2;HSP90B1;ANKZF1;MARCHF6;SELENOS
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.3728801181740672,-0.728976248029253,0.8656716417910447,1.0,1.0,2/25,8.64%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.4174459073809761,0.7288698090267287,0.8095238095238095,1.0,1.0,2/9,14.01%,SORL1;EIPR1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.36684360918597725,-0.7286985367552311,0.8571428571428571,1.0,1.0,1/27,0.85%,KCNE2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.35135743178036744,0.7286911004882769,0.8285714285714286,1.0,1.0,2/19,5.27%,F2RL1;MDK
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3923477601910421,-0.7286577170290192,0.78125,1.0,1.0,6/16,30.01%,COA5;SCO2;FASTKD3;OXA1L;COA3;COX18
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.4426195266908989,-0.7285763475197777,0.8392857142857143,1.0,1.0,3/7,35.41%,AGO1;AGO4;DDX3X
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.3828135364011018,0.7285024262996438,0.8214285714285714,1.0,1.0,3/17,7.35%,CATSPER2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.4727023578444839,-0.7284621738705694,0.8636363636363636,1.0,1.0,2/7,8.86%,GMFG;CORO1A
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.44541830392165593,-0.728358545508817,0.8571428571428571,1.0,1.0,1/8,7.05%,CDC6
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.37708546801653087,-0.7282855277713756,0.7971014492753623,1.0,1.0,2/21,8.64%,RAC1;TGFB1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.46930085209144223,-0.7279002120569963,0.8,1.0,1.0,1/6,5.51%,PINK1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.46629710607789765,-0.7277681393577062,0.8421052631578947,1.0,1.0,2/6,18.11%,SVIP;USP14
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.3120090138639806,0.7277564023940357,0.9565217391304348,1.0,1.0,7/53,8.43%,GPC4;CYP1A2;SDC4;ALDH1A2;CYP4V2;AKR1C3;APOE
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.4310199620192122,0.7276071902402974,0.7027027027027027,1.0,1.0,1/7,5.79%,RAB7A
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.33633922833894236,0.7275402705386033,0.84,1.0,1.0,3/24,12.77%,DNAJC1;ARFIP1;CHP1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.3566924398228643,-0.727532502969634,0.8985507246376812,1.0,1.0,11/41,21.34%,MANBA;DAB2IP;RNASET2;NCBP1;NGLY1;ISG20;SUPV3L1;RAB12;ADAMTS9;RNASEH2C;DNASE1L1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.4527416013974215,-0.7269779990160522,0.8421052631578947,1.0,1.0,1/7,12.97%,CKB
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.4320916810579393,0.7269371062481425,0.825,1.0,1.0,1/6,13.00%,SIRT1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.38786561987231616,0.7268919584433731,0.9117647058823529,1.0,1.0,4/7,26.45%,SLC27A2;SLC25A17;PHYH;PEX13
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.23084933831047758,0.7265196976437718,1.0,1.0,1.0,63/454,15.09%,FBXL7;RFWD3;MYLIP;PELI2;RNF182;BCL2;SH3RF1;RNF126;TRIM36;CBFB;MARCHF1;PDZRN3;FBXW8;RNF217;MARCHF5;UBE2QL1;UBE2J2;SH3RF3;FBXO27;CCDC22;COMMD1;ERCC8;RNFT1;RBBP6;TRIM11;ZNRF1;ANAPC16;PELI1;UBE3D;TRIM47;TRIM4;THOP1;MARCHF3;KLHL25;CDC23;TSPAN17;UBE2E2;MARCHF8;UBE2D4;UBE2U;NEDD4L;HECW2;TRIM44;FBXL15;RNF103-CHMP3;TRIM71;BTRC;SIRT1;WWP1;RC3H1;KLHL20;RNF19B;EIPR1;PEX2;DTX1;RNF208;KLHL42;FBXL17;FBXL2;HERC2;NEDD4;UBE2R2;RNF25
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.37792044978605044,-0.7263680947060013,0.828125,1.0,1.0,2/18,12.27%,RGS10;CDK5R1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.40427118104550724,0.7259982574113217,0.8918918918918919,1.0,1.0,1/10,3.37%,GSDMB
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.3199515856784863,0.7259692877259304,0.775,1.0,1.0,3/18,12.42%,CPT1A;SLC25A20;ABCD2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.46985317780814384,-0.7257929896384315,0.8405797101449275,1.0,1.0,2/5,25.61%,PODXL;RAP1GAP
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.2580979995864609,0.7257847832076303,0.9655172413793104,1.0,1.0,31/111,22.15%,PIGQ;PIK3R6;SOCS6;SYNJ2;MTMR8;PI4K2A;PIP4K2A;PTPN13;PIK3R1;MTMR9;PIGP;SOCS2;PIGA;IP6K1;PIK3C2B;PITPNM1;DPM3;INPP5J;PTEN;MTMR6;MTM1;EFR3B;PIGU;PIP5K1C;IP6K2;PI4K2B;PLEKHA1;MTMR3;PI4KA;PIP5K1B;DPM2
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.31520813352986826,-0.7256485375822345,0.9142857142857143,1.0,1.0,7/53,14.75%,EIF5A2;PNPLA1;ACOX2;ABCB4;AQP9;SLC4A9;TLCD2
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.3629311262967612,0.7255507471229259,0.8780487804878049,1.0,1.0,6/19,21.13%,MTERF4;FBLL1;TFB2M;MRM1;NSUN4;METTL15
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.43781733888233587,-0.7252352415160083,0.8615384615384616,1.0,1.0,6/10,39.23%,GPLD1;C2CD2L;BAIAP3;CFTR;PLA2G6;TRPM4
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.33991792368667173,-0.7250216267781712,0.859375,1.0,1.0,8/41,22.17%,PLCD3;PLCH1;IMPA2;INPPL1;PLCG2;CALM1;IPMK;PLCD1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.46404095872545936,0.7250059021560872,0.8529411764705882,1.0,1.0,1/5,7.06%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.46404095872545936,0.7250059021560872,0.8529411764705882,1.0,1.0,1/5,7.06%,RASGRP1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.391182427548694,-0.7250013321845296,0.8225806451612904,1.0,1.0,5/13,22.72%,HLA-A;CTSH;EMP2;GNL1;BTN3A3
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3225121303475553,-0.7249204613359379,0.9295774647887324,1.0,1.0,4/44,9.79%,PNPLA1;DEGS2;ALOXE3;SPTLC3
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.27183398679466,-0.7246784675071456,0.9625,1.0,1.0,32/166,23.51%,PATL2;ENC1;RPS27L;NCBP2;PAIP2B;EPRS1;IGFBP5;EIF1B;ZNF540;NCBP1;ILF3;RPL5;EIF1;EEF2;DDX1;EIF4A2;EIF6;EIF2B2;RBM4B;CSDE1;RPS6KA1;NAT10;RBM4;NIBAN1;UPF3B;RPL13A;RPS4X;FXR1;YTHDF1;CYFIP1;CALR;RPS3
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.45900146555058374,-0.7245434090484744,0.8490566037735849,1.0,1.0,1/6,19.85%,NUP155
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.3583619872844158,0.7245312962110891,0.9285714285714286,1.0,1.0,2/13,6.83%,CSF1R;ARFIP2
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.4190626433899881,0.7244582171211293,0.7872340425531915,1.0,1.0,2/6,15.55%,FGFR3;MEF2C
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.43067240918237404,-0.7243569708603713,0.8,1.0,1.0,3/10,14.01%,CCL5;REST;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.43364009024549843,-0.7241075344013602,0.8571428571428571,1.0,1.0,2/9,15.22%,CD6;GBP5
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.46540796715459953,0.7240624977066537,0.8333333333333334,1.0,1.0,3/7,30.95%,CHTOP;MSH3;GTF2H2
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.25627735224913956,0.7238811900157449,0.96,1.0,1.0,9/135,8.14%,HSPB1;TENT5A;SAMD4A;ELAVL1;PRKCD;MEX3D;TENT5C;HSPA1A;IGF2BP3
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.34564528165686026,0.7236432308292587,0.8780487804878049,1.0,1.0,4/27,12.09%,SHLD1;TIMELESS;ERCC2;KMT5B
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.4380444147588375,-0.72360385966986,0.7540983606557377,1.0,1.0,2/9,22.82%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.45621940779064574,0.7230825453754484,0.8205128205128205,1.0,1.0,1/5,22.83%,PML
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.30637392745544917,0.7229148443024683,1.0,1.0,1.0,4/43,7.64%,EPHA5;WWC1;EFNA5;TRIM67
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.3669565891665145,0.7228582252482812,0.8571428571428571,1.0,1.0,5/17,8.11%,ABO;ST3GAL3;B4GALNT2;MPDU1;FUT9
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.2932861247336105,0.7228330038332987,0.9655172413793104,1.0,1.0,9/41,16.44%,PRKCD;TPR;ANP32B;BAG3;PIK3R1;NEDD4;DMAP1;CDH1;EMD
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.4683881428290548,-0.7228265796493768,0.8448275862068966,1.0,1.0,2/7,22.82%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.4683881428290548,-0.7228265796493768,0.8448275862068966,1.0,1.0,2/7,22.82%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.3505756224774312,-0.7226270935669954,0.8507462686567164,1.0,1.0,4/25,14.27%,CA12;CYB5R2;CA1;SLC4A9
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.4338123685951536,-0.7221139197872958,0.8548387096774194,1.0,1.0,4/9,37.89%,AKR1B1;TSPOAP1;STAR;CACNA1H
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.31580444365813437,-0.7221032099594027,0.922077922077922,1.0,1.0,9/69,10.83%,SCN4B;ATP1B1;SCN7A;ATP1A1;SCN9A;SLC24A1;SLC9A6;SLC5A2;SLC6A16
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.3589159896786488,-0.7220842963749681,0.8873239436619719,1.0,1.0,2/18,12.27%,RGS10;CDK5R1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.3002580642485554,-0.7215785421576103,0.8714285714285714,1.0,1.0,16/69,26.70%,TBP;NCBP2;INTS5;POLR2J;TAF6;POLR2K;NCBP1;PHAX;NABP1;INTS14;POLR2I;POLR2B;ELL2;TAF5;GTF2A2;POLR2D
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.27361748391886836,0.7212934647596295,1.0,1.0,1.0,12/79,16.96%,TSFM;MRPL17;MRPL33;MRPS27;MRPL58;MRPL39;MRPL41;MRPS7;MRPL21;MRPL4;MRPS18A;DAP3
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.4186216862116595,0.7209969519810184,0.717391304347826,1.0,1.0,1/5,14.13%,SMC1A
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.46235809301628433,0.7208421801881411,0.8378378378378378,1.0,1.0,1/6,3.64%,BMP6
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.4474021970319694,-0.720797869781619,0.7586206896551724,1.0,1.0,4/6,38.81%,SLC27A1;GPAM;PLA2G6;CDS2
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.31797129796428547,-0.720677616987755,0.918918918918919,1.0,1.0,11/49,22.58%,BNIP3;HEBP2;ACOX2;CALCR;CIDEB;CDKN1B;DAXX;PRR7;C1QA;NTRK1;ZNF746
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.277187332552135,0.7202657978112476,1.0,1.0,1.0,15/138,11.68%,EPHA3;PID1;IRS1;EGFR;RORA;HMGB1;BRINP1;TICAM1;LTK;TFPI;ADCY2;RUVBL2;SPHK2;MAPK8;GNAI1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.29336300284809114,-0.7199866468041152,0.971830985915493,1.0,1.0,21/89,26.73%,CD14;SERPINE1;PDCD1LG2;CD6;DAB2IP;GSTP1;CXCL13;STAP1;ADAM17;SLC11A1;HNRNPA0;ADAM9;LBP;PRDX3;NFKBIL1;NOS1;PAF1;PLAA;CPS1;IFNAR1;SELENOS
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.3246953530621667,-0.7198865181948116,0.855072463768116,1.0,1.0,8/44,16.66%,PNPLA1;DEGS2;ALOXE3;SPTLC3;ARG2;RHD;PCSK5;ASMT
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.26565189415167845,0.7196431788134507,0.9615384615384616,1.0,1.0,5/116,5.17%,ADARB2;PPP1R8;PCBP3;ATXN1;RBMS1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.4030882616881132,-0.7196161370075103,0.9253731343283582,1.0,1.0,1/13,1.55%,CHRNB1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.4273510540842217,0.7195079106132992,0.6976744186046512,1.0,1.0,3/7,24.07%,ATM;SMG6;TERF2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.34892408186336826,-0.7194966060404935,0.8888888888888888,1.0,1.0,11/31,25.08%,KLF5;CBLC;B3GNT3;PKP1;DUOXA1;IL13RA1;ITGB4;ENTPD2;IRF3;SCEL;CD24
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.33745976344639533,-0.7194133049033526,0.8533333333333334,1.0,1.0,5/41,7.98%,LDLRAP1;B2M;SERPINE1;NCKAP1L;GPC3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.309606832722969,0.7193119513693875,1.0,1.0,1.0,5/38,9.82%,QRICH2;LATS1;CCDC22;COMMD1;GNA12
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4133990897007084,0.719230004276071,0.8048780487804879,1.0,1.0,2/7,9.80%,BTC;EREG
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.4794923231589165,-0.7192059868221617,0.9107142857142857,1.0,1.0,1/5,8.55%,CHMP2A
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.33743623145219437,0.7190584770235984,0.8918918918918919,1.0,1.0,5/25,13.08%,KDR;MCU;MARCHF5;RALA;INF2
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.4526658414706825,0.7190496987856568,0.84375,1.0,1.0,5/5,54.74%,LPL;XBP1;PDK2;CDKN2B;USF1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.4268474272753585,-0.7189416319091967,0.8,1.0,1.0,2/9,14.93%,NKD2;CCBE1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.4589622680011549,0.7188677113891634,0.825,1.0,1.0,3/6,25.28%,PARP10;TLK2;TLK1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.35865624741825186,-0.7188309268227314,0.7796610169491526,1.0,1.0,4/22,20.46%,CCDC39;PCSK5;WNT7B;SHH
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.37903183914897426,-0.7188047976293949,0.8387096774193549,1.0,1.0,5/15,32.36%,RPS7;RPL5;RPL23;PARK7;RPL11
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.317887808575529,-0.7186839941679192,0.935064935064935,1.0,1.0,12/69,16.81%,CCDC86;MMP15;PRDX4;MBNL3;FKBP4;TEAD4;SLC52A2;HSD11B2;DHCR7;RPL8;FASN;HMGB3
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.46040287532042734,-0.7184201816580454,0.8846153846153846,1.0,1.0,1/5,16.61%,SLC11A1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.3513906916841323,-0.7183701293271271,0.8970588235294118,1.0,1.0,5/38,13.30%,AGT;CD74;DAB2IP;GSTP1;TRIM32
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.28193479222012585,0.7182876747228145,0.9411764705882353,1.0,1.0,11/56,18.73%,LEF1;FZD1;RYK;DVL2;NR4A2;LRP6;FRAT1;WNT5A;BCL9;PTEN;WNT3
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.44358028211212447,0.7179327431341305,0.7391304347826086,1.0,1.0,3/5,30.71%,TPRKB;TRIT1;OSGEP
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.41265606362293444,0.717846107492857,0.7297297297297297,1.0,1.0,1/9,0.55%,NOX4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2911824255195153,0.7177904397836385,1.0,1.0,1.0,14/48,23.75%,CRADD;BTG2;CASP2;EP300;ATM;TFDP1;CHEK2;TRIAP1;CNOT4;CDC25C;PML;TFDP2;RBL2;E2F4
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.43631257919478683,-0.7177882541009306,0.8727272727272727,1.0,1.0,1/7,17.97%,ULK1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.43631257919478683,-0.7177882541009306,0.8727272727272727,1.0,1.0,1/7,17.97%,ULK1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.372951115583882,0.7177168330559925,0.8863636363636364,1.0,1.0,7/14,30.02%,CEL;ACOT8;PLA2G15;NUDT19;LPIN3;ACAA1;LPIN2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.4401022194289517,-0.717394593962093,0.8181818181818182,1.0,1.0,1/7,15.08%,PHF23
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.3980483241718514,-0.7173008241886756,0.8266666666666667,1.0,1.0,5/19,33.73%,MSL3;WDR5;MSL1;KANSL2;KANSL1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.25518328425201653,0.7169248443237057,1.0,1.0,1.0,12/58,15.07%,SLC7A2;SLC16A7;SLC16A12;SLC6A13;SLC19A1;SLC7A1;SLC35B1;SLC25A1;SLC25A41;SLC1A2;ABCC1;SLC25A29
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.44175897625771715,-0.7167866342939729,0.8909090909090909,1.0,1.0,2/9,4.21%,TNFSF18;CD74
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.39698341856357594,-0.7167275441705248,0.8571428571428571,1.0,1.0,2/15,13.68%,CELF3;NCBP1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2718230790723207,-0.7164644339080587,0.9875,1.0,1.0,41/272,23.12%,RAB6C;CSRP3;FBLN5;CD74;WIPI1;ARCN1;CELSR1;ARL1;SLU7;RAB19;GRTP1;AMOT;SEPTIN14;STX19;PRPF19;RAB23;TBC1D13;LAMTOR2;DUOXA1;VPS35;CNTN2;RAB31;CNTNAP1;ARF3;STX16;SEPTIN1;ARF1;YWHAH;CPE;ARL6;ARL4C;SEPTIN5;EMP2;RRAGA;RUNDC1;STX1B;RAB1A;RAB1B;ARF4;RAB6D;SCG5
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.3942348382901656,-0.7158884501719066,0.9166666666666666,1.0,1.0,6/12,32.53%,SYTL4;MYOF;RAB3A;DYSF;SMPD1;ANXA6
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.330589743479033,-0.7158301212437475,0.9305555555555556,1.0,1.0,9/52,13.42%,AGT;BCL2L14;CASP8;TMC8;LTBR;PELI3;GSTP1;FADD;GPER1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.3241792067840616,-0.7157466519177565,0.9142857142857143,1.0,1.0,8/46,18.01%,HHIP;GPC3;GLI3;UCHL5;ZIC1;TXNDC15;GAS1;PDCL
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.36121245537374014,0.7156422227638463,0.8571428571428571,1.0,1.0,2/12,5.54%,UCK2;UPP2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.365561648301095,-0.7155176247151994,0.8611111111111112,1.0,1.0,5/27,14.59%,CYP1B1;SPTLC3;ARG2;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.46320981726057664,-0.7154577737299567,0.8909090909090909,1.0,1.0,2/8,16.78%,HTR2B;FLOT1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.42343658899041114,0.7154513377096499,0.8378378378378378,1.0,1.0,1/7,4.36%,DECR2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.32065015374772016,0.7154492008397026,0.7741935483870968,1.0,1.0,11/32,15.48%,SEMA6D;NRP1;SEMA5A;SEMA4C;NRTN;ERBB4;PHACTR4;SEMA3C;SEMA5B;RADIL;SEMA6A
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.44839117123179184,0.7153497479217932,0.8571428571428571,1.0,1.0,4/6,29.76%,NR1H3;NR1H2;PPARG;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.44839117123179184,0.7153497479217932,0.8571428571428571,1.0,1.0,4/6,29.76%,NR1H3;NR1H2;PPARG;PTPN2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.40430017534399987,-0.7151919754570414,0.8732394366197183,1.0,1.0,2/15,9.08%,GOT1;GAD1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.336529770607557,-0.7146600595078715,0.9436619718309859,1.0,1.0,11/41,17.52%,RDH10;HSPG2;RARRES2;GPC3;RBP2;ALDH1A1;RDH12;LRP2;RLBP1;GPC1;OPN1SW
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3926075365618529,0.7142559678559511,0.7941176470588235,1.0,1.0,2/7,6.70%,ZNF205;RAB27A
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.3040438246469904,0.7142275131299529,0.8787878787878788,1.0,1.0,5/32,16.60%,IRS1;APOE;DRD4;RAB11FIP3;NR1H3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3036532649145359,0.7140897765584248,0.84375,1.0,1.0,3/30,10.18%,SLC37A4;IRS2;DCXR
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.3996043133936973,0.7140678066327583,0.9117647058823529,1.0,1.0,2/9,7.35%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.3087344893282424,-0.7139684839167836,0.9130434782608695,1.0,1.0,16/76,19.27%,NDUFB9;NDUFA2;TMEM126B;COA5;NDUFB3;NDUFC1;NDUFB4;SCO2;DMAC1;NDUFB11;NDUFAB1;NDUFA1;NDUFB2;NDUFS2;NDUFB10;FASTKD3
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.4585711463267234,0.7138858926685708,0.7777777777777778,1.0,1.0,2/5,4.68%,HORMAD1;ANKRD31
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.32229032235310245,0.7137999180392567,0.8333333333333334,1.0,1.0,2/25,3.97%,GDAP1;PEX7
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.3233305893533941,-0.7136997812444079,0.9285714285714286,1.0,1.0,7/50,16.67%,TICRR;RPS27L;MRE11;CHEK1;BRCA1;RAD9B;DONSON
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.28145966634303987,0.7136608742630487,0.875,1.0,1.0,4/34,11.03%,PPP1R8;PRKCD;PPP6R1;NSMF
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3552653043374554,-0.7136043355976229,0.9130434782608695,1.0,1.0,11/25,29.96%,HSPA5;DAB2IP;HSPA1L;DAXX;HSPA9;HSPD1;BAX;BAK1;HSPA2;HSPA8;HSPA13
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.2937102849208196,-0.7132637075654161,0.9857142857142858,1.0,1.0,8/112,9.82%,EPHA1;CYP1B1;CD74;RAC1;NODAL;SERPINE1;IGFBP5;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.26147952332966956,0.7129139744168134,1.0,1.0,1.0,15/163,8.51%,PDE3A;PDE10A;RORA;BCL2;BMP7;SPRED1;EPM2A;SPRY3;WWC1;PDE4D;MINAR1;CCDC22;CD22;SHANK2;PKHD1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.3843798762875255,0.712741346633854,0.8181818181818182,1.0,1.0,4/9,14.62%,ABCC11;ABCC4;SLCO3A1;ABCC1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.30241263379415784,0.7125421201827472,0.8888888888888888,1.0,1.0,12/30,30.12%,BICD1;BORCS5;DYNC1I1;TRAK2;CLN3;BICDL1;TRAK1;KIF5B;MAPT;UXT;RAB6A;NDE1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3353734795319553,0.7125208706109146,0.9111111111111111,1.0,1.0,3/23,12.24%,IFIH1;TAB3;TAB1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.2468351489655206,0.7123317356117338,1.0,1.0,1.0,19/166,13.75%,NEDD1;HMMR;KCNH5;PCM1;CDC14B;CDC26;NEK6;PTPN6;ANAPC16;ERCC2;CEP135;TFAP4;CDC23;CDK5RAP2;HECW2;SIRT2;BTRC;ID2;MAPRE1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.365147970462184,-0.7123121339051516,0.8955223880597015,1.0,1.0,3/28,8.10%,ACOT4;ACOX2;ACSBG1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.31039599971032533,0.712278732169095,0.9375,1.0,1.0,6/50,8.09%,ACE2;SDC4;LAMB3;BTC;AKR1C3;RNF128
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.3284220663550279,-0.7122466648200361,0.9166666666666666,1.0,1.0,2/37,5.12%,LDLRAP1;STARD5
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.43188704989612875,0.7119598456636861,0.75,1.0,1.0,2/6,20.60%,TPR;PCID2
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.43188704989612875,0.7119598456636861,0.75,1.0,1.0,2/6,20.60%,TPR;PCID2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.36524836498916813,0.7117852046023948,0.8571428571428571,1.0,1.0,3/15,12.51%,GLYAT;SRR;PSPH
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3757995066129233,-0.7116515048394952,0.7777777777777778,1.0,1.0,7/14,35.39%,RAB23;GTPBP1;AK4;RAN;IMPDH2;ENTPD7;LRRK2
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.4039421968270146,0.7112960471566646,0.8,1.0,1.0,3/10,8.12%,UCK2;UPP2;HPRT1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.460357067824297,-0.7110348210660381,0.8208955223880597,1.0,1.0,2/5,24.02%,EIF6;RAN
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2446626595579803,0.7104895905997438,1.0,1.0,1.0,40/296,14.98%,FBXL7;RNF126;FEM1A;CDC26;DNAJB12;UBE2J2;FBXO27;ERCC8;PTTG1;ZNRF1;ANAPC16;PELI1;AGAP3;FAF1;UBE3D;DERL3;CDC23;DMAC2;RHBDD2;UBE2U;KCTD5;NEDD4L;FOXRED2;HECW2;SIRT2;UBXN2A;FBXL15;RNF103-CHMP3;TRIM71;BTRC;SIRT1;RNF216;WWP1;TMUB2;KLHL20;KLHL42;FBXL17;FBXL2;RNF175;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3223965513131968,0.7102126443871378,0.8421052631578947,1.0,1.0,1/18,2.25%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3223965513131968,0.7102126443871378,0.8421052631578947,1.0,1.0,1/18,2.25%,ZEB2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.27296344841599873,0.709848339630789,1.0,1.0,1.0,13/97,13.24%,GNG4;FGF13;SERTAD2;TGFB2;MINAR1;ENPP1;HSPA1A;SPHK2;PTPRS;RERG;BCL6;SIRT1;VGLL4
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.27581971611919404,0.7096675050862615,0.9393939393939394,1.0,1.0,10/105,10.46%,CYP1A2;PER2;GLYAT;MTHFS;ALDH1A2;CPT1A;IGF1;BSG;CROT;PC
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3641410313074341,-0.7096660215110051,0.819672131147541,1.0,1.0,7/20,25.96%,SPDYA;CCND2;ADAM17;RGCC;PSRC1;AKT1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.42485843490489444,0.7096487322751407,0.717391304347826,1.0,1.0,1/6,13.00%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.42051508171836727,-0.7095504836790921,0.9016393442622951,1.0,1.0,3/9,22.92%,DAB2IP;MMRN2;CNMD
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.2954694656142579,0.7093558199670371,1.0,1.0,1.0,19/97,17.12%,ADGRA1;NGB;GRIA2;GRM5;MMD2;BRINP1;FBLL1;NYAP1;ARHGAP39;ELAVL3;PPFIA3;NXPH1;DNER;TMEM198;SNAP91;GRIN1;MAP6;PRR36;KCNC1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.3847338395379494,-0.709263872673244,0.8166666666666667,1.0,1.0,3/22,4.48%,AGT;NOTCH1;CAV3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.2572493595819547,0.7092599444899053,1.0,1.0,1.0,18/73,18.18%,NUP62CL;ATXN1;RITA1;NUP42;RANBP17;TPR;RANBP3;THOC6;MALT1;U2AF2;SRRM1;CHP1;XPO7;RANBP3L;CASC3;LSG1;MAGOHB;CHTOP
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.47171364954376427,-0.7087807785109912,0.8653846153846154,1.0,1.0,3/6,31.96%,NDUFS2;NDUFB6;NDUFV1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3759636958616786,0.7087187083100117,0.8,1.0,1.0,1/12,2.05%,IFIH1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.27572759893980164,0.7086957278942343,1.0,1.0,1.0,7/94,9.51%,TEAD2;CD247;PARD3;LIN7A;WIPF1;TPR;TFAP4
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),0.4461919556553365,0.7084821872565324,0.8043478260869565,1.0,1.0,1/5,2.26%,BCL2L11
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.4127714442548597,0.7083416560615492,0.7222222222222222,1.0,1.0,3/6,27.36%,HAS1;MTSS2;SYAP1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.3457893648517979,0.7081921014114693,0.9032258064516129,1.0,1.0,11/26,21.65%,IL1RAPL1;LZTS3;PPFIA2;ABHD17A;SIPA1L1;HOMER1;WNT5A;ARHGAP44;ABHD17C;EPHA4;TANC2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.297316609196813,0.7080788708605874,0.967741935483871,1.0,1.0,1/30,0.86%,RAB7B
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.33418926378167235,-0.7079974959954619,0.8933333333333333,1.0,1.0,3/34,8.55%,LRP4;CHMP4B;CHMP2A
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.37561044568037966,0.7079521820406774,0.8857142857142857,1.0,1.0,3/15,7.48%,SAMSN1;IGLL1;CD22
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.431193324433895,-0.7076919690890509,0.8412698412698413,1.0,1.0,3/8,27.02%,TMSB4X;LAMTOR5;ZNF593
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.4818486568706772,-0.7076624173085236,0.8793103448275862,1.0,1.0,2/5,15.49%,CCL5;GPR183
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.4145898281364476,-0.7075998777342264,0.8545454545454545,1.0,1.0,2/13,3.43%,FGL1;IL4I1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3518697187445817,0.7074725396694281,0.8333333333333334,1.0,1.0,3/14,9.27%,DECR2;EHHADH;CROT
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.4448150439602383,-0.7071250601674196,0.8225806451612904,1.0,1.0,1/7,10.74%,MSN
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.37129957712581074,0.7070760249981534,0.8125,1.0,1.0,3/9,12.27%,GSTO2;RGN;CYB5A
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.322838933144892,0.706929594792797,0.9166666666666666,1.0,1.0,2/18,8.73%,TGFB2;EPHA7
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.33667714360917095,0.7069058151381258,0.84375,1.0,1.0,5/23,10.68%,KDR;SEMA5A;MDK;PKHD1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.35358772634787644,0.7068381202008448,0.8333333333333334,1.0,1.0,1/13,3.43%,HDAC9
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.34914313783639617,-0.7068278096699758,0.9180327868852459,1.0,1.0,4/23,18.76%,ABCB1;ABCB4;TMEM30A;ATP10B
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.3853046127360562,0.7066409504753446,0.7419354838709677,1.0,1.0,4/12,16.05%,IRS1;IRS2;SOCS2;SMARCA4
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.3853046127360562,0.7066409504753446,0.7419354838709677,1.0,1.0,4/12,16.05%,IRS1;IRS2;SOCS2;SMARCA4
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.2711122638783054,0.7066406838704197,0.9565217391304348,1.0,1.0,16/94,16.96%,TSFM;MRPL17;MRPL33;MRPS27;MRPL58;MRPL39;RARS2;LARS2;MRPL41;MRPS7;MTRF1L;MRPL21;MRPL4;MRPS18A;EARS2;DAP3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.38319626124589223,-0.7053630626287544,0.8571428571428571,1.0,1.0,2/16,6.25%,CGAS;IFIT1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.4197353978256603,-0.7051659235744495,0.8387096774193549,1.0,1.0,1/7,10.95%,EFEMP1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.37630063772240735,0.7050358856120332,0.8205128205128205,1.0,1.0,7/13,18.73%,CSF1R;LATS1;ERBB4;ID2;AKT2;JAK2;WNT3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.32772493924954593,-0.7048957056973914,0.9142857142857143,1.0,1.0,4/35,6.15%,ELANE;CD74;CD14;SERPINE1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.3266978539734236,0.7044253849442463,0.9117647058823529,1.0,1.0,4/21,10.73%,NFATC1;HEY1;JAG1;ROBO2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.28899932240728016,0.7041850340630722,0.9285714285714286,1.0,1.0,3/29,5.57%,NRP1;LEPR;WWC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3466676194475019,-0.7040138426432897,0.8421052631578947,1.0,1.0,7/25,25.44%,CHAC1;DAB2IP;ATP2A3;ERO1A;ITPR1;BAX;BAK1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.3865419139058953,-0.7039895706273229,0.8909090909090909,1.0,1.0,2/15,13.35%,PIGC;PIGH
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),0.44092972080869197,0.7037995500073673,0.7857142857142857,1.0,1.0,5/5,55.92%,PASK;SYT7;CRH;FFAR4;AIMP1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.28553125569187715,0.7037380153774251,0.9032258064516129,1.0,1.0,5/43,9.80%,EGFR;CCNA2;RBBP6;FAF1;EREG
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.2866538824818614,0.7035812932668354,0.9629629629629629,1.0,1.0,11/56,13.70%,RORA;FGFR4;HDAC9;LCAT;APOE;CYP7B1;CYP39A1;SCARB1;DISP3;SIRT1;ABCG8
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.31024388456642604,0.7034672196209105,0.8709677419354839,1.0,1.0,3/51,2.40%,CDH6;CDH20;PKP2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.30421321402306534,-0.7031310991765519,0.9459459459459459,1.0,1.0,8/66,15.16%,NXT1;DDX20;RANBP6;GEMIN4;SNRPD2;SPRN;NUP85;TSC2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.4117854462551388,-0.7031040154026834,0.8490566037735849,1.0,1.0,2/11,20.25%,CHAF1A;CHAF1B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.4377723305844513,-0.7029155598269844,0.8070175438596491,1.0,1.0,1/6,7.80%,RAB11A
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.29937865332458247,-0.702896881465505,0.9459459459459459,1.0,1.0,11/68,16.86%,FUT2;GCNT1;B3GNT5;B3GNT9;B3GNT4;B3GALT1;B3GNT3;XYLT1;B3GALNT1;B3GALT4;ALG1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.3728626101824702,-0.7027342370396698,0.8405797101449275,1.0,1.0,4/17,20.97%,AMN;MMUT;TCN2;CBLIF
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.3728626101824702,-0.7027342370396698,0.8405797101449275,1.0,1.0,4/17,20.97%,AMN;MMUT;TCN2;CBLIF
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.41325569154680375,-0.7027202802685463,0.84375,1.0,1.0,2/9,9.95%,BAAT;SDS
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.29224326884407276,0.7026413480402003,0.9259259259259259,1.0,1.0,22/92,19.80%,ARID1B;BAZ2B;ARID1A;ZBTB1;HDAC1;MYB;SUV39H2;RUVBL2;PBRM1;HMGA2;SIRT1;BRDT;SMARCAD1;HDAC5;SMARCA4;BPTF;SMARCB1;ZBTB7A;BAZ1B;KDM4C;TADA2A;BAHD1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.3126930405373742,0.702563987631065,0.9761904761904762,1.0,1.0,6/22,20.00%,TPR;ANP32B;BAG3;EMD;SIRT7;PTPN14
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.4787289440703002,-0.7025295795287048,0.8387096774193549,1.0,1.0,1/7,2.83%,SOX10
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.3496678872759593,0.7024938268624911,0.8787878787878788,1.0,1.0,1/19,0.86%,SOX13
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.3332536483288171,-0.7024257195944942,0.9333333333333333,1.0,1.0,5/29,17.70%,AHR;KCNQ1;IGFBP5;AQP9;HCN4
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.2719224960410433,0.7020727174430837,0.9259259259259259,1.0,1.0,14/91,14.98%,BMP6;PEX7;ATXN1;IDH2;NR3C2;CROT;CYP7B1;CYP39A1;SLC27A2;ABCA6;ABCD2;ABCG8;MLYCD;NEDD4
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.37445751287975515,0.7018890442142391,0.8648648648648649,1.0,1.0,5/16,18.48%,APOE;SLC27A3;SLC27A6;SLC22A9;SLC5A8
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.25226687753241767,0.701750183165947,1.0,1.0,1.0,19/120,15.95%,RAB3C;FGF13;PKP2;NECTIN3;KCNB2;KCNIP4;PTCH1;BSG;DPP6;TSPAN17;ZDHHC3;TSPAN33;CACNB2;RAB40A;ZDHHC2;SPTBN4;LRP6;EHD4;CDH1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.35234461602416645,0.701720245716143,0.8421052631578947,1.0,1.0,10/22,32.44%,SIRT1;EP300;GCK;SIRT7;ZNF692;DGKQ;PTPN2;GNMT;OGT;CRY1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.2941250980400862,0.701593537264144,0.918918918918919,1.0,1.0,5/33,16.89%,TGFBR1;ACVR1;PDGFB;EMD;MAPK7
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.44227658609495063,-0.7015390326277307,0.8421052631578947,1.0,1.0,3/5,37.30%,SLC25A11;SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.44227658609495063,-0.7015390326277307,0.8421052631578947,1.0,1.0,3/5,37.30%,SLC25A11;SLC13A3;SLC25A14
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.3738988783825516,-0.7014242550448097,0.8253968253968254,1.0,1.0,1/16,3.01%,LDLRAP1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.28306432736321396,0.7010607978975906,1.0,1.0,1.0,4/26,17.55%,SLC7A2;SLC7A1;SLC1A2;SLC1A6
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.3112084253612745,0.700918456800213,0.8979591836734694,1.0,1.0,4/26,13.75%,KANK1;PRKCD;SSH1;MAPRE1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.3392178192846165,-0.7007712541242657,0.9402985074626866,1.0,1.0,10/39,21.51%,HSPA5;TMC8;SVIP;KIF14;PEX5;ANKRD27;OPRD1;ULK1;CPTP;RPL13A
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.28267529071802455,0.7005811285220555,0.9333333333333333,1.0,1.0,4/47,13.20%,RAB3C;OLFM2;STEAP3;SVBP
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.3480137694188976,-0.7002683368028644,0.8787878787878788,1.0,1.0,2/25,5.96%,TPX2;TRIM54
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.2964544371319519,0.7001291483589704,0.875,1.0,1.0,14/36,25.17%,RNF126;UBE3D;UBE2R2;KLHL12;MGRN1;OBI1;CDC73;RAD18;KLHL22;NEURL1;UBE2O;PRKN;DTL;CUL3
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.4370641851695925,0.7000751507687167,0.85,1.0,1.0,2/6,8.08%,PDGFRA;SOX5
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.2814027890939359,-0.7000703193769406,1.0,1.0,1.0,24/131,23.32%,ACTC1;RND1;RAC1;MYO5B;RFLNA;CORO1A;TTN;MYO1F;HIP1R;MARCKSL1;TPM1;ARHGAP12;INPPL1;VIL1;WAS;TLE6;VILL;RHOH;DBN1;GHRL;EMP2;SHROOM3;WHAMM;TMOD2
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.31363976142898,0.6999797860313487,0.9210526315789473,1.0,1.0,4/33,11.06%,NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.31363976142898,0.6999797860313487,0.9210526315789473,1.0,1.0,4/33,11.06%,NUP210;NUP42;TPR;NUP37
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.24924875954853895,-0.699519133176101,1.0,1.0,1.0,68/433,20.51%,BTN2A2;WFS1;CYP1B1;MSX1;CDKN2D;TCHP;SFRP4;RND1;CDKN3;LRPAP1;NOTCH1;GMNN;BNIP3;CHMP4B;SOD2;ATF5;RASA1;SSTR1;CRLF3;IRF1;CDC6;FOXM1;CHMP2A;TGFB1;TDRD9;WDR6;DAB2IP;INHBA;IFIT3;TBX1;FABP3;CAMK2N1;REST;TP53TG5;IFNLR1;BTBD18;TAF6;ADGRB1;GPER1;NOTCH4;HTR2B;VPS35;KLF11;TSC2;TLR2;CDKN1B;INCA1;WNT9A;CLMN;RGCC;NAIF1;TPTE2;PDCD5;LPCAT3;PODXL;PDS5B;ESR2;DACT2;KANK2;NME6;OSGIN2;PLXNA3;FTH1;PRAME;KNG1;CD9;SHH;TXNIP
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.36097975319141196,-0.6994604028388863,0.8852459016393442,1.0,1.0,3/17,14.64%,ATP5IF1;MSN;VPS35
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.2893116500934196,0.6991973792786343,0.9230769230769231,1.0,1.0,11/55,13.70%,RORA;FGFR4;HDAC9;LCAT;APOE;CYP7B1;CYP39A1;SCARB1;DISP3;SIRT1;ABCG8
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.41722392239695455,0.6991013930868398,0.9117647058823529,1.0,1.0,3/8,11.55%,TGFBR1;ZBTB1;FGF10
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.2811420020896692,-0.6989800844008,0.9878048780487805,1.0,1.0,12/91,17.36%,NES;LRP4;CYP19A1;FJX1;DAB2IP;TEAD4;SRPX;SNAI2;BOK;PPIC;SMARCA1;GPC1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.3559343819663328,0.6989119898148992,0.8333333333333334,1.0,1.0,8/18,20.44%,FAF1;NEDD4L;FAM83D;SNF8;ZDHHC2;CHEK2;ZDHHC7;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.3497469328615018,-0.6986815211884041,0.8888888888888888,1.0,1.0,1/18,4.48%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3706447092386398,-0.698452664222405,0.9076923076923077,1.0,1.0,3/17,6.95%,PINK1;SOD2;NONO
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.320894063322241,0.6982311829408431,0.8928571428571429,1.0,1.0,10/32,22.23%,CLN6;CLVS1;ARSB;HOOK3;CLVS2;CLN3;TPP1;VPS18;TFEB;MYO7A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.3570587529000464,0.6982254724474446,0.6923076923076923,1.0,1.0,6/12,32.97%,PARP10;PARP6;TNKS;PARP11;PARP16;PARP3
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.4314436706147969,-0.6980752704735783,0.8727272727272727,1.0,1.0,1/9,0.95%,NES
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.3389788940565982,0.6978751550236328,0.8108108108108109,1.0,1.0,6/21,17.29%,NTRK3;NGF;MAGI2;RAP1A;RAPGEF1;TMEM108
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.2521539643825869,-0.6978379545596265,1.0,1.0,1.0,26/347,15.18%,TRIM58;ARIH2;TRIM22;EPAS1;TRIM5;ENC1;RNF212B;PINK1;TRIML2;TRIM54;SKP1;CBLC;RNF213;RNF39;C10ORF90;HLA-A;EYA1;RNF26;UFM1;NUP85;TRIM32;HIF3A;PCNA;RNF181;NEUROD2;BRCA1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.353364171585975,0.6977993799618244,0.8333333333333334,1.0,1.0,2/11,15.77%,RAB27A;KIF5C
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.3552736907915786,0.6977128157276359,0.8387096774193549,1.0,1.0,1/11,8.43%,APOE
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.26314503831875613,-0.6974832921834044,1.0,1.0,1.0,42/276,23.56%,FIP1L1;SYF2;CSTF2T;DDX39A;NONO;NCBP2;SLU7;UBL5;SNRPD2;PCBP1;ZMAT2;PPWD1;FRG1;POLR2J;POLR2K;PRPF19;BUD13;NCBP1;SNRNP48;RNPS1;CDC40;SUPT5H;RBM4B;ALYREF;HNRNPA0;CMTR1;USP39;CWC25;RBM4;CRNKL1;RNMT;MFAP1;UPF3B;SF3B2;DHX38;CLP1;THOC5;DHX16;LSM4;POLR2I;POLR2B;BUD31
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.3026471472025074,-0.6974480930501269,0.9577464788732394,1.0,1.0,10/70,20.33%,MMP15;RABGGTB;MANBA;UBL5;PHEX;PIGH;ERO1A;PLOD2;CPE;ATG3
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.3686521420565403,-0.6973798296300681,0.9047619047619048,1.0,1.0,3/17,9.16%,RARRES2;P2RY12;CCL5
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.3699001649039026,0.6971500547500897,0.9117647058823529,1.0,1.0,5/16,8.11%,ABO;ST3GAL3;B4GALNT2;MPDU1;FUT9
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.3792229374937646,-0.6970278065307915,0.8412698412698413,1.0,1.0,3/15,10.69%,SFRP4;TMEM204;LRIT3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.34099705297330235,0.6969470403079779,0.8387096774193549,1.0,1.0,7/20,16.60%,HMGB1;XKR6;XKR4;SCARB1;MEGF10;RHOBTB1;NR1H3
prerank,MSigDB_Hallmark_2020__Coagulation,0.291900522836312,0.6967807724050707,0.9629629629629629,1.0,1.0,9/89,8.65%,F11;PROS1;KLKB1;S100A13;CASP9;HTRA1;S100A1;GNG12;PLAT
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.3219762984151096,0.6965627014116532,0.8823529411764706,1.0,1.0,6/39,12.24%,TLR1;TRAF3;HMGB1;S100A1;TAB3;TAB1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.3625639375283041,-0.6965493801029371,0.8529411764705882,1.0,1.0,2/13,12.31%,GAR1;TRUB1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.2927005621912441,0.6965471122763337,1.0,1.0,1.0,8/77,8.43%,UNC5B;SLC30A10;BCL2;PM20D1;TOX3;MDK;TGFB3;APOE
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.312629746326228,-0.6964263677747116,0.9027777777777778,1.0,1.0,5/37,10.81%,FBLN2;NOTCH1;RAC1;ECM2;PIK3CB
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.45838893868038466,-0.6963914180934195,0.7903225806451613,1.0,1.0,2/5,22.63%,PDZD7;LRTOMT
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.32788422690097246,-0.6956293546215404,0.875,1.0,1.0,9/48,15.20%,TRIM5;STAT1;IFIT1;CCL5;OAS3;TRIM32;IFIT5;ILF3;ISG20
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.24403905242281393,0.6955769546358569,1.0,1.0,1.0,27/187,16.85%,BCL2L11;PCM1;BRCA2;LATS1;ARFIP2;MID1;WASF2;RASA2;BIN1;PLEKHG2;KPTN;CDK5RAP2;ACTN4;RASAL2;HOOK3;ESPL1;MAPRE1;TIAM1;SMC1A;NUMA1;CNTROB;ALMS1;SUN2;VCL;LMNB1;MYO1E;PXN
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.38361384617498373,-0.6950859897969406,0.8529411764705882,1.0,1.0,2/12,12.71%,RAC1;ADGRB1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.37392726213409294,-0.6948180695537811,0.8923076923076924,1.0,1.0,1/16,5.16%,WNT8A
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.3491070502145163,0.6946975152045597,0.8636363636363636,1.0,1.0,6/13,29.43%,PPP3CA;PPP5C;NCK1;PPP1CA;PPP1R15B;PPM1F
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.3652898227301309,0.6945528929608468,0.8333333333333334,1.0,1.0,6/11,25.47%,SPHK2;GPD1L;WNT5A;ADRA1A;VEGFA;DGKD
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.3429709300021387,0.6941001231776786,0.8888888888888888,1.0,1.0,1/15,2.05%,IFIH1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.4256788109811544,0.6940414032453162,0.8478260869565217,1.0,1.0,1/5,2.11%,TLR1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.32392763612756775,0.6939445708341515,0.9210526315789473,1.0,1.0,6/30,18.72%,EPM2A;MINAR1;KPTN;SIRT1;ATM;DDIT4
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.4002312200643451,0.6938816549215835,0.8363636363636363,1.0,1.0,1/5,14.72%,PLEKHM1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3182873069736691,-0.6938163461318937,0.9367088607594937,1.0,1.0,10/50,20.65%,ELANE;MANBA;DAB2IP;CLPX;SIAH1;PRPF19;NGLY1;RAB12;ADAMTS9;LAMP2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.42132314535860366,-0.6937733602415751,0.828125,1.0,1.0,2/8,15.27%,PDZD11;LIN7C
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.42132314535860366,-0.6937733602415751,0.828125,1.0,1.0,2/8,15.27%,PDZD11;LIN7C
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3080736232372511,0.6936225241317004,0.9411764705882353,1.0,1.0,9/40,21.95%,GREM1;NAF1;PARM1;PNKP;TERF1;ATM;CTNNB1;SMG6;NVL
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.3562774228665522,-0.6935895246401746,0.8428571428571429,1.0,1.0,4/27,14.80%,NOTCH1;DRD3;SYT4;STXBP6
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.31699368651941834,-0.6934859298024972,0.9054054054054054,1.0,1.0,8/37,18.74%,TMEM184A;KLF5;ALOXE3;B3GNT3;WNT7B;GPRC5A;ITGB4;KRT86
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.45529827328187666,-0.6933452597991798,0.8461538461538461,1.0,1.0,1/6,4.48%,CAV3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.3943074376918153,0.6932746384786069,0.85,1.0,1.0,1/12,2.27%,NRP1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.2804636674960141,-0.6927161726685773,0.9855072463768116,1.0,1.0,10/88,17.05%,IHO1;ATF5;RAB11A;CALM3;BORA;KIF20B;GPER1;CHEK1;PLK4;KIF11
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.3684388976478604,-0.6926597853711559,0.8870967741935484,1.0,1.0,3/17,14.64%,DAB2IP;MSN;VPS35
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.3648143665300082,-0.6925981953342962,0.8769230769230769,1.0,1.0,1/18,4.64%,PPA1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.45443374668866543,-0.6925812836567805,0.864406779661017,1.0,1.0,3/5,46.32%,TMLHE;BBOX1;SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.45443374668866543,-0.6925812836567805,0.864406779661017,1.0,1.0,3/5,46.32%,TMLHE;BBOX1;SHMT1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.2802565468214403,0.6922046909123183,0.9375,1.0,1.0,3/28,6.58%,PLCB1;MDK;HMGB1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.34191285393217774,-0.6921360361923249,0.9264705882352942,1.0,1.0,5/36,15.70%,MARVELD2;CLDN1;F11R;CLDN20;CLDN10
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.36676555758377916,0.6921308487572411,0.875,1.0,1.0,2/11,7.58%,KLK6;PRMT5
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.3642291610178996,-0.6918195819130952,0.9076923076923077,1.0,1.0,1/18,9.19%,SKP1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4234293679033303,-0.691781073741474,0.9206349206349206,1.0,1.0,1/10,5.45%,NODAL
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.4102942642763074,0.6917361486395879,0.8484848484848485,1.0,1.0,2/6,7.35%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.44027671329073176,-0.6915339054809895,0.8421052631578947,1.0,1.0,3/5,40.30%,PLN;CRYAB;INSIG1
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.45732266569202906,0.6913517202187114,0.8,1.0,1.0,1/5,2.40%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.2979829753140275,-0.6911780372409015,0.9583333333333334,1.0,1.0,17/81,23.51%,PATL2;ENC1;PAIP2B;EPRS1;IGFBP5;DAB2IP;CAMK2N1;ZNF540;ILF3;CDK5;RBM4;KNG1;RPL13A;FXR1;ATRAID;CALR;RPS3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.39531891009882447,-0.6911623238802513,0.8709677419354839,1.0,1.0,1/8,10.74%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.39531891009882447,-0.6911623238802513,0.8709677419354839,1.0,1.0,1/8,10.74%,MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.39531891009882447,-0.6911623238802513,0.8709677419354839,1.0,1.0,1/8,10.74%,MSN
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.2826810185577946,-0.6911163133156767,0.9743589743589743,1.0,1.0,11/96,16.34%,FANCI;WFS1;PINK1;UBE3A;CAMLG;DNAJA1;ADGRB1;TSPYL5;PHF23;BRCA1;DAXX
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.38278570071198537,0.6910577486911398,0.8205128205128205,1.0,1.0,2/9,13.49%,STX18;SORL1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.30937885722259506,0.6908773049273097,0.9393939393939394,1.0,1.0,5/23,17.55%,SLC19A1;PDPN;SLC22A6;SLC1A2;SLC1A6
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.32433399991693496,0.6907652256914623,0.9375,1.0,1.0,4/22,13.55%,ZDHHC14;ZDHHC11B;ZDHHC3;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.32433399991693496,0.6907652256914623,0.9375,1.0,1.0,4/22,13.55%,ZDHHC14;ZDHHC11B;ZDHHC3;ZDHHC2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.27736118464933274,-0.6900813758479069,1.0,1.0,1.0,24/153,20.29%,LRP4;NOTUM;HIC1;SFRP4;PSMB6;PSMB8;NKD2;GLI3;DAB2IP;RNF213;KREMEN1;SNAI2;PSMA3;PSMA5;PSMC3;TSC2;PSMA7;PSMC6;PSME1;RBX1;TLE6;WIF1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.42633443137065524,-0.6900045660509904,0.8571428571428571,1.0,1.0,3/6,24.64%,MOCS2;NFS1;MOCOS
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.4288248100320731,0.6897195216623263,0.8285714285714286,1.0,1.0,2/5,20.39%,TRPC1;TPH1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.42955457099589034,-0.6896772022611473,0.8596491228070176,1.0,1.0,2/9,12.80%,ERLEC1;SVIP
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3939779529168097,-0.6896312492598015,0.873015873015873,1.0,1.0,2/10,18.46%,HAT1;H3-3A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.34528895425781836,-0.6895738055979914,0.9032258064516129,1.0,1.0,1/19,7.34%,SUB1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.27727599083921267,-0.6894288961150715,0.987012987012987,1.0,1.0,31/168,20.80%,SLC7A11;CD82;HINT1;EPHX1;NOTCH1;H1-2;GM2A;RPL36;RPS27L;CCND2;TGFB1;GPX2;PROCR;DRAM1;GADD45A;CDK5R1;HSPA4L;BLCAP;RETSAT;PCNA;ISCU;CSRNP2;AEN;RAD51C;TGFA;ANKRA2;ITGB4;TCN2;TNFSF9;TXNIP;LDHB
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.29537971644076505,0.6893865922948683,0.9696969696969697,1.0,1.0,9/30,24.30%,GRM5;PRKCD;TCOF1;NANOS3;FOXO3;GEMIN5;NR1H4;PUM3;METTL18
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.36571556058953597,0.6892814321213947,0.9166666666666666,1.0,1.0,2/12,9.20%,IWS1;TPR
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.3187316790539183,-0.6887796253384091,0.9206349206349206,1.0,1.0,4/36,9.79%,PNPLA1;DEGS2;ALOXE3;SPTLC3
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.4290408288094376,-0.6886047687414107,0.8909090909090909,1.0,1.0,1/7,8.90%,AGER
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3345991338052555,0.6885542191108541,0.8666666666666667,1.0,1.0,2/31,6.46%,IFI16;FHIT
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.3870937437666523,-0.6884802474024289,0.85,1.0,1.0,1/10,3.96%,RND1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.34616417885858725,-0.6884608241734815,0.9375,1.0,1.0,1/21,7.35%,KCNQ1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.2732369405474166,-0.6884099897024211,0.987012987012987,1.0,1.0,11/136,10.28%,PRLR;ANKS4B;TMEM35A;EID2;TCP1;CCDC39;CHMP4B;CHMP2A;TGFB1;RPL38;CASQ1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.37155988816281077,0.6883503002940515,0.7906976744186046,1.0,1.0,3/10,20.38%,PTPRS;RTN4R;EPHA4
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.3515846631269215,-0.6882492993134357,0.9333333333333333,1.0,1.0,4/20,19.55%,LDLRAP1;MBTPS2;LPCAT3;FMO5
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.39958476384562325,0.688027844994992,0.8421052631578947,1.0,1.0,2/6,21.67%,ETF1;APEH
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.2521394796195697,0.6878336512911521,1.0,1.0,1.0,13/93,15.73%,TSFM;MRPL17;EEFSEC;MRPL33;MRPS27;EEF1D;MRPL58;MRPL39;MRPL41;MRPS7;MRPL21;MRPL4;MRPS18A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.4520179452123742,-0.6874145088772936,0.8412698412698413,1.0,1.0,1/6,4.48%,CAV3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.3690413088969832,-0.6873283691354078,0.9152542372881356,1.0,1.0,1/14,4.62%,COASY
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.44551276646331295,0.6872532561663515,0.8888888888888888,1.0,1.0,2/7,21.56%,HMGA2;HSF1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.3444005159860267,0.6869342648329178,0.8611111111111112,1.0,1.0,2/14,7.24%,PTBP3;PTBP2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.43856785377974805,-0.6866330524304809,0.9230769230769231,1.0,1.0,2/5,14.59%,REST;SYT4
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.4537360109872854,-0.6865876813013088,0.9019607843137255,1.0,1.0,1/6,12.35%,IFNLR1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.31624617274590316,-0.6859073844913064,0.8983050847457628,1.0,1.0,3/38,5.08%,LIPH;LIPI;DDHD2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.3231047575953123,0.685889772735771,0.9629629629629629,1.0,1.0,2/12,13.96%,TPR;KLHL20
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.40083743393977883,0.6857574893520452,0.8,1.0,1.0,1/5,4.33%,VLDLR
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.3943328812042525,-0.6851971897212126,0.8333333333333334,1.0,1.0,2/11,13.15%,GOT1;L2HGDH
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.36640166944148744,-0.684940003033817,0.8360655737704918,1.0,1.0,6/17,24.74%,SPDYA;CCND2;ADAM17;RGCC;PSRC1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.3749978972807667,-0.6846882557796062,0.9016393442622951,1.0,1.0,3/12,15.31%,NOTCH1;TGFB1;PTPRZ1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.43117738557818774,0.6845350014715379,0.825,1.0,1.0,1/5,5.03%,XRCC4
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.3755207442242825,0.6844446784171897,0.8541666666666666,1.0,1.0,2/10,16.15%,FNBP1L;PACSIN2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2656463758443565,-0.6842524356042176,1.0,1.0,1.0,9/154,12.81%,F8;LMAN1;ARCN1;SPTBN5;BCAP31;F10;DCTN1;CTSZ;MPPE1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3760002386949486,-0.6840423937474585,0.8703703703703703,1.0,1.0,4/14,26.74%,RAD51AP1;WAS;FANCB;ACTR2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.32022629619876336,-0.683864341410947,0.9452054794520548,1.0,1.0,6/35,9.16%,TNFSF18;CTF1;IL15;FLT3;CRLF1;CCL5
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.3863928148311323,0.6838523394861897,0.8378378378378378,1.0,1.0,3/7,20.43%,VAMP3;NMB;EDN1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.3229238399473186,-0.683838797557259,0.9420289855072463,1.0,1.0,5/31,14.69%,TGFB1;ZIC1;UFM1;RAB23;APOD
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.4194646327734115,-0.6835754995013804,0.8888888888888888,1.0,1.0,2/9,13.96%,SDS;SERINC3
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.2689638324233232,0.6835449106432022,1.0,1.0,1.0,20/86,22.73%,EGFR;BCL2;TGFBR1;TGFB2;IGF1;SLC25A33;NEDD4L;SYT1;NGF;MAP3K13;ADNP2;USP47;UNC13A;EDN1;RIMS2;RPTOR;ITSN2;LIMK1;KLHL22;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.28271282817169946,-0.6835378997421584,0.9864864864864865,1.0,1.0,12/125,10.67%,CD4;PTPRC;AGT;TPX2;DOK7;TOM1L1;SPDYA;STRADB;CCL5;DAB2IP;CALM3;BORA
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.361528715564483,0.683371918339214,0.8787878787878788,1.0,1.0,5/12,31.10%,RAP1A;MAP4K4;RAP2A;RAP2B;RAPGEF2
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.361528715564483,0.683371918339214,0.8787878787878788,1.0,1.0,5/12,31.10%,RAP1A;MAP4K4;RAP2A;RAP2B;RAPGEF2
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.2564076202407147,0.6833502434105406,0.96875,1.0,1.0,11/90,10.16%,RIMBP2;FGFR4;GAL3ST1;KIF26A;FAM163B;TOX3;CACNG4;HGFAC;DUSP8;FBLL1;CARMIL3
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.4087119831083961,-0.6832202141121876,0.9056603773584906,1.0,1.0,2/9,20.09%,PDZD11;BTD
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.30242234511412386,0.6830503935517465,0.84375,1.0,1.0,9/42,13.79%,GAL3ST1;PARD3;AMIGO1;KLK6;SLC8A3;SBF2;SIRT2;ABCD2;MBP
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.40467372609919194,-0.6830172179372768,0.8852459016393442,1.0,1.0,1/9,10.74%,MSN
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.25586966334348743,0.6827032726983211,1.0,1.0,1.0,10/49,16.23%,RAB7A;CCDC22;SNF8;DENND1A;PTPN23;STX6;EIPR1;EHD4;VPS53;RAB11FIP3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.34858945402582886,0.6824405286093219,0.9032258064516129,1.0,1.0,1/12,2.40%,PKP2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.3030151103117714,-0.6823445449889476,0.9285714285714286,1.0,1.0,11/60,25.03%,CPNE5;MCOLN1;SYT2;SYT4;NEUROD2;PLCG2;RASGRP2;GPLD1;RYR3;SYT13;SYT9
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4302692058212862,-0.6821400294920165,0.8688524590163934,1.0,1.0,5/10,29.40%,GBP5;CPTP;USP50;NLRP2B;CD36
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.4272076469804955,0.682079898005083,0.825,1.0,1.0,3/6,28.09%,MTG2;NLGN3;ATP1A2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.3081588844871316,-0.682035862144585,0.9714285714285714,1.0,1.0,8/47,16.71%,HSD17B2;CDKN2D;WNT8A;TBX1;CTSH;WNT9A;ZNF35;WNT7B
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.3373871419430439,0.6819321974199287,0.9230769230769231,1.0,1.0,3/18,10.74%,CSF1R;MDK;IL34
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.32982372583181857,-0.6817751385047827,0.9047619047619048,1.0,1.0,5/25,16.32%,MARVELD2;MSN;F11R;MYADM;TJP3
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.42229859201827585,-0.6813627835716075,0.8571428571428571,1.0,1.0,2/7,15.49%,CCL5;GPR183
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.41861674361320966,-0.681287978661778,0.8688524590163934,1.0,1.0,1/8,7.10%,UNC119B
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.3575740746569501,-0.6808942391711661,0.8714285714285714,1.0,1.0,5/16,17.71%,RBP2;LRP2;CYP2R1;RLBP1;TTPA
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),0.4053247005407541,0.6808935361031824,0.8269230769230769,1.0,1.0,2/5,27.21%,ABCA2;SPHK1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.3135915563701481,0.6801579996642173,0.9032258064516129,1.0,1.0,6/24,15.95%,PRKCD;TPR;BAG3;PIK3R1;DMAP1;CDH1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.37908205626964375,0.6799499372361058,0.7954545454545454,1.0,1.0,1/7,11.89%,PIBF1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.32279408926352504,-0.679679162212148,0.8955223880597015,1.0,1.0,2/28,7.97%,RAC1;BRK1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.3988230912285942,-0.6792300620650238,0.8405797101449275,1.0,1.0,2/10,21.39%,GPC3;MESP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3232496592197559,-0.6792071680858116,1.0,1.0,1.0,6/40,13.95%,BCL2L2;PINK1;BCAP31;HERPUD1;SIAH1;BOK
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.3336648941189866,-0.6791738626429582,0.92,1.0,1.0,2/24,4.48%,CHRNB1;CAV3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.3143542747278302,-0.6789479096626506,0.9152542372881356,1.0,1.0,3/39,5.08%,LIPH;LIPI;DDHD2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.3468043049122719,0.6788233567787331,0.9615384615384616,1.0,1.0,4/29,8.65%,PTPN3;DNAJC1;TM4SF20;PLAT
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.3138268747171765,-0.6786111790890008,0.9420289855072463,1.0,1.0,4/50,11.98%,HSD17B10;ALOX12;ECI2;ADH5
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.2848900363631008,-0.6783467859892816,1.0,1.0,1.0,16/90,21.11%,ACOT4;BAAT;ACOT12;ACOT13;PLAAT5;PDZD11;ACOT2;ACSM4;CPM;ACSM6;DHFR2;ACOT1;CPE;BTD;ST6GAL1;ACSM3
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3042437739058819,0.6779542825967504,0.9090909090909091,1.0,1.0,9/39,12.74%,PER2;OSBPL7;OSBPL6;AKR1C3;PNPO;CYP7B1;CYP39A1;SLC27A2;OSBPL3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3461774433250626,-0.6777116902723677,0.9642857142857143,1.0,1.0,6/23,16.34%,MOAP1;CASP8;DAB2IP;SPI1;FADD;DAXX
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4106798109935951,0.6774644623962206,0.8717948717948718,1.0,1.0,2/6,6.33%,TGFB2;ACVR1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.28162734388670313,0.6773986478776926,1.0,1.0,1.0,8/66,10.24%,ADAMTS2;LAMA4;PCDH18;FNDC1;PDGFRA;PLAT;TAGLN;MSRB3
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.3156097978397462,0.6770891800453525,0.868421052631579,1.0,1.0,2/19,7.70%,KANK1;NLGN1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.36367891449225337,0.6764543691171389,0.8055555555555556,1.0,1.0,5/8,33.33%,CLN3;CPNE1;CPNE6;AGK;CPNE7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.43451131215130256,-0.6761863089399182,0.8688524590163934,1.0,1.0,2/6,20.50%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.3398017879662497,0.6754133193044431,0.9393939393939394,1.0,1.0,4/18,10.73%,NFATC1;HEY1;JAG1;ROBO2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.2836244090365033,-0.6753378293777572,0.9868421052631579,1.0,1.0,15/82,20.29%,PSMB6;PSMB8;TOLLIP;SKP1;PELI3;PSMA3;PSMA5;PSMC3;NFKBIA;PSMA7;PSMC6;PSME1;RBX1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.3936936603292498,-0.6752524431897031,0.8260869565217391,1.0,1.0,4/8,22.94%,SERPINA10;SPINK13;PLA2G10;GLRA1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.3864095951966181,0.6751009360613173,0.8611111111111112,1.0,1.0,1/8,12.41%,ETF1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.40409343514459717,-0.6750600962478367,0.84375,1.0,1.0,2/11,11.35%,ELANE;TMSB4X
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.3683399494999016,0.6750467235356794,0.9090909090909091,1.0,1.0,1/9,4.74%,FGFR3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.2925052379692064,-0.6746226808442352,0.9342105263157895,1.0,1.0,4/68,11.01%,ARIH2;CAV3;NKD2;DDA1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.40273497299552524,0.6744345934999828,0.8048780487804879,1.0,1.0,3/6,24.82%,PNPLA2;MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.38233622669205114,0.6740805515889768,0.782608695652174,1.0,1.0,3/5,17.56%,SLC19A1;ABCC4;ABCC5
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.32889345313166,-0.6740789602666558,0.9558823529411765,1.0,1.0,6/29,9.16%,TNFSF18;CTF1;IL15;FLT3;CRLF1;CCL5
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.3587063963391468,-0.6740168153694057,0.8688524590163934,1.0,1.0,8/22,23.40%,AMN;SLC52A2;SLC23A1;TTPA;TCN2;CBLIF;SLC52A1;SLC27A1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.37695514042514816,0.6737621294736476,0.8536585365853658,1.0,1.0,2/11,12.03%,PARD3;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.44142511813449914,0.6735423808312453,0.8958333333333334,1.0,1.0,1/5,8.22%,ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.287305233405606,-0.6731176430239937,0.9565217391304348,1.0,1.0,13/80,23.51%,PATL2;ENC1;PAIP2B;EPRS1;IGFBP5;ZNF540;ILF3;RBM4;RTN2;RPL13A;FXR1;CALR;RPS3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.2765336433320254,0.672558844837738,0.9722222222222222,1.0,1.0,4/64,8.92%,CCNH;ELP4;IWS1;ERCC2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.3017448196693466,0.672463228404316,0.9032258064516129,1.0,1.0,3/20,14.98%,RAB7A;SORL1;NEDD4
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.4274320060255795,-0.6724332098040035,0.9122807017543859,1.0,1.0,3/8,32.74%,VPS4A;VPS39;ANKFY1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.29116441286897893,-0.6723218029573959,0.971830985915493,1.0,1.0,16/93,18.36%,HCK;BIK;PINK1;KIF9;BRK1;TGFB1;HSPA5;TMC8;DAB2IP;SVIP;HRK;SLF1;PEX5;OPRD1;ULK1;ANKRA2
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.4403094791868004,-0.6722902099414024,0.8813559322033898,1.0,1.0,3/5,37.99%,LYN;JAK3;CD274
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.4186978983042877,-0.6720430048769259,0.8571428571428571,1.0,1.0,3/9,23.01%,DAB2IP;ATRAID;FURIN
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4209816074776039,-0.6719266997737647,0.8727272727272727,1.0,1.0,2/10,12.80%,ERLEC1;SVIP
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.34966631287806116,-0.6718538495874605,0.9027777777777778,1.0,1.0,4/21,20.27%,SOX10;LIN7C;ARHGAP12;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.2876892672160121,-0.671819877427472,0.9866666666666667,1.0,1.0,13/57,26.24%,TCP1;CCT6A;TGFB1;CCT8;ZIC1;LAMTOR5;CCT7;YAP1;PYHIN1;CCT2;RAN;AKT1;JUP
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.36371536534668303,0.6713067496628453,0.8888888888888888,1.0,1.0,1/9,11.85%,GUCY1A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.27670461168560945,-0.6712792215918678,1.0,1.0,1.0,21/120,19.12%,BTN2A2;PTPRC;ELANE;ZFPM1;RAC1;NCKAP1L;PDCD1LG2;SIGIRR;AGER;TRIM25;INHBA;TMSB4X;APOD;SFTPD;CMKLR1;RGCC;SLC11A1;CUEDC2;NLRC5;C1QBP;ISG15
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.413090110794353,0.6712305295940095,0.8409090909090909,1.0,1.0,2/6,27.69%,SETD1A;SETD4
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.34668527300364604,-0.6712261851468888,0.9027777777777778,1.0,1.0,7/17,23.47%,SERPINE1;AGER;CCL5;C1QBP;CXCL17;PLA2G7;CALR
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.299070167474821,-0.6710363469055167,0.958904109589041,1.0,1.0,11/53,22.19%,ATP5IF1;PINK1;PGAM1;NUP85;EIF6;COX7A2L;NUP155;GCKR;COX7A2;AK4;NUP188
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.43605017137310387,-0.6708759968827815,0.9253731343283582,1.0,1.0,2/6,37.02%,SLC7A5;SLC6A15
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.24997603334670634,0.6704669735401088,1.0,1.0,1.0,19/149,14.18%,SEM1;RFWD3;RAD51B;BRCA2;XRCC4;PAXX;HMGB1;DCLRE1B;NSMCE1;BABAM2;EME2;SAMHD1;SMARCAL1;MAPK8;EYA3;SPIDR;BRCC3;SMARCAD1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.3239644411881858,0.6701950574537168,0.972972972972973,1.0,1.0,4/19,19.15%,RUVBL2;SPHK2;SMARCB1;TADA2A
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),0.37133819282079483,0.6700786526466848,0.8421052631578947,1.0,1.0,5/5,62.87%,PTPN1;MTMR2;DTX3L;ITCH;LAPTM5
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.3529563737286041,-0.6700717205021893,0.9,1.0,1.0,2/18,10.67%,SUV39H1;EEF1AKMT2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.41384228519661126,0.6698958482973163,0.8529411764705882,1.0,1.0,1/5,20.52%,BDP1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.43460750322581887,-0.6698684598042532,0.8928571428571429,1.0,1.0,2/6,16.00%,ABCB1;TCAF2
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.27710135410352166,0.6698521754539241,1.0,1.0,1.0,9/41,17.55%,NUP210;NUP42;TPR;NUP37;EP300;JMJD8;AAAS;ZBTB7A;GCK
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.348155562325331,-0.6698215541242284,0.9365079365079365,1.0,1.0,6/18,25.58%,IL4I1;PDCD1LG2;SFTPD;LYN;GPNMB;SOX11
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.39484635224210235,-0.6697245969220481,0.9402985074626866,1.0,1.0,4/12,17.82%,CD74;TGFB1;PLCG2;CUEDC2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.2912080763908059,-0.6697093231034249,0.9428571428571428,1.0,1.0,16/57,29.45%,RPL38;RPS7;RPL26L1;RPL35A;RPL5;WDR12;EMG1;RPS24;RPS15;SURF6;RPF2;RBIS;NIP7;MRTO4;ZNF622;RPS25
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.31596120917562487,0.6696574615262378,0.9393939393939394,1.0,1.0,7/25,14.18%,BTC;IGF1;EREG;CDC23;ESPL1;PDGFB;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.4610211869888847,-0.6693532370999332,0.8703703703703703,1.0,1.0,1/5,14.56%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.4610211869888847,-0.6693532370999332,0.8703703703703703,1.0,1.0,1/5,14.56%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.4610211869888847,-0.6693532370999332,0.8703703703703703,1.0,1.0,1/5,14.56%,SLF1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.34414523023192045,0.6692162441379926,0.8928571428571429,1.0,1.0,4/17,10.33%,CTNNA2;ARFIP2;WASF2;ARFIP1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.4322308269545363,0.6692144066198635,0.813953488372093,1.0,1.0,1/5,18.58%,TANK
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.2983547139818033,0.6690465058029177,0.9333333333333333,1.0,1.0,7/26,14.67%,NUP42;RANBP17;TPR;RANBP3;CHP1;XPO7;RANBP3L
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.33199905445979994,-0.669028937001624,0.9298245614035088,1.0,1.0,5/21,24.42%,SLC14A1;SLC14A2;CPTP;SLC27A1;SLC38A5
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.3471812768324637,0.6689613172984727,0.8611111111111112,1.0,1.0,3/14,10.74%,CSF1R;MDK;IL34
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.32835001679941256,0.668877142608163,0.9142857142857143,1.0,1.0,1/15,3.78%,SLC22A13
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.3586526128353987,-0.6688445597713124,0.9428571428571428,1.0,1.0,8/16,23.60%,GNLY;CCL5;GBP5;CD5;SKAP1;PYHIN1;TRBC2;CD8B
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.35244797325625743,-0.6683074781702509,0.9411764705882353,1.0,1.0,4/17,17.29%,DRD3;PDGFRB;RGCC;TGFA
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.4170345919292173,-0.6682320359421865,0.8787878787878788,1.0,1.0,2/7,24.02%,EIF6;RAN
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.3312129768447915,0.6680685789657028,0.9444444444444444,1.0,1.0,6/18,21.25%,NRXN1;NLGN1;GRIN1;RELN;PTEN;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.38724423456194873,0.6680500138754706,0.8529411764705882,1.0,1.0,5/8,16.76%,COMMD1;LEPROTL1;NEDD4L;GPM6B;GOPC
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.32171863577781,-0.6680363628971315,0.9047619047619048,1.0,1.0,10/28,28.45%,IRF1;OAS3;TLR2;FLOT1;ISG15;IRF3;POLR3G;RIPK2;TBK1;PTPN11
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.2629033497752386,-0.6677476746447861,0.9868421052631579,1.0,1.0,24/169,23.57%,SPAG4;CAV3;LMAN1;SYNGR2;ZFP69B;CHMP2B;ARL1;SPTBN5;RNF26;GOLGA8O;GOLGA8B;OTOF;TANGO2;TLCD2;HOOK2;MYOF;NUP155;PLEKHF1;VPS4A;REEP5;RAB1A;ATL1;FER1L6;ARFGEF2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.38230519017060804,0.6676363026062831,0.8367346938775511,1.0,1.0,3/7,29.48%,PRPS1;CTPS2;TPK1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.3635150234536293,-0.6674353269241723,0.8529411764705882,1.0,1.0,1/15,7.61%,NCBP2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.32021224766892553,0.6673422483718001,0.8536585365853658,1.0,1.0,3/24,11.55%,PTPRK;ANGPT1;FGF10
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.30288770240221596,-0.6673161967178803,0.961038961038961,1.0,1.0,6/64,11.80%,HCK;ITGA5;FYB1;TXK;TEC;DOCK1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.2686147982001933,0.667207520754065,0.9583333333333334,1.0,1.0,5/96,5.30%,RFWD3;ITGA4;CEP85;URB2;TIMELESS
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.31990702776375224,-0.6670261332921068,0.9393939393939394,1.0,1.0,4/33,15.50%,PTGIS;SNAI2;BRCA1;ACMSD
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.30716176181996235,0.6668901266820524,0.9393939393939394,1.0,1.0,4/27,12.84%,MAP3K20;MAP3K5;MAPK8;BTRC
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.42453580495919724,-0.6667499210424793,0.8275862068965517,1.0,1.0,1/5,13.94%,CXCL13
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.3772200174931105,-0.6667034359004704,0.9333333333333333,1.0,1.0,6/16,30.95%,NEFL;MAP1A;KIF5A;KIF1A;SOD1;KIF1C
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.3075011070614306,-0.6666505207964181,0.9508196721311475,1.0,1.0,23/44,36.08%,ATP5F1E;GHITM;ATP5F1C;ATP5MC3;ATP5PD;ROMO1;HSPA9;MICOS10;ATP5F1A;ATP5PB;ATP5ME;TIMM8A;TIMM22;SPG7;TIMM8B;MICOS13;LETM1;AFG3L2;APOO;ATP5F1B;MTX2;ATP5MC1;IMMT
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.40835155824218206,-0.6665901268337581,0.88,1.0,1.0,2/7,11.97%,NOTCH1;SNAI2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.3191985658316226,-0.6663073112723777,0.9411764705882353,1.0,1.0,9/29,26.57%,HSD17B13;GPER1;EIF6;ASXL3;CREBL2;PRKAB2;AKT1;CEACAM1;ASAH1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.31557518128096385,0.6661110462559413,0.9393939393939394,1.0,1.0,5/24,18.12%,CEPT1;CHKA;ABHD4;PCYT2;PHOSPHO1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.3521804925024076,0.6659548073511994,0.8611111111111112,1.0,1.0,11/11,64.80%,SYK;PRKCQ;RARA;HAVCR2;ZP3;CEBPB;TNFSF4;HLA-E;PRKCZ;SLC7A5;NLRP3
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.305481326799234,0.6658296688438593,0.9705882352941176,1.0,1.0,3/28,9.94%,SMYD2;PRDM5;SUV39H2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.3922363537983702,0.6657533173813368,0.8157894736842105,1.0,1.0,1/8,12.88%,HMGA2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.2564246309169403,-0.6656940749802537,1.0,1.0,1.0,56/298,24.69%,RAB6C;AMN;CD74;ATP6V1B2;ATP6AP1;CHMP2B;ARCN1;UNC119B;ARL1;SLU7;RAB19;ATP6V1D;ATP6V1E1;CHMP2A;GRTP1;RCN3;MCOLN1;STX19;NEURL1B;LRP2;RAB23;TBC1D13;VPS35;TANGO2;PREPL;RAB31;ATP6V1E2;ARF3;ATP6V1C1;STX16;ARF1;YWHAH;ATP6V0B;RAB12;SNX4;TXNIP;LAMP2;KIF3A;ARL6;ARL4C;ATP6V1G1;RUNDC1;STX1B;RAB1A;RAB1B;ARF4;RAB6D;ATP6V1C2;SCG5;RAMP1;AP4M1;ARF5;SCAMP1;ARL6IP5;RAB8A;CANX
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.424996652017327,-0.6656865485467364,0.8524590163934426,1.0,1.0,2/7,17.70%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.4508082104855491,-0.665406334458224,0.8888888888888888,1.0,1.0,1/5,13.68%,NCBP1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.2946173108254226,0.6652768261273845,0.9333333333333333,1.0,1.0,5/36,9.77%,WWTR1;LATS1;TPR;EIF2AK3;BYSL
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.37068977621525895,0.6649757029801941,0.7727272727272727,1.0,1.0,5/8,23.74%,MAPK12;ATM;CHEK2;ABL1;MAP2K6
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.3790725303554551,0.6646772992991363,0.8604651162790697,1.0,1.0,3/6,20.69%,SRR;PSPH;SERINC5
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3079689557973988,-0.6645383809825797,0.9696969696969697,1.0,1.0,10/44,21.34%,RAC1;PREX1;WASF1;VIL1;DIAPH3;WAS;VILL;CATIP;CFL1;GHRL
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.3560243920323863,-0.6644608758884137,0.8939393939393939,1.0,1.0,6/16,25.45%,SOD2;IFI6;BOK;BAX;BAK1;DNM1L
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.31512508413553886,-0.6640812444344847,0.9577464788732394,1.0,1.0,8/39,26.90%,CHMP2B;CORO1A;RNF26;HOOK2;PLEKHF1;ARFGEF2;USP50;SNX11
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.3268326749034022,-0.6635838817512179,0.9166666666666666,1.0,1.0,3/26,16.51%,ALOX12;GGTA1;FASN
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.38017032427684866,-0.663583468888059,0.9032258064516129,1.0,1.0,1/12,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.26030982913226036,-0.6635541866215315,1.0,1.0,1.0,20/133,20.29%,SFRP4;PSMB6;ATP6AP2;DEPDC1B;PSMB8;GPC3;TGFB1;RSPO2;RSPO3;PSMA3;RSPO4;PSMA5;PSMC3;TLR2;PSMA7;PSMC6;PSME1;DAAM2;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.44106453720545297,-0.6633993584986606,0.8813559322033898,1.0,1.0,1/6,8.14%,CIITA
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.29820968903718303,0.6633554832857774,0.9782608695652174,1.0,1.0,6/38,13.55%,SHLD1;TIMELESS;MGMT;PNKP;KMT5B;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.3175259675518851,0.6632270621957319,0.972972972972973,1.0,1.0,7/20,20.43%,CASK;APOE;TFPI;CRK;PTEN;PHLDB2;EDN1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.3783526813755818,-0.6631805769561833,0.8985507246376812,1.0,1.0,2/8,26.26%,GGTA1;PLA2G4A
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.28725099572084223,-0.6628892213214915,0.9868421052631579,1.0,1.0,14/61,26.28%,CHMP4B;CASP8;CLPX;CTSZ;PRPF19;NGLY1;CTSH;ISG15;VPS4A;RPS27A;UBC;CTSK;ADAMTS12;MARCHF6
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2768256485553589,-0.6625538675228264,0.9746835443037974,1.0,1.0,6/87,11.01%,ARIH2;NKD2;CAMLG;HERPUD1;UCHL5;DDA1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.43416684176057185,-0.6622150980929675,0.8571428571428571,1.0,1.0,3/5,40.05%,RACK1;MTRES1;LTN1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3756373594801886,-0.6619084103635752,0.8333333333333334,1.0,1.0,1/10,12.93%,TMEM30A
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.2659810560593586,-0.6618862641233116,0.9879518072289156,1.0,1.0,7/122,9.49%,PLEKHG7;ROPN1B;RREB1;RAC1;CELSR1;BRK1;GPSM2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.23029544216586945,0.661852880552069,1.0,1.0,1.0,24/79,22.65%,KHDRBS3;SF3B4;NOVA1;RBFOX1;NSRP1;SFSWAP;U2AF2;CELF2;CELF1;KHDRBS2;TRA2A;HNRNPL;RBFOX2;QKI;CELF4;ZBTB7A;MBNL1;SON;RBFOX3;SRRM4;PTBP1;RBM39;DDX5;CELF5
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.2700817968427755,0.6615671053099393,1.0,1.0,1.0,5/44,13.55%,IFI16;MAP3K20;EEF1D;SIRT1;SPIDR
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.34341784168681966,-0.6614005176664366,0.9253731343283582,1.0,1.0,4/18,28.91%,DGAT2L6;GPAM;PLA2G4A;DGAT1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.42217741077130977,0.6613033298762678,0.8222222222222222,1.0,1.0,3/5,25.78%,ABL1;MARK2;MAP2
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.43672390923741117,-0.6612194043587465,0.9344262295081968,1.0,1.0,1/6,11.08%,DCTN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.38915246754991734,0.660930532061397,0.7948717948717948,1.0,1.0,1/7,2.22%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3767916438249813,-0.6609001330572878,0.9032258064516129,1.0,1.0,2/12,14.59%,CACNA1G;SYT4
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2860916300257779,-0.6606514517564618,0.9701492537313433,1.0,1.0,10/66,22.05%,DRD3;CDC6;RAB11A;CALM3;KIF20B;KIF14;PLK4;CALM1;RACGAP1;VPS4A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.436226197625035,-0.6600947469046246,0.8983050847457628,1.0,1.0,2/5,20.50%,GPSM2;EPB41L2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.33915534041820394,0.659891097790613,0.9354838709677419,1.0,1.0,6/19,15.48%,SEMA6D;SEMA5A;SEMA4C;SEMA3C;SEMA5B;SEMA6A
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.31245885125996387,-0.6595759199873151,0.9230769230769231,1.0,1.0,15/33,37.71%,NOB1;RPS8;NAT10;NGDN;HELB;TSR2;TSR3;RPS19;SNU13;RPS28;RPS16;RPS14;HEATR1;MRPS11;UTP6
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.3726397758793962,-0.6595138013601358,0.9672131147540983,1.0,1.0,4/13,22.34%,ERVFRD-1;ERVW-1;CD9;NOS1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.3530215581470065,-0.6594118222618965,0.9545454545454546,1.0,1.0,2/16,9.95%,GOT1;SDS
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.3966810800835224,0.6592391857412052,0.825,1.0,1.0,2/5,16.19%,SNF8;VPS25
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.3966810800835224,0.6592391857412052,0.825,1.0,1.0,2/5,16.19%,SNF8;VPS25
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.26950938492019455,-0.659069205461257,1.0,1.0,1.0,22/134,21.39%,LRP4;NOTUM;SFRP4;PSMB6;PSMB8;NKD2;GLI3;DAB2IP;KREMEN1;SNAI2;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;RBX1;TLE6;PSMD12;PSMB2;HECW1;MESP1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.3082372116160828,0.6589204845395443,0.9487179487179487,1.0,1.0,3/23,9.20%,KANK1;PRKCD;SSH1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.2803777657894213,-0.6587289677985695,0.9864864864864865,1.0,1.0,7/86,15.56%,C4BPB;GPC3;DAB2IP;EEF1A1;ADGRB1;TRIM32;CDKN1B
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.4130347889775976,-0.6587190900992067,0.8771929824561403,1.0,1.0,1/8,8.90%,AGER
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.39227748612963376,0.6586990407709072,0.8064516129032258,1.0,1.0,2/5,15.07%,SLC25A20;SLC25A29
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.33415427967723327,-0.65830231955703,0.971830985915493,1.0,1.0,9/25,28.26%,SLC17A8;OTOF;SLC18A2;CDK5;SLC32A1;WNT7A;CPLX1;RAB3A;DNAJC5
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.41505963158388903,0.6581106277324872,0.851063829787234,1.0,1.0,2/5,22.35%,TCF4;SETD2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.2885110324043497,0.6580189332071184,0.9285714285714286,1.0,1.0,5/32,14.20%,SDC4;RAB7A;RAB27A;SNF8;TSG101
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.29196806641032824,-0.6579908574897829,0.9863013698630136,1.0,1.0,15/66,25.29%,POLE3;MORF4L1;SPI1;HAT1;TAF6;MORF4L2;MSL3;ACTL6A;WDR5;PER1;TADA1;BRD8;KAT5;TAF5;NAA40
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.44120591136808784,-0.6579003270853734,0.9038461538461539,1.0,1.0,1/6,10.89%,ACTA2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.3832208713928091,0.6576085632218858,0.918918918918919,1.0,1.0,1/10,2.27%,NRP1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.2928358928350213,0.6572562226993717,0.9166666666666666,1.0,1.0,5/26,20.48%,PARP10;SIRT2;SIRT1;PARP6;SIRT3
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3034287581974562,0.6572259285581954,0.9761904761904762,1.0,1.0,1/35,0.69%,IFI16
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.31207053596045536,-0.657188967402313,0.9558823529411765,1.0,1.0,1/25,5.51%,PINK1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.4024660738265034,0.6571401913448077,0.8285714285714286,1.0,1.0,1/8,1.73%,HOMER2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.31448187581168685,-0.6569945491648274,0.9452054794520548,1.0,1.0,9/40,18.99%,DRD3;TOM1L1;BORA;PDGFRB;KIF20B;CHEK1;RGCC;TGFA;NME6
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.39105790974650156,-0.6569717864495936,0.8947368421052632,1.0,1.0,2/8,9.51%,GBA3;B3GALT1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3303590190470054,-0.6567565277309195,0.9523809523809523,1.0,1.0,5/21,18.63%,CBLC;ADAM17;GPRC5A;TGFA;SHC1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3040988310045722,0.6562062258876206,0.967741935483871,1.0,1.0,3/18,11.09%,CAMKMT;SAG;PPEF1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.3768246738053922,-0.6560190007812884,0.9295774647887324,1.0,1.0,4/14,27.58%,CALCR;AKAP5;PJA2;AKAP7
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.38278850121498326,0.655768394445607,0.8409090909090909,1.0,1.0,7/7,61.73%,VEGFA;PPP1R16B;JCAD;FGF2;IL12A;THBS1;PDCD10
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.27521813876798196,-0.6556801618962156,0.9736842105263158,1.0,1.0,32/82,34.83%,PSMB6;PSMB8;SKP1;PSMA3;ZNF16;PSMA5;PSMC3;CDKN1B;PSMA7;PSMC6;PSME1;PSMD12;PSMB2;NEK11;ANAPC2;PSMD2;UBE2S;NEK10;PSMA1;PSMD8;PSMC4;PSMC1;BUB1B;ANAPC15;XPC;PSMB4;PSMD3;DBF4;ANAPC11;PSMD7;PSMD4;PSMA8
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.28859500234716634,0.6552561997757018,0.9696969696969697,1.0,1.0,8/40,17.38%,ARID1B;ARID1A;HDAC1;PBRM1;SMARCAD1;DMAP1;SMARCA4;SMARCB1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.26968245015502845,-0.6552489076824156,0.975609756097561,1.0,1.0,10/92,15.18%,CTNNA1;P2RY1;AHR;P2RY12;KCNQ1;IGFBP5;TSHR;AQP9;LAMTOR2;BRCA1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3795488778436543,-0.6549953516513495,0.927536231884058,1.0,1.0,3/13,21.77%,MRE11;RAD9B;NEK11
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.32873949495957233,-0.6549225874791708,0.9411764705882353,1.0,1.0,5/27,23.27%,SPI1;AEBP2;H3-3A;JARID2;SUZ12
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3145112062558205,-0.6548142112557263,0.9420289855072463,1.0,1.0,5/32,13.95%,MSX1;BCAP31;RPS7;SIAH1;BOK
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.360813071377762,-0.6544020369151525,0.8955223880597015,1.0,1.0,1/12,10.74%,MSN
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.44095609535943436,-0.6542769331844268,0.8888888888888888,1.0,1.0,1/5,12.93%,TMEM30A
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.29596670696148425,-0.6541925119599807,0.9850746268656716,1.0,1.0,13/54,25.96%,TCP1;RFC5;CCT6A;CCT8;PDGFRB;PCNA;RGCC;CCT7;PKIB;CCT2;CHTF18;HGF;HSP90AB1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.32153915842045006,-0.6540635679123826,0.9206349206349206,1.0,1.0,2/30,5.66%,LDLRAP1;NSDHL
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.39126336394451666,0.6537061580445455,0.9210526315789473,1.0,1.0,3/9,21.67%,ENPP1;SULT2B1;BPNT1
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),0.36613885399568197,0.6533044887388693,0.8378378378378378,1.0,1.0,1/7,11.85%,GUCY1A1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.3081331328676399,0.6531320800369419,0.8571428571428571,1.0,1.0,7/13,27.50%,BACE2;IDE;NCSTN;APEH;MME;MGAT3;PSEN1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.24773823105547518,0.6530276898801475,1.0,1.0,1.0,20/98,16.15%,MDK;PLD2;APOE;BIN1;FMNL2;PAK5;MAST4;MARK1;SIPA1L3;CDC42BPB;FMNL3;KLHL20;PAK4;PDZD8;MICAL3;SEMA6A;RHOBTB1;FITM2;MAST2;PACSIN2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.30165871854532544,-0.6527440549151187,0.9852941176470589,1.0,1.0,11/52,22.87%,TRPV6;ZACN;CALM3;TTN;AQP9;HVCN1;ADAM9;KHK;CALM1;SLC30A8;SLC30A4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.3279902751852909,-0.6526795271508482,0.9206349206349206,1.0,1.0,4/33,15.16%,DRD3;PIK3CB;GPER1;TSC2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.35039227197370765,0.6526625909275275,0.8717948717948718,1.0,1.0,3/10,14.09%,TNFRSF11A;PTPRO;PDGFB
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.2820469102862664,-0.6524152532157707,0.967741935483871,1.0,1.0,7/63,15.93%,IHO1;RFC5;RPA3;MRE11;PCNA;ISG20;DDX1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.3418195395524096,0.6523341519067807,0.9,1.0,1.0,2/16,6.71%,CSF1R;TNFRSF11A
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.4143679882599349,-0.65227028222855,0.8666666666666667,1.0,1.0,1/5,20.01%,ZNF304
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.37102372226247193,-0.6521523964783777,0.8676470588235294,1.0,1.0,3/12,24.02%,EIF6;RPS15;RAN
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.2839198893813953,0.6518037497734303,1.0,1.0,1.0,9/39,21.82%,EGFR;APOE;SIRT2;NFKB1;ITGAV;BANP;RILP;EDN1;LDLR
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.35413323552335985,0.6515737130291126,0.8648648648648649,1.0,1.0,7/7,64.60%,PRKN;MARCHF7;XIAP;SPSB4;BIRC2;PTPN22;DDX3X
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.36138092247402664,-0.6514258118453905,0.9104477611940298,1.0,1.0,4/16,19.66%,LDLRAP1;APH1B;ADAM17;NSG1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.30758103677390614,-0.651409525992274,0.9459459459459459,1.0,1.0,6/31,27.64%,LAMTOR2;LAMTOR5;GLRA3;RRAGA;GLRA1;LAMTOR3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.328251842619168,0.6509358791860071,0.9032258064516129,1.0,1.0,10/18,27.21%,SGPP2;SPTLC1;SPHK2;PLPP1;ACER1;SPTLC2;ACER3;ABCA2;PLPP3;SPHK1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.31084688255764154,0.650344116692174,0.95,1.0,1.0,3/14,18.37%,PRKCB;BRAF;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.3537180025408285,-0.6501434903274518,0.8888888888888888,1.0,1.0,4/13,15.87%,RFLNA;EFEMP1;SNAI2;WNT9A
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.30108740294269376,-0.6500071231270382,0.9850746268656716,1.0,1.0,16/53,26.14%,HSPG2;STAT1;DAB2IP;STAB1;AMOT;ADGRB1;RGCC;SERPINF1;GHRL;CD160;CNMD;SPARC;DCN;AGO1;PGK1;FOXO4
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),-0.44833686596323163,-0.649949986894818,0.9661016949152542,1.0,1.0,1/5,11.97%,SNAI2
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.2870197531789922,-0.6496632525530304,0.9873417721518988,1.0,1.0,17/77,24.74%,NXT1;PXMP2;PEX11B;RANBP6;PEX16;SPRN;NUP85;TSC2;TOMM22;PEX5;NUP155;LAMP2;GCKR;NUP188;HSPA4;RAN;AKT1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.34101625401319996,0.6496571443921336,0.9285714285714286,1.0,1.0,6/14,22.88%,ST8SIA3;ST6GALNAC4;ST8SIA4;ST8SIA2;LARGE1;ST8SIA5
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.3142436529304472,0.6496230514573507,0.9473684210526315,1.0,1.0,3/19,11.55%,IGLL1;TICAM1;FGF10
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3018744608870912,-0.649511788690437,0.96875,1.0,1.0,6/34,24.28%,RFC5;RPA3;PCNA;RBX1;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.30699197293511965,0.6493803216027981,0.967741935483871,1.0,1.0,5/24,13.00%,ABCA13;PTCH1;APOE;EEPD1;SIRT1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.2954444328015469,0.6493153278825375,0.975,1.0,1.0,2/31,2.53%,CHCHD6;BCL2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.3310582981091413,0.6492470577525504,0.9512195121951219,1.0,1.0,3/17,12.03%,KDR;IGF1;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.36871504121367416,-0.6492275660222874,0.8813559322033898,1.0,1.0,3/9,12.02%,SMTNL1;ADRA1D;TBXA2R
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.39956970438657535,0.6491041214501376,0.9210526315789473,1.0,1.0,4/11,17.70%,AKR1C3;CTBP2;KLF2;DHRS3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.28322899256277795,-0.6490788657285341,1.0,1.0,1.0,9/51,25.80%,HENMT1;TRUB1;BCDIN3D;THG1L;NAT10;DTWD2;NOP10;SSB;METTL3
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.41141170640763913,-0.6486160337173416,0.8709677419354839,1.0,1.0,1/6,6.41%,ATP6AP2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.4151756461710425,-0.6484847444641225,0.8805970149253731,1.0,1.0,2/6,11.35%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.28006189832356587,0.6483953523570488,0.967741935483871,1.0,1.0,1/27,2.55%,ARID5A
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.33307426185782274,0.6483341799095138,0.8717948717948718,1.0,1.0,4/16,19.30%,EIF2AK3;LYAR;UBTF;SIRT7
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.36300360018263783,0.6477952816963891,0.8333333333333334,1.0,1.0,2/9,5.54%,UCK2;UPP2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.36300360018263783,0.6477952816963891,0.8333333333333334,1.0,1.0,2/9,5.54%,UCK2;UPP2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.32236799079714884,-0.6475409834516684,0.9230769230769231,1.0,1.0,5/17,29.41%,SRP14;MAN1A1;SPCS1;RAB3GAP2;SRP54
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.3695799112639259,-0.647308001999943,0.9310344827586207,1.0,1.0,2/14,13.32%,BORA;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.27444565512520347,0.6472449909142717,0.9666666666666667,1.0,1.0,9/48,13.00%,IFI16;GRIN2A;HMGB1;PERP;MAP3K5;FYN;MALT1;GRAMD4;SIRT1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.292337753582423,-0.6466600534470569,0.9861111111111112,1.0,1.0,10/55,17.39%,TERF2IP;CD14;LRRC19;AGER;SPI1;TMSB4X;CD27;TLR2;NFKBIA;C1QTNF4
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.2986488741281333,-0.6464754513507492,0.9710144927536232,1.0,1.0,4/39,10.95%,SALL2;ADAMTS18;LAMA1;EFEMP1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.3646602233195257,0.646433697656578,0.8974358974358975,1.0,1.0,3/12,11.33%,H6PD;PGM2;RPEL1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.4061339568147435,0.6462231563115818,0.875,1.0,1.0,5/5,59.40%,XRN1;TOE1;PARN;PDE12;TRIR
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.3225416754228148,-0.6462143269461368,0.9565217391304348,1.0,1.0,4/22,20.22%,TGFB1;CALM3;ANKLE2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.38545195096470164,-0.6461169146204523,0.8870967741935484,1.0,1.0,2/9,18.99%,RNF26;C1QBP
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.3698611109576434,0.646065148464252,0.9230769230769231,1.0,1.0,1/9,4.19%,ACADVL
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.2989776850963323,-0.6457637810314869,0.9324324324324325,1.0,1.0,8/36,27.94%,POLR2J;POLR2K;RNPS1;CREBL2;POLR2I;POLR2B;POLR2D;PWP1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.3713871564528045,-0.6450799148122375,0.8840579710144928,1.0,1.0,1/10,5.24%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.3926007693645636,0.6447288577059735,0.8918918918918919,1.0,1.0,2/5,12.31%,PARP10;TRIM44
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.35331570271340507,0.6446082918200813,0.9354838709677419,1.0,1.0,5/11,22.66%,UVRAG;TBC1D25;RUBCN;CLN3;CALCOCO2
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.34587983657569693,-0.6444935789973231,0.9344262295081968,1.0,1.0,2/17,11.77%,MYO5B;MYO1F
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.32762515179307705,-0.6439292918099756,0.9365079365079365,1.0,1.0,2/20,11.08%,GPSM2;DCTN1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.26100933736593795,0.6437911267957304,1.0,1.0,1.0,1/81,0.23%,FBXL7
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.3705299834953236,0.643600078512879,0.8157894736842105,1.0,1.0,6/6,62.96%,TANK;VCP;TNIP1;SART3;WDR48;NOP53
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.34083622298715566,-0.6434191328238995,0.9090909090909091,1.0,1.0,4/14,22.62%,SMARCE1;SET;GRWD1;RPL23
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.36102866054388083,-0.643255459960614,0.8985507246376812,1.0,1.0,2/10,9.16%,SERPINE1;CCL5
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.3700389333802151,0.6427778210725527,0.8863636363636364,1.0,1.0,2/7,13.00%,ERCC8;SIRT1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.36557845166782255,-0.6427185823606981,0.8627450980392157,1.0,1.0,3/9,28.89%,CLP1;AGO1;AGO4
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3120401343149073,-0.6425735833243508,0.8985507246376812,1.0,1.0,4/26,13.44%,DRD3;CDC6;KIF20B;KIF14
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.2964060588136343,0.642571249744137,0.9393939393939394,1.0,1.0,4/16,14.09%,PDGFRA;APOE;CELA2A;PDGFB
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.3264529322910902,0.6424964439423505,0.9230769230769231,1.0,1.0,1/13,3.23%,TRAF3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.41750145665178756,-0.6419584434089964,0.9056603773584906,1.0,1.0,3/5,38.30%,AGO1;AGO4;MOV10
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2920547324770796,0.6415495290737472,1.0,1.0,1.0,7/29,18.56%,BABAM2;STAMBPL1;USP25;BRCC3;OTUD7B;OTUD7A;UIMC1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.281202151021459,-0.6415031103220679,1.0,1.0,1.0,15/74,23.29%,TBP;POLR1E;SPI1;AEBP2;CGGBP1;POLR2K;POLR1H;DEK;TDG;H3-3A;GPX1;POLR1C;JARID2;SUZ12;POLR1F
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.40585554598114293,-0.641430983499807,0.9464285714285714,1.0,1.0,2/6,20.44%,BRCA1;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.38619047236887527,0.6413063729104764,0.8611111111111112,1.0,1.0,2/10,8.22%,TICAM1;ZBTB1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.3031357588392899,0.6412139641563139,1.0,1.0,1.0,4/33,13.04%,IFIH1;REL;PTPRS;RNF216
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2867130259835432,-0.6410991017164874,0.9871794871794872,1.0,1.0,12/62,20.29%,B2M;PSMB6;PSMB8;HLA-A;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.3684932583254712,0.6404301322082445,0.8529411764705882,1.0,1.0,1/7,9.54%,CHRM3
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.3218094582541593,0.6403023108961102,0.9722222222222222,1.0,1.0,4/21,14.88%,IGLL1;GULP1;ELMO1;SNX18
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.2671198120670011,-0.6400082299343097,0.9857142857142858,1.0,1.0,15/91,21.89%,NES;LRP4;FJX1;GLI3;DAB2IP;EYA1;SIX4;SMARCA1;TUBB2B;FKBP10;GPR161;YAP1;CTXN1;IGDCC4;NR2F2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.32969046366302623,0.6396545660225493,0.8947368421052632,1.0,1.0,5/9,21.47%,APOE;SCAP;ERLIN2;NFKB1;BMP2
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.32173666296414327,-0.6395949931899068,0.9130434782608695,1.0,1.0,7/28,15.92%,CD74;IL7;AGER;OAS3;IL18;TLR2;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3746968264338756,-0.6395250467336826,0.9393939393939394,1.0,1.0,1/9,4.32%,FKBP1B
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.3731579378881055,-0.6392958257076043,0.9523809523809523,1.0,1.0,6/14,31.33%,MANBA;NGLY1;ADAMTS9;ADAMTS12;OGA;FBXO6
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.37852296292532733,0.6392306469503728,0.9318181818181818,1.0,1.0,1/9,11.28%,PARP10
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.26147459780015947,0.6391072846758694,1.0,1.0,1.0,6/60,7.88%,BMP6;UNC13B;TGFB2;RAB27A;TGFB3;IGF1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.24108892233132825,0.63906206090235,1.0,1.0,1.0,15/108,13.70%,SLC22A2;SLC6A4;SLC22A10;RAB7A;ABCA13;SLC22A3;CHKA;ABCC11;SLC19A1;SLC22A6;ABCA6;LRP1B;ABCD2;SCAMP4;ABCG8
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.32100153490968414,-0.6390249452857028,0.9354838709677419,1.0,1.0,8/26,28.45%,OAS3;FADD;NLRC5;ISG15;STAT2;METTL3;HSP90AB1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.3735097803598467,0.6387059912565654,0.85,1.0,1.0,2/6,17.38%,AUTS2;SMARCB1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.37931098543728836,-0.6385351846351709,0.921875,1.0,1.0,2/8,14.59%,REST;SYT4
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.4130823456446459,0.6381496448926931,0.8222222222222222,1.0,1.0,1/5,5.59%,RABL3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.2947308522367993,-0.6377746144799802,0.967741935483871,1.0,1.0,6/36,24.28%,RFC5;RPA3;PCNA;RBX1;RPS27A;UBC
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2867329666780116,-0.6377628673487826,0.987012987012987,1.0,1.0,12/60,20.29%,B2M;PSMB6;PSMB8;HLA-A;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.37977719152260486,0.6377021904329153,0.8421052631578947,1.0,1.0,1/7,6.33%,ACVR1
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.41553742665211535,-0.6376513907238424,0.9016393442622951,1.0,1.0,3/6,26.15%,TBX1;SHH;SMO
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.3097404186774894,0.6373246948844616,0.9117647058823529,1.0,1.0,5/18,18.16%,ADAM19;BACE2;DAG1;SPPL3;NCSTN
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.31762057754270556,-0.6372164842047086,0.9682539682539683,1.0,1.0,4/26,20.26%,NOTCH1;SKP1;RBX1;NOTCH2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.3405308933878503,-0.6371065353688566,0.9552238805970149,1.0,1.0,3/17,15.09%,ERVFRD-1;ERVW-1;SIX4
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.35195012601623826,0.6371022952474042,0.9090909090909091,1.0,1.0,3/9,14.60%,OSBPL7;PTCH1;LRP6
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.30460862151770535,-0.636233729768662,0.9565217391304348,1.0,1.0,5/31,14.19%,DRD3;CDC6;KIF20B;KIF14;HTR2B
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.34870976729576325,0.6359799922642978,0.8888888888888888,1.0,1.0,2/7,8.92%,CCDC22;FAF1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3795374224521737,0.6359110809451698,0.9,1.0,1.0,3/11,12.03%,NRP1;MST1R;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.24665254349867105,-0.6359004177407324,1.0,1.0,1.0,11/149,13.99%,EPHA1;RGS10;DOCK8;CCL5;GRTP1;F11R;ADRB1;ARHGAP22;GMIP;CXCL13;TBC1D13
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.3136080451562435,-0.6357419554074015,0.9571428571428572,1.0,1.0,6/19,22.61%,RARRES2;CCL5;MSN;CMKLR1;CXCL17;LYN
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.2926872587084747,-0.6355173280033896,1.0,1.0,1.0,7/36,24.61%,CHMP2B;RNF26;HOOK2;CLCN3;PLEKHF1;ARFGEF2;USP50
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.39668388589403053,-0.6354564561847701,0.896551724137931,1.0,1.0,1/7,1.78%,C17ORF99
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.37009358097011263,-0.635437704963823,0.9552238805970149,1.0,1.0,4/10,39.05%,PAF1;CTR9;RNF8;WAC
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3896917404292828,-0.6352487371432506,0.9508196721311475,1.0,1.0,2/11,15.18%,CHEK1;BRCA1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.26867847934755534,0.6351669206606089,0.96875,1.0,1.0,6/29,14.74%,RUBCNL;LIX1;VAMP8;SNAP29;TSG101;UVRAG
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.36889790509202447,-0.6347933005624972,0.890625,1.0,1.0,2/11,16.73%,CBLC;GPRC5A
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3486495589662987,0.6347206626469396,0.9444444444444444,1.0,1.0,1/13,2.26%,BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.41783096395704006,-0.6346906883716309,0.8548387096774194,1.0,1.0,1/5,18.99%,C1QBP
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.3461828845545467,-0.6344513799316682,0.9104477611940298,1.0,1.0,2/13,12.84%,PIK3CB;KBTBD6
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.26227445474687683,-0.6343191610523792,1.0,1.0,1.0,14/85,20.29%,CLEC4C;PSMB6;PSMB8;SKP1;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;PSME1;MUCL1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.26227445474687683,-0.6343191610523792,1.0,1.0,1.0,14/85,20.29%,CLEC4C;PSMB6;PSMB8;SKP1;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;PSME1;MUCL1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.26227445474687683,-0.6343191610523792,1.0,1.0,1.0,14/85,20.29%,CLEC4C;PSMB6;PSMB8;SKP1;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PLCG2;PSME1;MUCL1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.3954785394511895,-0.634317516399627,0.8620689655172413,1.0,1.0,2/7,15.61%,PRKCH;STAP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.3594883587335206,0.6342176369623835,0.8780487804878049,1.0,1.0,4/8,16.28%,GREM1;MYOCD;MEF2C;FRS2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.3718191375174886,0.6339160310549723,0.9166666666666666,1.0,1.0,1/8,4.61%,JAM2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.4148418089345933,-0.6338109996938968,0.9344262295081968,1.0,1.0,2/6,18.99%,CMKLR1;C1QBP
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.2779837449611711,-0.6337956400222917,0.9722222222222222,1.0,1.0,9/53,23.54%,CAV3;PLSCR4;PLSCR5;OTOF;TLCD2;SYTL4;MYOF;WHAMM;FER1L6
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.39388796758122024,-0.6336580645197171,0.9152542372881356,1.0,1.0,1/8,6.41%,ATP6AP2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3350365179451437,0.6336411226706085,0.9285714285714286,1.0,1.0,1/11,11.89%,PIBF1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.24620726308065954,-0.6335134451580158,1.0,1.0,1.0,27/168,20.22%,ALPL;PTPRC;PPA1;ALDOB;HKDC1;TOLLIP;PLCD3;PLCH1;TGFB1;PLPPR3;PIK3CB;ACYP1;GFPT2;IMPA2;HTR2B;G6PD;CERKL;LPCAT4;INPPL1;TPTE2;PLCG2;PLA2G10;CDK5;DUSP16;BCKDK;DUSP28;CALM1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2392819542694855,-0.6332776564528594,1.0,1.0,1.0,31/190,20.94%,TERF2IP;TRIM22;TNFSF18;TRIM5;AGT;NODAL;BEX1;TRIML2;IL18R1;AGER;TRIM25;PRKCH;ROR1;TRIM32;IL18;NEUROD2;MBTPS2;TLR2;NFKBIA;RGCC;PLCG2;FLOT1;OPRD1;ESR2;LAMTOR5;ESR1;COPS5;RTKN2;KDM1A;SHH;PRDX3
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.2758301515909594,-0.6329841967167418,0.972972972972973,1.0,1.0,5/70,14.64%,LMAN1;PINK1;MSN;F11R;VPS35
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.4197189346297066,-0.6324871951732834,0.9310344827586207,1.0,1.0,3/7,20.46%,PLA2G10;ABCG5;SHH
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.33751215283335084,-0.6323960705758461,0.8805970149253731,1.0,1.0,3/19,13.94%,NCKAP1L;CCL5;CXCL13
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.3491440212494833,-0.6322671450403696,0.9423076923076923,1.0,1.0,3/13,17.44%,SMARCE1;SET;GRWD1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.3491440212494833,-0.6322671450403696,0.9423076923076923,1.0,1.0,3/13,17.44%,SMARCE1;SET;GRWD1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.3642445098137227,-0.6321714428850633,0.9090909090909091,1.0,1.0,2/10,22.82%,EXOSC6;EXOSC8
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.38188165165286936,-0.6318062432726698,0.9629629629629629,1.0,1.0,1/8,8.45%,MGME1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.2905760970159401,0.6317582180278397,0.9666666666666667,1.0,1.0,3/20,12.42%,CPT1A;SLC25A20;ABCD2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.37922603739939614,-0.6317366969513449,0.9107142857142857,1.0,1.0,2/11,13.82%,KCNN4;KCNK10
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.3414184212555583,0.6317364921589755,0.9210526315789473,1.0,1.0,3/11,15.30%,STX18;ATL2;VAPB
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.278990509380945,-0.6317343724313921,0.9833333333333333,1.0,1.0,11/43,26.50%,CD14;CD6;ADAM17;SLC11A1;HNRNPA0;LBP;PRDX3;NOS1;CD24;CPS1;IFNAR1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.32861532585278325,-0.6316453519045854,0.9047619047619048,1.0,1.0,2/22,10.84%,USP20;OTUB1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.22752143178609552,0.6315489376268053,1.0,1.0,1.0,19/123,15.95%,RAB3C;FGF13;PKP2;KCNB2;KCNIP4;LIN7A;PTCH1;BSG;DPP6;TSPAN17;ZDHHC3;TSPAN33;CACNB2;RAB40A;ZDHHC2;SPTBN4;LRP6;EHD4;CDH1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.27273464840445927,0.6314893218586395,0.9166666666666666,1.0,1.0,1/28,2.22%,FGF13
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.27837283186316053,-0.6313850470723571,1.0,1.0,1.0,6/53,14.75%,PNPLA1;ACOX2;ABCB4;FABP3;RCN3;TLCD2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.31913960162894167,0.6313354360615632,0.9444444444444444,1.0,1.0,2/18,7.78%,BCL2;TRPC5
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.36921696297464024,-0.6310335606861952,0.9354838709677419,1.0,1.0,1/10,13.37%,DNAJC19
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.3035299700640389,-0.6307310730393875,0.9857142857142858,1.0,1.0,2/25,11.08%,GPSM2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.3505584186738395,0.6304661509921665,0.9047619047619048,1.0,1.0,1/10,6.40%,LRRC17
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3891886025169633,-0.6303839284088906,0.9230769230769231,1.0,1.0,5/10,28.99%,PSMC3;PSMC6;ESR1;THRA;PSMC4
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.34751200688236594,-0.6298598961759464,0.9508196721311475,1.0,1.0,1/13,4.55%,GMNN
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.3158078527787852,-0.6298004859108878,0.984375,1.0,1.0,4/23,21.68%,CEMIP;TCAF2;MIEF1;PDZK1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.3796977711648486,0.6295718253415292,0.9166666666666666,1.0,1.0,4/7,16.51%,GRIN2A;GRIN2C;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3127139781504302,-0.6292538592076959,0.9298245614035088,1.0,1.0,5/20,18.75%,CASP8;NMT1;YWHAB;YWHAG;YWHAH
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3127139781504302,-0.6292538592076959,0.9298245614035088,1.0,1.0,5/20,18.75%,CASP8;NMT1;YWHAB;YWHAG;YWHAH
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.40397625354279143,0.6291727821223065,0.8536585365853658,1.0,1.0,2/5,8.22%,HMGB1;ZBTB1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.40478219309941155,-0.6284542158101026,0.9019607843137255,1.0,1.0,1/5,13.20%,BCAT2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.3429239554772884,0.6282979188409622,0.9696969696969697,1.0,1.0,1/15,1.06%,TRPC3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3027459039083234,-0.6282062489612013,0.9836065573770492,1.0,1.0,5/36,13.26%,ATP5IF1;ZFPM1;NCKAP1L;INHBA;SLC25A5
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.34423402049747265,0.6282061961565166,0.875,1.0,1.0,3/7,21.18%,CDH1;CTNNB1;CBL
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.2891473053134366,-0.6280861717757855,0.9857142857142858,1.0,1.0,3/46,16.78%,B2M;HIP1R;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.32759087557608124,-0.628062697384933,0.9642857142857143,1.0,1.0,6/22,27.97%,STMN1;F11R;WAS;MET;INPP5K;ARHGAP28
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.38985434044133116,-0.628044561062608,0.967741935483871,1.0,1.0,1/8,7.86%,GBA3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.31349886502354446,-0.6275823404065947,0.9375,1.0,1.0,12/27,39.68%,RFLNA;LCP1;PAWR;EPS8;CORO1B;EZR;RFLNB;PLS1;MYO1B;BAIAP2L1;CALD1;DMTN
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.35207504224837394,-0.6275509981023194,0.9285714285714286,1.0,1.0,4/14,23.66%,TBX19;ITGB4;MESP1;KDM6B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3499060950527592,0.6275181737115368,0.9512195121951219,1.0,1.0,4/10,20.64%,CDC14B;BTRC;PTEN;GORASP1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.33711687366284604,0.6274839089126356,0.8529411764705882,1.0,1.0,3/14,7.12%,TGFB2;PDGFRA;PKDCC
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.41613979458700767,-0.6274060216705538,0.9344262295081968,1.0,1.0,2/7,11.35%,IRF1;HLA-A
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.2989580389822912,-0.6272712024949317,1.0,1.0,1.0,9/34,20.45%,UBE3A;TMF1;GPER1;KDM3A;DAXX;DDX54;ESR2;ESR1;YAP1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.2657795410039573,0.6266991824177149,1.0,1.0,1.0,9/41,17.55%,NUP210;NUP42;TPR;NUP37;EP300;JMJD8;AAAS;ZBTB7A;GCK
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.3401508700690591,0.6266355543335234,0.9166666666666666,1.0,1.0,1/7,9.20%,TPR
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.38738589846292704,0.6261564589301909,0.9512195121951219,1.0,1.0,1/6,10.31%,DUSP10
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.29562164226873383,-0.6260401813384915,1.0,1.0,1.0,6/30,28.89%,NOTCH4;EIF6;RBM4;RAN;AGO1;AGO4
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.335001242532325,-0.6260250533587527,0.927536231884058,1.0,1.0,1/17,1.81%,SCN4B
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.3280670875693916,-0.6255848296339415,0.921875,1.0,1.0,3/21,13.94%,NCKAP1L;CCL5;CXCL13
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.23200586208969165,-0.6253488380215595,1.0,1.0,1.0,28/360,15.60%,HSD17B10;ROPN1B;NDP;HSD17B13;LMAN1;PEX11B;PINK1;CHMP4B;KIF9;ZFP69B;CHMP2B;ARL1;SPTBN5;CHMP2A;PEX16;PPID;GOLGA8O;MCOLN1;ZMYM3;GOLGA8B;CFAP126;TPM1;TANGO2;CYCS;PAK6;SPRYD3;FGD3;RAB31
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.36653797064204763,0.6248277019134331,0.8571428571428571,1.0,1.0,1/6,5.00%,EPHB2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.38697683287900875,-0.6244470695462349,0.875,1.0,1.0,3/8,25.13%,PIK3CB;LYN;PIK3CD
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.37213679975197667,-0.6244316216147949,0.921875,1.0,1.0,3/7,15.96%,NOTCH1;LIN7C;ARHGAP12
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.3008872323235234,-0.6244136309418333,0.9649122807017544,1.0,1.0,2/25,9.19%,PINK1;SKP1
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4125247481599109,-0.6240813266899509,0.9857142857142858,1.0,1.0,3/10,30.95%,STX19;STX1B;STX3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.35693587523118314,-0.6238553363926045,0.9649122807017544,1.0,1.0,2/9,19.91%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.34290734437868853,-0.6237846885814363,0.9565217391304348,1.0,1.0,1/13,5.61%,CHMP4B
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.38252393978626326,-0.6237668070846907,0.9154929577464789,1.0,1.0,1/6,24.02%,RAN
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.23300943616989178,0.6235453874172144,1.0,1.0,1.0,13/85,16.96%,MRPL17;MRPL33;MRPS27;MRPL58;MRPL39;MRPL41;ETF1;MRPS7;MTRF1L;MRPL21;MRPL4;MRPS18A;DAP3
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.38932503445430555,-0.6233054981648488,0.8813559322033898,1.0,1.0,3/6,36.79%,C1QA;C1QB;CX3CL1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.4077098817357654,0.6232294395930653,0.9555555555555556,1.0,1.0,1/5,7.09%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.4077098817357654,0.6232294395930653,0.9555555555555556,1.0,1.0,1/5,7.09%,PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.29753259558596457,-0.6231088568303507,0.9375,1.0,1.0,5/23,24.61%,AGER;APH1B;PSME1;LYN;USP50
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.314801866979743,-0.6227270455315946,0.9692307692307692,1.0,1.0,2/28,6.22%,GLRX2;MTCH1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.277391823901719,-0.6218010484303356,1.0,1.0,1.0,11/42,26.38%,CTNNA1;AHR;MLC1;BRCA1;MAP4K1;AKR1C2;GPLD1;GLRA1;SMO;JUP;BLM
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.42387893038555435,-0.6217157328427574,0.9298245614035088,1.0,1.0,1/5,9.19%,GLI3
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.25449839552450315,0.6215619904702879,1.0,1.0,1.0,17/71,19.13%,PM20D1;RRAS2;FOS;GRID2;EIF2S1;EGLN3;NSMF;MAP3K5;FYN;CHP1;SORL1;GRIN2B;MEF2C;WNT5A;RILPL1;DDIT4;CSF1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.2389502786262328,-0.6213041909948519,1.0,1.0,1.0,47/282,24.86%,RAB6C;NXT1;CD74;LMAN1;RANBP6;ARCN1;ARL1;SLU7;RAB19;STRADB;TGFB1;GRTP1;SPRN;STX19;NUP85;RAB23;TBC1D13;VPS35;TSC2;RAB31;ARF3;STX16;STRADA;ARF1;YWHAH;NUP155;LAMP2;ARL6;RTN2;ARL4C;GCKR;AP1M2;NUP188;RUNDC1;STX1B;RAB1A;RAB1B;ARF4;RAB6D;SCG5;CALR;RAN;AP4M1;ARF5;AKT1;VPS28;VPS36
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.2624411483702569,0.6209604575133622,0.9615384615384616,1.0,1.0,6/43,10.92%,HSPB1;HSPA1A;DNAJC4;RHBDD1;DNAJB4;BAG3
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.3892887163900437,-0.6205741034818328,0.9166666666666666,1.0,1.0,1/6,10.03%,PRKCH
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.36497852628227984,-0.6205192535258202,0.8983050847457628,1.0,1.0,4/10,29.03%,ISG20;DNASE1L1;REXO4;DFFB
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.31225179424372584,0.6204248337704961,0.8648648648648649,1.0,1.0,5/17,22.78%,TIMELESS;SPIDR;HSF1;NR1H4;ROCK2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.3837838612811415,-0.6203569637446099,0.9433962264150944,1.0,1.0,3/9,21.90%,PDGFRB;NOTCH4;ACVR2B
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.36112356829417847,-0.6200842414732209,0.9322033898305084,1.0,1.0,1/11,11.34%,STMN1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.3136721413022314,0.6200522613879929,0.9736842105263158,1.0,1.0,2/18,7.59%,COX10;COX19
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.3303192359463637,0.6199513666948178,0.918918918918919,1.0,1.0,3/13,25.09%,TPR;NUP107;NUP98
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.3328926400726133,-0.6198026624293691,0.9206349206349206,1.0,1.0,3/21,13.94%,NCKAP1L;CCL5;CXCL13
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.33834468907285975,0.6193559523214688,0.8536585365853658,1.0,1.0,1/7,13.75%,AKT2
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.25817186985766605,-0.6188900159746441,1.0,1.0,1.0,5/58,15.18%,POLQ;NHEJ1;MRE11;PRPF19;BRCA1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.23629284136102846,0.6185572350026418,1.0,1.0,1.0,7/53,15.07%,PCM1;FIGN;HOOK3;MAP10;CHP1;NUMA1;SPAST
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.4183749306378743,0.6184849814649647,0.9047619047619048,1.0,1.0,2/5,13.00%,MYB;SIRT1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.3802452934623272,0.6182488097043729,0.8666666666666667,1.0,1.0,2/7,13.11%,VAMP8;SNAP29
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3433530001687794,0.6181951101212277,0.8529411764705882,1.0,1.0,3/9,27.04%,ICE1;RPTOR;ICE2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.2761271354898711,-0.6177145369162858,1.0,1.0,1.0,4/47,11.08%,WFS1;WIPI1;HSPA5;DCTN1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.33980393045776947,0.6173231965218788,0.9285714285714286,1.0,1.0,4/9,24.55%,ABCD2;PTEN;ABCD1;MYRF
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.36602675947621943,0.6170608373027193,0.9347826086956522,1.0,1.0,4/7,30.47%,DYRK3;DHX8;KIF5B;VCP
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.3482187886846088,0.6170478279643076,0.896551724137931,1.0,1.0,7/7,65.19%,DNMT3A;PCGF5;MECP2;PCGF3;KDM1B;PRMT7;DIRAS3
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3618563529234991,0.6169096668625385,0.90625,1.0,1.0,4/13,11.85%,DDAH1;APOE;KCNC2;GUCY1A1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.4115916540676868,-0.6167702886957592,0.9583333333333334,1.0,1.0,1/5,16.17%,WASF1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.34010454878943497,0.6165747754465521,0.8333333333333334,1.0,1.0,10/10,66.01%,POGZ;CENPT;CENPA;MIS12;CENPC;CENPE;CENPF;CENPH;NUF2;CENPW
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.34778772807571856,-0.6165731057676872,0.9041095890410958,1.0,1.0,2/12,16.81%,NIPAL3;NIPAL4
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.32993047413998067,0.6161506715258007,0.9444444444444444,1.0,1.0,2/11,10.77%,RNFT1;USP25
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.2687047397727176,-0.6159872995937176,0.9857142857142858,1.0,1.0,5/43,15.18%,RFC5;RPA3;TRIM25;PCNA;BRCA1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.3269925591642951,-0.6152995162923655,0.9264705882352942,1.0,1.0,8/21,30.95%,TUBB;TUBA1B;HOOK2;KIF5A;TUBA1A;KIF1A;CCDC186;KIF1C
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.390539128516049,-0.6152519549220891,0.9629629629629629,1.0,1.0,1/6,13.85%,TXN
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.3471520416307462,-0.614877464198,0.9259259259259259,1.0,1.0,2/12,17.64%,SESN3;RNF152
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.2609429459286103,0.6144817974694905,1.0,1.0,1.0,11/55,20.82%,ARL13B;RAB7A;WDR81;DYNC1I2;ATM;LGALS8;AUP1;DYNC1I1;KLHL3;PCNT;ATG2B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.24459917472434123,0.6142956076271477,1.0,1.0,1.0,6/57,11.34%,WWTR1;CROCC;EIF2AK3;GNL3L;BICD1;FYN
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.3419531399738849,-0.6142648846334675,0.9285714285714286,1.0,1.0,2/12,15.92%,APH1B;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.26316947840917737,-0.6142289047034746,1.0,1.0,1.0,13/83,23.51%,PATL2;ENC1;PAIP2B;EPRS1;IGFBP5;ZNF540;ILF3;RBM4;RPL13A;FXR1;YTHDF1;CALR;RPS3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.3442701356366899,0.6140788761612134,0.8888888888888888,1.0,1.0,1/11,4.00%,LATS1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.3240350856772265,-0.6139843051203496,0.95,1.0,1.0,1/18,10.95%,EFEMP1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3370379859927259,-0.6138898809780652,0.953125,1.0,1.0,3/12,38.07%,RNF168;RNF8;NELFCD
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.36297711637438124,-0.6134037944913492,0.873015873015873,1.0,1.0,1/9,10.01%,BMP1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.3300097122347829,-0.6132062063633069,0.9365079365079365,1.0,1.0,2/14,9.56%,ADAMTS18;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.3650819875607566,-0.6131622456196525,0.9264705882352942,1.0,1.0,1/9,6.15%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.2887150909679689,0.6129403038008696,1.0,1.0,1.0,10/30,21.65%,LZTS3;NLGN1;PPFIA2;SIPA1L1;NGEF;ARHGAP44;RELN;PTEN;EPHA4;TANC2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.2543101429019689,-0.6125619142294078,1.0,1.0,1.0,14/93,20.26%,MSX1;CDKN2D;TCHP;NOTCH1;CRLF3;TGFB1;INHBA;TP53TG5;CDKN1B;NAIF1;ESR2;NME6;OSGIN2;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.3537534433264038,-0.6117452026417316,0.9855072463768116,1.0,1.0,2/13,15.40%,CD300LF;TLR2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.3579222446359802,0.6116144240038865,0.8666666666666667,1.0,1.0,6/6,64.22%,SENP1;SENP6;SENP2;SENP5;USPL1;SENP7
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.3496772657398953,-0.6115731089445123,0.9545454545454546,1.0,1.0,6/9,38.34%,PCSK5;FURIN;SPCS1;SPCS3;SEC11C;SPCS2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.3616439631207526,-0.611515563586449,0.9137931034482759,1.0,1.0,2/9,15.61%,RIN3;STAP1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.38095715543001,-0.6114005788815903,0.9152542372881356,1.0,1.0,1/7,9.16%,CCL5
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.3106939043470851,-0.61109864309319,0.9411764705882353,1.0,1.0,2/23,10.67%,SUV39H1;EEF1AKMT2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.27654421431681503,-0.610832529467621,0.9857142857142858,1.0,1.0,12/46,29.89%,CPNE5;SYT2;SYT4;NTN1;DBN1;GHRL;ISLR2;PLAA;CPNE9;TWF2;AGRN;GHR
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.2631047169911317,0.6105651172441222,1.0,1.0,1.0,4/23,16.40%,FGFR4;DACH1;PDGFB;ATM
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.3035246237794668,-0.6102048952275918,0.9692307692307692,1.0,1.0,2/23,9.55%,PEX11B;PEX16
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.27674037929631595,0.610051774912086,0.9696969696969697,1.0,1.0,6/25,15.95%,PRKCD;TPR;BAG3;PIK3R1;DMAP1;CDH1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.3000318274845844,0.609943178440338,0.9230769230769231,1.0,1.0,2/8,11.40%,PNKP;AK5
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.30174366188761725,-0.609614402709943,0.9324324324324325,1.0,1.0,6/21,33.37%,ATXN7L3;UHRF1;PAF1;UBE2B;CTR9;RNF8
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.3259744725718202,0.609548949509822,0.9090909090909091,1.0,1.0,2/9,13.49%,REP15;SORL1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.2893707471893245,0.6085756585629394,1.0,1.0,1.0,6/28,17.24%,HSPA1A;SF3B4;PIK3R1;U2AF2;TRA2A;CELF4
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.39146653127145803,-0.608140188146854,0.9285714285714286,1.0,1.0,1/5,16.78%,FLOT1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.34495185453518695,0.6080501962643092,0.8378378378378378,1.0,1.0,3/7,21.45%,CXCL12;FERMT3;FERMT2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.30342174276497885,0.6080420347512455,0.9,1.0,1.0,3/16,6.73%,GREM1;HMGB1;MOSPD2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.27194756374783763,-0.6079379124380693,1.0,1.0,1.0,4/55,15.13%,LDLRAP1;NSDHL;DHCR7;G6PD
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.21566993800243534,0.6078974488452398,1.0,1.0,1.0,21/231,13.93%,INO80D;IFIH1;RCE1;SENP8;TRAF3;TGFBR1;DESI2;CLSPN;CCNA2;RNF128;SMAD2;BABAM2;STAMBPL1;USP31;USP25;TAB1;MBD5;OTUD3;EP300;FOXK1;BRCC3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3053226968484862,-0.6076919486375114,0.9814814814814815,1.0,1.0,6/21,25.35%,CASP8;RNF34;RPS27A;UBC;AAMP;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.3146383520901468,0.6075939182144906,0.9375,1.0,1.0,5/13,21.44%,AUTS2;MYB;DNMT1;CTNNB1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.32651051123486563,-0.6075356061085279,0.9193548387096774,1.0,1.0,3/16,14.93%,DAB2IP;PIK3CB;CCBE1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.2445455759560188,-0.6073375353569433,1.0,1.0,1.0,13/105,16.89%,RGS10;DOCK8;PINK1;GBA3;CCL5;CALM3;RCN3;F11R;ADRB1;PSAP;CTSH;MMUT;RASGRP2
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.3741703538024085,0.6066814003094492,0.9210526315789473,1.0,1.0,2/7,16.16%,FYN;DOCK3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.250915976821821,0.6066679106096873,1.0,1.0,1.0,4/57,7.35%,EGFR;TGFB2;TGM1;EIF4EBP1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.261491252163024,0.6063878212058122,0.9375,1.0,1.0,14/60,18.97%,PTPRK;CASP9;PRKCD;ZBTB1;EIF2S1;RHBDD1;RUVBL2;SIRT1;EP300;NEDD4;TRIAP1;CREBBP;USP47;YY1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.24782219265608696,0.6062179611815933,1.0,1.0,1.0,6/33,16.49%,PNPO;AGPAT5;GPHN;IP6K1;FITM2;PCYT2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.3955257246436656,-0.606109995468322,0.9137931034482759,1.0,1.0,1/5,10.03%,PRKCH
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.28059001492574853,0.6057412225776421,1.0,1.0,1.0,4/20,11.33%,H6PD;PGM2;G6PC3;RPEL1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.35698277887800123,-0.6057006994339673,0.9047619047619048,1.0,1.0,2/10,18.57%,SLC24A4;OR2M4
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.36927890505788524,0.6056652046864585,0.8571428571428571,1.0,1.0,1/5,7.48%,PNPO
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.367857289148237,-0.605525770301373,0.9298245614035088,1.0,1.0,2/9,15.13%,NCKAP1L;G6PD
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.22027265462608384,0.6054898541144194,1.0,1.0,1.0,21/223,13.93%,INO80D;IFIH1;RCE1;SENP8;TRAF3;TGFBR1;DESI2;CLSPN;CCNA2;RNF128;SMAD2;BABAM2;STAMBPL1;USP31;USP25;TAB1;MBD5;OTUD3;EP300;FOXK1;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.31121971880396393,-0.6053297941098676,0.9661016949152542,1.0,1.0,5/30,18.99%,RREB1;RAC1;DOCK1;MYADM;C1QBP
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.29258012754763973,-0.6050498235835746,1.0,1.0,1.0,3/35,8.67%,GCM2;CHAC1;WDR62
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.3776637837076162,0.6050388512490589,0.8780487804878049,1.0,1.0,2/5,22.12%,FGF10;STAT3
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.3867202727251965,-0.6049515519918559,0.9420289855072463,1.0,1.0,2/7,18.69%,SLC24A1;ARF1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.30467427329939556,-0.6047665021592699,0.96875,1.0,1.0,5/21,19.57%,RAB11A;ATAD5;CDC25A;RAD51C;CDK4
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.23760809206038966,-0.6044062448161778,1.0,1.0,1.0,23/159,21.20%,HSD17B10;BIK;BNIP3;PINK1;TOMM20;MGME1;BCAP31;TOMM7;DNAJC19;SLC25A4;CYCS;TOMM22;WASF1;THG1L;COX7A2L;SLIRP;SUPV3L1;TIMM17B;HIGD1C;MIGA1;ATPAF1;PRDX3;MIEF1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.3503301915886782,0.6041238708074104,0.8863636363636364,1.0,1.0,2/6,13.75%,IRS2;AKT2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3257606533181474,-0.6037900511441147,0.9692307692307692,1.0,1.0,6/17,30.87%,PAICS;AK4;GMPR2;AMPD2;IMPDH2;AMPD3
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.333553249525284,-0.603734956702899,0.9696969696969697,1.0,1.0,1/12,10.74%,MSN
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.3606564892495302,0.6035290549231299,0.8913043478260869,1.0,1.0,5/5,63.94%,STX1A;GRK2;VIP;KCNB1;CHRNB2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.25002923296689694,0.603321025261463,0.9583333333333334,1.0,1.0,21/88,19.09%,KCNB2;IGDCC3;PLPPR5;EPHA8;CACNG4;LIN28B;RHBDL3;PHF21B;FBLL1;NYAP1;MSI1;GRM8;CRABP1;PPM1E;DPYSL5;SNAP91;ST8SIA2;VGF;UNC13A;CACNA1B;CLVS2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.342956776884888,-0.6030564195723821,0.9130434782608695,1.0,1.0,3/11,20.46%,TBX1;PDGFRB;ADAMTS9
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.3482028241335044,0.6022827971447071,0.9032258064516129,1.0,1.0,6/6,65.19%,DNMT3A;MECP2;CTCF;KDM1B;PRMT7;DIRAS3
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.20691211487155922,0.6019618319592739,1.0,1.0,1.0,34/162,22.88%,ADARB2;ATXN1;RBMS1;LIN28B;SF3B4;NOVA1;IVNS1ABP;BICD1;KHSRP;U2AF2;SRRM1;CELF2;CELF1;SNRPG;HNRNPL;HNRNPH1;SNRPN;LSM6;MAGOHB;MBNL1;SON;SCAF11;SRRM4;CDK12;DHX8;SETX;RSRC1;ELAVL4;PTBP1;RBM39;AURKAIP1;THOC1;SNRPB;SF3A2
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.2908970870625047,0.6018218655534601,0.9444444444444444,1.0,1.0,2/13,19.30%,SPIN1;SIRT7
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.28001166777689196,-0.6017388925188044,0.9571428571428572,1.0,1.0,5/33,22.94%,SESN3;LAMTOR2;LAMTOR5;RRAGA;GLRA1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.39177153405064363,-0.6012833227159724,0.9538461538461539,1.0,1.0,3/6,24.04%,PDZD11;LIN7C;AP4M1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.2557975179408389,0.6012327203537302,1.0,1.0,1.0,4/26,13.53%,MN1;PTPN6;FAM83D;ID2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.29594794057560636,-0.6006838796271582,0.9850746268656716,1.0,1.0,4/26,16.95%,DAB2IP;SNAI2;EEF1A1;VIL1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.27809052002226176,0.6005848224553195,1.0,1.0,1.0,10/25,28.43%,TET2;SETMAR;WDR82;BEND3;SETD1A;TET3;PRDM7;PAXIP1;SETD4;KMT2C
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.3617281714430094,-0.6001434163011758,0.9152542372881356,1.0,1.0,1/12,12.07%,F11R
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.3637043618750486,-0.5989285960786705,0.9402985074626866,1.0,1.0,4/7,30.95%,SYT4;KIF5A;KIF1A;KIF1C
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.36616532552724834,-0.5989134923384734,0.9473684210526315,1.0,1.0,1/9,11.08%,DCTN1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.3058650317280228,0.5987345772602464,0.9545454545454546,1.0,1.0,4/12,22.83%,MT1E;ATP7B;HSF1;SNCA
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26040288937293876,0.598285449266355,1.0,1.0,1.0,3/46,7.76%,F2RL1;CFLAR;HSPA1A
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.393274211915953,-0.5980882810267251,0.9137931034482759,1.0,1.0,2/5,23.76%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.393274211915953,-0.5980882810267251,0.9137931034482759,1.0,1.0,2/5,23.76%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.393274211915953,-0.5980882810267251,0.9137931034482759,1.0,1.0,2/5,23.76%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.316932975281041,-0.5980319056653145,0.9726027397260274,1.0,1.0,2/21,10.25%,FKBP1B;CALM3
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.40789745252818455,-0.5976407411889513,0.95,1.0,1.0,2/5,22.51%,CRYL1;AKR1A1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.40789745252818455,-0.5976407411889513,0.95,1.0,1.0,2/5,22.51%,CRYL1;AKR1A1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.40789745252818455,-0.5976407411889513,0.95,1.0,1.0,2/5,22.51%,CRYL1;AKR1A1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.32452011873298037,-0.5976382420871339,0.9473684210526315,1.0,1.0,1/19,4.40%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.2697081148665851,-0.5975896498376246,0.9827586206896551,1.0,1.0,9/48,18.06%,BNIP3;PINK1;SESN3;SLC25A5;SLC25A4;TSC2;SUPT5H;VDAC1;PIP4K2C
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.3108923333641107,0.5972086291656099,1.0,1.0,1.0,3/19,10.74%,CSF1R;MDK;IL34
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.35526648271381667,0.5970859866788889,0.9210526315789473,1.0,1.0,1/7,11.15%,SPHK2
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.40399315344029163,-0.5962994832144817,0.9836065573770492,1.0,1.0,1/5,13.97%,CACNA1G
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.39887635274151945,0.5960562117052013,0.8780487804878049,1.0,1.0,1/5,9.84%,KIF13A
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.35686994828925495,-0.5960019177680833,0.9454545454545454,1.0,1.0,2/10,11.23%,NOTCH1;TTN
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.31429912239692714,-0.5958452268674271,0.9863013698630136,1.0,1.0,1/20,5.24%,DRD3
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.33915477256556553,-0.5954390306899114,0.9310344827586207,1.0,1.0,6/12,36.99%,VPS4A;OSBPL2;STAR;SERAC1;NPC2;ARV1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.36224336647692107,-0.5952457725519112,0.8928571428571429,1.0,1.0,2/5,35.35%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.36224336647692107,-0.5952457725519112,0.8928571428571429,1.0,1.0,2/5,35.35%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.3534684393316816,0.5949883061670133,0.8974358974358975,1.0,1.0,2/5,17.38%,SPHK2;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.29664859646429387,-0.5949275147605004,0.9827586206896551,1.0,1.0,7/27,18.75%,CASP8;HIP1R;BOK;NMT1;YWHAB;YWHAG;YWHAH
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.342382626170857,0.594715720138659,0.9142857142857143,1.0,1.0,3/8,20.01%,NR1H3;PROM2;CLN3
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.3479277461947552,0.5946255821389397,0.96,1.0,1.0,6/6,65.22%,TRPM7;CNNM4;SLC7A8;ATP13A2;UNC80;COX11
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.24510389812910502,0.5945152506651553,1.0,1.0,1.0,6/56,13.50%,CROCC;CDKL1;TBC1D10B;TBC1D2;CEP120;TBC1D16
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.31870762706269473,0.5944879374453125,0.8809523809523809,1.0,1.0,5/10,20.69%,SRR;PSPH;SEPHS1;CTH;SERINC5
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),-0.391829888865554,-0.5940806392150011,0.953125,1.0,1.0,1/5,7.25%,ABCB4
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.34903033693209606,-0.5940664007225069,0.9636363636363636,1.0,1.0,3/12,30.28%,SLC30A8;CAMK2G;PARK7
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.3632057032145386,-0.593599264207361,0.896551724137931,1.0,1.0,2/7,12.61%,PLSCR4;PLSCR5
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.28467316976852874,-0.5926173089482699,1.0,1.0,1.0,4/27,21.68%,CEMIP;TCAF2;MIEF1;PDZK1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.36725866053595135,0.5925853966574828,0.9210526315789473,1.0,1.0,1/6,7.76%,HSPA1A
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.4099501778467126,-0.5918838409502726,0.9655172413793104,1.0,1.0,1/5,13.31%,CMPK2
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.3775686940635141,0.5916801879496084,0.85,1.0,1.0,2/6,16.16%,FYN;DOCK3
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.28017266560711546,-0.5915456388166856,0.9857142857142858,1.0,1.0,10/29,29.96%,HSPA5;DAB2IP;HSPA1L;DAXX;HSPA9;BAX;BAK1;HSPA2;HSPA8;HSPA13
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.36388048640310383,0.5909237944166588,0.8947368421052632,1.0,1.0,1/7,11.01%,LIMS1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.3754198681194969,-0.5909102688103666,0.9824561403508771,1.0,1.0,1/5,12.01%,HIP1R
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.28402547891053587,0.5906869857670005,0.972972972972973,1.0,1.0,2/17,7.53%,POLD3;DCLRE1B
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.3922645440463709,-0.5904010463197451,0.8983050847457628,1.0,1.0,4/5,25.00%,PCNA;RPS3;AKT1;DDX11
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.22819503061040533,0.5903510757787401,1.0,1.0,1.0,8/112,9.83%,HSPB1;SAMD4A;PRR5L;ELAVL1;PRKCD;HSPA1A;IGF2BP3;EXOSC1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.2895951205376841,0.5900175601860566,0.9655172413793104,1.0,1.0,4/17,16.38%,RNF2;RYBP;PCGF1;RING1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.2965469937382281,0.5898391684125095,0.9487179487179487,1.0,1.0,5/21,13.75%,CSF1R;TGFBR1;PDPN;ACTN4;AKT2
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.33347341810924924,-0.58977062713588,0.9552238805970149,1.0,1.0,2/9,20.05%,C1QBP;UFD1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.22684420912634992,0.5894025740003099,1.0,1.0,1.0,12/79,16.96%,MRPL17;MRPL33;MRPS27;MRPL58;MRPL39;MRPL41;MRPS7;MTRF1L;MRPL21;MRPL4;MRPS18A;DAP3
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.318568801256668,-0.5893622534147811,0.9705882352941176,1.0,1.0,2/14,16.15%,PGAM1;SRPX2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.31174126225578824,-0.5892537178297165,0.953125,1.0,1.0,2/19,11.77%,MYO5B;MYO1F
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.2648655923301783,0.5889599918868236,0.967741935483871,1.0,1.0,6/29,16.70%,FER1L5;UBXN2A;VAMP3;CHP1;SNAP29;MX1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.3813624477514157,-0.5889034069212903,0.9655172413793104,1.0,1.0,1/5,28.63%,CD226
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.3813624477514157,-0.5889034069212903,0.9655172413793104,1.0,1.0,1/5,28.63%,CD226
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.3313821683323251,-0.5887406435062238,0.9516129032258065,1.0,1.0,1/9,7.83%,CHST1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.2612003614971312,0.5887146079122596,1.0,1.0,1.0,5/27,13.02%,TNFRSF11A;DUSP10;DVL2;MAP3K5;MAP3K10
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.23463579760212283,-0.5880336811835957,1.0,1.0,1.0,15/114,20.29%,SFRP4;PSMB6;ATP6AP2;PSMB8;GPC3;TGFB1;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;DAAM2;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.2561689899090962,0.5878631625331049,1.0,1.0,1.0,8/28,18.24%,ZBTB20;APOE;SCARB1;CHP1;PLIN5;CREB1;NR1H3;PPARA
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.29895062457608623,-0.5876277959885039,1.0,1.0,1.0,7/25,29.66%,STMN1;F11R;WAS;MET;INPP5K;ARHGAP28;SHANK3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.2865488607713151,-0.5874050100402199,1.0,1.0,1.0,3/31,15.60%,AMN;PREPL;RAB31
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.3206553708308739,0.5870742831989111,0.9375,1.0,1.0,3/13,13.25%,IGF1;PTCH1;MBD5
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.2430644028626292,-0.5868805565366383,1.0,1.0,1.0,26/91,31.23%,BNIP3;LMAN1;TOM1L1;ARCN1;ATP1A1;STX16;ARF1;CLCN3;LAMP2;ANP32E;ARFGEF2;SCAMP1;DNM1L;CLTC;CLTA;TMED10;YKT6;M6PR;PPT1;NAPG;SOD1;VPS4B;AP2M1;NAPA;COPB1;ERGIC3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.27051155275660216,-0.5864374621605654,0.972972972972973,1.0,1.0,6/36,24.42%,ATP1B1;SFXN3;KCNJ11;SLC25A19;TRPM6;SLC38A5
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.31409744574610143,-0.5860188602255897,0.95,1.0,1.0,5/13,18.60%,CIITA;GSTP1;GPER1;SLC18A2;ASXL3
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.38592267841462813,-0.5856367177019319,0.9482758620689655,1.0,1.0,1/5,15.97%,NCEH1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.32044345329270174,-0.5855383290440959,0.9848484848484849,1.0,1.0,4/15,29.84%,NCKAP1L;GHRL;SELENOS;CD200
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3090478989404499,0.5854756418487885,1.0,1.0,1.0,1/17,3.09%,BMP7
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.3850468989460773,-0.5847897855814641,0.9047619047619048,1.0,1.0,1/5,25.01%,CTDP1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.3357669880124612,-0.5844190118900522,0.9818181818181818,1.0,1.0,3/12,24.59%,FADS2;ELOVL2;ACOX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3232487641052329,-0.5843371735196112,0.9649122807017544,1.0,1.0,2/18,19.20%,RPA3;RBX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3232487641052329,-0.5843371735196112,0.9649122807017544,1.0,1.0,2/18,19.20%,RPA3;RBX1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.3040668416554792,-0.5842874984700647,0.9523809523809523,1.0,1.0,4/19,18.78%,CAPN1;TTC6;SLC25A31;TDRD5
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.3255499503794022,0.5841055566763129,0.9743589743589743,1.0,1.0,1/7,6.63%,DDAH1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2234036884131374,0.5841049207042396,1.0,1.0,1.0,15/112,13.81%,NUP210;ATF3;VASH1;NEK6;CASP9;NUP42;HSPA1A;TPR;BAG3;NUP37;BAG2;SIRT1;IER3;EP300;PNPT1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.24686114576542043,-0.5838882417125074,1.0,1.0,1.0,17/70,24.28%,RFC5;RPA3;XRCC1;COPS2;POLR2J;POLR2K;PRPF19;PCNA;RBX1;COPS5;COPS8;COPS7B;POLR2I;POLR2B;RPS27A;UVSSA;UBC
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2679288298042254,-0.5836978946369185,1.0,1.0,1.0,17/54,26.62%,TOM1L1;CHMP2A;DAB2IP;CBX5;GPER1;CHEK1;BRCA1;NME6;CBX3;L3MBTL2;VPS4A;SUZ12;RBBP8;CDC7;FOXO4;CCP110;FBXO43
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.2620733075941215,0.5831066290012612,1.0,1.0,1.0,10/45,15.95%,RUBCNL;LIX1;FZD1;VAMP8;DVL2;SNAP29;TSG101;LRP6;UVRAG;FRAT1
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.34007336084364975,0.5829709464091545,0.9444444444444444,1.0,1.0,8/8,66.01%,POGZ;CENPT;CENPA;MIS12;CENPC;CENPE;CENPF;CENPW
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.3898110947360172,-0.5828522363967795,0.9821428571428571,1.0,1.0,2/5,26.89%,AGBL3;AGBL2
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.35736219956231063,-0.5824185460350663,0.953125,1.0,1.0,4/11,22.98%,CORO1A;VIL1;ARF1;WHAMM
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.37400402383673037,0.5822640878668868,0.926829268292683,1.0,1.0,1/6,9.84%,KIF13A
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),0.3733094943382387,0.5817355120932208,0.8913043478260869,1.0,1.0,5/5,62.68%,SPHK1;ORMDL1;ORMDL2;PRKAA1;ORMDL3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.2901867979575882,0.5808887188620924,0.9090909090909091,1.0,1.0,3/13,21.24%,EP300;CREBBP;NAA15
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.3808897741370721,-0.579926526079816,0.9310344827586207,1.0,1.0,1/5,10.51%,SLC9A6
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.26955757000183644,0.5796561547553223,1.0,1.0,1.0,1/24,2.97%,TSFM
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.3291447216481583,-0.5794795028793713,0.9722222222222222,1.0,1.0,3/10,28.63%,LBP;HSPD1;CD226
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.36287364753346774,0.5791167669023771,0.9285714285714286,1.0,1.0,6/6,63.72%,ZNF516;FFAR4;UCP1;PPARGC1A;PRDM16;METRNL
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.3533531788702745,-0.5790240162624892,0.984375,1.0,1.0,1/11,5.24%,DRD3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.24984095297915296,0.5789228704002616,1.0,1.0,1.0,8/54,10.45%,PTPRK;CASP9;PRKCD;ZBTB1;SAG;EIF2S1;RHBDD1;RUVBL2
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.30884425760462986,0.5788491491374455,1.0,1.0,1.0,2/22,7.88%,COBL;ARID5B
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.27370868438638024,-0.5786776756359601,0.9661016949152542,1.0,1.0,1/27,5.31%,SUV39H1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.2429445219704566,-0.5783602253266811,1.0,1.0,1.0,12/102,17.41%,CPNE5;B2M;BNIP3;MCOLN1;SYT2;SYT4;NEUROD2;CDKN1B;DAXX;PLCG2;RASGRP2;HVCN1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.32374506236964795,-0.5781029564541968,0.9629629629629629,1.0,1.0,2/10,18.46%,TLR2;ZCCHC3
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.335442797733765,0.5781017041983397,0.9743589743589743,1.0,1.0,3/8,24.37%,HPRT1;PRPS1;SHMT2
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.3635900777001795,-0.577822172523756,0.9841269841269841,1.0,1.0,1/7,8.64%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.29398494647863177,-0.5777100276333905,0.9428571428571428,1.0,1.0,2/16,11.34%,RASIP1;STMN1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3201531351634186,-0.5774671355372725,1.0,1.0,1.0,2/14,17.15%,HERPUD1;SYVN1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2806975104785535,-0.5770723025372634,0.9836065573770492,1.0,1.0,6/23,25.35%,CASP8;LACC1;RPS27A;UBC;AAMP;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.32130052802656384,-0.5769693142216191,0.9473684210526315,1.0,1.0,2/18,19.14%,DCP2;NAT10
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.2453372880237194,0.5769490076301528,1.0,1.0,1.0,9/54,13.92%,BCL2;LEPR;MTMR8;DAP;TAB3;MTMR9;SIRT2;NRBP2;FOXK1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.3116136215854654,-0.5769438283544605,0.9857142857142858,1.0,1.0,2/13,21.91%,CYP2R1;IPMK
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.31034054814235484,0.5765465304161395,0.9555555555555556,1.0,1.0,1/14,3.78%,SLC22A13
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.3588742270608202,-0.576446061489253,0.9545454545454546,1.0,1.0,4/9,29.35%,PLCG2;LBP;GRN;DYSF
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3306973179605006,-0.5759761726500116,0.9692307692307692,1.0,1.0,3/13,19.23%,PAIP2B;EIF2AK1;RBM4
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.3399046396479001,0.5759072379649162,0.9428571428571428,1.0,1.0,6/6,66.02%,UXT;LRPPRC;MAP1S;RHOT2;RHOT1;UBB
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.3165726919094428,-0.5758870263654963,0.9538461538461539,1.0,1.0,3/14,18.99%,RNPS1;SAP18;C1QBP
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.3172155386077108,0.5756953349512861,0.9782608695652174,1.0,1.0,3/10,19.42%,FGF10;PTEN;MAP4K4
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.24265951248016174,-0.5755774702133699,1.0,1.0,1.0,12/76,20.29%,RAC1;PSMB6;CELSR1;PSMB8;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.338591869184675,-0.5755052420519491,0.9538461538461539,1.0,1.0,2/12,10.93%,PINK1;DNAJA1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.31164021290490407,-0.5754417291710209,0.9850746268656716,1.0,1.0,4/17,24.53%,POLR1E;GTF3C6;GTF3C4;GTF3C3
prerank,MSigDB_Hallmark_2020__DNA Repair,0.2222039916549138,0.5752154538683866,1.0,1.0,1.0,10/136,9.90%,PNP;ZNF707;POLD3;ERCC8;ADA;HPRT1;ERCC2;DUT;TAF12;RALA
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.31828737689520425,-0.5745736622720253,0.9272727272727272,1.0,1.0,4/10,36.16%,DIMT1;UTP15;TRMT112;HEATR1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.3200379416209318,0.574447875352456,0.9565217391304348,1.0,1.0,2/10,17.38%,SMARCA4;SMARCB1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.3245780944242572,-0.5742923858265285,0.921875,1.0,1.0,5/13,31.38%,RAB11A;ARL6;BBS7;RAB17;MKKS
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.3245780944242572,-0.5742923858265285,0.921875,1.0,1.0,5/13,31.38%,RAB11A;ARL6;BBS7;RAB17;MKKS
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.2647508030923458,-0.5741357482763421,0.9836065573770492,1.0,1.0,10/37,32.47%,ETFB;UQCRB;CYCS;UQCRH;OXA1L;UQCR10;ETFDH;MTFR1L;MTFR1;NDUFA5
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.2597366204498745,0.574131936612064,0.9714285714285714,1.0,1.0,2/22,6.71%,KANK1;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.27080821297525615,0.5733560576025938,0.972972972972973,1.0,1.0,4/19,18.50%,LATS1;TFAP4;MYOCD;PTEN
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.3315407823450239,0.5718988906105926,0.9714285714285714,1.0,1.0,2/8,13.33%,MTR;DHFR
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.3183241111196285,-0.5717187964586491,0.9538461538461539,1.0,1.0,3/13,13.32%,DAB2IP;SEMA3A;KIF20B
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.348048664127492,-0.5716552093392444,0.9354838709677419,1.0,1.0,1/9,7.10%,UNC119B
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.30815710800102575,0.5714059533740741,1.0,1.0,1.0,2/17,7.36%,ACADVL;AKR1C3
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.27880876499801366,-0.5711225022561557,1.0,1.0,1.0,10/33,25.36%,RNASET2;NCBP1;ISG20;NUDT1;SUPV3L1;RNASEH2C;DNASE1L1;ENTPD2;NUDT15;ENTPD5
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.3752233239904475,-0.5710026450725638,0.9807692307692307,1.0,1.0,1/5,10.81%,PIK3CB
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.33906191845133293,0.570743962996527,0.9,1.0,1.0,2/8,13.79%,PLA2G4C;CHPT1
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.3491037454728831,0.5705907275517332,0.9230769230769231,1.0,1.0,5/5,65.10%,STX1A;HRH3;KCNB1;ADRA2C;ADRA2A
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.37951990529219165,-0.5704148451046214,0.8867924528301887,1.0,1.0,3/5,24.90%,BOK;CYCS;BAX
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.3392263532060211,-0.5702232314323398,0.967741935483871,1.0,1.0,3/9,24.64%,RAB11A;STX1B;RAB8A
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.23791459378619723,-0.569709504117899,1.0,1.0,1.0,12/75,20.29%,RAC1;PSMB6;CELSR1;PSMB8;PSMA3;PSMA5;PSMC3;PSMA7;PSMC6;PSME1;PSMD12;PSMB2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.34389326975976525,0.5693287507481944,0.8780487804878049,1.0,1.0,6/6,65.62%,PTHLH;ACHE;GLI2;LRP5;MEN1;LIMD1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.3079812352560851,0.5692513181262256,0.9393939393939394,1.0,1.0,2/12,8.92%,CCDC22;FAF1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.3560765199493466,-0.5690566119926812,0.9384615384615385,1.0,1.0,4/7,38.45%,PPT1;CDC42;ANKFY1;APPL1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.2513766519823789,0.5687603129486913,0.9743589743589743,1.0,1.0,26/26,74.89%,FSCN3;AIF1L;SHROOM2;SHROOM1;FSCN1;DPYSL3;FAM107A;MICAL1;BAIAP2;ADD2;PLS3;ADD1;LIMA1;NEDD9;BAIAP2L2;DMTN;CALD1;BAIAP2L1;MYO1B;PLS1;EZR;CORO1B;EPS8;PAWR;HSP90B1;LCP1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.35843409586809144,0.5684203324087308,0.8857142857142857,1.0,1.0,4/7,25.05%,TNRC6B;STAT3;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.35843409586809144,0.5684203324087308,0.8857142857142857,1.0,1.0,4/7,25.05%,TNRC6B;STAT3;AGO2;EIF4G1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.27910214429362074,-0.5677191928207191,1.0,1.0,1.0,4/24,25.03%,SYT2;SYT4;SYT13;SYT9
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.3051337992117919,-0.5675200088176526,0.9682539682539683,1.0,1.0,1/17,3.47%,HSD17B13
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.28521849243322533,-0.5674212297352553,1.0,1.0,1.0,2/24,11.08%,GPSM2;DCTN1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.23128572459789284,0.5672448717103813,1.0,1.0,1.0,9/40,20.21%,PAPSS2;ADCY2;AK5;GUCY1A1;PANK3;PANK1;ADCY9;PPCDC;ADCY8
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.2694312917286916,0.5671412718925563,0.9722222222222222,1.0,1.0,3/28,9.20%,PCM1;PRR5L;TPR
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.31847283552625233,-0.5667473718155791,1.0,1.0,1.0,1/14,8.00%,SLU7
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.28424055743597443,-0.5660480672237449,0.9375,1.0,1.0,7/22,32.03%,MAP1A;GPX1;CHRNA7;CAMSAP1;HSPA8;PARK7;EFEMP2
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.3028758455578769,-0.5656583149442181,0.9577464788732394,1.0,1.0,2/15,14.69%,P2RY12;APOD
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.30206133955592335,-0.5651090825650162,0.9571428571428572,1.0,1.0,10/17,37.75%,GPS2;CD160;CEACAM1;PHPT1;EZR;DUSP3;THY1;PTPN22;LAPTM5;PRNP
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.31282259193958734,0.5647722490485741,0.9333333333333333,1.0,1.0,2/10,15.02%,MDK;RIPOR2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.24020922562853816,0.564647837347566,1.0,1.0,1.0,9/33,20.21%,PTGFR;AKR1C3;ADCY2;SPHK2;GNAI1;NR3C1;LARP1;DCPS;ADCY8
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.2992342610848733,0.5639691282771754,0.9787234042553191,1.0,1.0,9/9,70.09%,CHP1;CTSS;SLC9A1;RAB11B;TRPV1;RAB11FIP5;IMPACT;LGMN;PKD1L3
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.3364692689336912,0.563501748815129,0.9523809523809523,1.0,1.0,3/7,14.62%,ABCC11;ABCC4;ABCC1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.3132036324494356,-0.5631416467783072,0.9705882352941176,1.0,1.0,3/16,20.46%,MANBA;NGLY1;ADAMTS9
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.29562180396717463,-0.5629336730032453,0.9864864864864865,1.0,1.0,3/17,24.47%,RAB11A;CDK5;KIF5A
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.35484604363148514,-0.5627879882280439,0.9473684210526315,1.0,1.0,1/6,10.96%,SPI1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.3490973666394871,-0.5627079549446353,0.9310344827586207,1.0,1.0,6/9,35.78%,AK4;NT5C1A;AMPD2;AMPD3;NT5E;ADSS2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.31348499083407266,0.5625912641333317,0.95,1.0,1.0,4/10,21.91%,SMAD2;PUS10;SRRT;DGCR8
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.33269519553762833,0.5618933060991872,0.9285714285714286,1.0,1.0,4/6,30.91%,DENND1A;DENND4B;DENND4A;DENND3
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.2835999154483032,-0.5618291976823724,1.0,1.0,1.0,5/24,24.62%,SKP1;ATXN7L3;UHRF1;RNF168;PAF1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.324334891758993,0.5617746298412691,0.9166666666666666,1.0,1.0,6/10,25.13%,FER1L5;CSF1;AZU1;SPACA3;ADAM10;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.36897808700547485,-0.56175721572087,0.9655172413793104,1.0,1.0,2/5,26.98%,SIX4;EPHB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.31762925360867916,-0.5615815255644835,0.9830508474576272,1.0,1.0,6/13,25.44%,HIP1R;SLC25A5;BOK;TMEM14A;BAX;BAK1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.24329624673987524,0.5610259298799586,0.9722222222222222,1.0,1.0,6/39,12.49%,SMPD4;GLA;CLN6;GLB1;ST8SIA3;NEU3
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.317110531900214,-0.5609956462999439,0.9142857142857143,1.0,1.0,3/14,28.91%,GPAM;PCK2;DGAT1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.29437257912474957,0.5606367584534105,0.9487179487179487,1.0,1.0,2/11,20.81%,FBLL1;EXOSC5
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.30051457125709247,-0.5606322488551908,0.971830985915493,1.0,1.0,9/21,30.01%,MOAP1;TOMM22;ROMO1;HSPA4;BAX;TIMM8A;TIMM22;TIMM8B;COX18
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.2522507198603458,0.5606207487218493,1.0,1.0,1.0,4/35,11.06%,NUP210;NUP42;TPR;NUP37
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.24665672764835334,-0.5603036155280857,1.0,1.0,1.0,7/65,16.50%,RPS27L;FOXM1;GADD45A;PCNA;CNOT11;CDKN1B;RGCC
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.3271350999315408,0.5603006093404647,0.9047619047619048,1.0,1.0,1/6,12.82%,ANO6
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3176930968671896,-0.5601777708800775,0.9545454545454546,1.0,1.0,3/13,18.99%,RNPS1;SAP18;C1QBP
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.22735218855272202,0.5597515957316013,1.0,1.0,1.0,6/39,13.05%,NRXN1;LIN7A;SYN3;SYN2;SYT1;PPFIA3
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.25196595066762456,-0.5596854839935798,1.0,1.0,1.0,12/62,23.76%,TPX2;RAB11A;STARD9;GOLGA8O;GOLGA8B;TUBGCP4;KIF11;MZT1;HAUS6;RPS3;TUBGCP2;ABRAXAS1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.242313835562793,0.5593630666546098,1.0,1.0,1.0,12/42,22.88%,SRPK3;TXNL4A;CELF2;CELF1;SNRPG;CELF4;SCAF11;SMN1;SETX;SNRPE;CELF5;SF3A2
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.35769726045192546,0.558292310593847,0.9318181818181818,1.0,1.0,1/5,11.89%,SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.35769726045192546,0.558292310593847,0.9318181818181818,1.0,1.0,1/5,11.89%,SLC8A1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.2675254879056255,0.5579667104427883,1.0,1.0,1.0,1/24,2.05%,IFIH1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),0.34388516235893274,0.5578387029337369,0.9714285714285714,1.0,1.0,3/5,28.10%,RAB11FIP3;RAB11FIP1;IL11
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.3198074277854196,0.5569100469738811,0.975609756097561,1.0,1.0,8/8,68.03%,ICE1;SNAPC3;ICE2;SNAPC4;ZC3H8;ELL;SNAPC5;SNAPC1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.371363665915323,0.5565982831791343,0.95,1.0,1.0,1/5,10.54%,DUSP12
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.33186635139957527,-0.5565661317128108,0.9365079365079365,1.0,1.0,1/10,6.57%,GAR1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3045613472988128,0.5564279351975581,0.9230769230769231,1.0,1.0,2/8,18.47%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.29963017652066987,0.5558013730098128,1.0,1.0,1.0,3/10,14.01%,PTPN23;SORL1;EIPR1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.3067254718232313,-0.5548161685338565,0.9649122807017544,1.0,1.0,5/10,40.97%,VCPIP1;GOLGA2;PLK3;PDCD10;PLK5
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.3350881071336904,-0.5547348867723157,0.9692307692307692,1.0,1.0,4/8,31.40%,TGFB1;ESR1;DND1;POU5F1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.23083650500893688,-0.5537080258482038,1.0,1.0,1.0,18/114,20.40%,PSMB6;PSMB8;NFYB;PSMA3;NQO1;PSMA5;PSMC3;DHCR7;PSAP;PSMA7;PSMC6;FASN;GPS2;AZIN1;PSME1;PSMD12;PSMB2;SQLE
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.2605233638236836,0.5536728963186882,0.9411764705882353,1.0,1.0,3/12,20.59%,MAPK8;STIM1;CACNA1D
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.2752507272791332,-0.5536098829146364,0.9852941176470589,1.0,1.0,6/27,30.28%,CDKN1B;EIF4A2;PRDX3;PHPT1;INPP5K;PARK7
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.34813338613847816,-0.5534478691959308,0.9516129032258065,1.0,1.0,1/7,17.97%,ULK1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.32594531731256265,-0.5528753043539606,0.9473684210526315,1.0,1.0,2/8,22.13%,CMPK2;AK4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2544054054960353,-0.5526848081231893,1.0,1.0,1.0,4/51,16.54%,PATL2;DCP2;CNOT11;EXOSC6
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.36263232110533494,-0.551637924955388,0.9565217391304348,1.0,1.0,4/6,31.80%,AQP9;SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2596932611794318,-0.5515561363459112,1.0,1.0,1.0,5/33,17.38%,CAMLG;UCHL5;RPS7;RPL5;MAP1A
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.3393728205829194,0.5509679235117471,0.9736842105263158,1.0,1.0,1/5,8.43%,APOE
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.2719088198226236,-0.5506527511860166,0.9821428571428571,1.0,1.0,7/29,26.21%,CCL5;SCIMP;GBP5;ZCCHC3;POLR3G;GRN;LY86
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.3078219957498266,0.5506266948128825,0.9714285714285714,1.0,1.0,3/7,20.44%,HMGA2;ITGA8;ITGB1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.34644478063540085,0.5499898271606841,0.9230769230769231,1.0,1.0,5/5,65.36%,NAA15;NAA20;NAA25;NAA16;NAA30
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.36347182239049447,-0.5497909943069221,0.9523809523809523,1.0,1.0,2/5,24.80%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3095476242279868,-0.5496882375387444,0.9846153846153847,1.0,1.0,3/15,21.02%,CAV3;TCAF2;HECW1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.263678629615761,0.5495877474891186,1.0,1.0,1.0,1/23,2.99%,QRICH2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.3533095686080236,-0.549567632076901,0.9701492537313433,1.0,1.0,1/6,14.86%,IL18
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.2570737314624686,-0.549380737009066,1.0,1.0,1.0,8/39,25.93%,DCP2;RNASET2;NCBP1;ISG20;SUPV3L1;RNASEH2C;METTL3;NUDT12
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.3779010299431408,-0.5489752208238882,0.9615384615384616,1.0,1.0,1/5,5.91%,P2RY12
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.28969291417636694,-0.5486239152458011,1.0,1.0,1.0,4/27,15.96%,RAC1;DOCK1;ADGRB1;ARHGAP12
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.3077255451201441,-0.5485495483080052,0.96875,1.0,1.0,4/12,29.75%,CTSH;BRD8;KLF9;RDX
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.37260801027579654,-0.5479807072088221,0.9841269841269841,1.0,1.0,1/5,22.82%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.37260801027579654,-0.5479807072088221,0.9841269841269841,1.0,1.0,1/5,22.82%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.37260801027579654,-0.5479807072088221,0.9841269841269841,1.0,1.0,1/5,22.82%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.37260801027579654,-0.5479807072088221,0.9841269841269841,1.0,1.0,1/5,22.82%,EXOSC8
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.22186002495586138,0.5474632560443969,1.0,1.0,1.0,6/40,13.05%,NRXN1;LIN7A;SYN3;SYN2;SYT1;PPFIA3
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.30116007153010227,0.5470785386494219,0.9767441860465116,1.0,1.0,9/9,69.90%,HMGCLL1;OXCT1;SLC27A5;BDH1;ACSS3;BDH2;AACS;HMGCL;ACAT1
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.3479477674320366,-0.5468723595414308,0.9841269841269841,1.0,1.0,2/6,15.47%,RBP2;RLBP1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.337353818192209,0.5454113957817709,0.9705882352941176,1.0,1.0,2/7,10.61%,BMP7;TOM1L2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.21120796778267983,-0.5449348434478455,1.0,1.0,1.0,34/189,26.28%,ENC1;PSMB6;IFI27;PSMB8;ERLEC1;RCN3;PSMA3;KBTBD6;SIAH1;KIF14;PRPF19;PSMA5;PSMC3;PSMA7;PSMC6;SYVN1;PSME1;CCDC47;RBX1;PRAME;PSMD12;PSMB2;HECW1;RNF187;RNF122;RNF34;SPSB1;KCTD2;CRBN;KAT5;PLAA;PSMD2;TNFAIP1;MARCHF6
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.3644637573441115,-0.5448695580071917,0.9841269841269841,1.0,1.0,1/5,8.64%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.3644637573441115,-0.5448695580071917,0.9841269841269841,1.0,1.0,1/5,8.64%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3054018742740469,-0.5448250860400157,0.9827586206896551,1.0,1.0,2/13,17.82%,APOD;CUEDC2
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.28094041316485113,-0.5445185925569433,0.9838709677419355,1.0,1.0,4/20,23.88%,GAR1;DIMT1;NAT10;NOP10
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3358954228821224,0.5444959963152359,0.9534883720930233,1.0,1.0,4/8,26.51%,PLXNA2;PLXNC1;PLXNA1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.3029819995398186,-0.5441063654235335,0.9682539682539683,1.0,1.0,3/15,17.85%,MEST;NFKBIA;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.31283178840228093,-0.543960018672503,0.9666666666666667,1.0,1.0,1/11,20.01%,ZNF304
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.29174080673022007,-0.5437957766867413,0.9558823529411765,1.0,1.0,2/13,16.81%,HAT1;HMGB3
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.2611605921076946,-0.5437257188792927,1.0,1.0,1.0,3/25,20.46%,CCDC39;WNT7B;SHH
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.30007398835478705,0.5436412005620697,1.0,1.0,1.0,6/11,26.69%,LCMT1;TTL;AGBL1;ICMT;ATG7;AGBL4
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.26497246517960227,-0.5418655571795961,0.9857142857142858,1.0,1.0,6/32,19.46%,CDC6;PRPF19;CHEK1;RAD9B;DONSON;RAD1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.3454994927969448,-0.540632553870829,0.9838709677419355,1.0,1.0,2/7,24.02%,RPS15;RAN
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.31698952108299033,0.540527233099314,0.9117647058823529,1.0,1.0,1/9,12.88%,HMGA2
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.30784488617455197,-0.5404125288314501,0.95,1.0,1.0,5/14,31.38%,RAB11A;ARL6;BBS7;RAB17;MKKS
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.30784488617455197,-0.5404125288314501,0.95,1.0,1.0,5/14,31.38%,RAB11A;ARL6;BBS7;RAB17;MKKS
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.29931224209078405,0.5400445490526886,0.9318181818181818,1.0,1.0,8/8,70.08%,PPARA;HDAC4;FBP1;NCOR1;GIT1;PFKFB1;CBFA2T3;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.29931224209078405,0.5400445490526886,0.9318181818181818,1.0,1.0,8/8,70.08%,PPARA;HDAC4;FBP1;NCOR1;GIT1;PFKFB1;CBFA2T3;NUPR1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.274277854195323,0.5396043717099934,0.9444444444444444,1.0,1.0,8/8,72.58%,KYAT3;KYNU;AADAT;KYAT1;KMO;IDO1;AFMID;TDO2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.27649933018236056,-0.5393930821916467,0.9701492537313433,1.0,1.0,4/20,19.27%,MPV17L2;RCC1L;C1QBP;FASTKD3
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.3461237846439583,0.5390957520308237,0.9166666666666666,1.0,1.0,1/5,8.42%,SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.31493800512001535,-0.5382358375186693,1.0,1.0,1.0,3/10,23.01%,ADAM9;GPLD1;FURIN
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.2401665453016294,0.5382175288909222,1.0,1.0,1.0,7/66,12.24%,TLR1;TRAF3;HMGB1;TICAM1;S100A1;TAB3;TAB1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.2027906527424392,0.5376359347243115,1.0,1.0,1.0,22/85,22.88%,PCBP3;HSPA1A;SF3B4;EREG;U2AF2;CELF1;LSM10;PNPT1;SNRPG;PCF11;LSM6;SON;SCAF11;SRRM4;HSF1;SNRPE;DIS3L2;PTBP1;AURKAIP1;DDX5;SNRPB;SF3A2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.24045671551580877,-0.5375936240840066,1.0,1.0,1.0,9/37,26.10%,NCBP2;NUP85;XPOT;PHAX;NUP155;NUP188;RAN;SSB;NUP214
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.31557673044276646,0.5365889550908081,0.9354838709677419,1.0,1.0,3/6,20.36%,MBP;MAPK7;APOA1
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.31557673044276646,0.5365889550908081,0.9354838709677419,1.0,1.0,3/6,20.36%,MBP;MAPK7;APOA1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23921769261456088,0.5357610286410693,0.9743589743589743,1.0,1.0,11/30,24.77%,PATL1;EXOSC1;LSM6;DCP1B;DCPS;DIS3;EXOSC5;DIS3L2;EXOSC7;DCP1A;POLR2G
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.31952932926663125,0.5348816027911045,0.9230769230769231,1.0,1.0,1/5,14.57%,LCLAT1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.3708616333473246,0.5347720431650616,0.9375,1.0,1.0,1/5,12.41%,COQ2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.27014254930057785,0.5340218326781543,1.0,1.0,1.0,6/16,17.43%,CLN6;ST8SIA3;NEU3;ST6GALNAC4;ST8SIA4;ST8SIA2
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.3172500655567751,0.5335174168979878,0.9333333333333333,1.0,1.0,2/8,10.61%,BMP7;TOM1L2
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.27799890893323936,0.53337474455085,0.9210526315789473,1.0,1.0,3/9,24.04%,SLC6A1;CLN3;SHANK1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3055920482058817,-0.5333545728630891,0.9852941176470589,1.0,1.0,6/13,38.23%,MAGEF1;CIAO2A;ISCA2;CISD3;MMS19;GLRX3
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.2740397667005275,-0.5327095802126147,0.984375,1.0,1.0,8/19,26.73%,EIF2B2;EIF2B5;KHK;GCKR;GPLD1;SLC30A8;HNF4A;SELENOS
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.29826402326421336,0.5324980526803158,0.926829268292683,1.0,1.0,3/7,22.38%,MYOCD;MEF2C;DDX5
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.25324535311427065,-0.5314528543811591,1.0,1.0,1.0,11/32,32.36%,CAMLG;UCHL5;GABARAPL2;MAP1A;HSP90AB1;LAMP3;PARK7;PRKCG;AQP11;GIPC1;RPL11
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.30292771037600674,-0.5303168137468157,0.9838709677419355,1.0,1.0,1/13,15.74%,NEFL
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.3340067406889747,0.5299623820577085,0.9318181818181818,1.0,1.0,1/5,8.09%,RNF128
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.30284273269142603,0.529793455471811,0.9736842105263158,1.0,1.0,8/8,69.73%,MAPKAPK2;FOXP1;CX3CR1;ZFP36;SIRPA;CD47;CD274;PARK7
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.22838935560024293,0.5293671212348574,1.0,1.0,1.0,4/41,13.81%,NBDY;HSPA1A;RC3H1;PNPT1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.2858023468652135,0.528756952500572,0.918918918918919,1.0,1.0,1/9,7.88%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.2789942699896175,-0.5279399304903101,0.9846153846153847,1.0,1.0,7/14,35.69%,GHITM;GPX1;AKT1;HGF;PRELID1;CLU;PSMD10
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.24404874656768005,-0.527387329620392,1.0,1.0,1.0,3/43,11.34%,CHMP4B;RASA1;STMN1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.3164626598817219,0.526664097612747,0.8823529411764706,1.0,1.0,5/5,68.36%,CLN3;ATP2C1;CNST;ACSL3;RACK1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.2154833596733596,0.5263890617487795,1.0,1.0,1.0,6/35,16.20%,APOE;PTPRS;NRCAM;MAP3K13;SIN3A;RTN4R
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.26672258998610904,0.525957853441247,1.0,1.0,1.0,3/23,12.24%,TLR1;TAB3;TAB1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.34322257509449045,-0.5249825322397702,0.9855072463768116,1.0,1.0,1/5,15.18%,BRCA1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.3228253046364238,-0.5249817544970037,1.0,1.0,1.0,3/6,26.96%,PDGFRB;AAMP;CCN3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.24867774896108016,-0.5249631450617143,1.0,1.0,1.0,6/37,23.76%,TPX2;RAB11A;KIF11;MZT1;RACGAP1;ABRAXAS1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.3416430566919182,-0.5244768421345455,0.9347826086956522,1.0,1.0,1/6,18.91%,EMG1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.3465364690780728,0.522898783346505,0.9285714285714286,1.0,1.0,5/5,65.35%,HMGCLL1;MCCC2;MCCC1;HMGCL;IVD
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.3394014184715234,0.5227595573493347,0.9487179487179487,1.0,1.0,2/5,24.73%,TRIP11;TBC1D23
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.3053393763651266,0.522704916777097,0.9069767441860465,1.0,1.0,3/5,30.47%,DYRK3;KIF5B;VCP
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.34556236902476184,-0.5226738889872455,0.9655172413793104,1.0,1.0,3/6,29.40%,GBP5;USP50;CD36
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.2593030227594496,-0.522269570601399,1.0,1.0,1.0,5/19,22.62%,SKP1;RPS7;RPL5;RAB1A;RPL23
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.33010122160000877,-0.522133609923502,1.0,1.0,1.0,2/8,20.35%,IFI27;CFL1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.29683136402267113,0.5219999545749352,0.9142857142857143,1.0,1.0,2/8,11.89%,PDE4D;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.280013517537372,0.521041486397568,0.9722222222222222,1.0,1.0,1/9,8.43%,APOE
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.24584455997847005,-0.5208490090909567,1.0,1.0,1.0,6/47,19.23%,MBNL3;CELF3;REST;RNPS1;SAP18;RBM4
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.26959935556803816,-0.5199576269085031,1.0,1.0,1.0,7/24,22.90%,SOX10;PTPRZ1;GPC1;CDK5;EIF2B5;SHH;METRN
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.30791654473146995,-0.5194385646313341,1.0,1.0,1.0,4/11,29.75%,CTSH;BRD8;KLF9;RDX
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.2626586379357661,-0.5193770568015305,0.9855072463768116,1.0,1.0,3/25,16.05%,RAC1;CCL5;EIF6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),-0.334218757085575,-0.519331923828134,0.9838709677419355,1.0,1.0,2/7,22.57%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),-0.334218757085575,-0.519331923828134,0.9838709677419355,1.0,1.0,2/7,22.57%,ALYREF;THOC5
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.3024643556924158,-0.5187998434067741,0.967741935483871,1.0,1.0,1/9,8.90%,AGER
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.30396900372246505,-0.5179632740056286,0.9861111111111112,1.0,1.0,2/8,22.13%,CMPK2;AK4
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.35566250556069,-0.5175282428794853,0.9846153846153847,1.0,1.0,1/5,15.77%,NFKBIA
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.2596258099189335,0.5175124630351714,1.0,1.0,1.0,2/19,8.55%,CFLAR;PELI1
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.30011392295285183,0.5172566795710654,0.972972972972973,1.0,1.0,3/6,28.89%,FER;BLK;SYK
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.3486215448125872,-0.5165024361802126,1.0,1.0,1.0,2/5,25.71%,KIF5A;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.3486215448125872,-0.5165024361802126,1.0,1.0,1.0,2/5,25.71%,KIF5A;KIF17
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.25854540326836273,-0.5151387236300592,0.9857142857142858,1.0,1.0,7/23,31.16%,SLC4A9;HCN4;SLC30A8;SLC30A4;CAMK2D;FHL1;SLC4A8
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.2573057742779871,-0.5150721740057045,0.9811320754716981,1.0,1.0,15/25,36.08%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5PD;ATP5F1A;ATP5PB;ATP5ME;SPG7;MICOS13;LETM1;AFG3L2;APOO;ATP5F1B;ATP5MC1;IMMT
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.28623193326578056,0.5149008741739775,1.0,1.0,1.0,2/9,20.57%,IP6K1;IP6K2
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.3124099499557931,0.5147816908620475,0.9333333333333333,1.0,1.0,1/5,14.71%,TAPBP
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.3363156220350959,-0.5135599048835421,1.0,1.0,1.0,4/6,31.16%,GPER1;STX1B;BAIAP3;SLC4A8
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.3105388726352644,-0.513090081172518,0.9622641509433962,1.0,1.0,2/9,14.91%,DAB2IP;NEUROD2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.23476831231269402,-0.5126734361792494,1.0,1.0,1.0,6/54,22.17%,WIPI1;MAP1LC3B;RIPOR1;ULK1;LAMP2;RRAGA
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),-0.33216188223384346,-0.5123590366474653,0.9827586206896551,1.0,1.0,2/5,29.41%,IGSF3;SRP54
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.27709010781882687,-0.511282201240262,0.9692307692307692,1.0,1.0,1/15,14.69%,APOD
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.27709010781882687,-0.511282201240262,0.9692307692307692,1.0,1.0,1/15,14.69%,APOD
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.24385433865345818,0.5112023779947316,1.0,1.0,1.0,14/14,75.63%,MLYCD;NUDT7;ACACA;ACACB;ACSS1;HMGCS1;MVK;DIP2A;MVD;ACLY;PMVK;ACAT1;TDO2;PPCS
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.24136840456203162,-0.5109588159392597,0.984375,1.0,1.0,10/35,26.14%,DAB2IP;CBX5;CHEK1;BRCA1;CBX3;L3MBTL2;SUZ12;RBBP8;CDC7;FOXO4
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.30891252521547763,0.5108432935106,1.0,1.0,1.0,6/6,69.12%,YY1;POLH;WRN;BCL3;MAP3K4;IMPACT
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.23002586166290373,-0.5103560606870883,1.0,1.0,1.0,19/52,30.56%,TMEM97;MAP3K6;GNL3;PLK4;GRWD1;NOP56;SUPV3L1;CDK4;CBX3;HSPD1;PA2G4;IMP4;LAS1L;NIP7;MCM4;MRTO4;DDX18;NDUFAF4;AIMP2
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.3115088320884648,0.5103156042198055,0.9302325581395349,1.0,1.0,3/6,24.40%,ANGPT1;SH3GL2;VEGFA
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.24742268007842788,-0.5085418971252119,1.0,1.0,1.0,5/28,27.64%,LAMTOR2;LAMTOR5;RRAGA;GLRA1;LAMTOR3
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.29210694422147804,0.5082232844162438,0.9666666666666667,1.0,1.0,1/7,8.56%,PDPN
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.3186577676090897,-0.5069490936707861,0.9841269841269841,1.0,1.0,1/5,24.26%,BCAR3
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.3011462631820268,0.5068907103024443,1.0,1.0,1.0,8/8,69.90%,HMGCLL1;SLC27A5;BDH1;ACSS3;BDH2;AACS;HMGCL;ACAT1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.24605272291830382,0.50466260323397,0.972972972972973,1.0,1.0,3/19,14.69%,EIF2S1;BICD1;LSM14A
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.24414181833787235,0.5045646526310905,0.9772727272727273,1.0,1.0,4/15,22.67%,TELO2;PIP4P1;GPR137C;KLHL22
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.29628931836904765,-0.5042133113621808,0.9846153846153847,1.0,1.0,5/9,39.03%,METAP1D;NAA30;NAA16;NAA25;METAP1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.25842393573846023,0.5041621957120015,1.0,1.0,1.0,2/23,7.35%,PRR5L;EIF4EBP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.3283243114525987,0.5038238356899638,0.9444444444444444,1.0,1.0,1/6,13.75%,AKT2
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.29149077916315325,-0.5028147837770299,0.9322033898305084,1.0,1.0,1/7,10.96%,SPI1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2636224940720578,0.5026026355692856,1.0,1.0,1.0,2/13,15.67%,LIN28B;TARBP2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2275038736501526,0.5010983024616413,0.975,1.0,1.0,9/28,23.49%,PATL1;EXOSC1;LSM6;DCP1B;DCPS;DIS3;EXOSC5;EXOSC7;DCP1A
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.33432869596868187,0.4991090710435843,0.8780487804878049,1.0,1.0,3/5,26.00%,ATM;XRCC6;NIPBL
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.23549802980651496,-0.4986330773780459,1.0,1.0,1.0,10/37,26.14%,DAB2IP;CBX5;CHEK1;BRCA1;CBX3;L3MBTL2;SUZ12;RBBP8;CDC7;FOXO4
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.3172189034289814,0.49862322559787975,0.9777777777777777,1.0,1.0,1/5,8.56%,PDPN
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.2298295813067732,0.49860791791842296,1.0,1.0,1.0,3/24,15.04%,GNL3L;DACH1;TERF1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.20535201901430783,0.49812641796590984,1.0,1.0,1.0,5/51,12.76%,NUP210;NUP42;TPR;NUP37;TRIM71
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.20535201901430783,0.49812641796590984,1.0,1.0,1.0,5/51,12.76%,NUP210;NUP42;TPR;NUP37;TRIM71
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.3203135744739376,0.4973620787171057,0.9111111111111111,1.0,1.0,5/5,67.98%,COLGALT1;RB1;CHADL;AEBP1;EFEMP2
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.312880689903369,-0.49628079039916395,0.96875,1.0,1.0,2/6,23.87%,AQP9;SLC5A11
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.3478292555024103,0.4960438577119785,0.9361702127659575,1.0,1.0,1/5,13.89%,MMP24
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.20878145016764613,-0.49485646765395297,1.0,1.0,1.0,9/75,19.85%,FKBP4;RPA3;BAG4;DNAJC2;NUP85;HSPA1L;DNAJB1;HSPH1;NUP155
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.28464807197010944,-0.494448834102791,0.9629629629629629,1.0,1.0,2/8,16.78%,ADGRB1;FLOT1
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.2886942967174031,0.49430909984425064,0.9772727272727273,1.0,1.0,6/6,71.14%,GBF1;STX5;VRK1;PLK5;PLK3;GOLGA2
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.2966937221992939,0.49414441247674845,0.9565217391304348,1.0,1.0,11/11,70.35%,NEURL1;SYNGR1;DRD2;APP;NETO1;CAMK2B;SYP;NPTN;RAB5A;DLG4;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.250404153202169,-0.49370256053756373,1.0,1.0,1.0,2/22,15.40%,APOD;TLR2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.31109888598542146,0.49331348214834225,0.9361702127659575,1.0,1.0,5/5,68.90%,CTPS2;CAD;UMPS;DHODH;CTPS1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.20285398792843715,0.49300906854833504,1.0,1.0,1.0,6/61,16.23%,CDK2AP2;KIF13A;SIRT2;PRDM15;UVRAG;RAB11FIP3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.22060280552884015,0.492839458794079,0.967741935483871,1.0,1.0,4/17,20.60%,APOE;SCAP;ERLIN2;SREBF2
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.26567228992077785,0.4920111985045178,1.0,1.0,1.0,3/9,22.83%,MT1E;HSF1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.31369795963037295,-0.4916378145779652,0.9558823529411765,1.0,1.0,1/5,24.55%,ARL6IP5
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.25262161539692685,0.4915092668189483,0.9743589743589743,1.0,1.0,5/17,21.44%,AUTS2;MYB;DNMT1;CTNNB1;DNMT3B
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.31056749151797514,-0.49031629948576916,1.0,1.0,1.0,2/8,14.91%,DAB2IP;NEUROD2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.30933575165032845,-0.4893698721772424,1.0,1.0,1.0,1/6,18.99%,C1QBP
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.25202005210113315,-0.48766281535911055,0.9672131147540983,1.0,1.0,3/16,20.45%,TSPYL5;KDM1A;YAP1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.2977767183937147,-0.48744991358348294,0.984375,1.0,1.0,4/7,36.90%,GPS2;PLAA;DDX3X;PTPN22
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.25658171052711626,-0.48649656878872255,0.9857142857142858,1.0,1.0,4/19,18.07%,LPCAT4;LPCAT3;PLA2G10;MBOAT7
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.27066158104679533,0.4860554727796579,1.0,1.0,1.0,3/10,20.39%,SRM;PAH;TPH1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.2243124870993648,-0.48601963272117354,1.0,1.0,1.0,10/49,25.62%,MANBA;GCNT1;NGLY1;MAN1A1;MGAT4B;ADAMTS9;CNMD;AGA;MAN1B1;MGAT4A
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.25097251717456104,0.485239020137862,1.0,1.0,1.0,7/19,28.99%,PNKP;ATM;SMG6;TERF2;TNKS;HNRNPD;PRKCQ
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.3028420468170294,-0.4844803641332549,0.9545454545454546,1.0,1.0,2/6,35.91%,NOP10;METTL4
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.25907867689852765,0.4842757158595708,1.0,1.0,1.0,2/9,14.57%,PLA2G4C;LCLAT1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.3130243432815295,0.48339867786706053,1.0,1.0,1.0,5/5,68.70%,PPP5C;PPP1CA;MAPT;PLSCR1;PPP2CB
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2524589246644935,-0.48329552611155807,1.0,1.0,1.0,2/23,19.14%,DCP2;NAT10
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.31817542554557104,-0.4820520727559486,0.9365079365079365,1.0,1.0,4/6,30.81%,CALM3;CALM1;SRI;CAMK2D
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.3179490358412325,-0.4813410130138807,1.0,1.0,1.0,2/6,28.32%,CALM1;ATP2A2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.28012707837065737,-0.4803659407034365,1.0,1.0,1.0,3/12,24.02%,MBTPS2;LPCAT3;RAN
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.275816341976145,0.4800272753438867,1.0,1.0,1.0,2/8,20.83%,ABL2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.28675274935182965,0.4791217799622966,0.9743589743589743,1.0,1.0,3/5,20.74%,LRCH1;RIPOR2;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.28171663996934304,0.4788522903853547,1.0,1.0,1.0,2/8,14.74%,BACE2;ACOT8
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.19902338131920383,-0.4786982653884355,1.0,1.0,1.0,14/62,27.35%,TGFB1;POLR2J;POLR2K;NUP85;H3-3A;NUP155;FXR1;NUP188;POLR2I;POLR2B;AGO1;NUP214;POLR2D;DND1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.3057365992831017,-0.47820766233425405,1.0,1.0,1.0,1/6,18.26%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.2584008313461904,0.47633814442893524,1.0,1.0,1.0,6/9,29.78%,NR1H3;PPARA;ITGAV;NR1H2;PPARG;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.27473935217842654,0.4757920980379934,0.9523809523809523,1.0,1.0,3/9,22.38%,PIP4K2A;ELAPOR1;SH3GLB1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.2182136786660448,0.47524174637090344,0.9705882352941176,1.0,1.0,3/31,10.92%,HSPA1A;TPR;BAG3
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.23849756739966793,-0.4740627409907076,1.0,1.0,1.0,1/25,4.58%,CENPK
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.23316651173409053,0.47228736338590566,0.975,1.0,1.0,2/11,18.79%,UGGT2;AUP1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.2600833974927414,-0.47172122021086876,0.9811320754716981,1.0,1.0,4/13,27.66%,WAS;CD9;FBLN1;SP100
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.2631282616907968,-0.47166222369602256,1.0,1.0,1.0,1/12,7.39%,EPHB6
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.2888001086450897,-0.47153285681344603,0.967741935483871,1.0,1.0,1/6,15.73%,ITM2C
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.23542746723218078,-0.4712950982874372,1.0,1.0,1.0,3/26,20.44%,NODAL;H3-3A;KDM1A
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.30044392749926624,-0.4712235020734654,0.984375,1.0,1.0,2/5,33.74%,NPHP4;TMEM107
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.31256590106817045,0.47118059694306624,1.0,1.0,1.0,5/5,68.75%,WDR70;RNF40;CDK9;RNF20;CTR9
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.27620621501403436,0.47082055836410447,1.0,1.0,1.0,4/10,21.44%,MYB;SIRT1;DNMT1;DNMT3B
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.2861731327472183,-0.4707938683375208,0.9672131147540983,1.0,1.0,2/8,27.41%,BRCA1;UBE2S
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.2545629643217463,0.47044830606530064,1.0,1.0,1.0,12/12,74.56%,MTM1;TRAK2;TRAK1;MAPT;MEF2A;CLUH;ATCAY;HAP1;MSTO1;LRRK2;ARMC1;DNM1L
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.2495507849647398,0.469925775856294,0.972972972972973,1.0,1.0,2/11,15.68%,MT1E;ZNF658
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.2805536175472788,-0.46943693497980543,0.9672131147540983,1.0,1.0,4/9,34.16%,BRCA1;CCNF;CENATAC;TRIM37
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.3047265392197313,-0.46895859395924105,1.0,1.0,1.0,5/5,69.54%,VCPIP1;TRAIP;TEX264;SPRTN;VCP
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3088983633612982,0.46889710394587325,0.9787234042553191,1.0,1.0,5/5,69.12%,NCK1;EIF4G1;EIF2AK4;DDX3X;IMPACT
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.3178369802553215,0.4685147149786981,1.0,1.0,1.0,1/5,10.47%,UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.2939905263766509,-0.46697095748569467,0.9803921568627451,1.0,1.0,1/7,18.46%,ZCCHC3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.26742409095461334,-0.46684640328073285,1.0,1.0,1.0,4/12,23.16%,BRCA1;WDR5;KDM1A;JARID2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.24259578988263944,0.46660138076584506,1.0,1.0,1.0,4/10,19.03%,HR;KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.23185260367874622,0.46654657260669596,0.972972972972973,1.0,1.0,4/16,17.55%,SLC6A13;SLC6A1;SLC1A2;SLC1A6
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.22342983344747971,-0.466094217259921,1.0,1.0,1.0,8/35,28.49%,IARS2;MRPS14;MRPL51;MRPS34;MRPL16;TFAM;TWNK;GFM2
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.28711621819890465,-0.46609142860206587,0.9838709677419355,1.0,1.0,2/6,28.00%,NUP155;LDB1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.2771081042482995,0.46539478551107794,0.9714285714285714,1.0,1.0,3/7,25.52%,CHP1;FKTN;ABCA2
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.26272982012923185,-0.4636104353454512,1.0,1.0,1.0,3/14,19.69%,DDX54;ESR2;ESR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.2672840638180818,0.4625588821908863,1.0,1.0,1.0,6/6,73.28%,CXCL12;MERTK;GAS6;HCLS1;AXL;SELENOS
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.2673330887747616,0.46179910890677256,1.0,1.0,1.0,10/10,73.28%,SIRT7;ZNF692;DGKQ;GNMT;OGT;FBP1;PDK2;USP7;SDHAF3;SELENOS
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.28319273794241706,0.46147932465926206,0.9534883720930233,1.0,1.0,6/6,71.69%,ANK2;RYR1;NOL3;RYR2;TRDN;ATP2A2
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.26840382194114454,-0.46145311367572395,0.9864864864864865,1.0,1.0,3/15,33.73%,WDR5;KANSL2;KANSL1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.26840382194114454,-0.46145311367572395,0.9864864864864865,1.0,1.0,3/15,33.73%,WDR5;KANSL2;KANSL1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),0.27317599162973355,0.461105850205741,0.967741935483871,1.0,1.0,1/7,8.56%,PDPN
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.23384202943440963,0.46099587250914276,1.0,1.0,1.0,2/19,12.61%,MOV10L1;CELF1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.22332430828246844,-0.46098533359761107,1.0,1.0,1.0,9/35,30.42%,MYO5B;MYO1F;SYT4;RAB1A;NDEL1;KIF1A;MYO15A;CCDC186;MYO7B
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.2612781954887217,0.46045173110001064,0.975609756097561,1.0,1.0,6/6,73.88%,SNCA;PRKN;MT3;HDAC6;ETFBKMT;OXA1L
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.25265957446808524,0.46036870135035374,0.9772727272727273,1.0,1.0,10/10,74.75%,PSMG2;PSMD13;OTUD6B;PSMD11;PSMD5;PSMD10;PSMD4;POMP;ADRM1;PSMG1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.2973671071699696,-0.4578513103630798,1.0,1.0,1.0,2/6,22.68%,REST;DKK3
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.30142637675533657,0.45749234813585027,0.9591836734693877,1.0,1.0,1/5,11.33%,RPEL1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.2988697634408354,-0.45748244323147547,0.9666666666666667,1.0,1.0,2/7,24.70%,SUPV3L1;TRMT10B
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.26084084168442123,-0.45680444862635405,0.9848484848484849,1.0,1.0,1/13,9.34%,IGFBP5
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.29802701854819214,-0.4567662391965527,1.0,1.0,1.0,2/7,22.38%,INHBA;LHX6
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.26219224553858017,0.4556679643221102,1.0,1.0,1.0,2/8,20.53%,ESPL1;CTNNB1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.24066428112670882,0.45368000124931424,1.0,1.0,1.0,20/20,75.96%,ICE1;ZNF345;RPTOR;ICE2;POLR3F;POLR3C;BRF2;MAF1;MTOR;PRDX5;CHD8;DHX36;TENM1;ZNF76;ZC3H8;ZNF143;ELL;NAB2;AR;POLR3G
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.2825777755904529,-0.4534499615705164,1.0,1.0,1.0,3/7,33.83%,DNM1L;MIEF2;DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.2825777755904529,-0.4534499615705164,1.0,1.0,1.0,3/7,33.83%,DNM1L;MIEF2;DNM1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.28992890211383426,-0.4530241033090728,0.9655172413793104,1.0,1.0,1/5,18.07%,MBOAT7
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.28214855663643645,-0.45207458996928396,0.9836065573770492,1.0,1.0,1/5,22.48%,AMDHD1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.28214855663643645,-0.45207458996928396,0.9836065573770492,1.0,1.0,1/5,22.48%,AMDHD1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.2686954799458139,-0.45167004068904204,0.9836065573770492,1.0,1.0,3/12,17.85%,LPCAT4;LPCAT3;PLA2G10
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.2791765006187823,0.45065177936096323,1.0,1.0,1.0,3/7,28.89%,FER;BLK;SYK
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.2515251865807656,-0.45061094157266557,0.9838709677419355,1.0,1.0,5/17,29.82%,VIL1;VILL;EPS8;TWF2;FLII
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.2515251865807656,-0.45061094157266557,0.9838709677419355,1.0,1.0,5/17,29.82%,VIL1;VILL;EPS8;TWF2;FLII
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.2684856808835514,-0.45003431905793806,1.0,1.0,1.0,3/8,32.53%,TPM1;SRI;ANXA6
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.20682694072306854,0.4490991063525004,1.0,1.0,1.0,22/22,79.34%,KIF13A;DYNC1I1;TRAK2;CLN3;BICDL1;TRAK1;KIF5B;KIFAP3;NDE1;KIF3B;HTT;DYNC1H1;FBXW11;HAP1;PAFAH1B1;FYCO1;KIF1C;KIF1A;KIF5A;NDEL1;RAB1A;KIF3A
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.2572222532482451,-0.4478317013149047,1.0,1.0,1.0,1/11,15.74%,NEFL
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.23738388844323757,0.4468002314748649,1.0,1.0,1.0,5/13,26.83%,SLC8A1;SPIDR;CASP7;RYR1;RAD51
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.19606693114728835,0.44587836122779007,1.0,1.0,1.0,4/23,18.79%,ZER1;UGGT2;FBXL17;AUP1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.2584751178760196,-0.44564806168054866,0.9857142857142858,1.0,1.0,5/9,38.39%,PPCS;ACAT1;PDHB;PDHA1;ACLY
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.21767326093856013,0.4443917593534237,1.0,1.0,1.0,5/19,18.60%,ST8SIA3;GANC;ST8SIA4;ST8SIA2;PRKCSH
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.28441520325879877,-0.4435164671004368,1.0,1.0,1.0,1/6,27.15%,TMED10
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.28441520325879877,-0.4435164671004368,1.0,1.0,1.0,1/6,27.15%,TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.28441520325879877,-0.4435164671004368,1.0,1.0,1.0,1/6,27.15%,TMED10
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.2637659896382559,0.4431913107745397,0.975609756097561,1.0,1.0,7/7,73.63%,TERF1;TERF2;WRN;POT1;SLX4;RECQL4;BLM
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.2637780834479597,0.4428891212316942,1.0,1.0,1.0,8/8,73.63%,TERF1;TERF2;XRCC3;WRN;POT1;SLX4;RECQL4;BLM
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.22390387084938548,0.4427040875706939,1.0,1.0,1.0,14/14,77.62%,SCAP;MIA3;SEC23B;SEC31B;SEC24C;TBC1D20;SEC13;SEC24D;SEC24A;SAR1A;SEC24B;SEC31A;SEC23A;RAB1A
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.22216234971810445,0.44087258836222204,1.0,1.0,1.0,4/19,21.84%,NLGN1;RAP1A;RIMS2;VPS18
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.24644946910841753,0.4403677995308547,1.0,1.0,1.0,2/9,19.42%,FGF10;MAP4K4
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.22785364970699723,-0.43996896656359596,1.0,1.0,1.0,3/21,20.45%,TSPYL5;KDM1A;YAP1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.2337155097219479,-0.43946139934751577,1.0,1.0,1.0,9/24,33.99%,RBX1;RPS27A;UBC;CETN2;RNF111;XPC;UBA52;RAD23B;UBB
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.2334528193581343,0.43878264206563417,1.0,1.0,1.0,1/16,5.78%,MEIS1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.22613860481087295,0.4366372828763877,1.0,1.0,1.0,4/8,27.55%,PLIN5;NFKB1;C3;LPL
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.2121279946094317,-0.43551172272565747,1.0,1.0,1.0,5/26,33.37%,BTBD18;RNF168;LDB1;EAF1;RNF8
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.20169332404500515,-0.4353576207123544,1.0,1.0,1.0,6/37,27.64%,NCKAP1L;LAMTOR2;LAMTOR5;RRAGA;HTR6;LAMTOR3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.24777803498540885,-0.43525777721241155,0.9672131147540983,1.0,1.0,1/12,9.79%,SPTLC3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.24777803498540885,-0.43525777721241155,0.9672131147540983,1.0,1.0,1/12,9.79%,SPTLC3
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.23403182172497605,0.4350854042008702,1.0,1.0,1.0,9/9,76.61%,LCLAT1;PGS1;HADHB;HADHA;TAMM41;PNPLA8;PLA2G6;PLA2G4A;SLC27A1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.22971914646602154,0.4330329482466773,1.0,1.0,1.0,1/23,4.19%,ACADVL
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.28183646487813097,0.4324163436259579,0.9736842105263158,1.0,1.0,2/5,24.39%,PIGU;PGAP1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.22502486235355512,0.42979840325013907,1.0,1.0,1.0,1/12,8.43%,APOE
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.2092864178485261,0.4289819249284891,1.0,1.0,1.0,3/14,15.60%,TRAP1;PNPT1;IDE
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.22674361980718388,-0.4279328309810396,1.0,1.0,1.0,2/18,22.34%,BRCA1;NOS1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.2940906798698025,0.4276487752166267,1.0,1.0,1.0,5/5,70.60%,ZFAND2B;SEC61A2;SEC61A1;SEC61B;SRP54
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.27562299768762,-0.4267653834538403,0.984375,1.0,1.0,3/6,28.45%,DNAJC19;SHH;PTPN11
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.25797922201275625,-0.4239824114534786,1.0,1.0,1.0,3/10,28.43%,SLC25A18;ARL6IP5;PRAF2
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.20298128047486658,-0.42376397498080465,1.0,1.0,1.0,4/32,22.17%,SESN3;RNF152;LAMTOR5;RRAGA
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.22532021005971192,0.42373398536471385,1.0,1.0,1.0,4/10,21.89%,LRCH1;RIPOR2;CD200R1;MIA3
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.22778090997842435,-0.42326687927239837,1.0,1.0,1.0,8/14,37.88%,WDR12;RPF2;RPL35;RPL7L1;DDX18;FTSJ3;NIFK;RPL7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.22637138081856495,-0.42283381590171315,0.984375,1.0,1.0,8/20,33.99%,RBX1;RPS27A;UBC;CETN2;XPC;UBA52;RAD23B;UBB
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.27922240281079447,-0.4225312720604421,1.0,1.0,1.0,1/5,19.00%,SUPV3L1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.22710387525796796,0.41910397379841813,1.0,1.0,1.0,13/13,77.30%,PNKP;TNKS;HNRNPD;PRKCQ;NABP2;MAP2K7;MAPK1;MAP3K4;MAPK3;NEK7;TNKS2;MAPKAPK5;PKIB
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.2505157947824493,0.41889483108614484,1.0,1.0,1.0,7/7,74.96%,TARBP2;AGO2;ADAR;AGO3;DICER1;AGO4;AGO1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.1861105294609688,0.41756757723853666,1.0,1.0,1.0,4/32,17.29%,BLOC1S4;AP3B2;SPAST;TMEM108
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.24954026657208989,-0.41745735467269346,0.9821428571428571,1.0,1.0,2/7,35.35%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.2479913641550483,-0.4172497392164459,1.0,1.0,1.0,1/6,21.49%,USP1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.20046396038349945,-0.41645571165859124,1.0,1.0,1.0,7/27,32.67%,MRE11;GNL3;PKIB;MAPKAPK5;RAD50;TNKS2;SLX4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.24402879017099893,0.4159428519648191,1.0,1.0,1.0,5/5,75.60%,WNT5A;MAPT;NLGN2;DVL1;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.2654688641365206,-0.4108050420978834,1.0,1.0,1.0,3/5,36.69%,CLCN3;SHANK3;KCNMA1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.2439273228150961,-0.4107060176719869,1.0,1.0,1.0,1/8,19.20%,RBX1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.2690810322106538,-0.4080998355173184,1.0,1.0,1.0,2/5,31.81%,ZNF304;MTF2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.22451973774700834,0.40529733908534266,1.0,1.0,1.0,7/7,77.56%,ANK3;SNCA;FBP1;THBS1;SLC41A1;D2HGDH;RYR3
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.2584260227122294,-0.4051826542333257,1.0,1.0,1.0,1/5,18.60%,KCNE3
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.2513692651897662,0.4037411269135181,0.9791666666666666,1.0,1.0,3/6,26.20%,MAP10;AURKC;KIF23
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.2513692651897662,0.4037411269135181,0.9791666666666666,1.0,1.0,3/6,26.20%,MAP10;AURKC;KIF23
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.2554098750289816,0.39814199725687716,1.0,1.0,1.0,1/5,12.77%,CHP1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.22069882611885544,0.3979654244861803,1.0,1.0,1.0,10/10,77.94%,XPO5;STAT3;WTIP;ZFP36;DHX9;PUM2;PUM1;FMR1;LIMD1;FXR1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.24972889221025849,-0.39719775652057837,1.0,1.0,1.0,1/7,17.79%,TMEM79
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.1992472687172796,0.3946864473668831,1.0,1.0,1.0,6/24,22.18%,LIN28B;DIS3;EXOSC5;DIS3L2;EXOSC7;MTREX
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.248949515904283,-0.38862763726743466,1.0,1.0,1.0,1/6,22.61%,LYN
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.1966071374174814,0.38846378411778737,1.0,1.0,1.0,6/17,26.81%,SLC25A1;FITM2;ACACA;FAR2;HSD17B4;GCDH
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.21282991798077194,-0.38339929134337947,1.0,1.0,1.0,1/11,15.73%,ITM2C
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.23106546854942234,0.37404017017549035,1.0,1.0,1.0,6/6,76.90%,DNMT1;ZNF445;UHRF2;HELLS;USP7;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.20751010744942705,0.3702192972283259,1.0,1.0,1.0,3/11,22.38%,PIP4K2A;ELAPOR1;SH3GLB1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.1971539238056167,-0.36737623955389054,1.0,1.0,1.0,4/16,36.16%,DIMT1;UTP15;TRMT112;HEATR1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.20534690695648186,-0.3647584081996341,1.0,1.0,1.0,11/11,79.48%,KDM1A;CX3CL1;DCT;ZNF335;FZD3;CX3CR1;DRD2;SMARCD3;VEGFA;DISC1;CTNNB1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.20301519271562085,-0.35918886553042784,1.0,1.0,1.0,8/14,38.39%,FASN;PPCS;PPT1;ACAT1;CBR4;SCD5;SCD;ACLY
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.19401151753530843,0.3497598206094596,1.0,0.9999118339574106,1.0,1/13,9.81%,VSTM5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.19311985622810512,-0.3399091981251847,1.0,1.0,1.0,5/14,36.18%,GNL3;PARK7;MUL1;PIAS3;ZMIZ1
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.19972246388152415,-0.3145953595116295,1.0,1.0,1.0,1/8,19.94%,CYP2E1
